[
    {
        "realidx": "10135926",
        "question": "Patients transported by helicopter often require advanced airway management. The purpose of this study was to determine whether or not the in-flight environment of air medical transport in a BO-105 helicopter impairs the ability of flight nurses to perform oral endotracheal intubation.\nThe study was conducted in an MBB BO-105 helicopter.\nFlight nurses performed three manikin intubations in each of the two study environments: on an emergency department stretcher and in-flight in the BO-105 helicopter.\nThe mean time required for in-flight intubation (25.9 +/- 10.9 seconds) was significantly longer than the corresponding time (13.2 +/- 2.8 seconds) required for intubation in the control setting (ANOVA, F = 38.7, p<.001). All intubations performed in the control setting were placed correctly in the trachea; there were two (6.7%) esophageal intubations in the in-flight setting. The difference in appropriate endotracheal intubation between the two settings was not significant (chi 2 = 0.3; p>0.05).\nIs oral endotracheal intubation efficacy impaired in the helicopter environment?",
        "answer": "yes",
        "answer_rationale": "Oral endotracheal intubation in the in-flight setting of the BO-105 helicopter takes approximately twice as long as intubation in a ground setting. The results support pre-flight intubation of patients who appear likely to require urgent intubation during air medical transport in the BO-105 helicopter.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Patients transported by helicopter often require advanced airway management. The purpose of this study was to determine whether or not the in-flight environment of air medical transport in a BO-105 helicopter impairs the ability of flight nurses to perform oral endotracheal intubation.\nThe study was conducted in an MBB BO-105 helicopter.\nFlight nurses performed three manikin intubations in each of the two study environments: on an emergency department stretcher and in-flight in the BO-105 helicopter.\nThe mean time required for in-flight intubation (25.9 +/- 10.9 seconds) was significantly longer than the",
        "q2": " corresponding time (13.2 +/- 2.8 seconds) required for intubation in the control setting (ANOVA, F = 38.7, p<.001). All intubations performed in the control setting were placed correctly in the trachea; there were two (6.7%) esophageal intubations in the in-flight setting. The difference in appropriate endotracheal intubation between the two settings was not significant (chi 2 = 0.3; p>0.05).\nIs oral endotracheal intubation efficacy impaired in the helicopter environment?",
        "generated_text": "time required for intubation on the stretcher (17.1 +/- 5.9 seconds; p < 0.001). The in-flight intubation success rate (83%) was significantly lower than the stretcher intubation success rate (97%; p < 0.001). The in-flight intubation success rate was significantly lower in the group of nurses with less than 1 year of flight experience (67%) compared with the group with greater than 1 year of flight experience (90%; p < 0.001). The in",
        "levenshtein_distance": 354
    },
    {
        "realidx": "10158597",
        "question": "To evaluate the effectiveness of the role of a discharge coordinator whose sole responsibility was to plan and coordinate the discharge of patients from medical wards.\nAn intervention study in which the quality of discharge planning was assessed before and after the introduction of a discharge coordinator. Patients were interviewed on the ward before discharge and seven to 10 days after being discharged home.\nThe three medical wards at the Homerton Hospital in Hackney, East London.\n600 randomly sampled adult patients admitted to the medical wards of the study hospital, who were resident in the district (but not in institutions), were under the care of physicians (excluding psychiatry), and were discharged home from one of the medical wards. The sampling was conducted in three study phases, over 18 months.\nPhase I comprised base line data collection; in phase II data were collected after the introduction of the district discharge planning policy and a discharge form (checklist) for all patients; in phase III data were collected after the introduction of the discharge coordinator.\nThe quality and out come of discharge planning. Readmission rates, duration of stay, appropriateness of days of care, patients' health and satisfaction, problems after discharge, and receipt of services.\nThe discharge coordinator resulted in an improved discharge planning process, and there was a reduction in problems experienced by patients after discharge, and in perceived need for medical and healthcare services. There was no evidence that the discharge coordinator resulted in a more timely or effective provision of community services after discharge, or that the appropriateness or efficiency of bed use was improved.\nDoes a dedicated discharge coordinator improve the quality of hospital discharge?",
        "answer": "yes",
        "answer_rationale": "The introduction of a discharge coordinator improved the quality of discharge planning, but at additional cost.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate the effectiveness of the role of a discharge coordinator whose sole responsibility was to plan and coordinate the discharge of patients from medical wards.\nAn intervention study in which the quality of discharge planning was assessed before and after the introduction of a discharge coordinator. Patients were interviewed on the ward before discharge and seven to 10 days after being discharged home.\nThe three medical wards at the Homerton Hospital in Hackney, East London.\n600 randomly sampled adult patients admitted to the medical wards of the study hospital, who were resident in the district (but not in institutions), were under the care of physicians (excluding psychiatry), and were discharged home from one of the medical wards. The sampling was conducted in three study phases, over 18 months.\nPhase I comprised base line data collection; in phase II",
        "q2": " data were collected after the introduction of the district discharge planning policy and a discharge form (checklist) for all patients; in phase III data were collected after the introduction of the discharge coordinator.\nThe quality and out come of discharge planning. Readmission rates, duration of stay, appropriateness of days of care, patients' health and satisfaction, problems after discharge, and receipt of services.\nThe discharge coordinator resulted in an improved discharge planning process, and there was a reduction in problems experienced by patients after discharge, and in perceived need for medical and healthcare services. There was no evidence that the discharge coordinator resulted in a more timely or effective provision of community services after discharge, or that the appropriateness or efficiency of bed use was improved.\nDoes a dedicated discharge coordinator improve the quality of hospital discharge?",
        "generated_text": "a discharge coordinator was introduced; and in phase III the discharge coordinator was withdrawn and data were collected again. The discharge coordinator was a senior nurse with a background in community nursing, who was responsible for planning and coordinating the discharge of patients from the medical wards. The coordinator worked with the medical and nursing staff, social workers, and community services to ensure that patients had appropriate follow-up care and support after discharge.\nThe primary outcome measures were the quality of discharge planning, as assessed by patient interviews before and after discharge, and the number of readmissions within 28 days of discharge. Secondary outcomes included patient satisfaction with discharge planning and the efficiency of the discharge process.\nThe study found that the introduction of a discharge coordinator significantly improved the quality of discharge planning, as measured by patient interviews. Patients reported",
        "levenshtein_distance": 701
    },
    {
        "realidx": "10173769",
        "question": "To consider whether the Barthel Index alone provides sufficient information about the long term outcome of stroke.\nCross sectional follow up study with a structured interview questionnaire and measures of impairment, disability, handicap, and general health. The scales used were the hospital anxiety and depression scale, mini mental state examination, Barthel index, modified Rankin scale, London handicap scale, Frenchay activities index, SF36, Nottingham health profile, life satisfaction index, and the caregiver strain index.\nSouth east London.\nPeople, and their identified carers, resident in south east London in 1989-90 when they had their first in a life-time stroke aged under 75 years.\nObservational study.\nComparison and correlation of the individual Barthel index scores with the scores on other outcome measures.\nOne hundred and twenty three (42%) people were known to be alive, of whom 106 (86%) were interviewed. The median age was 71 years (range 34-79). The mean interval between the stroke and follow up was 4.9 years. The rank correlation coefficients between the Barthel and the different dimensions of the SF36 ranged from r = 0.217 (with the role emotional dimension) to r = 0.810 (with the physical functioning dimension); with the Nottingham health profile the range was r = -0.189 (with the sleep dimension, NS) to r = -0.840 (with the physical mobility dimension); with the hospital and anxiety scale depression component the coefficient was r = -0.563, with the life satisfaction index r = 0.361, with the London handicap scale r = 0.726 and with the Frenchay activities index r = 0.826.\nLonger term quality of life and outcome in stroke patients: is the Barthel index alone an adequate measure of outcome?",
        "answer": "yes",
        "answer_rationale": "The place of the Barthel index as the standard outcome measure for populations of stroke patients is still justified for long term follow up, and may be a proxy for different outcome measures intended for the assessment of other domains.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To consider whether the Barthel Index alone provides sufficient information about the long term outcome of stroke.\nCross sectional follow up study with a structured interview questionnaire and measures of impairment, disability, handicap, and general health. The scales used were the hospital anxiety and depression scale, mini mental state examination, Barthel index, modified Rankin scale, London handicap scale, Frenchay activities index, SF36, Nottingham health profile, life satisfaction index, and the caregiver strain index.\nSouth east London.\nPeople, and their identified carers, resident in south east London in 1989-90 when they had their first in a life-time stroke aged under 75 years.\nObservational study.\nComparison and correlation of the individual Barthel index scores with the scores on other outcome measures.\nOne hundred and twenty three (42%) people were known to be alive, of whom 106 (86%) were interviewed. The median age was 71",
        "q2": " years (range 34-79). The mean interval between the stroke and follow up was 4.9 years. The rank correlation coefficients between the Barthel and the different dimensions of the SF36 ranged from r = 0.217 (with the role emotional dimension) to r = 0.810 (with the physical functioning dimension); with the Nottingham health profile the range was r = -0.189 (with the sleep dimension, NS) to r = -0.840 (with the physical mobility dimension); with the hospital and anxiety scale depression component the coefficient was r = -0.563, with the life satisfaction index r = 0.361, with the London handicap scale r = 0.726 and with the Frenchay activities index r = 0.826.\nLonger term quality of life and outcome in stroke patients: is the Barthel index alone an adequate measure of outcome?",
        "generated_text": "years (range 30-74), and 58 (55%) were men. The median time since stroke was 10.5 years (range 9-12). The median Barthel index score was 95 (range 0-100). The Barthel index was significantly correlated with the modified Rankin scale (r=0.72), the London handicap scale (r=0.64), the Frenchay activities index (r=0.61), the Nottingham health profile (r=0.54), the SF36 (r=0.48), the caregiver strain index (r=0.44), the life satisfaction index (r=0.41), and the hospital anxiety and depression scale (r=0.34). The Barthel index was not significantly correlated with the mini mental state examination (",
        "levenshtein_distance": 536
    },
    {
        "realidx": "10201555",
        "question": "Serum chloride level is routinely assayed in clinical laboratories in the management of patients with kidney disorders and with metabolic diseases. It is a biological parameter that is easily, precisely and relatively cheaply measured. The epidemiological features of serum chloride levels have not been studied before.\nFor the random sample of men and women from the Belgian Interuniversity Research on Nutrition and Health aged 25-74 years, free of symptomatic coronary heart disease at baseline, serum chloride concentrations were measured, among those of other electrolytes. The cohort was followed up for 10 years with respect to subsequent cause-specific mortality.\nThe results are based on observations of 4793 men and 4313 women. According to Cox regression analysis serum chloride level was one of the strongest predictors of total, cardiovascular disease (CVD) and non-CVD mortalities independently of age, body mass index, sex, smoking, systolic blood pressure, levels of total and high-density lipoprotein cholesterol, uric acid, serum creatinine and serum total proteins and intake of diuretics. This relation was proved to be independent of levels of other serum electrolytes and similar for men and women. The estimated adjusted risk ratio for CVD death for subjects with a serum chloride level<or =100 mmol/l compared with those with levels above that limit was 1.65 (95% confidence interval 1.06-2.57) for men and 2.16 (95% confidence interval 1.11-4.22) for women. The study of adjusted risk ratios for four groups of subjects defined on the basis of their baseline serum chloride levels revealed a decreasing log-linear 'dose-response' relation to total and cardiovascular mortalities.\nIs low serum chloride level a risk factor for cardiovascular mortality?",
        "answer": "yes",
        "answer_rationale": "This s the first report from a population-based study to indicate that there is an association between serum chloride level and the incidence of total, CVD and non-CVD mortalities. The risk ratio for CVD mortality associated with a low serum chloride level was comparable to or higher than those observed for well-established CVD risk factors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Serum chloride level is routinely assayed in clinical laboratories in the management of patients with kidney disorders and with metabolic diseases. It is a biological parameter that is easily, precisely and relatively cheaply measured. The epidemiological features of serum chloride levels have not been studied before.\nFor the random sample of men and women from the Belgian Interuniversity Research on Nutrition and Health aged 25-74 years, free of symptomatic coronary heart disease at baseline, serum chloride concentrations were measured, among those of other electrolytes. The cohort was followed up for 10 years with respect to subsequent cause-specific mortality.\nThe results are based on observations of 4793 men and 4313 women. According to Cox regression analysis serum chloride level was one of the strongest predictors of total, cardiovascular disease (CVD) and non-CVD mortalities independently of age, body mass index, sex, smoking, syst",
        "q2": "olic blood pressure, levels of total and high-density lipoprotein cholesterol, uric acid, serum creatinine and serum total proteins and intake of diuretics. This relation was proved to be independent of levels of other serum electrolytes and similar for men and women. The estimated adjusted risk ratio for CVD death for subjects with a serum chloride level<or =100 mmol/l compared with those with levels above that limit was 1.65 (95% confidence interval 1.06-2.57) for men and 2.16 (95% confidence interval 1.11-4.22) for women. The study of adjusted risk ratios for four groups of subjects defined on the basis of their baseline serum chloride levels revealed a decreasing log-linear 'dose-response' relation to total and cardiovascular mortalities.\nIs low serum chloride level a risk factor for cardiovascular mortality?",
        "generated_text": "olic blood pressure, total cholesterol, high-density lipoprotein cholesterol, triglycerides, glucose, creatinine, sodium, potassium, calcium, magnesium, alcohol consumption, education, physical activity, energy intake, and dietary patterns. The hazard ratios (95% confidence intervals) for total mortality in the highest compared with the lowest quintile of serum chloride were 1.52 (1.24-1.86) in men and 1.51 (1.19-1.92) in women. The corresponding hazard ratios for CVD mortality were 1.51 (1.12-2.03) in men and 1.51 (1.05-2.17) in women, and for non-CVD mortality 1.53 (1.17-2.0",
        "levenshtein_distance": 561
    },
    {
        "realidx": "10223070",
        "question": "To critically assess the evidence that appendiceal perforation is a risk factor for subsequent tubal infertility or ectopic pregnancy.\nEpidemiologic studies investigating the relationship between appendectomy and infertility or ectopic pregnancy were identified by searching the MEDLINE database from 1966 to 1997. Appropriate citations were also extracted from a manual search of the bibliographies of selected papers.\nTwenty-three articles were retrieved. Only 4 presented original data including comparisons to a nonexposed control group and they form the basis for this study.\nBecause the raw data or specific techniques of data analysis were not always explicitly described, indices of risk for exposure were extracted from the data as presented and were analysed without attempting to convert them to a common measure.\nArticles were assessed according to the criteria of the Evidence-Based Medicine Working Group for evaluating articles on harm. Review of the literature yielded estimates of the risk of adverse fertility outcomes ranging from 1.6 (95% confidence interval [CI] 1.1 to 2.5) for ectopic pregnancy after an appendectomy to 4.8 (95% CI 1.5 to 14.9) for tubal infertility from perforation of the appendix. Recall bias, and poor adjustment for confounding variables in some reports, weakened the validity of the studies.\nIs perforation of the appendix a risk factor for tubal infertility and ectopic pregnancy?",
        "answer": "maybe",
        "answer_rationale": "The methodologic weaknesses of the studies do not permit acceptance of increased risk of tubal pregnancy or infertility as a consequence of perforation of the appendix, so a causal relationship cannot be supported by the data currently available. Only a well-designed case-control study with unbiased ascertainment of exposure and adjustment for confounding variables will provide a definitive answer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To critically assess the evidence that appendiceal perforation is a risk factor for subsequent tubal infertility or ectopic pregnancy.\nEpidemiologic studies investigating the relationship between appendectomy and infertility or ectopic pregnancy were identified by searching the MEDLINE database from 1966 to 1997. Appropriate citations were also extracted from a manual search of the bibliographies of selected papers.\nTwenty-three articles were retrieved. Only 4 presented original data including comparisons to a nonexposed control group and they form the basis for this study.\nBecause the raw data or specific techniques of data analysis were not always explicitly described, indices of risk for exposure were extracted from the data as presented and were analysed without attempting to",
        "q2": " convert them to a common measure.\nArticles were assessed according to the criteria of the Evidence-Based Medicine Working Group for evaluating articles on harm. Review of the literature yielded estimates of the risk of adverse fertility outcomes ranging from 1.6 (95% confidence interval [CI] 1.1 to 2.5) for ectopic pregnancy after an appendectomy to 4.8 (95% CI 1.5 to 14.9) for tubal infertility from perforation of the appendix. Recall bias, and poor adjustment for confounding variables in some reports, weakened the validity of the studies.\nIs perforation of the appendix a risk factor for tubal infertility and ectopic pregnancy?",
        "generated_text": "standardize for age or other confounding variables. The results of the 4 studies were combined using a random effects model.\nThe combined relative risk for tubal infertility was 1.4 (95% confidence interval [CI] 1.1-1.8), and for ectopic pregnancy 1.5 (95% CI 1.2-1.9). The relative risk for tubal infertility was higher in studies that adjusted for confounding variables (1.6 [95% CI 1.2-2.1]) than in those that did not (1.2 [95% CI 0.9-1.6]). The relative risk",
        "levenshtein_distance": 402
    },
    {
        "realidx": "10331115",
        "question": "All currently available atypical antipsychotics have, at clinically relevant doses: i) high serotonin (5-HT)2 occupancy; ii) greater 5-HT2 than dopamine (D)2 occupancy; and iii) a higher incidence of extrapyramidal side effects when their D2 occupancy exceeds 80%. A review of pharmacologic and behavioral data suggested that amoxapine should also conform to this profile; therefore, we undertook a positron-emission tomography (PET) study of its 5-HT2 and D2 occupancy.\nSeven healthy volunteers received 50-250 mg/day of amoxapine for 5 days and then had [11C]-raclopride and [18F]-setoperone PET scans.\n5-HT2 receptors showed near saturation at doses of 100 mg/day and above. The D2 receptor occupancies showed a dose-dependent increase, never exceeding 80%; at all doses 5-HT2 occupancy exceeded D2 occupancy.\nIs amoxapine an atypical antipsychotic?",
        "answer": "yes",
        "answer_rationale": "PET data show that amoxapine's profile is very similar to that of the established atypical antipsychotics. These data, together with amoxapine's in vitro pharmacologic profile, effectiveness in animal models, and efficacy in psychotic depression raise the possibility of amoxapine as an \"atypical\" antipsychotic agent in the treatment of schizophrenia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "All currently available atypical antipsychotics have, at clinically relevant doses: i) high serotonin (5-HT)2 occupancy; ii) greater 5-HT2 than dopamine (D)2 occupancy; and iii) a higher incidence of extrapyramidal side effects when their D2 occupancy exceeds 80%. A review of pharmacologic and behavioral data suggested that amoxapine should also conform to this profile; therefore, we undertook a positron-emission tomography (PET) study of its 5-HT",
        "q2": "2 and D2 occupancy.\nSeven healthy volunteers received 50-250 mg/day of amoxapine for 5 days and then had [11C]-raclopride and [18F]-setoperone PET scans.\n5-HT2 receptors showed near saturation at doses of 100 mg/day and above. The D2 receptor occupancies showed a dose-dependent increase, never exceeding 80%; at all doses 5-HT2 occupancy exceeded D2 occupancy.\nIs amoxapine an atypical antipsychotic?",
        "generated_text": "2 and D2 receptor occupancies in 10 healthy volunteers. Amoxapine was administered in a double-blind, placebo-controlled, crossover design in three doses: 25, 50, and 100 mg/day for 7 days. [11C]raclopride and [11C]MDL 100,907 were used as radioligands for D2 and 5-HT2 receptors, respectively. Amoxapine produced dose-related increases in plasma",
        "levenshtein_distance": 291
    },
    {
        "realidx": "10375486",
        "question": "to describe variation in utilisation of carotid endarterectomy (CEA) within two English health regions and explore relationships between use, need and proximity to services.\nconsecutive case series of operations. Comparison at a population level with district stroke mortality, hospital admissions and material deprivation.\nstandardised utilisation rates for CEA and measures of inter-district variability. Spearman's rank correlation coefficients for associations between variables.\nvariation in utilisation rates was considerable (14-fold difference across district populations). More individuals had bilateral surgery in the Yorkshire region than in the Northern (11.7% vs. 5.5%, p=0.002). There was no association between utilisation rates for CEA and district stroke mortality (r=-0.06, 95% CI -0.41 to 0.30) or admission rates for stroke (r=0.17, 95% CI -0.2 to 0.49). There was a strong relationship between residence in districts where services were located and higher utilisation. Rates of CEA were lowest in the regions' most affluent wards.\nAre variations in the use of carotid endarterectomy explained by population Need?",
        "answer": "no",
        "answer_rationale": "use of CEA varies widely, depending on area of residence. Variation is not a consequence of differences in need, but reflects clinical practice and supply of services. There is evidence to suggest unmet need for CEA.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "to describe variation in utilisation of carotid endarterectomy (CEA) within two English health regions and explore relationships between use, need and proximity to services.\nconsecutive case series of operations. Comparison at a population level with district stroke mortality, hospital admissions and material deprivation.\nstandardised utilisation rates for CEA and measures of inter-district variability. Spearman's rank correlation coefficients for associations between variables.\nvariation in utilisation rates was considerable (14-fold difference across district populations). More individuals had bilateral surgery in the Yorkshire region than in the Northern (11.7% vs. 5",
        "q2": ".5%, p=0.002). There was no association between utilisation rates for CEA and district stroke mortality (r=-0.06, 95% CI -0.41 to 0.30) or admission rates for stroke (r=0.17, 95% CI -0.2 to 0.49). There was a strong relationship between residence in districts where services were located and higher utilisation. Rates of CEA were lowest in the regions' most affluent wards.\nAre variations in the use of carotid endarterectomy explained by population Need?",
        "generated_text": ".3%, p < 0.001). There was no relationship between CEA utilisation and district stroke mortality, hospital admissions or deprivation. There was a significant relationship between CEA utilisation and distance to the nearest CEA centre (r = -0.52, p = 0.001).\nthere is considerable variation in CEA utilisation between districts. This variation is not related to need, but is related to distance to the nearest CEA centre.",
        "levenshtein_distance": 289
    },
    {
        "realidx": "10381996",
        "question": "To determine whether the use of empiric chest radiography (CXR) is of significant value in detecting clinically unsuspected acute chest syndrome (ACS) in febrile patients with sickle cell disease (SCD).\nPatients with SCD presenting to the emergency department and hematology clinic with temperature greater than or equal to 38 degrees C were prospectively evaluated using a physician-completed questionnaire. The questionnaire included inquiries into the patient's physical signs and symptoms and the physician's clinical impression for the presence of ACS. The questionnaire was completed before obtaining CXR results in all patients.\nSeventy-three patients with SCD with 96 febrile events were evaluated over a 1-year period. Twenty-four percent (23/96) of the patients had CXR evidence of ACS. On the basis of the questionnaire data, 61% (14/23) of ACS cases were not clinically suspected by the evaluating physician before obtaining CXR. Comparing the patients with and without ACS revealed that, with the exception of splinting (4/23 [17%] versus 0/73 [0%]), no symptom or physical examination finding helped to identify which patients had ACS. Fifty-seven percent of patients with ACS had completely normal findings on physical examination. The presentation of patients with clinically detected versus clinically unsuspected ACS also did not differ significantly. Length of hospitalization, oxygen use, and need for transfusion were the same in both the unsuspected and detected ACS groups. Overall physician sensitivity for predicting ACS was only 39%, and diagnostic accuracy did not improve significantly with increasing levels of pediatric training.\nClinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?",
        "answer": "no",
        "answer_rationale": "ACS is common in patients with SCD who present with fever and was grossly underestimated by evaluating physicians. History and physical examination appear to be of little value in defining which febrile patients require CXR. In view of the mortality and morbidity associated with ACS, empiric CXR should be considered when evaluating a febrile patient with SCD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine whether the use of empiric chest radiography (CXR) is of significant value in detecting clinically unsuspected acute chest syndrome (ACS) in febrile patients with sickle cell disease (SCD).\nPatients with SCD presenting to the emergency department and hematology clinic with temperature greater than or equal to 38 degrees C were prospectively evaluated using a physician-completed questionnaire. The questionnaire included inquiries into the patient's physical signs and symptoms and the physician's clinical impression for the presence of ACS. The questionnaire was completed before obtaining CXR results in all patients.\nSeventy-three patients with SCD with 96 febrile events were evaluated over a 1-year period. Twenty-four percent (23/96) of the patients had CXR evidence of ACS. On the basis of the questionnaire data, 61% (14/23",
        "q2": ") of ACS cases were not clinically suspected by the evaluating physician before obtaining CXR. Comparing the patients with and without ACS revealed that, with the exception of splinting (4/23 [17%] versus 0/73 [0%]), no symptom or physical examination finding helped to identify which patients had ACS. Fifty-seven percent of patients with ACS had completely normal findings on physical examination. The presentation of patients with clinically detected versus clinically unsuspected ACS also did not differ significantly. Length of hospitalization, oxygen use, and need for transfusion were the same in both the unsuspected and detected ACS groups. Overall physician sensitivity for predicting ACS was only 39%, and diagnostic accuracy did not improve significantly with increasing levels of pediatric training.\nClinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?",
        "generated_text": ") of the patients with ACS were clinically suspected of having ACS, whereas 39% (9/23) were not clinically suspected of having ACS. The sensitivity, specificity, positive predictive value, and negative predictive value of the questionnaire in detecting ACS were 61%, 94%, 82%, and 82%, respectively. The overall accuracy of the questionnaire in detecting ACS was 81%.\nThe use of empiric CXR in febrile patients with SCD is of significant value in detecting clinically unsuspected ACS. The use of empiric CXR should be considered in all febrile patients with SCD.",
        "levenshtein_distance": 674
    },
    {
        "realidx": "10401824",
        "question": "Laparoscopic techniques can be used to treat patients whose antireflux surgery has failed.\nCase series.\nTwo academic medical centers.\nForty-six consecutive patients, of whom 21 were male and 25 were female (mean age, 55.6 years; range, 15-80 years). Previous antireflux procedures were laparoscopic (21 patients), laparotomy (21 patients), thoracotomy (3 patients), and thoracoscopy (1 patient).\nThe cause of failure, operative and postoperative morbidity, and the level of follow-up satisfaction were determined for all patients.\nThe causes of failure were hiatal herniation (31 patients [67%]), fundoplication breakdown (20 patients [43%]), fundoplication slippage (9 patients [20%]), tight fundoplication (5 patients [11%]), misdiagnosed achalasia (2 patients [4%]), and displaced Angelchik prosthesis (2 patients [4%]). Twenty-two patients (48%) had more than 1 cause. Laparoscopic reoperative procedures were Nissen fundoplication (n = 22), Toupet fundoplication (n = 13), paraesophageal hernia repair (n = 4), Dor procedure (n = 2), Angelchik prosthesis removal (n = 2), Heller myotomy (n = 2), and the takedown of a wrap (n = 1). In addition, 18 patients required crural repair and 13 required paraesophageal hernia repair. The mean +/- SEM duration of surgery was 3.5+/-1.1 hours. Operative complications were fundus tear (n = 8), significant bleeding (n = 4), bougie perforation (n = 1), small bowel enterotomy (n = 1), and tension pneumothorax (n = 1). The conversion rate (from laparoscopic to an open procedure) was 20% overall (9 patients) but 0% in the last 10 patients. Mortality was 0%. The mean +/- SEM hospital stay was 2.3+/-0.9 days for operations completed laparoscopically. Follow-up was possible in 35 patients (76%) at 17.2+/-11.8 months. The well-being score (1 best; 10, worst) was 8.6+/-2.1 before and 2.9+/-2.4 after surgery (P<.001). Thirty-one (89%) of 35 patients were satisfied with their decision to have reoperation.\nIs laparoscopic reoperation for failed antireflux surgery feasible?",
        "answer": "yes",
        "answer_rationale": "Antireflux surgery failures are most commonly associated with hiatal herniation, followed by the breakdown of the fundoplication. The laparoscopic approach may be used successfully to treat patients with failed antireflux operations. Good results were achieved despite the technical difficulty of the procedures.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Laparoscopic techniques can be used to treat patients whose antireflux surgery has failed.\nCase series.\nTwo academic medical centers.\nForty-six consecutive patients, of whom 21 were male and 25 were female (mean age, 55.6 years; range, 15-80 years). Previous antireflux procedures were laparoscopic (21 patients), laparotomy (21 patients), thoracotomy (3 patients), and thoracoscopy (1 patient).\nThe cause of failure, operative and postoperative morbidity, and the level of follow-up satisfaction were determined for all patients.\nThe causes of failure were hiatal herniation (31 patients [67%]), fundoplication breakdown (20 patients [43%]), fundoplication slippage (9 patients [20%]), tight fundoplication (5 patients [11%]), misdiagnosed achalasia (2 patients [4%]), and displaced Angelchik prosthesis (2 patients [4%]). Twenty-two patients (48%) had more than 1 cause. Laparoscopic reoperative procedures were Nissen fundoplication (n = 22), Toupet fundoplication (n = 13), paraesophageal hernia repair (n = 4), Dor procedure (n = 2), Angelchik prosthesis removal (n = 2), Heller myotomy",
        "q2": " (n = 2), and the takedown of a wrap (n = 1). In addition, 18 patients required crural repair and 13 required paraesophageal hernia repair. The mean +/- SEM duration of surgery was 3.5+/-1.1 hours. Operative complications were fundus tear (n = 8), significant bleeding (n = 4), bougie perforation (n = 1), small bowel enterotomy (n = 1), and tension pneumothorax (n = 1). The conversion rate (from laparoscopic to an open procedure) was 20% overall (9 patients) but 0% in the last 10 patients. Mortality was 0%. The mean +/- SEM hospital stay was 2.3+/-0.9 days for operations completed laparoscopically. Follow-up was possible in 35 patients (76%) at 17.2+/-11.8 months. The well-being score (1 best; 10, worst) was 8.6+/-2.1 before and 2.9+/-2.4 after surgery (P<.001). Thirty-one (89%) of 35 patients were satisfied with their decision to have reoperation.\nIs laparoscopic reoperation for failed antireflux surgery feasible?",
        "generated_text": "(n = 2), and vagotomy (n = 1). The mean operative time was 155 minutes (range, 45-300 minutes). The mean estimated blood loss was 100 mL (range, 25-500 mL). There were no conversions to laparotomy. There were 2 minor complications (4%): 1 patient had a small subphrenic fluid collection that resolved with percutaneous drainage, and 1 patient had a small wound infection that resolved with antibiotics. The mean follow-up was 14 months (range, 6-36 months). Thirty-eight patients (83%) were satisfied with the results of the reoperative procedure, 7 patients (15%) were neutral, and 1 patient (2%) was dissatisfied.\nLaparoscopic reoperative antireflux surgery is feasible and safe in appropriately selected patients.",
        "levenshtein_distance": 674
    },
    {
        "realidx": "10456814",
        "question": "Although desflurane is commonly used to control surgically induced hypertension, its effects on left ventricular (LV) function have not been investigated in this clinical situation. The purpose of the present study was to evaluate the LV function response to desflurane, when used to control intraoperative hypertension.\nIn 50 patients, scheduled for vascular surgery, anesthesia was induced with sufentanil 0.5 microg/kg, midazolam 0.3 mg/kg and atracurium 0.5 mg/kg. After tracheal intubation, anesthesia was maintained with increments of drugs with controlled ventilation (N2O/O2=60/40%) until the start of surgery. A 5 Mhz transesophageal echocardiography (TEE) probe was inserted after intubation. Pulmonary artery catheter and TEE measurements were obtained after induction (to)(control value), at surgical incision (t1) if it was associated with an increase in systolic arterial pressure (SAP) greater than 140 mmHg (hypertension) and after control of hemodynamic parameters by administration of desflurane (return of systolic arterial pressure to within 20% of the control value) (t2) in a fresh gas flow of 31/ min.\nSixteen patients developed hypertension at surgical incision. SAP was controlled by desflurane in all 16 patients. Afterload assessed by systemic vascular resistance index (SVRI), end-systolic wall-stress (ESWS) and left-ventricular stroke work index (LVSWI) increased with incision until the hypertension returned to post-induction values with mean end-tidal concentration of 5.1+/-0.7% desflurane. No change in heart rate, cardiac index, mean pulmonary arterial pressure, stroke volume, end-diastolic and end-systolic cross-sectional areas, fractional area change and left ventricular circumferential fiber shortening was noted when desflurane was added to restore blood pressure.\nDoes desflurane alter left ventricular function when used to control surgical stimulation during aortic surgery?",
        "answer": "no",
        "answer_rationale": "This study demonstrates that in patients at risk for cardiac morbidity undergoing vascular surgery, desflurane is effective to control intraoperative hypertension without fear of major cardiac depressant effect.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Although desflurane is commonly used to control surgically induced hypertension, its effects on left ventricular (LV) function have not been investigated in this clinical situation. The purpose of the present study was to evaluate the LV function response to desflurane, when used to control intraoperative hypertension.\nIn 50 patients, scheduled for vascular surgery, anesthesia was induced with sufentanil 0.5 microg/kg, midazolam 0.3 mg/kg and atracurium 0.5 mg/kg. After tracheal intubation, anesthesia was maintained with increments of drugs with controlled ventilation (N2O/O2=60/40%) until the start of surgery. A 5 Mhz transesophageal echocardiography (TEE) probe was inserted after intubation. Pulmonary artery catheter and TEE measurements were obtained after induction (to)(control value), at surgical incision (t1) if it was associated with an increase in systolic arterial pressure (SAP) greater than 140 mmHg (hypertension) and",
        "q2": " after control of hemodynamic parameters by administration of desflurane (return of systolic arterial pressure to within 20% of the control value) (t2) in a fresh gas flow of 31/ min.\nSixteen patients developed hypertension at surgical incision. SAP was controlled by desflurane in all 16 patients. Afterload assessed by systemic vascular resistance index (SVRI), end-systolic wall-stress (ESWS) and left-ventricular stroke work index (LVSWI) increased with incision until the hypertension returned to post-induction values with mean end-tidal concentration of 5.1+/-0.7% desflurane. No change in heart rate, cardiac index, mean pulmonary arterial pressure, stroke volume, end-diastolic and end-systolic cross-sectional areas, fractional area change and left ventricular circumferential fiber shortening was noted when desflurane was added to restore blood pressure.\nDoes desflurane alter left ventricular function when used to control surgical stimulation during aortic surgery?",
        "generated_text": "10 min after desflurane administration (t2). Desflurane was administered in a concentration of 2% to control hypertension.\nAt t1, SAP increased from 125+/-17 to 150+/-17 mmHg (P<0.001). Desflurane decreased SAP to 128+/-17 mmHg (P<0.001 vs t1). At t1, LV ejection fraction (LVEF) decreased from 64+/-7 to 59+/-7% (P<0.001), and increased to 63+/-7% at t2 (P<0.05 vs t1). LV end-diastolic area (LVEDA) decreased from 32+/-5 to 29+/-5 cm2 (P<0.001) at t1 and increased to 31+/-5 cm2 at t2 (P",
        "levenshtein_distance": 739
    },
    {
        "realidx": "10490564",
        "question": "To determine whether anginal episodes might be related to extremes of hypotension in patients with ischaemic heart disease taking drugs to treat angina and heart failure.\nObservational study of patients with ischaemic heart disease attending an urban tertiary referral cardiology centre.\nA selected patient population was enrolled, having: angina on one or more hypotensive cardiovascular medications; hypotension on clinic or ambulatory measurement; and a resting ECG suitable for ambulatory monitoring. Patients had echocardiography, ambulatory blood pressure monitoring, and Holter monitoring. Hypotension induced ischaemic (HII) events were defined as episodes of ST segment ischaemia occurring at least one minute after an ambulatory blood pressure measurement (systolic/diastolic) below 100/65 mm Hg during the day, or 90/50 mm Hg at night.\n25 suitable patients were enrolled, and 107 hypotensive events were documented. 40 ST events occurred in 14 patients, of which a quarter were symptomatic. Fourteen HII events occurred in eight patients, with 13 of the 14 preceded by a fall in diastolic pressure (median diastolic pressure 57.5 mm Hg, interquartile range 11, maximum 72 mm Hg, minimum 45 mm Hg), and six preceded by a fall in systolic pressure (chi(2) = 11.9, p<0.001). ST events were significantly associated with preceding hypotensive events (chi(2) = 40.2, p<0.0001). Patients with HII events were more frequently taking multiple hypotensive drug regimens (8/8 v 9/17, chi(2) = 5.54, p = 0.022).\nHypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?",
        "answer": "yes",
        "answer_rationale": "In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine whether anginal episodes might be related to extremes of hypotension in patients with ischaemic heart disease taking drugs to treat angina and heart failure.\nObservational study of patients with ischaemic heart disease attending an urban tertiary referral cardiology centre.\nA selected patient population was enrolled, having: angina on one or more hypotensive cardiovascular medications; hypotension on clinic or ambulatory measurement; and a resting ECG suitable for ambulatory monitoring. Patients had echocardiography, ambulatory blood pressure monitoring, and Holter monitoring. Hypotension induced ischaemic (HII) events were defined as episodes of ST segment ischaemia occurring at least one minute after an ambulatory blood pressure measurement (systolic/diastolic) below 100/65 mm Hg during the day, or 90/50 mm Hg at night.\n25 suitable patients were enrolled, and 107 hypotensive events were documented. 40",
        "q2": " ST events occurred in 14 patients, of which a quarter were symptomatic. Fourteen HII events occurred in eight patients, with 13 of the 14 preceded by a fall in diastolic pressure (median diastolic pressure 57.5 mm Hg, interquartile range 11, maximum 72 mm Hg, minimum 45 mm Hg), and six preceded by a fall in systolic pressure (chi(2) = 11.9, p<0.001). ST events were significantly associated with preceding hypotensive events (chi(2) = 40.2, p<0.0001). Patients with HII events were more frequently taking multiple hypotensive drug regimens (8/8 v 9/17, chi(2) = 5.54, p = 0.022).\nHypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?",
        "generated_text": "% of these events were associated with ischaemia, and 25% of the ischaemic events occurred during hypotension. The mean systolic blood pressure at the time of ischaemia was 92 mm Hg, and the mean diastolic blood pressure was 54 mm Hg. The mean heart rate was 70 beats per minute. The ischaemic events were more likely to occur during the day than at night (60% vs. 40%). The ischaemic events were more likely to occur during periods of physical activity than during rest (70% vs. 30%). The ischaemic events were more likely to occur in patients with a history of myocardial infarction than in those without (60% vs. 40%). The ischaemic events were more likely to occur in patients with left ventricular ejection fraction less than 40%",
        "levenshtein_distance": 534
    },
    {
        "realidx": "10548670",
        "question": "The National Institutes of Health Stroke Scale (NIHSS) is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect.\nWe examined the placebo arm of the NINDS t-PA stroke trial to test the hypothesis that the total volume of cerebral infarction in patients with right hemisphere strokes would be greater than the volume of cerebral infarction in patients with left hemisphere strokes who have similar NIHSS scores. The volume of stroke was determined by computerized image analysis of CT films and CT images stored on computer tape and optical disks. Cube-root transformation of lesion volume was performed for each CT. Transformed lesion volume was analyzed in a logistic regression model to predict volume of stroke by NIHSS score for each hemisphere. Spearman rank correlation was used to determine the relation between the NIHSS score and lesion volume.\nThe volume for right hemisphere stroke was statistically greater than the volume for left hemisphere strokes, adjusting for the baseline NIHSS (P<0. 001). For each 5-point category of the NIHSS score<20, the median volume of right hemisphere strokes was approximately double the median volume of left hemisphere strokes. For example, for patients with a left hemisphere stroke and a 24-hour NIHSS score of 16 to 20, the median volume of cerebral infarction was 48 mL (interquartile range 14 to 111 mL) as compared with 133 mL (interquartile range 81 to 208 mL) for patients with a right hemisphere stroke (P<0.001). The median volume of a right hemisphere stroke was roughly equal to the median volume of a left hemisphere stroke in the next highest 5-point category of the NIHSS. The Spearman rank correlation between the 24-hour NIHSS score and 3-month lesion volume was 0.72 for patients with left hemisphere stroke and 0.71 for patients with right hemisphere stroke.\nDoes the National Institutes of Health Stroke Scale favor left hemisphere strokes?",
        "answer": "yes",
        "answer_rationale": "For a given NIHSS score, the median volume of right hemisphere strokes is consistently larger than the median volume of left hemisphere strokes. The clinical implications of our finding need further exploration.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The National Institutes of Health Stroke Scale (NIHSS) is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect.\nWe examined the placebo arm of the NINDS t-PA stroke trial to test the hypothesis that the total volume of cerebral infarction in patients with right hemisphere strokes would be greater than the volume of cerebral infarction in patients with left hemisphere strokes who have similar NIHSS scores. The volume of stroke was determined by computerized image analysis of CT films and CT images stored on computer tape and optical disks. Cube-root transformation of lesion volume was performed for each CT. Transformed lesion volume was analyzed in a logistic regression model to predict volume of stroke by NIHSS score for each hemisphere. Spearman rank correlation was used to determine the relation between the NIHSS score and lesion volume.\nThe volume for right hemisphere stroke was statistically greater than the volume for left hemisphere strokes, adjusting for the baseline NIHSS (P",
        "q2": "<0. 001). For each 5-point category of the NIHSS score<20, the median volume of right hemisphere strokes was approximately double the median volume of left hemisphere strokes. For example, for patients with a left hemisphere stroke and a 24-hour NIHSS score of 16 to 20, the median volume of cerebral infarction was 48 mL (interquartile range 14 to 111 mL) as compared with 133 mL (interquartile range 81 to 208 mL) for patients with a right hemisphere stroke (P<0.001). The median volume of a right hemisphere stroke was roughly equal to the median volume of a left hemisphere stroke in the next highest 5-point category of the NIHSS. The Spearman rank correlation between the 24-hour NIHSS score and 3-month lesion volume was 0.72 for patients with left hemisphere stroke and 0.71 for patients with right hemisphere stroke.\nDoes the National Institutes of Health Stroke Scale favor left hemisphere strokes?",
        "generated_text": "< .001). The correlation between NIHSS and lesion volume was higher for left hemisphere strokes (r = 0.62) compared with right hemisphere strokes (r = 0.47).\nThe NIHSS is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect. The NIHSS is a useful tool for measuring the severity of stroke and for determining the appropriate treatment options for patients.",
        "levenshtein_distance": 627
    },
    {
        "realidx": "10749257",
        "question": "The United States Food and Drug Administration implemented federal regulations governing mammography under the Mammography Quality Standards Act (MQSA) of 1992. During 1995, its first year in implementation, we examined the impact of the MQSA on the quality of mammography in North Carolina.\nAll mammography facilities were inspected during 1993-1994, and again in 1995. Both inspections evaluated mean glandular radiation dose, phantom image evaluation, darkroom fog, and developer temperature. Two mammography health specialists employed by the North Carolina Division of Radiation Protection performed all inspections and collected and codified data.\nThe percentage of facilities that met quality standards increased from the first inspection to the second inspection. Phantom scores passing rate was 31.6% versus 78.2%; darkroom fog passing rate was 74.3% versus 88.5%; and temperature difference passing rate was 62.4% versus 86.9%.\nHas the mammography quality standards act affected the mammography quality in North Carolina?",
        "answer": "yes",
        "answer_rationale": "In 1995, the first year that the MQSA was in effect, there was a significant improvement in the quality of mammography in North Carolina. This improvement probably resulted from facilities' compliance with federal regulations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The United States Food and Drug Administration implemented federal regulations governing mammography under the Mammography Quality Standards Act (MQSA) of 1992. During 1995, its first year in implementation, we examined the impact of the MQSA on the quality of mammography in North Carolina.\nAll mammography facilities were inspected during 1993-1994, and again in 1995. Both inspections evaluated mean glandular radiation dose, phantom image evaluation, darkroom fog, and developer temperature. Two mammography health",
        "q2": " specialists employed by the North Carolina Division of Radiation Protection performed all inspections and collected and codified data.\nThe percentage of facilities that met quality standards increased from the first inspection to the second inspection. Phantom scores passing rate was 31.6% versus 78.2%; darkroom fog passing rate was 74.3% versus 88.5%; and temperature difference passing rate was 62.4% versus 86.9%.\nHas the mammography quality standards act affected the mammography quality in North Carolina?",
        "generated_text": "physicists inspected each facility, and the results were compared for the two inspections.\nA total of 100 facilities were inspected in 1993-1994 and 95 in 1995. The mean glandular radiation dose decreased from 3.1 mGy in 1993-1994 to 2.7 mGy in 1995 (p < 0.001). The percentage of facilities with mean gland",
        "levenshtein_distance": 383
    },
    {
        "realidx": "10781708",
        "question": "Most studies on thrombosis prophylaxis focus on postoperative venous thrombosis. In medical wards thrombosis prophylaxis is generally restricted to patients who are immobilised. Our primary aim was to investigate the incidence of venous thrombosis in a general internal ward, to assess whether more rigorous prophylaxis would be feasible.\nWe investigated the incidence of venous thrombosis in patients hospitalised from 1992 to 1996 and related our findings to literature reports.\nThe incidence of symptomatic venous thrombosis in internal patients during hospitalisation was 39/6332 (0.6%). Among these 39 patients, 24 had a malignancy, whereas 876 out of all 6332 patients had a known malignancy. So, the incidence in this group with cancer was 2.7% compared with 0.3% (15/5456) in the non-cancer group (relative risk for venous thrombosis due to malignancy was 10.0 (95%C.I. 5.3-18.9).\nThrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense?",
        "answer": "no",
        "answer_rationale": "The incidence of venous thrombosis during hospitalisation in a department of general internal medicine is low and does not justify prophylaxis in all internal patients. Cancer is a strong risk factor for hospital-acquired thrombosis in the medical ward. Further studies may answer the question as to whether thrombosis prophylaxis in this subgroup is feasible.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Most studies on thrombosis prophylaxis focus on postoperative venous thrombosis. In medical wards thrombosis prophylaxis is generally restricted to patients who are immobilised. Our primary aim was to investigate the incidence of venous thrombosis in a general internal ward, to assess whether more rigorous prophylaxis would be feasible.\nWe investigated the incidence of venous thrombosis in patients hospitalised from 1992 to 1996 and related our findings to literature reports.\nThe incidence of symptomatic venous thrombosis in internal patients during hospitalisation was 39/6332 (0.6",
        "q2": "%). Among these 39 patients, 24 had a malignancy, whereas 876 out of all 6332 patients had a known malignancy. So, the incidence in this group with cancer was 2.7% compared with 0.3% (15/5456) in the non-cancer group (relative risk for venous thrombosis due to malignancy was 10.0 (95%C.I. 5.3-18.9).\nThrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense?",
        "generated_text": "2%). The incidence of asymptomatic venous thrombosis was 10/100 (10%) in patients with a high risk of venous thrombosis. The incidence of venous thrombosis in patients with a high risk of venous thrombosis was 10/100 (10%) in patients with a high risk of venous thrombosis. The incidence of venous thrombosis in patients with a high risk of venous thrombosis was 10/100 (10%) in",
        "levenshtein_distance": 298
    },
    {
        "realidx": "10798511",
        "question": "Physical examination to detect abdominal injuries has been considered unreliable in alcohol-intoxicated trauma patients. Computed tomography (CT) plays the primary role in these abdominal evaluations.\nWe reviewed medical records of all blunt trauma patients admitted to our trauma service from January 1, 1992, to March 31, 1998. Study patients had a blood alcohol level>or =80 mg/dL, Glasgow Coma Scale (GCS) score of 15, and unremarkable abdominal examination.\nOf 324 patients studied, 317 (98%) had CT scans negative for abdominal injury. Abdominal injuries were identified in 7 patients (2%), with only 2 (0.6%) requiring abdominal exploration. A significant association was found between major chest injury and abdominal injury.\nBlunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?",
        "answer": "no",
        "answer_rationale": "The incidence of abdominal injury in intoxicated, hemodynamically stable, blunt trauma patients with a normal abdominal examination and normal mentation is low. Physical examination and attention to clinical risk factors allow accurate abdominal evaluation without CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Physical examination to detect abdominal injuries has been considered unreliable in alcohol-intoxicated trauma patients. Computed tomography (CT) plays the primary role in these abdominal evaluations.\nWe reviewed medical records of all blunt trauma patients admitted to our trauma service from January 1, 1992, to March 31, 1998. Study patients had a blood alcohol level>or =80 mg/dL, Glasgow Coma Scale (GCS",
        "q2": ") score of 15, and unremarkable abdominal examination.\nOf 324 patients studied, 317 (98%) had CT scans negative for abdominal injury. Abdominal injuries were identified in 7 patients (2%), with only 2 (0.6%) requiring abdominal exploration. A significant association was found between major chest injury and abdominal injury.\nBlunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?",
        "generated_text": ") score>or =13, and a negative focused abdominal sonography for trauma (FAST) examination. Patients with penetrating trauma, isolated head injury, or isolated extremity injury were excluded. The primary outcome was the presence of intra-abdominal injury requiring laparotomy or angiographic embolization.\nA total of 1,014 patients met the inclusion criteria. The mean age was 32 years, and",
        "levenshtein_distance": 307
    },
    {
        "realidx": "10834864",
        "question": "Avascular necrosis of bone (AVN) is a well known complication in patients with systemic lupus erythematosus (SLE).\nTo investigate the role of antiphospholipid antibody status (IgM and IgG anticardiolipin antibodies and lupus anticoagulant) with adjustment for corticosteroid use as risk factors for the development of AVN.\nA cohort of 265 patients receiving long term follow up in our SLE clinic from 1978 to 1998 was analysed. Patients with AVN complications were detected and then matched for age, sex, ethnicity, duration of disease, and organ disease with two other patients with SLE. A further 31 patients were chosen at random for the analysis.\nEleven patients had AVN, giving a point prevalence of 4%. There were no significant differences demonstrable in the presence of individual antiphospholipid antibodies (aPL) or their combination between the group with AVN or the two control groups.\nRisk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?",
        "answer": "no",
        "answer_rationale": "Incorporating an adjustment for corticosteroid use we were unable to show a link between the presence of aPL and the development of AVN in patients with SLE.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Avascular necrosis of bone (AVN) is a well known complication in patients with systemic lupus erythematosus (SLE).\nTo investigate the role of antiphospholipid antibody status (IgM and IgG anticardiolipin antibodies and lupus anticoagulant) with adjustment for corticosteroid use as risk factors for the development of AVN.\nA cohort of 265 patients receiving long term follow up in our SLE clinic from 1978 to 1998 was analysed. Patients with AVN complications were detected and then matched for age,",
        "q2": " sex, ethnicity, duration of disease, and organ disease with two other patients with SLE. A further 31 patients were chosen at random for the analysis.\nEleven patients had AVN, giving a point prevalence of 4%. There were no significant differences demonstrable in the presence of individual antiphospholipid antibodies (aPL) or their combination between the group with AVN or the two control groups.\nRisk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?",
        "generated_text": "sex, and duration of disease with two controls without AVN. The antiphospholipid antibody status and the cumulative corticosteroid dose were compared between the two groups.\nTwenty two patients (8.3%) developed AVN during the follow up period. The mean age at diagnosis of SLE was 32.4 years (range 14-65), and the mean duration of disease was 10.2 years (range 1-29). The mean cumulative corticosteroid dose was 10.2 g (range",
        "levenshtein_distance": 395
    },
    {
        "realidx": "10877371",
        "question": "Phacodonesis can occur in pseudoexfoliation syndrome because of impaired zonular support. This study investigates whether the increased mobility of the lens influences anterior chamber depth in patients with pseudoexfoliation while assuming a prone position.\nCentral anterior chamber depth was measured in 39 patients with clinically apparent unilateral pseudoexfoliation and elevated intraocular pressure. Patients were placed in a face-up position for 5 minutes, at which time anterior chamber depth and axial length were measured by A scan, and intraocular pressure was measured by Tonopen (Oculab, La Jolla, CA) in both eyes. The measurements were repeated on both eyes after 5 minutes in a face-down position.\nNo significant differences in intraocular pressure or axial length between the prone and supine positions were found in either eye. Anterior chamber depth in eyes with pseudoexfoliation decreased from a mean of 3.08 mm in the supine position to a mean of 2.95 mm in the prone position, whereas mean anterior chamber depth in the fellow eyes decreased from 3.01 mm to 2.97 mm. The decrease in anterior chamber depth when facing down in the eyes with pseudoexfoliation was significantly greater than in the fellow eyes.\nDoes head positioning influence anterior chamber depth in pseudoexfoliation syndrome?",
        "answer": "yes",
        "answer_rationale": "In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Phacodonesis can occur in pseudoexfoliation syndrome because of impaired zonular support. This study investigates whether the increased mobility of the lens influences anterior chamber depth in patients with pseudoexfoliation while assuming a prone position.\nCentral anterior chamber depth was measured in 39 patients with clinically apparent unilateral pseudoexfoliation and elevated intraocular pressure. Patients were placed in a face-up position for 5 minutes, at which time anterior chamber depth and axial length were measured by A scan, and intraocular pressure was measured by Tonopen (Oculab, La Jolla, CA) in both eyes. The measurements were repeated on both eyes after 5",
        "q2": " minutes in a face-down position.\nNo significant differences in intraocular pressure or axial length between the prone and supine positions were found in either eye. Anterior chamber depth in eyes with pseudoexfoliation decreased from a mean of 3.08 mm in the supine position to a mean of 2.95 mm in the prone position, whereas mean anterior chamber depth in the fellow eyes decreased from 3.01 mm to 2.97 mm. The decrease in anterior chamber depth when facing down in the eyes with pseudoexfoliation was significantly greater than in the fellow eyes.\nDoes head positioning influence anterior chamber depth in pseudoexfoliation syndrome?",
        "generated_text": "minutes in a prone position.\nIn the pseudoexfoliation eyes, the mean anterior chamber depth was 2.72 mm in the face-up position and 2.57 mm in the prone position (P < .001). In the fellow eyes, the mean anterior chamber depth was 2.74 mm in the face-up position and 2.60 mm in the prone position (P < .001). The difference in anterior chamber depth between the face-up and prone positions was 0.15 mm in the pseudoexfoliation eyes and 0.14 mm in the fellow eyes (P = .",
        "levenshtein_distance": 408
    },
    {
        "realidx": "10922093",
        "question": "The use of open access endoscopy is increasing. Its effect on the adequacy of patient informed consent, procedure acceptance and the impact on subsequent communication/transfer of procedure results to the patient have not been evaluated. The aim of our study was to compare the extent of preknowledge of procedures and test explanation, patient medical complexity, information transfer and overall patient satisfaction between a patient group referred for outpatient open access endoscopy versus a patient group from a gastrointestinal (GI) subspecialty clinic.\nInformation was obtained from all patients presenting for outpatient upper and lower endoscopy by using a 1-page questionnaire. Patients from the two groups who had an outpatient upper/lower endoscopic procedure were contacted by phone after the procedure to obtain information with a standardized questionnaire.\nThe open access patients reported receiving significantly less information to help them identify the procedure (p<0.01) and less explanation concerning the nature of the procedure than the group of patients referred from the subspecialty clinic (p<0.005). There was no difference between the two groups in satisfaction scores for examinations performed under conscious sedation. For flexible sigmoidoscopy without sedation, however, the GI clinic patient group were more satisfied with their procedure. The majority of patients, regardless of access, were more likely to receive endoscopic results from a gastroenterologist than the referring physician. Furthermore, the patients in the GI clinic group who underwent colonoscopy felt significantly better at follow-up.\nDoes open access endoscopy close the door to an adequately informed patient?",
        "answer": "yes",
        "answer_rationale": "Patients undergoing open access procedures are less likely to be properly informed about their endoscopic procedure. Our results indicate that with open access endoscopy, a defined mechanism needs to be in place for communication of endoscopic results to the patient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The use of open access endoscopy is increasing. Its effect on the adequacy of patient informed consent, procedure acceptance and the impact on subsequent communication/transfer of procedure results to the patient have not been evaluated. The aim of our study was to compare the extent of preknowledge of procedures and test explanation, patient medical complexity, information transfer and overall patient satisfaction between a patient group referred for outpatient open access endoscopy versus a patient group from a gastrointestinal (GI) subspecialty clinic.\nInformation was obtained from all patients presenting for outpatient upper and lower endoscopy by using a 1-page questionnaire. Patients from the two groups who had an outpatient upper/lower endoscopic procedure were contacted by phone after the procedure to obtain information with a standardized questionnaire.\nThe",
        "q2": " open access patients reported receiving significantly less information to help them identify the procedure (p<0.01) and less explanation concerning the nature of the procedure than the group of patients referred from the subspecialty clinic (p<0.005). There was no difference between the two groups in satisfaction scores for examinations performed under conscious sedation. For flexible sigmoidoscopy without sedation, however, the GI clinic patient group were more satisfied with their procedure. The majority of patients, regardless of access, were more likely to receive endoscopic results from a gastroenterologist than the referring physician. Furthermore, the patients in the GI clinic group who underwent colonoscopy felt significantly better at follow-up.\nDoes open access endoscopy close the door to an adequately informed patient?",
        "generated_text": "open access group had a higher proportion of patients who had a preknowledge of the procedure (80% vs 50%, p < 0.001). The open access group had a higher proportion of patients who had a preknowledge of the procedure (80% vs 50%, p < 0.001). The open access group had a higher proportion of patients who had a preknowledge of the procedure (80% vs 50%, p < 0.001). The open access group had a higher proportion of patients who had a preknowledge of the procedure (80% vs 50%, p < 0.001). The open access group had a higher proportion",
        "levenshtein_distance": 599
    },
    {
        "realidx": "10966943",
        "question": "The records of 465 patients with an established diagnosis of age related macular degeneration who had attended a specialist macular clinic between 1990 and 1998 were scrutinised. A full clinical examination and standardised refraction had been carried out in 189 of these cases on a minimum of two occasions. Cases were looked for where an improvement of one or more lines of either distance or near acuity was recorded in the eye unaffected by macular disease. In each one of these cases the improvement in visual acuity could not be attributed to treatment of other existing pathology.\n12 such cases were detected. In nine of these the eye showing improvement of acuity had a history of amblyopia. The mean improvement in distance and near acuity in amblyopic eyes by 12 months was 3.3 and 1.9 lines logMAR respectively. The improvement in acuity generally occurred between 1 and 12 months from baseline and remained stable over the period of follow up.\nAmblyopia: is visual loss permanent?",
        "answer": "no",
        "answer_rationale": "Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be sustained.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The records of 465 patients with an established diagnosis of age related macular degeneration who had attended a specialist macular clinic between 1990 and 1998 were scrutinised. A full clinical examination and standardised refraction had been carried out in 189 of these cases on a minimum of two occasions. Cases were looked for where an improvement of one or more lines of either distance or near acuity was recorded in the eye unaffected by macular disease. In each one of these cases the improvement in visual acuity",
        "q2": " could not be attributed to treatment of other existing pathology.\n12 such cases were detected. In nine of these the eye showing improvement of acuity had a history of amblyopia. The mean improvement in distance and near acuity in amblyopic eyes by 12 months was 3.3 and 1.9 lines logMAR respectively. The improvement in acuity generally occurred between 1 and 12 months from baseline and remained stable over the period of follow up.\nAmblyopia: is visual loss permanent?",
        "generated_text": "was confirmed by re-examination. The clinical notes were then scrutinised for possible explanations for the improvement in visual acuity. The most common explanation was a change in spectacle correction, either because of a change in refraction or because of a change in the spectacle lens material. In 10 cases the improvement in visual acuity was unexplained. The results suggest that in patients with macular disease, changes in refraction and spectacle lens material can lead to improvements in visual acuity.",
        "levenshtein_distance": 378
    },
    {
        "realidx": "10973547",
        "question": "It is generally assumed, that patients with Werlhof's disease (WD) are at increased risk for bleeding complications when undergoing cardiac surgery with extracorporeal circulation. Therefore we performed this case control study to estimate the real risk for bleeding complications of these patients.\nBetween 05/95 and 07/98, ten patients with WD (eight males, two females) underwent cardiac surgery employing extracorporeal circulation (WD-group). Five of these patients with platelet counts below 80/nl were treated by immunoglobulins preoperatively. Each patient with WD was matched to five patients without WD (no-WD-group) using diagnosis, age, gender, ejection fraction, number of distal anastomosis and body-mass-index as matching criteria.\nMean number of platelet counts were significant lower in the WD-group than in the no-WD-group despite a significant increase of platelet counts after immunoglobulin treatment (54/nl-->112/nl, P=0.018). On the day before, directly after and on the first day after surgery they were 141/nl vs. 215/nl (P=0.012), 75/nl vs. 147/nl (P=0.001) and 93/nl vs. 136/nl (P=0.009). Accordingly, patients of the WD-group received significantly more platelet concentrates than patients of the no-WD-group (mean number of platelet concentrates: 2.3 versus 0.7, P=0.007). Total drainage loss via the mediastinal chest tubes was almost identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient of each group suffered from a bleeding complication requiring reexploration. Three patients of the no-WD-group (6%) and one patient of the WD-group (10%) expired postoperatively unrelated to WD.\nAre patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?",
        "answer": "no",
        "answer_rationale": "Patients with WD may possibly undergo cardiac surgery without a markedly enhanced risk for bleeding complications despite a more than usual transfusion requirement and significantly lower platelet counts perioperatively.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "It is generally assumed, that patients with Werlhof's disease (WD) are at increased risk for bleeding complications when undergoing cardiac surgery with extracorporeal circulation. Therefore we performed this case control study to estimate the real risk for bleeding complications of these patients.\nBetween 05/95 and 07/98, ten patients with WD (eight males, two females) underwent cardiac surgery employing extracorporeal circulation (WD-group). Five of these patients with platelet counts below 80/nl were treated by immunoglobulins preoperatively. Each patient with WD was matched to five patients without WD (no-WD-group) using diagnosis, age, gender, ejection fraction, number of distal anastomosis and body-mass-index as matching criteria.\nMean number of platelet counts were significant lower in the WD-group than in the no-WD-group despite a significant increase of platelet counts after immunoglobulin treatment (54/nl-->112/nl, P=0.018). On the day",
        "q2": " before, directly after and on the first day after surgery they were 141/nl vs. 215/nl (P=0.012), 75/nl vs. 147/nl (P=0.001) and 93/nl vs. 136/nl (P=0.009). Accordingly, patients of the WD-group received significantly more platelet concentrates than patients of the no-WD-group (mean number of platelet concentrates: 2.3 versus 0.7, P=0.007). Total drainage loss via the mediastinal chest tubes was almost identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient of each group suffered from a bleeding complication requiring reexploration. Three patients of the no-WD-group (6%) and one patient of the WD-group (10%) expired postoperatively unrelated to WD.\nAre patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?",
        "generated_text": "of operation, the mean number of platelet counts was 102/nl in the WD-group and 172/nl in the no-WD-group (P=0.001). There was no significant difference in the number of transfused platelets and red blood cells between both groups. The mean number of transfused platelets was 1.4 units in the WD-group and 1.2 units in the no-WD-group (P=0.54). The mean number of transfused red blood cells was 4.1 units in the WD-group and 3.8 units in the no-WD-group (P=0.64). The mean number of chest tube drainage was 620 ml in the WD-group and 570 ml in the no-WD-group (P=0.54). The mean number of postoperative bleeding was 100 ml in the WD-group and 110 ml in the no",
        "levenshtein_distance": 565
    },
    {
        "realidx": "11035130",
        "question": "It is postulated that some aspects of methotrexate toxicity may be related to its action as an anti-folate. Folic acid (FA) is often given as an adjunct to methotrexate therapy, but there is no conclusive proof that it decreases the toxicity of methotrexate and there is a theoretical risk that it may decrease the efficacy of methotrexate.\nTo look at the effect of stopping FA supplementation in UK rheumatoid arthritis (RA) patients established on methotrexate<20 mg weekly and FA 5 mg daily, to report all toxicity (including absolute changes in haematological and liver enzyme indices) and to report changes in the efficacy of methotrexate.\nIn a prospective, randomized, double-blind, placebo-controlled study, 75 patients who were established on methotrexate<20 mg weekly and FA 5 mg daily were asked to stop their FA and were randomized to one of two groups: placebo or FA 5 mg daily. Patients were evaluated for treatment toxicity and efficacy before entry and then at intervals of 3 months for 1 yr.\nOverall, 25 (33%) patients concluded the study early, eight (21%) in the group remaining on FA and 17 (46%) in the placebo group (P = 0.02). Two patients in the placebo group discontinued because of neutropenia. At 9 months there was an increased incidence of nausea in the placebo group (45 vs. 7%, P = 0.001). The placebo group had significantly lower disease activity on a few of the variables measured, but these were probably not of clinical significance.\nDo patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?",
        "answer": "yes",
        "answer_rationale": "It is important to continue FA supplementation over the long term in patients on methotrexate and FA in order to prevent them discontinuing treatment because of mouth ulcers or nausea and vomiting. Our data suggest that FA supplementation is also helpful in preventing neutropenia, with very little loss of efficacy of methotrexate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "It is postulated that some aspects of methotrexate toxicity may be related to its action as an anti-folate. Folic acid (FA) is often given as an adjunct to methotrexate therapy, but there is no conclusive proof that it decreases the toxicity of methotrexate and there is a theoretical risk that it may decrease the efficacy of methotrexate.\nTo look at the effect of stopping FA supplementation in UK rheumatoid arthritis (RA) patients established on methotrexate<20 mg weekly and FA 5 mg daily, to report all toxicity (including absolute changes in haematological and liver enzyme indices) and to report changes in the efficacy of methotrexate.\nIn a prospective, randomized, double-blind, placebo-controlled study, 75 patients who were established on methotrexate<20 mg weekly and FA 5 mg daily were asked",
        "q2": " to stop their FA and were randomized to one of two groups: placebo or FA 5 mg daily. Patients were evaluated for treatment toxicity and efficacy before entry and then at intervals of 3 months for 1 yr.\nOverall, 25 (33%) patients concluded the study early, eight (21%) in the group remaining on FA and 17 (46%) in the placebo group (P = 0.02). Two patients in the placebo group discontinued because of neutropenia. At 9 months there was an increased incidence of nausea in the placebo group (45 vs. 7%, P = 0.001). The placebo group had significantly lower disease activity on a few of the variables measured, but these were probably not of clinical significance.\nDo patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?",
        "generated_text": "to stop FA and to take either FA 5 mg daily or placebo for 12 weeks. The primary outcome measure was the proportion of patients who developed toxicity, defined as any of the following: (1) any increase in liver enzymes; (2) any decrease in haemoglobin, white cell count or platelet count; (3) any new symptom or sign attributed to methotrexate toxicity by the patient or the investigator; (4) any new abnormality on physical examination attributed to methotrexate toxicity by the investigator. Secondary outcome measures included changes in disease activity and health assessment questionnaire (HAQ) scores.\nThere was no significant difference in the proportion of patients who developed toxicity between the FA and placebo groups (12/37 (32%) vs 11/38 (29%); P=0.74). There was no significant difference",
        "levenshtein_distance": 621
    },
    {
        "realidx": "11079675",
        "question": "The purpose of this study is to evaluate right ventricular (RV) volume and function after pulmonary valve replacement (PVR) and to address the issue of optimal surgical timing in these patients.\nChronic pulmonary regurgitation (PR) following repair of tetralogy of Fallot (TOF) leads to RV dilation and an increased incidence of sudden cardiac death in adult patients.\nWe studied 25 consecutive adult patients who underwent PVR for significant PR late after repair of TOF. Radionuclide angiography was performed in all at a mean of 8.2 months (+/- 8 months) before PVR and repeated at a mean of 28.0 months (+/- 22.8 months) after the operation. Right ventricular (RV) end-systolic volume (RVESV), RV end-diastolic volume (RVEDV) and RV ejection fraction (RVEF) were measured.\nMean RVEDV, RVESV and RVEF remained unchanged after PVR (227.1 ml versus 214.9 ml, p = 0.74; 157.4 ml versus 155.4 ml, p = 0.94; 35.6% versus 34.7%, p = 0.78, respectively). Of the 10 patients with RVEF>or = 0.40 before PVR, 5 patients (50%) maintained a RVEF>or = 0.40 following PVR, whereas only 2 out of 15 patients (13%) with pre-operative values<0.40 reached an RVEF>or = 0.40 postoperatively (p<0.001).\nPulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late?",
        "answer": "yes",
        "answer_rationale": "Right ventricular recovery following PVR for chronic significant pulmonary regurgitation after repair of TOF may be compromised in the adult population. In order to maintain adequate RV contractility, pulmonary valve implant in these patients should be considered before RV function deteriorates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study is to evaluate right ventricular (RV) volume and function after pulmonary valve replacement (PVR) and to address the issue of optimal surgical timing in these patients.\nChronic pulmonary regurgitation (PR) following repair of tetralogy of Fallot (TOF) leads to RV dilation and an increased incidence of sudden cardiac death in adult patients.\nWe studied 25 consecutive adult patients who underwent PVR for significant PR late after repair of TOF. Radionuclide angiography was performed in all at a mean of 8.2 months (+/- 8 months) before PVR and repeated at a mean of 28.0 months (+/- 22.8 months) after the operation. Right ventricular (RV) end-systolic volume (RVESV), RV end-diastolic volume (RVEDV) and RV ejection fraction (RVEF) were",
        "q2": " measured.\nMean RVEDV, RVESV and RVEF remained unchanged after PVR (227.1 ml versus 214.9 ml, p = 0.74; 157.4 ml versus 155.4 ml, p = 0.94; 35.6% versus 34.7%, p = 0.78, respectively). Of the 10 patients with RVEF>or = 0.40 before PVR, 5 patients (50%) maintained a RVEF>or = 0.40 following PVR, whereas only 2 out of 15 patients (13%) with pre-operative values<0.40 reached an RVEF>or = 0.40 postoperatively (p<0.001).\nPulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late?",
        "generated_text": "measured. The results were compared with those of 10 normal subjects.\nThe mean RVESV, RVEDV and RVEF in the patients before PVR were 102.1 ml/m2 (+/- 40.1 ml/m2), 174.1 ml/m2 (+/- 50.1 ml/m2) and 41.5% (+/- 7.1%), respectively. These values were significantly different from those of the normal subjects (RVESV 52.1 ml/m2 (+/- 10.1 ml/m2), RVEDV 92.1 ml/m2 (+/- 14.1 ml/m2), RVEF 44.1% (+/- 4.1%); p < 0.001). The RVESV and RVEDV decreased significantly after",
        "levenshtein_distance": 427
    },
    {
        "realidx": "11138995",
        "question": "Alexithymia is presumed to play an important predisposing role in the pathogenesis of medically unexplained physical symptoms. However, no research on alexithymia has been done among general medical outpatients who present with medically unexplained physical symptoms as their main problem and in which anxiety and depression have been considered as possible confounding factors. This study investigated whether patients with medically unexplained physical symptoms are more alexithymic than those with explained symptoms and whether, in patients with unexplained symptoms, alexithymia is associated with subjective health experience and use of medical services.\nWe conducted a cross-sectional study among patients attending an internal medicine outpatient clinic. All patients were given a standardized interview and completed a number of questionnaires.\nAfter complete physical examinations, 169 of 321 patients had unexplained physical symptoms according to two independent raters. Patients with medically unexplained symptoms more often had a mental disorder, but overall they were not more alexithymic. In patients with unexplained physical symptoms, alexithymia was not associated with subjective health experience or use of medical services. However, patients with both unexplained symptoms and a mental disorder who also denied any possible connection between emotional problems and their physical symptoms did have more alexithymic traits.\nIs alexithymia a risk factor for unexplained physical symptoms in general medical outpatients?",
        "answer": "no",
        "answer_rationale": "In the majority of patients with medically unexplained physical symptoms, alexithymia does not play a role of clinical significance. Patients with unexplained physical symptoms are heterogeneous with respect to psychiatric syndrome pathology and probably also with respect to personality pathology.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Alexithymia is presumed to play an important predisposing role in the pathogenesis of medically unexplained physical symptoms. However, no research on alexithymia has been done among general medical outpatients who present with medically unexplained physical symptoms as their main problem and in which anxiety and depression have been considered as possible confounding factors. This study investigated whether patients with medically unexplained physical symptoms are more alexithymic than those with explained symptoms and whether, in patients with unexplained symptoms, alexithymia is associated with subjective health experience and use of medical services.\nWe conducted a cross-sectional study among patients attending an internal medicine outpatient clinic. All patients were given",
        "q2": " a standardized interview and completed a number of questionnaires.\nAfter complete physical examinations, 169 of 321 patients had unexplained physical symptoms according to two independent raters. Patients with medically unexplained symptoms more often had a mental disorder, but overall they were not more alexithymic. In patients with unexplained physical symptoms, alexithymia was not associated with subjective health experience or use of medical services. However, patients with both unexplained symptoms and a mental disorder who also denied any possible connection between emotional problems and their physical symptoms did have more alexithymic traits.\nIs alexithymia a risk factor for unexplained physical symptoms in general medical outpatients?",
        "generated_text": "a questionnaire that included the 20-item Toronto Alexithymia Scale, the Hospital Anxiety and Depression Scale, and questions about their subjective health experience and use of medical services. Patients with medically unexplained physical symptoms were compared with those with explained symptoms on alexithymia and its subscales. In addition, in patients with unexplained symptoms, the associations between alexithymia and subjective health experience and use of medical services were investigated.\nA total of 190 patients were included in the study. Patients with medically unexplained physical symptoms had higher scores on alexithymia and its subscales than those with explained symptoms. In patients with unexplained symptoms,",
        "levenshtein_distance": 477
    },
    {
        "realidx": "11146778",
        "question": "The APACHE II (Acute Physiology and Chronic Health Evaluation II) score used as an intensive care unit (ICU) admission score in emergency surgical patients is not independent of the effects of treatment and might lead to considerable bias in the comparability of defined groups of patients and in the evaluation of treatment policies. Postoperative monitoring with the APACHE II score is clinically irrelevant.\nInception cohort study.\nSecondary referral center.\nEighty-five consecutive emergency surgical patients admitted to the surgical ICU in 1999. The APACHE II score was calculated before surgery; after admission to the ICU; and on postoperative days 3, 7, and 10.\nAPACHE II scores and predicted and observed mortality rates.\nThe mean +/- SD APACHE II score of 24.2 +/- 8.3 at admission to the ICU was approximately 36% greater than the initial APACHE II score of 17.8 +/- 7.7, a difference that was highly statistically significant (P<.001). The overall mortality of 32% favorably corresponds with the predicted mortality of 34% according to the initial APACHE II score. However, the predicted mortality of 50% according to the APACHE II score at admission to the ICU was significantly different from the observed mortality rate (P =.02). In 40 long-term patients (>/=10 days in the ICU), the difference between the APACHE II scores of survivors and patients who died was statistically significant on day 10 (P =.04).\nRisk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment?",
        "answer": "yes",
        "answer_rationale": "For risk stratification in emergency surgical patients, it is essential to measure the APACHE II score before surgical treatment. Longitudinal APACHE II scoring reveals continuous improvement of the score in surviving patients but has no therapeutic relevance in the individual patient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The APACHE II (Acute Physiology and Chronic Health Evaluation II) score used as an intensive care unit (ICU) admission score in emergency surgical patients is not independent of the effects of treatment and might lead to considerable bias in the comparability of defined groups of patients and in the evaluation of treatment policies. Postoperative monitoring with the APACHE II score is clinically irrelevant.\nInception cohort study.\nSecondary referral center.\nEighty-five consecutive emergency surgical patients admitted to the surgical ICU in 1999. The APACHE II score was calculated before surgery; after admission to the ICU; and on postoperative days 3, 7, and 10.\nAPACHE II scores and predicted and observed mortality rates.\nThe mean +/- SD APACHE II score of 24.2 +/- 8.3 at admission to",
        "q2": " the ICU was approximately 36% greater than the initial APACHE II score of 17.8 +/- 7.7, a difference that was highly statistically significant (P<.001). The overall mortality of 32% favorably corresponds with the predicted mortality of 34% according to the initial APACHE II score. However, the predicted mortality of 50% according to the APACHE II score at admission to the ICU was significantly different from the observed mortality rate (P =.02). In 40 long-term patients (>/=10 days in the ICU), the difference between the APACHE II scores of survivors and patients who died was statistically significant on day 10 (P =.04).\nRisk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment?",
        "generated_text": "the ICU was significantly higher than the preoperative score of 18.1 +/- 8.0 (p < 0.001). The predicted mortality rate increased from 22% to 35% after admission to the ICU. The APACHE II score decreased significantly on postoperative day 3 to 17.1 +/- 8.4 and on day 7 to 11.1 +/- 7.0. The observed mortality rate was 17% and the predicted mortality rate was 35% on admission to the ICU and 22% on postoperative day 3. The APACHE II score was significantly higher in nonsurvivors than in survivors on all days (p < 0.001). The APACHE II score was significantly",
        "levenshtein_distance": 498
    },
    {
        "realidx": "11411430",
        "question": "The purpose of this study is to determine if baseline antral follicle assessment may serve as additional information in predicting in vitro fertilization outcome.\nProspective, descriptive preliminary study of in vitro fertilization outcome. From July 1998 to July 1999, 224 patients underwent antral follicle assessment (follicle 2-6 mm in diameter) on baseline of the planned, stimulated in vitro fertilization cycle. The outcomes were analyzed with respect to antral follicle assessment (<or = 6 or>6), basal cycle day 3 follicle stimulated hormone (<or = 10 or>10 IU/L) and maternal age (<or = 35 or>35 years).\nThe clinical pregnancy rate was significantly higher in the group with baseline antral follicle>6 compared to that in the group with antral follicle<or = 6 (51% vs. 19%, respectively). Controlling for patient age, and basal follicle stimulated hormone, the pregnancy rate was significantly higher in the group with antral follicle>6 compared to that in the group with antral follicle<or = 6. The cancellation rate was significantly increased with advancing maternal age, elevated basal follicle stimulated hormone levels, and baseline antral follicle<or = 6. The cancellation rate was significantly higher in the group with antral follicle<or = 6 compared to that in the group with antral follicle>or = 6 (33% vs. 1%, respectively).\nAntral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?",
        "answer": "maybe",
        "answer_rationale": "In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The purpose of this study is to determine if baseline antral follicle assessment may serve as additional information in predicting in vitro fertilization outcome.\nProspective, descriptive preliminary study of in vitro fertilization outcome. From July 1998 to July 1999, 224 patients underwent antral follicle assessment (follicle 2-6 mm in diameter) on baseline of the planned, stimulated in vitro fertilization cycle. The outcomes were analyzed with respect to antral follicle assessment (<or = 6 or>6), basal cycle day 3 follicle stimulated hormone (<or = 10 or>10 IU/L) and maternal age (<or = 35 or>35 years).\nThe clinical pregnancy rate was significantly higher in the group with baseline antral follicle>6 compared to that in the group with",
        "q2": " antral follicle<or = 6 (51% vs. 19%, respectively). Controlling for patient age, and basal follicle stimulated hormone, the pregnancy rate was significantly higher in the group with antral follicle>6 compared to that in the group with antral follicle<or = 6. The cancellation rate was significantly increased with advancing maternal age, elevated basal follicle stimulated hormone levels, and baseline antral follicle<or = 6. The cancellation rate was significantly higher in the group with antral follicle<or = 6 compared to that in the group with antral follicle>or = 6 (33% vs. 1%, respectively).\nAntral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?",
        "generated_text": "antral follicle<or=6 (30.4% vs. 14.3%, P=0.004). The clinical pregnancy rate was also higher in the group with basal follicle stimulating hormone<or=10 IU/L compared to that in the group with basal follicle stimulating hormone>10 IU/L (30.4% vs. 14.3%, P=0.004). The clinical pregnancy rate was higher in the group with maternal age<or=35 years compared to that in the group with maternal age>35 years (30.4% vs. 14.3%, P=0.004). The clinical pregnancy rate was higher in the group with antral follicle>6 and basal follic",
        "levenshtein_distance": 430
    },
    {
        "realidx": "11438275",
        "question": "It is generally believed that positioning of the patient in a head-down tilt (Trendelenberg position) decreases the likelihood of a venous air embolism during liver resection.\nThe physiological effect of variation in horizontal attitude on central and hepatic venous pressure was measured in 10 patients during liver surgery. Hemodynamic indices were recorded with the operating table in the horizontal, 20 degrees head-up and 20 degrees head-down positions.\nThere was no demonstrable pressure gradient between the hepatic and central venous levels in any of the positions. The absolute pressures did, however, vary in a predictable way, being highest in the head-down and lowest during head-up tilt. However, on no occasion was a negative intraluminal pressure recorded.\nDoes patient position during liver surgery influence the risk of venous air embolism?",
        "answer": "no",
        "answer_rationale": "The effect on venous pressures caused by the change in patient positioning alone during liver surgery does not affect the risk of venous air embolism.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "It is generally believed that positioning of the patient in a head-down tilt (Trendelenberg position) decreases the likelihood of a venous air embolism during liver resection.\nThe physiological effect of variation in horizontal attitude on central and hepatic venous pressure was measured in 10 patients during liver surgery. Hemodynamic indices were recorded with the operating table in the horizontal, 20 degrees head-up and 20 degrees",
        "q2": " head-down positions.\nThere was no demonstrable pressure gradient between the hepatic and central venous levels in any of the positions. The absolute pressures did, however, vary in a predictable way, being highest in the head-down and lowest during head-up tilt. However, on no occasion was a negative intraluminal pressure recorded.\nDoes patient position during liver surgery influence the risk of venous air embolism?",
        "generated_text": "head-down positions. Central venous pressure (CVP) and hepatic venous pressure (HVP) were measured by a transducer connected to a central venous catheter and to a hepatic venous catheter, respectively. The difference between CVP and HVP (CVP-HVP) was calculated. The mean CVP was 10.1 mmHg in the horizontal position",
        "levenshtein_distance": 292
    },
    {
        "realidx": "11458136",
        "question": "By requiring or encouraging enrollees to obtain a usual source of care, managed care programs hope to improve access to care without incurring higher costs.\n(1) To examine the effects of managed care on the likelihood of low-income persons having a usual source of care and a usual physician, and; (2) To examine the association between usual source of care and access.\nCross-sectional survey of households conducted during 1996 and 1997.\nA nationally representative sample of 14,271 low-income persons.\nUsual source of care, usual physician, managed care enrollment, managed care penetration.\nHigh managed care penetration in the community is associated with a lower likelihood of having a usual source of care for uninsured persons (54.8% vs. 62.2% in low penetration areas) as well as a lower likelihood of having a usual physician (60% vs. 72.8%). Managed care has only marginal effects on the likelihood of having a usual source of care for privately insured and Medicaid beneficiaries. Having a usual physician substantially reduces unmet medical needs for the insured but less so for the uninsured.\nDoes managed care enable more low income persons to identify a usual source of care?",
        "answer": "maybe",
        "answer_rationale": "Having a usual physician can be an effective tool in improving access to care for low-income populations, although it is most effective when combined with insurance coverage. However, the effectiveness of managed care in linking more low-income persons to a medical home is uncertain, and may have unintended consequences for uninsured persons.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "By requiring or encouraging enrollees to obtain a usual source of care, managed care programs hope to improve access to care without incurring higher costs.\n(1) To examine the effects of managed care on the likelihood of low-income persons having a usual source of care and a usual physician, and; (2) To examine the association between usual source of care and access.\nCross-sectional survey of households conducted during 1996 and 1997.\nA nationally representative sample of 14,271 low-income persons.\nUsual source of care, usual physician, managed care enrollment, managed care penetration",
        "q2": ".\nHigh managed care penetration in the community is associated with a lower likelihood of having a usual source of care for uninsured persons (54.8% vs. 62.2% in low penetration areas) as well as a lower likelihood of having a usual physician (60% vs. 72.8%). Managed care has only marginal effects on the likelihood of having a usual source of care for privately insured and Medicaid beneficiaries. Having a usual physician substantially reduces unmet medical needs for the insured but less so for the uninsured.\nDoes managed care enable more low income persons to identify a usual source of care?",
        "generated_text": ", and access to care.\nLow-income persons enrolled in managed care were more likely to have a usual source of care (84.1 percent) and a usual physician (74.1 percent) than those in fee-for-service (FFS) (74.1 and 62.9 percent, respectively). The association between managed care and usual source of care was stronger in areas with higher managed care penetration. Usual source of care was associated with better access to care, including fewer unmet needs and fewer problems obtaining care.\nManaged care is associated with higher rates of having a",
        "levenshtein_distance": 423
    },
    {
        "realidx": "11481172",
        "question": "The authors sought to determine whether the manic/mixed episode distinction in patients with bipolar disorder runs true over time.\nOver an 11-year period, the observed distribution of manic and mixed episodes (N=1,224) for patients with three or more entries in the management information system of a community mental health center (N=241) was compared to the expected distribution determined by averaging 1,000 randomly generated simulations.\nEpisodes were consistent (all manic or all mixed) in significantly more patients than would be expected by chance.\nDoes the manic/mixed episode distinction in bipolar disorder patients run true over time?",
        "answer": "yes",
        "answer_rationale": "These data suggest a pattern of diagnostic stability over time for manic and mixed episodes in patients with bipolar disorder. Careful prospective studies of this issue are needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The authors sought to determine whether the manic/mixed episode distinction in patients with bipolar disorder runs true over time.\nOver an 11-year period, the observed distribution of manic and mixed episodes (N=1,224) for patients with three or more entries in the management information system of a community mental",
        "q2": " health center (N=241) was compared to the expected distribution determined by averaging 1,000 randomly generated simulations.\nEpisodes were consistent (all manic or all mixed) in significantly more patients than would be expected by chance.\nDoes the manic/mixed episode distinction in bipolar disorder patients run true over time?",
        "generated_text": "health center was examined.\nThe authors found that 70% of patients had only manic episodes, 15% had only mixed episodes, and 15% had both types of episodes. The authors also found that the manic/mixed episode distinction runs true over time for most patients with bipolar disorder",
        "levenshtein_distance": 214
    },
    {
        "realidx": "11481599",
        "question": "The purpose of this study was to delineate early respiratory predictors of mortality in children with hemato-oncology malignancy who developed acute respiratory distress syndrome (ARDS).\nWe conducted a retrospective chart review of children with malignant and ARDS who needed mechanical ventilation and were admitted to a pediatric intensive care unit from January 1987 to January 1997.\nSeventeen children with ARDS and malignancy aged 10.5 +/- 5.1 years were identified. Six of the 17 children (35.3%) survived. Sepsis syndrome was present in 70.6% of all the children. Peak inspiratory pressure, positive end-expiratory pressure (PEEP), and ventilation index values could distinguish outcome by day 3. A significant relationship between respiratory data and outcome related to efficiency of oxygenation, as determined by PaO(2)/FIO(2) and P(A-a)O(2), was present from day 8 after onset of mechanical ventilation.\nAcute respiratory distress syndrome in children with malignancy--can we predict outcome?",
        "answer": "yes",
        "answer_rationale": "Peak inspiratory pressure, PEEP, and ventilation index values could distinguish survivors from nonsurvivors by day 3. This may assist in early application of supportive nonconventional therapies in children with malignancy and ARDS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study was to delineate early respiratory predictors of mortality in children with hemato-oncology malignancy who developed acute respiratory distress syndrome (ARDS).\nWe conducted a retrospective chart review of children with malignant and ARDS who needed mechanical ventilation and were admitted to a pediatric intensive care unit from January 1987 to January 1997.\nSeventeen children with ARDS and malignancy aged 10.5 +/- 5.1 years were identified. Six of the 17 children (35.3%) survived. Se",
        "q2": "psis syndrome was present in 70.6% of all the children. Peak inspiratory pressure, positive end-expiratory pressure (PEEP), and ventilation index values could distinguish outcome by day 3. A significant relationship between respiratory data and outcome related to efficiency of oxygenation, as determined by PaO(2)/FIO(2) and P(A-a)O(2), was present from day 8 after onset of mechanical ventilation.\nAcute respiratory distress syndrome in children with malignancy--can we predict outcome?",
        "generated_text": "vere ARDS was present in 12 children (70.6%). The mean duration of mechanical ventilation was 12.5 +/- 10.1 days. The mean PaO2/FiO2 ratio was 108.4 +/- 45.1 mm Hg. The mean PEEP was 10.1 +/- 2.7 cm H2O. The mean plateau pressure was 28.1 +/- 5.1 cm H2O. The mean respiratory system",
        "levenshtein_distance": 362
    },
    {
        "realidx": "11483547",
        "question": "To determine the incidence and severity of acute side effects from the use of polyvalent antivenin in victims of rattlesnake bites.\nWe retrospectively reviewed the records of all patients who presented with rattlesnake bites to a university teaching hospital during an 11-year period. From patient medical records, we extracted demographic data, clinical measurements, and outcomes during emergency department evaluation and subsequent hospitalization. Data regarding serum sickness were not collected.\nPrimary outcome variables were the occurrence of immediate hypersensitivity reaction to antivenin, the type of reaction, permanent disability at hospital discharge, and mortality.\nWe identified a total of 73 patients with rattlesnake bites during the study period. Bite envenomation was graded as nonenvenomated, 7 patients (10%); mild, 23 patients (32%); moderate, 32 patients (44%); and severe, 11 patients (15%). We identified 65 patients who received antivenin. Antivenin doses ranged from 1 to 30 vials per patient (mean, 12.0 +/- 6.0), for a total of 777 vials. In 43 patients (66%), 10 or more vials of antivenin were given. The mean number of vials of antivenin given to each snakebite grade were as follows: mild, 8.4 (+/-4.0); moderate, 11.8 (+/-5.7); and severe, 18.7 (+/-6.3). No deaths, amputations, or permanent disability from snakebite occurred in the patients receiving antivenin. Acute side effects of antivenin-occurring within the first 6 hours after administration-were seen in 12 patients (18%; 95% confidence interval, 10%-30%). Acute side effects consisted solely of urticaria in all but 1 patient (2%; 95% confidence interval, 0%-8%). This patient had a history of previous antivenin reaction and required a short course of intravenous epinephrine for blood pressure support. No other complications occurred.\nDoes the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects?",
        "answer": "no",
        "answer_rationale": "The administration of polyvalent Crotalidae antivenin is safe. Acute hypersensitivity, when it occurs, consists solely in most cases of urticaria. Serious side effects are uncommon.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine the incidence and severity of acute side effects from the use of polyvalent antivenin in victims of rattlesnake bites.\nWe retrospectively reviewed the records of all patients who presented with rattlesnake bites to a university teaching hospital during an 11-year period. From patient medical records, we extracted demographic data, clinical measurements, and outcomes during emergency department evaluation and subsequent hospitalization. Data regarding serum sickness were not collected.\nPrimary outcome variables were the occurrence of immediate hypersensitivity reaction to antivenin, the type of reaction, permanent disability at hospital discharge, and mortality.\nWe identified a total of 73 patients with rattlesnake bites during the study period. Bite envenomation was graded as nonenvenomated, 7 patients (10%); mild, 23 patients (32%); moderate, 32 patients (44%); and severe, 11 patients (15%). We identified 65 patients who received antivenin. Antivenin doses ranged from 1 to 30 vials per patient (mean, 12.0 +/- 6.0), for a total",
        "q2": " of 777 vials. In 43 patients (66%), 10 or more vials of antivenin were given. The mean number of vials of antivenin given to each snakebite grade were as follows: mild, 8.4 (+/-4.0); moderate, 11.8 (+/-5.7); and severe, 18.7 (+/-6.3). No deaths, amputations, or permanent disability from snakebite occurred in the patients receiving antivenin. Acute side effects of antivenin-occurring within the first 6 hours after administration-were seen in 12 patients (18%; 95% confidence interval, 10%-30%). Acute side effects consisted solely of urticaria in all but 1 patient (2%; 95% confidence interval, 0%-8%). This patient had a history of previous antivenin reaction and required a short course of intravenous epinephrine for blood pressure support. No other complications occurred.\nDoes the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects?",
        "generated_text": "of 780 vials. The incidence of immediate hypersensitivity reaction to antivenin was 12% (8 of 65 patients). The type of reaction was urticaria in 5 patients (7.7%), bronchospasm in 2 patients (3.1%), and anaphylaxis in 1 patient (1.5%). There were no permanent disabilities or deaths.\nThe incidence of immediate hypersensitivity reaction to antivenin in our study was 12%, which is higher than previously reported. The type of reaction was predominantly urticaria, with only 1 patient experiencing anaphylaxis. There were no permanent disabilities or deaths related to antivenin use in our study population.",
        "levenshtein_distance": 645
    },
    {
        "realidx": "11567820",
        "question": "To test the hypothesis that increasing the nerve length within the treatment volume for trigeminal neuralgia radiosurgery would improve pain relief.\nEighty-seven patients with typical trigeminal neuralgia were randomized to undergo retrogasserian gamma knife radiosurgery (75 Gy maximal dose with 4-mm diameter collimators) using either one (n = 44) or two (n = 43) isocenters. The median follow-up was 26 months (range 1-36).\nPain relief was complete in 57 patients (45 without medication and 12 with low-dose medication), partial in 15, and minimal in another 15 patients. The actuarial rate of obtaining complete pain relief (with or without medication) was 67.7% +/- 5.1%. The pain relief was identical for one- and two-isocenter radiosurgery. Pain relapsed in 30 of 72 responding patients. Facial numbness and mild and severe paresthesias developed in 8, 5, and 1 two-isocenter patients vs. 3, 4, and 0 one-isocenter patients, respectively (p = 0.23). Improved pain relief correlated with younger age (p = 0.025) and fewer prior procedures (p = 0.039) and complications (numbness or paresthesias) correlated with the nerve length irradiated (p = 0.018).\nDoes increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery?",
        "answer": "no",
        "answer_rationale": "Increasing the treatment volume to include a longer nerve length for trigeminal neuralgia radiosurgery does not significantly improve pain relief but may increase complications.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To test the hypothesis that increasing the nerve length within the treatment volume for trigeminal neuralgia radiosurgery would improve pain relief.\nEighty-seven patients with typical trigeminal neuralgia were randomized to undergo retrogasserian gamma knife radiosurgery (75 Gy maximal dose with 4-mm diameter collimators) using either one (n = 44) or two (n = 43) isocenters. The median follow-up was 26 months (range 1-36).\nPain relief was complete in 57 patients (45 without medication and 12 with low-dose medication), partial in 15, and minimal in another 15 patients. The actuarial rate of obtaining complete pain relief (with or without medication) was 67.7% +/- ",
        "q2": "5.1%. The pain relief was identical for one- and two-isocenter radiosurgery. Pain relapsed in 30 of 72 responding patients. Facial numbness and mild and severe paresthesias developed in 8, 5, and 1 two-isocenter patients vs. 3, 4, and 0 one-isocenter patients, respectively (p = 0.23). Improved pain relief correlated with younger age (p = 0.025) and fewer prior procedures (p = 0.039) and complications (numbness or paresthesias) correlated with the nerve length irradiated (p = 0.018).\nDoes increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery?",
        "generated_text": "4.5% at 1 year and 62.5% +/- 4.7% at 3 years. The actuarial rate of obtaining complete pain relief without medication was 51.7% +/- 4.9% at 1 year and 46.5% +/- 5.1% at 3 years. The actuarial rate of obtaining complete pain relief (with or without medication) was 70.5% +/- 5.7% in the one-isocenter group and 64.9% +/- 6.1% in the two-isocenter group (p = 0.52). The actuarial rate of obtaining complete pain relief without medication was 54.",
        "levenshtein_distance": 432
    },
    {
        "realidx": "11570976",
        "question": "Sulfasalazine is a widely used anti-inflammatory agent in the treatment of inflammatory bowel disease and several rheumatological disorders. Although as many as 20% of treated patients may experience reversible, dose-dependent side effects, less frequent but potentially severe, systemic reactions have also been reported.\nA severe systemic reaction to sulfasalazine developed in a 21-year old female with rheumatoid arthritis characterized by eosinophilia, granulomatous enteritis and myelotoxicity, cholestatic hepatitis, and seizures. The clinical course and management of this patient are presented as well as a review of the incidence and outcome of severe systemic reactions to sulfasalazine.\nIs it Crohn's disease?",
        "answer": "maybe",
        "answer_rationale": "Granulomatous myelotoxicity and enteritis developed in a 21 year old female within 3 weeks of initiating sulfasalazine for rheumatoid arthritis. Following a short course of corticosteroids, the patient had resolution of her cholestatic hepatitis, rash, eosinophilia, and gastrointestinal symptoms with no residual manifestations at 7 months follow-up. Although severe reactions to sulfasalazine are rare and unpredictable, practicing physicians should be aware of unusual clinical presentations of toxicity when prescribing sulfasalazine.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Sulfasalazine is a widely used anti-inflammatory agent in the treatment of inflammatory bowel disease and several rheumatological disorders. Although as many as 20% of treated patients may experience reversible, dose-dependent side effects, less frequent but potentially severe, systemic reactions have also been reported.\nA severe systemic reaction to sulfasalazine developed in a ",
        "q2": "21-year old female with rheumatoid arthritis characterized by eosinophilia, granulomatous enteritis and myelotoxicity, cholestatic hepatitis, and seizures. The clinical course and management of this patient are presented as well as a review of the incidence and outcome of severe systemic reactions to sulfasalazine.\nIs it Crohn's disease?",
        "generated_text": "22-year-old woman with ulcerative colitis. The patient presented with a 2-week history of fever, malaise, and arthralgia. She had been taking sulfasalazine for 6 months prior to the onset of symptoms. Laboratory tests revealed elevated liver enzymes, and a skin biopsy showed interface dermatitis. The patient",
        "levenshtein_distance": 248
    },
    {
        "realidx": "11833948",
        "question": "To detemine the relationship between delay in transfer to rehabilitation wards and outcome for patients aged over 75 years with fracture of the proximal femur.\nAn observational study in a district general hospital of all patients admitted to hospital aged over 75 years with fracture of the proximal femur over 3 1/2 years. Outcome data collected included the number of patients discharged back to their usual residence and total hospital length of stay related to age, gender, usual residence and delay in transfer to a rehabilitation ward.\n58% of 455 patients were transferred to a rehabilitation ward. For those patients who were transferred to a rehabilitation ward only age predicted discharge to a more dependent residence. The relative risk for discharge to a more dependent residence for people aged over 85 years compared to younger people was 1.47 (95% CI 1.15-1.88). Delay in transfer to rehabilitation was associated with a longer total hospital length of stay of 0.64 (95% CI 0.23-1.05) days per day of delay in transfer.\nDoes a delay in transfer to a rehabilitation unit for older people affect outcome after fracture of the proximal femur?",
        "answer": "yes",
        "answer_rationale": "Delay in transfer to a rehabilitation ward was associated with a disproportionate increase in total hospital length of stay for patients aged over 75 with fracture of the proximal femur.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To detemine the relationship between delay in transfer to rehabilitation wards and outcome for patients aged over 75 years with fracture of the proximal femur.\nAn observational study in a district general hospital of all patients admitted to hospital aged over 75 years with fracture of the proximal femur over 3 1/2 years. Outcome data collected included the number of patients discharged back to their usual residence and total hospital length of stay related to age, gender, usual residence and delay in transfer to a rehabilitation ward.\n58% of 455 patients were transferred to a rehabilitation ward. For those patients who",
        "q2": " were transferred to a rehabilitation ward only age predicted discharge to a more dependent residence. The relative risk for discharge to a more dependent residence for people aged over 85 years compared to younger people was 1.47 (95% CI 1.15-1.88). Delay in transfer to rehabilitation was associated with a longer total hospital length of stay of 0.64 (95% CI 0.23-1.05) days per day of delay in transfer.\nDoes a delay in transfer to a rehabilitation unit for older people affect outcome after fracture of the proximal femur?",
        "generated_text": "were transferred to a rehabilitation ward, the median delay was 10 days (range 1-112). The median delay for those not transferred was 1 day (range 0-112). The median age was 83 years (range 75-100). 64% were female. 52% were living at home prior to admission. 44% were discharged back to their usual residence. Median length of stay was 28 days (range 1-112). Delay in transfer to a rehabilitation ward",
        "levenshtein_distance": 350
    },
    {
        "realidx": "11862129",
        "question": "To determine if clinical variables assessed in relation to Albuterol aerosol treatments accurately identify children with pathologic radiographs during their initial episode of bronchospasm.\nA prospective convenience sample of children with a first episode of wheezing. Data collected included demographics, baseline and post-treatment clinical score and physical examination, number of aerosols, requirement for supplemental oxygen, and disposition. Chest radiographs were obtained and interpreted, and patients were divided into 2 groups based on a pathologic versus nonpathologic radiograph interpretation. Chi2 testing was performed for categoric variables, and the student t test was performed for continuous variables. A discriminant analysis was used to develop a model.\nPathologic radiographs were identified in 61 patients (9%). Between groups, a significant difference was noted for pretreatment oxygen saturation only. Clinical score, respiratory rate, and presence of rales both pretreatment and posttreatment were not significantly different between groups. The discriminant analysis correctly predicted 90% of nonpathologic radiographs but only 15% of pathologic radiographs.\nDo clinical variables predict pathologic radiographs in the first episode of wheezing?",
        "answer": "no",
        "answer_rationale": "Clinical variables, either isolated or as components of a model, could not identify all children with pathologic radiographs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine if clinical variables assessed in relation to Albuterol aerosol treatments accurately identify children with pathologic radiographs during their initial episode of bronchospasm.\nA prospective convenience sample of children with a first episode of wheezing. Data collected included demographics, baseline and post-treatment clinical score and physical examination, number of aerosols, requirement for supplemental oxygen, and disposition. Chest radiographs were obtained and interpreted, and patients were divided into 2 groups based on a pathologic versus nonpathologic radiograph interpretation. Chi2 testing was performed for categoric variables, and the student",
        "q2": " t test was performed for continuous variables. A discriminant analysis was used to develop a model.\nPathologic radiographs were identified in 61 patients (9%). Between groups, a significant difference was noted for pretreatment oxygen saturation only. Clinical score, respiratory rate, and presence of rales both pretreatment and posttreatment were not significantly different between groups. The discriminant analysis correctly predicted 90% of nonpathologic radiographs but only 15% of pathologic radiographs.\nDo clinical variables predict pathologic radiographs in the first episode of wheezing?",
        "generated_text": "t test was used for continuous variables. A p value of <0.05 was considered significant.\nA total of 100 patients were enrolled, 50 with pathologic and 50 with nonpathologic radiographs. There was no difference in age, sex, race, or insurance status between the 2 groups. There was no difference in the number of aerosols, the need for supplemental oxygen, or disposition between the 2 groups. There was no difference in the baseline or post-treatment clinical scores between the 2 groups. There",
        "levenshtein_distance": 417
    },
    {
        "realidx": "11867487",
        "question": "To examine the attitudes of players and coaches to the use of protective headgear, particularly with respect to the prevention of concussion.\nA questionnaire designed to assess attitudes to headgear was administered to 63 players from four different Canadian teams, each representing a different level of play (high school, university, community club, national). In addition, coaches from all four levels were questioned about team policies and their personal opinions about the use of headgear to prevent concussion.\nAlthough the players tended to believe that the headgear could prevent concussion (62%), the coaches were less convinced (33%). Despite the players' belief that headgear offers protection against concussion, only a minority reported wearing headgear (27%) and few (24%) felt that its use should be made mandatory. Common reasons for not wearing headgear were \"its use is not mandatory\", \"it is uncomfortable\", and \"it costs too much\".\nDoes rugby headgear prevent concussion?",
        "answer": "maybe",
        "answer_rationale": "Although most players in the study believe that rugby headgear may prevent concussion, only a minority reported wearing it. Coaches tended to be less convinced than the players that rugby headgear can prevent concussion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To examine the attitudes of players and coaches to the use of protective headgear, particularly with respect to the prevention of concussion.\nA questionnaire designed to assess attitudes to headgear was administered to 63 players from four different Canadian teams, each representing a different level of play (high school, university, community club, national). In addition, coaches from all four levels were questioned about team policies and their personal opinions about the use of headgear to prevent concussion.\nAlthough the",
        "q2": " players tended to believe that the headgear could prevent concussion (62%), the coaches were less convinced (33%). Despite the players' belief that headgear offers protection against concussion, only a minority reported wearing headgear (27%) and few (24%) felt that its use should be made mandatory. Common reasons for not wearing headgear were \"its use is not mandatory\", \"it is uncomfortable\", and \"it costs too much\".\nDoes rugby headgear prevent concussion?",
        "generated_text": "majority of players and coaches believed that headgear could prevent concussion, there was a significant difference in the perceived effectiveness of headgear between players and coaches. Players were more likely to believe that headgear could prevent concussion, while coaches were more cautious in their assessment. Additionally, there was a notable variation in team policies regarding the use of headgear across the different levels of play.\nThe study suggests that there is a need for more education and standardization regarding the use of",
        "levenshtein_distance": 372
    },
    {
        "realidx": "11926574",
        "question": "Hepatitis G virus can cause chronic infection in man but the role of this agent in chronic liver disease is poorly understood. Little is known about the relation of another newly discovered agent, the TT virus, with chronic liver disease.AIM: To investigate the rate of infection with hepatitis G virus and TT virus in patients with cryptogenic chronic liver disease.\nA total of 23 subjects with chronically raised alanine transaminase and a liver biopsy in whom all known causes of liver disease had been excluded, and 40 subjects with hepatitis C virus-related chronic liver disease.\nEvaluation of anti-hepatitis G virus by enzyme immunoassay. Hepatitis G virus-RNA by polymerase chain reaction with primers from the 5' NC and NS5a regions. TT virus-DNA by nested polymerase chain reaction with primers from the ORF1 region. Results. Hepatitis G virus-RNA was detected in 4 out of 23 patients with cryptogenic chronic hepatitis and in 6 out of 40 with hepatitis C virus chronic hepatitis (17.4% vs 15% p=ns). At least one marker of hepatitis G virus infection (hepatitis G virus-RNA and/or anti-hepatitis G virus, mostly mutually exclusive) was present in 6 out of 23 patients with cryptogenic hepatitis and 16 out of 40 with hepatitis C virus liver disease (26. 1% vs 40% p=ns). T virus-DNA was present in serum in 3 subjects, 1 with cryptogenic and 2 with hepatitis C virus-related chronic liver disease. Demographic and clinical features, including stage and grade of liver histology, were comparable between hepatitis G virus-infected and uninfected subjects. Severe liver damage [chronic hepatitis with fibrosis or cirrhosis) were significantly more frequent in subjects with hepatitis C virus liver disease.\nAre hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?",
        "answer": "no",
        "answer_rationale": "In Southern Italy, hepatitis G virus infection is widespread among patients with chronic hepatitis, independently of parenteral risk factors. Its frequency in subjects with cryptogenic liver disease parallels that observed in hepatitis C virus chronic liver disease, thus ruling out an aetiologic role of hepatitis G virus. TT virus infection is uncommon in patients with cryptogenic or hepatitis C virus-related liver disease who do not have a history of parenteral exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Hepatitis G virus can cause chronic infection in man but the role of this agent in chronic liver disease is poorly understood. Little is known about the relation of another newly discovered agent, the TT virus, with chronic liver disease.AIM: To investigate the rate of infection with hepatitis G virus and TT virus in patients with cryptogenic chronic liver disease.\nA total of 23 subjects with chronically raised alanine transaminase and a liver biopsy in whom all known causes of liver disease had been excluded, and 40 subjects with hepatitis C virus-related chronic liver disease.\nEvaluation of anti-hepatitis G virus by enzyme immunoassay. Hepatitis G virus-RNA by polymerase chain reaction with primers from the 5' NC and NS5a regions. TT virus-DNA by nested polymerase chain reaction with primers from the ORF1 region. Results. Hepatitis G virus-RNA was detected in 4 out of 23 patients with cryptogenic chronic hepatitis and in",
        "q2": " 6 out of 40 with hepatitis C virus chronic hepatitis (17.4% vs 15% p=ns). At least one marker of hepatitis G virus infection (hepatitis G virus-RNA and/or anti-hepatitis G virus, mostly mutually exclusive) was present in 6 out of 23 patients with cryptogenic hepatitis and 16 out of 40 with hepatitis C virus liver disease (26. 1% vs 40% p=ns). T virus-DNA was present in serum in 3 subjects, 1 with cryptogenic and 2 with hepatitis C virus-related chronic liver disease. Demographic and clinical features, including stage and grade of liver histology, were comparable between hepatitis G virus-infected and uninfected subjects. Severe liver damage [chronic hepatitis with fibrosis or cirrhosis) were significantly more frequent in subjects with hepatitis C virus liver disease.\nAre hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?",
        "generated_text": "22 out of 40 patients with hepatitis C virus-related chronic liver disease (p < 0.001). TT virus-DNA was detected in 10 out of 23 patients with cryptogenic chronic hepatitis and in 14 out of 40 patients with hepatitis C virus-related chronic liver disease (p = NS). The rate of infection with hepatitis G virus and TT virus was similar in patients with cryptogenic chronic hepatitis and in patients with hepatitis C virus-related chronic liver disease.\nHepatitis G virus and TT virus are not involved in the pathogenesis of cryptogenic chronic liver disease.",
        "levenshtein_distance": 526
    },
    {
        "realidx": "11943048",
        "question": "To compare analgesic management of daily pain for dying nursing home residents enrolled and not enrolled in Medicare hospice.\nRetrospective, comparative cohort study.\nOver 800 nursing homes in Kansas, Maine, Mississippi, New York, and South Dakota.\nA subset of residents with daily pain near the end of life taken from a matched cohort of hospice (2,644) and nonhospice (7,929) nursing home residents who had at least two resident assessments (Minimum Data Sets (MDSs)) completed, their last between 1992 and 1996, and who died before April 1997. The daily pain subset consisted of 709 hospice and 1,326 nonhospice residents.\nDetailed drug use data contained on the last MDS before death were used to examine analgesic management of daily pain. Guidelines from the American Medical Directors Association (AMDA) were used to identify analgesics not recommended for use in managing chronic pain in long-term care settings. The study outcome, regular treatment of daily pain, examined whether patients received any analgesic, other than those not recommended by AMDA, at least twice a day for each day of documented daily pain (i.e., 7 days before date of last MDS).\nFifteen percent of hospice residents and 23% of nonhospice residents in daily pain received no analgesics (odds ratio (OR) = 0.57, 95% confidence interval (CI) = 0.45-0.74). A lower proportion of hospice residents (21%) than of nonhospice residents (29%) received analgesics not recommended by AMDA (OR = 0.65, 95% CI =0.52-0.80). Overall, acetaminophen (not in combination with other drugs) was used most frequently for nonhospice residents (25% of 1,673 prescriptions), whereas morphine derivatives were used most frequently for hospice residents (30% of 1,058 prescriptions). Fifty-one percent of hospice residents and 33% of nonhospice residents received regular treatment for daily pain. Controlling for clinical confounders, hospice residents were twice as likely as nonhospice residents to receive regular treatment for daily pain (adjusted odds ratio = 2.08, 95% CI = 1.68-2.56).\nDoes receipt of hospice care in nursing homes improve the management of pain at the end of life?",
        "answer": "yes",
        "answer_rationale": "Findings suggest that analgesic management of daily pain is better for nursing home residents enrolled in hospice than for those not enrolled in hospice.The prescribing practices portrayed by this study reveal that many dying nursing home residents in daily pain are receiving no analgesic treatment or are receiving analgesic treatment inconsistent with AMDA and other pain management guidelines. Improving the analgesic management of pain in nursing homes is essential if high-quality end-of-life care in nursing homes is to be achieved.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To compare analgesic management of daily pain for dying nursing home residents enrolled and not enrolled in Medicare hospice.\nRetrospective, comparative cohort study.\nOver 800 nursing homes in Kansas, Maine, Mississippi, New York, and South Dakota.\nA subset of residents with daily pain near the end of life taken from a matched cohort of hospice (2,644) and nonhospice (7,929) nursing home residents who had at least two resident assessments (Minimum Data Sets (MDSs)) completed, their last between 1992 and 1996, and who died before April 1997. The daily pain subset consisted of 709 hospice and 1,326 nonhospice residents.\nDetailed drug use data contained on the last MDS before death were used to examine analgesic management of daily pain. Guidelines from the American Medical Directors Association (AMDA) were used to identify analgesics not recommended for use in managing chronic pain in long-term care settings. The study outcome, regular treatment of daily pain, examined whether patients received any analgesic, other than those not recommended by AMDA, at least twice a day for each day of documented daily pain (i.e., 7 days before date of last MDS).\n",
        "q2": "Fifteen percent of hospice residents and 23% of nonhospice residents in daily pain received no analgesics (odds ratio (OR) = 0.57, 95% confidence interval (CI) = 0.45-0.74). A lower proportion of hospice residents (21%) than of nonhospice residents (29%) received analgesics not recommended by AMDA (OR = 0.65, 95% CI =0.52-0.80). Overall, acetaminophen (not in combination with other drugs) was used most frequently for nonhospice residents (25% of 1,673 prescriptions), whereas morphine derivatives were used most frequently for hospice residents (30% of 1,058 prescriptions). Fifty-one percent of hospice residents and 33% of nonhospice residents received regular treatment for daily pain. Controlling for clinical confounders, hospice residents were twice as likely as nonhospice residents to receive regular treatment for daily pain (adjusted odds ratio = 2.08, 95% CI = 1.68-2.56).\nDoes receipt of hospice care in nursing homes improve the management of pain at the end of life?",
        "generated_text": "Analyses were adjusted for clustering of residents within nursing homes and for differences in resident characteristics.\nOnly 38% of hospice and 28% of nonhospice residents received regular treatment of daily pain. Hospice residents were more likely to receive regular treatment of daily pain (odds ratio (OR)=1.6, 95% confidence interval (CI)=1.3-2.0). Among residents who received regular treatment of daily pain, 40% of hospice and 32% of nonhospice residents received at least one analgesic not recommended by AMDA (OR=1.5, 95% CI=1.1-2.1). Among residents who did not receive regular treatment of daily pain, 20% of hospice and 15% of nonhospice residents received at least one analgesic not recommended by AMDA (OR=1.4, 95% CI=1.0-1.9).\nHospice residents were more likely to receive regular treatment of daily pain, but also more likely to receive analgesics not recommended for chronic pain management. These findings suggest that hospice enrollment may improve analges",
        "levenshtein_distance": 705
    },
    {
        "realidx": "11955750",
        "question": "To show the results of treating posterior uveal melanomas with 106Ru plaque beta-ray radiotherapy and to review and discuss the literature concerning the optimal apical dose prescription (100 vs. 160 Gy).\nForty-eight patients with uveal melanomas (median height 3.85 mm + 1 mm sclera) were treated with ruthenium plaques. The median apical dose was 120 Gy, the median scleral dose 546 Gy.\nAfter 5.8 years of follow-up, the overall 5-year survival rate was 90%, the disease specific 5-year survival rate was 92% (3 patients alive with metastasis). Six percent received a second ruthenium application, 10% of the eyes had to be enucleated. Local control was achieved in 90% of the patients with conservative therapy alone. Central or paracentral tumors showed 50% of the pretherapeutic vision after 4 years, and 80% of the vision was preserved in those with peripheral tumors. The main side effects were mostly an uncomplicated retinopathy (30%); macular degeneration or scarring led to poor central vision in 30% of cases.\nDoes escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?",
        "answer": "no",
        "answer_rationale": "Brachytherapy with ruthenium applicators is an effective therapy for small- and medium-size posterior uveal melanomas. Our results are comparable to other series. The treatment outcome does not seem to be capable of improvement by increasing the apical dose. An internationally accepted model for defining the dosage in brachytherapy is needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To show the results of treating posterior uveal melanomas with 106Ru plaque beta-ray radiotherapy and to review and discuss the literature concerning the optimal apical dose prescription (100 vs. 160 Gy).\nForty-eight patients with uveal melanomas (median height 3.85 mm + 1 mm sclera) were treated with ruthenium plaques. The median apical dose was 120 Gy, the median scleral dose 546 Gy.\nAfter 5.8 years of follow-up, the overall 5-year survival rate was 90%, the disease specific 5-year survival rate was 92% (3 patients alive with metastasis). Six",
        "q2": " percent received a second ruthenium application, 10% of the eyes had to be enucleated. Local control was achieved in 90% of the patients with conservative therapy alone. Central or paracentral tumors showed 50% of the pretherapeutic vision after 4 years, and 80% of the vision was preserved in those with peripheral tumors. The main side effects were mostly an uncomplicated retinopathy (30%); macular degeneration or scarring led to poor central vision in 30% of cases.\nDoes escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?",
        "generated_text": "patients died of metastatic disease, 2 of other causes. The 5-year local control rate was 96% (1 local recurrence). The 5-year enucleation-free rate was 88% (6 enucleations). The 5-year visual acuity of 20/40 or better was 50% (n = 24). The 5-year visual acuity of 20/200 or better was 75% (n = 36). The 5-year visual acuity of light perception or better was 92% (n = 44). The 5-year rate",
        "levenshtein_distance": 438
    },
    {
        "realidx": "11970923",
        "question": "The prevalence of retinal haemorrhages after convulsions is not well established. As these haemorrhages are considered characteristic of child abuse, we investigated their occurrence after convulsive episodes to see whether the finding of haemorrhage should prompt further investigation.\nProspective study of 153 children (aged 2 months to 2 years), seen in the emergency department after a convulsive episode. After a thorough history and physical examination, a retinal examination was performed by an ophthalmologist. If findings were positive, further investigation was undertaken to rule out systemic disorder or child abuse.\nOne child was found with unilateral retinal haemorrhages following an episode of a simple febrile convulsion. A thorough investigation uncovered no other reason for this finding.\nConvulsions and retinal haemorrhage: should we look further?",
        "answer": "yes",
        "answer_rationale": "Retinal haemorrhages following a convulsive episode are rare. Such a finding should trigger an extensive search for other reasons, including child abuse.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The prevalence of retinal haemorrhages after convulsions is not well established. As these haemorrhages are considered characteristic of child abuse, we investigated their occurrence after convulsive episodes to see whether the finding of haemorrhage should prompt further investigation.\nProspective study of 153 children (aged 2 months to 2 years), seen in the emergency department after a convulsive episode. After a",
        "q2": " thorough history and physical examination, a retinal examination was performed by an ophthalmologist. If findings were positive, further investigation was undertaken to rule out systemic disorder or child abuse.\nOne child was found with unilateral retinal haemorrhages following an episode of a simple febrile convulsion. A thorough investigation uncovered no other reason for this finding.\nConvulsions and retinal haemorrhage: should we look further?",
        "generated_text": "standardised history and examination, all children had a complete ophthalmological examination, including dilatation of the pupils and examination with a binocular indirect ophthalmoscope. The children were followed up for 12 months.\nRetinal haemorrhages were found in 10 (6.5%) of the 153 children. The haemorrhages were unilateral in five children and bilateral",
        "levenshtein_distance": 310
    },
    {
        "realidx": "11977907",
        "question": "A side-to-side difference in systolic brachial arterial blood pressure is a common finding in subclavian artery stenosis and is frequently used as a screening tool for subclavian steal syndrome (SSS). It was the goal of this retrospective study to investigate the relationship between different vertebral artery waveform types and the side-to-side difference in systolic blood pressure in patients with sonographically proven SSS.\nThe records of 1860 patients from the Neuroultrasound Laboratory between January 2000 and December 2000 were screened for the diagnosis of SSS in the final ultrasound report. In all patients, bilateral brachial arterial blood pressure was measured in a sitting position prior to the ultrasound examination. Vertebral artery waveforms were classified as (1) systolic deceleration, (2) alternating flow, and (3) complete reversal at rest. Blood pressure difference as calculated by normal-side blood pressure minus lesion-side blood pressure was compared with the 3 Doppler waveform types.\nSSS was found in 51 of 1860 (2.7%) ultrasonography studies of 49 patients (17 men, 32 women; mean age 65.3 +/- 10.5 years). Two patients (4%) had bilateral SSS. In 3 patients (6%), SSS was related to an innominate artery stenosis. Waveform analysis showed a completely reversed flow in 16 (31%), an alternating flow in 24 (47%), and a systolic deceleration in 11 (22%) cases. Systolic blood pressure difference was significantly higher in the complete reversal and alternating groups than in the systolic deceleration group (P<.001).\nSubclavian steal syndrome: can the blood pressure difference between arms predict the severity of steal?",
        "answer": "yes",
        "answer_rationale": "Brachial systolic blood pressure difference is related to the severity of SSS and can be used as a screening tool for SSS. However, it performed better in severe steal than milder steal phenomena.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "A side-to-side difference in systolic brachial arterial blood pressure is a common finding in subclavian artery stenosis and is frequently used as a screening tool for subclavian steal syndrome (SSS). It was the goal of this retrospective study to investigate the relationship between different vertebral artery waveform types and the side-to-side difference in systolic blood pressure in patients with sonographically proven SSS.\nThe records of 1860 patients from the Neuroultrasound Laboratory between January 2000 and December 2000 were screened for the diagnosis of SSS in the final ultrasound report. In all patients, bilateral brachial arterial blood pressure was measured in a sitting position prior to the ultrasound examination. Vertebral artery waveforms were classified as (1) systolic deceleration, (2) alternating flow, and (3) complete reversal at rest. Blood pressure difference as calculated by",
        "q2": " normal-side blood pressure minus lesion-side blood pressure was compared with the 3 Doppler waveform types.\nSSS was found in 51 of 1860 (2.7%) ultrasonography studies of 49 patients (17 men, 32 women; mean age 65.3 +/- 10.5 years). Two patients (4%) had bilateral SSS. In 3 patients (6%), SSS was related to an innominate artery stenosis. Waveform analysis showed a completely reversed flow in 16 (31%), an alternating flow in 24 (47%), and a systolic deceleration in 11 (22%) cases. Systolic blood pressure difference was significantly higher in the complete reversal and alternating groups than in the systolic deceleration group (P<.001).\nSubclavian steal syndrome: can the blood pressure difference between arms predict the severity of steal?",
        "generated_text": "subtracting the lower from the higher systolic blood pressure was compared between the different waveform types.\nA total of 100 patients with SSS were identified. The mean age was 68.4 years (range, 37-91 years). The mean blood pressure difference was 14.1 mm Hg (range, 0-50 mm Hg). The mean blood pressure difference was 10.1 mm Hg in patients with systolic deceleration, 14.1 mm Hg in patients with alternating flow, and 20.1 mm Hg in patients with complete reversal at rest (P < .001). The mean blood pressure difference was 10.1 mm Hg in patients with systolic deceleration, 14.1 mm Hg in patients with alternating flow, and 2",
        "levenshtein_distance": 514
    },
    {
        "realidx": "12006913",
        "question": "Studies on coronary risk factors in men and women are mainly based on mortality data and few compare results of both sexes with consistent study design and diagnostic criteria. This study assesses the major risk factors for coronary events in men and women from the Reykjavik Study.\nWithin a prospective, population-based cohort study individuals without history of myocardial infarction were identified and the relative risk of baseline variables was assessed in relation to verified myocardial infarction or coronary death during follow-up.\nOf the 9681 women and 8888 men who attended risk assessment from 1967-1991, with follow-up period of up to 28 years, 706 women and 1700 men suffered a non-fatal myocardial infarction or coronary death.\nSerum cholesterol was a significant risk factor for both sexes, with hazard ratios (HR) decreasing with age. Systolic blood pressure was a stronger risk factor for women as was ECG-confirmed left ventricular hypertrophy (women HR 2.89, 95% confidence interval [CI] 1.67-5.01; men HR 1.11 [CI 0.86-1.43]). Fasting blood glucose>or =6.7 mmol/L identified significantly higher risk for women (HR 2.65) than men (HR 2.08) as did self-reported diabetes. Triglyceride risk was significantly higher for women and decreased significantly with age. Smoking increased risk two- to five-fold, increasing with dose, for women, which was significantly higher than the doubling in risk for men.\nDo lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men?",
        "answer": "no",
        "answer_rationale": "This large study of the major risk factors compared between the sexes demonstrates similar relative risk of myocardial infarction associated with cholesterol for both sexes, however, the relative risk is higher in women for many other risk factors such as smoking, diabetes, elevated triglycerides and left ventricular hypertrophy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Studies on coronary risk factors in men and women are mainly based on mortality data and few compare results of both sexes with consistent study design and diagnostic criteria. This study assesses the major risk factors for coronary events in men and women from the Reykjavik Study.\nWithin a prospective, population-based cohort study individuals without history of myocardial infarction were identified and the relative risk of baseline variables was assessed in relation to verified myocardial infarction or coronary death during follow-up.\nOf the 9681 women and 8888 men who attended risk assessment from 1967-1991, with follow-up period of up to 28 years, 706 women and 1700 men suffered a non-fatal myocardial infarction or coronary death.\nSerum cholesterol was a significant risk factor for both sexes, with hazard ratios (HR) decreasing with age. Systolic",
        "q2": " blood pressure was a stronger risk factor for women as was ECG-confirmed left ventricular hypertrophy (women HR 2.89, 95% confidence interval [CI] 1.67-5.01; men HR 1.11 [CI 0.86-1.43]). Fasting blood glucose>or =6.7 mmol/L identified significantly higher risk for women (HR 2.65) than men (HR 2.08) as did self-reported diabetes. Triglyceride risk was significantly higher for women and decreased significantly with age. Smoking increased risk two- to five-fold, increasing with dose, for women, which was significantly higher than the doubling in risk for men.\nDo lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men?",
        "generated_text": "blood pressure was a significant risk factor for both sexes, with HR decreasing with age. Smoking was a significant risk factor for both sexes, with HR decreasing with age. Diabetes was a significant risk factor for both sexes, with HR decreasing with age. Body mass index was a significant risk factor for both sexes, with HR decreasing with age. Physical activity was a significant risk factor for both sexes, with HR decreasing with age. Family history of myocardial infarction was a significant risk factor for both sexes, with HR decreasing with age.\nIn conclusion, the major risk factors for coronary events are similar in men and women, but the relative risk decreases with age in both sexes.",
        "levenshtein_distance": 518
    },
    {
        "realidx": "12040336",
        "question": "The role of early revascularization among patients with acute myocardial infarction complicated by cardiogenic shock remains controversial. Angioplasty registries, while suggesting a benefit, are subject to selection bias, and clinical trials have been underpowered to detect early benefits. If an invasive strategy is beneficial in this population, patients admitted to hospitals with onsite coronary revascularization might be expected to have a better prognosis. We sought to determine whether access to cardiovascular resources at the admitting hospital influenced the prognosis of patients with acute myocardial infarction complicated by cardiogenic shock.\nBy use of the Cooperative Cardiovascular Project database (a retrospective medical record review of Medicare patients discharged with acute myocardial infarction), we identified patients aged>or =65 years whose myocardial infarction was complicated by cardiogenic shock.\nOf the 601 patients with cardiogenic shock, 287 (47.8%) were admitted to hospitals without revascularization services and 314 (52.2%) were admitted to hospitals with coronary angioplasty and coronary artery bypass surgery facilities. Clinical characteristics were similar across the subgroups. Patients admitted to hospitals with revascularization services were more likely to undergo coronary revascularization during the index hospitalization and during the first month after acute myocardial infarction. After adjustment for demographic, clinical, hospital, and treatment strategies, the presence of onsite revascularization services was not associated with a significantly lower 30-day (odds ratio 0.83, 95% CI 0.47, 1.45) or 1-year mortality (odds ratio 0.91, 95% CI 0.49, 1.72).\nCardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival?",
        "answer": "no",
        "answer_rationale": "In a community-based cohort, patients with acute myocardial infarction complicated by cardiogenic shock did not have significantly different adjusted 30-day and 1-year mortality, irrespective of the revascularization capabilities of the admitting hospital.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The role of early revascularization among patients with acute myocardial infarction complicated by cardiogenic shock remains controversial. Angioplasty registries, while suggesting a benefit, are subject to selection bias, and clinical trials have been underpowered to detect early benefits. If an invasive strategy is beneficial in this population, patients admitted to hospitals with onsite coronary revascularization might be expected to have a better prognosis. We sought to determine whether access to cardiovascular resources at the admitting hospital influenced the prognosis of patients with acute myocardial infarction complicated by cardiogenic shock.\nBy use of the Cooperative Cardiovascular Project database (a retrospective medical record review of Medicare patients discharged with acute myocardial infarction), we identified patients aged>or =65 years whose myocardial infarction was complicated by cardiogenic shock.\nOf the 601 patients with cardiogenic shock, 287 (47.8%) were admitted to hospitals",
        "q2": " without revascularization services and 314 (52.2%) were admitted to hospitals with coronary angioplasty and coronary artery bypass surgery facilities. Clinical characteristics were similar across the subgroups. Patients admitted to hospitals with revascularization services were more likely to undergo coronary revascularization during the index hospitalization and during the first month after acute myocardial infarction. After adjustment for demographic, clinical, hospital, and treatment strategies, the presence of onsite revascularization services was not associated with a significantly lower 30-day (odds ratio 0.83, 95% CI 0.47, 1.45) or 1-year mortality (odds ratio 0.91, 95% CI 0.49, 1.72).\nCardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival?",
        "generated_text": "with onsite coronary revascularization, and 314 (52.2%) were admitted to hospitals without onsite coronary revascularization. Patients admitted to hospitals with onsite coronary revascularization were younger, more likely to be male, and had fewer comorbidities. After adjustment for age, sex, race, comorbidities, and year of admission, patients admitted to hospitals with onsite coronary revascularization had a lower in-hospital mortality (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.41 to 0.80; P=0.001). This difference persisted after adjustment for the use of invasive procedures (OR, 0.60; 95% CI, 0.42 to 0.85; P=0",
        "levenshtein_distance": 536
    },
    {
        "realidx": "12070552",
        "question": "A tonsillectomy audit was carried out and compared with other studies, to emphasize the role of antibiotics.\nThis study was carried out at North West Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia, during the year January 1999 through to December 1999. This is a retrospective study of patients who had tonsillectomy with or with adenoidectomy, the topics audited included indication for surgery, grade of surgeon, method of surgery, length of hospital stay, complications and the use of postoperative antibiotics.\nA total of 185 patients underwent tonsillectomy with or without adenoidectomy. The patients age ranged between 2 years to 53 years and the majority were children. In our audit we found no difference with regard to grade of surgeons, method of hemostasis in the outcome of surgery. Moreover, postoperative antibiotics had no role in pain control, postoperative fever, secondary hemorrhage or reduction in hospital stay. The administration of analgesics on the basis of, as required, had poor pain control.\nDo antibiotics decrease post-tonsillectomy morbidity?",
        "answer": "no",
        "answer_rationale": "Post tonsillectomy antibiotics did not prove to have a role in minimizing postoperative morbidity. Moreover, analgesics given on the basis of as required had a limited value.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "A tonsillectomy audit was carried out and compared with other studies, to emphasize the role of antibiotics.\nThis study was carried out at North West Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia, during the year January 1999 through to December 1999. This is a retrospective study of patients who had tonsillectomy with or with adenoidectomy, the topics audited included indication for surgery, grade of surgeon, method of surgery, length of hospital stay, complications and the use of postoperative antibiotics.\nA total of ",
        "q2": "185 patients underwent tonsillectomy with or without adenoidectomy. The patients age ranged between 2 years to 53 years and the majority were children. In our audit we found no difference with regard to grade of surgeons, method of hemostasis in the outcome of surgery. Moreover, postoperative antibiotics had no role in pain control, postoperative fever, secondary hemorrhage or reduction in hospital stay. The administration of analgesics on the basis of, as required, had poor pain control.\nDo antibiotics decrease post-tonsillectomy morbidity?",
        "generated_text": "100 patients were included in this study, 50 patients had tonsillectomy alone and 50 patients had tonsillectomy with adenoidectomy. The age ranged from 2 to 50 years, with a mean age of 12 years. The male to female ratio was 1.5:1. The indications for surgery were recurrent tonsillitis in 70% of cases, obstructive sleep apnea in 15%, peritonsillar abscess in 10",
        "levenshtein_distance": 374
    },
    {
        "realidx": "12090319",
        "question": "To determine the necessity of pelvic computed tomography (CT) in patients of renal cell carcinoma (RCC).\nWe reviewed the records of 400 patients of RCC, who underwent treatment at our institution between January 1988 and February 2001. These patients were evaluated pre-operatively with ultrasonograms (USG) and contrast enhanced CT scan of the abdomen and pelvis. USG or CT scans of these cases were reviewed for presence of pathology in the pelvis, which were classified into 3 categories viz; benign and likely to be insignificant, benign and likely to be significant; and malignant.\nOf the 400 cases, 114 were stage I, 68 were stage II, 99 were stage III and 119 were stage IV. In all patients, tumour was identified in the kidney on preoperative CT scan. Fourteen patients (3.5%) had an abnormality on pelvic CT. Five (1.25%) had category 1, three (0.75%) had category 2 and six (1.5%) had category 3 abnormality on pelvic CT. However, all these abnormalities in pelvis were detected prior to CT by other investigations (USG or plain x-ray). Of the six cases with malignant findings, two had superficial bladder cancer, one had RCC in a pelvic kidney and three had bone metastases in the pelvis.\nIs there a need for pelvic CT scan in cases of renal cell carcinoma?",
        "answer": "no",
        "answer_rationale": "Pelvic CT does not offer additional information in the vast majority of cases with RCC and should be performed selectively. Thus the cost of diagnostic imaging in RCC can be reduced.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine the necessity of pelvic computed tomography (CT) in patients of renal cell carcinoma (RCC).\nWe reviewed the records of 400 patients of RCC, who underwent treatment at our institution between January 1988 and February 2001. These patients were evaluated pre-operatively with ultrasonograms (USG) and contrast enhanced CT scan of the abdomen and pelvis. USG or CT scans of these cases were reviewed for presence of pathology in the pelvis, which were classified into 3 categories viz; benign and likely to be insignificant, benign and likely to be significant; and malignant.\nOf the 400 cases, 114 were stage I, 68 were stage II, 99 were stage III and ",
        "q2": "119 were stage IV. In all patients, tumour was identified in the kidney on preoperative CT scan. Fourteen patients (3.5%) had an abnormality on pelvic CT. Five (1.25%) had category 1, three (0.75%) had category 2 and six (1.5%) had category 3 abnormality on pelvic CT. However, all these abnormalities in pelvis were detected prior to CT by other investigations (USG or plain x-ray). Of the six cases with malignant findings, two had superficial bladder cancer, one had RCC in a pelvic kidney and three had bone metastases in the pelvis.\nIs there a need for pelvic CT scan in cases of renal cell carcinoma?",
        "generated_text": "119 were stage IV. In 114 patients of stage I, 10 had pelvic pathology, of which 9 were benign and 1 was malignant. In 68 patients of stage II, 11 had pelvic pathology, of which 10 were benign and 1 was malignant. In 99 patients of stage III, 17 had pelvic pathology, of which 15 were benign and 2 were malignant. In 119 patients of stage IV, 22 had pelvic pathology, of which 18 were benign and 4 were malignant. In 400 patients, 60 had pelvic pathology, of which 43",
        "levenshtein_distance": 426
    },
    {
        "realidx": "12094116",
        "question": "The purpose of this study was to identify the relationships between leg muscle power and sprinting speed with changes of direction.\nthe study was designed to describe relationships between physical qualities and a component of sports performance.\ntesting was conducted in an indoor sports hall and a biomechanics laboratory.\n15 male participants were required to be free of injury and have recent experience competing in sports involving sprints with changes of direction.\nsubjects were timed in 8 m sprints in a straight line and with various changes of direction. They were also tested for bilateral and unilateral leg extensor muscle concentric power output by an isokinetic squat and reactive strength by a drop jump.\nThe correlations between concentric power and straight sprinting speed were non-significant whereas the relationships between reactive strength and straight speed were statistically significant. Correlations between muscle power and speed while changing direction were generally low and non-significant for concentric leg power with some moderate and significant (p<0.05) coefficients found for reactive strength. The participants who turned faster to one side tended to have a reactive strength dominance in the leg responsible for the push-off action.\nIs muscle power related to running speed with changes of direction?",
        "answer": "yes",
        "answer_rationale": "The relationships between leg muscle power and change-of-direction speed were not consistent. Reactive strength as measured by the drop jump appears to have some importance for lateral change-of-direction speed, possibly because of similar push-off actions. It was concluded that reactive strength of the leg extensor muscles has some importance in change-of-direction performance but the other technical and perceptual factors than influence agility performance should also be considered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study was to identify the relationships between leg muscle power and sprinting speed with changes of direction.\nthe study was designed to describe relationships between physical qualities and a component of sports performance.\ntesting was conducted in an indoor sports hall and a biomechanics laboratory.\n15 male participants were required to be free of injury and have recent experience competing in sports involving sprints with changes of direction.\nsubjects were timed in 8 m sprints in a straight line and with various changes of direction. They were also tested for bilateral and unilateral leg extensor muscle concentric power output by an",
        "q2": " isokinetic squat and reactive strength by a drop jump.\nThe correlations between concentric power and straight sprinting speed were non-significant whereas the relationships between reactive strength and straight speed were statistically significant. Correlations between muscle power and speed while changing direction were generally low and non-significant for concentric leg power with some moderate and significant (p<0.05) coefficients found for reactive strength. The participants who turned faster to one side tended to have a reactive strength dominance in the leg responsible for the push-off action.\nIs muscle power related to running speed with changes of direction?",
        "generated_text": "isokinetic dynamometer.\nthe results showed that straight sprinting speed was related to leg power, but that changes of direction speed was not related to leg power.\nthe authors concluded that leg power is related to straight sprinting speed but not to changes of direction speed.\nthe study was well designed and the results are valid.\nthe authors have clearly described the methods and results.\nthe study has implications for coaches and athletes in sports involving sprints with changes of direction.\nthe study suggests that leg power is important for straight sprinting speed, but other factors may be more important for changes of",
        "levenshtein_distance": 495
    },
    {
        "realidx": "12098035",
        "question": "We tested the hypothesis that the treatment of patients with acute cholecystitis (AC) would be improved under the care of laparoscopic specialists.\nThe records of patients undergoing cholecystectomy for AC from 1 January 1996 to 31 December 1998 were reviewed retrospectively. Of 170 patients, 48 were cared for by three laparoscopic specialists (LS group), whereas 122 were treated by nine general surgeons who perform only laparoscopic cholecystectomy (LC) (GS group). The rates of successful LC, complications, and length of hospital stay were compared. Multivariate analysis was used to control for baseline differences.\nThe patients in the GS group were older (median age, 63 vs 53 years; p = 0.01). In all, 31 LS patients (65%), as compared with 44 GS patients (36%), had successful laparoscopic treatment (p = 0.001). The operating time was the same (median, 70 min). The proportion of patients with postoperative complications was similar in the two groups (37% in the GS vs 31% in the LS group; p = 0.6). The median postoperative hospital stay (3 vs 5 days; p<0.01) was shorter in the LS group. On logistic regression analysis, significant predictors of a successful laparoscopic operation included LS group (p<0.01) and age (p = 0). Predictors of prolonged length of hospital stay were age (p<0.01) and comorbidity score (p<0.01), with LS group status not a significant factor (p = 0.21).\nDoes a special interest in laparoscopy affect the treatment of acute cholecystitis?",
        "answer": "yes",
        "answer_rationale": "Patients with AC are more likely to undergo successful LC if cared for by a surgeon with an interest in laparoscopy. However, length of hospital stay is influenced more by patient factors in a multivariate model.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We tested the hypothesis that the treatment of patients with acute cholecystitis (AC) would be improved under the care of laparoscopic specialists.\nThe records of patients undergoing cholecystectomy for AC from 1 January 1996 to 31 December 1998 were reviewed retrospectively. Of 170 patients, 48 were cared for by three laparoscopic specialists (LS group), whereas 122 were treated by nine general surgeons who perform only laparoscopic cholecystectomy (LC) (GS group). The rates of successful LC, complications, and length of hospital stay were compared. Multivariate analysis was used to control for baseline differences.\nThe patients in the GS group were older (median age, 63 vs 53 years; p = 0.01). In all, 31 LS patients (65%), as compared with 44 GS patients (36%), had",
        "q2": " successful laparoscopic treatment (p = 0.001). The operating time was the same (median, 70 min). The proportion of patients with postoperative complications was similar in the two groups (37% in the GS vs 31% in the LS group; p = 0.6). The median postoperative hospital stay (3 vs 5 days; p<0.01) was shorter in the LS group. On logistic regression analysis, significant predictors of a successful laparoscopic operation included LS group (p<0.01) and age (p = 0). Predictors of prolonged length of hospital stay were age (p<0.01) and comorbidity score (p<0.01), with LS group status not a significant factor (p = 0.21).\nDoes a special interest in laparoscopy affect the treatment of acute cholecystitis?",
        "generated_text": "successful LC (p < 0.01). The conversion rate was 10% in the LS group and 21% in the GS group (p = 0.11). The overall complication rate was 12% in the LS group and 20% in the GS group (p = 0.17). The median hospital stay was 2 days in the LS group and 3 days in the GS group (p < 0.01). After controlling for age, sex, and American Society of Anesthesiologists (ASA) grade, the LS group had a higher rate of successful LC (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.4-6.9; p = 0.005), a lower rate of conversion (OR, 0",
        "levenshtein_distance": 464
    },
    {
        "realidx": "12121321",
        "question": "Mossy fibers are the sole excitatory projection from dentate gyrus granule cells to the hippocampus, forming part of the trisynaptic hippocampal circuit. They undergo significant plasticity during epileptogenesis and have been implicated in seizure generation. Mossy fibers are a highly unusual projection in the mammalian brain; in addition to glutamate, they release adenosine, dynorphin, zinc, and possibly other peptides. Mossy fiber terminals also show intense immunoreactivity for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), and immunoreactivity for GAD67. The purpose of this review is to present physiologic evidence of GABA release by mossy fibers and its modulation by epileptic activity.\nWe used hippocampal slices from 3- to 5-week-old guinea pigs and made whole-cell voltage clamp recordings from CA3 pyramidal cells. We placed stimulating electrodes in stratum granulosum and adjusted their position in order to recruit mossy fiber to CA3 projections.\nWe have shown that electrical stimuli that recruit dentate granule cells elicit monosynaptic GABAA receptor-mediated synaptic signals in CA3 pyramidal neurons. These inhibitory signals satisfy the criteria that distinguish mossy fiber-CA3 synapses: high sensitivity to metabotropic glutamate-receptor agonists, facilitation during repetitive stimulation, and N-methyl-D-aspartate (NMDA) receptor-independent long-term potentiation.\nDo mossy fibers release GABA?",
        "answer": "yes",
        "answer_rationale": "We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Mossy fibers are the sole excitatory projection from dentate gyrus granule cells to the hippocampus, forming part of the trisynaptic hippocampal circuit. They undergo significant plasticity during epileptogenesis and have been implicated in seizure generation. Mossy fibers are a highly unusual projection in the mammalian brain; in addition to glutamate, they release adenosine, dynorphin, zinc, and possibly other peptides. Mossy fiber terminals also show intense immunoreactivity for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), and immunoreactivity for GAD67. The purpose of this review is to present physiologic evidence of GABA release by mossy fibers and its modulation by epileptic activity.\nWe",
        "q2": " used hippocampal slices from 3- to 5-week-old guinea pigs and made whole-cell voltage clamp recordings from CA3 pyramidal cells. We placed stimulating electrodes in stratum granulosum and adjusted their position in order to recruit mossy fiber to CA3 projections.\nWe have shown that electrical stimuli that recruit dentate granule cells elicit monosynaptic GABAA receptor-mediated synaptic signals in CA3 pyramidal neurons. These inhibitory signals satisfy the criteria that distinguish mossy fiber-CA3 synapses: high sensitivity to metabotropic glutamate-receptor agonists, facilitation during repetitive stimulation, and N-methyl-D-aspartate (NMDA) receptor-independent long-term potentiation.\nDo mossy fibers release GABA?",
        "generated_text": "have previously shown that mossy fibers release GABA in addition to glutamate in the dentate gyrus of normal rats. This GABA release is mediated by voltage-gated calcium channels and is blocked by the GABA uptake inhibitor nipecotic acid. GABA release is also blocked by the GABA synthesis inhibitor vigabatrin. In addition, GABA release is increased by the GABA uptake inhibitor tiagabine. These results suggest that mossy fibers release GABA via a vesicular mechanism, similar to glutamate release.\nIn addition to normal rats, we have also studied GABA release by mossy fibers in epileptic rats. We have found that in pilocarpine-treated rats, which develop temporal lobe epilepsy, mossy",
        "levenshtein_distance": 565
    },
    {
        "realidx": "12145243",
        "question": "Type 2 diabetes may be present for several years before diagnosis, by which time many patients have already developed diabetic complications. Earlier detection and treatment may reduce this burden, but evidence to support this approach is lacking.\nGlycemic control and clinical and surrogate outcomes were compared for 5,088 of 5,102 U.K. Diabetes Prospective Study participants according to whether they had low (<140 mg/dl [<7.8 mmol/l]), intermediate (140 to<180 mg/dl [7.8 to<10.0 mmol/l]), or high (>or =180 mg/dl [>or =10 mmol/l]) fasting plasma glucose (FPG) levels at diagnosis. Individuals who presented with and without diabetic symptoms were also compared.\nFewer people with FPG in the lowest category had retinopathy, abnormal biothesiometer measurements, or reported erectile dysfunction. The rate of increase in FPG and HbA(1c) during the study was identical in all three groups, although absolute differences persisted. Individuals in the low FPG group had a significantly reduced risk for each predefined clinical outcome except stroke, whereas those in the intermediate group had significantly reduced risk for each outcome except stroke and myocardial infarction. The low and intermediate FPG groups had a significantly reduced risk for progression of retinopathy, reduction in vibration sensory threshold, or development of microalbuminuria.\nAre lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?",
        "answer": "yes",
        "answer_rationale": "People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Type 2 diabetes may be present for several years before diagnosis, by which time many patients have already developed diabetic complications. Earlier detection and treatment may reduce this burden, but evidence to support this approach is lacking.\nGlycemic control and clinical and surrogate outcomes were compared for 5,088 of 5,102 U.K. Diabetes Prospective Study participants according to whether they had low (<140 mg/dl [<7.8 mmol/l]), intermediate (140 to<180 mg/dl [7.8 to<10.0 mmol/l]), or high (>or =180 mg/dl [>or =10 mmol/l]) fasting plasma glucose (FPG) levels at diagnosis. Individuals who presented with and without diabetic symptoms were also",
        "q2": " compared.\nFewer people with FPG in the lowest category had retinopathy, abnormal biothesiometer measurements, or reported erectile dysfunction. The rate of increase in FPG and HbA(1c) during the study was identical in all three groups, although absolute differences persisted. Individuals in the low FPG group had a significantly reduced risk for each predefined clinical outcome except stroke, whereas those in the intermediate group had significantly reduced risk for each outcome except stroke and myocardial infarction. The low and intermediate FPG groups had a significantly reduced risk for progression of retinopathy, reduction in vibration sensory threshold, or development of microalbuminuria.\nAre lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?",
        "generated_text": "compared.\nAfter 10 years, the mean HbA1c was 7.9% in the low-FPG group, 8.0% in the intermediate-FPG group, and 8.1% in the high-FPG group (P = 0.0001). The adjusted relative risks (RRs) for microvascular complications were 1.0, 1.14, and 1.22, respectively (P = 0.0001). The RRs for myocardial infarction were 1.0, 1.14, and 1.22, respectively (P = 0.0001). The RRs",
        "levenshtein_distance": 627
    },
    {
        "realidx": "12163782",
        "question": "Neutrophil infiltration of the lung is characteristic of early posttraumatic acute respiratory distress syndrome (ARDS). This study examines the ability of neutrophils isolated (over the first 24 hrs) from the peripheral blood of patients admitted after major trauma to migrate in response to interleukin-8. Interleukin-8 is elevated in the lung within 2 hrs of major trauma in patients who later develop ARDS, and thus it plays a central role in the recruitment of neutrophils to the lung and their subsequent activation. We hypothesized that enhanced interleukin-8-mediated neutrophil migratory activity in the early postinjury phase, before the development of ARDS, may be a crucial factor in the etiology of ARDS.\nProspective observational study.\nUniversity Hospital Wales, the Royal Gwent Hospital, and East Glamorgan General Hospital. Laboratory work was conducted at the Institute of Nephrology.\nAdult blunt trauma victims with Injury Severity Score>or = 18.\nNeutrophils were isolated from citrated blood from 17 adult blunt major trauma patients at admission (0 hrs) and 8 and 24 hrs later. Identical samples were obtained from normal laboratory volunteers (n = 9). The neutrophil count in each specimen was measured, and the number of neutrophils migrating across porous tissue culture inserts in response to defined concentrations of interleukin-8 (0, 10, 30, and 100 ng/mL) was quantitated by peroxidase assay. Neutrophil counts in the whole blood specimens obtained from those later developing ARDS were elevated significantly at admission and declined rapidly throughout the next 24 hrs. Significantly greater numbers of trauma patients' neutrophils migrated to concentrations of interleukin-8 (30 and 100 ng/mL) at each time point when compared with normal volunteers (Mann-Whitney U test, p<.05). Neutrophils isolated from major trauma patients exhibited an enhanced migratory response to high concentrations of interleukin-8 throughout the first 24 hrs of admission, in contrast to the normal physiologic attenuation of migration seen in neutrophils isolated from normal laboratory volunteers.\nIncreased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome?",
        "answer": "yes",
        "answer_rationale": "These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Neutrophil infiltration of the lung is characteristic of early posttraumatic acute respiratory distress syndrome (ARDS). This study examines the ability of neutrophils isolated (over the first 24 hrs) from the peripheral blood of patients admitted after major trauma to migrate in response to interleukin-8. Interleukin-8 is elevated in the lung within 2 hrs of major trauma in patients who later develop ARDS, and thus it plays a central role in the recruitment of neutrophils to the lung and their subsequent activation. We hypothesized that enhanced interleukin-8-mediated neutrophil migratory activity in the early postinjury phase, before the development of ARDS, may be a crucial factor in the etiology of ARDS.\nProspective observational study.\nUniversity Hospital Wales, the Royal Gwent Hospital, and East Glamorgan General Hospital. Laboratory work was conducted at the Institute of Nephrology.\nAdult blunt trauma victims with Injury Severity Score>or = 18.\nNeutrophils were isolated from citrated blood from 17 adult blunt major trauma patients at admission (0 hrs) and 8 and 24 hrs later. Identical",
        "q2": " samples were obtained from normal laboratory volunteers (n = 9). The neutrophil count in each specimen was measured, and the number of neutrophils migrating across porous tissue culture inserts in response to defined concentrations of interleukin-8 (0, 10, 30, and 100 ng/mL) was quantitated by peroxidase assay. Neutrophil counts in the whole blood specimens obtained from those later developing ARDS were elevated significantly at admission and declined rapidly throughout the next 24 hrs. Significantly greater numbers of trauma patients' neutrophils migrated to concentrations of interleukin-8 (30 and 100 ng/mL) at each time point when compared with normal volunteers (Mann-Whitney U test, p<.05). Neutrophils isolated from major trauma patients exhibited an enhanced migratory response to high concentrations of interleukin-8 throughout the first 24 hrs of admission, in contrast to the normal physiologic attenuation of migration seen in neutrophils isolated from normal laboratory volunteers.\nIncreased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome?",
        "generated_text": "samples were obtained from 10 healthy volunteers. Neutrophil migratory activity was measured in response to interleukin-8 (100 ng/ml) using a modified Boyden chamber assay. The results are expressed as the percentage of neutrophils that migrated in response to interleukin-8.\nNeutrophils from trauma patients at 0 hrs had a significantly higher migratory activity in response to interleukin-8 compared with neutrophils from healthy volunteers (p < 0.001). This enhanced migratory activity was maintained at 8 and 24 hrs. There was no difference in migratory activity between patients who developed ARDS and those who did not.\nNeutrophils from trauma patients have an enhanced migratory activity in response to interleukin-8 in the early postinjury phase. This enhanced migratory activity is not associated with the development of ARDS. The mechanism underlying this enhanced migratory activity is unclear but may be related to the systemic inflammatory response to trauma.",
        "levenshtein_distance": 756
    },
    {
        "realidx": "12172698",
        "question": "Associations between several psychopathological alterations and lowered beta-endorphin(beta E) plasma levels have already been stated in former studies. However, whereas single measures during static conditions generally failed in linking beta E levels with psychopathology, dynamic changes of beta E in particular have been shown to be associated with spells of anxiety and depression. During alcohol withdrawal, a decreased secretion of beta E with a delayed normalization has been reported, but up to now only few data became available regarding the interaction of plasma beta E and psychopathological parameters.\nThe aim of our study was to test the hypothesis whether beta E during acute alcohol withdrawal is associated with anxiety, depression, and craving.\nWe observed self-rated anxiety, depression, and craving during alcohol withdrawal and assessed beta E levels (RIA) in a consecutive sample of 60 alcoholics on day 1 and day 14 after onset of withdrawal, and in 30 healthy volunteers. To control for mutual interactions of beta E and the pituitary-adrenocortical hormone secretion, plasma corticotropin (ACTH) and cortisol were also determined.\nIn accordance with prior studies, beta E was significantly lowered on day 1 and day 14 of alcohol withdrawal relative to controls. Plasma levels of ACTH correlated significantly with beta E in alcoholics at both time points and in controls, without differing significantly between the groups. Self-rated anxiety, depression, and alcohol craving decreased significantly between day 1 and day 14. Levels of beta E were inversely correlated with anxiety day 1 (r=-0.58) and day 14 (r=-0.71). Partial correlation coefficients controlling for ACTH plasma levels revealed that this correlation was largely independent from ACTH. In addition, a significant inverse relationship was found between beta E and craving on day 14 (r=-0.28). No association appeared between beta E and depression.\nIs withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?",
        "answer": "yes",
        "answer_rationale": "Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Associations between several psychopathological alterations and lowered beta-endorphin(beta E) plasma levels have already been stated in former studies. However, whereas single measures during static conditions generally failed in linking beta E levels with psychopathology, dynamic changes of beta E in particular have been shown to be associated with spells of anxiety and depression. During alcohol withdrawal, a decreased secretion of beta E with a delayed normalization has been reported, but up to now only few data became available regarding the interaction of plasma beta E and psychopathological parameters.\nThe aim of our study was to test the hypothesis whether beta E during acute alcohol withdrawal is associated with anxiety, depression, and craving.\nWe observed self-rated anxiety, depression, and craving during alcohol withdrawal and assessed beta E levels (RIA) in a consecutive sample of 60 alcoholics on day 1 and day 14 after onset of withdrawal, and in 30 healthy volunteers. To control for mutual interactions of beta E and the pituitary-ad",
        "q2": "renocortical hormone secretion, plasma corticotropin (ACTH) and cortisol were also determined.\nIn accordance with prior studies, beta E was significantly lowered on day 1 and day 14 of alcohol withdrawal relative to controls. Plasma levels of ACTH correlated significantly with beta E in alcoholics at both time points and in controls, without differing significantly between the groups. Self-rated anxiety, depression, and alcohol craving decreased significantly between day 1 and day 14. Levels of beta E were inversely correlated with anxiety day 1 (r=-0.58) and day 14 (r=-0.71). Partial correlation coefficients controlling for ACTH plasma levels revealed that this correlation was largely independent from ACTH. In addition, a significant inverse relationship was found between beta E and craving on day 14 (r=-0.28). No association appeared between beta E and depression.\nIs withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?",
        "generated_text": "renal axis, cortisol levels were measured simultaneously.\nIn alcoholics, beta E levels were significantly lower on day 1 compared to day 14 and to controls. In addition, beta E levels on day 1 correlated positively with anxiety and depression, but not with craving. On day 14, beta E levels correlated negatively with anxiety and depression, but not with craving. In controls, beta E levels correlated negatively with anxiety and depression, but not with craving.\nOur data suggest that beta E levels during acute alcohol withdrawal are associated with anxiety and depression, but not with craving. The direction of the correlation is reversed during acute withdrawal compared to the chronic state of alcoholism and to controls. This may indicate a disturbed regulation of beta E during acute alcohol withdrawal, which may be related to the psychopathology of alcoholism.",
        "levenshtein_distance": 684
    },
    {
        "realidx": "12221908",
        "question": "The principal causes of morbidity and mortality during pregnancy in Mexico, are preeclampsia/eclampsia, obstetric hemorrhage and puerperium complications; this is, 62% of maternal deaths in last years. HELLP syndrome was observed between 5 to 25% of the mortality in pregnancies of 36 weeks or less.\nTo analyze patients with HELLP syndrome in ICU's (Intensive Care Unit) of a Gynecology and Obstetric Hospital, related to the abnormal hematological, hepatic and renal results with the obstetric case history and the clinical complications.\nA transversal study in patients with HELLP syndrome during 1998 and 1999 were carry out.\nPeripheral blood with Microangiopathic hemolysis, elevated liver enzymes: AST, ALT over 40 UI/L, even when were LDH lower than 600 UI/L. It was evaluated the hepatic and renal function, platelets count, microangiopathic hemolysis, arterial pressure, seizures, icteric skin color, blindness, visual disturbances, nausea, vomiting and upper quadrant right abdominal pain. In newborn we analyzed gestational age, sex, weight and APGAR. We studied for an association between maternal and biochemical variables with Correlation Pearson Test, and dependence between variables with lineal regression model.\n2878 patients with hypertensives disorders in pregnancy (11.64%). The 1.15% (n = 33) had HELLP syndrome with specific maternal mortality of 0.4 per 10,000 live birth, perinatal mortality of 1.62 per 10,000 live birth; and renal damage in 84.5%. Coefficient beta was higher between number of pregnancies to platelets count (-0.33) and creatinine clearance (-0.401).\nThe HELPP syndrome--evidence of a possible systemic inflammatory response in pre-eclampsia?",
        "answer": "yes",
        "answer_rationale": "We found an important renal damage, low platelets, elevated liver enzymes in women with two or more pregnancies. Then we propose there are similarities between HELLP syndrome and Systemic Inflammatory Response Syndrome (SIRS) because they could have the same pathophysiology.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The principal causes of morbidity and mortality during pregnancy in Mexico, are preeclampsia/eclampsia, obstetric hemorrhage and puerperium complications; this is, 62% of maternal deaths in last years. HELLP syndrome was observed between 5 to 25% of the mortality in pregnancies of 36 weeks or less.\nTo analyze patients with HELLP syndrome in ICU's (Intensive Care Unit) of a Gynecology and Obstetric Hospital, related to the abnormal hematological, hepatic and renal results with the obstetric case history and the clinical complications.\nA transversal study in patients with HELLP syndrome during 1998 and 1999 were carry out.\nPeripheral blood with Microangiopathic hemolysis, elevated liver enzymes: AST, ALT over 40 UI/L, even when were LDH lower than 600 UI/L. It was evaluated the hepatic and renal function, platelets count, microangiopathic hem",
        "q2": "olysis, arterial pressure, seizures, icteric skin color, blindness, visual disturbances, nausea, vomiting and upper quadrant right abdominal pain. In newborn we analyzed gestational age, sex, weight and APGAR. We studied for an association between maternal and biochemical variables with Correlation Pearson Test, and dependence between variables with lineal regression model.\n2878 patients with hypertensives disorders in pregnancy (11.64%). The 1.15% (n = 33) had HELLP syndrome with specific maternal mortality of 0.4 per 10,000 live birth, perinatal mortality of 1.62 per 10,000 live birth; and renal damage in 84.5%. Coefficient beta was higher between number of pregnancies to platelets count (-0.33) and creatinine clearance (-0.401).\nThe HELPP syndrome--evidence of a possible systemic inflammatory response in pre-eclampsia?",
        "generated_text": "olysis, and the clinical complications.\nThe study included 10 patients, 80% were multiparous, 70% had preeclampsia, 30% had chronic hypertension, 30% had HELLP syndrome in previous pregnancies, 70% had HELLP syndrome before 34 weeks of gestation, 40% had HELLP syndrome before 30 weeks of gestation, 70% had HELLP syndrome before the delivery, 30% had HELLP syndrome after the delivery, 40% had HELLP syndrome in the puerperium, 70% had HELLP syndrome in the third trimester, 30% had HELLP syndrome in the second trimester, 70% had HELLP syndrome in the first trimester, 30% had HELLP syndrome in the first trimester, 70% had HEL",
        "levenshtein_distance": 615
    },
    {
        "realidx": "12377809",
        "question": "Dyschesia can be provoked by inappropriate defecation movements. The aim of this prospective study was to demonstrate dysfunction of the anal sphincter and/or the musculus (m.) puborectalis in patients with dyschesia using anorectal endosonography.\nTwenty consecutive patients with a medical history of dyschesia and a control group of 20 healthy subjects underwent linear anorectal endosonography (Toshiba models IUV 5060 and PVL-625 RT). In both groups, the dimensions of the anal sphincter and the m. puborectalis were measured at rest, and during voluntary squeezing and straining. Statistical analysis was performed within and between the two groups.\nThe anal sphincter became paradoxically shorter and/or thicker during straining (versus the resting state) in 85% of patients but in only 35% of control subjects. Changes in sphincter length were statistically significantly different (p<0.01, chi(2) test) in patients compared with control subjects. The m. puborectalis became paradoxically shorter and/or thicker during straining in 80% of patients but in only 30% of controls. Both the changes in length and thickness of the m. puborectalis were significantly different (p<0.01, chi(2) test) in patients versus control subjects.\nIs anorectal endosonography valuable in dyschesia?",
        "answer": "yes",
        "answer_rationale": "Linear anorectal endosonography demonstrated incomplete or even absent relaxation of the anal sphincter and the m. puborectalis during a defecation movement in the majority of our patients with dyschesia. This study highlights the value of this elegant ultrasonographic technique in the diagnosis of \"pelvic floor dyssynergia\" or \"anismus\".",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Dyschesia can be provoked by inappropriate defecation movements. The aim of this prospective study was to demonstrate dysfunction of the anal sphincter and/or the musculus (m.) puborectalis in patients with dyschesia using anorectal endosonography.\nTwenty consecutive patients with a medical history of dyschesia and a control group of 20 healthy subjects underwent linear anorectal endosonography (Toshiba models IUV 5060 and PVL-625 RT). In both groups, the dimensions of the anal sphincter and the m. puborectalis were measured at rest, and during voluntary squeezing and straining. Statistical analysis was performed within and between the two groups.\nThe anal",
        "q2": " sphincter became paradoxically shorter and/or thicker during straining (versus the resting state) in 85% of patients but in only 35% of control subjects. Changes in sphincter length were statistically significantly different (p<0.01, chi(2) test) in patients compared with control subjects. The m. puborectalis became paradoxically shorter and/or thicker during straining in 80% of patients but in only 30% of controls. Both the changes in length and thickness of the m. puborectalis were significantly different (p<0.01, chi(2) test) in patients versus control subjects.\nIs anorectal endosonography valuable in dyschesia?",
        "generated_text": "sphincter was significantly thicker in the patient group at rest (p < 0.001) and during squeezing (p < 0.001). The m. puborectalis was significantly thicker in the patient group at rest (p < 0.001) and during straining (p < 0.001). The cross-sectional area of the anal canal was significantly smaller in the patient group at rest (p < 0.001) and during straining (p < 0.001).\nDysfunction of the anal sphincter and the m. puborectalis can be demonstrated by anorectal endosonography in patients with dys",
        "levenshtein_distance": 428
    },
    {
        "realidx": "12380309",
        "question": "To evaluate prepuce development and retractibility in a group of boys. To point out the value of circumcision and prepucial forced dilation during childhood.\nPrepuce development and retractibility were evaluated in 400 boys ages between 0-16 year old.\nIn boys under 1 year prepuce retractibility (assessed only in children who did not undergo forced dilation previously) was type I (non retractile) in 71.5% whereas type V (completely retractile) was only 5.5%. In adolescent boys type I prepuce was observed in 1 boy only, 1.6%, whereas type V was observed in 82.3%. Furthermore, it was observed that at the time of examination for the study 106 boys who had undergone forced dilation at an earlier age had balano-prepucial adhesions again, which demonstrates that prepuce adheres again to glans penis in many boys after a forced dilation is performed. Only 11 boys were considered in need for circumcision, three of them for prepucial orifice stenosis, which prevented normal micturition, causing a prepucial sac, one case due to a constrictive ring below the prepucial edge that would have prevented ulterior retractability, two cases with repetitive balanopostitis, and five cases secondary to xerosol balanitis, accounting for 2.7% of all examined boys.\nShould circumcision be performed in childhood?",
        "answer": "no",
        "answer_rationale": "Incomplete separation between prepuce and glans penis is normal and common among new-borns, progressing until adolescence to spontaneous separation, at which time it is complete in the majority of boys. Accordingly to the criteria we have sustained for years and present study's findings, circumcision has few indications during childhood, as well as forced prepucial dilation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To evaluate prepuce development and retractibility in a group of boys. To point out the value of circumcision and prepucial forced dilation during childhood.\nPrepuce development and retractibility were evaluated in 400 boys ages between 0-16 year old.\nIn boys under 1 year prepuce retractibility (assessed only in children who did not undergo forced dilation previously) was type I (non retractile) in 71.5% whereas type V (completely retractile) was only 5.5%. In adolescent boys type I prepuce was observed in 1 boy only, 1.6%, whereas type V was observed in 82.3%. Furthermore, it was observed that at the time of",
        "q2": " examination for the study 106 boys who had undergone forced dilation at an earlier age had balano-prepucial adhesions again, which demonstrates that prepuce adheres again to glans penis in many boys after a forced dilation is performed. Only 11 boys were considered in need for circumcision, three of them for prepucial orifice stenosis, which prevented normal micturition, causing a prepucial sac, one case due to a constrictive ring below the prepucial edge that would have prevented ulterior retractability, two cases with repetitive balanopostitis, and five cases secondary to xerosol balanitis, accounting for 2.7% of all examined boys.\nShould circumcision be performed in childhood?",
        "generated_text": "birth 100% of boys had type I prepuce, whereas at 1 year of age 71.5% had type I, 23% type II, 5.5% type V. At 2 years of age 50% had type I, 40% type II, 10% type III, and at 3 years of age 30% type I, 50% type II, 20% type III. At 4 years of age 10% type I, 50% type II, 40% type III, at 5 years of age 5% type I, 40% type II, 5",
        "levenshtein_distance": 536
    },
    {
        "realidx": "12407608",
        "question": "To investigate whether prepuncture ultrasound evaluation of vascular anatomy facilitates internal jugular vein cannulation compared with landmark-guided puncture.\nProspective randomized study.\nSingle community hospital.\nAdult patients undergoing general anesthesia (n = 240).\nThe right internal jugular vein was cannulated using either anatomic landmarks or prepuncture ultrasound (3.75/7.5 MHz) guidance. In the landmark group, respiratory jugular venodilation was used as the primary landmark for locating the vein. Results of cannulation and the incidence of complications were compared.\nPatients were randomly assigned to the ultrasound or landmark group. Respiratory jugular venodilation was identified in 188 patients (78.3%), in whom results of cannulation did not differ between the 2 techniques with respect to the venous access rate (cannulated at the first attempt: 83.5% in the landmark v 85.7% in the ultrasound group), the success rate (cannulated within 3 attempts: 96.9% v 95.6%), and the incidence of arterial puncture (1.0% v 3.3%). In the remaining 52 respiratory jugular venodilation-unidentified patients, the access rate (30.4% v 86.2%, p<0.001) and the success rate (78.3 v 100%, p<0.05) were significantly better in the ultrasound group, and no arterial puncture was recorded in the ultrasound group, whereas the incidence was 13.0% in the landmark group. The results were similar regardless of the ultrasound frequency used.\nDoes ultrasound imaging before puncture facilitate internal jugular vein cannulation?",
        "answer": "maybe",
        "answer_rationale": "Prepuncture ultrasound evaluation did not improve the result of right internal jugular vein cannulation compared with the respiratory jugular venodilation-guided approach. When the landmark was not observed, however, the prepuncture ultrasound guidance was helpful in facilitating the cannulation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To investigate whether prepuncture ultrasound evaluation of vascular anatomy facilitates internal jugular vein cannulation compared with landmark-guided puncture.\nProspective randomized study.\nSingle community hospital.\nAdult patients undergoing general anesthesia (n = 240).\nThe right internal jugular vein was cannulated using either anatomic landmarks or prepuncture ultrasound (3.75/7.5 MHz) guidance. In the landmark group, respiratory jugular venodilation was used as the primary landmark for locating the vein. Results of cannulation and the incidence of complications were compared.\nPatients were randomly assigned to the ultrasound or landmark group. Respiratory jugular venodilation was identified in 188 patients (78.3%), in whom results of cannulation did not differ between the 2 techniques with respect to the venous access rate (cannulated at the first attempt:",
        "q2": " 83.5% in the landmark v 85.7% in the ultrasound group), the success rate (cannulated within 3 attempts: 96.9% v 95.6%), and the incidence of arterial puncture (1.0% v 3.3%). In the remaining 52 respiratory jugular venodilation-unidentified patients, the access rate (30.4% v 86.2%, p<0.001) and the success rate (78.3 v 100%, p<0.05) were significantly better in the ultrasound group, and no arterial puncture was recorded in the ultrasound group, whereas the incidence was 13.0% in the landmark group. The results were similar regardless of the ultrasound frequency used.\nDoes ultrasound imaging before puncture facilitate internal jugular vein cannulation?",
        "generated_text": "94.4% vs. 92.5%; P = 0.64; cannulated at the second attempt: 100% vs. 97.2%; P = 0.31). In the 52 patients (21.7%) without respiratory jugular venodilation, the ultrasound group had a higher venous access rate (cannulated at the first attempt: 84.6% vs. 53.8%; P = 0.02; cannulated at the second attempt: 100% vs. 76.9%; P = 0.04). The incidence of complications was similar in the 2 groups.\nPrepuncture ultrasound guidance for internal jugular vein cannulation is not superior to landmark-guided puncture",
        "levenshtein_distance": 461
    },
    {
        "realidx": "12419743",
        "question": "To determine whether patients with high-risk metastatic breast cancer draw benefit from combination chemotherapy as first-line treatment.\nA total of 260 women with measurable metastatic breast cancer fulfilling high-risk criteria, previously untreated with chemotherapy for their metastatic disease, were randomized to receive either mitoxantrone 12 mg/m(2) or the combination of fluorouracil 500 mg/m(2), epirubicin 50 mg/m(2) and cyclophosphamide 500 mg/m(2) (FEC) every 3 weeks. Treatment was continued until complete remission plus two cycles, or until disease progression. In the case of partial remission or stable disease, treatment was stopped after 12 cycles. Second-line treatment was vindesine, mitomycin and prednisolone. Gain from treatment was estimated using a modified Brunner's score composed of time to progression, patients' rating of the treatment benefit, alopecia, vomiting and performance status.\nAfter recruitment from 1992 to 1997 and observation from 1997 to 1999, the final evaluation showed that single-agent treatment with mitoxantrone does not differ significantly from combination treatment with FEC in terms of response, objective remission rate, remission duration, time to response, time to best response, time to progression or overall survival. There was, however, a significant difference in gain from treatment using a modified Brunner's score favoring the single-agent treatment arm. There was no evidence that any subgroup would fare better with combination treatment.\nIs first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy?",
        "answer": "yes",
        "answer_rationale": "No significant difference was detected between the treatment with mitoxantrone as a single agent and the combination of low-dose FEC in terms of response or survival; therefore, the imperative of the necessity of first-line combination chemotherapy for patients with high-risk metastatic breast cancer may be questioned. Since toxicity and quality of life score favored the single-agent mitoxantrone treatment arm, this treatment may be offered to patients preferring quality of life to a potential small prolongation of survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine whether patients with high-risk metastatic breast cancer draw benefit from combination chemotherapy as first-line treatment.\nA total of 260 women with measurable metastatic breast cancer fulfilling high-risk criteria, previously untreated with chemotherapy for their metastatic disease, were randomized to receive either mitoxantrone 12 mg/m(2) or the combination of fluorouracil 500 mg/m(2), epirubicin 50 mg/m(2) and cyclophosphamide 500 mg/m(2) (FEC) every 3 weeks. Treatment was continued until complete remission plus two cycles, or until disease progression. In the case of partial remission or stable disease, treatment was stopped after 12 cycles. Second-line treatment was vindesine, mitomycin and prednisolone. Gain from treatment was estimated using a modified",
        "q2": " Brunner's score composed of time to progression, patients' rating of the treatment benefit, alopecia, vomiting and performance status.\nAfter recruitment from 1992 to 1997 and observation from 1997 to 1999, the final evaluation showed that single-agent treatment with mitoxantrone does not differ significantly from combination treatment with FEC in terms of response, objective remission rate, remission duration, time to response, time to best response, time to progression or overall survival. There was, however, a significant difference in gain from treatment using a modified Brunner's score favoring the single-agent treatment arm. There was no evidence that any subgroup would fare better with combination treatment.\nIs first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy?",
        "generated_text": "version of the proportional hazards model, which allows for the inclusion of time-dependent covariates.\nThe combination regimen was associated with a higher response rate (54% vs 34%, P < 0.001), a longer time to progression (10.5 vs 7.5 months, P < 0.001), and a longer overall survival (24.5 vs 18.5 months, P < 0.001). The combination regimen was also associated with a higher incidence of severe neutropenia (P < 0.001), febrile neutropenia (P < 0.001), and severe mucositis (P < 0.001). The gain from treatment was higher in the combination group",
        "levenshtein_distance": 630
    },
    {
        "realidx": "12442934",
        "question": "To determine whether prior exposure of non-steroidal anti-inflammatory drugs increases perioperative blood loss associated with major orthopaedic surgery.\nFifty patients scheduled for total hip replacement were allocated to two groups (double blind, randomized manner). All patients were pretreated for 2 weeks before surgery: Group 1 with placebo drug, Group 2 with ibuprofen. All patients were injected intrathecally with bupivacaine 20mg plus morphine 0.1 mg, in a total volume of 4 mL, to provide surgical anaesthesia.\nThe presence of severe adverse effects caused eight patients in the ibuprofen group and six in the placebo group to terminate their participation in the trial. The perioperative blood loss increased by 45% in the ibuprofen group compared with placebo. The total (+/-SD) blood loss in the ibuprofen group was 1161 (+/-472) mL versus 796 (+/-337) mL in the placebo group.\nDoes ibuprofen increase perioperative blood loss during hip arthroplasty?",
        "answer": "yes",
        "answer_rationale": "Pretreatment with ibuprofen before elective total hip surgery increases the perioperative blood loss significantly. Early discontinuation of non-selective non-steroidal anti-inflammatory drugs is advised.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine whether prior exposure of non-steroidal anti-inflammatory drugs increases perioperative blood loss associated with major orthopaedic surgery.\nFifty patients scheduled for total hip replacement were allocated to two groups (double blind, randomized manner). All patients were pretreated for 2 weeks before surgery: Group 1 with placebo drug, Group 2 with ibuprofen. All patients were injected intrathecally with bupivacaine 20mg plus morphine 0.1 mg, in a total volume of 4 m",
        "q2": "L, to provide surgical anaesthesia.\nThe presence of severe adverse effects caused eight patients in the ibuprofen group and six in the placebo group to terminate their participation in the trial. The perioperative blood loss increased by 45% in the ibuprofen group compared with placebo. The total (+/-SD) blood loss in the ibuprofen group was 1161 (+/-472) mL versus 796 (+/-337) mL in the placebo group.\nDoes ibuprofen increase perioperative blood loss during hip arthroplasty?",
        "generated_text": "1. The amount of blood loss was measured by the difference between the preoperative and postoperative hemoglobin levels. The results were compared between the two groups.\nThe mean blood loss in Group 1 was 1020 ml and in Group 2 was 1200 ml. The difference was statistically significant (p < 0.05).\nPrior exposure to non-steroidal anti-inflammatory drugs increases perioperative blood loss associated with major orthopaedic surgery.",
        "levenshtein_distance": 346
    },
    {
        "realidx": "12484580",
        "question": "To ascertain whether a written information sheet is acceptable to patients and improves recall of the consent interview.\nProspective randomised controlled study using questionnaires, comparing a group of patients given information in a written sheet with appropriate explanation to a group given verbal information alone.\nA specialist orthopaedic surgery unit.\nThe test group was 126 patients undergoing revision or primary total hip arthroplasty; 65 patients were given information verbally, 61 patients were given written information.\nPatients' recall of information given, tested with a questionnaire completed on admission (mean of 18 days later).\nThe patients receiving written information scored significantly higher (48% correct answers) than the patients receiving verbal information (38% correct answers).\nInformed consent for total hip arthroplasty: does a written information sheet improve recall by patients?",
        "answer": "yes",
        "answer_rationale": "Written information sheets contribute to the process of informed consent. As patients' recall of information is generally poor, the sheets may also be useful medicolegally, as a permanent record of what was discussed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To ascertain whether a written information sheet is acceptable to patients and improves recall of the consent interview.\nProspective randomised controlled study using questionnaires, comparing a group of patients given information in a written sheet with appropriate explanation to a group given verbal information alone.\nA specialist orthopaedic surgery unit.\nThe test group was 126 patients undergoing revision or primary total hip arthroplasty; 65 patients were",
        "q2": " given information verbally, 61 patients were given written information.\nPatients' recall of information given, tested with a questionnaire completed on admission (mean of 18 days later).\nThe patients receiving written information scored significantly higher (48% correct answers) than the patients receiving verbal information (38% correct answers).\nInformed consent for total hip arthroplasty: does a written information sheet improve recall by patients?",
        "generated_text": "randomised to receive a written information sheet and 61 to receive verbal information alone.\nMain outcome measures\nPatients' understanding of the procedure, its risks, and the alternatives, and their recall of the information given at the consent interview.\nPatients who received a written information sheet had significantly better recall of the information given at the consent interview (p < 0.001). There was no significant",
        "levenshtein_distance": 330
    },
    {
        "realidx": "12595848",
        "question": "Implementation of the complex treatment strategies that have been shown to improve survival of patients with congestive heart failure (CHF) may require certain expertise. We wanted to examine the association between pattern of outpatient care and survival of patients with CHF.\nIn a retrospective cohort study conducted with national Veterans Health Administration (VHA) databases, we examined the association between the pattern of outpatient care and survival in 11,661 patients discharged from VA hospitals between October 1, 1991, and September 30, 1992, with the primary diagnosis of CHF (cohort 1). Patients were divided into 4 groups, on the basis of their pattern of outpatient care over a 12-month period after discharge: 1) general medicine clinic visits only (GM-only); 2) cardiology clinic visits only (CARD-only); 3) general medicine and cardiology (MIXED) clinic visits; and 4) neither general medicine nor cardiology clinic visits (no-GM/CARD). We used the Cox proportional hazards model to evaluate 1-year survival, controlling for clinical and demographic factors. Consistency of our results was examined by performing identical analysis on a cohort of patients discharged from VHA hospitals between October 1, 1994, and September 30, 1995 (cohort 2, n = 10,141).\nThe overall 1-year mortality rate was 23% in the primary cohort. The unadjusted mortality rate was highest for patients in the no-GM/CARD follow up (29%) and lowest for patients in the MIXED group (19%). By use of the MIXED group as reference and adjusting for important clinical and demographic factors, the risk of death (risk ratio [95% CI]) was 1.12 (0.94-1.34) in the CARD-only group, 1.26 (1.15-1.38) in the GM-only group, and 1.48 (1.28-1.72) in the no-GM/CARD group. Cohort-2 results were consistent with cohort 1 for most covariates, and significant survival differences were again found between GM-only and the MIXED group (1.25 [1.14-1.37]).\nIs specialty care associated with improved survival of patients with congestive heart failure?",
        "answer": "yes",
        "answer_rationale": "We found an improved survival associated with cardiologist care and a mixture of general practitioner and cardiologist care compared with general practitioner care. The pattern of outpatient care may therefore be important for the survival of patients with CHF.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Implementation of the complex treatment strategies that have been shown to improve survival of patients with congestive heart failure (CHF) may require certain expertise. We wanted to examine the association between pattern of outpatient care and survival of patients with CHF.\nIn a retrospective cohort study conducted with national Veterans Health Administration (VHA) databases, we examined the association between the pattern of outpatient care and survival in 11,661 patients discharged from VA hospitals between October 1, 1991, and September 30, 1992, with the primary diagnosis of CHF (cohort 1). Patients were divided into 4 groups, on the basis of their pattern of outpatient care over a 12-month period after discharge: 1) general medicine clinic visits only (GM-only); 2) cardiology clinic visits only (CARD-only); 3) general medicine and cardiology (MIXED) clinic visits; and 4) neither general medicine nor cardiology clinic visits (no-GM/CARD). We used the Cox proportional hazards model to evaluate 1-year survival, controlling for clinical and demographic factors. Consistency of our results was examined by performing identical analysis on a cohort of patients",
        "q2": " discharged from VHA hospitals between October 1, 1994, and September 30, 1995 (cohort 2, n = 10,141).\nThe overall 1-year mortality rate was 23% in the primary cohort. The unadjusted mortality rate was highest for patients in the no-GM/CARD follow up (29%) and lowest for patients in the MIXED group (19%). By use of the MIXED group as reference and adjusting for important clinical and demographic factors, the risk of death (risk ratio [95% CI]) was 1.12 (0.94-1.34) in the CARD-only group, 1.26 (1.15-1.38) in the GM-only group, and 1.48 (1.28-1.72) in the no-GM/CARD group. Cohort-2 results were consistent with cohort 1 for most covariates, and significant survival differences were again found between GM-only and the MIXED group (1.25 [1.14-1.37]).\nIs specialty care associated with improved survival of patients with congestive heart failure?",
        "generated_text": "discharged between October 1, 1992, and September 30, 1993 (cohort 2).\nIn cohort 1, 5,154 (44.2%) patients had GM-only visits, 2,140 (18.3%) had CARD-only visits, 3,110 (26.7%) had MIXED visits, and 1,257 (10.8%) had no-GM/CARD visits. The 1-year survival rates were 81.1%, 84.1%, 84.1%, and 77.1%, respectively. In the adjusted analysis, the hazard ratios (HRs) for 1-year mortality were 0.87 (95% confidence interval [CI], 0.77 to 0.98) for GM-only, 0.77 (95% CI, 0.67 to 0.88) for CARD-only, and 0.77 (95% CI, 0.68 to 0.",
        "levenshtein_distance": 618
    },
    {
        "realidx": "12630042",
        "question": "The long-term survival of patients with gastric cancer is governed by various factors, such as the clinical stage of the cancer, the patient's nutritional state, and the treatment and may be governed by the volume of intraperitoneal adipose tissue. The aim of this study is to clarify the relationship between the degree of the patients' body mass index and their long-term survival.\nGastric cancer patients who had undergone a gastrectomy with D2-lymphadenectomy and with resection A and B according to the criteria of the Japanese Research Society for Gastric Cancer Rules were subgrouped into those patients with a body mass index<0.185 (the lower body mass index group) and those patients with a body mass index>0.210 (the higher body mass index group). The patient's morbidity and long-term survival rate was retrospectively compared between the 2 groups.\nA significantly longer mean survival rate was observed for the lower body mass index group in stage 2 (1667 vs. 1322 days, P = 0.0240). Also, a significantly longer mean survival rate was observed for the higher BMI group in stage 3a (1431 vs. 943, P = 0.0071).\nDoes body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?",
        "answer": "maybe",
        "answer_rationale": "The body mass index is one of the prognostic factors of stage 2 and stage 3a gastric cancer. However, it does not appear to be useful for determining the prognosis of stage 1a, 1b, 3b, and 4a gastric cancers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The long-term survival of patients with gastric cancer is governed by various factors, such as the clinical stage of the cancer, the patient's nutritional state, and the treatment and may be governed by the volume of intraperitoneal adipose tissue. The aim of this study is to clarify the relationship between the degree of the patients' body mass index and their long-term survival.\nGastric cancer patients who had undergone a gastrectomy with D2-lymphadenectomy and with resection A and B according to the criteria of the Japanese Research Society for Gastric Cancer Rules were subgrouped into those patients with a body mass index<0.185 (the lower body mass",
        "q2": " index group) and those patients with a body mass index>0.210 (the higher body mass index group). The patient's morbidity and long-term survival rate was retrospectively compared between the 2 groups.\nA significantly longer mean survival rate was observed for the lower body mass index group in stage 2 (1667 vs. 1322 days, P = 0.0240). Also, a significantly longer mean survival rate was observed for the higher BMI group in stage 3a (1431 vs. 943, P = 0.0071).\nDoes body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?",
        "generated_text": "index group), 0.185-0.249 (the normal body mass index group), and \u22650.25 (the higher body mass index group). The relationship between the body mass index and the long-term survival was analyzed.\nThe 5-year survival rates of the lower, normal, and higher body mass index groups were 57.1%, 67.5%, and 64.7%, respectively. The 5-year survival rates of the lower and higher body mass index groups were significantly lower than that of the normal body mass index group (p=0.0001 and p=0.000",
        "levenshtein_distance": 374
    },
    {
        "realidx": "12632437",
        "question": "To investigate the association between primary systemic vasculitis (PSV) and environmental risk factors.\nSeventy-five PSV cases and 273 controls (220 nonvasculitis, 19 secondary vasculitis, and 34 asthma controls) were interviewed using a structured questionnaire. Factors investigated were social class, occupational and residential history, smoking, pets, allergies, vaccinations, medications, hepatitis, tuberculosis, and farm exposure in the year before symptom onset (index year). The Standard Occupational Classification 2000 and job-exposure matrices were used to assess occupational silica, solvent, and metal exposure. Stepwise multiple logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (95% CI) adjusted for potential confounders. Total PSV, subgroups (47 Wegener's granulomatosis [WG], 12 microscopic polyangiitis, 16 Churg-Strauss syndrome [CSS]), and antineutrophil cytoplasmic antibody (ANCA)-positive cases were compared with control groups.\nFarming in the index year was significantly associated with PSV (OR 2.3 [95% CI 1.2-4.6]), with WG (2.7 [1.2-5.8]), with MPA (6.3 [1.9-21.6]), and with perinuclear ANCA (pANCA) (4.3 [1.5-12.7]). Farming during working lifetime was associated with PSV (2.2 [1.2-3.8]) and with WG (2.7 [1.3-5.7]). Significant associations were found for high occupational silica exposure in the index year (with PSV 3.0 [1.0-8.4], with CSS 5.6 [1.3-23.5], and with ANCA 4.9 [1.3-18.6]), high occupational solvent exposure in the index year (with PSV 3.4 [0.9-12.5], with WG 4.8 [1.2-19.8], and with classic ANCA [cANCA] 3.9 [1.6-9.5]), high occupational solvent exposure during working lifetime (with PSV 2.7 [1.1-6.6], with WG 3.4 [1.3-8.9], and with cANCA 3.3 [1.0-10.8]), drug allergy (with PSV 3.6 [1.8-7.0], with WG 4.0 [1.8-8.7], and with cANCA 4.7 [1.9-11.7]), and allergy overall (with PSV 2.2 [1.2-3.9], with WG 2.7 [1.4-5.7]). No other significant associations were found.\nAre environmental factors important in primary systemic vasculitis?",
        "answer": "yes",
        "answer_rationale": "A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the association between primary systemic vasculitis (PSV) and environmental risk factors.\nSeventy-five PSV cases and 273 controls (220 nonvasculitis, 19 secondary vasculitis, and 34 asthma controls) were interviewed using a structured questionnaire. Factors investigated were social class, occupational and residential history, smoking, pets, allergies, vaccinations, medications, hepatitis, tuberculosis, and farm exposure in the year before symptom onset (index year). The Standard Occupational Classification 2000 and job-exposure matrices were used to assess occupational silica, solvent, and metal exposure. Stepwise multiple logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (95% CI) adjusted for potential confounders. Total PSV, subgroups (47 Wegener's granulomatosis [WG], 12 microscopic polyangiitis, 16 Churg-Strauss syndrome [CSS]), and antineutrophil cytoplasmic antibody (ANCA)-positive cases were compared with control groups.\nFarming in the index year was significantly associated with PSV (OR 2.3 [95% CI 1.2-4.6]), with WG (2.7 [1.2-5.8]), with MPA (6.3 [1.9-21.6]), and with perinuclear ANCA (pANCA) (4.3 [1.5-12.7]). Farming during working lifetime was associated with PSV (2.2",
        "q2": " [1.2-3.8]) and with WG (2.7 [1.3-5.7]). Significant associations were found for high occupational silica exposure in the index year (with PSV 3.0 [1.0-8.4], with CSS 5.6 [1.3-23.5], and with ANCA 4.9 [1.3-18.6]), high occupational solvent exposure in the index year (with PSV 3.4 [0.9-12.5], with WG 4.8 [1.2-19.8], and with classic ANCA [cANCA] 3.9 [1.6-9.5]), high occupational solvent exposure during working lifetime (with PSV 2.7 [1.1-6.6], with WG 3.4 [1.3-8.9], and with cANCA 3.3 [1.0-10.8]), drug allergy (with PSV 3.6 [1.8-7.0], with WG 4.0 [1.8-8.7], and with cANCA 4.7 [1.9-11.7]), and allergy overall (with PSV 2.2 [1.2-3.9], with WG 2.7 [1.4-5.7]). No other significant associations were found.\nAre environmental factors important in primary systemic vasculitis?",
        "generated_text": "[1.2-4.0]), WG (2.5 [1.3-4.8]), and pANCA (3.1 [1.3-7.4]). Farming in the index year was associated with CSS (OR 3.1 [95% CI 0.9-10.7]) and cytoplasmic ANCA (cANCA) (2.4 [0.9-6.4]). Occupational silica exposure was associated with PSV (1.7 [1.0-2.9]), WG (1.8 [1.0-3.2]), and pANCA (1.7 [1.0-2.9]). Occupational solvent exposure was associated with PSV (1.7 [1.0-2.9]), WG (1.8 [1.0-3.2]), and pANCA (1.7 [1.0-2.9]). Occupational metal exposure was associated with PSV (1.7 [1.0-2.9]), WG (1.8 [1.0-3.2]), and pANCA (1.7 [1.0-2.9]). Smoking was associated with PSV (1.7 [1.0-2.9]), WG (1.8 [1.0-3.2]), and pANCA (1.7 [1.0-2.9]). Pet ownership was associated with",
        "levenshtein_distance": 480
    },
    {
        "realidx": "12765819",
        "question": "A case of spinal subdural hematoma (SSDH) following subarachnoid hemorrhage (SAH) because of a ruptured internal carotid aneurysm is described. Such a case has never been reported.\nA 52-year-old woman underwent a craniotomy for a ruptured internal carotid aneurysm. A computed tomography scan showed that SAH existed predominantly in the posterior fossa and subdural hematoma beneath the cerebellar tentorium. Intrathecal administration of urokinase, IV administration of fasudil hydrochloride, and continuous cerebrospinal fluid (CSF) evacuation via cisternal drainage were performed as prophylactic treatments for vasospasm. On the sixth postoperative day, the patient complained of severe lower back and buttock pain. Magnetic resonance imaging showed a subdural hematoma in the lumbosacral region. Although the mass effect was extensive, the patient showed no neurologic symptoms other than the sciatica. She was treated conservatively. The hematoma dissolved gradually and had diminished completely 15 weeks later. Her pain gradually subsided, and she was discharged 7 weeks later without any neurologic deficit.\nSpinal subdural hematoma: a sequela of a ruptured intracranial aneurysm?",
        "answer": "yes",
        "answer_rationale": "Although the exact mechanism of SSDH in this case is unclear, we speculate that this SSDH was a hematoma that migrated from the intracranial subdural space. Low CSF pressure because of continuous drainage and intrathecal thrombolytic therapy may have played an important role in the migration of the hematoma through the spinal canal. It is important to recognize the SSDH as a possible complication of the SAH accompanied with intracranial subdural hematoma.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "A case of spinal subdural hematoma (SSDH) following subarachnoid hemorrhage (SAH) because of a ruptured internal carotid aneurysm is described. Such a case has never been reported.\nA 52-year-old woman underwent a craniotomy for a ruptured internal carotid aneurysm. A computed tomography scan showed that SAH existed predominantly in the posterior fossa and subdural hematoma beneath the cerebellar tentorium. Intrathecal administration of urokinase, IV administration of fasudil hydrochloride, and continuous cerebrospinal fluid (CSF) evacuation via cisternal drainage were",
        "q2": " performed as prophylactic treatments for vasospasm. On the sixth postoperative day, the patient complained of severe lower back and buttock pain. Magnetic resonance imaging showed a subdural hematoma in the lumbosacral region. Although the mass effect was extensive, the patient showed no neurologic symptoms other than the sciatica. She was treated conservatively. The hematoma dissolved gradually and had diminished completely 15 weeks later. Her pain gradually subsided, and she was discharged 7 weeks later without any neurologic deficit.\nSpinal subdural hematoma: a sequela of a ruptured intracranial aneurysm?",
        "generated_text": "performed. On the 10th postoperative day, the patient developed a fever and neck stiffness. A computed tomography scan showed a spinal subdural hematoma at the C2-3 level. The patient was treated with continuous CSF drainage via lumbar puncture and IV administration of urokinase and fasudil hydrochloride. The patient's symptoms improved, and she was discharged on the 40th postoperative day.\nSSDH is a rare complication of SAH. The pathogenesis of SSDH is unclear, but it is thought to be caused by the rupture of bridging veins in the spinal sub",
        "levenshtein_distance": 430
    },
    {
        "realidx": "12769830",
        "question": "Most staging systems for soft tissue sarcoma are based on histologic malignancy-grade, tumor size and tumor depth. These factors are generally dichotomized, size at 5 cm. We believe it is unlikely that tumor depth per se should influence a tumor's metastatic capability. Therefore we hypothesized that the unfavourable prognostic importance of depth could be explained by the close association between size and depth, deep-seated tumors on average being larger than the superficial ones. When tumor size is dichotomized, this effect should be most pronounced in the large size (>5 cm) group in which the size span is larger.\nWe analyzed the associations between tumor size and depth and the prognostic importance of grade, size and depth in a population-based series of 490 adult patients with soft tissue sarcoma of the extremity or trunk wall with complete, 4.5 years minimum, follow-up.\nMultivariate analysis showed no major prognostic effect of tumor depth when grade and size were taken into account. The mean size of small tumors was the same whether superficial or deep but the mean size of large and deep-seated tumors were one third larger than that of large but superficial tumors. Tumor depth influenced the prognosis in the subset of high-grade and large tumors. In this subset deep-seated tumors had poorer survival rate than superficial tumors, which could be explained by the larger mean size of the deep-seated tumors.\nShould tumor depth be included in prognostication of soft tissue sarcoma?",
        "answer": "no",
        "answer_rationale": "Most of the prognostic value of tumor depth in soft tissue sarcomas of the extremity or trunk wall can be explained by the association between tumor size and depth.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Most staging systems for soft tissue sarcoma are based on histologic malignancy-grade, tumor size and tumor depth. These factors are generally dichotomized, size at 5 cm. We believe it is unlikely that tumor depth per se should influence a tumor's metastatic capability. Therefore we hypothesized that the unfavourable prognostic importance of depth could be explained by the close association between size and depth, deep-seated tumors on average being larger than the superficial ones. When tumor size is dichotomized, this effect should be most pronounced in the large size (>5 cm) group in which the size span is larger.\nWe analyzed the associations between tumor size and depth and the prognostic importance of grade, size and depth in a population-based",
        "q2": " series of 490 adult patients with soft tissue sarcoma of the extremity or trunk wall with complete, 4.5 years minimum, follow-up.\nMultivariate analysis showed no major prognostic effect of tumor depth when grade and size were taken into account. The mean size of small tumors was the same whether superficial or deep but the mean size of large and deep-seated tumors were one third larger than that of large but superficial tumors. Tumor depth influenced the prognosis in the subset of high-grade and large tumors. In this subset deep-seated tumors had poorer survival rate than superficial tumors, which could be explained by the larger mean size of the deep-seated tumors.\nShould tumor depth be included in prognostication of soft tissue sarcoma?",
        "generated_text": "cohort of 1,000 adult patients with primary, non-metastatic soft tissue sarcoma diagnosed in Norway 1987-2002. Cox regression was used to estimate hazard ratios (HR) with 95% confidence intervals (CI).\nTumor depth was associated with size (p<0.001). In the large size group, 70% of the tumors were deep-seated compared to 30% in the small size group. In the small size group, 5-year overall survival (OS) was 82% for superficial and 77% for deep-seated tumors (p=0.04). In the large size group, 5-year",
        "levenshtein_distance": 526
    },
    {
        "realidx": "12790890",
        "question": "Mesial temporal sclerosis (MTS) is characterized by neuronal loss in the hippocampus. Studies on experimental models and patients with intractable epilepsy suggest that apoptosis may be involved in neuronal death induced by recurrent seizures.\nWe searched evidence for apoptotic cell death in temporal lobes resected from drug-resistant epilepsy patients with MTS by using the terminal deoxynucleotidyl transferase (TdT) and digoxigenin-11-dUTP (TUNEL) method and immunohistochemistry for Bcl-2, Bax, and caspase-cleaved actin fragment, fractin. The temporal lobe specimens were obtained from 15 patients (six women and nine men; mean age, 29 +/- 8 years).\nUnlike that in normal adult brain, we observed Bcl-2 immunoreactivity in some of the remaining neurons dispersed throughout the hippocampus proper as well as in most of the reactive astroglia. Bax immunopositivity was increased in almost all neurons. Fractin immunostaining, an indicator of caspase activity, was detected in approximately 10% of these neurons. Despite increased Bax expression and activation of caspases, we could not find evidence for DNA fragmentation by TUNEL staining. We also could not detect typical apoptotic changes in nuclear morphology by Hoechst-33258 or hematoxylin counterstaining.\nIs the cell death in mesial temporal sclerosis apoptotic?",
        "answer": "maybe",
        "answer_rationale": "These data suggest that either apoptosis is not involved in cell loss in MTS, or a very slow rate of cell demise may have precluded detecting TUNEL-positive neurons dying through apoptosis. Increased Bax expression and activation of caspases support the latter possibility.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Mesial temporal sclerosis (MTS) is characterized by neuronal loss in the hippocampus. Studies on experimental models and patients with intractable epilepsy suggest that apoptosis may be involved in neuronal death induced by recurrent seizures.\nWe searched evidence for apoptotic cell death in temporal lobes resected from drug-resistant epilepsy patients with MTS by using the terminal deoxynucleotidyl transferase (TdT) and digoxigenin-11-dUTP (TUNEL) method and immunohistochemistry for Bcl-2, Bax, and caspase-cleaved actin fragment, fractin. The temporal lobe specimens were obtained from 15 patients (six women and nine men; mean age, ",
        "q2": "29 +/- 8 years).\nUnlike that in normal adult brain, we observed Bcl-2 immunoreactivity in some of the remaining neurons dispersed throughout the hippocampus proper as well as in most of the reactive astroglia. Bax immunopositivity was increased in almost all neurons. Fractin immunostaining, an indicator of caspase activity, was detected in approximately 10% of these neurons. Despite increased Bax expression and activation of caspases, we could not find evidence for DNA fragmentation by TUNEL staining. We also could not detect typical apoptotic changes in nuclear morphology by Hoechst-33258 or hematoxylin counterstaining.\nIs the cell death in mesial temporal sclerosis apoptotic?",
        "generated_text": "27.5 years; range, 16-45 years) with intractable epilepsy and MTS. The control group consisted of 10 patients (five women and five men; mean age, 28.5 years; range, 18-45 years) with no history of epilepsy who underwent temporal lobectomy for tumor resection.\nIn the control group, no TUNEL-positive cells were observed in the hippocampus or the adjacent cortex. In the MTS group, TUNEL-positive cells were observed in the hippocampus and the adjacent cortex. The number of TUNEL-positive cells in the hippocampus was significantly higher in the MTS group than in the control group (P",
        "levenshtein_distance": 533
    },
    {
        "realidx": "12805495",
        "question": "Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH. In light of this consideration, should a patient with both a history of ICH and a clear indication for anticoagulation such as nonvalvular atrial fibrillation be anticoagulated? In the absence of data from a clinical trial, we used a decision-analysis model to compare the expected values of 2 treatment strategies-warfarin and no anticoagulation-for such patients.\nWe used a Markov state transition decision model stratified by location of hemorrhage (lobar or deep hemispheric). Effectiveness was measured in quality-adjusted life years (QALYs). Data sources included English language literature identified through MEDLINE searches and bibliographies from selected articles, along with empirical data from our own institution. The base case focused on a 69-year-old man with a history of ICH and newly diagnosed nonvalvular atrial fibrillation.\nFor patients with prior lobar ICH, withholding anticoagulation therapy was strongly preferred, improving quality-adjusted life expectancy by 1.9 QALYs. For patients with prior deep hemispheric ICH, withholding anticoagulation resulted in a smaller gain of 0.3 QALYs. In sensitivity analyses for patients with deep ICH, anticoagulation could be preferred if the risk of thromboembolic stroke is particularly high.\nCan patients be anticoagulated after intracerebral hemorrhage?",
        "answer": "maybe",
        "answer_rationale": "Survivors of lobar ICH with atrial fibrillation should not be offered long-term anticoagulation. Similarly, most patients with deep hemispheric ICH and atrial fibrillation should not receive anticoagulant therapy. However, patients with deep hemispheric ICH at particularly high risk for thromboembolic stroke or low risk of ICH recurrence might benefit from long-term anticoagulation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH. In light of this consideration, should a patient with both a history of ICH and a clear indication for anticoagulation such as nonvalvular atrial fibrillation be anticoagulated? In the absence of data from a clinical trial, we used a decision-analysis model to compare the expected values of 2 treatment strategies-warfarin and no anticoagulation-for such patients.\nWe used a Markov state transition decision model stratified by location of hemorrhage (lobar or deep hemispheric). Effectiveness was measured in quality-adjusted life years (QALYs). Data sources included English language literature",
        "q2": " identified through MEDLINE searches and bibliographies from selected articles, along with empirical data from our own institution. The base case focused on a 69-year-old man with a history of ICH and newly diagnosed nonvalvular atrial fibrillation.\nFor patients with prior lobar ICH, withholding anticoagulation therapy was strongly preferred, improving quality-adjusted life expectancy by 1.9 QALYs. For patients with prior deep hemispheric ICH, withholding anticoagulation resulted in a smaller gain of 0.3 QALYs. In sensitivity analyses for patients with deep ICH, anticoagulation could be preferred if the risk of thromboembolic stroke is particularly high.\nCan patients be anticoagulated after intracerebral hemorrhage?",
        "generated_text": "and expert opinion. The primary outcome was the incremental cost-effectiveness ratio (ICER) of warfarin compared with no anticoagulation. We performed 1-way and probabilistic sensitivity analyses to assess the robustness of the results.\nIn the base-case analysis, warfarin was associated with a higher expected cost and higher expected QALYs compared with no anticoagulation, with an ICER of $10,000 per QALY gained. The results were most sensitive to the risk of recurrent ICH and the risk of ischemic stroke. Probabilistic sensitivity analysis indicated that warfarin was cost-effective in 75% of simulations, with a threshold of $50,000 per QAL",
        "levenshtein_distance": 560
    },
    {
        "realidx": "12846929",
        "question": "As part of a prospective study on quality of life in newly diagnosed lung cancer patients an investigation was carried out to examine whether there were differences among patients' quality of life scores and their socioeconomic status.\nQuality of life was measured at two points in time (baseline and three months after initial treatment) using three standard instruments; the Nottingham Health Profile (NHP), the European Organization for Research and Cancer Treatment Quality of Life Questionnaire (EORTC QLQ-C30) and its lung cancer supplement (QLQ-LC13). Socioeconomic status for each individual patient was derived using Carstairs and Morris Deprivation Category ranging from 1 (least deprived) to 7 (most deprived) on the basis of the postcode sector of their address.\nIn all, 129 lung cancer patients entered into the study. Of these data for 82 patients were complete (at baseline and follow-up). 57% of patients were of lower socioeconomic status and they had more health problems, less functioning, and more symptoms as compared to affluent patients. Of these, physical mobility (P = 0.05), energy (P = 0.01), role functioning (P = 0.04), physical functioning (P = 0.03), and breathlessness (P = 0.02) were significant at baseline. However, at follow-up assessment there was no significant difference between patient groups nor did any consistent pattern emerge.\nQuality of life in lung cancer patients: does socioeconomic status matter?",
        "answer": "yes",
        "answer_rationale": "At baseline assessment patients of lower socioeconomic status showed lower health related quality of life. Since there was no clear trend at follow-up assessment this suggests that patients from different socioeconomic status responded to treatment similarly. In general, the findings suggest that quality of life is not only the outcome of the disease and its treatment, but is also highly dependent on each patients' socioeconomic characteristics.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "As part of a prospective study on quality of life in newly diagnosed lung cancer patients an investigation was carried out to examine whether there were differences among patients' quality of life scores and their socioeconomic status.\nQuality of life was measured at two points in time (baseline and three months after initial treatment) using three standard instruments; the Nottingham Health Profile (NHP), the European Organization for Research and Cancer Treatment Quality of Life Questionnaire (EORTC QLQ-C30) and its lung cancer supplement (QLQ-LC13). Socioeconomic status for each individual patient was derived using Carstairs and Morris Deprivation Category ranging from 1 (least deprived) to 7 (most deprived) on the basis of the postcode sector of their address.\n",
        "q2": "In all, 129 lung cancer patients entered into the study. Of these data for 82 patients were complete (at baseline and follow-up). 57% of patients were of lower socioeconomic status and they had more health problems, less functioning, and more symptoms as compared to affluent patients. Of these, physical mobility (P = 0.05), energy (P = 0.01), role functioning (P = 0.04), physical functioning (P = 0.03), and breathlessness (P = 0.02) were significant at baseline. However, at follow-up assessment there was no significant difference between patient groups nor did any consistent pattern emerge.\nQuality of life in lung cancer patients: does socioeconomic status matter?",
        "generated_text": "The study included 100 patients with newly diagnosed lung cancer.\nThe results showed that there were significant differences in quality of life scores between patients from different socioeconomic backgrounds. Patients from more deprived areas tended to have lower quality of life scores on all three instruments at both time points. These differences remained even after adjusting for other factors such as age, sex, and stage of disease.\nThese findings suggest that socioeconomic status plays an important role in determining the quality of life of lung cancer patients. Therefore, it is important to consider socioeconomic factors when designing interventions to improve quality of life in this population.\nIn conclusion, this study highlights the need to address socioeconomic inequalities in lung cancer care and to develop targeted interventions to improve quality of life for patients from deprived areas.",
        "levenshtein_distance": 659
    },
    {
        "realidx": "12848629",
        "question": "Tuberculosis has increased in parallel with the acquired immunodeficiency syndrome epidemic and the use of immunosuppressive therapy, and the growing incidence of extra-pulmonary tuberculosis, especially with intestinal involvement, reflects this trend. However, the duration of anti-tuberculous therapy has not been clarified in intestinal tuberculosis.AIM: To compare the efficacy of different treatment durations in tuberculous enterocolitis in terms of response and recurrence rates.\nForty patients with tuberculous enterocolitis were randomized prospectively: 22 patients into a 9-month and 18 into a 15-month group. Diagnosis was made either by colonoscopic findings of discrete ulcers and histopathological findings of caseating granuloma and/or acid-fast bacilli, or by clinical improvement after therapeutic trial. Patients were followed up with colonoscopy every other month until complete response or treatment completion, and then every 6 months for 1 year and annually. Complete response was defined as a resolution of symptoms and active tuberculosis by colonoscopy.\nComplete response was obtained in all patients in both groups. Two patients in the 9-month group and one in the 15-month group underwent operation due to intestinal obstruction and perianal fistula, respectively. No recurrence of active intestinal tuberculosis occurred during the follow-up period in either group.\nIs a 9-month treatment sufficient in tuberculous enterocolitis?",
        "answer": "yes",
        "answer_rationale": "Tuberculous enterocolitis can be managed by 9-month chemotherapy without disease recurrence. Further investigations are needed in immunocompromised patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Tuberculosis has increased in parallel with the acquired immunodeficiency syndrome epidemic and the use of immunosuppressive therapy, and the growing incidence of extra-pulmonary tuberculosis, especially with intestinal involvement, reflects this trend. However, the duration of anti-tuberculous therapy has not been clarified in intestinal tuberculosis.AIM: To compare the efficacy of different treatment durations in tuberculous enterocolitis in terms of response and recurrence rates.\nForty patients with tuberculous enterocolitis were randomized prospectively: 22 patients into a 9-month and 18 into a 15-month group. Diagnosis was made either by colonoscopic findings of discrete ulcers and histopathological findings of",
        "q2": " caseating granuloma and/or acid-fast bacilli, or by clinical improvement after therapeutic trial. Patients were followed up with colonoscopy every other month until complete response or treatment completion, and then every 6 months for 1 year and annually. Complete response was defined as a resolution of symptoms and active tuberculosis by colonoscopy.\nComplete response was obtained in all patients in both groups. Two patients in the 9-month group and one in the 15-month group underwent operation due to intestinal obstruction and perianal fistula, respectively. No recurrence of active intestinal tuberculosis occurred during the follow-up period in either group.\nIs a 9-month treatment sufficient in tuberculous enterocolitis?",
        "generated_text": "granulomas or by positive cultures for Mycobacterium tuberculosis. All patients received a standard 6-month regimen of isoniazid, rifampicin, pyrazinamide and ethambutol, followed by isoniazid and rifampicin for 3 months in the 9-month group and for 9 months in the 15-month group. Patients were followed up for 1 year with clinical, biochemical and endoscopic examinations.\nThe response rates at 6 months were 86% in the 9-month group and 89% in the 15-month group (P=0.78). The recurrence rates at",
        "levenshtein_distance": 518
    },
    {
        "realidx": "12913878",
        "question": "Nd:YAG laser-induced thermo therapy (LITT) of rat brains is associated with blood-brain barrier (BBB) permeability changes. We address the question of whether LITT-induced locoregional disruption of the BBB could possibly allow a locoregional passage of chemotherapeutic agents into brain tissue to treat malignant glioma.STUDY DESIGN/\nCD Fischer rats were subject to LITT of the left forebrain. Disruption of the BBB was analyzed using Evans blue and immunohistochemistry (IH). Animals were perfused with paclitaxel, and high-pressure liquid chromatography (HPLC) was employed to analyze the content of paclitaxel in brain and plasma samples.\nLITT induces an opening of the BBB as demonstrated by locoregional extravasation of Evans blue, C3C, fibrinogen, and IgM. HPLC proved the passage of paclitaxel across the disrupted BBB.\nLocoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?",
        "answer": "yes",
        "answer_rationale": "LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Nd:YAG laser-induced thermo therapy (LITT) of rat brains is associated with blood-brain barrier (BBB) permeability changes. We address the question of whether LITT-induced locoregional disruption of the BBB could possibly allow a locoregional passage of chemotherapeutic agents into brain tissue to treat malignant glioma.STUDY DESIGN/\nCD Fischer rats were subject to LITT of the left forebrain. Disruption of the BBB was analyzed using Evans blue and immunohistochemistry (IH). Animals were perfused with paclitaxel,",
        "q2": " and high-pressure liquid chromatography (HPLC) was employed to analyze the content of paclitaxel in brain and plasma samples.\nLITT induces an opening of the BBB as demonstrated by locoregional extravasation of Evans blue, C3C, fibrinogen, and IgM. HPLC proved the passage of paclitaxel across the disrupted BBB.\nLocoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?",
        "generated_text": "a chemotherapeutic agent, and the distribution of paclitaxel was analyzed using IH. The BBB permeability was quantified using the Evans blue method. The distribution of paclitaxel was quantified using IH. The data were analyzed using ANOVA and Student's t-test. The significance level was set at p < 0.05.RESULTS/\nLITT induced a significant disruption of the BBB in the left forebrain, as evidenced by increased Evans blue extravasation and loss of tight junction proteins. Paclit",
        "levenshtein_distance": 390
    },
    {
        "realidx": "12963175",
        "question": "It was the aim of the present study to elaborate criteria for the assessment of rapid hemodynamic progression of valvar aortic stenosis. These criteria are of special importance when cardiac surgery is indicated for other reasons but the established criteria for aortic valve replacement are not yet fulfilled. Such aspects of therapeutic planing were mostly disregarded in the past so that patients had to undergo cardiac reoperation within a few years.\nHemodynamic, echocardiographic, and clinical data of 169 men and 88 women with aortic stenosis, aged 55.2 +/- 15.7 years at their first and 63.4 +/- 15.6 years at their second cardiac catheterization, were analyzed.\nThe progression rate of aortic valve obstruction was found to be dependent on the degree of valvar calcification ([VC] scoring 0 to III) and to be exponentially correlated with the aortic valve opening area (AVA) at initial catheterization. Neither age nor sex of the patient nor etiology of the valvar obstruction significantly influence the progression of aortic stenosis. If AVA decreases below 0.75 cm(2) with a present degree of VC = 0, or AVA of 0.8 with VC of I, AVA of 0.9 with VC of II, or AVA of 1.0 with VC of III, it is probable that aortic stenosis will have to be operated upon in the following years.\nCan progression of valvar aortic stenosis be predicted accurately?",
        "answer": "yes",
        "answer_rationale": "The present data indicate that for clinical purposes and planning of valvar surgery the progression of asymptomatic aortic stenosis can be sufficiently predicted by the present aortic valve opening area and the degree of valvar calcification.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "It was the aim of the present study to elaborate criteria for the assessment of rapid hemodynamic progression of valvar aortic stenosis. These criteria are of special importance when cardiac surgery is indicated for other reasons but the established criteria for aortic valve replacement are not yet fulfilled. Such aspects of therapeutic planing were mostly disregarded in the past so that patients had to undergo cardiac reoperation within a few years.\nHemodynamic, echocardiographic, and clinical data of 169 men and 88 women with aortic stenosis, aged 55.2 +/- 15.7 years at their first and 63.4 +/- 15.6 years at their second cardiac catheterization, were analyzed.\nThe progression rate of aortic valve obstruction was found to be",
        "q2": " dependent on the degree of valvar calcification ([VC] scoring 0 to III) and to be exponentially correlated with the aortic valve opening area (AVA) at initial catheterization. Neither age nor sex of the patient nor etiology of the valvar obstruction significantly influence the progression of aortic stenosis. If AVA decreases below 0.75 cm(2) with a present degree of VC = 0, or AVA of 0.8 with VC of I, AVA of 0.9 with VC of II, or AVA of 1.0 with VC of III, it is probable that aortic stenosis will have to be operated upon in the following years.\nCan progression of valvar aortic stenosis be predicted accurately?",
        "generated_text": "related to the initial severity of aortic stenosis, the age of the patient, and the presence of coronary artery disease. The progression rate was higher in patients with aortic valve areas less than 1.0 cm2, in patients older than 60 years, and in patients with coronary artery disease. The progression rate was also higher in patients with aortic valve areas less than 0.75 cm2, in patients older than 65 years, and in patients with severe coronary artery disease.\nThe progression rate of aortic valve obstruction was found to be related to the initial severity of aortic stenosis, the age of the patient, and the presence of coronary artery disease. The progression rate was higher in patients with aortic valve areas less",
        "levenshtein_distance": 502
    },
    {
        "realidx": "12970636",
        "question": "To examine the impact of early discharge on newborn metabolic screening.\nMetabolic screening results were obtained from the Alabama State Lab for all infants born at our hospital between 8/1/97, and 1/31/99, and were matched with an existing database of early discharge infants. An early newborn discharge was defined as a discharge between 24 and 47 hours of age. Metabolic screening tests included phenylketonuria (PKU), hypothyroidism, and congenital adrenal hyperplasia (CAH). Early discharge and traditional stay infants were compared to determine the percentage of newborns screened and the timing of the first adequate specimen.\nThe state laboratory received specimens from 3860 infants; 1324 were on early discharge newborns and 2536 infants in the traditional stay group. At least one filter paper test (PKU, hypothyroidism, and CAH) was collected on 99.2% of early discharge infants and 96.0% of traditional stay infants (P<.0001). Early discharge infants had a higher rate of initial filter paper specimens being inadequate (22.9%) compared with traditional stay infants (14.3%, P<.0001) but had a higher rate of repeat specimens when the initial specimen was inadequate (85.0% early discharge vs 75.3% traditional stay, P=.002). The early discharge group was more likely to have an adequate specimen within the first 9 days of life (1001, 98.8% early discharge vs 2016, 96.7% traditional stay, P=.0005).\nDoes early discharge with nurse home visits affect adequacy of newborn metabolic screening?",
        "answer": "no",
        "answer_rationale": "In this well established early discharge program with nurse home visits, newborn metabolic screening is not compromised by early discharge.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To examine the impact of early discharge on newborn metabolic screening.\nMetabolic screening results were obtained from the Alabama State Lab for all infants born at our hospital between 8/1/97, and 1/31/99, and were matched with an existing database of early discharge infants. An early newborn discharge was defined as a discharge between 24 and 47 hours of age. Metabolic screening tests included phenylketonuria (PKU), hypothyroidism, and congenital adrenal hyperplasia (CAH). Early discharge and traditional stay infants were compared to determine the percentage of newborns screened and the timing of the first adequate specimen.\nThe state laboratory received specimens from 3860 infants; 1324 were on early discharge newborns and 2536 infants in the traditional stay group. At least one filter paper test (PKU,",
        "q2": " hypothyroidism, and CAH) was collected on 99.2% of early discharge infants and 96.0% of traditional stay infants (P<.0001). Early discharge infants had a higher rate of initial filter paper specimens being inadequate (22.9%) compared with traditional stay infants (14.3%, P<.0001) but had a higher rate of repeat specimens when the initial specimen was inadequate (85.0% early discharge vs 75.3% traditional stay, P=.002). The early discharge group was more likely to have an adequate specimen within the first 9 days of life (1001, 98.8% early discharge vs 2016, 96.7% traditional stay, P=.0005).\nDoes early discharge with nurse home visits affect adequacy of newborn metabolic screening?",
        "generated_text": "hypothyroidism, or CAH) was performed on 99.7% of the early discharge group and 99.8% of the traditional stay group. The mean time to first adequate specimen was 4.1 days for the early discharge group and 4.3 days for the traditional stay group. The percentage of infants with a first adequate specimen within 5 days of birth was 72.1% for the early discharge group and 70.1% for the traditional stay group. The percentage of infants with a first adequate specimen within 7 days of birth was 87.1% for the early discharge group and 85.7% for the traditional stay group. There was no significant difference in the percentage of infants screened or the timing of the first adequate specimen between the two groups.",
        "levenshtein_distance": 441
    },
    {
        "realidx": "14551704",
        "question": "Communication with terminally ill patients is a main responsibility of physicians. However, many physicians feel insufficiently prepared for this task. Models of courses resulting in improvements of communicative skills of participants have been published mainly in the Anglo-American literature. This study describes the realization of a 2-day course model based on the experiences of the first three courses of this kind in Rhineland-Palatinate, and analyzes changes of participants' communication behavior.\nAfter each seminary, an evaluation form concerning participants' satisfaction with the course was filled in. Furthermore, all course participants received a questionnaire at the beginning and at the end of the course, as well as 3 months afterwards. The participants were asked to assess their own sense of security in seven different communication settings on a visual analog scale, and to specify perceived changes in their communication behavior 3 months after the course.\nThe first three courses were attended by 31 participants. Course evaluation revealed high satisfaction scores with methods as well as with clarity and relevance of the contents. Self-assessment of participants showed a growing sense of security in different communication settings. Important increases could be demonstrated for communicating a diagnosis of cancer with good or less good prognosis, recurrence of cancer or a far progressive cancer disease without curative approach. 3 months after the course, participants described multiple changes indicating increased sensibility and professionalism in communication behavior.\nCan communication with terminally ill patients be taught?",
        "answer": "yes",
        "answer_rationale": "The realized communication skills courses resulted in relevant changes in communication behaviour and self-confidence of participants. Communication with terminally ill patients can be taught.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Communication with terminally ill patients is a main responsibility of physicians. However, many physicians feel insufficiently prepared for this task. Models of courses resulting in improvements of communicative skills of participants have been published mainly in the Anglo-American literature. This study describes the realization of a 2-day course model based on the experiences of the first three courses of this kind in Rhineland-Palatinate, and analyzes changes of participants' communication behavior.\nAfter each seminary, an evaluation form concerning participants' satisfaction with the course was filled in. Furthermore, all course participants received a questionnaire at the beginning and at the end of the course, as well as 3 months afterwards. The participants were asked to assess their",
        "q2": " own sense of security in seven different communication settings on a visual analog scale, and to specify perceived changes in their communication behavior 3 months after the course.\nThe first three courses were attended by 31 participants. Course evaluation revealed high satisfaction scores with methods as well as with clarity and relevance of the contents. Self-assessment of participants showed a growing sense of security in different communication settings. Important increases could be demonstrated for communicating a diagnosis of cancer with good or less good prognosis, recurrence of cancer or a far progressive cancer disease without curative approach. 3 months after the course, participants described multiple changes indicating increased sensibility and professionalism in communication behavior.\nCan communication with terminally ill patients be taught?",
        "generated_text": "own communicative behavior in 12 different situations.\nA total of 102 physicians participated in the three courses. The participants were satisfied with the course. The participants' self-assessment of their communicative behavior improved significantly in 10 of the 12 situations. The improvement was still present 3 months after the course.\nThe course model is feasible and acceptable for the participants. The participants' self-assessment of their communicative behavior improved significantly. This improvement was still present 3 months after the course.",
        "levenshtein_distance": 605
    },
    {
        "realidx": "14599616",
        "question": "Lymphedema may be identified by simpler circumference changes as compared with changes in limb volume.\nNinety breast cancer patients were prospectively enrolled in an academic trial, and seven upper extremity circumferences were measured quarterly for 3 years. A 10% volume increase or greater than 1 cm increase in arm circumference identified lymphedema with verification by a lymphedema specialist. Sensitivity and specificity of several different criteria for detecting lymphedema were compared using the academic trial as the standard.\nThirty-nine cases of lymphedema were identified by the academic trial. Using a 10% increase in circumference at two sites as the criterion, half the lymphedema cases were detected (sensitivity 37%). When using a 10% increase in circumference at any site, 74.4% of cases were detected (sensitivity 49%). Detection by a 5% increase in circumference at any site was 91% sensitive.\nCan a practicing surgeon detect early lymphedema reliably?",
        "answer": "maybe",
        "answer_rationale": "An increase of 5% in circumference measurements identified the most potential lymphedema cases compared with an academic trial.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Lymphedema may be identified by simpler circumference changes as compared with changes in limb volume.\nNinety breast cancer patients were prospectively enrolled in an academic trial, and seven upper extremity circumferences were measured quarterly for 3 years. A 10% volume increase or greater than 1 cm increase in arm circumference identified lymphedema with verification by a lymphedema specialist. Sensitivity and specificity of several different criteria for detecting lymphedema were compared using the academic trial as the standard",
        "q2": ".\nThirty-nine cases of lymphedema were identified by the academic trial. Using a 10% increase in circumference at two sites as the criterion, half the lymphedema cases were detected (sensitivity 37%). When using a 10% increase in circumference at any site, 74.4% of cases were detected (sensitivity 49%). Detection by a 5% increase in circumference at any site was 91% sensitive.\nCan a practicing surgeon detect early lymphedema reliably?",
        "generated_text": ".\nLymphedema was diagnosed in 20 patients (22%). The sensitivity and specificity of a 2 cm increase in arm circumference was 85% and 89%, respectively, and a 10% increase in volume was 85% and 89%, respectively. The sensitivity and specificity of a 1 cm increase in arm circumference was 95% and 77%, respectively, and a 5% increase in volume was 95% and 77%, respectively.",
        "levenshtein_distance": 292
    },
    {
        "realidx": "14627582",
        "question": "The purpose of our study was to determine the effectiveness, clinical impact, and feasibility of double reading barium enemas.\nIndependent double readings of 1,003 consecutive barium enemas (822 double- and 181 single-contrast examinations) were prospectively performed. From this pool of 1,003 examinations, 994 were included in our study. Examinations showing at least one polyp or carcinoma 5 mm or larger were considered to have positive results. For combined readings, results were considered positive if either of the two interpreters reported finding a polyp or carcinoma. A McNemar test was used to compare the first reader's results with the combined results of the first and second readers. Results were retrospectively correlated with endoscopic or surgical results in 360 patients, and agreement between first and combined readings and endoscopic results was determined.\nAdding a second reader increased the number of positive results on examinations from 249 to 315 (p<0.0001) and resulted in potential alteration of clinical treatment in 98 patients (9.9%). Sensitivity of the first and combined readings for detection of all lesions was identical, 76.3% (95% CI, 65.4-87.1%). Specificity decreased from 91.0% (95% CI, 87.9-94.3%) for the first reading to 86.4% (95% CI, 82.2-90.0%) for the combined reading. The overall measurement of agreement decreased from a kappa value of 61.8 (95% CI, 51.2-72.4%) for the first reading to 52.9 (95% CI, 42.2-63.6%) for the combined reading. The second reading required an average of 3.3 min. Sensitivity for the detection of adenocarcinomas was 100%.\nDouble reading of barium enemas: is it necessary?",
        "answer": "no",
        "answer_rationale": "Although feasible, double reading of barium enemas does not improve sensitivity for detection of polyps and produces a higher false-positive rate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The purpose of our study was to determine the effectiveness, clinical impact, and feasibility of double reading barium enemas.\nIndependent double readings of 1,003 consecutive barium enemas (822 double- and 181 single-contrast examinations) were prospectively performed. From this pool of 1,003 examinations, 994 were included in our study. Examinations showing at least one polyp or carcinoma 5 mm or larger were considered to have positive results. For combined readings, results were considered positive if either of the two interpreters reported finding a polyp or carcinoma. A McNemar test was used to compare the first reader's results with the combined results of the first and second readers. Results were retrospectively correlated with endoscopic or surgical results in 360 patients, and agreement between first and combined readings and endoscopic results was determined.\nAdding a second reader increased the number of positive results on examinations from 249 to 315 (p<0.0001) and",
        "q2": " resulted in potential alteration of clinical treatment in 98 patients (9.9%). Sensitivity of the first and combined readings for detection of all lesions was identical, 76.3% (95% CI, 65.4-87.1%). Specificity decreased from 91.0% (95% CI, 87.9-94.3%) for the first reading to 86.4% (95% CI, 82.2-90.0%) for the combined reading. The overall measurement of agreement decreased from a kappa value of 61.8 (95% CI, 51.2-72.4%) for the first reading to 52.9 (95% CI, 42.2-63.6%) for the combined reading. The second reading required an average of 3.3 min. Sensitivity for the detection of adenocarcinomas was 100%.\nDouble reading of barium enemas: is it necessary?",
        "generated_text": "increased the number of positive findings from 302 to 374 (p<0.0001). The number of polyps 5 mm or larger increased from 250 to 310 (p<0.0001). The number of carcinomas increased from 52 to 64 (p=0.0002). The number of patients with positive findings increased from 249 to 315 (p<0.0001). The number of patients with polyps 5 mm or larger increased from 224 to 278 (p<0.0001). The number of patients with carcinomas increased from 52 to 64 (p=0.0002). The number of patients with positive findings increased from 249 to 315 (p<0.0001). The number of patients with",
        "levenshtein_distance": 512
    },
    {
        "realidx": "14631523",
        "question": "The objectives were to identify prognostic factors for the survival of children with cerebellar astrocytoma, and to evaluate the reproducibility and prognostic value of histological sub-classification and grading.\nChildren aged 0-14 years treated in Denmark for a cerebellar astrocytoma in the period 1960-1984 were included and followed until January 2001 or until their death. The histological specimens from each patient were reviewed for revised grading and classification according to three different classification schemes: the WHO, the Kernohan and the Daumas-Duport grading systems.\nThe overall survival rate was 81% after a follow-up time of 15-40 years. The significant positive prognostic factors for survival were \"surgically gross-total removal\" of the tumour at surgery and location of the tumour in the cerebellum proper as opposed to location in the fourth ventricle. No difference in survival time was demonstrated when we compared pilocytic astrocytoma and fibrillary astrocytoma. Moreover, we found that the Kernohan and the WHO classification systems had no predictive value and that the Daumas-Duport system is unsuitable as a prognostic tool for low-grade posterior fossa astrocytomas.\nSub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?",
        "answer": "no",
        "answer_rationale": "Discordant observations due to interobserver variability make histological sub-classification of low-grade cerebellar astrocytomas in children insufficient for predicting prognosis and biological behaviour. Similar survival rates in a population of paediatric low-grade cerebellar astrocytomas of grades I and II indicate that tumour grade has no prognostic significance within this group of patients. \"Surgically gross-total removal\", especially if the tumour is located in the fourth ventricle is of the highest importance for long-term survival. Histological sub-classification of the tumours has no predictive value.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The objectives were to identify prognostic factors for the survival of children with cerebellar astrocytoma, and to evaluate the reproducibility and prognostic value of histological sub-classification and grading.\nChildren aged 0-14 years treated in Denmark for a cerebellar astrocytoma in the period 1960-1984 were included and followed until January 2001 or until their death. The histological specimens from each patient were reviewed for revised grading and classification according to three different classification schemes: the WHO, the Kernohan and the Daumas-Duport grading systems.\nThe overall survival rate was 81% after a follow-up time of 15",
        "q2": "-40 years. The significant positive prognostic factors for survival were \"surgically gross-total removal\" of the tumour at surgery and location of the tumour in the cerebellum proper as opposed to location in the fourth ventricle. No difference in survival time was demonstrated when we compared pilocytic astrocytoma and fibrillary astrocytoma. Moreover, we found that the Kernohan and the WHO classification systems had no predictive value and that the Daumas-Duport system is unsuitable as a prognostic tool for low-grade posterior fossa astrocytomas.\nSub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?",
        "generated_text": "years. The 15-year survival rate was 75% for children with a pilocytic astrocytoma and 87% for children with a fibrillary astrocytoma. The survival rate for children with a pilocytic astrocytoma was significantly better than for children with a fibrillary astrocytoma (p=0.001). The survival rate for children with a grade I tumour was 87% compared to 75% for children with a grade II tumour (p=0.001). The survival rate for children with a grade I tumour was significantly better than for children with a",
        "levenshtein_distance": 460
    },
    {
        "realidx": "14652839",
        "question": "Embolisation of atherosclerotic debris during abdominal aortic aneurysm (AAA) repair is responsible for significant peri-operative morbidity. Reports have suggested that preferential clamping of the distal vessel(s) before the proximal aorta may decrease the number of emboli passing distally and hence reduce complications.\nForty patients undergoing AAA repair were randomised to have either first clamping of the proximal aorta or the iliac vessels. Emboli passing through the Superficial Femoral Arteries were detected with a Transcranial Doppler ultrasound system.\nThere was no difference between the two groups in the number of emboli detected (p=0.49) and no significant correlation between number of emboli and dissection time (r=0.0008). However, there was a significantly higher number of emboli in the patient sub-group that were current smokers (p=0.034).\nDoes the sequence of clamp application during open abdominal aortic aneurysm surgery influence distal embolisation?",
        "answer": "no",
        "answer_rationale": "There appears to be no difference in the numbers of emboli detected when the first vascular clamp is applied to the proximal aorta or iliacs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Embolisation of atherosclerotic debris during abdominal aortic aneurysm (AAA) repair is responsible for significant peri-operative morbidity. Reports have suggested that preferential clamping of the distal vessel(s) before the proximal aorta may decrease the number of emboli passing distally and hence reduce complications.\nForty patients undergoing AAA repair were randomised to have either first clamping of the proximal aorta or the iliac vessels. Emboli passing through the Superficial Femoral Arteries were",
        "q2": " detected with a Transcranial Doppler ultrasound system.\nThere was no difference between the two groups in the number of emboli detected (p=0.49) and no significant correlation between number of emboli and dissection time (r=0.0008). However, there was a significantly higher number of emboli in the patient sub-group that were current smokers (p=0.034).\nDoes the sequence of clamp application during open abdominal aortic aneurysm surgery influence distal embolisation?",
        "generated_text": "detected using Transcranial Doppler (TCD). The number of emboli, the time to first embolus and the time to peak embolisation were recorded.\nThere was no significant difference in the number of emboli detected in the two groups (p=0.14). The time to first embolus was significantly shorter in the proximal first group (p=0.001). The time to peak embolisation was similar in both groups (p=0",
        "levenshtein_distance": 300
    },
    {
        "realidx": "14692023",
        "question": "Despite advances in therapies for breast cancer, improvement in survival for patients with recurrent or metastatic breast cancer has been difficult to establish. The objective of the current study was to determine whether the survival of women with recurrent breast cancer has improved from 1974 to 2000.\nThe authors analyzed the survival experience of 834 women who developed recurrent breast cancer between November 1974 and December 2000. All patients had been treated previously with adjuvant anthracycline-based protocols. Patients were divided into five consecutive groups based on year of breast cancer recurrence, and survival was compared across the five groups. Because some prognostic variables were divided unevenly divided among the cohorts, a multivariate model was created to determine the association of year of recurrence and survival after accounting for other prognostic factors.\nIn the unadjusted analysis, there was a statistically significant improvement in survival across the five groups, and the more recent cohorts had longer survival (P<0.001). Other variables that predicted longer survival after breast cancer recurrence included smaller initial tumor size, lower stage of disease, fewer lymph nodes involved, longer disease-free interval, estrogen receptor-positive tumors, and nonvisceral dominant site of disease recurrence. In the multivariate analysis, which adjusted for these prognostic factors, year of recurrence was associated with a trend toward improved survival, with a 1% reduction in risk for each increasing year.\nIs breast cancer survival improving?",
        "answer": "yes",
        "answer_rationale": "For these cohorts of patients, the authors present data suggesting that the prognosis for patients with recurrent breast cancer improved between 1974 and 2000.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Despite advances in therapies for breast cancer, improvement in survival for patients with recurrent or metastatic breast cancer has been difficult to establish. The objective of the current study was to determine whether the survival of women with recurrent breast cancer has improved from 1974 to 2000.\nThe authors analyzed the survival experience of 834 women who developed recurrent breast cancer between November 1974 and December 2000. All patients had been treated previously with adjuvant anthracycline-based protocols. Patients were divided into five consecutive groups based on year of breast cancer recurrence, and survival was compared across the five groups. Because some prognostic variables were divided unevenly divided among the cohorts, a multivariate model was created to",
        "q2": " determine the association of year of recurrence and survival after accounting for other prognostic factors.\nIn the unadjusted analysis, there was a statistically significant improvement in survival across the five groups, and the more recent cohorts had longer survival (P<0.001). Other variables that predicted longer survival after breast cancer recurrence included smaller initial tumor size, lower stage of disease, fewer lymph nodes involved, longer disease-free interval, estrogen receptor-positive tumors, and nonvisceral dominant site of disease recurrence. In the multivariate analysis, which adjusted for these prognostic factors, year of recurrence was associated with a trend toward improved survival, with a 1% reduction in risk for each increasing year.\nIs breast cancer survival improving?",
        "generated_text": "adjust for these differences.\nThe median survival of patients with recurrent breast cancer increased from 1.9 years in the first cohort to 3.1 years in the fifth cohort (P < 0.001). The multivariate analysis showed that the year of recurrence was an independent predictor of survival (P < 0.001). The 5-year survival rate increased from 10% in the first cohort to 22% in the fifth cohort (P < 0.001). The median survival of patients with visceral metastases increased from 1.4 years in the first cohort to 2.4 years in the fifth cohort (P < 0.0",
        "levenshtein_distance": 584
    },
    {
        "realidx": "14697414",
        "question": "To analyze, retrospectively, the patterns and behavior of metastatic lesions in prostate cancer patients treated with external beam radiotherapy and to investigate whether patients with<or =5 lesions had an improved outcome relative to patients with>5 lesions.\nThe treatment and outcome of 369 eligible patients with Stage T1-T3aN0-NXM0 prostate cancer were analyzed during a minimal 10-year follow-up period. All patients were treated with curative intent to a mean dose of 65 Gy. The full history of any metastatic disease was documented for each subject, including the initial site of involvement, any progression over time, and patient survival.\nThe overall survival rate for the 369 patients was 75% at 5 years and 45% at 10 years. The overall survival rate of patients who never developed metastases was 90% and 81% at 5 and 10 years, respectively. However, among the 74 patients (20%) who developed metastases, the survival rate at both 5 and 10 years was significantly reduced (p<0.0001). The overall survival rate for patients who developed bone metastases was 58% and 27% at 5 and 10 years, respectively, and patients with bone metastases to the pelvis fared worse compared with those with vertebral metastases. With regard to the metastatic number, patients with<or =5 metastatic lesions had superior survival rates relative to those with>5 lesions (73% and 36% at 5 and 10 years vs. 45% and 18% at 5 and 10 years, respectively; p = 0.02). In addition, both the metastasis-free survival rate and the interval measured from the date of the initial diagnosis of prostate cancer to the development of bone metastasis were statistically superior for patients with<or =5 lesions compared with patients with>5 lesions (p = 0.01 and 0.02, respectively). However, the survival rate and the interval from the date of diagnosis of bone metastasis to the time of death for patients in both groups were not significantly different, statistically (p = 0.17 and 0.27, respectively).\nIs there a favorable subset of patients with prostate cancer who develop oligometastases?",
        "answer": "yes",
        "answer_rationale": "Patients with<or =5 metastatic sites had significantly better survival rates than patients with>5 lesions. Because existing sites of metastatic disease may be the primary sites of origin for additional metastases, our findings suggest that early detection and aggressive treatment of patients with a small number of metastatic lesions is worth testing as an approach to improving long-term survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To analyze, retrospectively, the patterns and behavior of metastatic lesions in prostate cancer patients treated with external beam radiotherapy and to investigate whether patients with<or =5 lesions had an improved outcome relative to patients with>5 lesions.\nThe treatment and outcome of 369 eligible patients with Stage T1-T3aN0-NXM0 prostate cancer were analyzed during a minimal 10-year follow-up period. All patients were treated with curative intent to a mean dose of 65 Gy. The full history of any metastatic disease was documented for each subject, including the initial site of involvement, any progression over time, and patient survival.\nThe overall survival rate for the 369 patients was 75% at 5 years and 45% at 10 years. The overall survival rate of patients who never developed metastases was 90% and 81% at 5 and 10 years, respectively. However, among the 74 patients (20%) who developed metastases, the survival rate at both 5 and 10 years was significantly reduced (p<0.0001). The overall survival rate for patients who developed bone metastases was ",
        "q2": "58% and 27% at 5 and 10 years, respectively, and patients with bone metastases to the pelvis fared worse compared with those with vertebral metastases. With regard to the metastatic number, patients with<or =5 metastatic lesions had superior survival rates relative to those with>5 lesions (73% and 36% at 5 and 10 years vs. 45% and 18% at 5 and 10 years, respectively; p = 0.02). In addition, both the metastasis-free survival rate and the interval measured from the date of the initial diagnosis of prostate cancer to the development of bone metastasis were statistically superior for patients with<or =5 lesions compared with patients with>5 lesions (p = 0.01 and 0.02, respectively). However, the survival rate and the interval from the date of diagnosis of bone metastasis to the time of death for patients in both groups were not significantly different, statistically (p = 0.17 and 0.27, respectively).\nIs there a favorable subset of patients with prostate cancer who develop oligometastases?",
        "generated_text": "50% at 5 years and 10% at 10 years, compared with 70% and 20%, respectively, for patients who developed visceral metastases (p=0.0001). The number of metastatic lesions was also a significant prognostic factor. Patients with<or =5 metastatic lesions had a 5-year survival rate of 60% compared with 30% for patients with>5 lesions (p=0.0001). The 10-year survival rate was 15% and 0%, respectively (p=0.0001). The site of metastatic disease was also a significant prognostic factor. Patients with bone metastases had a 5-year survival rate of 50% compared with 70% for patients with visceral metastases (p=0.0001). The 10-year survival rate was 10% and 20%, respectively (p=0.0001). The number of metastatic lesions was also a significant prognostic factor. Patients",
        "levenshtein_distance": 675
    },
    {
        "realidx": "14872327",
        "question": "To study the prevalence of pain and risk factors for pain in psychiatric patients in a psychiatric hospital.\nUsing a questionnaire we investigated in a cross-sectional study the prevalence of pain, duration of pain, impairment and unfitness for work due to pain in 106 patients primarily diagnosed with a psychiatric disorder in the field of general adult psychiatry. Potential risk factors were explored.\nThe point prevalence of pain was about 50%, the 6-month prevalence 75.5% and the 12-month prevalence 76.5%. The patients' most frequent complaints were low back pain, headache and shoulder and neck pain. Patients with affective disorders most frequently had pain complaints, followed by those with neurotic, stress-related and somatoform disorders and those with psychotic disorders such as schizophrenia, schizotypic and delusional disorders. Almost 10% of all patients reported pain continuing at least 3 months in the past year. Impairment and unfitness for work were related to specific psychiatric diagnosis. Statistically significant risk factors for pain were depression (OR=6.05) and the number of past admissions to psychiatric hospitals (OR=3.609).\nIs pain a clinically relevant problem in general adult psychiatry?",
        "answer": "yes",
        "answer_rationale": "We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To study the prevalence of pain and risk factors for pain in psychiatric patients in a psychiatric hospital.\nUsing a questionnaire we investigated in a cross-sectional study the prevalence of pain, duration of pain, impairment and unfitness for work due to pain in 106 patients primarily diagnosed with a psychiatric disorder in the field of general adult psychiatry. Potential risk factors were explored.\nThe point prevalence of pain was about 50%, the 6-month prevalence 75.5% and the 12-month prevalence 76.5%. The patients' most frequent complaints were low back pain, headache and shoulder and neck pain. Patients",
        "q2": " with affective disorders most frequently had pain complaints, followed by those with neurotic, stress-related and somatoform disorders and those with psychotic disorders such as schizophrenia, schizotypic and delusional disorders. Almost 10% of all patients reported pain continuing at least 3 months in the past year. Impairment and unfitness for work were related to specific psychiatric diagnosis. Statistically significant risk factors for pain were depression (OR=6.05) and the number of past admissions to psychiatric hospitals (OR=3.609).\nIs pain a clinically relevant problem in general adult psychiatry?",
        "generated_text": "with pain had a significantly higher mean age, a higher mean BMI, a higher proportion of female patients, a higher proportion of patients with a somatic comorbidity, a higher proportion of patients with a chronic psychiatric disorder and a higher proportion of patients with a chronic pain disorder. The duration of pain was significantly longer in patients with a chronic pain disorder. The impairment due to pain was significantly higher in patients with a chronic pain disorder and in patients with a chronic psychiatric disorder. The proportion of patients who were unfit for work due to pain was significantly higher in patients with a chronic pain disorder.\nPain is a",
        "levenshtein_distance": 502
    },
    {
        "realidx": "14968373",
        "question": "Treatment of obstructive hydrocephalus in children with tuberculous meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. Air-encephalography is regarded as the gold standard for differentiating communicating and non-communicating hydrocephalus. Since air-encephalography involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The aim of this study was to determine whether communicating and non-communicating hydrocephalus in TBM can be differentiated by means of cranial computerised tomography (CT).\nA number of CT indices were measured in 50 children with communicating and 34 children with non-communicating hydrocephalus according to air-encephalographic findings.\nThe only CT finding that correlated with the type of hydrocephalus was the shape of the third ventricle. Significantly more children with non-communicating hydrocephalus had a rounded third ventricle than those with communicating hydrocephalus.\nCan CT predict the level of CSF block in tuberculous hydrocephalus?",
        "answer": "yes",
        "answer_rationale": "CT is therefore not useful in determining the level of CSF block in TBM. Air-encephalography remains the most reliable way of determining the level of CSF obstruction.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Treatment of obstructive hydrocephalus in children with tuberculous meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. Air-encephalography is regarded as the gold standard for differentiating communicating and non-communicating hydrocephalus. Since air-encephalography involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The aim of this study was to determine whether communicating and non-communicating hydrocephalus in TBM can be differentiated by means of cran",
        "q2": "ial computerised tomography (CT).\nA number of CT indices were measured in 50 children with communicating and 34 children with non-communicating hydrocephalus according to air-encephalographic findings.\nThe only CT finding that correlated with the type of hydrocephalus was the shape of the third ventricle. Significantly more children with non-communicating hydrocephalus had a rounded third ventricle than those with communicating hydrocephalus.\nCan CT predict the level of CSF block in tuberculous hydrocephalus?",
        "generated_text": "ial computed tomography (CT). MATERIALS AND METHODS. The study included 100 children with TBM and hydrocephalus. All patients underwent cranial CT and air-encephalography. The CT findings were compared with the results of air-encephalography. RESULTS. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of cranial CT in differentiating communicating and non-communicating hydrocephalus were 92.3%, 94.7%, 92.3%, 94.",
        "levenshtein_distance": 333
    },
    {
        "realidx": "15041506",
        "question": "Sources of reports about laparoscopic and percutaneous treatment of liver hydatid cysts are limited to just a few countries. To address the reason behind this, we carried out a survey of 30 surgeons in northern Jordan.\nA questionnaire was distributed to collect data regarding the surgical technique preferred by each surgeon. Further information was collected from those not adopting minimal-access techniques to determine their reasons for not doing so.\nOnly 3 surgeons (10%) considered laparoscopy as the first line of treatment. Of the 27 surgeons who did not consider percutaneous or laparoscopic treatment, fear of anaphylaxis and/or dissemination was the main reason given by 21 surgeons (78%) for not using minimal access techniques.\nIs fear of anaphylactic shock discouraging surgeons from more widely adopting percutaneous and laparoscopic techniques in the treatment of liver hydatid cyst?",
        "answer": "yes",
        "answer_rationale": "The seemingly exaggerated traditional fear of anaphylaxis seems to discourage surgeons from more widely adopting minimal access techniques for the treatment of hydatid cyst.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Sources of reports about laparoscopic and percutaneous treatment of liver hydatid cysts are limited to just a few countries. To address the reason behind this, we carried out a survey of 30 surgeons in northern Jordan.\nA questionnaire was distributed to collect data regarding the surgical technique preferred by each surgeon. Further information was collected from those not adopting minimal-access techniques to determine their reasons for not doing so.\nOnly 3 surgeons (",
        "q2": "10%) considered laparoscopy as the first line of treatment. Of the 27 surgeons who did not consider percutaneous or laparoscopic treatment, fear of anaphylaxis and/or dissemination was the main reason given by 21 surgeons (78%) for not using minimal access techniques.\nIs fear of anaphylactic shock discouraging surgeons from more widely adopting percutaneous and laparoscopic techniques in the treatment of liver hydatid cyst?",
        "generated_text": "10%) were using laparoscopic techniques, and 1 surgeon (3.3%) was using percutaneous techniques. The main reasons for not using minimal-access techniques were the lack of training and the lack of equipment.\nThe results of this survey suggest that the lack of training and equipment are the main reasons for the limited use of minimal-access techniques in the treatment of liver hydatid cysts in northern Jordan.",
        "levenshtein_distance": 291
    },
    {
        "realidx": "15050326",
        "question": "To determine whether the risk of secondary breast cancer after radiotherapy (RT) for Hodgkin's disease is greater among women who underwent RT around time of pregnancy.\nThe records of 382 women treated with RT for Hodgkin's disease were reviewed and divided into those who received RT around the time of pregnancy and those who were not pregnant. Comparisons of the overall incidence, actuarial rates, and latency to breast cancer between the two groups were made. Multivariate Cox regression modeling was performed to determine possible contributing factors.\nOf the 382 women, 14 developed breast cancer (3.7%). The increase in the overall incidence (16.0% vs. 2.3%, p = 0.0001) and the actuarial rate of breast cancer among the women in the pregnant group (p = 0.011) was statistically significant. The women treated around the time of pregnancy had a 10- and 15-year actuarial rate of breast cancer of 6.7% and 32.6%, respectively. The 10-year and 15-year actuarial rate for the nonpregnant women was 0.4% and 1.7%, respectively. The median latency from RT to the diagnosis of breast cancer was 13.1 and 18.9 years for women in the pregnant and nonpregnant groups, respectively. In the multivariate analysis, pregnancy around the time of RT was the only variable associated with an increased risk of breast cancer. The risk was dependent on the length of time from pregnancy to RT, with women receiving RT during pregnancy and within 1 month of pregnancy having an increased risk of breast cancer compared with nonpregnant women and women irradiated later than 1 month after pregnancy (hazard ratio, 22.49; 95% confidence interval, 5.56-90.88; p<0.001).\nDoes radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?",
        "answer": "yes",
        "answer_rationale": "The results of this study indicate that the risk of breast cancer after RT is greater with irradiation around the time of pregnancy. This suggests that pregnancy is a time of increased sensitivity of breast tissue to the carcinogenic effects of radiation. Because of the small sample size and limited follow-up, additional studies are recommended to confirm these findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine whether the risk of secondary breast cancer after radiotherapy (RT) for Hodgkin's disease is greater among women who underwent RT around time of pregnancy.\nThe records of 382 women treated with RT for Hodgkin's disease were reviewed and divided into those who received RT around the time of pregnancy and those who were not pregnant. Comparisons of the overall incidence, actuarial rates, and latency to breast cancer between the two groups were made. Multivariate Cox regression modeling was performed to determine possible contributing factors.\nOf the 382 women, 14 developed breast cancer (3.7%). The increase in the overall incidence (16.0% vs. 2.3%, p = 0.0001) and the actuarial rate of breast cancer among the women in the pregnant group (p = 0.011) was statistically significant. The women treated around the time of pregnancy had a 10- and 15-year actuarial rate of breast cancer of 6.7%",
        "q2": " and 32.6%, respectively. The 10-year and 15-year actuarial rate for the nonpregnant women was 0.4% and 1.7%, respectively. The median latency from RT to the diagnosis of breast cancer was 13.1 and 18.9 years for women in the pregnant and nonpregnant groups, respectively. In the multivariate analysis, pregnancy around the time of RT was the only variable associated with an increased risk of breast cancer. The risk was dependent on the length of time from pregnancy to RT, with women receiving RT during pregnancy and within 1 month of pregnancy having an increased risk of breast cancer compared with nonpregnant women and women irradiated later than 1 month after pregnancy (hazard ratio, 22.49; 95% confidence interval, 5.56-90.88; p<0.001).\nDoes radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?",
        "generated_text": "and 16.0%, respectively, compared with 0.7% and 2.3% in the nonpregnant group. The latency to breast cancer was significantly shorter in the pregnant group (p = 0.0001). The median latency was 10 years in the pregnant group and 15 years in the nonpregnant group. The multivariate analysis showed that pregnancy was the only significant factor associated with the development of breast cancer (p = 0.0001).\nThe risk of secondary breast cancer after RT for Hodgkin's disease is significantly increased among women who were pregnant at the time of RT. The risk is higher and the latency is shorter in this group compared with women who were not pregnant at the time of RT.\nTo determine whether the risk of secondary breast cancer after radiotherapy (RT) for Hodgkin's disease is greater among women who underwent RT around the time of pregnancy, a study was conducted involving 382 women",
        "levenshtein_distance": 586
    },
    {
        "realidx": "15052394",
        "question": "The gender difference in prevalence and incidence rates of depression is one of the most consistent findings in psychiatric epidemiology. We sought to examine whether any gender differences in symptom profile might account for this difference in rates.\nThis study was a population-based 13-year follow-up survey of community-dwelling adults living in East Baltimore in 1981. Subjects were the continuing participants of the Baltimore Epidemiologic Catchment Area Program. Participants interviewed between 1993 and 1996 with complete data on depressive symptoms and covariates were included (n = 1727). We applied structural equations with a measurement model for dichotomous data (the MIMIC-multiple indicators, multiple causes-model) to compare symptoms between women and men, in relation to the nine symptom groups comprising the diagnostic criteria for major depression, adjusting for several potentially influential characteristics (namely, age, self-reported ethnicity, educational attainment, marital status, and employment).\nThere were no significant gender differences in the self-report of depression symptoms even taking into account the higher level of depressive symptoms of women and the influence of other covariates. For example, women were no more likely to endorse sadness than were men, as evidenced by a direct effect coefficient that was not significantly different from the null [adjusted estimated direct effect of gender on report of sadness = 0.105, 95% confidence interval (-0.113, 0.323)].\nAre higher rates of depression in women accounted for by differential symptom reporting?",
        "answer": "no",
        "answer_rationale": "Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The gender difference in prevalence and incidence rates of depression is one of the most consistent findings in psychiatric epidemiology. We sought to examine whether any gender differences in symptom profile might account for this difference in rates.\nThis study was a population-based 13-year follow-up survey of community-dwelling adults living in East Baltimore in 1981. Subjects were the continuing participants of the Baltimore Epidemiologic Catchment Area Program. Participants interviewed between 1993 and 1996 with complete data on depressive symptoms and covariates were included (n = 1727). We applied structural equations with a measurement model for dichotomous data (the MIMIC-multiple indicators, multiple causes-model) to compare symptoms between women and men, in relation to",
        "q2": " the nine symptom groups comprising the diagnostic criteria for major depression, adjusting for several potentially influential characteristics (namely, age, self-reported ethnicity, educational attainment, marital status, and employment).\nThere were no significant gender differences in the self-report of depression symptoms even taking into account the higher level of depressive symptoms of women and the influence of other covariates. For example, women were no more likely to endorse sadness than were men, as evidenced by a direct effect coefficient that was not significantly different from the null [adjusted estimated direct effect of gender on report of sadness = 0.105, 95% confidence interval (-0.113, 0.323)].\nAre higher rates of depression in women accounted for by differential symptom reporting?",
        "generated_text": "the presence of a major depressive episode (MDE). We also compared the symptom profiles of women and men with MDE.\nWomen had higher rates of MDE than men (12.1% vs. 5.6%, p < 0.001). Women with MDE had higher rates of depressed mood, loss of interest, sleep disturbance, fatigue, and feelings of worthlessness, whereas men with MDE had higher rates of agitation, suicidal ideation, and suicidal attempts. The symptom profiles of women and men with MDE were similar, with the exception of sleep disturbance, which was more common in women.\nThe higher rates of MDE in women are not due to differences in symptom profiles, but rather to differences in",
        "levenshtein_distance": 597
    },
    {
        "realidx": "15053041",
        "question": "Increased aortic stiffness is a independent risk factor of cardiovascular disease in patients with hypertension. Acute changes of the heart rate (HR) have been reported not to affect the aortic stiffness in pacing. However, it is unknown whether acute changes in HR caused by sympathomimetics can affect the aortic stiffness in patients with hypertension. We investigated the effect of acute changes in HR produced by isoproterenol on the aortic stiffness in 17 hypertensive patientss (mean age: 59 +/- 9 years).\nAll vasoactive drugs were discontinued at least 3 days before the study. The carotid-to-femoral pulse wave velocity (PWV) was measured by the foot-to-foot method. The pulse waves were recorded at the baseline and at every increase of HR by 5 to 10 bpm with a gradual increase of the dose of isoproterenol. The blood pressures and HR were measured simultaneously. For the analysis, HR, PWV, compliance (C), and compliance index (Ci) were converted as percent changes (delta) from the baseline values. Percent changes of the parameters of the aortic stiffness, i.e., deltaPWV, deltaC, and deltaCi, were grouped by every 10% increase in deltaHR.\nThere was no significant difference among groups in deltaPWV, deltaC and deltaCi (p>0.05 for each of the group). The regression analysis showed no significant correlation of deltaHR with deltaPWV and deltaC (r = 0.18, 0.13 respectively, p>0.05 for each). deltaCi had a poor correlation with deltaHR (r = 0.22, p<0.05). However, only 4.6% of deltaCi could be referred to deltaHR (r2 = 0.046).\nDo acute changes in heart rate by isoproterenol affect aortic stiffness in patients with hypertension?",
        "answer": "no",
        "answer_rationale": "Aortic stiffness was not affected by acute changes in HR produced by isoproterenol which suggests that it is not necessary to consider acute changes in HR when measuring aortic PWV.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Increased aortic stiffness is a independent risk factor of cardiovascular disease in patients with hypertension. Acute changes of the heart rate (HR) have been reported not to affect the aortic stiffness in pacing. However, it is unknown whether acute changes in HR caused by sympathomimetics can affect the aortic stiffness in patients with hypertension. We investigated the effect of acute changes in HR produced by isoproterenol on the aortic stiffness in 17 hypertensive patientss (mean age: 59 +/- 9 years).\nAll vasoactive drugs were discontinued at least 3 days before the study. The carotid-to-femoral pulse wave velocity (PWV) was measured by the foot-to-foot method. The pulse waves were recorded at the baseline and at every increase of HR by 5 to 10 bpm with a gradual increase of the dose of isoproterenol. The blood pressures and HR were measured simultaneously. For the analysis, HR, PWV, compliance",
        "q2": " (C), and compliance index (Ci) were converted as percent changes (delta) from the baseline values. Percent changes of the parameters of the aortic stiffness, i.e., deltaPWV, deltaC, and deltaCi, were grouped by every 10% increase in deltaHR.\nThere was no significant difference among groups in deltaPWV, deltaC and deltaCi (p>0.05 for each of the group). The regression analysis showed no significant correlation of deltaHR with deltaPWV and deltaC (r = 0.18, 0.13 respectively, p>0.05 for each). deltaCi had a poor correlation with deltaHR (r = 0.22, p<0.05). However, only 4.6% of deltaCi could be referred to deltaHR (r2 = 0.046).\nDo acute changes in heart rate by isoproterenol affect aortic stiffness in patients with hypertension?",
        "generated_text": "(C), and distensibility (D) were expressed as a function of HR.\nThe PWV increased with increasing HR (r = 0.71, p < 0.001). The C and D decreased with increasing HR (r = -0.65, p < 0.001; r = -0.63, p < 0.001, respectively). The PWV was positively correlated with systolic blood pressure (r = 0.51, p < 0.001), and negatively correlated with diastolic blood pressure (r = -0.41, p < 0.001). The C and D were positively correlated with diastolic blood pressure (r = 0.43, p < 0.001; r = 0.45, p < 0.001, respectively), and negatively",
        "levenshtein_distance": 534
    },
    {
        "realidx": "15095519",
        "question": "The purpose of this study was to determine if registered dietitian (RD) and registered nurse (RN) certified diabetes educators (CDEs) provide similar recommendations regarding carbohydrates and dietary supplements to individuals with diabetes.\nA survey was mailed to CDEs in the southern United States. Participants were asked to indicate their recommendations for use of carbohydrates, fiber, artificial sweeteners, and 12 selected dietary and herbal supplements when counseling individuals with diabetes.\nThe survey sample consisted of 366 CDEs: 207 were RNs and 159 were RDs. No statistically significant differences were found between RNs and RDs in typical carbohydrate recommendations for treatment of diabetes. However, RDs were more likely than RNs to make recommendations for fiber intake or use of the glycemic index. A significant difference also was found in the treatment of hypoglycemia: RNs were more likely than RDs to recommend consuming a carbohydrate source with protein to treat hypoglycemia.\nAre patients with diabetes receiving the same message from dietitians and nurses?",
        "answer": "no",
        "answer_rationale": "Although some differences existed, RD and RN CDEs are making similar overall recommendations in the treatment of individuals with diabetes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The purpose of this study was to determine if registered dietitian (RD) and registered nurse (RN) certified diabetes educators (CDEs) provide similar recommendations regarding carbohydrates and dietary supplements to individuals with diabetes.\nA survey was mailed to CDEs in the southern United States. Participants were asked to indicate their recommendations for use of carbohydrates, fiber, artificial sweeteners, and 12 selected dietary and herbal supplements when counseling individuals with diabetes.\nThe survey sample consisted of 366 CDEs: 207 were R",
        "q2": "Ns and 159 were RDs. No statistically significant differences were found between RNs and RDs in typical carbohydrate recommendations for treatment of diabetes. However, RDs were more likely than RNs to make recommendations for fiber intake or use of the glycemic index. A significant difference also was found in the treatment of hypoglycemia: RNs were more likely than RDs to recommend consuming a carbohydrate source with protein to treat hypoglycemia.\nAre patients with diabetes receiving the same message from dietitians and nurses?",
        "generated_text": "DNs and 159 were RNs. The majority of RDNs and RNs recommended the use of whole grains, fiber, and artificial sweeteners for individuals with diabetes. RDNs were more likely than RNs to recommend the use of whole grains (P < .001), fiber (P < .001), and artificial sweeteners (P < .001). RDNs were also more likely than RNs to recommend the use of chromium (P < .0",
        "levenshtein_distance": 357
    },
    {
        "realidx": "15151701",
        "question": "We sought to develop a more reliable structured implicit chart review instrument for use in assessing the quality of care for chronic disease and to examine if ratings are more reliable for conditions in which the evidence base for practice is more developed.\nWe conducted a reliability study in a cohort with patient records including both outpatient and inpatient care as the objects of measurement. We developed a structured implicit review instrument to assess the quality of care over one year of treatment. 12 reviewers conducted a total of 496 reviews of 70 patient records selected from 26 VA clinical sites in two regions of the country. Each patient had between one and four conditions specified as having a highly developed evidence base (diabetes and hypertension) or a less developed evidence base (chronic obstructive pulmonary disease or a collection of acute conditions). Multilevel analysis that accounts for the nested and cross-classified structure of the data was used to estimate the signal and noise components of the measurement of quality and the reliability of implicit review.\nFor COPD and a collection of acute conditions the reliability of a single physician review was quite low (intra-class correlation = 0.16-0.26) but comparable to most previously published estimates for the use of this method in inpatient settings. However, for diabetes and hypertension the reliability is significantly higher at 0.46. The higher reliability is a result of the reviewers collectively being able to distinguish more differences in the quality of care between patients (p<0.007) and not due to less random noise or individual reviewer bias in the measurement. For these conditions the level of true quality (i.e. the rating of quality of care that would result from the full population of physician reviewers reviewing a record) varied from poor to good across patients.\nProfiling quality of care: Is there a role for peer review?",
        "answer": "yes",
        "answer_rationale": "For conditions with a well-developed quality of care evidence base, such as hypertension and diabetes, a single structured implicit review to assess the quality of care over a period of time is moderately reliable. This method could be a reasonable complement or alternative to explicit indicator approaches for assessing and comparing quality of care. Structured implicit review, like explicit quality measures, must be used more cautiously for illnesses for which the evidence base is less well developed, such as COPD and acute, short-course illnesses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We sought to develop a more reliable structured implicit chart review instrument for use in assessing the quality of care for chronic disease and to examine if ratings are more reliable for conditions in which the evidence base for practice is more developed.\nWe conducted a reliability study in a cohort with patient records including both outpatient and inpatient care as the objects of measurement. We developed a structured implicit review instrument to assess the quality of care over one year of treatment. 12 reviewers conducted a total of 496 reviews of 70 patient records selected from 26 VA clinical sites in two regions of the country. Each patient had between one and four conditions specified as having a highly developed evidence base (diabetes and hypertension) or a less developed evidence base (chronic obstructive pulmonary disease or a collection of acute conditions). Multilevel analysis that accounts for the nested and cross-classified structure of the data was used to estimate the signal and",
        "q2": " noise components of the measurement of quality and the reliability of implicit review.\nFor COPD and a collection of acute conditions the reliability of a single physician review was quite low (intra-class correlation = 0.16-0.26) but comparable to most previously published estimates for the use of this method in inpatient settings. However, for diabetes and hypertension the reliability is significantly higher at 0.46. The higher reliability is a result of the reviewers collectively being able to distinguish more differences in the quality of care between patients (p<0.007) and not due to less random noise or individual reviewer bias in the measurement. For these conditions the level of true quality (i.e. the rating of quality of care that would result from the full population of physician reviewers reviewing a record) varied from poor to good across patients.\nProfiling quality of care: Is there a role for peer review?",
        "generated_text": "noise components of the variance in the ratings.\nThe reliability of the instrument was acceptable for diabetes (intraclass correlation coefficient [ICC]=0.70) and hypertension (ICC=0.67), but not for chronic obstructive pulmonary disease (ICC=0.40) or acute conditions (ICC=0.37). The reliability of the instrument was higher for diabetes and hypertension than for chronic obstructive pulmonary disease or acute conditions (p<0.001). The reliability of the instrument was higher for diabetes and hypertension than for chronic obstructive pulmonary disease or acute conditions (p<0.001). The reliability of the instrument was higher for diabetes and hypertension than for chronic obstructive pulmonary disease or acute conditions (p<0.001). The reliability of the instrument was higher for diabetes and hypertension than for chronic obstructive pulmonary disease or acute conditions (",
        "levenshtein_distance": 672
    },
    {
        "realidx": "15208005",
        "question": "Low intakes or blood levels of eicosapentaenoic and docosahexaenoic acids (EPA + DHA) are independently associated with increased risk of death from coronary heart disease (CHD). In randomized secondary prevention trials, fish or fish oil have been demonstrated to reduce total and CHD mortality at intakes of about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter called the Omega-3 Index) be considered a new risk factor for death from CHD.\nWe conducted clinical and laboratory experiments to generate data necessary for the validation of the Omega-3 Index as a CHD risk predictor. The relationship between this putative marker and risk for CHD death, especially sudden cardiac death (SCD), was then evaluated in several published primary and secondary prevention studies.\nThe Omega-3 Index was inversely associated with risk for CHD mortality. An Omega-3 Index of>or = 8% was associated with the greatest cardioprotection, whereas an index of<or = 4% was associated with the least.\nThe Omega-3 Index: a new risk factor for death from coronary heart disease?",
        "answer": "yes",
        "answer_rationale": "The Omega-3 Index may represent a novel, physiologically relevant, easily modified, independent, and graded risk factor for death from CHD that could have significant clinical utility.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Low intakes or blood levels of eicosapentaenoic and docosahexaenoic acids (EPA + DHA) are independently associated with increased risk of death from coronary heart disease (CHD). In randomized secondary prevention trials, fish or fish oil have been demonstrated to reduce total and CHD mortality at intakes of about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter called the Omega-3 Index) be considered a new risk factor for death from CHD.\nWe conducted clinical",
        "q2": " and laboratory experiments to generate data necessary for the validation of the Omega-3 Index as a CHD risk predictor. The relationship between this putative marker and risk for CHD death, especially sudden cardiac death (SCD), was then evaluated in several published primary and secondary prevention studies.\nThe Omega-3 Index was inversely associated with risk for CHD mortality. An Omega-3 Index of>or = 8% was associated with the greatest cardioprotection, whereas an index of<or = 4% was associated with the least.\nThe Omega-3 Index: a new risk factor for death from coronary heart disease?",
        "generated_text": "trials and observational studies to test the hypothesis that the Omega-3 Index is inversely associated with risk of death from CHD. In the observational studies, we measured the Omega-3 Index in stored blood samples from participants who died of CHD and compared them with those who did not die of CHD. In the clinical trials, we measured the Omega-3 Index at baseline and after intervention with fish or fish oil, and assessed the relationship between changes in the Omega-3 Index and risk of death from CHD.\n\nIn the observational studies, we found that participants with higher Omega-3 Index had a significantly lower risk of death",
        "levenshtein_distance": 466
    },
    {
        "realidx": "15223779",
        "question": "This study was conducted to investigate the expression and functional impact of the proto-oncogene c-kit in uveal melanoma.\nBased on immunohistochemical (IHC) study of paraffin-embedded specimens from 134 uveal melanomas and Western blot analysis on eight fresh-frozen samples the expression of c-kit in uveal melanoma was studied. Furthermore, the phosphorylation of c-kit and the impact of the tyrosine kinase inhibitor STI571 was examined in the three uveal melanoma cell lines OCM-1, OCM-3, and 92-1.\nEighty-four of 134 paraffin-embedded samples and six of eight fresh-frozen samples expressed c-kit. c-Kit was strongly expressed and tyrosine phosphorylated in cultured uveal melanoma cells compared with cutaneous melanoma cells. Moreover, in contrast to cutaneous melanoma cell lines c-kit maintained a high phosphorylation level in serum-depleted uveal melanoma cells. No activation-related mutations in exon 11 of the KIT gene were found. On the contrary, expression of the stem cell growth factor (c-kit ligand) was detected in all three uveal melanoma cell lines, suggesting the presence of autocrine (paracrine) stimulation pathways. Treatment of uveal melanoma cell lines with STI571, which blocks c-kit autophosphorylation, resulted in cell death. The IC(50) of the inhibitory effects on c-kit phosphorylation and cell proliferation was of equal size and less than 2.5 microM.\nc-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?",
        "answer": "yes",
        "answer_rationale": "The results confirm that c-kit is vastly expressed in uveal melanoma, suggest that the c-kit molecular pathway may be important in uveal melanoma growth, and point to its use as a target for therapy with STI571.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study was conducted to investigate the expression and functional impact of the proto-oncogene c-kit in uveal melanoma.\nBased on immunohistochemical (IHC) study of paraffin-embedded specimens from 134 uveal melanomas and Western blot analysis on eight fresh-frozen samples the expression of c-kit in uveal melanoma was studied. Furthermore, the phosphorylation of c-kit and the impact of the tyrosine kinase inhibitor STI571 was examined in the three uveal melanoma cell lines OCM-1, OCM-3, and 92-1.\nEighty-four of 134 paraffin-embedded samples and six of eight fresh-frozen samples expressed c-kit. c-Kit was strongly expressed and tyrosine phosphorylated in cultured uveal melanoma cells compared with cut",
        "q2": "aneous melanoma cells. Moreover, in contrast to cutaneous melanoma cell lines c-kit maintained a high phosphorylation level in serum-depleted uveal melanoma cells. No activation-related mutations in exon 11 of the KIT gene were found. On the contrary, expression of the stem cell growth factor (c-kit ligand) was detected in all three uveal melanoma cell lines, suggesting the presence of autocrine (paracrine) stimulation pathways. Treatment of uveal melanoma cell lines with STI571, which blocks c-kit autophosphorylation, resulted in cell death. The IC(50) of the inhibitory effects on c-kit phosphorylation and cell proliferation was of equal size and less than 2.5 microM.\nc-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?",
        "generated_text": "aneous melanoma cells. Treatment with STI571 led to a dose-dependent inhibition of c-kit phosphorylation and a decrease in cell proliferation in uveal melanoma cells, but not in cutaneous melanoma cells.\nc-Kit is expressed and activated in uveal melanoma and may represent a potential target for therapy.",
        "levenshtein_distance": 550
    },
    {
        "realidx": "15388567",
        "question": "To examine the evidence base of sports medicine research and assess how relevant and applicable it is to everyday practice.\nOriginal research articles, short reports, and case reports published in four major sport and exercise medicine journals were studied and classified according to the main topic of study and type of subjects used.\nThe most common topic was sports science, and very few studies related to the treatment of injuries and medical conditions. The majority of published articles used healthy subjects sampled from the sedentary population, and few studies have been carried out on injured participants.\nAre sports medicine journals relevant and applicable to practitioners and athletes?",
        "answer": "no",
        "answer_rationale": "There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To examine the evidence base of sports medicine research and assess how relevant and applicable it is to everyday practice.\nOriginal research articles, short reports, and case reports published in four major sport and exercise medicine journals were studied and classified according to the main topic of study and type of subjects used.\nThe",
        "q2": " most common topic was sports science, and very few studies related to the treatment of injuries and medical conditions. The majority of published articles used healthy subjects sampled from the sedentary population, and few studies have been carried out on injured participants.\nAre sports medicine journals relevant and applicable to practitioners and athletes?",
        "generated_text": "journals studied were the British Journal of Sports Medicine, Medicine and Science in Sports and Exercise, American Journal of Sports Medicine, and Clinical Journal of Sport Medicine. All issues from 1997 to 2000 were studied.\nThe main topics of study were biomechanics, exercise",
        "levenshtein_distance": 275
    },
    {
        "realidx": "15488260",
        "question": "Rates of relapse and predictive relapse factors were studied over more than 4 years in a sample of Spanish outpatients with DSM-III-R criteria for unipolar major depressive episode.\nA final sample of 139 outpatient was followed monthly in a naturalistic study. The Structured Clinical Interview for DSM-III-R was used. Phases of evolution were recorded using the Hamilton Depression Rating Scale, applying the Frank criteria. Survival analysis, Kaplan-Meier product limit and proportional hazards models were used.\nA higher rate of relapses was observed in the partial remission group (91.4%) compared to the complete remission one (51.3%). The four factors with predictive relapse value were: \"partial remission versus complete remission\", \"the intensity of clinical symptoms\", \"the age\" and \"the number of previous depressive episodes\". The existence of partial remission was the most powerful predictive factor.\nThe decreasing sample size during the follow-up and the difficulty in warranting the treatment compliance.\nIs the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?",
        "answer": "yes",
        "answer_rationale": "At medium term, relapse rates for a major depressive episode are high. Partial remission after a depressive episode seems to be an important predictive factor for relapses in a 4-year follow-up.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Rates of relapse and predictive relapse factors were studied over more than 4 years in a sample of Spanish outpatients with DSM-III-R criteria for unipolar major depressive episode.\nA final sample of 139 outpatient was followed monthly in a naturalistic study. The Structured Clinical Interview for DSM-III-R was used. Phases of evolution were recorded using the Hamilton Depression Rating Scale, applying the Frank criteria. Survival analysis, Kaplan-Meier product limit and proportional hazards models were used.\nA higher rate of relapses was observed in the partial",
        "q2": " remission group (91.4%) compared to the complete remission one (51.3%). The four factors with predictive relapse value were: \"partial remission versus complete remission\", \"the intensity of clinical symptoms\", \"the age\" and \"the number of previous depressive episodes\". The existence of partial remission was the most powerful predictive factor.\nThe decreasing sample size during the follow-up and the difficulty in warranting the treatment compliance.\nIs the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?",
        "generated_text": "remission group (40.7%) than in the full remission group (15.4%). The mean time to relapse was 12.5 months in the partial remission group and 20.5 months in the full remission group. The risk of relapse was higher in the partial remission group (relative risk=2.64; 95% confidence interval=1.24-5.62). The risk of relapse was higher in patients with a history of previous episodes",
        "levenshtein_distance": 372
    },
    {
        "realidx": "15489384",
        "question": "Spasticity and loss of function in an affected arm are common after stroke. Although botulinum toxin is used to reduce spasticity, its functional benefits are less easily demonstrated. This paper reports an exploratory meta-analysis to investigate the relationship between reduced arm spasticity and improved arm function.\nIndividual data from stroke patients in two randomised controlled trials of intra-muscular botulinum toxin were pooled. The Modified Ashworth Scale (elbow, wrist, fingers) was used to calculate a \"Composite Spasticity Index\". Data from the arm section of the Barthel Activities of Daily Living Index (dressing, grooming, and feeding) and three subjective measures (putting arm through sleeve, cleaning palm, cutting fingernails) were summed to give a \"Composite Functional Index\". Change scores and the time of maximum change were also calculated.\nMaximum changes in both composite measures occurred concurrently in 47 patients. In 26 patients the improvement in spasticity preceded the improvement in function with 18 showing the reverse. There was a definite relationship between the maximum change in spasticity and the maximum change in arm function, independent of treatment (rho = -0.2822, p = 0.0008, n = 137). There was a clear relationship between the changes in spasticity and in arm function in patients treated with botulinum toxin (Dysport) at 500 or 1000 units (rho = -0.5679, p = 0.0090, n = 22; rho = -0.4430, p = 0.0018, n = 47), but not in those treated with placebo or 1500 units.\nDoes reducing spasticity translate into functional benefit?",
        "answer": "yes",
        "answer_rationale": "Using a targeted meta-analytic approach, it is possible to demonstrate that reducing spasticity in the arm is associated with a significant improvement in arm function.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Spasticity and loss of function in an affected arm are common after stroke. Although botulinum toxin is used to reduce spasticity, its functional benefits are less easily demonstrated. This paper reports an exploratory meta-analysis to investigate the relationship between reduced arm spasticity and improved arm function.\nIndividual data from stroke patients in two randomised controlled trials of intra-muscular botulinum toxin were pooled. The Modified Ashworth Scale (elbow, wrist, fingers) was used to calculate a \"Composite Spasticity Index\". Data from the arm section of the Barthel Activities of Daily Living Index (dressing, grooming, and feeding) and three subjective measures (putting arm through sleeve, cleaning palm, cutting fingernails) were summed to give a \"Composite Functional Index\". Change scores and the time of maximum change were also calculated.\nMaximum changes in both composite measures occurred",
        "q2": " concurrently in 47 patients. In 26 patients the improvement in spasticity preceded the improvement in function with 18 showing the reverse. There was a definite relationship between the maximum change in spasticity and the maximum change in arm function, independent of treatment (rho = -0.2822, p = 0.0008, n = 137). There was a clear relationship between the changes in spasticity and in arm function in patients treated with botulinum toxin (Dysport) at 500 or 1000 units (rho = -0.5679, p = 0.0090, n = 22; rho = -0.4430, p = 0.0018, n = 47), but not in those treated with placebo or 1500 units.\nDoes reducing spasticity translate into functional benefit?",
        "generated_text": "at 4 weeks. There was a significant correlation between the two composite measures at 4 weeks (r=0.32, p=0.0001). The correlation was stronger in patients with mild to moderate spasticity (r=0.41, p=0.0001) than in those with severe spasticity (r=0.17, p=0.17). The correlation was stronger in patients with mild to moderate spasticity who received botulinum toxin (r=0.44, p=0.0001) than in those who received placebo (r=0.24, p=0.08). In patients with severe spasticity, the correlation was similar in the two treatment groups (r=0.17, p=0.17",
        "levenshtein_distance": 466
    },
    {
        "realidx": "15502995",
        "question": "To analyse associations between indicators for adoption of new drugs and to test the hypothesis that physicians' early adoption of new drugs is a personal trait independent of drug groups.\nIn a population-based cohort study using register data, we analysed the prescribing of new drugs by Danish general practitioners. Angiotensin-II antagonists, triptans, selective cyclo-oxygenase-2 antagonists and esomeprazol were used in the assessment. As indicators of new drug uptake, we used adoption time, cumulative incidence, preference proportion, incidence rate and prescription cost and volume. For each measure, we ranked the general practices. Ranks were pair-wise plotted, and Pearson's correlation coefficient ( r) was calculated. Next, we analysed the correlation between ranks across different drug classes.\nFor all indicators, the general practitioners' adoption of one group of drugs was poorly associated with adoption of others ( r</=0.49), indicating that early adoption of one type of drugs is not associated with early adoption of another. For all drug groups, adoption time adjusted for practice size was only weakly associated with other indicators ( r: -0.56 to -0.27). Indicators, based on cost and volume of drugs, were highly correlated ( r: 0.96-0.99), and the others correlated reasonably well ( r: 0.51-0.91).\nDoes the early adopter of drugs exist?",
        "answer": "no",
        "answer_rationale": "Within drug groups, indicators of drug adoption, except for adoption time, correlate reasonably well. However, the theory that physicians' early adoption of new drugs is a personal trait independent of the type of drug could not be confirmed. The notion of the early-drug-adopting general practitioner may be mistaken.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To analyse associations between indicators for adoption of new drugs and to test the hypothesis that physicians' early adoption of new drugs is a personal trait independent of drug groups.\nIn a population-based cohort study using register data, we analysed the prescribing of new drugs by Danish general practitioners. Angiotensin-II antagonists, triptans, selective cyclo-oxygenase-2 antagonists and esomeprazol were used in the assessment. As indicators of new drug uptake, we used adoption time, cumulative incidence, preference proportion, incidence rate and prescription cost and volume. For each measure, we ranked the general practices. Ranks were pair-wise plotted, and Pearson's correlation coefficient ( r) was calculated. Next",
        "q2": ", we analysed the correlation between ranks across different drug classes.\nFor all indicators, the general practitioners' adoption of one group of drugs was poorly associated with adoption of others ( r</=0.49), indicating that early adoption of one type of drugs is not associated with early adoption of another. For all drug groups, adoption time adjusted for practice size was only weakly associated with other indicators ( r: -0.56 to -0.27). Indicators, based on cost and volume of drugs, were highly correlated ( r: 0.96-0.99), and the others correlated reasonably well ( r: 0.51-0.91).\nDoes the early adopter of drugs exist?",
        "generated_text": ", we analysed the association between the measures using linear regression. Finally, we tested the hypothesis that the general practitioners' early adoption of new drugs is a personal trait independent of drug groups by calculating the correlation between the general practitioners' ranks for the four drug groups.\nThe correlation coefficients for the measures of uptake ranged from 0.25 to 0.95. The correlation coefficients for the general practitioners' ranks for the four drug groups ranged from 0.12 to 0.40.\nThe measures of uptake are not interchangeable. The hypothesis that early adoption is a personal trait independent of drug groups is only partly supported.",
        "levenshtein_distance": 476
    },
    {
        "realidx": "15528969",
        "question": "Current guidelines include a recommendation that a pathologist with expertise in breast disease review all ductal carcinoma in situ (DCIS) specimens due to the presence of significant variability in pathologic reporting of DCIS. The objective of this study was to evaluate the completeness and accuracy of pathologic reporting of DCIS over the past decade and to determine the current impact of expert breast pathology assessment on the management of DCIS.\nAll patients with a diagnosis of DCIS referred to a single regional cancer centre between 1982 and 2000 have been reviewed. Inter-observer variability between initial and secondary reports has been evaluated using kappa statistics. For each case, the Van Nuys Prognostic Index (VNPI) using pathologic data obtained from the initial and reviewed pathology reports were compared. The impact of expert breast pathology on risk assessment and treatment was determined.\n481 individuals with DCIS were referred and pathology review was performed on 350 patients (73%). Inter-observer agreement was high for the main pathologic features of DCIS. From 1996 to 2000, secondary pathology assessments lead to a change in the assessment of local recurrence risk in 100 cases (29%) and contributed to a change in treatment recommendation in 93 (43%) cases.\nIs expert breast pathology assessment necessary for the management of ductal carcinoma in situ ?",
        "answer": "yes",
        "answer_rationale": "Expert breast pathology assessments continue to be necessary in the management of DCIS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Current guidelines include a recommendation that a pathologist with expertise in breast disease review all ductal carcinoma in situ (DCIS) specimens due to the presence of significant variability in pathologic reporting of DCIS. The objective of this study was to evaluate the completeness and accuracy of pathologic reporting of DCIS over the past decade and to determine the current impact of expert breast pathology assessment on the management of DCIS.\nAll patients with a diagnosis of DCIS referred to a single regional cancer centre between 1982 and 2000 have been reviewed. Inter-observer variability between initial and secondary reports has been evaluated using kappa statistics. For each case, the Van Nu",
        "q2": "ys Prognostic Index (VNPI) using pathologic data obtained from the initial and reviewed pathology reports were compared. The impact of expert breast pathology on risk assessment and treatment was determined.\n481 individuals with DCIS were referred and pathology review was performed on 350 patients (73%). Inter-observer agreement was high for the main pathologic features of DCIS. From 1996 to 2000, secondary pathology assessments lead to a change in the assessment of local recurrence risk in 100 cases (29%) and contributed to a change in treatment recommendation in 93 (43%) cases.\nIs expert breast pathology assessment necessary for the management of ductal carcinoma in situ ?",
        "generated_text": "ys Prognostic Index (VNPI) was calculated based on the initial and secondary reports.\nA total of 1,000 cases of DCIS were identified. The majority of cases (n=850) were reviewed by an expert breast pathologist. The initial and secondary reports were in agreement for grade in 78% of cases (kappa=0.52), for nuclear grade in 82% (kappa=0.58), for comedo necrosis in 85% (kappa=0.62), for margins in 88% (kappa=0.68),",
        "levenshtein_distance": 464
    },
    {
        "realidx": "15597845",
        "question": "The endogenous estradiol metabolite, 2-methoxyestradiol (2ME), has been shown to be a potent inhibitor of cell growth and a strong anti-angiogenic substance. We investigated for the first time whether in vitro combinations of 2ME with various chemotherapeutic compounds may result in an additive inhibitory effect on the proliferation of human ovary cancer cells.\nAs a model two different human ovary cancer cell lines were used. All cell lines were incubated with equimolar concentrations of 2ME (0.8-25 microM) and the chemotherapeutics epirubicine, doxorubicine, paclitaxel, docetaxel, carboplatin, vinorelbine, 5-fluorouracil and mafosfamide. Proliferation was measured after four days using the ATP-chemosensitivity test.\nFor both ovary cancer cell lines a significant additive effect of 2ME with epirubicine and carboplatin was observed at the lower concentration range of these chemotherapeutic substances.\nIs the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer?",
        "answer": "yes",
        "answer_rationale": "2ME is able to enhance the antiproliferative activity of certain chemotherapeutics at pharmacological relevant concentrations. This estradiol metabolite is currently in a phase II trial in patients with refractary metastatic breast cancer and the tolerability has been shown to be very good. The combination of 2ME with chemotherapeutics may therefore offer a new clinically relevant treatment regimen for hormone-dependent cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The endogenous estradiol metabolite, 2-methoxyestradiol (2ME), has been shown to be a potent inhibitor of cell growth and a strong anti-angiogenic substance. We investigated for the first time whether in vitro combinations of 2ME with various chemotherapeutic compounds may result in an additive inhibitory effect on the proliferation of human ovary cancer cells.\nAs a model two different human ovary cancer cell lines were used. All cell lines were incubated with equimolar concentrations of 2ME (0.8-25 microM) and the chemotherapeutics epirub",
        "q2": "icine, doxorubicine, paclitaxel, docetaxel, carboplatin, vinorelbine, 5-fluorouracil and mafosfamide. Proliferation was measured after four days using the ATP-chemosensitivity test.\nFor both ovary cancer cell lines a significant additive effect of 2ME with epirubicine and carboplatin was observed at the lower concentration range of these chemotherapeutic substances.\nIs the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer?",
        "generated_text": "isin, cisplatin, carboplatin, paclitaxel, or vinorelbine. The proliferation of the cells was determined by the MTT assay.\nIn all cell lines, 2ME alone inhibited cell proliferation in a dose-dependent manner. The combination of 2ME with epirubicin, cisplatin, carboplatin, or paclitaxel resulted in a significant additive inhibitory effect on cell proliferation. In contrast, the combination of 2ME with vinorelbine did not result in an additive inhibitory effect.\nOur data suggest that 2ME may be a",
        "levenshtein_distance": 361
    },
    {
        "realidx": "15708048",
        "question": "To determine the effect of prior benign prostate biopsies on the surgical and clinical outcomes of patients treated with radical perineal prostatectomy for prostate cancer.\nA total of 1369 patients with clinically localized prostate cancer underwent radical prostatectomy by a single surgeon between 1991 and 2001. A subset of 203 patients (14.9%), who had undergone at least one prior benign prostate biopsy for a rising prostate-specific antigen and/or abnormal digital rectal examination, constituted our study population. A total of 1115 patients with no prior biopsy represented our control group. After prostatectomy, patients were evaluated at 6-month intervals for biochemical evidence of recurrence, defined as a prostate-specific antigen level of 0.5 ng/mL or greater.\nPatients with a prior benign biopsy had more favorable pathologic features with more organ-confined (74% versus 64%; P<0.001) and less margin-positive (9.8% versus 18%) disease. Only 24 patients (12%) in the study group (versus 20% in control group; P = 0.01) had eventual evidence of biochemical failure. Kaplan-Meier analyses suggested that patients with prior benign biopsies have improved biochemical disease-free survival, especially for those with more aggressive disease (Gleason sum 7 or greater; P<0.01). Overall, patients in the study group had lower probability (odds ratio 0.57, P<0.001) of biochemical failure compared with those in the control group.\nDoes prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?",
        "answer": "yes",
        "answer_rationale": "A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine the effect of prior benign prostate biopsies on the surgical and clinical outcomes of patients treated with radical perineal prostatectomy for prostate cancer.\nA total of 1369 patients with clinically localized prostate cancer underwent radical prostatectomy by a single surgeon between 1991 and 2001. A subset of 203 patients (14.9%), who had undergone at least one prior benign prostate biopsy for a rising prostate-specific antigen and/or abnormal digital rectal examination, constituted our study population. A total of 1115 patients with no prior biopsy represented our control group. After prostatectomy, patients were evaluated at 6-month intervals for biochemical evidence of recurrence, defined as a prostate-specific antigen level of 0.5 ng/mL or greater.\nPatients with a prior benign biopsy had more favorable pathologic features",
        "q2": " with more organ-confined (74% versus 64%; P<0.001) and less margin-positive (9.8% versus 18%) disease. Only 24 patients (12%) in the study group (versus 20% in control group; P = 0.01) had eventual evidence of biochemical failure. Kaplan-Meier analyses suggested that patients with prior benign biopsies have improved biochemical disease-free survival, especially for those with more aggressive disease (Gleason sum 7 or greater; P<0.01). Overall, patients in the study group had lower probability (odds ratio 0.57, P<0.001) of biochemical failure compared with those in the control group.\nDoes prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?",
        "generated_text": ", including lower pathologic stage (P <.001), lower Gleason score (P <.001), and lower positive surgical margin rate (P =.001). The 5-year biochemical recurrence-free survival was 87.1% in the prior biopsy group and 79.1% in the control group (P =.001). In multivariate analysis, prior biopsy was an independent predictor of biochemical recurrence-free survival (P =.001).\nPrior benign prostate biopsy is associated with more favorable pathologic features and improved biochemical recurrence-free survival in patients treated with radical perineal prostatectomy for clinically localized prostate cancer.",
        "levenshtein_distance": 513
    },
    {
        "realidx": "15774570",
        "question": "The use of the private sector for health care is increasing, but it is unclear whether this will reduce demand on the NHS. The aim of this study was to examine the relationship between private and NHS outpatient referral rates accounting for their association with deprivation.\nThis is a prospective survey of general practitioner referrals to private and NHS consultant-led services between 1 January and 31 December 2001 from 10 general practices in the Trent Focus Collaborative Research Network, United Kingdom. Patient referrals were aggregated to give private and NHS referral rates for each electoral ward in each practice.\nOf 17,137 referrals, 90.4 percent (15,495) were to the NHS and 9.6 percent (1642) to the private sector. Private referral rates were lower in patients from the most deprived fifth of wards compared with the least deprived fifth (rate ratio 0.25, 95 percent CI 0.15 to 0.41, p<0.001), whereas NHS referral rates were slightly higher in patients in the most deprived fifth of wards (rate ratio 1.18, 95 percent CI 0.98 to 1.42, p = 0.08) both after age standardisation and adjustment for practice. The NHS referral rate was significantly higher (rate ratio 1.40, 95 percent CI 1.15 to 1.71, p = 0.001) in wards with private referral rates in the top fifth compared with the bottom fifth after adjustment for deprivation and practice.\nDoes increased use of private health care reduce the demand for NHS care?",
        "answer": "no",
        "answer_rationale": "Increased private health care activity does not reduce the demand for NHS care: NHS and private referral rates were positively associated with each other after adjusting for age, deprivation and practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The use of the private sector for health care is increasing, but it is unclear whether this will reduce demand on the NHS. The aim of this study was to examine the relationship between private and NHS outpatient referral rates accounting for their association with deprivation.\nThis is a prospective survey of general practitioner referrals to private and NHS consultant-led services between 1 January and 31 December 2001 from 10 general practices in the Trent Focus Collaborative Research Network, United Kingdom. Patient referrals were aggregated to give private and NHS referral rates for each electoral ward in each practice.\nOf 17,137 referrals, 90.4 percent (15,495) were to the NHS and 9.6 percent (1642) to the private sector. Private referral rates were lower in patients from the most deprived fifth of wards",
        "q2": " compared with the least deprived fifth (rate ratio 0.25, 95 percent CI 0.15 to 0.41, p<0.001), whereas NHS referral rates were slightly higher in patients in the most deprived fifth of wards (rate ratio 1.18, 95 percent CI 0.98 to 1.42, p = 0.08) both after age standardisation and adjustment for practice. The NHS referral rate was significantly higher (rate ratio 1.40, 95 percent CI 1.15 to 1.71, p = 0.001) in wards with private referral rates in the top fifth compared with the bottom fifth after adjustment for deprivation and practice.\nDoes increased use of private health care reduce the demand for NHS care?",
        "generated_text": "compared with the least deprived fifth (odds ratio 0.57, 95 percent confidence interval 0.44 to 0.74). NHS referral rates were higher in the most deprived fifth of wards compared with the least deprived fifth (odds ratio 1.32, 95 percent confidence interval 1.11 to 1.57). There was no evidence of a substitution effect between private and NHS referrals.\nPrivate and NHS referral rates are associated with deprivation, but there is no evidence of a substitution effect between them. This suggests that the use of the private sector for health care may not reduce demand on the NHS.",
        "levenshtein_distance": 378
    },
    {
        "realidx": "15841770",
        "question": "Annual data on children aged under 16 y treated for asthma, including consumption of regular medication for asthma, numbers of hospital periods, lengths of hospitalizations and annual proportions of readmissions, were collected using patient-specific medical records from 1995 to 1999. In the Kuopio province, on average, 35.6-36.7/1000 children were on maintenance for asthma, of which 23% were receiving cromones, 51% were taking inhaled steroids and 26% were treated with cromones plus intermittent steroids. In the Oulu province, the respective prevalence was 32.7-34.9/1000, and the respective proportions were 5%, 93% and 2%.\nTotal and first admissions, as well as hospital days were clearly less in the Oulu province. In the children aged>or = 6y, the average annual total admissions were 0.3/1000 (Oulu) vs 1.2/1000 (Kuopio) (p<0.001). Similarly, the first admissions were 0.2/1000 vs 1.0/1000 (p<0.001), proportions of readmissions 6.3% vs 19.3% (p<0.05), and numbers of hospital days 0.7/1000 vs 3.8/1000 (p<0.001). The differences were in the same direction, though less prominent, also among children 2-5 y of age.\nDo inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children?",
        "answer": "yes",
        "answer_rationale": "Our results suggest that inhaled steroids are better than cromones in preventing admissions for asthma when two provinces with different practices for maintenance medication of steady-state asthma were compared.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Annual data on children aged under 16 y treated for asthma, including consumption of regular medication for asthma, numbers of hospital periods, lengths of hospitalizations and annual proportions of readmissions, were collected using patient-specific medical records from 1995 to 1999. In the Kuopio province, on average, 35.6-36.7/1000 children were on maintenance for asthma, of which 23% were receiving cromones, 51% were taking inhaled steroids and 26% were treated with cromones plus intermittent steroids. In the Oulu province, the respective prevalence was 32.7-34.9/1000, and the respective proportions were 5%, 93% and 2%.\nTotal and first admissions, as well as hospital days were clearly less in the Oulu province",
        "q2": ". In the children aged>or = 6y, the average annual total admissions were 0.3/1000 (Oulu) vs 1.2/1000 (Kuopio) (p<0.001). Similarly, the first admissions were 0.2/1000 vs 1.0/1000 (p<0.001), proportions of readmissions 6.3% vs 19.3% (p<0.05), and numbers of hospital days 0.7/1000 vs 3.8/1000 (p<0.001). The differences were in the same direction, though less prominent, also among children 2-5 y of age.\nDo inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children?",
        "generated_text": ", but the proportion of readmissions was higher. The proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of readmissions was higher in the Oulu province, but the proportion of",
        "levenshtein_distance": 585
    },
    {
        "realidx": "15918864",
        "question": "Little is known about how information needs change over time in the early postpartum period or about how these needs might differ given socioeconomic circumstances. This study's aim was to examine women's concerns at the time of hospital discharge and unmet learning needs as self-identified at 4 weeks after discharge.\nData were collected as part of a cross-sectional survey of postpartum health outcomes, service use, and costs of care in the first 4 weeks after postpartum hospital discharge. Recruitment of 250 women was conducted from each of 5 hospitals in Ontario, Canada (n = 1,250). Women who had given vaginal birth to a single live infant, and who were being discharged at the same time as their infant, assuming care of their infant, competent to give consent, and able to communicate in one of the study languages were eligible. Participants completed a self-report questionnaire in hospital; 890 (71.2%) took part in a structured telephone interview 4 weeks after hospital discharge.\nApproximately 17 percent of participants were of low socioeconomic status. Breastfeeding and signs of infant illness were the most frequently identified concerns by women, regardless of their socioeconomic status. Signs of infant illness and infant care/behavior were the main unmet learning needs. Although few differences in identified concerns were evident, women of low socioeconomic status were significantly more likely to report unmet learning needs related to 9 of 10 topics compared with women of higher socioeconomic status. For most topics, significantly more women of both groups identified learning needs 4 weeks after discharge compared with the number who identified corresponding concerns while in hospital.\nLearning needs of postpartum women: does socioeconomic status matter?",
        "answer": "yes",
        "answer_rationale": "It is important to ensure that new mothers are adequately informed about topics important to them while in hospital. The findings highlight the need for accessible and appropriate community-based information resources for women in the postpartum period, especially for those of low socioeconomic status.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Little is known about how information needs change over time in the early postpartum period or about how these needs might differ given socioeconomic circumstances. This study's aim was to examine women's concerns at the time of hospital discharge and unmet learning needs as self-identified at 4 weeks after discharge.\nData were collected as part of a cross-sectional survey of postpartum health outcomes, service use, and costs of care in the first 4 weeks after postpartum hospital discharge. Recruitment of 250 women was conducted from each of 5 hospitals in Ontario, Canada (n = 1,250). Women who had given vaginal birth to a single live infant, and who were being discharged at the same time as their infant, assuming care of their infant, competent to give consent, and able to communicate in one of the study languages were",
        "q2": " eligible. Participants completed a self-report questionnaire in hospital; 890 (71.2%) took part in a structured telephone interview 4 weeks after hospital discharge.\nApproximately 17 percent of participants were of low socioeconomic status. Breastfeeding and signs of infant illness were the most frequently identified concerns by women, regardless of their socioeconomic status. Signs of infant illness and infant care/behavior were the main unmet learning needs. Although few differences in identified concerns were evident, women of low socioeconomic status were significantly more likely to report unmet learning needs related to 9 of 10 topics compared with women of higher socioeconomic status. For most topics, significantly more women of both groups identified learning needs 4 weeks after discharge compared with the number who identified corresponding concerns while in hospital.\nLearning needs of postpartum women: does socioeconomic status matter?",
        "generated_text": "eligible to participate. Data were collected by telephone interview at 4 weeks after discharge. The primary outcome was the identification of unmet learning needs at 4 weeks after discharge. The primary exposure was the identification of concerns at the time of discharge. Multivariable logistic regression was used to examine the association between concerns at discharge and unmet learning needs at 4 weeks, adjusting for maternal age, parity, education, and income.\nOf the 1,250 women recruited, 1,170 (93.6%) completed the 4-week interview. At discharge, 40.1% of women reported having concerns, and 27.1% reported unmet learning needs at 4 weeks. Women who had concerns at discharge were more likely to report unmet learning",
        "levenshtein_distance": 678
    },
    {
        "realidx": "15919266",
        "question": "The criteria for administration of adjuvant radiation therapy after thymoma resection remains controversial, and it is unclear whether patients with Masaoka stage III thymoma benefit from adjuvant radiation. The goal of this report was to determine whether or not this group benefits from radiation therapy in disease-specific survival and disease-free survival.\nCase records of the Massachusetts General Hospital were retrospectively reviewed from 1972 to 2004. One hundred and seventy-nine patients underwent resection for thymoma, of which 45 had stage III disease.\nForty-five stage III patients underwent resection and in 36 it was complete. Thirty-eight stage III patients received radiation therapy. Baseline prognostic factors between radiated and nonradiated groups were similar. The addition of adjuvant radiotherapy did not alter local or distant recurrence rates in patients with stage III thymoma. Disease-specific survival at 10 years in stage III patients who did not receive radiation was 75% (95% confidence interval, 32% to 100%) and in patients who did receive radiation therapy it was 79% (95% confidence interval, 64% to 94%) (p = 0.21). The most common site of relapse was the pleura.\nAdjuvant radiation of stage III thymoma: is it necessary?",
        "answer": "no",
        "answer_rationale": "Most patients who have stage III thymoma undergo complete resection. Some patients enjoy prolonged disease-free survival without adjuvant radiation after resection of stage III thymoma. Radiation does not seem to prevent pleural recurrences when given after resection of stage III thymomas. The use of routine adjuvant radiation after a complete resection of stage III thymoma needs to be re-addressed. There may be a role for the use of chemotherapy to reduce pleural recurrences.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The criteria for administration of adjuvant radiation therapy after thymoma resection remains controversial, and it is unclear whether patients with Masaoka stage III thymoma benefit from adjuvant radiation. The goal of this report was to determine whether or not this group benefits from radiation therapy in disease-specific survival and disease-free survival.\nCase records of the Massachusetts General Hospital were retrospectively reviewed from 1972 to 2004. One hundred and seventy-nine patients underwent resection for thymoma, of which 45 had stage III disease.\nForty-five stage III patients underwent resection and in 36 it was complete. Thirty-eight stage III patients received radiation therapy.",
        "q2": " Baseline prognostic factors between radiated and nonradiated groups were similar. The addition of adjuvant radiotherapy did not alter local or distant recurrence rates in patients with stage III thymoma. Disease-specific survival at 10 years in stage III patients who did not receive radiation was 75% (95% confidence interval, 32% to 100%) and in patients who did receive radiation therapy it was 79% (95% confidence interval, 64% to 94%) (p = 0.21). The most common site of relapse was the pleura.\nAdjuvant radiation of stage III thymoma: is it necessary?",
        "generated_text": "The median dose was 50 Gy (range, 30-60 Gy). The 5- and 10-year disease-specific survival rates for the entire group were 82% and 72%, respectively. The 5- and 10-year disease-free survival rates for the entire group were 62% and 52%, respectively. There was no difference in disease-specific survival or disease-free survival between patients who received radiation therapy and those who did not. There was no difference in disease-specific survival or disease-free survival between patients who received radiation therapy to less than 50 Gy and those who received 5",
        "levenshtein_distance": 426
    },
    {
        "realidx": "15943725",
        "question": "Serum pancreatic lipase may improve the diagnosis of pancreatitis compared to serum amylase. Both enzymes have been measured simultaneously at our hospital allowing for a comparison of their diagnostic accuracy.\nSeventeen thousand five hundred and thirty-one measurements of either serum amylase and or serum pancreatic lipase were made on 10 931 patients treated at a metropolitan teaching hospital between January 2001 and May 2003. Of these, 8937 were initially treated in the Emergency Department. These results were collected in a database, which was linked by the patients' medical record number to the radiology and medical records. Patients with either an elevated lipase value or a discharge diagnosis of acute pancreatitis had their radiological diagnosis reviewed along with their biochemistry and histology record. The diagnosis of acute pancreatitis was made if there was radiological evidence of peripancreatic inflammation.\nOne thousand eight hundred and twenty-five patients had either elevated serum amylase and or serum pancreatic lipase. The medical records coded for pancreatitis in a further 55 whose enzymes were not elevated. Three hundred and twenty of these had radiological evidence of acute pancreatitis. Receiver operator characteristic analysis of the initial sample from patients received in the Emergency Department showed improved diagnostic accuracy for serum pancreatic lipase (area under the curve (AUC) 0.948) compared with serum amylase (AUC, 0.906, P<0.05). A clinically useful cut-off point would be at the diagnostic threshold; 208 U/L (normal<190 U/L) for serum pancreatic lipase and 114 U/L (normal 27-100 U/L) for serum amylase where the sensitivity was 90.3 cf., 76.8% and the specificity was 93 cf., 92.6%. 18.8% of the acute pancreatitis patients did not have elevated serum amylase while only 2.9% did not have elevated serum pancreatic lipase on the first emergency department measurement.\nShould serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis?",
        "answer": "yes",
        "answer_rationale": "It is concluded that serum pancreatic lipase is a more accurate biomarker of acute pancreatitis than serum amylase.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Serum pancreatic lipase may improve the diagnosis of pancreatitis compared to serum amylase. Both enzymes have been measured simultaneously at our hospital allowing for a comparison of their diagnostic accuracy.\nSeventeen thousand five hundred and thirty-one measurements of either serum amylase and or serum pancreatic lipase were made on 10 931 patients treated at a metropolitan teaching hospital between January 2001 and May 2003. Of these, 8937 were initially treated in the Emergency Department. These results were collected in a database, which was linked by the patients' medical record number to the radiology and medical records. Patients with either an elevated lipase value or a discharge diagnosis of acute pancreatitis had their radiological diagnosis reviewed along with their biochemistry and histology record. The diagnosis of acute pancreatitis was made if there was radiological evidence of peripancreatic inflammation.\nOne thousand eight hundred and twenty-five patients had either elevated serum amylase and or serum pancreatic lipase. The medical records coded for pancreatitis in a further 55 whose enzymes were",
        "q2": " not elevated. Three hundred and twenty of these had radiological evidence of acute pancreatitis. Receiver operator characteristic analysis of the initial sample from patients received in the Emergency Department showed improved diagnostic accuracy for serum pancreatic lipase (area under the curve (AUC) 0.948) compared with serum amylase (AUC, 0.906, P<0.05). A clinically useful cut-off point would be at the diagnostic threshold; 208 U/L (normal<190 U/L) for serum pancreatic lipase and 114 U/L (normal 27-100 U/L) for serum amylase where the sensitivity was 90.3 cf., 76.8% and the specificity was 93 cf., 92.6%. 18.8% of the acute pancreatitis patients did not have elevated serum amylase while only 2.9% did not have elevated serum pancreatic lipase on the first emergency department measurement.\nShould serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis?",
        "generated_text": "not elevated. The radiology records were reviewed in 1880 patients. The diagnosis of acute pancreatitis was confirmed in 1002 patients. The sensitivity and specificity of serum pancreatic lipase for acute pancreatitis was 89% and 95% respectively. The sensitivity and specificity of serum amylase was 75% and 95% respectively. The positive predictive value of serum pancreatic lipase was 75% compared to 64% for serum amylase. The negative predictive value of serum pancreatic lipase was 98% compared to 95% for serum amylase.\nSerum pancreatic lipase is a better diagnostic test for acute pancreatitis than serum amylase. It is more sensitive and has a higher negative predictive value.",
        "levenshtein_distance": 591
    },
    {
        "realidx": "15995461",
        "question": "This article examines the hypothesis that the six U.S. states with the highest rates of road traffic deaths (group 1 states) also had above-average rates of other forms of injury such as falling, poisoning, drowning, fire, suffocation, homicide, and suicide, and also for the retail trade and construction industries. The converse, second hypothesis, for the six states with the lowest rates of road traffic deaths (group 2 states) is also examined.\nData for these 12 states for the period 1983 to 1995 included nine categories of unintentional and four categories of intentional injury. Seventy-four percent of the group 1 states conformed to the first hypothesis, and 85% of the group 2 states conformed to the second hypothesis.\nDo some U.S. states have higher/lower injury mortality rates than others?",
        "answer": "yes",
        "answer_rationale": "Group 1 states are likely to exhibit above-average rates for most other categories of injury death, whereas group 2 states are even more likely to exhibit below-average rates for most other categories of injury death.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This article examines the hypothesis that the six U.S. states with the highest rates of road traffic deaths (group 1 states) also had above-average rates of other forms of injury such as falling, poisoning, drowning, fire, suffocation, homicide, and suicide, and also for the retail trade and construction industries. The converse, second hypothesis, for the six states with the lowest rates of road traffic deaths (group 2",
        "q2": " states) is also examined.\nData for these 12 states for the period 1983 to 1995 included nine categories of unintentional and four categories of intentional injury. Seventy-four percent of the group 1 states conformed to the first hypothesis, and 85% of the group 2 states conformed to the second hypothesis.\nDo some U.S. states have higher/lower injury mortality rates than others?",
        "generated_text": "states), is that they had below-average rates of these other forms of injury and for the retail trade and construction industries.\n\nThe data for this analysis was obtained from the U.S. Bureau of Labor Statistics and the Centers for Disease Control and Prevention. The study period was from 2003 to 2010.\n\nThe results showed that for group 1 states, the rates of poisoning, drowning, fire, suff",
        "levenshtein_distance": 300
    },
    {
        "realidx": "16046584",
        "question": "Irregular bleeding affects many users of combined menopausal hormone therapy (HT) and commonly leads to invasive and expensive investigations to exclude underlying malignancy. In most cases no abnormality is found.\nThe main objective of this study was to explore the role of uterine natural killer (uNK) cells and their regulatory cytokine IL-15 in irregular bleeding in HT users.\nThis was a prospective observational study conducted between 2002 and 2004.\nThe study was conducted in a tertiary referral menopause clinic at King Edward Memorial Hospital, Western Australia.\nPatients included 117 postmenopausal women taking combined HT.\nOutpatient endometrial biopsies were taken during and outside bleeding episodes.\nThe relationship between endometrial uNK cells (CD56+) and bleeding patterns was measured. We also addressed the impact of HT exposure on uNK cell populations, the relationship between endometrial IL-15 expression and uNK cell populations, and killer Ig like receptor genotype in subjects with irregular bleeding.\nEndometrial CD56+ uNK cells were significantly increased in biopsies obtained during bleeding episodes (P<0.001), compared with HT users with no bleeding. The highest level of IL-15 expression was also seen in biopsies taken during bleeding. No clear relationship between killer Ig like receptor genotype and bleeding on HT was observed.\nMenopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?",
        "answer": "yes",
        "answer_rationale": "Little is known about the mechanisms underlying irregular bleeding in HT users. This is the first report of uNK cells and their association with regulating cytokines in postmenopausal endometrium and demonstrates a possible mechanism by which HT may induce irregular bleeding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Irregular bleeding affects many users of combined menopausal hormone therapy (HT) and commonly leads to invasive and expensive investigations to exclude underlying malignancy. In most cases no abnormality is found.\nThe main objective of this study was to explore the role of uterine natural killer (uNK) cells and their regulatory cytokine IL-15 in irregular bleeding in HT users.\nThis was a prospective observational study conducted between 2002 and 2004.\nThe study was conducted in a tertiary referral menopause clinic at King Edward Memorial Hospital, Western Australia.\nPatients included 117 postmenopausal women taking combined HT.\nOutpatient endometrial biopsies were taken during and outside bleeding episodes.\nThe relationship between endometrial u",
        "q2": "NK cells (CD56+) and bleeding patterns was measured. We also addressed the impact of HT exposure on uNK cell populations, the relationship between endometrial IL-15 expression and uNK cell populations, and killer Ig like receptor genotype in subjects with irregular bleeding.\nEndometrial CD56+ uNK cells were significantly increased in biopsies obtained during bleeding episodes (P<0.001), compared with HT users with no bleeding. The highest level of IL-15 expression was also seen in biopsies taken during bleeding. No clear relationship between killer Ig like receptor genotype and bleeding on HT was observed.\nMenopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?",
        "generated_text": "NK cells and IL-15 expression and bleeding was assessed.\nThe main outcome measures were the number of uNK cells and IL-15 expression in the endometrium during and outside bleeding episodes.\nThe number of uNK cells and IL-15 expression in the endometrium was significantly higher during bleeding episodes compared with non-bleeding episodes (P < 0.001). The number of uNK cells and IL-15 expression was also higher in women with irregular bleeding compared with regular bleeding (P < 0.001). The number of uNK cells and IL-15 expression was positively correlated with the severity of bleeding (P < 0.001",
        "levenshtein_distance": 479
    },
    {
        "realidx": "16147837",
        "question": "To compare maternal and neonatal outcomes among grandmultiparous women to those of multiparous women 30 years or older.\nA database of the vast majority of maternal and newborn hospital discharge records linked to birth/death certificates was queried to obtain information on all multiparous women with a singleton delivery in the state of California from January 1, 1997 through December 31, 1998. Maternal and neonatal pregnancy outcomes of grandmultiparous women were compared to multiparous women who were 30 years or older at the time of their last birth.\nThe study population included 25,512 grandmultiparous and 265,060 multiparous women 30 years or older as controls. Grandmultiparous women were predominantly Hispanic (56%). After controlling for potential confounding factors, grandmultiparous women were at significantly higher risk for abruptio placentae (odds ratio OR: 1.3; 95% confidence intervals CI: 1.2-1.5), preterm delivery (OR: 1.3; 95% CI: 1.2-1.4), fetal macrosomia (OR: 1.5; 95% CI: 1.4-1.6), neonatal death (OR: 1.5; 95% CI: 1.3-1.8), postpartum hemorrhage (OR: 1.2; 95% CI: 1.1-1.3) and blood transfusion (OR: 1.5; 95% CI: 1.3-1.8).\nIs grandmultiparity an independent risk factor for adverse perinatal outcomes?",
        "answer": "yes",
        "answer_rationale": "Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To compare maternal and neonatal outcomes among grandmultiparous women to those of multiparous women 30 years or older.\nA database of the vast majority of maternal and newborn hospital discharge records linked to birth/death certificates was queried to obtain information on all multiparous women with a singleton delivery in the state of California from January 1, 1997 through December 31, 1998. Maternal and neonatal pregnancy outcomes of grandmultiparous women were compared to multiparous women who were 30 years or older at the time of their last birth.\nThe study population included 25,512 grandmultiparous and 265,060 multiparous women 30 years or older as controls. Grandmultiparous women were predominantly Hispanic (56%). After controlling for potential confounding factors, grandmultiparous women were at significantly higher",
        "q2": " risk for abruptio placentae (odds ratio OR: 1.3; 95% confidence intervals CI: 1.2-1.5), preterm delivery (OR: 1.3; 95% CI: 1.2-1.4), fetal macrosomia (OR: 1.5; 95% CI: 1.4-1.6), neonatal death (OR: 1.5; 95% CI: 1.3-1.8), postpartum hemorrhage (OR: 1.2; 95% CI: 1.1-1.3) and blood transfusion (OR: 1.5; 95% CI: 1.3-1.8).\nIs grandmultiparity an independent risk factor for adverse perinatal outcomes?",
        "generated_text": "risk for cesarean delivery (adjusted odds ratio [aOR] 1.29, 95% confidence interval [CI] 1.23-1.35), placenta previa (aOR 1.44, 95% CI 1.18-1.76), placental abruption (aOR 1.30, 95% CI 1.07-1.58), and postpartum hemorrhage (aOR 1.20, 95% CI 1.08-1.33). Neonates of grandmultiparous women had higher risks of preterm birth (aOR 1.21, 95% CI 1.12-1.31), low birth weight (",
        "levenshtein_distance": 236
    },
    {
        "realidx": "16266387",
        "question": "Lifestyle changes over the last 30 years are the most likely explanation for the increase in allergic disease over this period.AIM: This study tests the hypothesis that the consumption of fast food is related to the prevalence of asthma and allergy.\nAs part of the International Study of Asthma and Allergies in Childhood (ISAAC) a cross-sectional prevalence study of 1321 children (mean age = 11.4 years, range: 10.1-12.5) was conducted in Hastings, New Zealand. Using standard questions we collected data on the prevalence of asthma and asthma symptoms, as well as food frequency data. Skin prick tests were performed to common environmental allergens and exercise-induced bronchial hyperresponsiveness (BHR) was assessed according to a standard protocol. Body mass index (BMI) was calculated as weight/height2 (kg/m2) and classified into overweight and obese according to a standard international definition.\nAfter adjusting for lifestyle factors, including other diet and BMI variables, compared with children who never ate hamburgers, we found an independent risk of hamburger consumption on having a history of wheeze [consumption less than once a week (OR = 1.44, 95% CI: 1.06-1.96) and 1+ times a week (OR = 1.65, 95% CI: 1.07-2.52)] and on current wheeze [consumption less than once a week (OR = 1.17, 95% CI: 0.80-1.70) and 1+ times a week (OR = 1.81, 95% CI: 1.10-2.98)]. Takeaway consumption 1+ times a week was marginally significantly related to BHR (OR = 2.41, 95% CI: 0.99-5.91). There was no effect on atopy.\nFast foods - are they a risk factor for asthma?",
        "answer": "yes",
        "answer_rationale": "Frequent consumption of hamburgers showed a dose-dependent association with asthma symptoms, and frequent takeaway consumption showed a similar association with BHR.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Lifestyle changes over the last 30 years are the most likely explanation for the increase in allergic disease over this period.AIM: This study tests the hypothesis that the consumption of fast food is related to the prevalence of asthma and allergy.\nAs part of the International Study of Asthma and Allergies in Childhood (ISAAC) a cross-sectional prevalence study of 1321 children (mean age = 11.4 years, range: 10.1-12.5) was conducted in Hastings, New Zealand. Using standard questions we collected data on the prevalence of asthma and asthma symptoms, as well as food frequency data. Skin prick tests were performed to common environmental allergens and exercise-induced bronchial hyperresponsiveness (BHR) was assessed according to a standard protocol. Body mass index (BMI) was calculated as weight/height2 (kg/m2) and classified into overweight and obese according to a standard international definition.\nAfter adjusting for lifestyle factors, including other diet and BMI variables, compared with children who",
        "q2": " never ate hamburgers, we found an independent risk of hamburger consumption on having a history of wheeze [consumption less than once a week (OR = 1.44, 95% CI: 1.06-1.96) and 1+ times a week (OR = 1.65, 95% CI: 1.07-2.52)] and on current wheeze [consumption less than once a week (OR = 1.17, 95% CI: 0.80-1.70) and 1+ times a week (OR = 1.81, 95% CI: 1.10-2.98)]. Takeaway consumption 1+ times a week was marginally significantly related to BHR (OR = 2.41, 95% CI: 0.99-5.91). There was no effect on atopy.\nFast foods - are they a risk factor for asthma?",
        "generated_text": "reported never eating fast food, those who reported eating fast food at least once per week had an increased risk of severe asthma (adjusted odds ratio (aOR) = 1.8, 95% CI: 1.1-2.9), severe eczema (aOR = 1.7, 95% CI: 1.1-2.7) and severe rhinoconjunctivitis (aOR = 1.6, 95% CI: 1.0-2.5). There was a dose-response relationship between fast food consumption and severe asthma, severe eczema and severe rhinoconjunctivitis, with the highest consumption of fast food being associated with the highest risk of these conditions. There was no association between fast food consumption and skin prick test reactivity or exercise-induced BHR.\nThis study provides evidence that fast food consumption is associated with an increased risk of severe asthma, severe eczema and severe rhino",
        "levenshtein_distance": 548
    },
    {
        "realidx": "16296668",
        "question": "To investigate the ability of a bedside swallowing assessment to reliably exclude aspiration following acute stroke.\nConsecutive patients admitted within 24 h of stroke onset to two hospitals.\nA prospective study. Where possible, all patients had their ability to swallow assessed on the day of admission by both a doctor and a speech and language therapist using a standardized proforma. A videofluoroscopy examination was conducted within 3 days of admission.\n94 patients underwent videofluoroscopy; 20 (21%) were seen to be aspirating, although this was not detected at the bedside in 10. In 18 (22%) of the patients the speech and language therapist considered the swallow to be unsafe. In the medical assessment, 39 patients (41%) had an unsafe swallow. Bedside assessment by a speech and language therapist gave a sensitivity of 47%, a specificity of 86%, positive predictive value (PPV) of 50% and a negative predictive value (NPV) of 85% for the presence of aspiration. Multiple logistic regression was used to identify the optimum elements of the bedside assessments for predicting the presence of aspiration. A weak voluntary cough and any alteration in conscious level gave a sensitivity of 75%, specificity of 72%, PPV of 41% and NPV of 91% for aspiration.\nCan bedside assessment reliably exclude aspiration following acute stroke?",
        "answer": "no",
        "answer_rationale": "Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To investigate the ability of a bedside swallowing assessment to reliably exclude aspiration following acute stroke.\nConsecutive patients admitted within 24 h of stroke onset to two hospitals.\nA prospective study. Where possible, all patients had their ability to swallow assessed on the day of admission by both a doctor and a speech and language therapist using a standardized proforma. A videofluoroscopy examination was conducted within 3 days of admission.\n94 patients underwent videofluoroscopy; 20 (21%) were seen to be aspirating, although this was not detected at the bedside in 10. In 18 (22%) of the patients the speech and language therapist considered the swallow to be unsafe",
        "q2": ". In the medical assessment, 39 patients (41%) had an unsafe swallow. Bedside assessment by a speech and language therapist gave a sensitivity of 47%, a specificity of 86%, positive predictive value (PPV) of 50% and a negative predictive value (NPV) of 85% for the presence of aspiration. Multiple logistic regression was used to identify the optimum elements of the bedside assessments for predicting the presence of aspiration. A weak voluntary cough and any alteration in conscious level gave a sensitivity of 75%, specificity of 72%, PPV of 41% and NPV of 91% for aspiration.\nCan bedside assessment reliably exclude aspiration following acute stroke?",
        "generated_text": ", and in 12 (13%) the doctor considered the swallow to be unsafe. The sensitivity of the bedside assessment for aspiration was 50% for the doctor and 55% for the speech and language therapist, with specificities of 88% and 91%, respectively. The positive predictive values were 50% and 56%, and the negative predictive values 88% and 90%. The interobserver agreement between the two assessors was poor (kappa 0.17). The sensitivity of the bedside assessment was not improved by using a combination of the two assessments.\nThe bedside swallowing assessment is a poor screening test for",
        "levenshtein_distance": 466
    },
    {
        "realidx": "16392897",
        "question": "Quantitative real-time PCR has become the predominant molecular technique to monitor BCRABL levels in response to treatment in Ph(+) leukemia patients. However, without some form of standardized methodology between laboratories, the correlation of results is difficult.\nUsing TaqMan-based assays, parallel quantitative real-time PCR analysis was performed on 70 clinical specimens at Vanderbilt University Medical Center and Virginia Commonwealth University. While the same positive control cell line (K562) and quality control gene (BCR) were used, the RNA isolation technique, cDNA synthesis, BCR control cell line, and PCR primer and probe sequences were different.\nThe detection of BCRABL-positive results spanned a dynamic range from 10(0) to 10(5)/100,000 cells. Forty-three samples were negative at both facilities. A Spearman rank correlation analysis was performed for the 22 BCRABL-positive paired results. The correlation coefficient, r(s), was 0.9435 (p<0.00001), suggesting a strong correlation of the results. One discordant result was obtained for consecutive samples from one patient with a low BCRABL copy number as a result of a minimal RNA yield at one laboratory.\nBCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays?",
        "answer": "maybe",
        "answer_rationale": "These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for patients who are monitored at different facilities, but also for larger investigative studies in which hematologic, cytogenetic and molecular responses are to be compared.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Quantitative real-time PCR has become the predominant molecular technique to monitor BCRABL levels in response to treatment in Ph(+) leukemia patients. However, without some form of standardized methodology between laboratories, the correlation of results is difficult.\nUsing TaqMan-based assays, parallel quantitative real-time PCR analysis was performed on 70 clinical specimens at Vanderbilt University Medical Center and Virginia Commonwealth University. While the same positive control cell line (K562) and quality control gene (BCR) were used, the RNA isolation technique, cDNA synthesis, BCR control cell line, and PCR primer and probe sequences were different.\nThe detection of BCRABL-positive results",
        "q2": " spanned a dynamic range from 10(0) to 10(5)/100,000 cells. Forty-three samples were negative at both facilities. A Spearman rank correlation analysis was performed for the 22 BCRABL-positive paired results. The correlation coefficient, r(s), was 0.9435 (p<0.00001), suggesting a strong correlation of the results. One discordant result was obtained for consecutive samples from one patient with a low BCRABL copy number as a result of a minimal RNA yield at one laboratory.\nBCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays?",
        "generated_text": "was 100% concordant between the two laboratories. The correlation of BCRABL/BCR ratios was significant (r = 0.82, P < 0.0001). The correlation of BCRABL/BCR ratios was also significant when the data were normalized to the same positive control cell line (r = 0.81, P < 0.0001). The correlation of BCRABL/BCR ratios was significant when the data were normalized to the same positive control cell line (r = 0.81, P < 0.0001",
        "levenshtein_distance": 430
    },
    {
        "realidx": "16403186",
        "question": "To examine family-based transmission of the number of 5' flanking arginine vasopressin V1a receptor (AVPR1A) microsatellites, which include [(GATA)(14)] and complex [(CT)(4)-TT-(CT)(8)-(GT)(24)]repeats, in probands with a prepubertal and early adolescent bipolar disorder phenotype (PEA-BP). Preferential transmission of the number of AVPR1A microsatellite repeats to hypersexual and uninhibited people-seeking probands was hypothesized, based on reports from preclinical work in the literature.\nProbands were 83 participants in an ongoing controlled study of PEA-BP. The PEA-BP phenotype was defined by DSM-IV mania with at least one of the cardinal symptoms of mania (elation and/or grandiosity) to avoid diagnosing mania only by symptoms that overlapped with those for attention-deficit hyperactivity disorder (ADHD). Comprehensive assessment of the probands included separate Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) interviews of parents about their children and of children about themselves. Hypersexuality and uninhibited people-seeking were assessed from the corresponding WASH-U-KSADS items. Microsatellite genotyping of the AVPR1A repeats was conducted using fluorescently labeled primers and detected by laser-induced fluorescence. Alleles were determined with the assistance of semi-automated allele-calling software. There were 32 complete, biological trios (28 informative families) for the GATA repeat and 34 complete, biological trios (30 informative families) for the complex repeat. Data were analyzed using case-control and family-based association methods.\nPreferential transmission of AVPR1A GATA or complex repeats was not significant for hypersexuality or uninhibited people-seeking, using the transmission disequilibrium test. Similarly, case-control analyses found no significant associations between hypersexuality or uninhibited people-seeking and the number of AVPR1A GATA or complex repeats. For p<0.05, there was about 80% power to detect odds ratios of 5.0 and 4.0 (in the family-based analyses) and 3.5 and 2.6 (in the case-control analyses), for allele frequencies of 0.1 and 0.5, respectively.\nAre the arginine vasopressin V1a receptor microsatellites related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype?",
        "answer": "no",
        "answer_rationale": "Preferential transmission of AVPR1A to hypersexual or uninhibited people-seeking probands was not supported.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To examine family-based transmission of the number of 5' flanking arginine vasopressin V1a receptor (AVPR1A) microsatellites, which include [(GATA)(14)] and complex [(CT)(4)-TT-(CT)(8)-(GT)(24)]repeats, in probands with a prepubertal and early adolescent bipolar disorder phenotype (PEA-BP). Preferential transmission of the number of AVPR1A microsatellite repeats to hypersexual and uninhibited people-seeking probands was hypothesized, based on reports from preclinical work in the literature.\nProbands were 83 participants in an ongoing controlled study of PEA-BP. The PEA-BP phenotype was defined by DSM-IV mania with at least one of the cardinal symptoms of mania (elation and/or grandiosity) to avoid diagnosing mania only by symptoms that overlapped with those for attention-deficit hyperactivity disorder (ADHD). Comprehensive assessment of the probands included separate Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) interviews of parents about their children and of children about themselves. Hypersexuality and uninhibited people-seeking were assessed from the corresponding WASH-U-KSADS items.",
        "q2": " Microsatellite genotyping of the AVPR1A repeats was conducted using fluorescently labeled primers and detected by laser-induced fluorescence. Alleles were determined with the assistance of semi-automated allele-calling software. There were 32 complete, biological trios (28 informative families) for the GATA repeat and 34 complete, biological trios (30 informative families) for the complex repeat. Data were analyzed using case-control and family-based association methods.\nPreferential transmission of AVPR1A GATA or complex repeats was not significant for hypersexuality or uninhibited people-seeking, using the transmission disequilibrium test. Similarly, case-control analyses found no significant associations between hypersexuality or uninhibited people-seeking and the number of AVPR1A GATA or complex repeats. For p<0.05, there was about 80% power to detect odds ratios of 5.0 and 4.0 (in the family-based analyses) and 3.5 and 2.6 (in the case-control analyses), for allele frequencies of 0.1 and 0.5, respectively.\nAre the arginine vasopressin V1a receptor microsatellites related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype?",
        "generated_text": "The parents of the probands were interviewed about their own psychiatric history. The parents and the probands provided blood samples for DNA extraction. The number of AVPR1A microsatellite repeats was determined by polymerase chain reaction (PCR) and capillary electrophoresis. The transmission disequilibrium test (TDT) was used to test for preferential transmission of the number of AVPR1A microsatellite repeats to the probands.\nThe number of AVPR1A microsatellite repeats was transmitted to the probands more often than expected by chance (p=0.00000000000000022). The number of AVPR1A microsatellite repeats was preferentially transmitted to hypersexual probands (p=0.00000000000000022). The number of AVPR1A microsatellite repeats was preferentially transmitted to uninhibited people-seeking probands (p=0.00000000000000022). The number of AVPR1A microsatellite repeats was preferentially transmitted to probands with both hypersexuality and uninhibited people-seeking (p=0.0000",
        "levenshtein_distance": 879
    },
    {
        "realidx": "16418930",
        "question": "Assessment of visual acuity depends on the optotypes used for measurement. The ability to recognize different optotypes differs even if their critical details appear under the same visual angle. Since optotypes are evaluated on individuals with good visual acuity and without eye disorders, differences in the lower visual acuity range cannot be excluded. In this study, visual acuity measured with the Snellen E was compared to the Landolt C acuity.\n100 patients (age 8 - 90 years, median 60.5 years) with various eye disorders, among them 39 with amblyopia due to strabismus, and 13 healthy volunteers were tested. Charts with the Snellen E and the Landolt C (Precision Vision) which mimic the ETDRS charts were used to assess visual acuity. Three out of 5 optotypes per line had to be correctly identified, while wrong answers were monitored. In the group of patients, the eyes with the lower visual acuity, and the right eyes of the healthy subjects, were evaluated.\nDifferences between Landolt C acuity (LR) and Snellen E acuity (SE) were small. The mean decimal values for LR and SE were 0.25 and 0.29 in the entire group and 0.14 and 0.16 for the eyes with strabismus amblyopia. The mean difference between LR and SE was 0.55 lines in the entire group and 0.55 lines for the eyes with strabismus amblyopia, with higher values of SE in both groups. The results of the other groups were similar with only small differences between LR and SE.\nLandolt C and snellen e acuity: differences in strabismus amblyopia?",
        "answer": "no",
        "answer_rationale": "Using the charts described, there was only a slight overestimation of visual acuity by the Snellen E compared to the Landolt C, even in strabismus amblyopia. Small differences in the lower visual acuity range have to be considered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Assessment of visual acuity depends on the optotypes used for measurement. The ability to recognize different optotypes differs even if their critical details appear under the same visual angle. Since optotypes are evaluated on individuals with good visual acuity and without eye disorders, differences in the lower visual acuity range cannot be excluded. In this study, visual acuity measured with the Snellen E was compared to the Landolt C acuity.\n100 patients (age 8 - 90 years, median 60.5 years) with various eye disorders, among them 39 with amblyopia due to strabismus, and 13 healthy volunteers were tested. Charts with the Snellen E and the Landolt C (Precision Vision) which mimic the ETDRS charts were used to assess visual acuity. Three out of 5 optotypes per line had to be correctly identified, while",
        "q2": " wrong answers were monitored. In the group of patients, the eyes with the lower visual acuity, and the right eyes of the healthy subjects, were evaluated.\nDifferences between Landolt C acuity (LR) and Snellen E acuity (SE) were small. The mean decimal values for LR and SE were 0.25 and 0.29 in the entire group and 0.14 and 0.16 for the eyes with strabismus amblyopia. The mean difference between LR and SE was 0.55 lines in the entire group and 0.55 lines for the eyes with strabismus amblyopia, with higher values of SE in both groups. The results of the other groups were similar with only small differences between LR and SE.\nLandolt C and snellen e acuity: differences in strabismus amblyopia?",
        "generated_text": "the Landolt C had to be correctly oriented. The visual acuity was measured in the better eye.\nThe mean visual acuity was 0.42 logMAR (SD 0.42) with the Snellen E and 0.47 logMAR (SD 0.43) with the Landolt C. The difference between the two optotypes was 0.05 logMAR (95% CI 0.02 - 0.08, p < 0.001). The difference was larger in the amblyopic group (0.09 logMAR, 95% CI 0.04 - 0.14, p < 0.001) than in the non-amblyopic group (0.02 logMAR, 95% CI -",
        "levenshtein_distance": 507
    },
    {
        "realidx": "16465002",
        "question": "To study the correlation and agreement between end-tidal carbon dioxide (EtCO2) and arterial carbon dioxide (PaCO(2)) in ventilated extremely low birth weight (ELBW) infants in the first week of life.\nRetrospective chart review of all ELBW (<1,000 g) infants admitted to a level III NICU from January 2003 to December 2003. Data collected included demographic details and simultaneous EtCO(2) (mainstream capnography) and arterial blood gas values (pH, PaCO(2), PaO(2)).\nThe correlation coefficient, degree of bias with 95% confidence interval between the EtCO(2) and PaCO(2).\nThere were 754 end-tidal and arterial CO(2) pairs from 31 ELBW infants (21 male and 10 female). The overall EtCO(2) values were significantly lower than PaCO(2) value. In only 89/754(11.8%) pairs, the EtCO(2) was higher than the PaCO(2). The overall bias was 5.6 +/- 6.9 mmHg (95% C.I. 5.11-6.09). The intraclass correlation coefficient was 0.81. Using EtCO2 ranges of 30 to 50 mmHg, the capnographic method was able to identify 84% of instances where PaCO(2) was between 35 (<35 = hypocarbia) and 55 mmHg (>55= hypercapnia).\nDose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life?",
        "answer": "yes",
        "answer_rationale": "There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To study the correlation and agreement between end-tidal carbon dioxide (EtCO2) and arterial carbon dioxide (PaCO(2)) in ventilated extremely low birth weight (ELBW) infants in the first week of life.\nRetrospective chart review of all ELBW (<1,000 g) infants admitted to a level III NICU from January 2003 to December 2003. Data collected included demographic details and simultaneous EtCO(2) (mainstream capnography) and arterial blood gas values (pH, PaCO(2), PaO(2)).\nThe correlation coefficient, degree of bias with 95% confidence interval between the EtCO(2) and PaCO(2).\nThere were 754 end-tidal and arterial CO(2) pairs from 31 ELBW infants (21 male and 10 female",
        "q2": "). The overall EtCO(2) values were significantly lower than PaCO(2) value. In only 89/754(11.8%) pairs, the EtCO(2) was higher than the PaCO(2). The overall bias was 5.6 +/- 6.9 mmHg (95% C.I. 5.11-6.09). The intraclass correlation coefficient was 0.81. Using EtCO2 ranges of 30 to 50 mmHg, the capnographic method was able to identify 84% of instances where PaCO(2) was between 35 (<35 = hypocarbia) and 55 mmHg (>55= hypercapnia).\nDose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life?",
        "generated_text": "). The mean birth weight was 740 g (SD 120 g) and the mean gestational age was 25.5 weeks (SD 1.5 weeks). The mean PaCO(2) was 45.5 mm Hg (SD 11.5 mm Hg) and the mean EtCO(2) was 43.5 mm Hg (SD 11.5 mm Hg). The correlation coefficient between PaCO(2) and EtCO(2) was 0.82 (P < 0.001). The mean difference between PaCO(2) and EtCO(2) was 2.0 mm Hg (95% CI 1.6-2.4 mm Hg). The limits of agreement were",
        "levenshtein_distance": 426
    },
    {
        "realidx": "16538201",
        "question": "To determine whether the use of hydrophilic guidewires has increased the technical success rate of peripheral percutaneous transluminal angioplasty (PTA).MATERIAL/\nWe performed 125 procedures and analyzed the technical success rates of PTA using the conventional guidewire first and then if needed, the hydrophilic guidewire for iliac and SFA stenoses or occlusions. Angioplasty was performed on 25 stenosed, 25 occluded iliac arteries and 25 stenosed, 50 occluded femoral arteries. The result was defined as technical success when the lesion was crossed by a guidewire and balloon, then it was dilated with restoration of vessel lumen and less than 30% residual stenosis and the rise in ABI values was at least 0.15 after 24 hours.\nThe technical success rate after PTA of stenosed iliac arteries was achieved in 96% (24/25) using conventional wires and 100% using hydrophilic guidewire; in iliac occlusions, the rates were 60% (15/25) and 96%, respectively; in femoral stenosis - 84% (21/25) and 100%; in occlusions in the first group: lesions<10 cm -64% (16/25) and 96%, in the second group: lesions>10 cm -48% (12/25) and 88%. In the iliac group, there was no significant difference in the success of iliac stenosis PTA. However, there were significant changes in the success rates of PTA performed for SFA stenosis and iliac and SFA occlusions.\nDoes use of hydrophilic guidewires significantly improve technical success rates of peripheral PTA?",
        "answer": "maybe",
        "answer_rationale": "In summary, we report an overall improvement and high technical success rate for peripherial PTA. The use of hydrophilic guidewires made significant difference to the technical success rate of PTA, especially in occlusion and more complicated lesions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To determine whether the use of hydrophilic guidewires has increased the technical success rate of peripheral percutaneous transluminal angioplasty (PTA).MATERIAL/\nWe performed 125 procedures and analyzed the technical success rates of PTA using the conventional guidewire first and then if needed, the hydrophilic guidewire for iliac and SFA stenoses or occlusions. Angioplasty was performed on 25 stenosed, 25 occluded iliac arteries and 25 stenosed, 50 occluded femoral arteries. The result was defined as technical success when the lesion was crossed by a guidewire and balloon, then it was dilated with restoration of vessel lumen and less than 30% residual stenosis and the rise in ABI values was at least 0.15 after 24 hours.\nThe technical success rate after PTA of stenosed iliac arteries",
        "q2": " was achieved in 96% (24/25) using conventional wires and 100% using hydrophilic guidewire; in iliac occlusions, the rates were 60% (15/25) and 96%, respectively; in femoral stenosis - 84% (21/25) and 100%; in occlusions in the first group: lesions<10 cm -64% (16/25) and 96%, in the second group: lesions>10 cm -48% (12/25) and 88%. In the iliac group, there was no significant difference in the success of iliac stenosis PTA. However, there were significant changes in the success rates of PTA performed for SFA stenosis and iliac and SFA occlusions.\nDoes use of hydrophilic guidewires significantly improve technical success rates of peripheral PTA?",
        "generated_text": "was 96% (24/25), and 88% (22/25) for occluded iliac arteries. The technical success rate after PTA of stenosed femoral arteries was 92% (23/25), and 88% (44/50) for occluded femoral arteries. The technical success rate after PTA of iliac arteries was 92% (46/50), and 90% (67/75) for femoral arteries. The technical success rate after PTA of iliac and femoral arteries was 91% (113/125). The technical success rate after PTA of stenosed arteries was 94% (47/50), and 89% (66/",
        "levenshtein_distance": 473
    },
    {
        "realidx": "16678696",
        "question": "It is widely accepted that exemplary surgical care involves a surgeon's involvement in the preoperative, perioperative, and postoperative periods. In an era of ever-expanding therapeutic modalities available to the vascular surgeon, it is important that trainees gain experience in preoperative decision-making and how this affects a patient's operative and postoperative course. The purpose of this study was to define the current experience of residents on a vascular surgery service regarding the continuity of care they are able to provide for patients and the factors affecting this experience.\nThis prospective cohort study was approved by the Institutional Review Board and conducted at the University of British Columbia during January 2005. All patients who underwent a vascular procedure at either of the two teaching hospitals were included. In addition to type of case (emergent, outpatient, inpatient), resident demographic data and involvement in each patient's care (preoperative assessment, postoperative daily assessment, and follow-up clinic assessment) were recorded. Categoric data were analyzed with the chi2 test.\nThe study included 159 cases, of which 65% were elective same-day admission patients, 20% were elective previously admitted patients; and 15% were emergent. The overall rate of preoperative assessment was 67%, involvement in the decision to operate, 17%; postoperative assessment on the ward, 79%; and patient follow-up in clinic, 3%. The rate of complete in-hospital continuity of care (assessing patient pre-op and post-op) was 57%. Emergent cases were associated with a significantly higher rate of preoperative assessment (92% vs 63%, P<.05). For elective cases admitted before the day of surgery compared with same-day admission patients, the rates of preoperative assessment (78% vs 58%, P<.05) and involvement in the decision to operate (16% vs 4%, P<.05) were significantly higher.\nContinuity of care experience of residents in an academic vascular department: are trainees learning complete surgical care?",
        "answer": "no",
        "answer_rationale": "The continuity-of-care experiences of vascular trainees are suboptimal. This is especially true for postoperative clinic assessment. Same-day admission surgery accounted for most of the cases and was associated with the poorest continuity of care. To provide complete surgical training in an era of changing therapeutic modalities and same-day admission surgery, vascular programs must be creative in structuring training to include adequate ambulatory experience.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "It is widely accepted that exemplary surgical care involves a surgeon's involvement in the preoperative, perioperative, and postoperative periods. In an era of ever-expanding therapeutic modalities available to the vascular surgeon, it is important that trainees gain experience in preoperative decision-making and how this affects a patient's operative and postoperative course. The purpose of this study was to define the current experience of residents on a vascular surgery service regarding the continuity of care they are able to provide for patients and the factors affecting this experience.\nThis prospective cohort study was approved by the Institutional Review Board and conducted at the University of British Columbia during January 2005. All patients who underwent a vascular procedure at either of the two teaching hospitals were included. In addition to type of case (emergent, outpatient, inpatient), resident demographic data and involvement in each patient's care (preoperative assessment, postoperative daily assessment, and follow-up clinic assessment) were recorded. Categoric data were analyzed with the chi2 test.\nThe study included ",
        "q2": "159 cases, of which 65% were elective same-day admission patients, 20% were elective previously admitted patients; and 15% were emergent. The overall rate of preoperative assessment was 67%, involvement in the decision to operate, 17%; postoperative assessment on the ward, 79%; and patient follow-up in clinic, 3%. The rate of complete in-hospital continuity of care (assessing patient pre-op and post-op) was 57%. Emergent cases were associated with a significantly higher rate of preoperative assessment (92% vs 63%, P<.05). For elective cases admitted before the day of surgery compared with same-day admission patients, the rates of preoperative assessment (78% vs 58%, P<.05) and involvement in the decision to operate (16% vs 4%, P<.05) were significantly higher.\nContinuity of care experience of residents in an academic vascular department: are trainees learning complete surgical care?",
        "generated_text": "100 patients who underwent 102 vascular procedures. The majority of the procedures were performed on inpatients (n = 64, 63%). The remaining procedures were performed on outpatients (n = 28, 27.5%) and emergent patients (n = 10, 9.8%). The majority of the procedures were performed by a single resident (n = 72, 70.6%). The remaining procedures were performed by two residents (n = 24, 23.5%) and three residents (n = 6, 5.9%). The majority of the residents were Canadian (n = 12, 75%), with the remaining being international medical graduates (n = 4, 25%). The majority of the residents were in their first year of training (n = 10, 62.5%), with the remaining being in their second year",
        "levenshtein_distance": 643
    },
    {
        "realidx": "16713745",
        "question": "Cytokine concentration in pancreatic juice of patients with pancreatic disease is unknown. Secretin stimulation allows endoscopic collection of pancreatic juice secreted into the duodenum. We aimed to evaluate the cytokine concentrations in pancreatic juice of patients with abdominal pain to discriminate presence from absence of pancreatic disease.\nFrom January 2003-December 2004, consecutive patients with abdominal pain compatible with pancreatic origin were enrolled. Patients underwent upper endoscopy. Intravenous secretin (0.2 mug/kg) was given immediately before scope intubation. Pancreatic juice collected from the duodenum was immediately snap-frozen in liquid nitrogen until assays were performed. Pancreatic juice levels of interleukin-8, interleukin-6, intercellular adhesion molecule 1, and transforming growth factor-beta 1 were measured by modified enzyme-linked immunosorbent assays. The final diagnosis was made by the primary gastroenterologist on the basis of medical history; laboratory, endoscopic, and imaging studies; and clinical follow-up. Fisher exact test and Kruskal-Wallis rank sum test were used for statistical analysis.\nOf 130 patients screened, 118 met the inclusion criteria. Multivariate analysis revealed that only interleukin-8 was able to discriminate between normal pancreas and chronic pancreatitis (P = .011), pancreatic cancer (P = .044), and the presence of pancreatic diseases (P = .007). Individual cytokine concentrations were not significantly different in chronic pancreatitis compared with pancreatic cancer.\nDo cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?",
        "answer": "yes",
        "answer_rationale": "Cytokine levels can be measured in pancreatic juice obtained from the duodenum without direct cannulation of the pancreatic duct. Interleukin-8 concentration in pancreatic juice can be used to discriminate between normal pancreas and patients with pancreatic disease. This is a relatively simple and noninvasive method to aid in the diagnosis of pancreatic diseases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Cytokine concentration in pancreatic juice of patients with pancreatic disease is unknown. Secretin stimulation allows endoscopic collection of pancreatic juice secreted into the duodenum. We aimed to evaluate the cytokine concentrations in pancreatic juice of patients with abdominal pain to discriminate presence from absence of pancreatic disease.\nFrom January 2003-December 2004, consecutive patients with abdominal pain compatible with pancreatic origin were enrolled. Patients underwent upper endoscopy. Intravenous secretin (0.2 mug/kg) was given immediately before scope intubation. Pancreatic juice collected from the duodenum was immediately snap-frozen in liquid nitrogen until assays were performed. Pancreatic juice levels of interleukin-8, interleukin-6, intercellular adhesion molecule 1, and",
        "q2": " transforming growth factor-beta 1 were measured by modified enzyme-linked immunosorbent assays. The final diagnosis was made by the primary gastroenterologist on the basis of medical history; laboratory, endoscopic, and imaging studies; and clinical follow-up. Fisher exact test and Kruskal-Wallis rank sum test were used for statistical analysis.\nOf 130 patients screened, 118 met the inclusion criteria. Multivariate analysis revealed that only interleukin-8 was able to discriminate between normal pancreas and chronic pancreatitis (P = .011), pancreatic cancer (P = .044), and the presence of pancreatic diseases (P = .007). Individual cytokine concentrations were not significantly different in chronic pancreatitis compared with pancreatic cancer.\nDo cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?",
        "generated_text": "tumor necrosis factor-alpha were measured by enzyme-linked immunosorbent assay. Patients were divided into two groups: those with pancreatic disease (PD) and those without pancreatic disease (non-PD). The PD group included patients with pancreatitis, pancreatic cancer, and pancreatic cystic neoplasms. The non-PD group included patients with biliary disease, peptic ulcer disease, and functional abdominal pain. The primary outcome was to determine whether cytokine levels in pancreatic juice could distinguish between PD and non-PD groups.\nA total of 100 patients were enrolled, with 50 in the PD group and 50 in the non-PD group. The mean age was 55 years, and 55% were male. In the PD group, 2",
        "levenshtein_distance": 598
    },
    {
        "realidx": "16735905",
        "question": "To investigate polysomnographic and anthropomorphic factors predicting need of high optimal continuous positive airway pressure (CPAP).\nRetrospective data analysis.\nThree hundred fifty-three consecutive obstructive sleep apnea (OSA) patients who had a successful manual CPAP titration in our sleep disorders unit.\nThe mean optimal CPAP was 9.5 +/- 2.4 cm H2O. The optimal CPAP pressure increases with an increase in OSA severity from 7.79 +/- 2.2 in the mild, to 8.7 +/- 1.8 in the moderate, and to 10.1 +/- 2.3 cm H2O in the severe OSA group. A high CPAP was defined as the mean + 1 standard deviation (SD;>or =12 cm H2O). The predictor variables included apnea-hypopnea index (AHI), age, sex, body mass index (BMI), Epworth Sleepiness Scale (ESS), and the Multiple Sleep Latency Test (MSLT). High CPAP was required in 2 (6.9%), 6 (5.8%), and 63 (28.6%) patients with mild, moderate, and severe OSA, respectively. On univariate analysis, AHI, BMI, ESS score, and the proportion of males were significantly higher in those needing high CPAP. They also have a lower MSLT mean. On logistic regression, the use of high CPAP was 5.90 times more frequent (95% confidence interval 2.67-13.1) in severe OSA patients after adjustment for the other variables. The area under the receiver operator curve was 72.4%, showing that the model was adequate.\nDoes the severity of obstructive sleep apnea predict patients requiring high continuous positive airway pressure?",
        "answer": "maybe",
        "answer_rationale": "Severe OSA patients are much more likely to need high CPAP levels. However, because of the low positive predictive value (only 28.6%), the clinical value of such information is limited. ESS and MSLT did not increase the predictive value for the need for high CPAP.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To investigate polysomnographic and anthropomorphic factors predicting need of high optimal continuous positive airway pressure (CPAP).\nRetrospective data analysis.\nThree hundred fifty-three consecutive obstructive sleep apnea (OSA) patients who had a successful manual CPAP titration in our sleep disorders unit.\nThe mean optimal CPAP was 9.5 +/- 2.4 cm H2O. The optimal CPAP pressure increases with an increase in OSA severity from 7.79 +/- 2.2 in the mild, to 8.7 +/- 1.8 in the moderate, and to 10.1 +/- 2.3 cm H2O in the severe OSA group. A high CPAP was defined as the mean + 1 standard deviation (SD;>or =12 cm H2O). The predictor variables included apnea-hypopnea index (AHI), age, sex, body",
        "q2": " mass index (BMI), Epworth Sleepiness Scale (ESS), and the Multiple Sleep Latency Test (MSLT). High CPAP was required in 2 (6.9%), 6 (5.8%), and 63 (28.6%) patients with mild, moderate, and severe OSA, respectively. On univariate analysis, AHI, BMI, ESS score, and the proportion of males were significantly higher in those needing high CPAP. They also have a lower MSLT mean. On logistic regression, the use of high CPAP was 5.90 times more frequent (95% confidence interval 2.67-13.1) in severe OSA patients after adjustment for the other variables. The area under the receiver operator curve was 72.4%, showing that the model was adequate.\nDoes the severity of obstructive sleep apnea predict patients requiring high continuous positive airway pressure?",
        "generated_text": "mass index (BMI), neck circumference, and the presence of hypertension, diabetes, and smoking. The independent predictors of high CPAP were AHI, neck circumference, and BMI. The combination of AHI >or =30, neck circumference >or =43 cm, and BMI >or =32 kg/m2 had a sensitivity of 80% and a specificity of 85% for predicting a high CPAP.\nAHI, neck circumference, and BMI are independent predictors of high CPAP. A combination of AHI >or =30, neck circumference >or =43 cm, and BMI >or =32 kg/m2 can be used to predict a high CPAP with a sensitivity of 80% and a specificity of 85%.",
        "levenshtein_distance": 558
    },
    {
        "realidx": "16769333",
        "question": "Despite surgical refinements, perioperative use of tracheobronchoscopy (TBS) as part of surgical approach to esophageal atresia (EA) is still controversial. The purpose of this study was to evaluate the influence of preoperative TBS in newborns with EA in preventing complications and improving diagnosis and surgical treatment.\nIn the period ranging from 1997 to 2003, 62 patients with EA underwent preoperative TBS. The procedure was carried out with flexible bronchoscope maintaining spontaneous breathing. When a wide carinal fistula was found, this was mechanically occluded by Fogarty catheter and cannulated with rigid bronchoscopy. Type of EA, surgical procedure variations caused by TBS, and associated anomalies not easily detectable were recorded.\nBefore TBS, the Gross classification of the 62 patients was as follows: type A, 9 patients; type B, none; type C, 51 patients. At TBS, however, 3 of 9 type A patients had an unsuspected proximal fistula (type B). These 3 patients, plus the 2 with H-type fistula, were repaired through a cervical approach. In 4 patients, previously undetected malformations of the respiratory tree (2 aberrant right upper bronchus and 2 hypoplastic bronchi) were found at TBS. Carinal fistulas in 14 type C patients were occluded by Fogarty catheter to improve ventilation during repair. No complications were observed. Overall, TBS was clinically useful in 28 (45.2%) of 62 patients, including 15 (24.2%) of 62 infants in whom it was crucial in modifying the surgical approach.\nPreoperative tracheobronchoscopy in newborns with esophageal atresia: does it matter?",
        "answer": "yes",
        "answer_rationale": "Tracheobronchoscopy is a useful and safe procedure and should be recommended in tertiary centers for babies with EA before surgical repair.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Despite surgical refinements, perioperative use of tracheobronchoscopy (TBS) as part of surgical approach to esophageal atresia (EA) is still controversial. The purpose of this study was to evaluate the influence of preoperative TBS in newborns with EA in preventing complications and improving diagnosis and surgical treatment.\nIn the period ranging from 1997 to 2003, 62 patients with EA underwent preoperative TBS. The procedure was carried out with flexible bronchoscope maintaining spontaneous breathing. When a wide carinal fistula was found, this was mechanically occluded by Fogarty catheter and cannulated with rigid bronchoscopy. Type of EA, surgical procedure variations caused by TBS, and associated anomalies not easily detectable were recorded.\nBefore TBS, the Gross classification of the 62 patients was as follows: type A, 9 patients; type B, none;",
        "q2": " type C, 51 patients. At TBS, however, 3 of 9 type A patients had an unsuspected proximal fistula (type B). These 3 patients, plus the 2 with H-type fistula, were repaired through a cervical approach. In 4 patients, previously undetected malformations of the respiratory tree (2 aberrant right upper bronchus and 2 hypoplastic bronchi) were found at TBS. Carinal fistulas in 14 type C patients were occluded by Fogarty catheter to improve ventilation during repair. No complications were observed. Overall, TBS was clinically useful in 28 (45.2%) of 62 patients, including 15 (24.2%) of 62 infants in whom it was crucial in modifying the surgical approach.\nPreoperative tracheobronchoscopy in newborns with esophageal atresia: does it matter?",
        "generated_text": "type C, 32 patients; type D, 12 patients; type E, 9 patients. After TBS, the Gross classification was as follows: type A, 10 patients; type B, 1 patient; type C, 28 patients; type D, 12 patients; type E, 11 patients. The diagnosis was changed in 11 patients (17.7%). In 10 patients, a wide carinal fistula was found and occluded with Fogarty catheter. In 1 patient, a type C was reclassified as type B. In 10 patients, a type D was reclassified as type E. In 1 patient, a type E was reclassified as type C. In 10 patients, the surgical approach was modified. In 1 patient, a type B was treated with primary anast",
        "levenshtein_distance": 508
    },
    {
        "realidx": "16772913",
        "question": "This study provides the first large-volume (1000 implant) comparison of the deflation rates of Poly Implant Prosthesis prefilled textured saline breast implants versus a control group of Mentor Siltex textured saline implants.\nA consecutive series of 500 Poly Implant Prosthesis prefilled textured saline breast implants was compared with a consecutive series of 500 Mentor Siltex breast implants. Each breast implant was evaluated for a 4-year period, and the annual deflation rate (number of deflations during a given year divided by the total number of implants) and cumulative deflation rate (cumulative total of deflations through a given year divided by the total number of implants) were recorded. Statistical significance was calculated using the Fisher's exact test at year 1 and the chi-square analysis at years 2 through 4.\nThe cumulative deflation rates of the Poly Implant Prosthesis implants was as follows: year 1, 1.2 percent; year 2, 5.6 percent; year 3, 11.4 percent; and year 4, 15.4 percent. The cumulative deflation rates of the Mentor implants was: year 1, 0.2 percent; year 2, 0.6 percent; year 3, 1.6 percent; and year 4, 4.4 percent. At year 1, the difference between deflation rates was not statistically significant (Fisher's exact test, p>0.05). However, at year 2 (chi-square, 13.29; p<0.001), year 3 (chi-square, 37.91; p<0.001), and year 4 (chi-square, 32.69; p<0.001), the difference was statistically significant.\nA comparison of 500 prefilled textured saline breast implants versus 500 standard textured saline breast implants: is there a difference in deflation rates?",
        "answer": "yes",
        "answer_rationale": "There was a statistically significant difference between the overall deflation rates of Poly Implant Prosthesis prefilled textured saline breast implants and Mentor Siltex breast implants at year 2, year 3, and year 4. After 4 years, the 15.56 percent cumulative deflation rate of Poly Implant Prosthesis implants was over 3.5 times higher than the 4.31 percent deflation rate of the Mentor Siltex implants. There may be several factors contributing to the higher deflation rate seen in Poly Implant Prosthesis implants, including possible in vitro deflation before implantation and silicone shell curing technique. Nevertheless, this statistically significant deflation difference must be taken into account when balancing the risks and benefits of Poly Implant Prosthesis breast implants.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study provides the first large-volume (1000 implant) comparison of the deflation rates of Poly Implant Prosthesis prefilled textured saline breast implants versus a control group of Mentor Siltex textured saline implants.\nA consecutive series of 500 Poly Implant Prosthesis prefilled textured saline breast implants was compared with a consecutive series of 500 Mentor Siltex breast implants. Each breast implant was evaluated for a 4-year period, and the annual deflation rate (number of deflations during a given year divided by the total number of implants) and cumulative deflation rate (cumulative total of deflations through a given year divided by the total number of implants) were recorded. Statistical significance was calculated using the Fisher's exact test at year 1 and the chi-square analysis at years 2 through 4.\nThe cumulative deflation rates of the Poly Implant Prosthesis implants was as follows: year 1, 1.2 percent; year 2, 5.6",
        "q2": " percent; year 3, 11.4 percent; and year 4, 15.4 percent. The cumulative deflation rates of the Mentor implants was: year 1, 0.2 percent; year 2, 0.6 percent; year 3, 1.6 percent; and year 4, 4.4 percent. At year 1, the difference between deflation rates was not statistically significant (Fisher's exact test, p>0.05). However, at year 2 (chi-square, 13.29; p<0.001), year 3 (chi-square, 37.91; p<0.001), and year 4 (chi-square, 32.69; p<0.001), the difference was statistically significant.\nA comparison of 500 prefilled textured saline breast implants versus 500 standard textured saline breast implants: is there a difference in deflation rates?",
        "generated_text": "percent; year 3, 10.4 percent; and year 4, 14.4 percent. The cumulative deflation rates of the Mentor implants was as follows: year 1, 0.4 percent; year 2, 0.8 percent; year 3, 1.2 percent; and year 4, 1.6 percent. The difference in deflation rates between the two groups was statistically significant at year 1 (p = 0.04), year 2 (p < 0.001), year 3 (p < 0.001), and year 4 (p < 0.001).\nThe deflation rates of the Poly Implant Prosthesis prefilled textured saline breast implants are significantly higher than those of the Mentor Siltex textured saline breast implants.",
        "levenshtein_distance": 274
    },
    {
        "realidx": "16776337",
        "question": "A retrospective analysis of a contemporary series of patients with pituitary apoplexy was performed to ascertain whether the histopathological features influence the clinical presentation or the outcome.\nA retrospective analysis was performed in 59 patients treated for pituitary apoplexy at the University of Virginia Health System, Charlottesville, Virginia, or Groote Schuur Hospital, University of Cape Town, South Africa. The patients were divided into two groups according to the histological features of their disease: one group with infarction alone, comprising 22 patients; and the other with hemorrhagic infarction and/or frank hemorrhage, comprising 37 patients. The presenting symptoms, clinical features, endocrinological status, and outcome were compared between the two groups.\nPituitary apoplexy: do histological features influence the clinical presentation and outcome?",
        "answer": "yes",
        "answer_rationale": "The patients who presented with histological features of pituitary tumor infarction alone had less severe clinical features on presentation, a longer course prior to presentation, and a better outcome than those presenting with hemorrhagic infarction or frank hemorrhage. The endocrine replacement requirements were similar in both groups.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "A retrospective analysis of a contemporary series of patients with pituitary apoplexy was performed to ascertain whether the histopathological features influence the clinical presentation or the outcome.\nA retrospective analysis was performed in 59 patients treated for pituitary apoplexy at the University of Virginia Health System, Charlottesville, Virginia, or Groote Schuur Hospital, University of Cape Town, South Africa. The patients were divided into",
        "q2": " two groups according to the histological features of their disease: one group with infarction alone, comprising 22 patients; and the other with hemorrhagic infarction and/or frank hemorrhage, comprising 37 patients. The presenting symptoms, clinical features, endocrinological status, and outcome were compared between the two groups.\nPituitary apoplexy: do histological features influence the clinical presentation and outcome?",
        "generated_text": "two groups: those with hemorrhagic apoplexy and those with ischemic apoplexy. The clinical presentation, treatment, and outcome were compared between the two groups.\nThe results showed that patients with hemorrhagic apoplexy were more likely to present with acute symptoms such as severe headache, visual disturbances, and altered mental status, while patients with ischemic apoplexy presented with more insidious symptoms such as",
        "levenshtein_distance": 324
    },
    {
        "realidx": "16778275",
        "question": "Pneumothorax following flexible bronchoscopy (FB) with transbronchial biopsy (TBB) occurs in 1 to 6% of cases. Routine chest radiography (CXR) following TBB is therefore requested by most pulmonologists in an attempt to detect complications, particularly pneumothorax. The objective of this study was to determine if routine CXR after bronchoscopy and TBB is necessary.\nThe study group included 350 consecutive patients who underwent FB with TBB at our institution between December 2001 and January 2004. Routine CXR was performed up to 2 h after the procedure in all cases. Additionally, the following information was recorded in all patients: sex, age, immune status, indication for bronchoscopy, total number of biopsies done, segment sampled, pulse oxygen saturation, and development of symptoms suggestive of pneumothorax.\nPneumothorax was diagnosed radiologically in 10 patients (2.9%). Seven patients had symptoms strongly suggestive of pneumothorax prior to CXR, including four patients with large (>10%) pneumothorax. The other three patients were asymptomatic, with only minimal pneumothorax (</= 10%), which resolved completely 24 to 48 h later.\nIs routine chest radiography after transbronchial biopsy necessary?",
        "answer": "no",
        "answer_rationale": "We conclude that routine CXR after bronchoscopy with TBB is necessary only in patients with symptoms suggestive of pneumothorax. In asymptomatic patients, pneumothorax is rare and usually small, so routine CXR is not necessary in this category of patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Pneumothorax following flexible bronchoscopy (FB) with transbronchial biopsy (TBB) occurs in 1 to 6% of cases. Routine chest radiography (CXR) following TBB is therefore requested by most pulmonologists in an attempt to detect complications, particularly pneumothorax. The objective of this study was to determine if routine CXR after bronchoscopy and TBB is necessary.\nThe study group included 350 consecutive patients who underwent FB with TBB at our institution between December 2001 and January 2004. Routine CXR was performed up to 2 h after the procedure in all cases. Additionally, the following information",
        "q2": " was recorded in all patients: sex, age, immune status, indication for bronchoscopy, total number of biopsies done, segment sampled, pulse oxygen saturation, and development of symptoms suggestive of pneumothorax.\nPneumothorax was diagnosed radiologically in 10 patients (2.9%). Seven patients had symptoms strongly suggestive of pneumothorax prior to CXR, including four patients with large (>10%) pneumothorax. The other three patients were asymptomatic, with only minimal pneumothorax (</= 10%), which resolved completely 24 to 48 h later.\nIs routine chest radiography after transbronchial biopsy necessary?",
        "generated_text": "was collected: age, sex, indication for bronchoscopy, number of TBBs, presence of pneumothorax on CXR, and need for chest tube insertion.\nPneumothorax was detected in 12 patients (3.4%). The mean number of TBBs in patients with pneumothorax was 10.3 (range 4-16). In 11 patients, the pneumothorax was small and did not require chest tube insertion. One patient had a large pneumothorax and required chest tube insertion. The mean number of TBBs in this patient was 16. The mean number of TBB",
        "levenshtein_distance": 388
    },
    {
        "realidx": "16809243",
        "question": "To investigate if fetal gender (1) affects the risk of having an emergency department (ED) visit for asthma; and (2) is associated with adverse pregnancy outcomes among women who had at least one visit to the ED for asthma during pregnancy.\nWe linked two provincial administrative databases containing records on in-patient deliveries and ED visits. The study sample included women who delivered a live singleton baby between April 2003 and March 2004. Pregnant women who made at least one ED visit for asthma were counted as cases and the rest of the women as control subjects. We performed a multivariable analysis using logistic regression to model the risk of having an ED visit for asthma, with fetal gender being one of the predictors. In addition, a series of multivariable logistic regressions were also constructed separately for cases and controls for the following adverse delivery outcomes: low birth weight baby, preterm delivery, and delivery via Caesarian section.\nAmong 109,173 live singleton deliveries, 530 women had visited ED due to asthma during pregnancy. While having an ED visit for asthma was positively associated with teenage pregnancy, low income, and presence of pregnancy-induced hypertension, it was not associated with fetal gender (OR 1.01, 95% CI 0.85-1.19). Fetal gender was not a significant predictor of adverse pregnancy outcomes among women who had an asthma ED visit during pregnancy.\nIs fetal gender associated with emergency department visits for asthma during pregnancy?",
        "answer": "no",
        "answer_rationale": "Fetal gender does not affect the risk of having an ED visit for asthma during pregnancy, and it is not associated with adverse pregnancy outcomes among women who had an asthma-related ED during pregnancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To investigate if fetal gender (1) affects the risk of having an emergency department (ED) visit for asthma; and (2) is associated with adverse pregnancy outcomes among women who had at least one visit to the ED for asthma during pregnancy.\nWe linked two provincial administrative databases containing records on in-patient deliveries and ED visits. The study sample included women who delivered a live singleton baby between April 2003 and March 2004. Pregnant women who made at least one ED visit for asthma were counted as cases and the rest of the women as control subjects. We performed a multivariable analysis using logistic regression to model the risk of having an ED visit for asthma, with fetal gender being one of the predictors. In addition,",
        "q2": " a series of multivariable logistic regressions were also constructed separately for cases and controls for the following adverse delivery outcomes: low birth weight baby, preterm delivery, and delivery via Caesarian section.\nAmong 109,173 live singleton deliveries, 530 women had visited ED due to asthma during pregnancy. While having an ED visit for asthma was positively associated with teenage pregnancy, low income, and presence of pregnancy-induced hypertension, it was not associated with fetal gender (OR 1.01, 95% CI 0.85-1.19). Fetal gender was not a significant predictor of adverse pregnancy outcomes among women who had an asthma ED visit during pregnancy.\nIs fetal gender associated with emergency department visits for asthma during pregnancy?",
        "generated_text": "we performed a similar analysis to model the risk of adverse pregnancy outcomes among women who had at least one ED visit for asthma during pregnancy.\nOf 40,000 deliveries, 1,000 (2.5%) women had at least one ED visit for asthma during pregnancy. The proportion of male fetuses was higher among cases (53.4%) than among controls (51.1%). After adjusting for maternal age, parity, income, and smoking, fetal gender was not associated with the risk of having an ED visit for asthma (adjusted odds ratio [aOR] 1.05, 95% confidence interval [CI] 0.95-1.16). Among",
        "levenshtein_distance": 529
    },
    {
        "realidx": "16816043",
        "question": "To determine under what conditions lay people and health professionals find it acceptable for a physician to breach confidentiality to protect the wife of a patient with a sexually transmitted disease (STD).\nIn a study in France, breaching confidentiality in 48 scenarios were accepted by 144 lay people, 10 psychologists and 7 physicians. The scenarios were all possible combinations of five factors: severity of the disease (severe, lethal); time taken to discuss this with (little time, much time); intent to inform the spouse about the disease (none, one of these days, immediately); intent to adopt protective behaviours (no intent, intent); and decision to consult an expert in STDs (yes, no), 2 x 2 x 3 x 2 x 2. The importance and interactions of each factor were determined, at the group level, by performing analyses of variance and constructing graphs.\nThe concept of breaching confidentiality to protect a wife from her husband's STD was favoured much more by lay people and psychologists than by physicians (mean ratings 11.76, 9.28 and 2.90, respectively, on a scale of 0-22). The patient's stated intentions to protect his wife and to inform her of the disease had the greatest impact on acceptability. A cluster analysis showed groups of lay participants who found breaching confidentiality \"always acceptable\" (n = 14), \"depending on the many circumstances\" (n = 87), requiring \"consultation with an expert\" (n = 30) and \"never acceptable (n = 13)\".\nDo French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease?",
        "answer": "maybe",
        "answer_rationale": "Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To determine under what conditions lay people and health professionals find it acceptable for a physician to breach confidentiality to protect the wife of a patient with a sexually transmitted disease (STD).\nIn a study in France, breaching confidentiality in 48 scenarios were accepted by 144 lay people, 10 psychologists and 7 physicians. The scenarios were all possible combinations of five factors: severity of the disease (severe, lethal); time taken to discuss this with (little time, much time); intent to inform the spouse about the disease (none, one of these days, immediately); intent to adopt protective behaviours (no intent, intent); and decision to consult an expert in STDs (yes, no), 2 x 2 x 3 x 2 x 2. The importance and interactions of each factor were determined, at the group level, by performing",
        "q2": " analyses of variance and constructing graphs.\nThe concept of breaching confidentiality to protect a wife from her husband's STD was favoured much more by lay people and psychologists than by physicians (mean ratings 11.76, 9.28 and 2.90, respectively, on a scale of 0-22). The patient's stated intentions to protect his wife and to inform her of the disease had the greatest impact on acceptability. A cluster analysis showed groups of lay participants who found breaching confidentiality \"always acceptable\" (n = 14), \"depending on the many circumstances\" (n = 87), requiring \"consultation with an expert\" (n = 30) and \"never acceptable (n = 13)\".\nDo French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease?",
        "generated_text": "a general linear model analysis, and at the individual level, by performing a logistic regression analysis.\nThe general linear model analysis showed that the most important factor was the intent to inform the spouse about the disease (p < 0.0001). The other factors were also significant (p < 0.0001). The logistic regression analysis showed that the most important factor was the intent to inform the spouse about the disease (p < 0.0001). The other factors were also significant (p < 0.0001). The interaction between the severity of the disease and the intent to inform the spouse about the disease was significant (p < 0.0001). The interaction between the time taken to discuss this with and the intent to inform the spouse about the disease was also significant (",
        "levenshtein_distance": 632
    },
    {
        "realidx": "16827975",
        "question": "Few studies have assessed whether the advantage chemotherapy has been shown to have in treating advanced non-small lung carcinoma in clinical trials is transferrable to normal health care activity. This could explain the skepticism of a large number of pneumologists towards this treatment. The objective of our study was to analyze prognostic factors related to survival and to see whether cytostatic treatment was an independent predictor.\nPatients enrolled in the study had been diagnosed with non-small cell carcinoma in stages IV or IIIB with pleural or N2-N3 involvement and with a performance status of 2 or below according to the Eastern Cooperative Oncology Group (ECOG). Survival was analyzed with regard to the following variables: age, sex, comorbidity, weight loss, laboratory test results, histological type, ECOG score, TNM staging, and treatment. The Student t test, the chi(2) test, the Kaplan-Meier method, the log-rank test, and Cox regression analysis were used in the statistical analysis.\nWe enrolled 190 patients (157 men and 33 women) with a mean (SD) age of 61.75 (10.85) years (range, 33-85 years). Of these patients, 144 received cytostatic treatment and 46 palliative treatment. The median survival was 31 weeks and was related to absence of weight loss (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.26-2.39; P=.001), cytostatic treatment (HR, 1.85; 95% CI, 1.25-2.76; P=.002), and ECOG score of 0 to 1 (HR, 2.84; 95% CI, 1.62-5.00; P=.0001). In patients with ECOG scores of 0 to 1, weight loss and treatment were significant prognostic factors. Survival in the ECOG 2 group was 15 weeks for patients undergoing cytostatic treatment and 11 weeks for patients with symptomatic treatment.\nChemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?",
        "answer": "no",
        "answer_rationale": "In normal clinical practice, chemotherapy significantly prolongs survival in patients with performance status of less than 2, more time being gained if there is no associated weight loss. We conclude that the reluctance shown by many pneumologists toward using this treatment is not entirely justified.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Few studies have assessed whether the advantage chemotherapy has been shown to have in treating advanced non-small lung carcinoma in clinical trials is transferrable to normal health care activity. This could explain the skepticism of a large number of pneumologists towards this treatment. The objective of our study was to analyze prognostic factors related to survival and to see whether cytostatic treatment was an independent predictor.\nPatients enrolled in the study had been diagnosed with non-small cell carcinoma in stages IV or IIIB with pleural or N2-N3 involvement and with a performance status of 2 or below according to the Eastern Cooperative Oncology Group (ECOG). Survival was analyzed with regard to the following variables: age, sex, comorbidity, weight loss, laboratory test results, histological type, ECOG score, TNM staging, and treatment. The Student t test, the chi(2) test, the Kaplan-Meier method, the log-rank test, and Cox regression analysis were used in the statistical analysis.\nWe enrolled 190 patients (157 men and 33 women) with a mean (SD) age of",
        "q2": " 61.75 (10.85) years (range, 33-85 years). Of these patients, 144 received cytostatic treatment and 46 palliative treatment. The median survival was 31 weeks and was related to absence of weight loss (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.26-2.39; P=.001), cytostatic treatment (HR, 1.85; 95% CI, 1.25-2.76; P=.002), and ECOG score of 0 to 1 (HR, 2.84; 95% CI, 1.62-5.00; P=.0001). In patients with ECOG scores of 0 to 1, weight loss and treatment were significant prognostic factors. Survival in the ECOG 2 group was 15 weeks for patients undergoing cytostatic treatment and 11 weeks for patients with symptomatic treatment.\nChemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?",
        "generated_text": "64.2 (10.1) years. The mean (SD) survival time was 10.1 (10.1) months. The variables that were significantly associated with survival in the univariate analysis were age, weight loss, ECOG score, histological type, and treatment. In the multivariate analysis, only ECOG score and treatment were independent predictors of survival.\nIn our series, treatment with cytostatic drugs was an independent predictor of survival in patients with advanced non-small cell lung carcinoma. This suggests that the results of clinical trials can be extrapolated to normal clinical practice.",
        "levenshtein_distance": 547
    },
    {
        "realidx": "16872243",
        "question": "In this study, an expert panel assessed causality of adverse reports by using the WHO global introspection (GI) method. The same reports were independently assessed using 15 published algorithms. The causality assessment level 'possible' was considered the lower limit for a report to be considered to be drug related. For a given algorithm, sensitivity was determined by the proportion of reports simultaneously classified as drug related by the algorithm and the GI method. Specificity was measured as the proportion of reports simultaneously considered non-drug related. The analysis was performed for the total sample and within serious or unexpected events.\nFive hundred adverse reports were studied. Algorithms presented high rates of sensitivity (average of 93%, positive predictive value of 89%) and low rates of specificity (average of 7%, negative predictive value of 31%).\nCan decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?",
        "answer": "no",
        "answer_rationale": "Decisional algorithms are sensitive methods for the detection of ADRs, but they present poor specificity. A reference method was not identified. Algorithms do not replace GI and are not definite alternatives in the individual causality assessment of suspected ADRs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "In this study, an expert panel assessed causality of adverse reports by using the WHO global introspection (GI) method. The same reports were independently assessed using 15 published algorithms. The causality assessment level 'possible' was considered the lower limit for a report to be considered to be drug related. For a given algorithm, sensitivity was determined by the proportion of reports simultaneously classified as drug related by the algorithm and the GI method. Specificity was measured",
        "q2": " as the proportion of reports simultaneously considered non-drug related. The analysis was performed for the total sample and within serious or unexpected events.\nFive hundred adverse reports were studied. Algorithms presented high rates of sensitivity (average of 93%, positive predictive value of 89%) and low rates of specificity (average of 7%, negative predictive value of 31%).\nCan decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?",
        "generated_text": "by the proportion of reports not classified as drug related by the algorithm among those not classified as drug related by the GI method. Positive predictive value was the proportion of reports classified as drug related by the algorithm that were also classified as drug related by the GI method. Negative predictive value was the proportion of reports not classified as drug related by the algorithm that were also not classified as drug related by the GI method. The receiver operating characteristic (ROC) curve was used to",
        "levenshtein_distance": 372
    },
    {
        "realidx": "16962519",
        "question": "To estimate changes in uterine myoma volume during pregnancy.\nReview of departmental electronic perinatal database and medical records. Canadian Task Force Classification II-3.\nObstetrical ultrasound unit in an academic tertiary care center.\nOne hundred-seven patients diagnosed with uterine myomas during pregnancy and who had two or more obstetrical ultrasounds in different periods of pregnancy.\nWe analyzed the change in volume of uterine myomas between the first half of pregnancy (up until 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The volume of largest uterine myoma was calculated using the formula Volume (mm3)=Pi/6x(length mm)x(width mm)x(height mm).\nThe mean age of the population was 31+/-6 years. Between the first and the second study periods, the percentage of uterine myomas that decreased in size was 55.1% (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%.\nVolume change of uterine myomas during pregnancy: do myomas really grow?",
        "answer": "no",
        "answer_rationale": "Contrary to common belief, we found that uterine myomas commonly decrease in volume over the course of pregnancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To estimate changes in uterine myoma volume during pregnancy.\nReview of departmental electronic perinatal database and medical records. Canadian Task Force Classification II-3.\nObstetrical ultrasound unit in an academic tertiary care center.\nOne hundred-seven patients diagnosed with uterine myomas during pregnancy and who had two or more obstetrical ultrasounds in different periods of pregnancy.\nWe analyzed the change in volume of uterine myomas between the first half of pregnancy (up until 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The volume of largest uterine myoma was calculated using the formula Volume (mm3)=Pi/6x(length mm)x(width mm)x(height mm).\nThe mean age of the population was 31+/-6 years. Between the first and the second study",
        "q2": " periods, the percentage of uterine myomas that decreased in size was 55.1% (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%.\nVolume change of uterine myomas during pregnancy: do myomas really grow?",
        "generated_text": ", the mean volume increased from 102+/-142 to 140+/-198 mm3 (p=0.0001). Between the second and third study, the mean volume increased from 140+/-198 to 160+/-220 mm3 (p=0.0001). The mean volume increased from 102+/-142 to 160+/-220 mm3 between the first and third study (p=0.0001). The mean increase in volume was 37% between the first and second study, 14% between the second and third study, and 57% between the first and third study.\nUterine myomas increase",
        "levenshtein_distance": 400
    },
    {
        "realidx": "16968876",
        "question": "The aim of this prognostic factor analysis was to investigate if a patient's self-reported health-related quality of life (HRQOL) provided independent prognostic information for survival in non-small cell lung cancer (NSCLC) patients.\nPretreatment HRQOL was measured in 391 advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module (QLQ-LC13). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap validation technique was used to assess the stability of the outcomes.\nThe final multivariate Cox regression model retained four parameters as independent prognostic factors for survival: male gender with a hazard ratio (HR) = 1.32 (95% CI 1.03-1.69; P = 0.03); performance status (0 to 1 versus 2) with HR = 1.63 (95% CI 1.04-2.54; P = 0.032); patient's self-reported score of pain with HR= 1.11 (95% CI 1.07-1.16; P<0.001) and dysphagia with HR = 1.12 (95% CI 1.04-1.21; P = 0.003). A 10-point shift worse in the scale measuring pain and dysphagia translated into an 11% and 12% increased in the likelihood of death respectively. A risk group categorization was also developed.\nIs a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients?",
        "answer": "maybe",
        "answer_rationale": "The results suggest that patients' self-reported HRQOL provide independent prognostic information for survival. This finding supports the collection of such data in routine clinical practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The aim of this prognostic factor analysis was to investigate if a patient's self-reported health-related quality of life (HRQOL) provided independent prognostic information for survival in non-small cell lung cancer (NSCLC) patients.\nPretreatment HRQOL was measured in 391 advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module (QLQ-LC13). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap validation technique was used to assess the stability of the outcomes.\nThe final multivariate Cox regression model retained four parameters as independent prognostic factors for survival: male gender with a hazard ratio (HR) = 1.32 (95% CI 1.03-1.69; P = 0.",
        "q2": "03); performance status (0 to 1 versus 2) with HR = 1.63 (95% CI 1.04-2.54; P = 0.032); patient's self-reported score of pain with HR= 1.11 (95% CI 1.07-1.16; P<0.001) and dysphagia with HR = 1.12 (95% CI 1.04-1.21; P = 0.003). A 10-point shift worse in the scale measuring pain and dysphagia translated into an 11% and 12% increased in the likelihood of death respectively. A risk group categorization was also developed.\nIs a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients?",
        "generated_text": "03), Eastern Cooperative Oncology Group (ECOG) performance status (PS) with HR = 1.71 (95% CI 1.31-2.23; P < 0.001), and two HRQOL dimensions: dyspnoea with HR = 1.30 (95% CI 1.04-1.63; P = 0.02) and insomnia with HR = 1.31 (95% CI 1.05-1.64; P = 0.02). The bootstrap validation technique confirmed the stability of the results.\nThis is the first study to show that HRQOL dimensions are independent prognostic factors for survival in advanced NSCLC patients. These results suggest that HRQ",
        "levenshtein_distance": 356
    },
    {
        "realidx": "16971978",
        "question": "Coronary atherosclerotic burden is excessive in diabetic patients. Diabetes mellitus (DM) is an independent predictor for both death and myocardial infarction. It is not known whether the prevalence of complex coronary lesions, such as bifurcation and ostial lesions, is different in diabetics from nondiabetics.\nThe aim of present study was to investigate the prevalence of these lesions in patients with DM.\nOne thousand fourteen consecutive patients (mean age 61.3+/-10.7 years) were investigated. Coronary angiograms were examined for bifurcation and ostial lesions using a digital quantitative system. Patients were classified as diabetic (n=281) or nondiabetic (n=733).\nPatient mean age, and rates of hypertension and hyperlipidemia were significantly higher in the diabetic group than in the nondiabetic group (P<0.0001), although smoking was significantly lower (P=0.001). Reasons for coronary angiography and treatment were comparable between the two groups. The prevalence of bifurcation lesions and ostial lesions was significantly greater in the diabetic group than in the nondiabetic group (9.8% versus 4.3% [P=0.001] and 38.4% versus 29.2% [P=0.003]in the diabetic group versus the nondiabetic group). The presence of DM and greater age were found to be independent predictors for bifurcation lesions (OR=2.27 [P=0.004] and OR=1.03 [P=0.01], for DM and age, respectively) and ostial lesions (OR=1.40 [P=0.027] and OR=1.02 [P=0.001], for DM and age, respectively) in multivariate analysis.\nAre complex coronary lesions more frequent in patients with diabetes mellitus?",
        "answer": "yes",
        "answer_rationale": "Complex coronary lesions such as bifurcation and ostial lesions were significantly more common in diabetic patients than in nondiabetic patients. Greater age and the presence of DM were independent predictors for these complex lesions. These results may help to explain the poor prognosis of coronary artery disease among diabetic patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Coronary atherosclerotic burden is excessive in diabetic patients. Diabetes mellitus (DM) is an independent predictor for both death and myocardial infarction. It is not known whether the prevalence of complex coronary lesions, such as bifurcation and ostial lesions, is different in diabetics from nondiabetics.\nThe aim of present study was to investigate the prevalence of these lesions in patients with DM.\nOne thousand fourteen consecutive patients (mean age 61.3+/-10.7 years) were investigated. Coronary angiograms were examined for bifurcation and ostial lesions using a digital quantitative system. Patients were classified as diabetic (n=281) or nondiabetic (n=733).\nPatient mean age, and rates of hypertension and hyperlipidemia were significantly higher in the diabetic group than in the nondiabetic group (P<0.0001), although smoking was significantly lower (P=0.001). Reasons",
        "q2": " for coronary angiography and treatment were comparable between the two groups. The prevalence of bifurcation lesions and ostial lesions was significantly greater in the diabetic group than in the nondiabetic group (9.8% versus 4.3% [P=0.001] and 38.4% versus 29.2% [P=0.003]in the diabetic group versus the nondiabetic group). The presence of DM and greater age were found to be independent predictors for bifurcation lesions (OR=2.27 [P=0.004] and OR=1.03 [P=0.01], for DM and age, respectively) and ostial lesions (OR=1.40 [P=0.027] and OR=1.02 [P=0.001], for DM and age, respectively) in multivariate analysis.\nAre complex coronary lesions more frequent in patients with diabetes mellitus?",
        "generated_text": "for coronary angiography were similar in both groups. The prevalence of bifurcation and ostial lesions was higher in the diabetic group (P<0.0001). The prevalence of bifurcation lesions was 20.3% in the diabetic group and 12.3% in the nondiabetic group (P<0.0001). The prevalence of ostial lesions was 15.3% in the diabetic group and 8.7% in the nondiabetic group (P<0.0001). The prevalence of both bifurcation and ostial lesions was 7.8% in the diabetic group and 3.8% in the nondiabetic group (P=0.0001). The prevalence of bifurcation and/or ostial lesions was 27.8% in the diabetic group and 17.2% in the nond",
        "levenshtein_distance": 433
    },
    {
        "realidx": "17032327",
        "question": "The quality of surgical excision is held to be a major determinant of outcome following surgery for rectal cancer. Macroscopic examination of the excised mesorectum allows for reproducible assessment of the quality of surgery. We aimed to determine whether quality of excision undertaken by colorectal trainees under supervision was comparable with that performed by consultants, as measured using mesorectal grades.\nA total of 130 consecutive patients undergoing potentially curative resection for primary adenocarcinoma of the rectum in our centre from 2001 to 2003 were included in the study. The pathologists graded the excised mesorectum according to staged classification proposed by Quirke. The outcome (quality of mesorectal excision and secondary outcomes including local recurrence and overall recurrence) of operations performed by consultants was compared with that of trainees. Statistical significance was tested using Pearson chi(2) test.\nEighty-nine operations were performed by consultants and 41 by senior colorectal trainees with consultant supervision. Forty-four patients (49%) had good mesorectum when operated by consultants in comparison with 17 (41.5%) by the trainees. There was no statistically significant difference (P = 0.717) between the two groups in terms of quality of mesorectum excised after potentially curative resection. Furthermore, there were seven local recurrences in patients operated by consultants (7.8%) when compared with four in the trainee group (9.5%) and once again there was no statistical significance between the two groups (P = 0.719).\nDo supervised colorectal trainees differ from consultants in terms of quality of TME surgery?",
        "answer": "no",
        "answer_rationale": "We conclude that the quality of rectal cancer excision, as defined by mesorectal grades, achieved by supervised colorectal trainees is comparable with that achieved by consultants.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The quality of surgical excision is held to be a major determinant of outcome following surgery for rectal cancer. Macroscopic examination of the excised mesorectum allows for reproducible assessment of the quality of surgery. We aimed to determine whether quality of excision undertaken by colorectal trainees under supervision was comparable with that performed by consultants, as measured using mesorectal grades.\nA total of 130 consecutive patients undergoing potentially curative resection for primary adenocarcinoma of the rectum in our centre from 2001 to 2003 were included in the study. The pathologists graded the excised mesorectum according to staged classification proposed by Quirke. The outcome (quality of mesorectal excision and secondary outcomes including local recurrence and overall recurrence) of operations performed by consultants was compared with that of",
        "q2": " trainees. Statistical significance was tested using Pearson chi(2) test.\nEighty-nine operations were performed by consultants and 41 by senior colorectal trainees with consultant supervision. Forty-four patients (49%) had good mesorectum when operated by consultants in comparison with 17 (41.5%) by the trainees. There was no statistically significant difference (P = 0.717) between the two groups in terms of quality of mesorectum excised after potentially curative resection. Furthermore, there were seven local recurrences in patients operated by consultants (7.8%) when compared with four in the trainee group (9.5%) and once again there was no statistical significance between the two groups (P = 0.719).\nDo supervised colorectal trainees differ from consultants in terms of quality of TME surgery?",
        "generated_text": "operations performed by trainees under supervision.\nThe mean age of the patients was 65 years (range 25-87 years). The mean follow-up period was 36 months (range 12-48 months). The mean tumour size was 4.5 cm (range 1-10 cm). The mean number of lymph nodes harvested was 14.5 (range 0-40). The mean number of positive lymph nodes was 2.5 (range 0-10). The mean number of circumferential resection margin (CRM) positive cases was 1.5 (range 0-5). The mean number of patients with positive circumferential resection margin (CRM) was 1.5 (range 0-5). The",
        "levenshtein_distance": 606
    },
    {
        "realidx": "17051586",
        "question": "Several studies have suggested a protective effect of folic acid (FA) on congenital heart anomalies. Down syndrome (DS) infants are known to have a high frequency of heart anomalies. Not all children with DS suffer from heart anomalies, which raises the question whether maternal factors might affect the risk of these anomalies. Our objectives were to investigate whether first-trimester FA use protects against heart anomalies among DS children.\nWomen with liveborn DS children participating in the Slone Epidemiology Center Birth Defects Study between 1976 and 1997 were included. We performed case-control analyses using DS, with heart anomalies as cases and DS, without heart anomalies as controls. Subanalyses were performed for defects that have been associated with FA in non-DS populations (conotruncal, ventricular septal [VSD]) and for those that are associated with DS (ostium secundum type atrial septal defects [ASD]and endocardial cushion defects [ECD]). Exposure was defined as the use of any FA-containing product for an average of at least 4 days per week during the first 12 weeks of pregnancy, whereas no exposure was defined as no use of FA in these 12 weeks.\nOf the 223 cases, 110 (49%) were exposed versus 84 (46%) of the 184 controls. After adjustment for possible confounders, no protective effect of FA was found on heart anomalies overall (OR 0.95, 95% CI: 0.61-1.47) nor separately for conotruncal defects, VSDs, ASDs, or ECDs.\nCan folic acid protect against congenital heart defects in Down syndrome?",
        "answer": "no",
        "answer_rationale": "Our study does not show a protective effect of FA on heart anomalies among infants with DS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Several studies have suggested a protective effect of folic acid (FA) on congenital heart anomalies. Down syndrome (DS) infants are known to have a high frequency of heart anomalies. Not all children with DS suffer from heart anomalies, which raises the question whether maternal factors might affect the risk of these anomalies. Our objectives were to investigate whether first-trimester FA use protects against heart anomalies among DS children.\nWomen with liveborn DS children participating in the Slone Epidemiology Center Birth Defects Study between 1976 and 1997 were included. We performed case-control analyses using DS, with heart anomalies as cases and DS, without heart anomalies as controls. Subanalyses were performed for defects that have been associated with FA in non-DS populations (conotruncal, ventricular septal [VSD]) and for those that are associated with",
        "q2": " DS (ostium secundum type atrial septal defects [ASD]and endocardial cushion defects [ECD]). Exposure was defined as the use of any FA-containing product for an average of at least 4 days per week during the first 12 weeks of pregnancy, whereas no exposure was defined as no use of FA in these 12 weeks.\nOf the 223 cases, 110 (49%) were exposed versus 84 (46%) of the 184 controls. After adjustment for possible confounders, no protective effect of FA was found on heart anomalies overall (OR 0.95, 95% CI: 0.61-1.47) nor separately for conotruncal defects, VSDs, ASDs, or ECDs.\nCan folic acid protect against congenital heart defects in Down syndrome?",
        "generated_text": "DS but not with FA in non-DS populations (atrial septal [ASD], endocardial cushion defects [ECD]). Logistic regression was used to adjust for maternal age, race, and education.\nA total of 104 DS children with heart anomalies and 104 without were included. FA use was associated with a 60% reduction in the risk of heart anomalies (adjusted odds ratio [aOR], 0.4; 95% confidence interval [CI], 0.2-0.9). The reduction in risk was similar for conotruncal defects (aOR, 0.3; 95% CI, 0.1-1.1), VSD (aOR, 0.4; 95% CI, 0.1-1",
        "levenshtein_distance": 455
    },
    {
        "realidx": "17054994",
        "question": "Frozen section (FS) evaluation during thyroid surgery is often used to guide intraoperative management. We sought to determine the utility of FS in patients undergoing thyroidectomy for multinodular thyroid disease.\nFrom May 1994 through November 2004, 236 patients with multinodular goiter underwent thyroidectomy at our institution. Patient data were retrospectively analyzed to see if a frozen section was performed during the procedure and whether it changed the patient's outcome.\nOf the 236 patients, 135 (57%) had intra-operative FS. There were no differences between patients who had FS analysis and those who did not with regard to age, gender, and the incidence of malignancy. Of the patients who had FS, 4/135 (3%) were subsequently diagnosed with thyroid cancer on permanent histology. Three of these FS were misread as benign. Therefore, the sensitivity of FS for the diagnosis of thyroid cancer was only 25%. Importantly, in none of the 135 patients did FS alter the intraoperative management.\nDoes frozen section alter surgical management of multinodular thyroid disease?",
        "answer": "no",
        "answer_rationale": "While FS was commonly used in patients undergoing thyroidectomy at our institution, in no patient over the last decade did FS correctly alter the intraoperative management. Given the time required to perform FS and the cost associated with it, we believe that routine FS should not be performed in these patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Frozen section (FS) evaluation during thyroid surgery is often used to guide intraoperative management. We sought to determine the utility of FS in patients undergoing thyroidectomy for multinodular thyroid disease.\nFrom May 1994 through November 2004, 236 patients with multinodular goiter underwent thyroidectomy at our institution. Patient data were retrospectively analyzed to see if a frozen section was performed during the procedure and whether it changed the patient's outcome.\nOf the 236 patients, 135 (57%) had intra-operative FS. There were no",
        "q2": " differences between patients who had FS analysis and those who did not with regard to age, gender, and the incidence of malignancy. Of the patients who had FS, 4/135 (3%) were subsequently diagnosed with thyroid cancer on permanent histology. Three of these FS were misread as benign. Therefore, the sensitivity of FS for the diagnosis of thyroid cancer was only 25%. Importantly, in none of the 135 patients did FS alter the intraoperative management.\nDoes frozen section alter surgical management of multinodular thyroid disease?",
        "generated_text": "significant differences in age, sex, preoperative thyroid function, or preoperative fine-needle aspiration (FNA) results between the FS and non-FS groups. The FS group had a higher rate of total thyroidectomy (70% vs. 50%, p < 0.001). The FS group had a higher rate of malignancy (12% vs. 4%, p = 0.007). In the FS group, 10 patients (7.4%) had a change in",
        "levenshtein_distance": 396
    },
    {
        "realidx": "17062234",
        "question": "Occlusion of the atherosclerotic ascending aorta by an endoaortic inflatable balloon has been proposed as an alternative to conventional cross-clamping to prevent injury to the vessel and distal embolization of debris. The safety and the effectiveness of endoaortic occlusion have not been documented in this setting.\nEndoaortic occlusion was employed in 52 of 2,172 consecutive patients. Surgeon's choice was based on preoperative identification of aortic calcifications or intraoperative epiaortic ultrasonographic scanning. Deaths and strokes were analyzed casewise and in aggregate.\nIn 10 patients (19.2%), the endoaortic balloon had to be replaced by the ordinary cross-clamp because of incomplete occlusion (n = 5), hindered exposure (n = 2), or balloon rupture (n = 3). In-hospital death occurred in 13 patients (25%), and stroke on awakening from anesthesia in 2 (3.8%). The death rate of patients treated by endoaortic occlusion was significantly higher compared with all other patients (4.2%, p<0.0001) and with the expected estimate by European System for Cardiac Operative Risk Evaluation (10.5%, p = 0.05). By multivariable analysis, use of endoaortic occlusion was independently associated with in-hospital death (odds ratio = 5.609, 95% confidence interval: 2.684 to 11.719). Although the stroke rate was higher in the endoaortic occlusion group compared with all other patients, the difference was only possibly significant (3.8% versus 0.8%, p = 0.067).\nSurgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe?",
        "answer": "no",
        "answer_rationale": "In this series, the endoaortic occlusion was frequently ineffective, and was associated with a significantly higher risk of in-hospital death and a numerically higher risk of stroke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Occlusion of the atherosclerotic ascending aorta by an endoaortic inflatable balloon has been proposed as an alternative to conventional cross-clamping to prevent injury to the vessel and distal embolization of debris. The safety and the effectiveness of endoaortic occlusion have not been documented in this setting.\nEndoaortic occlusion was employed in 52 of 2,172 consecutive patients. Surgeon's choice was based on preoperative identification of aortic calcifications or intraoperative epiaortic ultrasonographic scanning. Deaths and strokes were analyzed casewise and in aggregate.\nIn 10 patients (19.2%), the endoaortic balloon had to be replaced by the ordinary cross-clamp because of incomplete occlusion (n = 5), hindered exposure (n = 2), or balloon rupture (n = 3). In-hospital death occurred in 13 patients (25%), and stroke",
        "q2": " on awakening from anesthesia in 2 (3.8%). The death rate of patients treated by endoaortic occlusion was significantly higher compared with all other patients (4.2%, p<0.0001) and with the expected estimate by European System for Cardiac Operative Risk Evaluation (10.5%, p = 0.05). By multivariable analysis, use of endoaortic occlusion was independently associated with in-hospital death (odds ratio = 5.609, 95% confidence interval: 2.684 to 11.719). Although the stroke rate was higher in the endoaortic occlusion group compared with all other patients, the difference was only possibly significant (3.8% versus 0.8%, p = 0.067).\nSurgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe?",
        "generated_text": "in 10 (19.2%). The overall mortality and stroke rate was 44.2%, which was significantly higher than in the entire series (10.5%, p < 0.001). The mortality and stroke rate in the 42 patients in whom endoaortic occlusion was successful was 21.4% and 14.3%, respectively, which was still higher than in the entire series (p < 0.001 and p = 0.001, respectively). The mortality and stroke rate in the 10 patients in whom endoaortic occlusion was unsuccessful was 50% and 30%, respectively. The mortality and stroke rate in the 2,120 patients in whom conventional cross-clamping was employed was 10.2% and 4.5%, respectively.\nEndoa",
        "levenshtein_distance": 526
    },
    {
        "realidx": "17076091",
        "question": "We sought to determine whether patients with obstructive sleep apnea (OSA) had an objective change in aerobic fitness during cycle ergometry compared to a normal population. The most accurate test of aerobic fitness is measurement of maximum oxygen consumption (VO2max) with cycle ergometry.\nWe performed a retrospective cohort analysis (247 patients with OSA) of VO2max from annual cycle ergometry tests compared to a large control group (normative data from 1.4 million US Air Force tests) in a tertiary care setting.\nOverall, individuals with OSA had increased VO2max when compared to the normalized US Air Force data (p<.001). Patients with an apnea-hypopnea index of greater than 20 demonstrated a decreased VO2max as compared to normalized values (p<.001). No differences in VO2max were observed after either medical or surgical therapy for OSA.\nDoes obstructive sleep apnea affect aerobic fitness?",
        "answer": "maybe",
        "answer_rationale": "Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with OSA severity and treatment is needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "We sought to determine whether patients with obstructive sleep apnea (OSA) had an objective change in aerobic fitness during cycle ergometry compared to a normal population. The most accurate test of aerobic fitness is measurement of maximum oxygen consumption (VO2max) with cycle ergometry.\nWe performed a retrospective cohort analysis (247 patients with OSA) of VO2max from annual cycle ergometry tests compared to a large control group (normative data from 1.4 million US",
        "q2": " Air Force tests) in a tertiary care setting.\nOverall, individuals with OSA had increased VO2max when compared to the normalized US Air Force data (p<.001). Patients with an apnea-hypopnea index of greater than 20 demonstrated a decreased VO2max as compared to normalized values (p<.001). No differences in VO2max were observed after either medical or surgical therapy for OSA.\nDoes obstructive sleep apnea affect aerobic fitness?",
        "generated_text": "adults). We used linear regression to assess the association between OSA and VO2max, adjusting for age, sex, and body mass index (BMI). We also assessed the association between OSA severity (apnea-hypopnea index [AHI]) and VO2max.\nPatients with OSA had lower VO2max compared to the control group (35.1 vs. 40.1 mL/kg/min, p < 0.00",
        "levenshtein_distance": 326
    },
    {
        "realidx": "17192736",
        "question": "The aim of this study was to assess the efficacy of ureteroscopy for lower ureteric stones without the use of fluoroscopy.\nBetween June 2001 and January 2005, a total of 110 patients with a mean age of 33.5 years (range 12-65) suffering from of lower ureteral calculi (below the upper margin of the sacroiliac joint) prospectively underwent ureteroscopic removal. Retrograde pyelography was avoided, and no safety guidewire was placed. Whenever required, the ureteric meatus was dilated with a ureteric balloon under direct vision. Double-J stent placement was done with the aid of ureteroscopy. A fluoroscope was kept standby. The patients had a postoperative X-ray of the kidney-ureter-bladder region to document the stone clearance.\nThe mean stone size was 8.7 mm (range 6-15). Complete clearance without the use of fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients who required balloon dilatation it was successfully achieved without fluoroscopy. Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction (n = 2), and perforation (n = 1). All these patients had correct placement of the stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively.\nIs fluoroscopy essential for retrieval of lower ureteric stones?",
        "answer": "no",
        "answer_rationale": "To uphold the notion for radiation exposure to be as low as reasonably achievable, ureteroscopic stone retrieval can safely be done without the use of fluoroscopy in a significant number of patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The aim of this study was to assess the efficacy of ureteroscopy for lower ureteric stones without the use of fluoroscopy.\nBetween June 2001 and January 2005, a total of 110 patients with a mean age of 33.5 years (range 12-65) suffering from of lower ureteral calculi (below the upper margin of the sacroiliac joint) prospectively underwent ureteroscopic removal. Retrograde pyelography was avoided, and no safety guidewire was placed. Whenever required, the ureteric meatus was dilated with a ureteric balloon under direct vision. Double-J stent placement was done with the aid of ureteroscopy. A fluoroscope was kept standby. The patients had a postoperative X-ray of the kidney-ureter-bladder region to document the stone clearance.\nThe mean stone size was 8.7 mm (range 6",
        "q2": "-15). Complete clearance without the use of fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients who required balloon dilatation it was successfully achieved without fluoroscopy. Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction (n = 2), and perforation (n = 1). All these patients had correct placement of the stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively.\nIs fluoroscopy essential for retrieval of lower ureteric stones?",
        "generated_text": "-15 mm). The mean operative time was 45 minutes (range 20-120 minutes). The mean hospital stay was 2.5 days (range 1-5 days). The mean follow-up was 12 months (range 6-24 months). The overall success rate was 95.4%. The mean time to stent removal was 15 days (range 10-20 days). The mean time to stone clearance was 20 days (range 15-30 days). The mean time to complete relief of symptoms was 10 days (range 5-15 days). The mean time to return to normal activity was 12 days (range 7-15 days). The mean time to return to work was 14 days (range 10-20 days). The mean time to return to sports",
        "levenshtein_distance": 568
    },
    {
        "realidx": "17208539",
        "question": "The transanal endorectal pull-through (TERPT) is becoming the most popular procedure in the treatment of Hirschsprung disease (HD), but overstretching of the anal sphincters remains a critical issue that may impact the continence. This study examined the long-term outcome of TERPT versus conventional transabdominal (ABD) pull-through for HD.\nRecords of 41 patients more than 3 years old who underwent a pull-through for HD (TERPT, n = 20; ABD, n = 21) were reviewed, and their families were thoroughly interviewed and scored via a 15-item post-pull-through long-term outcome questionnaire. Patients were operated on between the years 1995 and 2003. During this time, our group transitioned from the ABD to the TERPT technique. Total scoring ranged from 0 to 40: 0 to 10, excellent; 11 to 20 good; 21 to 30 fair; 31 to 40 poor. A 2-tailed Student t test, analysis of covariance, as well as logistic and linear regression were used to analyze the collected data with confidence interval higher than 95%.\nOverall scores were similar. However, continence score was significantly better in the ABD group, and the stool pattern score was better in the TERPT group. A significant difference in age at interview between the 2 groups was noted; we therefore reanalyzed the data controlling for age, and this showed that age did not significantly affect the long-term scoring outcome between groups.\nAre the long-term results of the transanal pull-through equal to those of the transabdominal pull-through?",
        "answer": "no",
        "answer_rationale": "Our long-term study showed significantly better (2-fold) results regarding the continence score for the abdominal approach compared with the transanal pull-through. The stool pattern and enterocolitis scores were somewhat better for the TERPT group. These findings raise an important issue about the current surgical management of HD; however, more cases will need to be studied before a definitive conclusion can be drawn.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The transanal endorectal pull-through (TERPT) is becoming the most popular procedure in the treatment of Hirschsprung disease (HD), but overstretching of the anal sphincters remains a critical issue that may impact the continence. This study examined the long-term outcome of TERPT versus conventional transabdominal (ABD) pull-through for HD.\nRecords of 41 patients more than 3 years old who underwent a pull-through for HD (TERPT, n = 20; ABD, n = 21) were reviewed, and their families were thoroughly interviewed and scored via a 15-item post-pull-through long-term outcome questionnaire. Patients were operated on between the years 1995 and 2003. During this time, our group transitioned from the ABD to the TERPT technique. Total scoring ranged",
        "q2": " from 0 to 40: 0 to 10, excellent; 11 to 20 good; 21 to 30 fair; 31 to 40 poor. A 2-tailed Student t test, analysis of covariance, as well as logistic and linear regression were used to analyze the collected data with confidence interval higher than 95%.\nOverall scores were similar. However, continence score was significantly better in the ABD group, and the stool pattern score was better in the TERPT group. A significant difference in age at interview between the 2 groups was noted; we therefore reanalyzed the data controlling for age, and this showed that age did not significantly affect the long-term scoring outcome between groups.\nAre the long-term results of the transanal pull-through equal to those of the transabdominal pull-through?",
        "generated_text": "from 0 to 15, with higher scores indicating better continence. The mean follow-up was 10.5 years (range, 5-17 years). The mean age at operation was 4.5 years (range, 3-14 years) in the TERPT group and 4.3 years (range, 3-12 years) in the ABD group.\nThe TERPT group had a significantly higher mean score (12.5 vs. 10.5, p = 0.001). The TERPT group had a significantly higher percentage of patients with a score of 15 (35% vs. 0%, p = 0.001). The TERPT group had a significantly lower percentage of patients with a score",
        "levenshtein_distance": 545
    },
    {
        "realidx": "17274051",
        "question": "The aim of the study was to evaluate the outcomes and patterns of failure in patients with metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary origin, who were treated curatively with radiotherapy, with or without neck dissection.\nThe study included 61 patients referred to the McGill University Hospital Centers from 1987 to 2002. The median age was 57 years, with male to female ratio of 4:1. Distribution of patients by N status was as follows: N1, 16 patients (26%); N2a, 18 (30%); N2b, 13 (22%); N2c, 7 (11%); and N3, 7 (11%). Twenty patients underwent neck dissection (11 radical, 9 functional) and 41 patients had biopsy (9 fine-needle aspiration and 32 excisional biopsy). All patients received radiotherapy. The median dose to the involved node(s) was 64 Gy, and 60 Gy to the rest of the neck. Treatment of the neck was bilateral in 50 patients (82%) and ipsilateral in 11 (18%). The minimum duration of the follow-up was 12 months, with the median of 32 months.\nThe 5- and 8-year overall survival for the whole population was 79% and 67%, respectively. There was no statistically significant difference in the 8-year actuarial overall survival (64.8% and 67.6%, respectively, p = .64) and local relapse-free survival (75% vs 74.5%, respectively, p = .57), among patients who had biopsy versus those who had neck dissection.\nMetastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?",
        "answer": "no",
        "answer_rationale": "In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The aim of the study was to evaluate the outcomes and patterns of failure in patients with metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary origin, who were treated curatively with radiotherapy, with or without neck dissection.\nThe study included 61 patients referred to the McGill University Hospital Centers from 1987 to 2002. The median age was 57 years, with male to female ratio of 4:1. Distribution of patients by N status was as follows: N1, 16 patients (26%); N2a, 18 (30%); N2b, 13 (22%); N2c, 7 (11%); and N3, 7 (11%). Twenty patients underwent neck dissection (11 radical, 9 functional) and 41 patients had biopsy (9 fine-needle aspiration and 32 excisional biopsy). All patients received radi",
        "q2": "otherapy. The median dose to the involved node(s) was 64 Gy, and 60 Gy to the rest of the neck. Treatment of the neck was bilateral in 50 patients (82%) and ipsilateral in 11 (18%). The minimum duration of the follow-up was 12 months, with the median of 32 months.\nThe 5- and 8-year overall survival for the whole population was 79% and 67%, respectively. There was no statistically significant difference in the 8-year actuarial overall survival (64.8% and 67.6%, respectively, p = .64) and local relapse-free survival (75% vs 74.5%, respectively, p = .57), among patients who had biopsy versus those who had neck dissection.\nMetastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?",
        "generated_text": "ography of the head and neck, chest, and abdomen, and 42 patients (69%) had a barium swallow. The primary site was not identified in 42 patients (69%). The remaining 19 patients had a primary site identified in the oropharynx (n = 10), hypopharynx (n = 4), larynx (n = 3), nasopharynx (n = 1), and unknown primary in the head and neck (n = 1). All patients received radiotherapy to the neck, with a median dose of 66 Gy (range, 50-70 Gy). The primary site was irradiated in 19 patients, with a median dose of 60 Gy (range, 50-70 Gy). The median follow-up was 4.5 years (range, 1-",
        "levenshtein_distance": 555
    },
    {
        "realidx": "17276182",
        "question": "This study sought to evaluate mutations in genes encoding the slow component of the cardiac delayed rectifier K+ current (I(Ks)) channel in familial atrial fibrillation (AF).\nAlthough AF can have a genetic etiology, links between inherited gene defects and acquired factors such as atrial stretch have not been explored.\nMutation screening of the KCNQ1, KCNE1, KCNE2, and KCNE3 genes was performed in 50 families with AF. The effects of mutant protein on cardiac I(Ks) activation were evaluated using electrophysiological studies and human atrial action potential modeling.\nOne missense KCNQ1 mutation, R14C, was identified in 1 family with a high prevalence of hypertension. Atrial fibrillation was present only in older individuals who had developed atrial dilation and who were genotype positive. Patch-clamp studies of wild-type or R14C KCNQ1 expressed with KCNE1 in CHO cells showed no statistically significant differences between wild-type and mutant channel kinetics at baseline, or after activation of adenylate cyclase with forskolin. After exposure to hypotonic solution to elicit cell swelling/stretch, mutant channels showed a marked increase in current, a leftward shift in the voltage dependence of activation, altered channel kinetics, and shortening of the modeled atrial action potential duration.\nStretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?",
        "answer": "yes",
        "answer_rationale": "These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study sought to evaluate mutations in genes encoding the slow component of the cardiac delayed rectifier K+ current (I(Ks)) channel in familial atrial fibrillation (AF).\nAlthough AF can have a genetic etiology, links between inherited gene defects and acquired factors such as atrial stretch have not been explored.\nMutation screening of the KCNQ1, KCNE1, KCNE2, and KCNE3 genes was performed in 50 families with AF. The effects of mutant protein on cardiac I(Ks) activation were evaluated using electrophysiological studies and human atrial action potential modeling.\nOne missense KCNQ1 mutation, R14C, was identified in 1 family with a high prevalence of hypertension",
        "q2": ". Atrial fibrillation was present only in older individuals who had developed atrial dilation and who were genotype positive. Patch-clamp studies of wild-type or R14C KCNQ1 expressed with KCNE1 in CHO cells showed no statistically significant differences between wild-type and mutant channel kinetics at baseline, or after activation of adenylate cyclase with forskolin. After exposure to hypotonic solution to elicit cell swelling/stretch, mutant channels showed a marked increase in current, a leftward shift in the voltage dependence of activation, altered channel kinetics, and shortening of the modeled atrial action potential duration.\nStretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?",
        "generated_text": "and AF. The R14C mutation was not present in 200 control chromosomes. The R14C mutation caused a significant reduction in I(Ks) activation, which was associated with a significant increase in action potential duration and an increased propensity for AF.\nThis study provides the first evidence that mutations in genes encoding the I(Ks) channel can cause familial AF and suggests that the R14C mutation may predispose to AF by increasing the vulnerability of the atrium to stretch-induced remodeling.",
        "levenshtein_distance": 554
    },
    {
        "realidx": "17306983",
        "question": "Enlargement of the ascending aorta is often combined with valvular, coronary, or other cardiac diseases. Reduction aortoplasty can be an optional therapy; however, indications regarding the diameter of aorta, the history of dilatation (poststenosis, bicuspid aortic valve), or the intraoperative management (wall excision, reduction suture, external reinforcement) are not established.\nIn a retrospective study between 1997 and 2005, we investigated 531 patients operated for aneurysm or ectasia of the ascending aorta (diameter: 45-76mm). Of these, in 50 patients, size-reducing ascending aortoplasty was performed. External reinforcement with a non-coated dacron prosthesis was added in order to stabilize the aortic wall.\nAortoplasty was associated with aortic valve replacement in 47 cases (35 mechanical vs 12 biological), subvalvular myectomy in 29 cases, and CABG in 13 cases. The procedure was performed with low hospital mortality (2%) and a low postoperative morbidity. Computertomographic and echocardiographic diameters were significantly smaller after reduction (55.8+/-9mm down to 40.51+/-6.2mm (CT), p<0.002; 54.1+/-6.7mm preoperatively down to 38.7+/-7.1mm (echocardiography), p<0.002), with stable performance in long-term follow-up (mean follow-up time: 70 months).\nIs size-reducing ascending aortoplasty with external reinforcement an option in modern aortic surgery?",
        "answer": "yes",
        "answer_rationale": "As demonstrated in this study, size reduction of the ascending aorta using aortoplasty with external reinforcement is a safe procedure with excellent long-term results. It is a therapeutic option in modern aortic surgery in patients with poststenotic dilatation of the aorta without impairment of the sinotubular junction of the aortic valve and root.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Enlargement of the ascending aorta is often combined with valvular, coronary, or other cardiac diseases. Reduction aortoplasty can be an optional therapy; however, indications regarding the diameter of aorta, the history of dilatation (poststenosis, bicuspid aortic valve), or the intraoperative management (wall excision, reduction suture, external reinforcement) are not established.\nIn a retrospective study between 1997 and 2005, we investigated 531 patients operated for aneurysm or ectasia of the ascending aorta (diameter: 45-76mm). Of these, in 50 patients, size-reducing ascending aortoplasty was performed. External reinforcement with a non-coated dacron prosthesis was added in order to stabilize the aortic wall.\nAortoplasty was associated with aortic",
        "q2": " valve replacement in 47 cases (35 mechanical vs 12 biological), subvalvular myectomy in 29 cases, and CABG in 13 cases. The procedure was performed with low hospital mortality (2%) and a low postoperative morbidity. Computertomographic and echocardiographic diameters were significantly smaller after reduction (55.8+/-9mm down to 40.51+/-6.2mm (CT), p<0.002; 54.1+/-6.7mm preoperatively down to 38.7+/-7.1mm (echocardiography), p<0.002), with stable performance in long-term follow-up (mean follow-up time: 70 months).\nIs size-reducing ascending aortoplasty with external reinforcement an option in modern aortic surgery?",
        "generated_text": "valve replacement in 24 patients, coronary artery bypass grafting in 12, and both in 14 patients. The mean diameter of the ascending aorta was 55.5mm (45-76mm). The mean diameter of the aortic root was 35.5mm (28-45mm). The mean diameter of the aortic annulus was 22.5mm (18-28mm). The mean diameter of the aortic sinuses was 32.5mm (25-45mm). The mean diameter of the aortic valve was 24.5mm (18-32mm). The mean diameter of the descending aorta was 28.5mm (22-36mm). The mean diameter of",
        "levenshtein_distance": 454
    },
    {
        "realidx": "17342562",
        "question": "Some patients with suspected common bile duct (CBD) stones are found to have sludge and no stones. Although sludge in the gallbladder is a precursor of gallbladder stones, the significance of bile duct sludge (BDS) is poorly defined. This study aimed to compare BDS with bile duct stones in terms of frequency, associated risk factors, and clinical outcome after endoscopic therapy.\nThe study enrolled 228 patients who underwent therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for suspected choledocholithiasis. The patients were divided into two groups: patients with BDS but no stones on ERCP and patients with CBD stones. The presence of risk factors for bile duct stones (age, periampullary diverticulum, ductal dilation or angulation, previous open cholecystectomy) were assessed at ERCP. Follow-up data (36 +/- 19 months) were obtained from medical records and by patient questioning.\nBile duct sludge occurred in 14% (31/228) of patients and was more common in females. After endoscopic clearance, CBD stones recurred in 17% (33/197) of the patients with CBD stones, and in 16% (5/31) of the patients with BDS (p = 0.99). Common bile duct dilation was less common in the sludge group. The other known risk factors for recurrent CBD stones (age, previous open cholecystectomy, bile duct angulation, and the presence of a peripampullary diverticulum) were not statistically different between the two groups.\nThe clinical significance of bile duct sludge: is it different from bile duct stones?",
        "answer": "no",
        "answer_rationale": "The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Some patients with suspected common bile duct (CBD) stones are found to have sludge and no stones. Although sludge in the gallbladder is a precursor of gallbladder stones, the significance of bile duct sludge (BDS) is poorly defined. This study aimed to compare BDS with bile duct stones in terms of frequency, associated risk factors, and clinical outcome after endoscopic therapy.\nThe study enrolled 228 patients who underwent therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for suspected choledocholithiasis. The patients were divided into two groups: patients with BDS but no stones on ERCP and patients with CBD stones. The presence of risk factors for bile duct stones (age, periampullary diverticulum, ductal dilation or angulation, previous open cholecystectomy) were assessed at",
        "q2": " ERCP. Follow-up data (36 +/- 19 months) were obtained from medical records and by patient questioning.\nBile duct sludge occurred in 14% (31/228) of patients and was more common in females. After endoscopic clearance, CBD stones recurred in 17% (33/197) of the patients with CBD stones, and in 16% (5/31) of the patients with BDS (p = 0.99). Common bile duct dilation was less common in the sludge group. The other known risk factors for recurrent CBD stones (age, previous open cholecystectomy, bile duct angulation, and the presence of a peripampullary diverticulum) were not statistically different between the two groups.\nThe clinical significance of bile duct sludge: is it different from bile duct stones?",
        "generated_text": "ERCP. The clinical outcome was evaluated by the need for repeat ERCP and/or surgery.\nBDS was found in 32 patients (14.0%) and stones in 196 (86.0%). The frequency of BDS was higher in patients with periampullary diverticulum (p = 0.001), previous open cholecystectomy (p = 0.001), and ductal angulation (p = 0.001). The frequency of BDS was higher in patients with ductal dilation (p = 0.001). The frequency of BDS was higher in patients with periampullary diverticulum (p = 0.001), previous open cholecystectomy (p = 0.001), and duct",
        "levenshtein_distance": 517
    },
    {
        "realidx": "17355582",
        "question": "The validity of quality of care measurement has important implications for practicing clinicians, their patients, and all involved with health care delivery. We used empirical data from managed care patients enrolled in west coast physician organizations to test the hypothesis that observed changes in health-related quality of life across a 2.5-year window reflecting process of care.DATA SOURCES/\nPatient self-report data as well as clinically detailed medical record review regarding 963 patients with chronic disease associated with managed care from three west coast states.\nProspective cohort study of change in health-related quality of life scores across 30 months as measured by change in SF-12 physical component scores.DATA COLLECTION/\nPatient self-report and medical record abstraction.\nWe found a positive relationship between better process scores and higher burden of illness (p<.05). After adjustment for burden of illness, using an instrumental variables approach revealed better process is associated with smaller declines in SF-12 scores across a 30-month observation window (p=.014). The application of the best quartile of process of care to patients currently receiving poor process is associated with a 4.24 increment in delta SF-12-physical component summary scores.\nDoes ambulatory process of care predict health-related quality of life outcomes for patients with chronic disease?",
        "answer": "yes",
        "answer_rationale": "The use of instrumental variables allowed us to demonstrate a significant relationship between better ambulatory process of care and better health-related quality of life. This finding underscores the importance of efforts to improve the process of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The validity of quality of care measurement has important implications for practicing clinicians, their patients, and all involved with health care delivery. We used empirical data from managed care patients enrolled in west coast physician organizations to test the hypothesis that observed changes in health-related quality of life across a 2.5-year window reflecting process of care.DATA SOURCES/\nPatient self-report data as well as clinically detailed medical record review regarding 963 patients with chronic disease associated with managed care from three west coast states.\nProspective cohort study of change in health-related quality of life scores across 30 months as measured by change in SF-12 physical component",
        "q2": " scores.DATA COLLECTION/\nPatient self-report and medical record abstraction.\nWe found a positive relationship between better process scores and higher burden of illness (p<.05). After adjustment for burden of illness, using an instrumental variables approach revealed better process is associated with smaller declines in SF-12 scores across a 30-month observation window (p=.014). The application of the best quartile of process of care to patients currently receiving poor process is associated with a 4.24 increment in delta SF-12-physical component summary scores.\nDoes ambulatory process of care predict health-related quality of life outcomes for patients with chronic disease?",
        "generated_text": "summary (PCS) and mental component summary (MCS) scores.\nMAIN RESULTS/\nWe found that the mean PCS and MCS scores increased by 1.1 and 0.7 points, respectively, over 30 months. The PCS and MCS scores increased by 1.2 and 0.8 points, respectively, for patients with diabetes, 1.1 and 0.7 points for patients with hypertension, and 0.9 and 0.6 points for patients with hyperlipidemia. The PCS and MCS scores increased by 1.3 and 0.9 points, respectively",
        "levenshtein_distance": 510
    },
    {
        "realidx": "17445978",
        "question": "To evaluate renal damage and impairment of renal function 1 yr after laparoscopic partial nephrectomy (LPN) with warm ischemia>30 min.\nFrom July 2004 to June 2005, 18 patients underwent LPN with warm ischemia time>30 min. Kidney damage markers (daily proteinuria and tubular enzymes) and renal function (serum creatinine, cystatin C, and creatinine clearances) were assessed on postoperative days 1 and 5 and at 12 mo. Glomerular filtration rate (GFR) was evaluated before surgery and at 3 mo. Renal scintigraphy was performed before the procedure, at 5 d and at 3 and 12 mo postoperatively. Statistical analysis was performed using the Student t test and logistic regression analysis.\nIn terms of kidney damage and renal function markers, the statistical analysis demonstrated that at 1 yr there was complete return to the normal range and no statistical difference between the values at the various time points. The GFR was not significantly different before and 3 mo after surgery. In terms of scintigraphy of the operated kidney, the values were 48.35+/-3.82% (40-50%) before the procedure, 36.88+/-8.42 (16-50%) on postoperative day 5 (p=0.0001), 40.56+/-8.96 (20-50%) at 3 mo (p=0.003), and 42.8+/-7.2% (20-50%) 1 yr after surgery (p=0.001).\nIs renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible?",
        "answer": "no",
        "answer_rationale": "Our results demonstrate that kidney damage occurs during LPN when warm ischemia is>30 min. This damage is only partially reversible and efforts should be made to keep warm ischemia within 30 min.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To evaluate renal damage and impairment of renal function 1 yr after laparoscopic partial nephrectomy (LPN) with warm ischemia>30 min.\nFrom July 2004 to June 2005, 18 patients underwent LPN with warm ischemia time>30 min. Kidney damage markers (daily proteinuria and tubular enzymes) and renal function (serum creatinine, cystatin C, and creatinine clearances) were assessed on postoperative days 1 and 5 and at 12 mo. Glomerular filtration rate (GFR) was evaluated before surgery and at 3 mo. Renal scintigraphy was performed before the procedure, at 5 d and at 3 and 12 mo postoperatively. Statistical analysis was performed using the Student t test and logistic regression analysis.\nIn terms of kidney damage and renal function markers, the",
        "q2": " statistical analysis demonstrated that at 1 yr there was complete return to the normal range and no statistical difference between the values at the various time points. The GFR was not significantly different before and 3 mo after surgery. In terms of scintigraphy of the operated kidney, the values were 48.35+/-3.82% (40-50%) before the procedure, 36.88+/-8.42 (16-50%) on postoperative day 5 (p=0.0001), 40.56+/-8.96 (20-50%) at 3 mo (p=0.003), and 42.8+/-7.2% (20-50%) 1 yr after surgery (p=0.001).\nIs renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible?",
        "generated_text": "only significant difference was a decrease in creatinine clearance at 12 mo (P=0.001). The mean GFR decreased from 101.2 to 91.2 ml/min/1.73 m(2) (P=0.001). The mean GFR in the remaining kidney increased from 101.2 to 110.2 ml/min/1.73 m(2) (P=0.001). The mean GFR in the operated kidney decreased from 101.2 to 82.2 ml/min/1.73 m(2) (P=0.001). The mean GFR in the operated kidney decreased by 19.0 ml/min/1.73 m(2). The",
        "levenshtein_distance": 454
    },
    {
        "realidx": "17565137",
        "question": "To evaluate the effect of an antismoking advertisement on young people's perceptions of smoking in movies and their intention to smoke.SUBJECTS/\n3091 cinema patrons aged 12-24 years in three Australian states; 18.6% of the sample (n = 575) were current smokers.DESIGN/\nQuasi-experimental study of patrons, surveyed after having viewed a movie. The control group was surveyed in week 1, and the intervention group in weeks 2 and 3. Before seeing the movie in weeks 2 and 3, a 30 s antismoking advertisement was shown, shot in the style of a movie trailer that warned patrons not to be sucked in by the smoking in the movie they were about to see.\nAttitude of current smokers and non-smokers to smoking in the movies; intention of current smokers and non-smokers to smoke in 12 months.\nAmong non-smokers, 47.8% of the intervention subjects thought that the smoking in the viewed movie was not OK compared with 43.8% of the control subjects (p = 0.04). However, there was no significant difference among smokers in the intervention (16.5%) and control (14.5%) groups (p = 0.4). A higher percentage of smokers in the intervention group indicated that they were likely to be smoking in 12 months time (38.6%) than smokers in the control group (25.6%; p<0.001). For non-smokers, there was no significant difference in smoking intentions between groups, with 1.2% of intervention subjects and 1.6% of controls saying that they would probably be smoking in 12 months time (p = 0.54).\nOut of the smokescreen II: will an advertisement targeting the tobacco industry affect young people's perception of smoking in movies and their intention to smoke?",
        "answer": "yes",
        "answer_rationale": "This real-world study suggests that placing an antismoking advertisement before movies containing smoking scenes can help to immunise non-smokers against the influences of film stars' smoking. Caution must be exercised in the type of advertisement screened as some types of advertising may reinforce smokers' intentions to smoke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate the effect of an antismoking advertisement on young people's perceptions of smoking in movies and their intention to smoke.SUBJECTS/\n3091 cinema patrons aged 12-24 years in three Australian states; 18.6% of the sample (n = 575) were current smokers.DESIGN/\nQuasi-experimental study of patrons, surveyed after having viewed a movie. The control group was surveyed in week 1, and the intervention group in weeks 2 and 3. Before seeing the movie in weeks 2 and 3, a 30 s antismoking advertisement was shown, shot in the style of a movie trailer that warned patrons not to be sucked in by the smoking in the movie they were about to see.\nAttitude of current smokers and non-smokers to smoking in the movies; intention of current smokers and non-smokers to smoke in 12 months.\nAmong non-smokers, 47.8%",
        "q2": " of the intervention subjects thought that the smoking in the viewed movie was not OK compared with 43.8% of the control subjects (p = 0.04). However, there was no significant difference among smokers in the intervention (16.5%) and control (14.5%) groups (p = 0.4). A higher percentage of smokers in the intervention group indicated that they were likely to be smoking in 12 months time (38.6%) than smokers in the control group (25.6%; p<0.001). For non-smokers, there was no significant difference in smoking intentions between groups, with 1.2% of intervention subjects and 1.6% of controls saying that they would probably be smoking in 12 months time (p = 0.54).\nOut of the smokescreen II: will an advertisement targeting the tobacco industry affect young people's perception of smoking in movies and their intention to smoke?",
        "generated_text": "in the control group thought that smoking in movies was cool or very cool, compared with 38.1% in the intervention group (adjusted odds ratio [AOR] 0.69, 95% CI 0.54-0.88). Among current smokers, 40.1% in the control group thought that smoking in movies was cool or very cool, compared with 29.1% in the intervention group (AOR 0.61, 95% CI 0.43-0.86). Among non-smokers, 11.1% in the control group intended to smoke in 12 months, compared with 7.7% in the intervention group (AOR 0.64, 95% CI 0.44-0.93). Among current smokers, 22.1% in the control group intended",
        "levenshtein_distance": 571
    },
    {
        "realidx": "17598882",
        "question": "A genetic component is well established in the etiology of breast cancer. It is not well known, however, whether genetic traits also influence prognostic features of the malignant phenotype.\nWe carried out a population-based cohort study in Sweden based on the nationwide Multi-Generation Register. Among all women with breast cancer diagnosed from 1961 to 2001, 2,787 mother-daughter pairs and 831 sister pairs with breast cancer were identified; we achieved complete follow-up and classified 5-year breast cancer-specific prognosis among proband (mother or oldest sister) into tertiles as poor, intermediary, or good. We used Kaplan-Meier estimates of survival proportions and Cox models to calculate relative risks of dying from breast cancer within 5 years depending on the proband's outcome.\nThe 5-year survival proportion among daughters whose mothers died within 5 years was 87% compared to 91% if the mother was alive (p = 0.03). Among sisters, the corresponding proportions were 70% and 88%, respectively (p = 0.001). After adjustment for potential confounders, daughters and sisters of a proband with poor prognosis had a 60% higher 5-year breast cancer mortality compared to those of a proband with good prognosis (hazard ratio [HR], 1.6; 95% confidence interval [CI], 1.2 to 2.2; p for trend 0.002). This association was slightly stronger among sisters (HR, 1.8; 95% CI, 1.0 to 3.4) than among daughters (HR, 1.6; 95% CI, 1.1 to 2.3).\nIs breast cancer prognosis inherited?",
        "answer": "yes",
        "answer_rationale": "Breast cancer prognosis of a woman predicts the survival in her first-degree relatives with breast cancer. Our novel findings suggest that breast cancer prognosis might be inherited.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "A genetic component is well established in the etiology of breast cancer. It is not well known, however, whether genetic traits also influence prognostic features of the malignant phenotype.\nWe carried out a population-based cohort study in Sweden based on the nationwide Multi-Generation Register. Among all women with breast cancer diagnosed from 1961 to 2001, 2,787 mother-daughter pairs and 831 sister pairs with breast cancer were identified; we achieved complete follow-up and classified 5-year breast cancer-specific prognosis among proband (mother or oldest sister) into tertiles as poor, intermediary, or good. We used Kaplan-Meier estimates of survival proportions and Cox models to calculate relative risks of dying from breast cancer within 5 years depending on the proband's outcome.\nThe 5-year survival proportion among daughters whose mothers died within 5 years was 87% compared to ",
        "q2": "91% if the mother was alive (p = 0.03). Among sisters, the corresponding proportions were 70% and 88%, respectively (p = 0.001). After adjustment for potential confounders, daughters and sisters of a proband with poor prognosis had a 60% higher 5-year breast cancer mortality compared to those of a proband with good prognosis (hazard ratio [HR], 1.6; 95% confidence interval [CI], 1.2 to 2.2; p for trend 0.002). This association was slightly stronger among sisters (HR, 1.8; 95% CI, 1.0 to 3.4) than among daughters (HR, 1.6; 95% CI, 1.1 to 2.3).\nIs breast cancer prognosis inherited?",
        "generated_text": "94% among daughters whose mothers survived beyond 5 years (P < 0.001). The corresponding proportions among sisters were 85% and 94% (P < 0.001). The relative risk of dying within 5 years was 2.0 (95% confidence interval [CI] = 1.4-2.9) for daughters whose mothers died within 5 years and 1.9 (95% CI = 1.1-3.2) for sisters whose older sisters died within 5 years, compared to those whose relatives survived beyond 5 years.\nOur results suggest that genetic factors influence the prognosis of breast cancer. This may have implications for genetic counseling and for the identification of genetic variants associated with prognosis.",
        "levenshtein_distance": 469
    },
    {
        "realidx": "17621202",
        "question": "A prospective randomized clinical study.\nTo determine whether shaving the incision site before spinal surgery causes postsurgical infection.\nSpine surgeons usually shave the skin of the incision site immediately before surgery is performed. However, evidence from some surgical series suggests that presurgical shaving may increase the postsurgical infection rate. To our knowledge, no previously published studies have addressed this issue.\nA total of 789 patients scheduled to undergo spinal surgery were randomly allocated into 2 groups: those in whom the site of operation was shaved immediately before surgery (shaved group; 371 patients) and the patients in whom presurgical shaving was not performed (unshaved group; 418 patients). The mean duration of anesthesia and the infection rates in both groups were recorded and compared.\nThe duration of anesthesia did not differ in the 2 groups (P>0.05). A postoperative infection developed in 4 patients in the shaved group and in 1 patient in the nonshaved group (P<0.01).\nDoes shaving the incision site increase the infection rate after spinal surgery?",
        "answer": "maybe",
        "answer_rationale": "The shaving of the incision site immediately before spinal surgery may increase the rate of postoperative infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "A prospective randomized clinical study.\nTo determine whether shaving the incision site before spinal surgery causes postsurgical infection.\nSpine surgeons usually shave the skin of the incision site immediately before surgery is performed. However, evidence from some surgical series suggests that presurgical shaving may increase the postsurgical infection rate. To our knowledge, no previously published studies have addressed this issue.\nA total of 789 patients scheduled to undergo spinal surgery were randomly allocated into 2 groups: those in whom the site of operation was shaved immediately before surgery (shaved",
        "q2": " group; 371 patients) and the patients in whom presurgical shaving was not performed (unshaved group; 418 patients). The mean duration of anesthesia and the infection rates in both groups were recorded and compared.\nThe duration of anesthesia did not differ in the 2 groups (P>0.05). A postoperative infection developed in 4 patients in the shaved group and in 1 patient in the nonshaved group (P<0.01).\nDoes shaving the incision site increase the infection rate after spinal surgery?",
        "generated_text": "group) and those in whom the site was not shaved (nonshaved group). The primary outcome measure was the postsurgical infection rate. Secondary outcome measures included the duration of hospitalization, the duration of surgery, and the need for blood transfusion.\nThe postsurgical infection rate was 1.8% in the shaved group and 0.6% in the nonshaved group (P = 0.12). The duration of hospitalization was 10.2 days in the shaved group and 1",
        "levenshtein_distance": 294
    },
    {
        "realidx": "17682349",
        "question": "To identify gender differences in delay time and the reasons why African Americans delay in seeking medical care for symptoms of acute myocardial infarction (AMI).\nCross-sectional.\nFive hospitals in the San Francisco and East Bay areas.\nSixty-one African American men and women diagnosed with an AMI.\nPrehospital delay time.\nMedian delay time was longer for women compared to men (4.4 hours vs 3.5 hours), although the difference was not significant. Single women delayed longer than single men (P = .03), and women who were alone when symptoms began delayed longer than women with someone (P = .03). Women who received advice to seek help or call 911 upon symptom onset had shorter delays compared to women who were not advised to call 911 (P = .01). Men at home delayed longer than men who experienced their symptoms outside the home (P = .01). Men with emergency room insurance delayed longer than men without emergency room insurance (P = .03), and men who took an ambulance to the hospital had shorter delay times than men who took other means of transportation (P = .04).\nAre there gender differences in the reasons why African Americans delay in seeking medical help for symptoms of an acute myocardial infarction?",
        "answer": "yes",
        "answer_rationale": "Women compared to men often delay seeking treatment for an AMI, which further increases their risks. Our findings suggest specific characteristics that can serve as a profile to those African Americans most likely to delay seeking treatment for AMI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To identify gender differences in delay time and the reasons why African Americans delay in seeking medical care for symptoms of acute myocardial infarction (AMI).\nCross-sectional.\nFive hospitals in the San Francisco and East Bay areas.\nSixty-one African American men and women diagnosed with an AMI.\nPrehospital delay time.\nMedian delay time was longer for women compared to men (4.4 hours vs 3.5 hours), although the difference was not significant. Single women delayed longer than single men (P = .03), and women who were alone when symptoms began delayed longer than women with someone (P = .03).",
        "q2": " Women who received advice to seek help or call 911 upon symptom onset had shorter delays compared to women who were not advised to call 911 (P = .01). Men at home delayed longer than men who experienced their symptoms outside the home (P = .01). Men with emergency room insurance delayed longer than men without emergency room insurance (P = .03), and men who took an ambulance to the hospital had shorter delay times than men who took other means of transportation (P = .04).\nAre there gender differences in the reasons why African Americans delay in seeking medical help for symptoms of an acute myocardial infarction?",
        "generated_text": "Women who were alone when symptoms began delayed longer than men who were alone (P = .002). Women who were alone when symptoms began were more likely to delay longer than 120 minutes compared to men who were alone (P = .002). Women who were alone when symptoms began were more likely to delay longer than 120 minutes compared to women who were with someone (P = .03). Women who were alone when symptoms began were more likely to delay longer than 120 minutes compared to men who were with someone (P = .001). Women who",
        "levenshtein_distance": 426
    },
    {
        "realidx": "17691856",
        "question": "Rising health care costs and the need to consolidate expertise in tertiary services have led to the centralisation of services. In the UK, the result has been that many rural maternity units have become midwife-led. A key consideration is that midwives have the skills to competently and confidently provide maternity services in rural areas, which may be geographically isolated and where the midwife may only see a small number of pregnant women each year. Our objective was to compare the views of midwives in rural and urban settings, regarding their competence and confidence with respect to 'competencies' identified as being those which all professionals should have in order to provide effective and safe care for low-risk women.\nThis was a comparative questionnaire survey involving a stratified sample of remote and rural maternity units and an ad hoc comparison group of three urban maternity units in Scotland. Questionnaires were sent to 82 midwives working in remote and rural areas and 107 midwives working in urban hospitals with midwife-led units.\nThe response rate from midwives in rural settings was considerably higher (85%) than from midwives in the urban areas (60%). Although the proportion of midwives who reported that they were competent was broadly similar in the two groups, there were some significant differences regarding specific competencies. Midwives in the rural group were more likely to report competence for breech delivery (p = 0.001), while more urban midwives reported competence in skills such as intravenous fluid replacement (p<0.001) and initial and discharge examination of the newborn (p<0.001). Both groups reported facing barriers to continuing professional development; however, more of the rural group had attended an educational event within the last month (p<0.001). Lack of time was a greater barrier for urban midwives (p = 0.02), whereas distance to training was greater for rural midwives (p = 0.009). Lack of motivation or interest was significantly higher in urban units (p = 0.006).\nMidwives' competence: is it affected by working in a rural location?",
        "answer": "maybe",
        "answer_rationale": "It is often assumed that midwives in rural areas where there are fewer deliveries, will be less competent and confident in their practice. Our exploratory study suggests that the issue of competence is far more complex and deserves further attention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Rising health care costs and the need to consolidate expertise in tertiary services have led to the centralisation of services. In the UK, the result has been that many rural maternity units have become midwife-led. A key consideration is that midwives have the skills to competently and confidently provide maternity services in rural areas, which may be geographically isolated and where the midwife may only see a small number of pregnant women each year. Our objective was to compare the views of midwives in rural and urban settings, regarding their competence and confidence with respect to 'competencies' identified as being those which all professionals should have in order to provide effective and safe care for low-risk women.\nThis was a comparative questionnaire survey involving a stratified sample of remote and rural maternity units and an ad hoc comparison group of three urban maternity units in Scotland. Questionnaires were sent to 82 midwives working in remote and rural areas and 107 midwives working in urban hospitals with midwife-led units.\nThe response rate from midwives in rural settings was considerably",
        "q2": " higher (85%) than from midwives in the urban areas (60%). Although the proportion of midwives who reported that they were competent was broadly similar in the two groups, there were some significant differences regarding specific competencies. Midwives in the rural group were more likely to report competence for breech delivery (p = 0.001), while more urban midwives reported competence in skills such as intravenous fluid replacement (p<0.001) and initial and discharge examination of the newborn (p<0.001). Both groups reported facing barriers to continuing professional development; however, more of the rural group had attended an educational event within the last month (p<0.001). Lack of time was a greater barrier for urban midwives (p = 0.02), whereas distance to training was greater for rural midwives (p = 0.009). Lack of motivation or interest was significantly higher in urban units (p = 0.006).\nMidwives' competence: is it affected by working in a rural location?",
        "generated_text": "higher (75%) than in urban settings (45%). The majority of midwives in both settings felt competent and confident in their ability to provide care for low-risk women. However, midwives in rural settings were more likely to feel competent and confident in their ability to provide care for women with more complex needs, such as those with medical co-morbidities, and those requiring induction of labour or augmentation of labour. Midwives in rural settings were also more likely to feel competent and confident in their ability to provide care for women who had previously had a caesarean section.\nOur findings suggest that midwives in rural settings feel more competent and confident in their ability to provide care for women with more complex needs than their counterparts in urban settings. This may be due to the fact that midwives in rural settings have to deal with a wider range of clinical scenarios due to the limited availability of specialist services. It is important that midwives in rural settings receive appropriate training and support to enable them to provide safe and effective care for",
        "levenshtein_distance": 798
    },
    {
        "realidx": "17894828",
        "question": "An association has been described between elevated serum angiotensin-converting enzyme (ACE) and an increased risk of severe hypoglycaemia (SH). To ascertain whether this reported association could be replicated in a different country, it was re-examined in 300 individuals with Type 1 diabetes.\nPeople with Type 1 diabetes, none of whom was taking renin-angiotensin system blocking drugs, were recruited. Participants recorded the frequency with which they had experienced SH. Glycated haemoglobin (HbA(1c)) and serum ACE were measured. The difference in the incidence of SH between different quartiles of ACE activity and the relationship between serum ACE and SH were examined using non-parametric statistical tests and a negative binomial model.\nData were obtained from 300 patients [158 male; HbA(1c) median (range) 8.2% (5.2-12.8%), median age 36 years (16-88); duration of diabetes 14.5 years (2-49)]. The incidence of SH was 0.93 episodes per patient year. The mean incidence of SH in the top and bottom quartiles of ACE activity was 0.5 and 1.7 episodes per patient year, respectively, but this difference was not statistically significant (P = 0.075). Spearman's test showed a very weak, although statistically significant, association between serum ACE level and SH incidence (r = 0.115, P = 0.047). The binomial model also showed a statistically significant (P = 0.002), but clinically weak, relationship between serum ACE and SH.\nSerum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist?",
        "answer": "yes",
        "answer_rationale": "The present survey showed a weak relationship between serum ACE and the frequency of SH, the clinical relevance of which is unclear. This limits the proposed role for serum ACE as an index of risk for SH.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "An association has been described between elevated serum angiotensin-converting enzyme (ACE) and an increased risk of severe hypoglycaemia (SH). To ascertain whether this reported association could be replicated in a different country, it was re-examined in 300 individuals with Type 1 diabetes.\nPeople with Type 1 diabetes, none of whom was taking renin-angiotensin system blocking drugs, were recruited. Participants recorded the frequency with which they had experienced SH. Glycated haemoglobin (HbA(1c)) and serum ACE were measured. The difference in the incidence of SH between different quartiles of ACE activity and the relationship between serum ACE and SH were examined using non-parametric statistical tests and a negative binomial model.\nData were obtained from 300 patients [158 male; HbA(1c) median (range) 8.2% (5.",
        "q2": "2-12.8%), median age 36 years (16-88); duration of diabetes 14.5 years (2-49)]. The incidence of SH was 0.93 episodes per patient year. The mean incidence of SH in the top and bottom quartiles of ACE activity was 0.5 and 1.7 episodes per patient year, respectively, but this difference was not statistically significant (P = 0.075). Spearman's test showed a very weak, although statistically significant, association between serum ACE level and SH incidence (r = 0.115, P = 0.047). The binomial model also showed a statistically significant (P = 0.002), but clinically weak, relationship between serum ACE and SH.\nSerum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist?",
        "generated_text": "5-13.5%); diabetes duration 20 (0.5-50) years]. The median (range) number of SH per patient per year was 0 (0-12). There was no difference in the incidence of SH between quartiles of ACE activity (P=0.12). There was no relationship between serum ACE and SH in the negative binomial model [incidence rate ratio (IRR) 1.01; 95% CI 0.98-1.04; P=0.50]. There was no relationship between serum ACE and SH in patients with HbA(1c) <7.5% (IRR 1.01; 95% CI 0.97-1.05; P=0.70) or in those with HbA",
        "levenshtein_distance": 499
    },
    {
        "realidx": "17910536",
        "question": "Adults with a mild intellectual disability (ID) often show poor decoding and reading comprehension skills. The goal of this study was to investigate the effects of teaching text comprehension strategies to these adults. Specific research goals were to determine (1) the effects of two instruction conditions, i.e. strategy instruction to individuals and strategy instruction in small groups in a reciprocal teaching context; (2) intervention programme effects on specific strategy tests (so-called direct effects), and possible differences between strategies; (3) (long-term) transfer effects of the programme on general reading comprehension ability; and (4) the regression of general text comprehension by the variables of technical reading, IQ, reading comprehension of sentences (RCS), and pretest and posttest scores on the strategies taught.\nIn total, 38 adults (age range 20-72 years; mean age of 36 years) with ID participated in the study. IQs ranged from 45 to 69 with a mean IQ of 58. The intervention programme involved 15 weekly lessons of 1 h each, taught during 3 months. Blocks of lessons included each of Brown and Palincsar's strategies of summarizing, questioning, clarifying and predicting, as participants read and studied narrative and expository texts.\nResults indicated no significant difference between group and individual instruction conditions. Second, direct programme effects - as determined by posttest-pretest contrasts for strategy tests - were substantial, except for the questioning strategy. Third, even more substantial was the transfer effect to general text comprehension. Moreover, the results on this test were well maintained at a follow-up test. Finally, the variance of general reading comprehension ability was best explained by the test of RCS, and only moderately by the strategies trained.\nAdults with mild intellectual disabilities: can their reading comprehension ability be improved?",
        "answer": "yes",
        "answer_rationale": "The presently used intervention programme provides a good starting point for adults with ID to become better readers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Adults with a mild intellectual disability (ID) often show poor decoding and reading comprehension skills. The goal of this study was to investigate the effects of teaching text comprehension strategies to these adults. Specific research goals were to determine (1) the effects of two instruction conditions, i.e. strategy instruction to individuals and strategy instruction in small groups in a reciprocal teaching context; (2) intervention programme effects on specific strategy tests (so-called direct effects), and possible differences between strategies; (3) (long-term) transfer effects of the programme on general reading comprehension ability; and (4) the regression of general text comprehension by the variables of technical reading, IQ, reading comprehension of sentences (RCS), and pretest and posttest scores on the strategies taught.\nIn total, 38 adults (age range 20-72 years; mean age of 36 years) with ID participated in the study. IQ",
        "q2": "s ranged from 45 to 69 with a mean IQ of 58. The intervention programme involved 15 weekly lessons of 1 h each, taught during 3 months. Blocks of lessons included each of Brown and Palincsar's strategies of summarizing, questioning, clarifying and predicting, as participants read and studied narrative and expository texts.\nResults indicated no significant difference between group and individual instruction conditions. Second, direct programme effects - as determined by posttest-pretest contrasts for strategy tests - were substantial, except for the questioning strategy. Third, even more substantial was the transfer effect to general text comprehension. Moreover, the results on this test were well maintained at a follow-up test. Finally, the variance of general reading comprehension ability was best explained by the test of RCS, and only moderately by the strategies trained.\nAdults with mild intellectual disabilities: can their reading comprehension ability be improved?",
        "generated_text": "scores ranged from 50 to 70 (mean 61). The participants were randomly assigned to one of two instruction conditions: (1) strategy instruction to individuals (n=19), or (2) strategy instruction in small groups in a reciprocal teaching context (n=19). The control group consisted of 10 adults with ID who did not receive any instruction. The intervention programme consisted of 12 sessions, each lasting 60 minutes, and was delivered over a period of 6 weeks. The strategies taught were: (1) predicting, (2) questioning, (3) clarifying, and (4) summarizing.\nThe results showed that both instruction conditions led to significant improvements in the specific strategy tests, with no significant differences between the two conditions. However, there were significant differences between the strategies, with predicting and questioning showing larger improvements than clarifying",
        "levenshtein_distance": 717
    },
    {
        "realidx": "17940352",
        "question": "To evaluate the impact of HER2 immunoreactivity on clinical outcome in locally advanced urothelial carcinoma patients who received surgery alone, or methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) as adjuvant chemotherapy.\nWe studied 114 formalin-fixed paraffin-embedded specimens obtained from locally advanced urothelial carcinoma patients receiving surgery alone or adjuvant M-VEC. The authors evaluated HER2 immunoreactivity using immunohistochemical staining and explored the influence of pathological parameters and HER2 immunoreactivity on progression-free survival (PFS) and disease-specific overall survival (OS) using univariate and multivariate Cox's analyses.\nUrothelial carcinoma of the bladder had a significantly higher frequency of HER2 immunoreactivity than that of the upper urinary tract (60.7 vs. 20.7%, p<0.0001). Overall, nodal status was a strong and independent prognostic indicator for clinical outcome. The HER2 immunoreactivity was significantly associated with PFS (p = 0.02) and disease-specific OS (p = 0.005) in advanced urothelial carcinoma patients. As for patients with adjuvant M-VEC, HER2 immunoreactivity was a significant prognostic factor for PFS (p = 0.03) and disease-specific OS (p = 0.02) using univariate analysis, but not multivariate analysis, and not for patients receiving watchful waiting.\nDoes HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?",
        "answer": "maybe",
        "answer_rationale": "HER2 immunoreactivity might have a limited prognostic value for advanced urothelial carcinoma patients with adjuvant M-VEC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To evaluate the impact of HER2 immunoreactivity on clinical outcome in locally advanced urothelial carcinoma patients who received surgery alone, or methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) as adjuvant chemotherapy.\nWe studied 114 formalin-fixed paraffin-embedded specimens obtained from locally advanced urothelial carcinoma patients receiving surgery alone or adjuvant M-VEC. The authors evaluated HER2 immunoreactivity using immunohistochemical staining and explored the influence of pathological parameters and HER2 immunoreactivity on progression-free survival (PFS) and disease-specific overall survival (OS) using univariate and multivariate Cox's analyses.\nUrothelial carcinoma of the bladder had a significantly higher frequency of HER2 immunoreactivity than that of the upper urinary tract",
        "q2": " (60.7 vs. 20.7%, p<0.0001). Overall, nodal status was a strong and independent prognostic indicator for clinical outcome. The HER2 immunoreactivity was significantly associated with PFS (p = 0.02) and disease-specific OS (p = 0.005) in advanced urothelial carcinoma patients. As for patients with adjuvant M-VEC, HER2 immunoreactivity was a significant prognostic factor for PFS (p = 0.03) and disease-specific OS (p = 0.02) using univariate analysis, but not multivariate analysis, and not for patients receiving watchful waiting.\nDoes HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?",
        "generated_text": "(P < 0.001). HER2 immunoreactivity was significantly associated with tumor grade (P = 0.001), tumor stage (P = 0.001), and lymph node metastasis (P = 0.001). HER2 immunoreactivity was an independent prognostic factor for PFS (P = 0.001) and OS (P = 0.001). Patients with HER2 immunoreactivity had a significantly worse PFS and OS than those without HER2 immunoreactivity. Adjuvant M-VEC significantly improved PFS and OS in patients with HER2 immunoreactivity, but not in those without HER2 immunoreactivity.\nHER2 immunoreactivity is an independent prognostic factor for PFS and",
        "levenshtein_distance": 487
    },
    {
        "realidx": "17971187",
        "question": "The study was carried on 2096 school children (1043 male, 1053 female) in Ankara. Their mean age was 9.03 years. Demographic properties of the study group and their families were determined and the serum lipid levels of the subjects were obtained. The relation between these demographic properties and lipid levels were investigated.\nIn 135 of the subjects' serum cholesterol level was>or=200 mg/dL and in 83 subjects serum LDL-cholesterol level was>or=130 mg/dL. Despite 64.4% of the subjects reported a family history of hyperlipidemia, no relations between family history and serum lipid levels were found.\nCholesterol screening in school children: is family history reliable to choose the ones to screen?",
        "answer": "no",
        "answer_rationale": "We suggest that regardless of family history, all children over 5 years should be screened for hyperlipidemia. Education about hyperlipidemia and precautions for its complications should be given to both children and families. The best and easiest way to reach children is to screen them at schools. School is also a good place for education of children about hyperlipidemia and risk factors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The study was carried on 2096 school children (1043 male, 1053 female) in Ankara. Their mean age was 9.03 years. Demographic properties of the study group and their families were determined and the serum lipid levels of the subjects were obtained. The relation between these demographic properties and lipid levels were investigated.\nIn 135 of the subjects' serum cholesterol level",
        "q2": " was>or=200 mg/dL and in 83 subjects serum LDL-cholesterol level was>or=130 mg/dL. Despite 64.4% of the subjects reported a family history of hyperlipidemia, no relations between family history and serum lipid levels were found.\nCholesterol screening in school children: is family history reliable to choose the ones to screen?",
        "generated_text": "was higher than 200 mg/dl, in 101 triglyceride level was higher than 150 mg/dl, in 102 HDL-cholesterol level was lower than 35 mg/dl, and in 115 LDL-cholesterol level was higher than 130 mg/dl. The mean",
        "levenshtein_distance": 245
    },
    {
        "realidx": "18019905",
        "question": "To illustrate how maternal mortality audit identifies different causes of and contributing factors to maternal deaths in different settings in low- and high-income countries and how this can lead to local solutions in reducing maternal deaths.\nDescriptive study of maternal mortality from different settings and review of data on the history of reducing maternal mortality in what are now high-income countries.\nKalabo district in Zambia, Farafenni division in The Gambia, Onandjokwe district in Namibia, and the Netherlands.\nPopulation of rural areas in Zambia and The Gambia, peri-urban population in Namibia and nationwide data from The Netherlands.\nData from facility-based maternal mortality audits from three African hospitals and data from the latest confidential enquiry in The Netherlands.\nMaternal mortality ratio (MMR), causes (direct and indirect) and characteristics.\nMMR ranged from 10 per 100,000 (the Netherlands) to 1540 per 100,000 (The Gambia). Differences in causes of deaths were characterized by HIV/AIDS in Namibia, sepsis and HIV/AIDS in Zambia, (pre-)eclampsia in the Netherlands and obstructed labour in The Gambia.\nThe use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor?",
        "answer": "no",
        "answer_rationale": "Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to be promoted through audit, both national and local.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To illustrate how maternal mortality audit identifies different causes of and contributing factors to maternal deaths in different settings in low- and high-income countries and how this can lead to local solutions in reducing maternal deaths.\nDescriptive study of maternal mortality from different settings and review of data on the history of reducing maternal mortality in what are now high-income countries.\nKalabo district in Zambia, Farafenni division in The Gambia, Onandjokwe district in Namibia, and the Netherlands.\nPopulation of rural areas in Zambia and The Gambia, peri-urban population in Namibia and nationwide data from The Netherlands.\nData from facility-based maternal mortality",
        "q2": " audits from three African hospitals and data from the latest confidential enquiry in The Netherlands.\nMaternal mortality ratio (MMR), causes (direct and indirect) and characteristics.\nMMR ranged from 10 per 100,000 (the Netherlands) to 1540 per 100,000 (The Gambia). Differences in causes of deaths were characterized by HIV/AIDS in Namibia, sepsis and HIV/AIDS in Zambia, (pre-)eclampsia in the Netherlands and obstructed labour in The Gambia.\nThe use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor?",
        "generated_text": "audits in Kalabo and Farafenni and from a community-based maternal mortality study in Onandjokwe. Data on maternal mortality in the Netherlands from national statistics.\nIn Kalabo, 100% of maternal deaths occurred at home, and 80% of the deaths were due to direct obstetric causes. In Farafenni, 75% of the deaths occurred at home, and 50% of the deaths were due to direct obstetric causes. In Onandjokwe, 50% of the deaths occurred at home, and 60% of the deaths",
        "levenshtein_distance": 409
    },
    {
        "realidx": "18041059",
        "question": "Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada-Common Toxicity Criteria [version 2.0] was demonstrated.\nPhase 3 randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast cancer were considered eligible for this review. The event-based risk ratios (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of heterogeneity was applied. Finally, absolute differences (ADs) in event rates and the number of patients needed to harm 1 patient (NNH) were determined.\nSeven eligible RCTs (19,818 patients) reported CVAE results. When considering all RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%), tamoxifen versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). This translated into an NNH value of 189 patients; when only third-generation AIs were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 0.42-0.65; P<.0001), without significant heterogeneity (P= .21). An AD of 1.17% and an NNH value of 85 patients were observed.\nDo adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer?",
        "answer": "yes",
        "answer_rationale": "According to the results from this meta-analysis, the risk of grade 3 and 4 CVAEs in patients who were receiving AIs was higher compared with the risk in patients who were receiving tamoxifen, and the difference reached statistical significance. However, the AD was relatively low, and from 160 to 180 patients had to be treated to produce 1 event.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada-Common Toxicity Criteria [version 2.0] was demonstrated.\nPhase 3 randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast cancer were considered eligible for this review. The event-based risk ratios (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of heterogeneity was applied. Finally, absolute differences (ADs) in event rates and the number of patients needed to harm 1 patient (NNH) were determined.\nSeven eligible RCTs (19,818 patients) reported CVAE results. When considering all RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%),",
        "q2": " tamoxifen versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). This translated into an NNH value of 189 patients; when only third-generation AIs were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 0.42-0.65; P<.0001), without significant heterogeneity (P= .21). An AD of 1.17% and an NNH value of 85 patients were observed.\nDo adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer?",
        "generated_text": "the RR (1.22; 95% CI, 1.01-1.47; P = .04), and the NNH (192; 95% CI, 100-1,000) were determined. The AD of the secondary endpoint (cardiovascular death) was 0.17%, the RR was 1.27 (95% CI, 0.91-1.77; P = .16), and the NNH was 588 (95% CI, 250-10,000). The AD of the tertiary endpoint (myocardial infarction) was 0.21%, the RR was 1.41 (95% CI, 1.02-1.95; P = .04), and the NNH was 47",
        "levenshtein_distance": 489
    },
    {
        "realidx": "18065862",
        "question": "We searched for factors present preoperatively which could be used to predict the intensity of postoperative pain.\nWe undertook a prospective study among all patients aged over 18 years who underwent shoulder surgery from January to September 2004 in our unit. The study included 86 patients for which the following data were noted preoperatively: past history of pain, intensity and duration of prior pain, triggering factors, localization, psychological context. The intensity of the postoperative pain was measured on a visual analog scale (VAS); measurements were noted up to 24 hours postop then at one month. Data processing was performed with Statview5.5.\nSignificant postoperative pain was correlated with a prior history of surgical pain, with duration of prior pain, with intensity of preoperative pain, and with depression.\nSignificant sustained preoperative pain can favor memory of pain leading to postoperative sensitivization of nociception neurons. Intense postoperative pain can favor the development of refractory chronic pain.\nCan the postoperative pain level be predicted preoperatively?",
        "answer": "yes",
        "answer_rationale": "Significant postoperative pain can be expected in the following situations: pain after prior surgery, presence of chronic pain sustained for more than six months, intense preoperative pain, state of depression.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We searched for factors present preoperatively which could be used to predict the intensity of postoperative pain.\nWe undertook a prospective study among all patients aged over 18 years who underwent shoulder surgery from January to September 2004 in our unit. The study included 86 patients for which the following data were noted preoperatively: past history of pain, intensity and duration of prior pain, triggering factors, localization, psychological context. The intensity of the postoperative pain was measured on a visual analog scale (VAS);",
        "q2": " measurements were noted up to 24 hours postop then at one month. Data processing was performed with Statview5.5.\nSignificant postoperative pain was correlated with a prior history of surgical pain, with duration of prior pain, with intensity of preoperative pain, and with depression.\nSignificant sustained preoperative pain can favor memory of pain leading to postoperative sensitivization of nociception neurons. Intense postoperative pain can favor the development of refractory chronic pain.\nCan the postoperative pain level be predicted preoperatively?",
        "generated_text": "the data were collected at 6, 12, 24, 48 and 72 hours postoperatively. The data were analyzed using the Mann-Whitney test and the Kruskal-Wallis test.\nThe mean age was 52.5 years (range 18-82 years). The mean VAS was 5.2 (range 0-10). The mean VAS was higher in patients with a history of pain (p=",
        "levenshtein_distance": 423
    },
    {
        "realidx": "18158048",
        "question": "There is controversy surrounding the optimal management of the testicular remnant associated with the vanishing testes syndrome. Some urologists advocate the need for surgical exploration, whereas others believe this is unnecessary. These differing opinions are based on the variable reports of viable germ cell elements found within the testicular remnants. To better understand the pathology associated with this syndrome and the need for surgical management, we reviewed our experience regarding the incidence of viable germ cell elements within the testicular remnant.\nAn institutional review board-approved, retrospective review was performed of all consecutive patients undergoing exploration for a nonpalpable testis at Eastern Virginia Medical School and Geisinger Medical Center between 1994 and 2006. Patients who were found to have spermatic vessels and a vas deferens exiting a closed internal inguinal ring were included in this analysis.\nFifty-six patients underwent removal of the testicular remnant. Patient age ranged from 11 to 216 months. In 8 of the specimens (14%), we identified viable germ cell elements. In an additional 4 patients (7%), we identified seminiferous tubules without germ cell elements.\nHistologic evaluation of the testicular remnant associated with the vanishing testes syndrome: is surgical management necessary?",
        "answer": "yes",
        "answer_rationale": "In our review, we identified that a significant number of testicular remnants associated with the vanishing testes syndrome can harbor viable germ cell elements or seminiferous tubules. The exact fate of these residual elements remains unknown; however, there may exist the potential for malignant transformation. Given the potential for malignant degeneration, we believe that these remnants should be removed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "There is controversy surrounding the optimal management of the testicular remnant associated with the vanishing testes syndrome. Some urologists advocate the need for surgical exploration, whereas others believe this is unnecessary. These differing opinions are based on the variable reports of viable germ cell elements found within the testicular remnants. To better understand the pathology associated with this syndrome and the need for surgical management, we reviewed our experience regarding the incidence of viable germ cell elements within the testicular remnant.\nAn institutional review board-approved, retrospective review was performed of all consecutive patients undergoing exploration for a nonpalpable testis at Eastern Virginia Medical School and",
        "q2": " Geisinger Medical Center between 1994 and 2006. Patients who were found to have spermatic vessels and a vas deferens exiting a closed internal inguinal ring were included in this analysis.\nFifty-six patients underwent removal of the testicular remnant. Patient age ranged from 11 to 216 months. In 8 of the specimens (14%), we identified viable germ cell elements. In an additional 4 patients (7%), we identified seminiferous tubules without germ cell elements.\nHistologic evaluation of the testicular remnant associated with the vanishing testes syndrome: is surgical management necessary?",
        "generated_text": "Children's Hospital of The King's Daughters from 1995 to 2005. Patients with a history of ambiguous genitalia, cryptorchidism, or testicular torsion were excluded. The testicular remnant was evaluated for the presence of viable germ cells by a single pathologist. The presence of viable germ cells was correlated with patient age, side, and location of the testicular remnant.\nA total of 102 patients met the inclusion criteria. The mean age at exploration was 10.2 months (range, 1 month to 12 years). The",
        "levenshtein_distance": 423
    },
    {
        "realidx": "18179827",
        "question": "To determine whether post-operative administration of topical ropivacaine hydrochloride decreases morbidity following adenotonsillectomy.\nProspective, randomized, double-blind clinical trial.\nUniversity referral center; ENT Department.\nFourty one children, aged 4-16 years, undergoing tonsillectomy.\nPatients received 1.0% ropivacaine hydrochloride soaked swabs packed in their tonsillar fossae while the control group received saline-soaked swabs. Mc Grath's face scale was used to compare the two groups in respect of pain control. Chi-square and two-tailed unpaired Student's t-tests or Mann-Whitney-U-tests were used to compare the two independent groups. As 10 we made 11 comparison between groups, for Bonferroni correction, p<0.005 was accepted as statistically significant.\nOnly first hour there was no significant pain-relieving effect seen in the ropivacaine group (p>0.05). The other hours and days there were statistically significance between the two groups (p<0.001). Also, the other post-operative parameters such as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not statistically different between the two groups. There were no complications associated with ropivacaine hydrochloride. No patients in this study suffered systemic side effects related to the use of this medication.\nDoes topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric patients?",
        "answer": "yes",
        "answer_rationale": "Locally 1.0% ropivacaine administration significantly relieves the pain of pediatric tonsillectomy and, it is a safe and effective method. High concentrations of ropivaciane may produce clinically significant pain relief. It is more effective to reduce of post-operative analgesic requirement after first hour.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine whether post-operative administration of topical ropivacaine hydrochloride decreases morbidity following adenotonsillectomy.\nProspective, randomized, double-blind clinical trial.\nUniversity referral center; ENT Department.\nFourty one children, aged 4-16 years, undergoing tonsillectomy.\nPatients received 1.0% ropivacaine hydrochloride soaked swabs packed in their tonsillar fossae while the control group received saline-soaked swabs. Mc Grath's face scale was used to compare the two groups in respect of pain control. Chi-square and two-tailed unpaired Student's t-tests or Mann-Whitney-U-tests were used to compare the two independent groups. As 10 we made 11 comparison",
        "q2": " between groups, for Bonferroni correction, p<0.005 was accepted as statistically significant.\nOnly first hour there was no significant pain-relieving effect seen in the ropivacaine group (p>0.05). The other hours and days there were statistically significance between the two groups (p<0.001). Also, the other post-operative parameters such as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not statistically different between the two groups. There were no complications associated with ropivacaine hydrochloride. No patients in this study suffered systemic side effects related to the use of this medication.\nDoes topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric patients?",
        "generated_text": ", the p value was adjusted to 0.005.\nThere was no significant difference between the two groups in respect of age, gender, weight, and ASA physical status. There was no significant difference between the two groups in respect of post-operative pain control on the first and second post-operative days. There was no significant difference between the two groups in respect of post-operative bleeding, nausea and vomiting, and post-operative dehydration.\nTopical ropivacaine hydrochloride soaked swabs do not decrease morbidity following adenotonsillectomy.\nAdenotonsillectomy is one of the most common surgical procedures performed in children. It is associated with significant post-operative morbidity, including pain, bleeding, nausea and vomiting, and dehydration",
        "levenshtein_distance": 562
    },
    {
        "realidx": "18182265",
        "question": "In this study, the authors discussed the feasibility and value of diffusion-weighted (DW) MR imaging in the detection of uterine endometrial cancer in addition to conventional nonenhanced MR images.\nDW images of endometrial cancer in 23 patients were examined by using a 1.5-T MR scanner. This study investigated whether or not DW images offer additional incremental value to conventional nonenhanced MR imaging in comparison with histopathological results. Moreover, the apparent diffusion coefficient (ADC) values were measured in the regions of interest within the endometrial cancer and compared with those of normal endometrium and myometrium in 31 volunteers, leiomyoma in 14 patients and adenomyosis in 10 patients. The Wilcoxon rank sum test was used, with a p<0.05 considered statistically significant.\nIn 19 of 23 patients, endometrial cancers were detected only on T2-weighted images. In the remaining 4 patients, of whom two had coexisting leiomyoma, no cancer was detected on T2-weighted images. This corresponds to an 83% detection sensitivity for the carcinomas. When DW images and fused DW images/T2-weighted images were used in addition to the T2-weighted images, cancers were identified in 3 of the remaining 4 patients in addition to the 19 patients (overall detection sensitivity of 96%). The mean ADC value of endometrial cancer (n=22) was (0.97+/-0.19)x10(-3)mm(2)/s, which was significantly lower than those of the normal endometrium, myometrium, leiomyoma and adenomyosis (p<0.05).\nBody diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?",
        "answer": "yes",
        "answer_rationale": "DW imaging can be helpful in the detection of uterine endometrial cancer in nonenhanced MR imaging.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "In this study, the authors discussed the feasibility and value of diffusion-weighted (DW) MR imaging in the detection of uterine endometrial cancer in addition to conventional nonenhanced MR images.\nDW images of endometrial cancer in 23 patients were examined by using a 1.5-T MR scanner. This study investigated whether or not DW images offer additional incremental value to conventional nonenhanced MR imaging in comparison with histopathological results. Moreover, the apparent diffusion coefficient (ADC) values were measured in the regions of interest within the endometrial cancer and compared with those of normal endometrium and myometrium in 31 volunteers, leiomyoma in 14 patients and adenomyosis in 10 patients. The Wilcoxon rank sum test was used, with a p<0.05 considered statistically significant.\nIn 19 of 23 patients, endometrial cancers were detected only on T2-weighted",
        "q2": " images. In the remaining 4 patients, of whom two had coexisting leiomyoma, no cancer was detected on T2-weighted images. This corresponds to an 83% detection sensitivity for the carcinomas. When DW images and fused DW images/T2-weighted images were used in addition to the T2-weighted images, cancers were identified in 3 of the remaining 4 patients in addition to the 19 patients (overall detection sensitivity of 96%). The mean ADC value of endometrial cancer (n=22) was (0.97+/-0.19)x10(-3)mm(2)/s, which was significantly lower than those of the normal endometrium, myometrium, leiomyoma and adenomyosis (p<0.05).\nBody diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?",
        "generated_text": "images, whereas in 4 patients, endometrial cancers were detected on both T2-weighted and DW images. The ADC values of endometrial cancer (1.02\u00b10.21\u00d710-3 mm2/s) were significantly lower than those of normal endometrium (1.51\u00b10.21\u00d710-3 mm2/s, p<0.001), myometrium (1.49\u00b10.21\u00d710-3 mm2/s, p<0.001), leiomyoma (1.41\u00b10.21\u00d710-3 mm2/s, p<0.001), and adenomyosis (1.39\u00b10.21\u00d710-3 mm2/s, p<0.001). The ADC values of normal endometrium were not significantly",
        "levenshtein_distance": 543
    },
    {
        "realidx": "18222909",
        "question": "The hypothesis was tested that pectin content and methylation degree participate in regulation of cell wall mechanical properties and in this way may affect tissue growth and freezing resistance over the course of plant cold acclimation and de-acclimation.\nExperiments were carried on the leaves of two double-haploid lines of winter oil-seed rape (Brassica napus subsp. oleifera), differing in winter survival and resistance to blackleg fungus (Leptosphaeria maculans).\nPlant acclimation in the cold (2 degrees C) brought about retardation of leaf expansion, concomitant with development of freezing resistance. These effects were associated with the increases in leaf tensile stiffness, cell wall and pectin contents, pectin methylesterase (EC 3.1.1.11) activity and the low-methylated pectin content, independently of the genotype studied. However, the cold-induced modifications in the cell wall properties were more pronounced in the leaves of the more pathogen-resistant genotype. De-acclimation promoted leaf expansion and reversed most of the cold-induced effects, with the exception of pectin methylesterase activity.\nAre pectins involved in cold acclimation and de-acclimation of winter oil-seed rape plants?",
        "answer": "yes",
        "answer_rationale": "The results show that the temperature-dependent modifications in pectin content and their methyl esterification degree correlate with changes in tensile strength of a leaf tissue, and in this way affect leaf expansion ability and its resistance to freezing and to fungus pathogens.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The hypothesis was tested that pectin content and methylation degree participate in regulation of cell wall mechanical properties and in this way may affect tissue growth and freezing resistance over the course of plant cold acclimation and de-acclimation.\nExperiments were carried on the leaves of two double-haploid lines of winter oil-seed rape (Brassica napus subsp. oleifera), differing in winter survival and resistance to blackleg fungus (Leptosphaeria maculans).\nPlant acclimation in the cold (2 degrees C) brought about retardation of leaf expansion, concomitant with development of freezing resistance.",
        "q2": " These effects were associated with the increases in leaf tensile stiffness, cell wall and pectin contents, pectin methylesterase (EC 3.1.1.11) activity and the low-methylated pectin content, independently of the genotype studied. However, the cold-induced modifications in the cell wall properties were more pronounced in the leaves of the more pathogen-resistant genotype. De-acclimation promoted leaf expansion and reversed most of the cold-induced effects, with the exception of pectin methylesterase activity.\nAre pectins involved in cold acclimation and de-acclimation of winter oil-seed rape plants?",
        "generated_text": "The rate of leaf expansion was higher in the more winter-hardy line. The pectin content in the cell walls of both lines increased during cold acclimation, but the degree of pectin methylation decreased. The pectin content in the more winter-hardy line was higher, but the degree of pectin methylation was lower than in the less winter-hardy line. The mechanical properties of the cell walls were determined by atomic force microscopy. The elastic modulus of the cell walls increased during cold acclimation, but the adhesion force decreased. The elastic modulus was higher in the more winter-hard",
        "levenshtein_distance": 459
    },
    {
        "realidx": "18235194",
        "question": "In a prospective study 218 preschool children were enrolled (stratified in 2 training programs, one specialized for phonologic awareness in order to prevent dyslexia, the other consisting in training of general perception) during the last year of kindergarten. After finishing the first grade 131 children were compared in their reading and writing abilities.\nIn the whole group only a slight difference was found between both training modalities concerning their writing abilities. However, children with a history of hearing loss, actual hearing loss or pathologic middle ear findings profited most from the specialized training program compared to the control in their reading abilities.\nIs a specialised training of phonological awareness indicated in every preschool child?",
        "answer": "maybe",
        "answer_rationale": "A specialized training program to improve phonologic awareness as a basis for reading and writing in every kindergarten and preschool child seems to be unnecessary. However, children with temporary hearing deficits benefit from such a program. For all other children general perception training may be sufficient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "In a prospective study 218 preschool children were enrolled (stratified in 2 training programs, one specialized for phonologic awareness in order to prevent dyslexia, the other consisting in training of general perception) during the last year of kindergarten. After finishing the first grade 131 children were compared in their reading and writing abilities.\nIn",
        "q2": " the whole group only a slight difference was found between both training modalities concerning their writing abilities. However, children with a history of hearing loss, actual hearing loss or pathologic middle ear findings profited most from the specialized training program compared to the control in their reading abilities.\nIs a specialised training of phonological awareness indicated in every preschool child?",
        "generated_text": "the group of children who had received the phonologic training, 10% had reading and writing difficulties, while in the group who had received the general perception training, 25% had reading and writing difficulties.\n\nWhat is the relative risk of having reading and writing difficulties in the group that received the general perception training compared to the group",
        "levenshtein_distance": 298
    },
    {
        "realidx": "18239988",
        "question": "Specific markers for differentiation of nonalcoholic (NASH) from alcoholic steatohepatitis (ASH) are lacking. We investigated the role of routine laboratory parameters in distinguishing NASH from ASH.\nLiver biopsies performed at our hospital over a 10-year period were reviewed, 95 patients with steatohepatitis identified and their data prior to biopsy reevaluated. The diagnosis NASH or ASH was assigned (other liver diseases excluded) on the basis of the biopsy and history of alcohol consumption (<140 g/week). Logistic regression models were used for analysis.\nNASH was diagnosed in 58 patients (61%; 30 f) and ASH in 37 (39%; 9 f). High-grade fibrosis (59% vs. 19%, P<0.0001) and an AST/ALT ratio>1 (54.1% vs 20.7%, P = 0.0008) were more common in ASH. The MCV was elevated in 53% of ASH patients and normal in all NASH patients (P<0.0001). Multivariate analysis identified the MCV (P = 0.0013), the AST/ALT ratio (P = 0.011) and sex (P = 0.0029) as relevant regressors (aROC = 0.92). The AST/ALT ratio (P<0.0001) and age (P = 0.00049) were independent predictors of high-grade fibrosis. Differences in MCV were more marked in high-grade fibrosis.\nDifferentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?",
        "answer": "yes",
        "answer_rationale": "Higher MCVs and AST/ALT ratios in ASH reflect the severity of underlying liver disease and do not differentiate NASH from ASH. Instead, these biomarkers might prove useful in guiding selection of patients for liver biopsy and in targeting therapy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Specific markers for differentiation of nonalcoholic (NASH) from alcoholic steatohepatitis (ASH) are lacking. We investigated the role of routine laboratory parameters in distinguishing NASH from ASH.\nLiver biopsies performed at our hospital over a 10-year period were reviewed, 95 patients with steatohepatitis identified and their data prior to biopsy reevaluated. The diagnosis NASH or ASH was assigned (other liver diseases excluded) on the basis of the biopsy and history of alcohol consumption (<140 g/week). Logistic regression models were used for analysis.\nNASH was diagnosed in 58 patients (61%; 30 f) and ASH in 37 (39%; 9 f). High-grade fibrosis (59% vs. 19%, P<0.0001) and an AST/ALT ratio>1",
        "q2": " (54.1% vs 20.7%, P = 0.0008) were more common in ASH. The MCV was elevated in 53% of ASH patients and normal in all NASH patients (P<0.0001). Multivariate analysis identified the MCV (P = 0.0013), the AST/ALT ratio (P = 0.011) and sex (P = 0.0029) as relevant regressors (aROC = 0.92). The AST/ALT ratio (P<0.0001) and age (P = 0.00049) were independent predictors of high-grade fibrosis. Differences in MCV were more marked in high-grade fibrosis.\nDifferentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?",
        "generated_text": "(62% vs. 27%, P=0.0004) were more frequent in ASH. In multivariate analysis, only the AST/ALT ratio>1 (OR 4.1, 95% CI 1.4-12.1, P=0.01) and high-grade fibrosis (OR 5.1, 95% CI 1.4-18.5, P=0.01) were independently associated with ASH. The combination of both parameters had a sensitivity of 70% and a specificity of 86% for ASH.\nIn patients with steatohepatitis, high-grade fibrosis and an AST/ALT ratio>1 are independently associated with ASH. The combination of both parameters may help to distinguish ASH",
        "levenshtein_distance": 406
    },
    {
        "realidx": "18243752",
        "question": "This study aims to evaluate local failure patterns in node negative breast cancer patients treated with post-mastectomy radiotherapy including internal mammary chain only.\nRetrospective analysis of 92 internal or central-breast node-negative tumours with mastectomy and external irradiation of the internal mammary chain at the dose of 50 Gy, from 1994 to 1998.\nLocal recurrence rate was 5 % (five cases). Recurrence sites were the operative scare and chest wall. Factors associated with increased risk of local failure were age<or = 40 years and tumour size greater than 20mm, without statistical significance.\nShould chest wall irradiation be included after mastectomy and negative node breast cancer?",
        "answer": "maybe",
        "answer_rationale": "Post-mastectomy radiotherapy should be discussed for a sub-group of node-negative patients with predictors factors of local failure such as age<or = 40 years and larger tumour size.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "This study aims to evaluate local failure patterns in node negative breast cancer patients treated with post-mastectomy radiotherapy including internal mammary chain only.\nRetrospective analysis of 92 internal or central-breast node-negative tumours with mastectomy and external irradiation of the internal mammary chain at the dose of 50 Gy, from 1994",
        "q2": " to 1998.\nLocal recurrence rate was 5 % (five cases). Recurrence sites were the operative scare and chest wall. Factors associated with increased risk of local failure were age<or = 40 years and tumour size greater than 20mm, without statistical significance.\nShould chest wall irradiation be included after mastectomy and negative node breast cancer?",
        "generated_text": "to 2004. Median follow-up was 10 years. Local recurrence was defined as ipsilateral breast or chest wall recurrence, supraclavicular or internal mammary recurrence, or both.\nAt 10 years, the overall survival was 80%, disease-free survival was 75%, and local recurrence-free survival was 9",
        "levenshtein_distance": 258
    },
    {
        "realidx": "18274917",
        "question": "To investigate whether low-tone SD was a precursor of Meniere's disease and whether patients with low-tone SD suffered from endolymphatic hydrops.\nThis was a retrospective case review in the university hospital. A total of 184 patients with low-tone SD were divided into two groups with single and recurrent episodes. The progress, follow-up audiograms, and ECochG results of the patients were reviewed and compared with those of patients with high-tone SD and Meniere's disease.\nIn all, 83 of 177 patients with low-tone SD unaccompanied by vertigo had recurrent hearing loss; 15 of the 83 developed vertiginous attacks. The remaining 94 patients had a single episode. Three of the seven patients with low-tone SD accompanied by vertigo had recurrent hearing loss; two of the three were subsequently confirmed to have Meniere's disease. The other four had a single episode. No difference in rate of progress from SD to Meniere's disease was observed among the low-tone and the high-tone SD groups. The average -SP/AP of each group with a single episode is smaller than that of other groups with recurrent episodes and Meniere's disease.\nPrognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?",
        "answer": "no",
        "answer_rationale": "We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To investigate whether low-tone SD was a precursor of Meniere's disease and whether patients with low-tone SD suffered from endolymphatic hydrops.\nThis was a retrospective case review in the university hospital. A total of 184 patients with low-tone SD were divided into two groups with single and recurrent episodes. The progress, follow-up audiograms, and ECochG results of the patients were reviewed and compared with those of patients with high-tone SD and Meniere's disease.\nIn all, 83 of 177 patients with low-tone SD unaccompanied by vertigo had recurrent hearing loss; 15 of the 83 developed vert",
        "q2": "iginous attacks. The remaining 94 patients had a single episode. Three of the seven patients with low-tone SD accompanied by vertigo had recurrent hearing loss; two of the three were subsequently confirmed to have Meniere's disease. The other four had a single episode. No difference in rate of progress from SD to Meniere's disease was observed among the low-tone and the high-tone SD groups. The average -SP/AP of each group with a single episode is smaller than that of other groups with recurrent episodes and Meniere's disease.\nPrognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?",
        "generated_text": "igo and were diagnosed with Meniere's disease. The incidence of Meniere's disease in patients with recurrent low-tone SD was 18.1% (15/83). The incidence of Meniere's disease in patients with single low-tone SD was 1.1% (1/84). The incidence of Meniere's disease in patients with recurrent low-tone SD was significantly higher than that in patients with single low-tone SD (p < 0.05). The incidence of Meniere's disease in patients with recurrent low-tone SD was significantly lower than that in patients with recurrent high-tone SD (p < 0.0",
        "levenshtein_distance": 430
    },
    {
        "realidx": "18284441",
        "question": "Paraffin-embedded tissues in Cukurova University Faculty of Medicine Department of Pathology between January 2002 and February 2006 were searched restrospectively to investigate this issue. We performed immunohistochemistry on biopsies of 125 patients with HBV infection, grouped as: mild, moderate and severe hepatitis, cirrhosis and HCC, 25 patients in each of them, using anti c-kit monoclonal antibody. The severity of parenchymal inflammation and of interface hepatitis was semiquantitatively graded on a haematoxylin and eosin stained paraffin sections. Additionally, 50 more HCC, formed on HBV basis, were studied to determine the prevalence of c-kit overexpression.\nIn cirrhotic liver, lower intensity of staining and rarely c-kit positivity were present. The greatest number of the c-kit positivity and higher intensity of staining was found in the livers of patients with severe hepatitis and HCC. In chronic hepatitis B infection, the staining intensity was parallel with the grade and stage of the disease. In the areas where fibrosis was seen, c-kit positivity was rare or absent. In the HCC specimens, c-kit positivity appeared both inside and around the cancerous nodes. C-kit expression was observed in 62 of 75 HCC tissue specimens (82%) (p<0.001).\nExpression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?",
        "answer": "maybe",
        "answer_rationale": "C-kit positivity was observed in the mitotic, proliferating and also dysplastic hepatic cells. These results suggest that c-kit expression may be used as an early diagnostic indicator for HBV induced HCC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Paraffin-embedded tissues in Cukurova University Faculty of Medicine Department of Pathology between January 2002 and February 2006 were searched restrospectively to investigate this issue. We performed immunohistochemistry on biopsies of 125 patients with HBV infection, grouped as: mild, moderate and severe hepatitis, cirrhosis and HCC, 25 patients in each of them, using anti c-kit monoclonal antibody. The severity of parenchymal inflammation and of interface hepatitis was semiquantitatively graded on a haematoxylin and eosin stained paraffin sections. Additionally, 50 more HCC, formed on HBV basis, were studied to determine the prevalence of c-kit overexpression.\nIn cirrh",
        "q2": "otic liver, lower intensity of staining and rarely c-kit positivity were present. The greatest number of the c-kit positivity and higher intensity of staining was found in the livers of patients with severe hepatitis and HCC. In chronic hepatitis B infection, the staining intensity was parallel with the grade and stage of the disease. In the areas where fibrosis was seen, c-kit positivity was rare or absent. In the HCC specimens, c-kit positivity appeared both inside and around the cancerous nodes. C-kit expression was observed in 62 of 75 HCC tissue specimens (82%) (p<0.001).\nExpression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?",
        "generated_text": "osis and HCC, c-kit expression was found to be higher than in hepatitis groups. In hepatitis groups, c-kit expression was found to be higher in severe hepatitis group than in mild and moderate hepatitis groups. In HCC, c-kit expression was found to be higher in patients with higher tumor grade and in patients with higher tumor stage. In HCC, c-kit expression was found to be higher in patients with higher tumor size and in patients with higher tumor number. In HCC, c-kit expression was found to be higher in patients with higher tumor differentiation and in patients with higher tumor invasion. In HCC, c-kit expression was found to be higher in patients with higher tumor metastasis and in patients with higher tumor recurrence. In HCC, c-kit expression",
        "levenshtein_distance": 562
    },
    {
        "realidx": "18307476",
        "question": "The robust relationship between socioeconomic factors and health suggests that social and economic policies might substantially affect health, while other evidence suggests that medical care, the main focus of current health policy, may not be the primary determinant of population health. Income support policies are one promising avenue to improve population health. This study examines whether the federal cash transfer program to poor elderly, the Supplemental Security Income (SSI) program, affects old-age disability.\nThis study uses the 1990 and 2000 censuses, employing state and year fixed-effect models, to test whether within-state changes in maximum SSI benefits over time lead to changes in disability among people aged sixty-five and older.\nHigher benefits are linked to lower disability rates. Among all single elderly individuals, 30 percent have mobility limitations, and an increase of $100 per month in the maximum SSI benefit caused the rate of mobility limitations to fall by 0.46 percentage points. The findings were robust to sensitivity analyses. First, analyses limited to those most likely to receive SSI produced larger effects, but analyses limited to those least likely to receive SSI produced no measurable effect. Second, varying the disability measure did not meaningfully alter the findings. Third, excluding the institutionalized, immigrants, individuals living in states with exceptionally large benefit changes, and individuals living in states with no SSI supplements did not change the substantive conclusions. Fourth, Medicaid did not confound the effects. Finally, these results were robust for married individuals.\nUpstream solutions: does the supplemental security income program reduce disability in the elderly?",
        "answer": "yes",
        "answer_rationale": "Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The robust relationship between socioeconomic factors and health suggests that social and economic policies might substantially affect health, while other evidence suggests that medical care, the main focus of current health policy, may not be the primary determinant of population health. Income support policies are one promising avenue to improve population health. This study examines whether the federal cash transfer program to poor elderly, the Supplemental Security Income (SSI) program, affects old-age disability.\nThis study uses the 1990 and 2000 censuses, employing state and year fixed-effect models, to test whether within-state changes in maximum SSI benefits over time lead to changes in disability among people aged sixty-five and older.\nHigher benefits are linked to lower disability rates. Among all single elderly individuals, 30 percent have mobility limitations",
        "q2": ", and an increase of $100 per month in the maximum SSI benefit caused the rate of mobility limitations to fall by 0.46 percentage points. The findings were robust to sensitivity analyses. First, analyses limited to those most likely to receive SSI produced larger effects, but analyses limited to those least likely to receive SSI produced no measurable effect. Second, varying the disability measure did not meaningfully alter the findings. Third, excluding the institutionalized, immigrants, individuals living in states with exceptionally large benefit changes, and individuals living in states with no SSI supplements did not change the substantive conclusions. Fourth, Medicaid did not confound the effects. Finally, these results were robust for married individuals.\nUpstream solutions: does the supplemental security income program reduce disability in the elderly?",
        "generated_text": ", but only 25 percent of those living in states with higher SSI benefits have such limitations. The results suggest that a 10 percent increase in SSI benefits is associated with a 1.4 percentage point reduction in the prevalence of mobility limitations, a 1.1 percentage point reduction in the prevalence of activity limitations, and a 0.7 percentage point reduction in the prevalence of cognitive limitations. The results are robust to alternative specifications and to the inclusion of state-specific time trends.\nThis study suggests that income support policies for the elderly may be an important tool for improving health and reducing disability in old age. The findings indicate that higher SSI benefits are associated with lower rates of mobility, activity, and cognitive limitations among the elderly, particularly among",
        "levenshtein_distance": 669
    },
    {
        "realidx": "18319270",
        "question": "IVF singletons have poorer perinatal outcomes than singletons from spontaneous conceptions. This may be due to the influence of ovarian stimulation on the chromosomal constitution of the embryos which could be translated into localized chromosomal anomalies in the placenta. The aim of this study was to compare the incidence of confined placental mosaicism (CPM) in IVF/ICSI pregnancies and spontaneous conceptions.\nWe conducted a multi-centre retrospective analysis of karyotype results obtained by chorionic villus sampling (CVS), performed due to advanced maternal age (>or=36 years at 18 weeks of gestation), in the Netherlands between 1995 and 2005.\nFrom a total of 322 246 pregnancies, 20 885 CVS results were analysed: 235 in the IVF/ICSI group and 20 650 in the control group. The mean age of women in both groups was 38.4 years (mean difference -0.08, 95% CI -0.35 to 0.18). Data relating to the fetal karyotype were missing in 143 cases in the control group. When taking into account missing data, the incidence of CPM was lower in the IVF-ICSI group than in the control group, 1.3% versus 2.2% (odds ratio 0.59, 95% CI 0.19-1.85), whereas the incidence of fetal chromosomal anomalies was increased 4.3% versus 2.4% (odds ratio 1.81, 95% CI 0.95-3.42). Neither differences were statistically significant.\nDoes confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?",
        "answer": "no",
        "answer_rationale": "The incidence of CPM is not increased in IVF/ICSI pregnancies compared with spontaneous conceptions. CPM probably does not account for the adverse perinatal outcomes following IVF/ICSI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "IVF singletons have poorer perinatal outcomes than singletons from spontaneous conceptions. This may be due to the influence of ovarian stimulation on the chromosomal constitution of the embryos which could be translated into localized chromosomal anomalies in the placenta. The aim of this study was to compare the incidence of confined placental mosaicism (CPM) in IVF/ICSI pregnancies and spontaneous conceptions.\nWe conducted a multi-centre retrospective analysis of karyotype results obtained by chorionic villus sampling (CVS), performed due to advanced maternal age (>or=36 years at 18 weeks of gestation), in the Netherlands between 1995 and 2005.\nFrom a total of 322 246 pregnancies, 20 885 CVS results were analysed: 235 in the IVF/ICSI group and 20 650 in the control group. The mean age",
        "q2": " of women in both groups was 38.4 years (mean difference -0.08, 95% CI -0.35 to 0.18). Data relating to the fetal karyotype were missing in 143 cases in the control group. When taking into account missing data, the incidence of CPM was lower in the IVF-ICSI group than in the control group, 1.3% versus 2.2% (odds ratio 0.59, 95% CI 0.19-1.85), whereas the incidence of fetal chromosomal anomalies was increased 4.3% versus 2.4% (odds ratio 1.81, 95% CI 0.95-3.42). Neither differences were statistically significant.\nDoes confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?",
        "generated_text": "of the mothers was 38.4 years in the IVF/ICSI group and 38.1 years in the control group. The overall incidence of CPM was 1.1% (23/20885). The incidence of CPM in the IVF/ICSI group was 1.7% (4/235) and 1.1% (216/20650) in the control group (P=0.3). The incidence of CPM in the IVF/ICSI group was higher in women aged 40 years and older (2.4% vs 1.0%, P=0.04). The incidence of CPM in the IVF/ICSI group was higher in women with a history of recurrent miscarriages (3.3%",
        "levenshtein_distance": 416
    },
    {
        "realidx": "18322741",
        "question": "Atrial fibrillation, which occurs in 12% of all major foregut surgeries, can prolong hospital stay and increase morbidity. Minimally invasive techniques in foregut surgery have been suggested to cause less tissue trauma. We examined the factors associated with new-onset atrial fibrillation after foregut surgery at our institution.\nWe retrospectively examined the records of 154 adult patients who underwent major foregut surgery which included esophagectomy, partial or total gastrectomy, redo Heller myotomy, redo or transthoracic fundoplications. Univariate and multivariate logistic regression analysis with standard modeling techniques were performed to determine risk factors for new-onset atrial fibrillation.\nOf the 154 patients, 14 patients developed new-onset atrial fibrillation with a higher mean age of 67.1 years (+/-8.8 years) versus 56.4 years (+/-14.1 years) (p = 0.006). Laparoscopic (p = 0.004) and nonthoracic surgeries (p = 0.01) were associated with lower risk of atrial fibrillation. Patients with atrial fibrillation had received more fluid (6.5 +/- 2.8 liters versus 5.3 +/- 2.0 liters) and had longer operations (370 +/- 103 min versus 362 +/- 142 min), none of which were statistically significant. The average intensive care length of stay of patients was longer: 7.5 +/- 6.8 days versus 4.0 +/- 7.1 days (p = 0.004). Multivariate analysis revealed an association of atrial fibrillation with age (OR 1.08, 95% CI 1.02-1.14, p = 0.01), and laparoscopic surgery (OR 0.09, 95% CI 0.01-0.95, p = 0.04) after adjusting for surgery type.\nDoes laparoscopic surgery decrease the risk of atrial fibrillation after foregut surgery?",
        "answer": "yes",
        "answer_rationale": "Laparoscopic surgery is associated with lower risk of atrial fibrillation in foregut surgery. Development of atrial fibrillation is associated with increased length of intensive care stay. We recommend a prospective trial to confirm our findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Atrial fibrillation, which occurs in 12% of all major foregut surgeries, can prolong hospital stay and increase morbidity. Minimally invasive techniques in foregut surgery have been suggested to cause less tissue trauma. We examined the factors associated with new-onset atrial fibrillation after foregut surgery at our institution.\nWe retrospectively examined the records of 154 adult patients who underwent major foregut surgery which included esophagectomy, partial or total gastrectomy, redo Heller myotomy, redo or transthoracic fundoplications. Univariate and multivariate logistic regression analysis with standard modeling techniques were performed to determine risk factors for new-onset atrial fibrillation.\nOf the 154 patients, 14 patients developed new-onset atrial fibrillation with a higher mean age of 67.1 years (+/-8.8 years) versus 56.4 years (+/-14.1 years) (p = 0.006). Laparoscopic (p = 0.004) and nonthoracic surgeries (",
        "q2": "p = 0.01) were associated with lower risk of atrial fibrillation. Patients with atrial fibrillation had received more fluid (6.5 +/- 2.8 liters versus 5.3 +/- 2.0 liters) and had longer operations (370 +/- 103 min versus 362 +/- 142 min), none of which were statistically significant. The average intensive care length of stay of patients was longer: 7.5 +/- 6.8 days versus 4.0 +/- 7.1 days (p = 0.004). Multivariate analysis revealed an association of atrial fibrillation with age (OR 1.08, 95% CI 1.02-1.14, p = 0.01), and laparoscopic surgery (OR 0.09, 95% CI 0.01-0.95, p = 0.04) after adjusting for surgery type.\nDoes laparoscopic surgery decrease the risk of atrial fibrillation after foregut surgery?",
        "generated_text": "p = 0.001) were associated with a lower incidence of atrial fibrillation. On multivariate analysis, age (p = 0.001) and open approach (p = 0.001) were independent risk factors for new-onset atrial fibrillation.\nAge and open approach are independent risk factors for new-onset atrial fibrillation after major foregut surgery. Minimally invasive techniques may be associated with a lower incidence of atrial fibrillation.",
        "levenshtein_distance": 490
    },
    {
        "realidx": "18359123",
        "question": "Swedish hospital mergers seem to stem from a conviction among policy makers that bigger hospitals lead to lower average costs and improved clinical outcomes. The effects of mergers in the form of multisited hospitals have not been systematically evaluated. The purpose of this article is to contribute to this area of knowledge by exploring responses to the merger of Blekinge Hospital.\nThe evaluation was guided by the philosophy of triangulation. A questionnaire was sent to 597 randomly selected employees, that is 24% of the health care staff. Four hundred ninety-eight employees answered the questionnaire, giving a response rate of 83%. Furthermore, interviews of different groups of stakeholders were conducted.\nA moderate increase of quality was assessed, which, a low proportion of the employees perceived had decisively or largely to do with the merger. The majority perceives economical incentives as the drivers of change, but, at the same time, only 10% of this group believes this target was reached completely or to a large extent.\nIs it better to be big?",
        "answer": "no",
        "answer_rationale": "The employees believe the merger has neither generated economy of scale advantages nor substantial quality improvement. Instead, it seems more rewarding to promote cross-functional collaboration together with clinical specialisation. Needs for both integration and differentiation could thereby be fulfilled.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Swedish hospital mergers seem to stem from a conviction among policy makers that bigger hospitals lead to lower average costs and improved clinical outcomes. The effects of mergers in the form of multisited hospitals have not been systematically evaluated. The purpose of this article is to contribute to this area of knowledge by exploring responses to the merger of Blekinge Hospital.\nThe evaluation was guided by the philosophy of triangulation. A questionnaire was sent to 597 randomly selected employees, that is 24% of the health care staff.",
        "q2": " Four hundred ninety-eight employees answered the questionnaire, giving a response rate of 83%. Furthermore, interviews of different groups of stakeholders were conducted.\nA moderate increase of quality was assessed, which, a low proportion of the employees perceived had decisively or largely to do with the merger. The majority perceives economical incentives as the drivers of change, but, at the same time, only 10% of this group believes this target was reached completely or to a large extent.\nIs it better to be big?",
        "generated_text": "The response rate was 60%. In addition, 12 focus group interviews were conducted with 52 employees. The questionnaire was based on a previously validated instrument, the Maslach Burnout Inventory (MBI). The focus group interviews were analyzed using content analysis.\nThe results show that the merger was associated with increased emotional exhaustion and depersonalization and decreased personal accomplishment. The focus group interviews revealed that the merger was associated with a loss of identity, a loss of control, and a",
        "levenshtein_distance": 411
    },
    {
        "realidx": "18378554",
        "question": "The authors examined equivalence of wandering and physically nonaggressive agitation (PNA) as concepts.\nA cross-sectional correlational design was used.\nParticipants were recruited from 22 nursing homes and 6 assisted living facilities in two states.\nAmbulatory residents meeting DSM-IV criteria for dementia (N = 181) were studied.\nVideo-tapes for up to twelve 20-minute observations per participant were coded for wandering using an empirically derived taxonomy of ambulation patterns. Separate raters coded the same tapes for six PNA behaviors on the agitation behavior mapping instrument.\nMost participants (73.5%) wandered; all showed PNA behaviors. Factor analyses yielded an one-factor solution for wandering (explained variance = 43.66%) and a two-factor solution for PNA (explained variance = 53.45%). Overall wandering correlated significantly with PNA Factor 1 (df =179, r = 0.68, p<0.001) and Factor 2, but at a lower value (df = 179, r = 0.26, p<0.01).\nAre wandering and physically nonaggressive agitation equivalent?",
        "answer": "no",
        "answer_rationale": "Findings depict wandering and PNA as overlapping, but nonequivalent phenomena. Evidence supporting construct validity of wandering was more robust than that for PNA. Results have implications for accuracy in scientific and clinical detection and labeling of wandering and agitation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The authors examined equivalence of wandering and physically nonaggressive agitation (PNA) as concepts.\nA cross-sectional correlational design was used.\nParticipants were recruited from 22 nursing homes and 6 assisted living facilities in two states.\nAmbulatory residents meeting DSM-IV criteria for dementia (N = 181) were studied.\nVideo-tapes for up to twelve 20-minute observations per participant were coded for wandering using an empirically derived taxonomy of ambulation patterns. Separate raters coded the same tapes for six PNA behaviors on the agitation behavior mapping instrument.\nMost participants (",
        "q2": "73.5%) wandered; all showed PNA behaviors. Factor analyses yielded an one-factor solution for wandering (explained variance = 43.66%) and a two-factor solution for PNA (explained variance = 53.45%). Overall wandering correlated significantly with PNA Factor 1 (df =179, r = 0.68, p<0.001) and Factor 2, but at a lower value (df = 179, r = 0.26, p<0.01).\nAre wandering and physically nonaggressive agitation equivalent?",
        "generated_text": "84%) were diagnosed with Alzheimer\u2019s disease, and 54% were female. The mean age was 84.5 years (SD = 8.1). The mean Mini-Mental State Examination score was 14.2 (SD = 6.4). The mean number of observations per participant was 7.4 (SD = 3.1). The mean duration of observations per participant was 148 minutes (SD = 62). The mean percentage of time spent wandering was 12.5% (SD =",
        "levenshtein_distance": 324
    },
    {
        "realidx": "18399830",
        "question": "To evaluate whether robotically assisted laparoscopic prostatectomy (RALP) is less invasive than radical retropubic prostatectomy (RRP), as experimental studies suggest that the acute phase reaction is proportional to surgery-induced tissue damage.\nBetween May and November 2006, all patients undergoing RRP or RALP in our department were prospectively assessed. Blood samples were collected 24 h before (T0), during surgery (T1), at the end of anaesthesia (T2), and 12 (T3) and 24 h after surgery (T4), and assayed for interleukin(IL)-6 and IL-1 alpha, C-reactive protein (CRP), and lactate. The Mann-Whitney U-, Student's t- and Friedman tests were used to compare continuous variables, and the Pearson chi-square and Fisher test for categorical variables, with a two-sided P<0.05 considered to indicate significance.\nIn all, 35 and 26 patients were assessed for RALP and RRP, respectively; the median (interquartile range) age was 62 (56-68) and 68.5 (59.2-71.2) years, respectively (P<0.009). Baseline levels (T0) of IL-1, IL-6, CRP and lactate were comparable in both arms. IL-6, CRP and lactates levels increased during both kinds of surgery. The mean IL-6 and CPR values were higher for RRP at T1 (P = 0.01 and 0.001), T2 (P = 0.001 and<0.001), T3 (P = 0.002 and<0.001) and T4 (P<0.001 and 0.02), respectively. Lactate was higher for RRP at T2 (P = 0.001), T3 (P = 0.001) and T4 (P = 0.004), although remaining within the normal ranges. IL-1 alpha did not change at the different sample times.\nIs robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy?",
        "answer": "yes",
        "answer_rationale": "This study showed for the first time that RALP induces lower tissue trauma than RRP.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate whether robotically assisted laparoscopic prostatectomy (RALP) is less invasive than radical retropubic prostatectomy (RRP), as experimental studies suggest that the acute phase reaction is proportional to surgery-induced tissue damage.\nBetween May and November 2006, all patients undergoing RRP or RALP in our department were prospectively assessed. Blood samples were collected 24 h before (T0), during surgery (T1), at the end of anaesthesia (T2), and 12 (T3) and 24 h after surgery (T4), and assayed for interleukin(IL)-6 and IL-1 alpha, C-reactive protein (CRP), and lactate. The Mann-Whitney U-, Student's t- and Friedman tests were used to compare continuous variables, and the Pearson chi-square and Fisher test for categorical variables, with a two-sided P<0.05 considered to indicate significance.\nIn all, 35 and 26 patients were assessed for RALP and RRP, respectively; the median (interquartile range) age was 62 (",
        "q2": "56-68) and 68.5 (59.2-71.2) years, respectively (P<0.009). Baseline levels (T0) of IL-1, IL-6, CRP and lactate were comparable in both arms. IL-6, CRP and lactates levels increased during both kinds of surgery. The mean IL-6 and CPR values were higher for RRP at T1 (P = 0.01 and 0.001), T2 (P = 0.001 and<0.001), T3 (P = 0.002 and<0.001) and T4 (P<0.001 and 0.02), respectively. Lactate was higher for RRP at T2 (P = 0.001), T3 (P = 0.001) and T4 (P = 0.004), although remaining within the normal ranges. IL-1 alpha did not change at the different sample times.\nIs robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy?",
        "generated_text": "58-66) and 64 (60-67) years, respectively (P=0.14). The median (interquartile range) operative time was 200 (170-240) and 180 (150-210) min for RALP and RRP, respectively (P=0.11). The median (interquartile range) estimated blood loss was 200 (100-300) and 400 (200-600) ml for RALP and RRP, respectively (P=0.001). The median (interquartile range) IL-6 levels at T0, T1, T2, T3 and T4 were 1.2 (0.8-1.7), 1.4 (0.9-2.1), 1.5 (1.0-2.2), 1.4 (0.9-2.1) and",
        "levenshtein_distance": 493
    },
    {
        "realidx": "18435678",
        "question": "Kell haemolytic disease in pregnancies has been suggested to be associated with decreased fetal platelet counts. The aim of this study was to evaluate the incidence and clinical significance of fetal thrombocytopenia in pregnancies complicated by Kell alloimmunization.\nIn this retrospective cohort study, fetal platelet counts were performed in 42 pregnancies with severe Kell alloimmunization prior to the first intrauterine blood transfusion. Platelet counts from 318 first intrauterine transfusions in RhD alloimmunized pregnancies were used as controls.\nFetal thrombocytopenia (platelet count<150 x 10(9)/l) was found in 4/42 (10%) in the Kell group and in 84/318 (26%) in the RhD group. None of the fetuses in the Kell alloimmunized pregnancies, including 15 with severe hydrops, had a clinically significant thrombocytopenia defined as a platelet count<50 x 10(9)/l. In the RhD alloimmunized pregnancies, 2/230 (1%) of the non-hydropic fetuses and 7/30 (23%) of the severely hydropic fetuses had a clinically significant thrombocytopenia.\nKell alloimmunization in pregnancy: associated with fetal thrombocytopenia?",
        "answer": "no",
        "answer_rationale": "In contrast to fetuses with severe anaemia and hydrops due to RhD alloimmunization, fetuses with severe anaemia due to Kell alloimmunization are generally not at risk for substantial thrombocytopenia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Kell haemolytic disease in pregnancies has been suggested to be associated with decreased fetal platelet counts. The aim of this study was to evaluate the incidence and clinical significance of fetal thrombocytopenia in pregnancies complicated by Kell alloimmunization.\nIn this retrospective cohort study, fetal platelet counts were performed in 42 pregnancies with severe Kell alloimmunization prior to the first intrauterine blood transfusion. Platelet counts from 318 first intrauterine transfusions in RhD alloimmunized pregnancies were used as controls.\nFetal thrombocytopenia (platelet count<150 x 10(9)/l) was found in 4/",
        "q2": "42 (10%) in the Kell group and in 84/318 (26%) in the RhD group. None of the fetuses in the Kell alloimmunized pregnancies, including 15 with severe hydrops, had a clinically significant thrombocytopenia defined as a platelet count<50 x 10(9)/l. In the RhD alloimmunized pregnancies, 2/230 (1%) of the non-hydropic fetuses and 7/30 (23%) of the severely hydropic fetuses had a clinically significant thrombocytopenia.\nKell alloimmunization in pregnancy: associated with fetal thrombocytopenia?",
        "generated_text": "42 (9.5%) Kell alloimmunized pregnancies and in 10/318 (3.1%) RhD alloimmunized pregnancies (p=0.11). The mean platelet count was 275 x 10(9)/l in Kell alloimmunized pregnancies and 324 x 10(9)/l in RhD alloimmunized pregnancies (p=0.11). There was no significant difference in the incidence of fetal thrombocytopenia between the two groups. However, the mean platelet count was lower in Kell alloimmun",
        "levenshtein_distance": 331
    },
    {
        "realidx": "18472368",
        "question": "The protraction of external beam radiotherapy (RT) time is detrimental in several disease sites. In prostate cancer, the overall treatment time can be considerable, as can the potential for treatment breaks. We evaluated the effect of elapsed treatment time on outcome after RT for prostate cancer.\nBetween April 1989 and November 2004, 1,796 men with prostate cancer were treated with RT alone. The nontreatment day ratio (NTDR) was defined as the number of nontreatment days divided by the total elapsed days of RT. This ratio was used to account for the relationship between treatment duration and total RT dose. Men were stratified into low risk (n = 789), intermediate risk (n = 798), and high risk (n = 209) using a single-factor model.\nThe 10-year freedom from biochemical failure (FFBF) rate was 68% for a NTDR<33% vs. 58% for NTDR>/=33% (p = 0.02; BF was defined as a prostate-specific antigen nadir + 2 ng/mL). In the low-risk group, the 10-year FFBF rate was 82% for NTDR<33% vs. 57% for NTDR>/=33% (p = 0.0019). The NTDR was independently predictive for FFBF (p = 0.03), in addition to T stage (p = 0.005) and initial prostate-specific antigen level (p<0.0001) on multivariate analysis, including Gleason score and radiation dose. The NTDR was not a significant predictor of FFBF when examined in the intermediate-risk group, high-risk group, or all risk groups combined.\nDoes treatment duration affect outcome after radiotherapy for prostate cancer?",
        "answer": "yes",
        "answer_rationale": "A proportionally longer treatment duration was identified as an adverse factor in low-risk patients. Treatment breaks resulting in a NTDR of>/=33% (e.g., four or more breaks during a 40-fraction treatment, 5 d/wk) should be avoided.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The protraction of external beam radiotherapy (RT) time is detrimental in several disease sites. In prostate cancer, the overall treatment time can be considerable, as can the potential for treatment breaks. We evaluated the effect of elapsed treatment time on outcome after RT for prostate cancer.\nBetween April 1989 and November 2004, 1,796 men with prostate cancer were treated with RT alone. The nontreatment day ratio (NTDR) was defined as the number of nontreatment days divided by the total elapsed days of RT. This ratio was used to account for the relationship between treatment duration and total RT dose. Men were stratified into low risk (n = 789), intermediate risk (n = 798), and high risk (n = 209) using a single-factor model.\nThe 10-year freedom from biochemical failure (FFBF) rate was 68% for a NTDR<",
        "q2": "33% vs. 58% for NTDR>/=33% (p = 0.02; BF was defined as a prostate-specific antigen nadir + 2 ng/mL). In the low-risk group, the 10-year FFBF rate was 82% for NTDR<33% vs. 57% for NTDR>/=33% (p = 0.0019). The NTDR was independently predictive for FFBF (p = 0.03), in addition to T stage (p = 0.005) and initial prostate-specific antigen level (p<0.0001) on multivariate analysis, including Gleason score and radiation dose. The NTDR was not a significant predictor of FFBF when examined in the intermediate-risk group, high-risk group, or all risk groups combined.\nDoes treatment duration affect outcome after radiotherapy for prostate cancer?",
        "generated_text": "0.5, 62% for a NTDR of 0.5-0.75, and 54% for a NTDR>0.75 (p = 0.0001). The 10-year overall survival (OS) rate was 79% for a NTDR<0.5, 74% for a NTDR of 0.5-0.75, and 67% for a NTDR>0.75 (p = 0.0001). The 10-year cause-specific survival (CSS) rate was 94% for a NTDR<0.5, 91% for a NTDR of 0.5-0.75, and 85% for a NTDR>0.75 (p = 0.00",
        "levenshtein_distance": 488
    },
    {
        "realidx": "18496363",
        "question": "To characterize the gender dimorphism after injury with specific reference to the reproductive age of the women (young,<48 yrs of age, vs. old,>52 yrs of age) in a cohort of severely injured trauma patients for which significant variation in postinjury care is minimized.\nSecondary data analysis of an ongoing prospective multicenter cohort study.\nAcademic, level I trauma and intensive care unit centers.\nBlunt-injured adults with hemorrhagic shock.\nNone.\nSeparate Cox proportional hazard regression models were formulated based on all patients to evaluate the effects of gender on mortality, multiple organ failure, and nosocomial infection, after controlling for all important confounders. These models were then used to characterize the effect of gender in young and old age groups. Overall mortality, multiple organ failure, and nosocomial infection rates for the entire cohort (n = 1,036) were 20%, 40%, and 45%, respectively. Mean Injury Severity Score was 32 +/- 14 (mean +/- SD). Men (n = 680) and women (n = 356) were clinically similar except that men required higher crystalloid volumes, more often had a history of alcoholism and liver disease, and had greater ventilatory and intensive care unit requirements. Female gender was independently associated with a 43% and 23% lower risk of multiple organ failure and nosocomial infection, respectively. Gender remained an independent risk factor in young and old subgroup analysis, with the protection afforded by female gender remaining unchanged.\nCharacterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible?",
        "answer": "no",
        "answer_rationale": "The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To characterize the gender dimorphism after injury with specific reference to the reproductive age of the women (young,<48 yrs of age, vs. old,>52 yrs of age) in a cohort of severely injured trauma patients for which significant variation in postinjury care is minimized.\nSecondary data analysis of an ongoing prospective multicenter cohort study.\nAcademic, level I trauma and intensive care unit centers.\nBlunt-injured adults with hemorrhagic shock.\nNone.\nSeparate Cox proportional hazard regression models were formulated based on all patients to evaluate the effects of gender on mortality, multiple organ failure, and nosocomial infection, after controlling for all important confounders. These models were then used to characterize the effect of gender in young and old age groups. Overall mortality, multiple organ failure, and nosocomial",
        "q2": " infection rates for the entire cohort (n = 1,036) were 20%, 40%, and 45%, respectively. Mean Injury Severity Score was 32 +/- 14 (mean +/- SD). Men (n = 680) and women (n = 356) were clinically similar except that men required higher crystalloid volumes, more often had a history of alcoholism and liver disease, and had greater ventilatory and intensive care unit requirements. Female gender was independently associated with a 43% and 23% lower risk of multiple organ failure and nosocomial infection, respectively. Gender remained an independent risk factor in young and old subgroup analysis, with the protection afforded by female gender remaining unchanged.\nCharacterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible?",
        "generated_text": "infection rates were 22%, 20%, and 22%, respectively. In the overall cohort, women had a lower risk of mortality (hazard ratio [HR], 0.72; 95% confidence interval [CI], 0.55-0.94; p=0.016), multiple organ failure (HR, 0.72; 95% CI, 0.56-0.92; p=0.009), and nosocomial infection (HR, 0.71; 95% CI, 0.55-0.92; p=0.009). In the young age group, women had a lower risk of mortality (HR",
        "levenshtein_distance": 583
    },
    {
        "realidx": "18507507",
        "question": "Specialty pharmaceuticals have evolved beyond their status as niche drugs designed to treat rare conditions and are now poised to become the standard of care in a wide variety of common chronic illnesses. Due in part to the cost of these therapies, payers are increasingly demanding evidence of their value. Determining the value of these medications is hampered by a lack of robust pharmacoeconomic data.\nTo outline emerging strategies and case study examples for the medical and pharmacy benefits management of specialty pharmaceuticals.\nThe promise of specialty pharmaceuticals: increased life expectancy, improved quality of life, enhanced workplace productivity, decreased burden of disease, and reduced health care spending comes at a significant cost. These agents require special handling, administration, patient education, clinical support, and risk mitigation. Additionally, specialty drugs require distribution systems that ensure appropriate patient selection and data collection. With the specialty pharmaceutical pipeline overflowing with new medicines and an aging population increasingly relying on these novel treatments to treat common diseases, the challenge of managing the costs associated with these agents can be daunting. Aided by sophisticated pharmacoeconomic models to assess value, the cost impacts of these specialty drugs can be appropriately controlled.\nThe promise of specialty pharmaceuticals: are they worth the price?",
        "answer": "yes",
        "answer_rationale": "Current evidence suggests that when used in targeted patient populations, specialty pharmaceuticals may represent a good health care value.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Specialty pharmaceuticals have evolved beyond their status as niche drugs designed to treat rare conditions and are now poised to become the standard of care in a wide variety of common chronic illnesses. Due in part to the cost of these therapies, payers are increasingly demanding evidence of their value. Determining the value of these medications is hampered by a lack of robust pharmacoeconomic data.\nTo outline emerging strategies and case study examples for the medical and pharmacy benefits management of specialty pharmaceuticals.\nThe promise of specialty pharmaceuticals: increased life expectancy, improved quality of life, enhanced workplace productivity, decreased burden of disease,",
        "q2": " and reduced health care spending comes at a significant cost. These agents require special handling, administration, patient education, clinical support, and risk mitigation. Additionally, specialty drugs require distribution systems that ensure appropriate patient selection and data collection. With the specialty pharmaceutical pipeline overflowing with new medicines and an aging population increasingly relying on these novel treatments to treat common diseases, the challenge of managing the costs associated with these agents can be daunting. Aided by sophisticated pharmacoeconomic models to assess value, the cost impacts of these specialty drugs can be appropriately controlled.\nThe promise of specialty pharmaceuticals: are they worth the price?",
        "generated_text": "and reduced overall healthcare costs. Specialty pharmaceuticals are a rapidly growing segment of the pharmaceutical market, characterized by their high cost, complex administration, and targeted treatment of specific diseases or patient populations. Historically, these drugs were developed to address rare or orphan diseases, but their scope has expanded to include treatments for more common chronic conditions such as diabetes, multiple sclerosis, and various types of cancer.\n\nOne of the key drivers behind the growth of specialty pharmaceuticals is the advancement in biotechnology and genomics, which has enabled the development of highly targeted therapies. These medications often offer significant clinical benefits, including",
        "levenshtein_distance": 575
    },
    {
        "realidx": "18537964",
        "question": "To determine the impact of a physician's specialty on the frequency and depth of medication history documented in patient medical records.\nA cross-sectional assessment of the frequency and depth of medication history information documented by 123 physicians for 900 randomly selected patients stratified across Cardiology, Chest, Dermatology, Endocrine, Gastroenterology, Haematology, Neurology, Psychiatry and Renal specialties was carried out at a 900-bed teaching hospital located in Ibadan, Nigeria.\nFour hundred and forty-three (49.2%) of the cohort were males and 457 (50.8%) were females; with mean ages 43.2 +/- 18.6 and 43.1 +/- 17.9 years respectively. Physicians' specialties significantly influenced the depth of documentation of the medication history information across the nine specialties (P<0.0001). Post hoc pair-wise comparisons with Tukey's HSD test showed that the mean scores for adverse drug reactions and adherence to medicines was highest in the Cardiology specialty; while the Chest specialty had the highest mean scores for allergy to drugs, food, chemicals and cigarette smoking. Mean scores for the use of alcohol; illicit drugs; dietary restrictions was highest for Gastroenterology, Psychiatry and Endocrine specialties respectively. Physicians' specialties also significantly influenced the frequency of documentation of the medication history across the nine specialties (P<0.0001).\nDoes a physician's specialty influence the recording of medication history in patients' case notes?",
        "answer": "yes",
        "answer_rationale": "Physicians appear to document more frequently and in greater depth medication history information that may aid the diagnostic tasks in their specific specialty. Researchers and other users of medication history data documented in patients' medical records by physicians may want to take special cognizance of this phenomenon.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine the impact of a physician's specialty on the frequency and depth of medication history documented in patient medical records.\nA cross-sectional assessment of the frequency and depth of medication history information documented by 123 physicians for 900 randomly selected patients stratified across Cardiology, Chest, Dermatology, Endocrine, Gastroenterology, Haematology, Neurology, Psychiatry and Renal specialties was carried out at a 900-bed teaching hospital located in Ibadan, Nigeria.\nFour hundred and forty-three (49.2%) of the cohort were males and 457 (50.8%) were females; with mean ages 43.2 +/- 18.6 and 43.1 +/- 17.9 years respectively. Physicians'",
        "q2": " specialties significantly influenced the depth of documentation of the medication history information across the nine specialties (P<0.0001). Post hoc pair-wise comparisons with Tukey's HSD test showed that the mean scores for adverse drug reactions and adherence to medicines was highest in the Cardiology specialty; while the Chest specialty had the highest mean scores for allergy to drugs, food, chemicals and cigarette smoking. Mean scores for the use of alcohol; illicit drugs; dietary restrictions was highest for Gastroenterology, Psychiatry and Endocrine specialties respectively. Physicians' specialties also significantly influenced the frequency of documentation of the medication history across the nine specialties (P<0.0001).\nDoes a physician's specialty influence the recording of medication history in patients' case notes?",
        "generated_text": "documentation of medication history was significantly higher in the Cardiology (p=0.0001), Chest (p=0.0001), Endocrine (p=0.0001), Gastroenterology (p=0.0001), Haematology (p=0.0001), Neurology (p=0.0001), Psychiatry (p=0.0001) and Renal (p=0.0001) specialties compared to Dermatology. The depth of medication history information documented was significantly higher in the Cardiology (p=0.0001), Chest (p=0.0001), End",
        "levenshtein_distance": 634
    },
    {
        "realidx": "18540901",
        "question": "DNA was collected for genotyping from 73 term newborns suffering from TTN and 55 healthy controls from a Caucasian cohort.\nTTN infants were more likely to be male (70% vs. 49%; p<0.05), had a lower mean birthweight (3120 +/- 450 vs. 3396 +/- 504 g; p<0.001) and gestational age (GA) (38.4 +/- 1.2 vs. 39.4 +/- 1.3 weeks; p<0.001) and were more often delivered by caesarean section (CS) (71% vs. 26%; p<0.001). The beta1Ser49Gly polymorphism differed significantly between cases and controls. Multivariate analysis provided beta1Gly49 homozygotes with higher risk for TTN (OR 18.5; 95%CI 1.5-229; p = 0.023) than beta1Ser49 allele carrier. Further analysis showed significant association of T-47C, A46G, C79G and C491T (TACC) haplotype in ADRB2 gene with TTN (p = 0.048).\nTransient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes?",
        "answer": "yes",
        "answer_rationale": "We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "DNA was collected for genotyping from 73 term newborns suffering from TTN and 55 healthy controls from a Caucasian cohort.\nTTN infants were more likely to be male (70% vs. 49%; p<0.05), had a lower mean birthweight (3120 +/- 450 vs. 3396 +/- 504 g; p<0.001) and gestational age (GA) (38.4 +/- 1.2 vs. 39.4 +/- 1.3 weeks; p<0.001) and were more often delivered by caesarean section (CS) (71% vs. 26%; p<0.001). The",
        "q2": " beta1Ser49Gly polymorphism differed significantly between cases and controls. Multivariate analysis provided beta1Gly49 homozygotes with higher risk for TTN (OR 18.5; 95%CI 1.5-229; p = 0.023) than beta1Ser49 allele carrier. Further analysis showed significant association of T-47C, A46G, C79G and C491T (TACC) haplotype in ADRB2 gene with TTN (p = 0.048).\nTransient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes?",
        "generated_text": "frequency of the IL-10 -1082 A allele was higher in TTN infants compared to controls (p=0.001). The frequency of the IL-10 -592 A allele was higher in TTN infants compared to controls (p=0.001). The frequency of the IL-10 -819 C allele was higher in TTN infants compared to controls (p=0.001). The frequency of the IL-10 -1082 AA genotype was higher in TTN infants compared to controls (p=0.001). The frequency of the IL-10 -592 AA genotype",
        "levenshtein_distance": 380
    },
    {
        "realidx": "18565233",
        "question": "Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being involved in colon cancerogenesis. In animal studies the lipid-lowering PPAR ligand bezafibrate suppressed colonic tumors. However, the effect of bezafibrate on colon cancer development in humans is unknown. Therefore, we proposed to investigate a possible preventive effect of bezafibrate on the development of colon cancer in patients with coronary artery disease during a 6-year follow-up.\nOur population included 3011 patients without any cancer diagnosis who were enrolled in the randomized, double blind Bezafibrate Infarction Prevention (BIP) Study. The patients received either 400 mg of bezafibrate retard (1506 patients) or placebo (1505 patients) once a day. Cancer incidence data were obtained by matching a subject's identification numbers with the National Cancer Registry. Each matched record was checked for correct identification.\nDevelopment of new cancer (all types) was recorded in 177 patients: in 79 (5.25%) patients from the bezafibrate group vs. 98 (6.51%) from the placebo group. Development of colon cancer was recorded in 25 patients: in 8 (0.53%) patients from the bezafibrate group vs. 17 (1.13%) from the placebo group, (Fisher's exact test: one side p = 0.05; two side p = 0.07). A difference in the incidence of cancer was only detectable after a 4 year lag and progressively increased with continued follow-up. On multivariable analysis the colon cancer risk in patients who received bezafibrate tended to be lower with a hazard ratio of 0.47 and 95% confidence interval 0.2-1.1.\nDoes the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?",
        "answer": "yes",
        "answer_rationale": "Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being involved in colon cancerogenesis. In animal studies the lipid-lowering PPAR ligand bezafibrate suppressed colonic tumors. However, the effect of bezafibrate on colon cancer development in humans is unknown. Therefore, we proposed to investigate a possible preventive effect of bezafibrate on the development of colon cancer in patients with coronary artery disease during a 6-year follow-up.\nOur population included 3011 patients without any cancer diagnosis who were enrolled in the randomized, double blind Bezafibrate Infarction Prevention (BIP) Study. The patients received either 400 mg of bezafibrate retard (1506 patients) or placebo (1505 patients) once a day. Cancer incidence data were obtained by matching a subject's identification numbers with the National Cancer Registry. Each",
        "q2": " matched record was checked for correct identification.\nDevelopment of new cancer (all types) was recorded in 177 patients: in 79 (5.25%) patients from the bezafibrate group vs. 98 (6.51%) from the placebo group. Development of colon cancer was recorded in 25 patients: in 8 (0.53%) patients from the bezafibrate group vs. 17 (1.13%) from the placebo group, (Fisher's exact test: one side p = 0.05; two side p = 0.07). A difference in the incidence of cancer was only detectable after a 4 year lag and progressively increased with continued follow-up. On multivariable analysis the colon cancer risk in patients who received bezafibrate tended to be lower with a hazard ratio of 0.47 and 95% confidence interval 0.2-1.1.\nDoes the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?",
        "generated_text": "patient was followed for a mean of 5.1 years (range, 0.1-6.2 years). The primary end point was the development of colon cancer.\nDuring the follow-up period, 10 patients in the bezafibrate group and 20 in the placebo group developed colon cancer (P = 0.04). The incidence of colon cancer was 0.8% in the bezafibrate group and 1.6% in the placebo group (P = 0.04). The relative risk of colon cancer in the bezafibrate group was 0.50 (95% confidence interval, 0.25-0.99; P = 0.04). The relative risk of colon cancer in the bezafibrate group was 0.48 (95% confidence interval, 0.23-1.00; P = 0.05) after adjustment for age, sex, and diabetes mellitus. The relative risk of colon",
        "levenshtein_distance": 571
    },
    {
        "realidx": "18568239",
        "question": "To evaluate the influence of the urologist's experience on the surgical results and complications of transurethral resection of the prostate (TURP).\nSixty-seven patients undergoing transurethral resection of the prostate without the use of a video camera were randomly allocated into three groups according to the urologist's experience: a urologist having done 25 transurethral resections of the prostate (Group I - 24 patients); a urologist having done 50 transurethral resections of the prostate (Group II - 24 patients); a senior urologist with vast transurethral resection of the prostate experience (Group III - 19 patients). The following were recorded: the weight of resected tissue, the duration of the resection procedure, the volume of irrigation used, the amount of irrigation absorbed and the hemoglobin and sodium levels in the serum during the procedure.\nThere were no differences between the groups in the amount of irrigation fluid used per operation, the amount of irrigation fluid absorbed or hematocrit and hemoglobin variation during the procedure. The weight of resected tissue per minute was approximately four times higher in group III than in groups I and II. The mean absorbed irrigation fluid was similar between the groups, with no statistical difference between them (p=0.24). Four patients (6%) presented with TUR syndrome, without a significant difference between the groups.\nIs the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience?",
        "answer": "yes",
        "answer_rationale": "The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate the influence of the urologist's experience on the surgical results and complications of transurethral resection of the prostate (TURP).\nSixty-seven patients undergoing transurethral resection of the prostate without the use of a video camera were randomly allocated into three groups according to the urologist's experience: a urologist having done 25 transurethral resections of the prostate (Group I - 24 patients); a urologist having done 50 transurethral resections of the prostate (Group II - 24 patients); a senior urologist with vast transurethral resection of the prostate experience (Group III - 19 patients). The following were recorded: the weight of resected tissue,",
        "q2": " the duration of the resection procedure, the volume of irrigation used, the amount of irrigation absorbed and the hemoglobin and sodium levels in the serum during the procedure.\nThere were no differences between the groups in the amount of irrigation fluid used per operation, the amount of irrigation fluid absorbed or hematocrit and hemoglobin variation during the procedure. The weight of resected tissue per minute was approximately four times higher in group III than in groups I and II. The mean absorbed irrigation fluid was similar between the groups, with no statistical difference between them (p=0.24). Four patients (6%) presented with TUR syndrome, without a significant difference between the groups.\nIs the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience?",
        "generated_text": "the duration of the operation, the amount of intraoperative bleeding, the amount of irrigation fluid used, the amount of fluid absorbed, the incidence of TUR syndrome, the incidence of bladder perforation, the incidence of urethral stricture, the incidence of urinary incontinence, the incidence of retrograde ejaculation, the incidence of erectile dysfunction, the incidence of postoperative urinary tract infection, the incidence of postoperative hematuria, the incidence of postoperative urinary retention, the incidence of postoperative pain, the incidence of postoperative fever, the incidence of postoperative nausea and vomiting, the incidence of postoperative dizziness, the incidence of postoperative headache, the incidence of postoperative fatigue, the incidence of postoperative anxiety, the incidence of postoperative depression, the",
        "levenshtein_distance": 615
    },
    {
        "realidx": "18568290",
        "question": "The etiology of hemodialysis (HD)-induced hypotension and hypertension remains speculative. There is mounting evidence that endothelin-1 (ET-1) may play a vital role in these hemodynamic changes. We examined the possible role of intradialytic changes of ET-1 in the pathogenesis of hypotension and rebound hypertension during HD.\nThe present study included 45 patients with end-stage renal disease (ESRD) on regular HD. They were divided according to their hemodynamic status during HD into three groups (group I had stable intradialytic hemodynamics, group II had dialysis-induced hypotension, and group III had rebound hypertension during HD). In addition, 15 healthy volunteers were included as a control group. Pulse and blood pressure were monitored before, during (every half hour), and after HD session. ET-1 level was measured at the beginning, middle, and end of HD. ET-1 was measured in the control group for comparison.\nPre-dialysis levels of ET-1 were significantly higher in dialysis patients compared to the controls (P<0.001); however, they were comparable in the three HD groups. The post-dialysis ET-1 level was not changed significantly in group I compared with predialysis values (14.49 +/- 2.04 vs. 14.33 +/- 2.23 pg/ml; P = NS), while the ET-1 concentration decreased significantly in group II and increased in group III in comparison to predialysis values (8.56 +/- 1.44 vs. 11.75 +/- 2.51; 16.39 +/- 3.12 vs. 11.93 +/- 2.11 pg/ml, respectively; P<0.001).\nIs there a role for endothelin-1 in the hemodynamic changes during hemodialysis?",
        "answer": "maybe",
        "answer_rationale": "Altered ET-1 levels may be involved in the pathogenesis of rebound hypertension and hypotension during HD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The etiology of hemodialysis (HD)-induced hypotension and hypertension remains speculative. There is mounting evidence that endothelin-1 (ET-1) may play a vital role in these hemodynamic changes. We examined the possible role of intradialytic changes of ET-1 in the pathogenesis of hypotension and rebound hypertension during HD.\nThe present study included 45 patients with end-stage renal disease (ESRD) on regular HD. They were divided according to their hemodynamic status during HD into three groups (group I had stable intradialytic hemodynamics, group II had dialysis-induced hypotension, and group III had rebound hypertension during HD). In addition, 15 healthy volunteers were included as a control group. Pulse and blood pressure were monitored before, during (every half hour), and after HD session. ET-1 level was measured at the beginning, middle, and end of HD. ET-",
        "q2": "1 was measured in the control group for comparison.\nPre-dialysis levels of ET-1 were significantly higher in dialysis patients compared to the controls (P<0.001); however, they were comparable in the three HD groups. The post-dialysis ET-1 level was not changed significantly in group I compared with predialysis values (14.49 +/- 2.04 vs. 14.33 +/- 2.23 pg/ml; P = NS), while the ET-1 concentration decreased significantly in group II and increased in group III in comparison to predialysis values (8.56 +/- 1.44 vs. 11.75 +/- 2.51; 16.39 +/- 3.12 vs. 11.93 +/- 2.11 pg/ml, respectively; P<0.001).\nIs there a role for endothelin-1 in the hemodynamic changes during hemodialysis?",
        "generated_text": "1 levels were also measured in the control group.\nIntradialytic hypotension was observed in 13 patients (28.9%), and rebound hypertension was observed in 12 patients (26.7%). The mean ET-1 level was significantly higher in ESRD patients than in the control group (P < 0.001). Intradialytic changes in ET-1 levels were significantly different among the three groups (P < 0.001). The mean ET-1 level was significantly higher in group II than in group I (P < 0.001). In group III, the mean ET-1 level was significantly higher than in group I (P < 0.001) and group II (P < 0.001). In group I, the mean ET-1 level was significantly higher at the end of HD than at the beginning and middle of",
        "levenshtein_distance": 518
    },
    {
        "realidx": "18570208",
        "question": "To determine the association between fetal biometry in the first or early second trimester and severe macrosomia at delivery.\nThis case-control study included 30 term severely macrosomic neonates; 90 appropriate-for-gestational age (AGA) neonates served as controls. All pregnancies underwent nuchal translucency (NT) screening at 11-14 weeks' gestation. Pregnancies were dated by accurate last menstrual period consistent with crown-rump length (CRL) measurements at the time of screening, early pregnancy CRL or date of fertilization. The association between birth weight and the difference between the measured and the expected CRL at the time of NT screening was analyzed.\nThe difference between measured and expected CRL, expressed both in mm and in days of gestation, was statistically greater in the severely macrosomic neonates compared with controls (mean, 6.66 +/- 4.78 mm vs. 1.17 +/- 4.6 mm, P<0.0001 and 3 +/- 2.2 days vs. 0.5 +/- 2.3 days, P<0.0001, respectively). Furthermore, there were significant correlations between the extent of macrosomia and the discrepancy between expected and measured fetal size at the time of NT screening (r = 0.47, P<0.01 and r = 0.48, P<0.01, respectively).\nIs severe macrosomia manifested at 11-14 weeks of gestation?",
        "answer": "yes",
        "answer_rationale": "Severe macrosomia apparently manifests as early as 11-14 weeks' gestation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine the association between fetal biometry in the first or early second trimester and severe macrosomia at delivery.\nThis case-control study included 30 term severely macrosomic neonates; 90 appropriate-for-gestational age (AGA) neonates served as controls. All pregnancies underwent nuchal translucency (NT) screening at 11-14 weeks' gestation. Pregnancies were dated by accurate last menstrual period consistent with crown-rump length (CRL) measurements at the time of screening, early pregnancy CRL or date of fertilization. The association between birth weight and the difference between the measured and the expected CRL at the time of NT screening was analyzed.\nThe difference between measured and expected CRL, expressed both in mm and in",
        "q2": " days of gestation, was statistically greater in the severely macrosomic neonates compared with controls (mean, 6.66 +/- 4.78 mm vs. 1.17 +/- 4.6 mm, P<0.0001 and 3 +/- 2.2 days vs. 0.5 +/- 2.3 days, P<0.0001, respectively). Furthermore, there were significant correlations between the extent of macrosomia and the discrepancy between expected and measured fetal size at the time of NT screening (r = 0.47, P<0.01 and r = 0.48, P<0.01, respectively).\nIs severe macrosomia manifested at 11-14 weeks of gestation?",
        "generated_text": "multiples of the median (MoM), was significantly higher in the macrosomic group compared with the controls (p < 0.001). The difference between measured and expected CRL was significantly associated with birth weight (p < 0.001). The area under the receiver operating characteristic curve for the difference between measured and expected CRL in predicting severe macrosomia was 0.82 (95% confidence interval [CI], 0.72-0.92). The optimal cut-off value for the difference between measured and expected CRL in multiples of the median was 1.25 MoM, with a sensitivity of 73% and a specificity of 80% for the prediction of severe",
        "levenshtein_distance": 452
    },
    {
        "realidx": "18594195",
        "question": "Refusal of patients to participate in intervention programs is an important problem in clinical trials but, in general, researchers devote relatively little attention to it. In this article, a comparison is made between patients who, after having been invited, agreed to participate in a self-management intervention (participants) and those who refused (refusers). Compared with other studies of refusers, relatively more information could be gathered with regard to both their characteristics and reasons for refusing, because all potential participants were invited personally.\nOlder patients from a Dutch outpatient clinic were invited to participate in a self-management intervention, and their characteristics were assessed. Demographic data were collected, as well as data on physical functioning and lack of emotional support. People who refused to participate were asked to give their reasons for refusing.\nOf the 361 patients invited, 267 (74%) refused participation. These refusers were more restricted in their mobility, lived further away from the location of the intervention, and had a partner more often than did the participants. No differences were found in level of education, age or gender. The main reasons given by respondents for refusing to participate were lack of time, travel distance, and transport problems.\nDo older patients who refuse to participate in a self-management intervention in the Netherlands differ from older patients who agree to participate?",
        "answer": "yes",
        "answer_rationale": "As in many studies, the refusal rate in this study is high, and seems to be related to physical mobility restrictions, travel distance and, partly, to availability of emotional support. These findings may be used to make the recruitment process more effective - for example, by offering transport to the location of the intervention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Refusal of patients to participate in intervention programs is an important problem in clinical trials but, in general, researchers devote relatively little attention to it. In this article, a comparison is made between patients who, after having been invited, agreed to participate in a self-management intervention (participants) and those who refused (refusers). Compared with other studies of refusers, relatively more information could be gathered with regard to both their characteristics and reasons for refusing, because all potential participants were invited personally.\nOlder patients from a Dutch outpatient clinic were invited to participate in a self-management intervention, and their characteristics were assessed. Demographic data were collected, as well",
        "q2": " as data on physical functioning and lack of emotional support. People who refused to participate were asked to give their reasons for refusing.\nOf the 361 patients invited, 267 (74%) refused participation. These refusers were more restricted in their mobility, lived further away from the location of the intervention, and had a partner more often than did the participants. No differences were found in level of education, age or gender. The main reasons given by respondents for refusing to participate were lack of time, travel distance, and transport problems.\nDo older patients who refuse to participate in a self-management intervention in the Netherlands differ from older patients who agree to participate?",
        "generated_text": "as data on health status, self-management, and self-efficacy. The participants and refusers were compared on these variables. In addition, the refusers were asked to indicate their reasons for refusing to participate.\nOf the 100 patients who were invited, 52 agreed to participate and 48 refused. The refusers were significantly older, had a lower level of education, and were less likely to be employed. They also had a higher level of comorbidity and a lower level of self-management. The most important reasons for refusing to participate were lack of time and interest, and the belief that they did not need the",
        "levenshtein_distance": 488
    },
    {
        "realidx": "18616781",
        "question": "Pigmentary dilution is observed in patients with homocystinuria. Therefore, it is possible that an increase of local homocysteine (Hcy) interferes with normal melanogenesis and plays a role in the pathogenesis of vitiligo. Vitamin B12 and folic acid, levels of which are decreased in vitiligo, are important cofactors in the metabolism of Hcy. Consequently, a nutritional deficiency in either of these two vitamins will result in an increase in homocysteine in the circulation, a finding that we expect to find in vitiligo.\nTo determine the level of Hcy in the blood of patients with vitiligo as a first step in revealing if it has any relationship with the pathogenesis of vitiligo and consequently if this will have an impact on the treatment of vitiligo.\nTwenty-six patients of both sexes with vitiligo (age range 20-50 years, mean 31.4 +/- 8.09) and 26 age-matched healthy controls were included in the study. After excluding factors that may affect serum Hcy levels, blood samples from patients and controls were obtained for homocysteine determination by enzyme immunoassay.\nThe mean serum level of Hcy was significantly higher in patients with vitiligo than in controls (21.61 +/- 13.28 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). The Hcy level was significantly higher in male patients than in female patients (28.67 +/- 15.95 vs. 15.56 +/- 6.2 micromol L(-1); P<0.001) and in male controls compared with female controls (15.07 +/- 4.61 vs. 12.05 +/- 4.82 micromol L(-1); P<0.001). The homocysteine level was related to the activity of vitiligo and was significantly higher in patients with progressive disease than in controls (25.4 +/- 14.99 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). No significant difference in Hcy levels was found between either untreated vitiligo patients (22.77 +/- 13.36 micromol L(-1)) or patients receiving ultraviolet therapy (20.45 +/- 13.73 micromol L(-1)) and the total patient group (21.62 +/- 13.28 micromol L(-1)).\nIs there a relationship between homocysteine and vitiligo?",
        "answer": "yes",
        "answer_rationale": "An elevated homocysteine level may be a precipitating factor for vitiligo in predisposed individuals. In view of the biological role of vitamin B(12) and folic acid in Hcy metabolism, we present our recommendations regarding the investigation and treatment of this common disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Pigmentary dilution is observed in patients with homocystinuria. Therefore, it is possible that an increase of local homocysteine (Hcy) interferes with normal melanogenesis and plays a role in the pathogenesis of vitiligo. Vitamin B12 and folic acid, levels of which are decreased in vitiligo, are important cofactors in the metabolism of Hcy. Consequently, a nutritional deficiency in either of these two vitamins will result in an increase in homocysteine in the circulation, a finding that we expect to find in vitiligo.\nTo determine the level of Hcy in the blood of patients with vitiligo as a first step in revealing if it has any relationship with the pathogenesis of vitiligo and consequently if this will have an impact on the treatment of vitiligo.\nTwenty-six patients of both sexes with vitiligo (age range 20-50 years, mean 31.4 +/- 8.09) and 26 age-matched healthy controls were included in the study. After excluding factors that may affect serum Hcy levels, blood samples from patients and controls were obtained for homocysteine determination by enzyme immunoassay.\nThe mean serum level of Hcy was significantly higher in patients with vitiligo than in controls (21",
        "q2": ".61 +/- 13.28 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). The Hcy level was significantly higher in male patients than in female patients (28.67 +/- 15.95 vs. 15.56 +/- 6.2 micromol L(-1); P<0.001) and in male controls compared with female controls (15.07 +/- 4.61 vs. 12.05 +/- 4.82 micromol L(-1); P<0.001). The homocysteine level was related to the activity of vitiligo and was significantly higher in patients with progressive disease than in controls (25.4 +/- 14.99 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). No significant difference in Hcy levels was found between either untreated vitiligo patients (22.77 +/- 13.36 micromol L(-1)) or patients receiving ultraviolet therapy (20.45 +/- 13.73 micromol L(-1)) and the total patient group (21.62 +/- 13.28 micromol L(-1)).\nIs there a relationship between homocysteine and vitiligo?",
        "generated_text": ".1 +/- 10.1 vs. 10.1 +/- 3.1 micromol/l, p < 0.001). There was a significant positive correlation between serum Hcy and disease duration (r = 0.42, p < 0.05). There was no significant difference in serum Hcy levels between patients with active and quiescent disease.\nOur results suggest that Hcy may play a role in the pathogenesis of vitiligo. This may have implications for the treatment of vitiligo.",
        "levenshtein_distance": 604
    },
    {
        "realidx": "18667100",
        "question": "Suicide is a leading cause of death and has been strongly associated with affective disorders. The influence of affective disorder polarity on subsequent suicide attempts or completions and any differential effect of suicide risk factors by polarity were assessed in a prospective cohort.\nParticipants with major affective disorders in the National Institute of Mental Health (NIMH) Collaborative Depression Study (CDS) were followed prospectively for up to 25 years. A total of 909 participants meeting prospective diagnostic criteria for major depressive and bipolar disorders were followed through 4204 mood cycles. Suicidal behavior was defined as suicide attempts or completions. Mixed-effects, grouped-time survival analysis assessed risk of suicidal behavior and differential effects of risk factors for suicidal behavior by polarity. In addition to polarity, the main effects of age, gender, hopelessness, married status, prior suicide attempts and active substance abuse were modeled, with mood cycle as the unit of analysis.\nAfter controlling for age of onset, there were no differences in prior suicide attempts by polarity although bipolar participants had more prior severe attempts. During follow-up, 40 cycles ended in suicide and 384 cycles contained at least one suicide attempt. Age, hopelessness and active substance abuse but not polarity predicted suicidal behavior. The effects of risk factors did not differ by polarity.\nDo risk factors for suicidal behavior differ by affective disorder polarity?",
        "answer": "no",
        "answer_rationale": "Bipolarity does not independently influence risk of suicidal behavior or alter the influence of well-established suicide risk factors within affective disorders. Suicide risk assessment strategies may continue to appraise these common risk factors without regard to mood polarity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Suicide is a leading cause of death and has been strongly associated with affective disorders. The influence of affective disorder polarity on subsequent suicide attempts or completions and any differential effect of suicide risk factors by polarity were assessed in a prospective cohort.\nParticipants with major affective disorders in the National Institute of Mental Health (NIMH) Collaborative Depression Study (CDS) were followed prospectively for up to 25 years. A total of 909 participants meeting prospective diagnostic criteria for major depressive and bipolar disorders were followed through 4204 mood cycles. Suicidal behavior was defined as suicide attempts or completions. Mixed-effects, grouped-time survival analysis assessed risk of suicidal behavior",
        "q2": " and differential effects of risk factors for suicidal behavior by polarity. In addition to polarity, the main effects of age, gender, hopelessness, married status, prior suicide attempts and active substance abuse were modeled, with mood cycle as the unit of analysis.\nAfter controlling for age of onset, there were no differences in prior suicide attempts by polarity although bipolar participants had more prior severe attempts. During follow-up, 40 cycles ended in suicide and 384 cycles contained at least one suicide attempt. Age, hopelessness and active substance abuse but not polarity predicted suicidal behavior. The effects of risk factors did not differ by polarity.\nDo risk factors for suicidal behavior differ by affective disorder polarity?",
        "generated_text": "by diagnostic group and by risk factors.\nSuicidal behavior was more common in participants with bipolar disorder (28.4%) than in those with major depressive disorder (15.4%). The risk of suicidal behavior was higher in participants with bipolar disorder (hazard ratio [HR], 2.02; 95% CI, 1.41-2.89; P < .001). The risk of suicidal behavior was higher in participants with a history of suicidal behavior (HR, 2.42; 95% CI, 1.71-3.42; P < .001),",
        "levenshtein_distance": 537
    },
    {
        "realidx": "18693227",
        "question": "This study was performed to describe the treatment plan modifications after a geriatric oncology clinic. Assessment of health and functional status and cancer assessment was performed in older cancer patients referred to a cancer center.\nBetween June 2004 and May 2005, 105 patients 70 years old or older referred to a geriatric oncology consultation at the Institut Curie cancer center were included. Functional status, nutritional status, mood, mobility, comorbidity, medication, social support, and place of residence were assessed. Oncology data and treatment decisions were recorded before and after this consultation. Data were analyzed for a possible correlation between one domain of the assessment and modification of the treatment plan.\nPatient characteristics included a median age of 79 years and a predominance of women with breast cancer. About one half of patients had an independent functional status. Nearly 15% presented severe undernourishment. Depression was suspected in 53.1% of cases. One third of these patients had>2 chronic diseases, and 74% of patients took>or =3 medications. Of the 93 patients with an initial treatment decision, the treatment plan was modified for 38.7% of cases after this assessment. Only body mass index and the absence of depressive symptoms were associated with a modification of the treatment plan.\nDoes a geriatric oncology consultation modify the cancer treatment plan for elderly patients?",
        "answer": "yes",
        "answer_rationale": "The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study was performed to describe the treatment plan modifications after a geriatric oncology clinic. Assessment of health and functional status and cancer assessment was performed in older cancer patients referred to a cancer center.\nBetween June 2004 and May 2005, 105 patients 70 years old or older referred to a geriatric oncology consultation at the Institut Curie cancer center were included. Functional status, nutritional status, mood, mobility, comorbidity, medication, social support, and place of residence were assessed. Oncology data and treatment decisions were recorded before and after this consultation. Data were analyzed for a possible correlation between one domain of the assessment and modification of the treatment plan.\nPatient characteristics included",
        "q2": " a median age of 79 years and a predominance of women with breast cancer. About one half of patients had an independent functional status. Nearly 15% presented severe undernourishment. Depression was suspected in 53.1% of cases. One third of these patients had>2 chronic diseases, and 74% of patients took>or =3 medications. Of the 93 patients with an initial treatment decision, the treatment plan was modified for 38.7% of cases after this assessment. Only body mass index and the absence of depressive symptoms were associated with a modification of the treatment plan.\nDoes a geriatric oncology consultation modify the cancer treatment plan for elderly patients?",
        "generated_text": "a median age of 78 years (range, 70 to 92 years), 58% women, 50% with breast cancer, 25% with lung cancer, and 25% with other cancers. The median number of comorbidities was 2 (range, 0 to 7). The median number of medications was 5 (range, 0 to 15). The median Charlson comorbidity index was 2 (range, 0 to 6). The median instrumental activities of daily living (IADL) score was 6 (range, 0 to 8). The median body mass index",
        "levenshtein_distance": 468
    },
    {
        "realidx": "18708308",
        "question": "Despite evidence against its utility, many surgeons continue to employ prophylactic nasogastric decompression in elective colonic resection. This study aimed to establish whether an easy and practical intervention, mailing out a summary of current evidence to surgeons, can change surgeons practice to bring it more in line with current evidence.\nThe use of prophylactic nasogastric (NG) decompression in elective colonic resections was documented for the 2 consecutive months of October and November, 2004 at the Royal Alexandra Hospital (RAH). A one page summary of recent evidence concerning this practice was then mailed to all general surgeons at that institution. A similar second review was carried out for the months of January and February, 2005. The two periods were compared with regards to prophylactic NG use.\nTwenty two patients underwent elective colonic resections during the months of October and November, 2004. Twenty one patients underwent such procedures in January and February, 2005. Seven out of the 22 cases in the first group (the pre-intervention block) received prophylactic NG decompression. Five out of the 21 cases in the second group (the post-intervention block) received prophylactic NG decompression. The difference in prophylactic NG use between the two groups was not statistically significant.\nCan surgeon familiarization with current evidence lead to a change in practice?",
        "answer": "no",
        "answer_rationale": "This study has shown that mailing out a summary of current evidence to surgeons concerning a certain issue is not sufficient to lead to a change in practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Despite evidence against its utility, many surgeons continue to employ prophylactic nasogastric decompression in elective colonic resection. This study aimed to establish whether an easy and practical intervention, mailing out a summary of current evidence to surgeons, can change surgeons practice to bring it more in line with current evidence.\nThe use of prophylactic nasogastric (NG) decompression in elective colonic resections was documented for the 2 consecutive months of October and November, 2004 at the Royal Alexandra Hospital (RAH). A one page summary of recent evidence concerning this practice was then mailed to all general surgeons at that institution. A similar second review was carried out for the months",
        "q2": " of January and February, 2005. The two periods were compared with regards to prophylactic NG use.\nTwenty two patients underwent elective colonic resections during the months of October and November, 2004. Twenty one patients underwent such procedures in January and February, 2005. Seven out of the 22 cases in the first group (the pre-intervention block) received prophylactic NG decompression. Five out of the 21 cases in the second group (the post-intervention block) received prophylactic NG decompression. The difference in prophylactic NG use between the two groups was not statistically significant.\nCan surgeon familiarization with current evidence lead to a change in practice?",
        "generated_text": "of October and November, 2005.\nIn the first review, 100% of surgeons used NG decompression in elective colonic resections. In the second review, 60% of surgeons had stopped using NG decompression, and 40% continued to use it.\nThis simple intervention of mailing out a summary of current evidence to surgeons was associated with a 40% reduction in the use of prophylactic NG decompression in elective colonic resections.",
        "levenshtein_distance": 466
    },
    {
        "realidx": "18714572",
        "question": "Vaginal intraepithelial neoplasia is a little known disease which could be related to risk factors different from simple HPV infections.\nTo ascertain wheter vaginal lesions have a natural history similar to cervical lesions.MATERIALS &\nA retrospective study to identify patients with vaginal lesions and synchronous cervical lesions through biopsy. The rate of mild cervical lesions (koilocytosis, warts, CIN I with and without koilocytosis) was compared with the rate of severe cervical lesions (CIN II and III, cervical carcinoma) in patients with mild vaginal lesions (warts and koilocytosis, and low-grade VAIN) and in patients with severe vaginal lesions (high-grade VAIN). Using koilocytosis as a marker, the rate of \"active\" cervical lesions was compared with the rate of \"non active\" cervical lesions in patients with \"active\" versus \"non active\" vaginal lesions. Finally, the rates of mild and severe cervical lesions were compared among each group of VAIN (low-grade, high-grade, with or without koilocytosis).\nIn patients with mild vaginal lesions, mild cervical lesions were significantly more frequent than severe cervical lesions. In patients with \"active\" vaginal lesions the rate of \"active\" cervical lesions was significantly higher than \"non active\" cervical lesions. The differences in rates of mild cervical lesions and severe cervical lesions among patients with high-grade VAIN and low-grade VAIN (with and without koilocytosis) were not significant.\nDoes vaginal intraepithelial neoplasia have the same evolution as cervical intraepithelial neoplasia?",
        "answer": "maybe",
        "answer_rationale": "These data suggest that CIN and VAIN may have some common features in certain cases, i.e., if an HPV infection is proved.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Vaginal intraepithelial neoplasia is a little known disease which could be related to risk factors different from simple HPV infections.\nTo ascertain wheter vaginal lesions have a natural history similar to cervical lesions.MATERIALS &\nA retrospective study to identify patients with vaginal lesions and synchronous cervical lesions through biopsy. The rate of mild cervical lesions (koilocytosis, warts, CIN I with and without koilocytosis) was compared with the rate of severe cervical lesions (CIN II and III, cervical carcinoma) in patients with mild vaginal lesions (warts and koilocytosis, and low-grade VAIN) and in patients with severe vaginal lesions (high-grade VAIN). Using koilocytosis as a marker, the rate of \"active\" cervical lesions was compared with the",
        "q2": " rate of \"non active\" cervical lesions in patients with \"active\" versus \"non active\" vaginal lesions. Finally, the rates of mild and severe cervical lesions were compared among each group of VAIN (low-grade, high-grade, with or without koilocytosis).\nIn patients with mild vaginal lesions, mild cervical lesions were significantly more frequent than severe cervical lesions. In patients with \"active\" vaginal lesions the rate of \"active\" cervical lesions was significantly higher than \"non active\" cervical lesions. The differences in rates of mild cervical lesions and severe cervical lesions among patients with high-grade VAIN and low-grade VAIN (with and without koilocytosis) were not significant.\nDoes vaginal intraepithelial neoplasia have the same evolution as cervical intraepithelial neoplasia?",
        "generated_text": "rate of \"active\" vaginal lesions in patients with cervical lesions. The rate of vaginal lesions in patients with cervical lesions was compared with the rate of cervical lesions in patients with vaginal lesions. The rate of vaginal lesions in patients with cervical lesions was compared with the rate of vaginal lesions in patients without cervical lesions. The rate of vaginal lesions in patients with cervical lesions was compared with the rate of vaginal lesions in patients with cervical lesions and with the rate of vaginal lesions in patients without cervical lesions. The rate of vaginal lesions in patients with cervical lesions was compared with the rate of vaginal lesions in patients with cervical lesions and with the rate of vaginal lesions in patients without cervical lesions. The rate of vaginal lesions in patients with cervical lesions was compared with the rate of vaginal lesions in patients with cervical lesions and with the rate of",
        "levenshtein_distance": 549
    },
    {
        "realidx": "18719011",
        "question": "To compare growth curves of body mass index from children to adolescents, and then to young adults, in Japanese girls and women in birth cohorts born from 1930 to 1999.\nRetrospective repeated cross sectional annual nationwide surveys (national nutrition survey, Japan) carried out from 1948 to 2005.\nJapan.\n76,635 females from 1 to 25 years of age.\nBody mass index.\nGenerally, body mass index decreased in preschool children (2-5 years), increased in children (6-12 years) and adolescents (13-18 years), and slightly decreased in young adults (19-25 years) in these Japanese females. However, the curves differed among birth cohorts. More recent cohorts were more overweight as children but thinner as young women. The increments in body mass index in early childhood were larger in more recent cohorts than in older cohorts. However, the increments in body mass index in adolescents were smaller and the decrease in body mass index in young adults started earlier, with lower peak values in more recent cohorts than in older cohorts. The decrements in body mass index in young adults were similar in all birth cohorts.\nDo overweight children necessarily make overweight adults?",
        "answer": "no",
        "answer_rationale": "An overweight birth cohort in childhood does not necessarily continue to be overweight in young adulthood. Not only secular trends in body mass index at fixed ages but also growth curves for wide age ranges by birth cohorts should be considered to study obesity and thinness. Growth curves by birth cohorts were produced by a repeated cross sectional annual survey over nearly six decades.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To compare growth curves of body mass index from children to adolescents, and then to young adults, in Japanese girls and women in birth cohorts born from 1930 to 1999.\nRetrospective repeated cross sectional annual nationwide surveys (national nutrition survey, Japan) carried out from 1948 to 2005.\nJapan.\n76,635 females from 1 to 25 years of age.\nBody mass index.\nGenerally, body mass index decreased in preschool children (2-5 years), increased in children (6-12 years) and adolescents (13-18 years), and slightly decreased",
        "q2": " in young adults (19-25 years) in these Japanese females. However, the curves differed among birth cohorts. More recent cohorts were more overweight as children but thinner as young women. The increments in body mass index in early childhood were larger in more recent cohorts than in older cohorts. However, the increments in body mass index in adolescents were smaller and the decrease in body mass index in young adults started earlier, with lower peak values in more recent cohorts than in older cohorts. The decrements in body mass index in young adults were similar in all birth cohorts.\nDo overweight children necessarily make overweight adults?",
        "generated_text": "in young adults (19-25 years). The body mass index of preschool children decreased from 1948 to 1955, increased from 1955 to 1970, and decreased again from 1970 to 2005. The body mass index of children and adolescents increased from 1948 to 2005, with the increase being greater in older age groups. The body mass index of young adults increased from 1948 to 1970 and decreased from 19",
        "levenshtein_distance": 434
    },
    {
        "realidx": "18783922",
        "question": "We analyzed cytokines levels in patients with epilepsy and new onset seizure and correlated it with various parameters.\nAfter obtaining consent, serum samples from 100 patients with epilepsy or new onset seizure were prospectively collected in the immediate post-ictal phase. In 16 patients, a second sample was collected during the seizure-free period. The serum cytokine levels [TNF-alpha, IFN-gamma, IL-1beta, IL-2, IL-4, and IL-6] were assessed (ELISA) in these patients and 100 matched healthy controls. CSF analysis was carried out in 9 patients of this cohort, when clinically indicated.\nThe type of seizures (n=100) was major (45), partial (41) and status epilepticus (SE=14), while the epilepsy syndromes were idiopathic generalized (53) and localization related (47). The detectable serum cytokines in the patient group (n=100) were: IL-6 (42), TNF-alpha (36), IL-2 (22), IL-4 (22), IFN-gamma (20) and IL-1 (11) compared to the controls. CSF IL-6 and IL-1 was detectable in 4/9 and 2/9 patients, respectively while, IL-2, IL-4, IFN-gamma was detectable 1 in each patient. Correlations were noted between male gender and IL-1beta (p=0.04), positive family history and IL-1beta (p=0.001), \"no alcohol use\" and TNF-alpha (p=0.05), more than one year history of epilepsy and IL-1beta (p=0.02), status epilepticus (SE) and IL-6 (p=0.04). There was no difference between the new onset seizures vs. epilepsy group. Serial analysis during the seizure-free period revealed a decrease in cytokine levels: TNF-alpha (25% to 12.5%), IFN-gamma (12.5% to 0%), IL-1 (25% to 0) and IL-2 (6.2% to 6.2%), IL-4 (18.8% to 0%) and IL-6 (18.8% to 6.2%).\nDo cytokines have any role in epilepsy?",
        "answer": "yes",
        "answer_rationale": "We found increased post-ictal serum cytokine levels in patients with several epilepsy syndromes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We analyzed cytokines levels in patients with epilepsy and new onset seizure and correlated it with various parameters.\nAfter obtaining consent, serum samples from 100 patients with epilepsy or new onset seizure were prospectively collected in the immediate post-ictal phase. In 16 patients, a second sample was collected during the seizure-free period. The serum cytokine levels [TNF-alpha, IFN-gamma, IL-1beta, IL-2, IL-4, and IL-6] were assessed (ELISA) in these patients and 100 matched healthy controls. CSF analysis was carried out in 9 patients of this cohort, when clinically indicated.\nThe type of seizures (n=100) was major (45), partial (41) and status epilepticus (SE=14), while the epilepsy syndromes were idiopathic generalized (53) and localization related (47). The detectable serum cytokines in the patient group (n=100) were: IL-6 (42), TNF-alpha (36), IL-2 (22), IL-4 (22), IFN-gamma (20) and IL-1 (11) compared to the controls. CSF IL-6 and",
        "q2": " IL-1 was detectable in 4/9 and 2/9 patients, respectively while, IL-2, IL-4, IFN-gamma was detectable 1 in each patient. Correlations were noted between male gender and IL-1beta (p=0.04), positive family history and IL-1beta (p=0.001), \"no alcohol use\" and TNF-alpha (p=0.05), more than one year history of epilepsy and IL-1beta (p=0.02), status epilepticus (SE) and IL-6 (p=0.04). There was no difference between the new onset seizures vs. epilepsy group. Serial analysis during the seizure-free period revealed a decrease in cytokine levels: TNF-alpha (25% to 12.5%), IFN-gamma (12.5% to 0%), IL-1 (25% to 0) and IL-2 (6.2% to 6.2%), IL-4 (18.8% to 0%) and IL-6 (18.8% to 6.2%).\nDo cytokines have any role in epilepsy?",
        "generated_text": "TNF-alpha were detected in 5 and 3 patients, respectively. The cytokine levels in the post-ictal phase were significantly higher in patients with SE compared to those with major and partial seizures. The cytokine levels in the post-ictal phase were significantly higher in patients with localization related epilepsy compared to those with idiopathic generalized epilepsy. The cytokine levels in the post-ictal phase were significantly higher in patients with SE compared to those with major and partial seizures. The cytokine levels in the post-ictal phase were significantly higher in patients with localization related epilepsy compared to those with idiopathic generalized epilepsy. The cytokine levels in the post-ictal phase were significantly higher in patients with SE compared to those with major and partial seizures. The cytokine levels in the post-ictal phase were significantly higher in patients with localization related epilepsy compared to those with idiopathic generalized epilepsy. The cytokine levels in the post-ictal phase were significantly higher in patients with SE compared to those with major and partial seizures. The cytokine levels in the post-ictal phase were significantly higher in patients with localization related epilepsy compared to those with idiopathic generalized epilepsy. The cytokine levels",
        "levenshtein_distance": 988
    },
    {
        "realidx": "18802997",
        "question": "Assessing the clinical course of inflammatory bowel disease (IBD) patients consists of periodical clinical evaluations and laboratory tests. We aimed to assess the role of calprotectin tests in predicting clinical relapse in IBD patients.\nNinety-seven patients with ulcerative colitis (UC) and 65 with Crohn's disease (CD) in clinical remission were prospectively included in the study. A 10-g stool sample was collected for calprotectin assay. The cutoff level was set at 130 mg/kg of feces. Patients were followed up for 1 yr after the test or until relapse. The cumulative proportion of relapses was estimated by the Kaplan-Meier analysis. Statistics for equality of survival distribution were tested using the log-rank test.\nThe calprotectin test was positive in 44 UC patients and 26 of them relapsed within a year, while 11 of 53 UC patients with a negative calprotectin test relapsed within the same time frame. Thirty CD patients had a positive calprotectin test and 13 of them relapsed within a year, as did 7 of the 35 with a negative test result. A significant correlation emerged between a positive calprotectin test and the probability of relapse in UC patients (P= 0.000). In CD patients, only cases of colonic CD showed a significant correlation between a positive calprotectin test and the probability of relapse, i.e., 6 colonic CD patients were positive for the calprotectin test and 4 relapsed (P= 0.02).\nCan calprotectin predict relapse risk in inflammatory bowel disease?",
        "answer": "maybe",
        "answer_rationale": "Measuring calprotectin may help to identify UC and colonic CD patients at higher risk of clinical relapse.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Assessing the clinical course of inflammatory bowel disease (IBD) patients consists of periodical clinical evaluations and laboratory tests. We aimed to assess the role of calprotectin tests in predicting clinical relapse in IBD patients.\nNinety-seven patients with ulcerative colitis (UC) and 65 with Crohn's disease (CD) in clinical remission were prospectively included in the study. A 10-g stool sample was collected for calprotectin assay. The cutoff level was set at 130 mg/kg of feces. Patients were followed up for 1 yr after the test or until relapse. The cumulative proportion of relapses was estimated by the Kaplan-Meier analysis. Statistics for equality of survival distribution were tested using the log-rank test.\nThe calprotectin test was positive in 44 UC patients",
        "q2": " and 26 of them relapsed within a year, while 11 of 53 UC patients with a negative calprotectin test relapsed within the same time frame. Thirty CD patients had a positive calprotectin test and 13 of them relapsed within a year, as did 7 of the 35 with a negative test result. A significant correlation emerged between a positive calprotectin test and the probability of relapse in UC patients (P= 0.000). In CD patients, only cases of colonic CD showed a significant correlation between a positive calprotectin test and the probability of relapse, i.e., 6 colonic CD patients were positive for the calprotectin test and 4 relapsed (P= 0.02).\nCan calprotectin predict relapse risk in inflammatory bowel disease?",
        "generated_text": "(45.4%) and in 24 CD patients (36.9%). The cumulative proportion of relapses was higher in patients with positive calprotectin test in both UC (P = 0.0001) and CD (P = 0.0001). The hazard ratio for relapse in patients with positive calprotectin test was 4.1 (95% confidence interval [CI], 2.1-8.1) in UC and 4.3 (95% CI, 1.8-10.1) in CD. The sensitivity of the test was 75% (95% CI, 58-87) in UC and 71% (95% CI, 48-",
        "levenshtein_distance": 501
    },
    {
        "realidx": "18926458",
        "question": "Several prospective randomized trials have proved carotid endarterectomy to be safe and effective for both symptomatic and asymptomatic patients younger than 80 years of age. Recently, carotid artery stenting (CAS) has been approved for use in selected high-risk patients. It has been proposed that being an octogenarian places patients in this high-risk category.\nAll patients between the ages of 80 to 89 years undergoing carotid endarterectomy during a 12-year period were included in the study. Information included indications for carotid endarterectomy, associated risk factors, length of stay, and hospital course. Perioperative morbidity and mortality, including neurologic events and myocardial infarction, were recorded.\nA total of 103 carotid endarterectomies were performed in 95 octogenarians. Procedures were performed on 59 men and 36 women. Indications for operation included symptomatic carotid stenosis in 44 patients (43%) and asymptomatic carotid stenosis in 59 (57%). Associated risk factors included diabetes mellitus (17%), hypertension (76%), coronary artery disease (28%), hyperlipidemia (39%), and history of smoking (42%). There were 4 perioperative neurologic complications, which included 1 transient ischemic attack (0.97%), 2 minor strokes (1.94%), and 1 major stroke (0.97%). There were no deaths.\nAre octogenarians at high risk for carotid endarterectomy?",
        "answer": "no",
        "answer_rationale": "Combined end points for adverse events are acceptable in the octogenarian. Carotid endarterectomy remains the gold standard for treatment of extracranial carotid disease in all age groups. Age alone should not place patients in the high-risk category for carotid endarterectomy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Several prospective randomized trials have proved carotid endarterectomy to be safe and effective for both symptomatic and asymptomatic patients younger than 80 years of age. Recently, carotid artery stenting (CAS) has been approved for use in selected high-risk patients. It has been proposed that being an octogenarian places patients in this high-risk category.\nAll patients between the ages of 80 to 89 years undergoing carotid endarterectomy during a 12-year period were included in the study. Information included indications for carotid endarterectomy, associated risk factors, length of stay, and hospital course. Perioperative morbidity and mortality, including neurologic events and myocardial infarction, were recorded.\nA total of 103 carotid end",
        "q2": "arterectomies were performed in 95 octogenarians. Procedures were performed on 59 men and 36 women. Indications for operation included symptomatic carotid stenosis in 44 patients (43%) and asymptomatic carotid stenosis in 59 (57%). Associated risk factors included diabetes mellitus (17%), hypertension (76%), coronary artery disease (28%), hyperlipidemia (39%), and history of smoking (42%). There were 4 perioperative neurologic complications, which included 1 transient ischemic attack (0.97%), 2 minor strokes (1.94%), and 1 major stroke (0.97%). There were no deaths.\nAre octogenarians at high risk for carotid endarterectomy?",
        "generated_text": "arterectomies were performed in 94 patients. The mean age was 83 years. The male to female ratio was 2:1. The mean follow-up was 2.5 years. The overall perioperative morbidity and mortality was 4.8%. There were no perioperative deaths. There were two minor strokes (1.9%) and one major stroke (0.9%). There was one myocardial infarction (0.9%). There was one reoperation for bleeding (0.9%). There was one case of cranial nerve injury (0.9%). There was one case of restenosis (0.9%). There was one case of wound infection (0.9%). There was",
        "levenshtein_distance": 431
    },
    {
        "realidx": "18928979",
        "question": "The objective of the study was to determine whether myometrial electrical activity can differentiate false from true preterm labor.\nElectrical uterine myography (EUM) was measured prospectively on 87 women, gestational age less than 35 weeks. The period between contractions, power of contraction peaks and movement of center of electrical activity (RMS), was used to develop an index score (1-5) for prediction of preterm delivery (PTD) within 14 days of the test. The score was compared with fetal fibronectin (fFN) and cervical length (CL).\nPatients delivering within 14 days from testing showed a higher index and mean RMS (P = .000). No patients with EUM index scores of 1-2 delivered in this time frame. Combining EUM with CL or fFN increased predictability. Logistic regression revealed that history of PTD and EUM index had 4- to 5-fold increased risk for PTD. Gestational age at testing, body mass index, fFN, and CL were nonsignificant contributors to PTD risk.\nCan myometrial electrical activity identify patients in preterm labor?",
        "answer": "yes",
        "answer_rationale": "Measuring myometrial electrical activity may enhance identification of patients in true premature labor.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The objective of the study was to determine whether myometrial electrical activity can differentiate false from true preterm labor.\nElectrical uterine myography (EUM) was measured prospectively on 87 women, gestational age less than 35 weeks. The period between contractions, power of contraction peaks and movement of center of electrical activity (RMS), was used to develop an index score (1-5) for prediction of preterm delivery (PTD) within 14 days of the test. The score was compared with fetal fibronectin (fFN) and cervical length (",
        "q2": "CL).\nPatients delivering within 14 days from testing showed a higher index and mean RMS (P = .000). No patients with EUM index scores of 1-2 delivered in this time frame. Combining EUM with CL or fFN increased predictability. Logistic regression revealed that history of PTD and EUM index had 4- to 5-fold increased risk for PTD. Gestational age at testing, body mass index, fFN, and CL were nonsignificant contributors to PTD risk.\nCan myometrial electrical activity identify patients in preterm labor?",
        "generated_text": "CL) in predicting PTD.\nThe index score was significantly higher in women who delivered within 14 days (p < 0.001). The area under the receiver operating characteristic curve (AUC) for the index score was 0.87 (95% CI 0.79-0.95), which was higher than fFN (AUC 0.71, 95% CI 0.59-0.82) and CL (AUC 0.74, 95% CI",
        "levenshtein_distance": 382
    },
    {
        "realidx": "19027440",
        "question": "The objectives of this study were to investigate longitudinal predictors of fear of recurrence in survivors of head and neck cancer (HNC) using Leventhal's Common Sense Model (CSM) as a framework. The research questions were as follows: (a) to what extent do HNC patients report fear of cancer recurrence? (b) To what extent are fears of recurrence manifestations of illness-related anxiety? (c) Are fears of recurrence closely related to current symptoms, disease, and treatment-related factors, or psychological/socio-demographic factors? (d) What factors are predictive of long-term fears of recurrence?\nA prospective repeat measures design was employed whereby a sample of 82 newly diagnosed HNC patients (54 males, 28 females, mean age 60 years) completed measures of fears of recurrence, illness perceptions, coping, and anxiety and depression, prior to treatment and 6-8 months after treatment (fears of recurrence only).\nA third of HNC patients at diagnosis reported relatively high levels of fears of recurrence, with 12% still reporting similar levels of fear 6-8 months after treatment. Fears of recurrence were not related to any socio-demographic factor (age, gender, ethnicity, marital status, and educational attainment) or disease, treatment, or symptom-related factors. Path analyses demonstrated that fears of cancer recurrence after treatment were directly predicted by pre-treatment fears and optimism.\nCan we predict which head and neck cancer survivors develop fears of recurrence?",
        "answer": "yes",
        "answer_rationale": "Although components of the CSM (cognitive and emotional representations, coping strategies) were associated with fears of recurrence, optimism was found to be the strongest predictor of fear, independent of anxiety and level of fear reported prior to treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The objectives of this study were to investigate longitudinal predictors of fear of recurrence in survivors of head and neck cancer (HNC) using Leventhal's Common Sense Model (CSM) as a framework. The research questions were as follows: (a) to what extent do HNC patients report fear of cancer recurrence? (b) To what extent are fears of recurrence manifestations of illness-related anxiety? (c) Are fears of recurrence closely related to current symptoms, disease, and treatment-related factors, or psychological/socio-demographic factors? (d) What factors are predictive of long-term fears of recurrence?\nA prospective repeat measures design was employed whereby a sample of 82 newly diagnosed HNC patients (54 males, 28 females",
        "q2": ", mean age 60 years) completed measures of fears of recurrence, illness perceptions, coping, and anxiety and depression, prior to treatment and 6-8 months after treatment (fears of recurrence only).\nA third of HNC patients at diagnosis reported relatively high levels of fears of recurrence, with 12% still reporting similar levels of fear 6-8 months after treatment. Fears of recurrence were not related to any socio-demographic factor (age, gender, ethnicity, marital status, and educational attainment) or disease, treatment, or symptom-related factors. Path analyses demonstrated that fears of cancer recurrence after treatment were directly predicted by pre-treatment fears and optimism.\nCan we predict which head and neck cancer survivors develop fears of recurrence?",
        "generated_text": "; mean age 58.5 years, SD = 10.1) completed questionnaires at pre-treatment, 3, 6, 12, and 24 months post-treatment. Measures included the Fear of Cancer Recurrence Inventory (FCRI), Hospital Anxiety and Depression Scale (HADS), EORTC QLQ-C30, and EORTC QLQ-H&N35. Patients also completed a demographic questionnaire and underwent a clinical assessment.\nResults indicated that fear of recurrence was a significant problem for HNC patients, with 40% of patients reporting clinically significant levels of fear of recurrence at 24 months post-treatment. Fear of recurrence was strongly related to",
        "levenshtein_distance": 556
    },
    {
        "realidx": "19100463",
        "question": "Tacrolimus is a potent immunosuppressive drug used in organ transplantation. Because of its substantial toxic effects, narrow therapeutic index, and interindividual pharmacokinetic variability, therapeutic drug monitoring of whole-blood tacrolimus concentrations has been recommended. We investigated the comparability of the results of 2 immunoassay systems, affinity column-mediated immunoassay (ACMIA) and microparticle enzyme immunoassay (MEIA), comparing differences in the tacrolimus concentrations measured by the 2 methods in relation to the hematologic and biochemical values of hepatic and renal functions.\nA total of 154 samples from kidney or liver transplant recipients were subjected to Dimension RxL HM with a tacrolimus Flex reagent cartilage for the ACMIA method and IMx tacrolimus II for the MEIA method.\nTacrolimus concentrations measured by the ACMIA method (n = 154) closely correlated with those measured by the MEIA method (r = 0.84). The Bland-Altman plot using concentration differences between the 2 methods and the average of the 2 methods showed no specific trends. The tacrolimus levels determined by both the MEIA method and the ACMIA method were not influenced by hematocrit levels, but the difference between the 2 methods (ACMIA - MEIA) tended to be larger in low hematocrit samples (P<.001).\nIs the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?",
        "answer": "yes",
        "answer_rationale": "The ACMIA method used for a tacrolimus assay is precise and has advantages, including the lack of a required pretreatment procedure. Furthermore, it is only slightly influenced by the hematologic or biochemical status of the samples.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Tacrolimus is a potent immunosuppressive drug used in organ transplantation. Because of its substantial toxic effects, narrow therapeutic index, and interindividual pharmacokinetic variability, therapeutic drug monitoring of whole-blood tacrolimus concentrations has been recommended. We investigated the comparability of the results of 2 immunoassay systems, affinity column-mediated immunoassay (ACMIA) and microparticle enzyme immunoassay (MEIA), comparing differences in the tacrolimus concentrations measured by the 2 methods in relation to the hematologic and biochemical values of hepatic and renal functions.\nA total of 154 samples from kidney or liver transplant recipients were subjected to Dimension RxL HM with a tacrolimus Flex reagent cartilage for the ACMIA method and IMx tacrolimus",
        "q2": " II for the MEIA method.\nTacrolimus concentrations measured by the ACMIA method (n = 154) closely correlated with those measured by the MEIA method (r = 0.84). The Bland-Altman plot using concentration differences between the 2 methods and the average of the 2 methods showed no specific trends. The tacrolimus levels determined by both the MEIA method and the ACMIA method were not influenced by hematocrit levels, but the difference between the 2 methods (ACMIA - MEIA) tended to be larger in low hematocrit samples (P<.001).\nIs the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?",
        "generated_text": "for the MEIA method. The results of the 2 methods were compared by linear regression analysis, Bland-Altman analysis, and Passing-Bablok regression analysis. The correlation between the differences in the tacrolimus concentrations measured by the 2 methods and the hematologic and biochemical values of hepatic and renal functions was also evaluated.\nThe correlation coefficient between the 2 methods was 0.972. The mean difference between the 2 methods was 0.22 ng/mL, and the 95% limits of agreement were -1.11 to 1.55 ng/mL. The Passing-Bablok regression analysis showed a significant difference between the 2 methods (P < 0.001). The difference in the tacrol",
        "levenshtein_distance": 490
    },
    {
        "realidx": "19103915",
        "question": "There is an urgent need to increase opportunistic screening for sexually transmitted infections (STIs) in community settings, particularly for those who are at increased risk including men who have sex with men (MSM). The aim of this qualitative study was to explore whether home sampling kits (HSK) for multiple bacterial STIs are potentially acceptable among MSM and to identify any concerns regarding their use. This study was developed as part of a formative evaluation of HSKs.\nFocus groups and one-to-one semi-structured interviews with MSM were conducted. Focus group participants (n = 20) were shown a variety of self-sampling materials and asked to discuss them. Individual interviewees (n = 24) had experience of the self-sampling techniques as part of a pilot clinical study. All data were digitally recorded and transcribed verbatim. Data were analysed using a framework analysis approach.\nThe concept of a HSK was generally viewed as positive, with many benefits identified relating to increased access to testing, enhanced personal comfort and empowerment. Concerns about the accuracy of the test, delays in receiving the results, the possible lack of support and potential negative impact on 'others' were raised.\nAre home sampling kits for sexually transmitted infections acceptable among men who have sex with men?",
        "answer": "maybe",
        "answer_rationale": "The widespread acceptability of using HSKs for the diagnosis of STIs could have important public health impacts in terms of earlier diagnosis of asymptomatic infections and thus a decrease in the rate of onward transmission. In addition, HSKs could potentially optimize the use of genitourinary medicine services and facilitate patient choice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "There is an urgent need to increase opportunistic screening for sexually transmitted infections (STIs) in community settings, particularly for those who are at increased risk including men who have sex with men (MSM). The aim of this qualitative study was to explore whether home sampling kits (HSK) for multiple bacterial STIs are potentially acceptable among MSM and to identify any concerns regarding their use. This study was developed as part of a formative evaluation of HSKs.\nFocus groups and one-to-one semi-structured interviews with MSM were conducted. Focus group participants (n = 20) were shown a variety of self-sampling materials and",
        "q2": " asked to discuss them. Individual interviewees (n = 24) had experience of the self-sampling techniques as part of a pilot clinical study. All data were digitally recorded and transcribed verbatim. Data were analysed using a framework analysis approach.\nThe concept of a HSK was generally viewed as positive, with many benefits identified relating to increased access to testing, enhanced personal comfort and empowerment. Concerns about the accuracy of the test, delays in receiving the results, the possible lack of support and potential negative impact on 'others' were raised.\nAre home sampling kits for sexually transmitted infections acceptable among men who have sex with men?",
        "generated_text": "asked to discuss their acceptability and usability. Semi-structured interviews (n = 10) were conducted to explore the acceptability of HSKs in more depth. All data were audio-recorded, transcribed verbatim and analysed using thematic analysis.\nParticipants were positive about the acceptability of HSKs for multiple bacterial STIs and thought that they would be acceptable to a wide range of MSM. The main concerns were around the accuracy of the tests and the need for a healthcare professional to interpret the results. Participants also expressed concerns about the potential for false negatives and the need for follow-up testing. Some participants also raised concerns",
        "levenshtein_distance": 463
    },
    {
        "realidx": "19106867",
        "question": "Recent suicide bombings pose the novel problem for Trauma Centers of the massive simultaneous arrival of many gravely wounded patients.\nWe report the experience of the French-German Military Trauma Group, a Level 2 Trauma Center, in Afghanistan during the wave of suicide bombings in February 2007.\nFourteen casualties were received. A first triage was carried out by the U S Army Level I group prior to evacuation. A second surgical triage was carried out with systematic ultrasound exam. Four cases (ISS>25) were re-categorized and underwent emergency surgical procedures.\nThe Main Gate Syndrome: a new format in mass-casualty victim \"surge\" management?",
        "answer": "yes",
        "answer_rationale": "Suicide bombing in crowded locations near an evacuation hospital may overwhelm the medical resources of the receiving center. It has been referred to as \"The Main Gate Syndrome.\" We introduced the novel concept of a semi-evacuation hospital or receiving center where a second surgical triage was carried out. These exceptional circumstances require open-minded flexibility, a tailored approach, and close cooperation between surgeons and anesthetists to share experience, opinions, and ideas. In the setting of mass casualties, emergency ultrasound exam was shown to be a valuable and effective tool by virtue of its mobility, reproducibility, and immediate results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Recent suicide bombings pose the novel problem for Trauma Centers of the massive simultaneous arrival of many gravely wounded patients.\nWe report the experience of the French-German Military Trauma Group, a Level 2 Trauma Center, in Afghanistan during the wave of suicide bombings in February 2007.\nFourteen casualties were received. A first tri",
        "q2": "age was carried out by the U S Army Level I group prior to evacuation. A second surgical triage was carried out with systematic ultrasound exam. Four cases (ISS>25) were re-categorized and underwent emergency surgical procedures.\nThe Main Gate Syndrome: a new format in mass-casualty victim \"surge\" management?",
        "generated_text": "age was performed in the helicopter landing zone, and a second one in the emergency room. The patients were divided into three groups: the first group was treated immediately, the second group was treated after the first group, and the third group was treated last. The first group had 5 patients, the second group had 6 patients, and",
        "levenshtein_distance": 256
    },
    {
        "realidx": "19108857",
        "question": "Tuberculosis continues to be a public health problem in emerging countries with a recent evidence of increased incidence of extrapulmonary localization in developed countries probably linked to HIV. To our knowledge the occurrence of cerebro-mediastinal tuberculosis in an immuno-competent child has not been previously described; moreover the child we describe has a probable Say-Barber-Miller syndrome. We discuss a putative causative link between this syndrome and the occurrence of tuberculosis.\nA seven-year-old girl presented to our department with a history of infantile encephalopathy since birth characterized by a facial dysmorphy (evocative of a bird face), microcephaly, and mental retardation, and with recurrent infections. The child had complained of back pain for several months; the parents reported anorexia, loss of weight. Spinal and cerebral MRI showed a mediastinal mass involving the spine and cerebral lesions evocative of tuberculomas. The tuberculin interdermal reaction was positive. Culture of a vertebral biopsy was positive for Koch bacillus. Anti-tuberculosis treatment improved general and local status. An extensive immunological work-up was normal.\nCerebromediastinal tuberculosis in a child with a probable Say-Barber-Miller syndrome: a causative link?",
        "answer": "yes",
        "answer_rationale": "[corrected] This observation is exceptional in many aspects: very early age of onset of extrapulmonary tuberculosis, no immune deficit, association with a rare congenital neurological syndrome. We discuss the possible link between this entity and the occurrence of tuberculosis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Tuberculosis continues to be a public health problem in emerging countries with a recent evidence of increased incidence of extrapulmonary localization in developed countries probably linked to HIV. To our knowledge the occurrence of cerebro-mediastinal tuberculosis in an immuno-competent child has not been previously described; moreover the child we describe has a probable Say-Barber-Miller syndrome. We discuss a putative causative link between this syndrome and the occurrence of tuberculosis.\nA seven-year-old girl presented to our department with a history of infantile encephalopathy since birth characterized by a facial dysmorphy (evocative of a bird face), microce",
        "q2": "phaly, and mental retardation, and with recurrent infections. The child had complained of back pain for several months; the parents reported anorexia, loss of weight. Spinal and cerebral MRI showed a mediastinal mass involving the spine and cerebral lesions evocative of tuberculomas. The tuberculin interdermal reaction was positive. Culture of a vertebral biopsy was positive for Koch bacillus. Anti-tuberculosis treatment improved general and local status. An extensive immunological work-up was normal.\nCerebromediastinal tuberculosis in a child with a probable Say-Barber-Miller syndrome: a causative link?",
        "generated_text": "pha-ly, severe psychomotor retardation, and epilepsy. She had a history of recurrent respiratory infections and had been hospitalized several times for pneumonia. She had a history of recurrent abdominal pain and had been operated on for an appendicitis at the age of 4 years. She had a history of recurrent headaches and had been treated for migraine. She had a history of recurrent otitis media and had undergone a bilateral myringotomy and placement of ventilation tubes. She had a history of recurrent urinary tract infections and had undergone a cystoscopy that revealed a normal bladder. She had a history of recurrent fever and had been treated for",
        "levenshtein_distance": 488
    },
    {
        "realidx": "19130332",
        "question": "Uncontrolled hemorrhage is the leading cause of fatality. The aim of this study was to evaluate the effect of zeolite mineral (QuikClot - Advanced Clotting Sponge [QC-ACS]) on blood loss and physiological variables in a swine extremity arterial injury model.\nSixteen swine were used. Oblique groin incision was created and a 5 mm incision was made. The animals were allocated to: control group (n: 6): Pressure dressing was applied with manual pressure over gauze sponge; or QC group (n: 10): QC was directly applied over lacerated femoral artery. Mean arterial pressure, blood loss and physiological parameters were measured during the study period.\nApplication of QC led to a slower drop in blood pressure. The control group had a significantly higher increase in lactate within 60 minutes. The mean prothrombin time in the control group was significantly increased at 60 minutes. The application of QC led to decreased total blood loss. The QC group had significantly higher hematocrit levels. QC application generated a significant heat production. There were mild edematous and vacuolar changes in nerve samples.\nIs the zeolite hemostatic agent beneficial in reducing blood loss during arterial injury?",
        "answer": "yes",
        "answer_rationale": "According to the physiological parameters, we observed that zeolite tends to reduce blood loss, however could not stop bleeding completely. We believe that further clinical trials are needed to conclude that zeolite could be used in the routine practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Uncontrolled hemorrhage is the leading cause of fatality. The aim of this study was to evaluate the effect of zeolite mineral (QuikClot - Advanced Clotting Sponge [QC-ACS]) on blood loss and physiological variables in a swine extremity arterial injury model.\nSixteen swine were used. Oblique groin incision was created and a 5 mm incision was made. The animals were allocated to: control group (n: 6): Pressure dressing was applied with manual pressure over gauze sponge; or QC group (n: 10): QC was directly applied over lacerated femoral",
        "q2": " artery. Mean arterial pressure, blood loss and physiological parameters were measured during the study period.\nApplication of QC led to a slower drop in blood pressure. The control group had a significantly higher increase in lactate within 60 minutes. The mean prothrombin time in the control group was significantly increased at 60 minutes. The application of QC led to decreased total blood loss. The QC group had significantly higher hematocrit levels. QC application generated a significant heat production. There were mild edematous and vacuolar changes in nerve samples.\nIs the zeolite hemostatic agent beneficial in reducing blood loss during arterial injury?",
        "generated_text": "artery and pressure dressing was applied over it. Arterial blood pressure, heart rate, and blood gases were measured at baseline and 15, 30, 45, and 60 min after injury. Blood loss was measured at 15, 30, 45, and 60 min after injury.\nIn the QC group, the mean blood loss was 100.5 \u00b1 100.5 ml, whereas in the control group, it was 1000 \u00b1 0 ml (p < 0.001). The mean arterial pressure",
        "levenshtein_distance": 484
    },
    {
        "realidx": "19142546",
        "question": "We compared left ventricular regional wall motion, the global left ventricular ejection fraction, and the New York Heart Association functional class pre- and postoperatively.\nEndomyocardial fibrosis is characterized by fibrous tissue deposition in the endomyocardium of the apex and/or inflow tract of one or both ventricles. Although left ventricular global systolic function is preserved, patients exhibit wall motion abnormalities in the apical and inferoapical regions. Fibrous tissue resection in New York Heart Association FC III and IV endomyocardial fibrosis patients has been shown to decrease morbidity and mortality.\nWe prospectively studied 30 patients (20 female, 30+/-10 years) before and 5+/-8 months after surgery. The left ventricular ejection fraction was determined using the area-length method. Regional left ventricular motion was measured by the centerline method. Five left ventricular segments were analyzed pre- and postoperatively. Abnormality was expressed in units of standard deviation from the mean motion in a normal reference population.\nLeft ventricular wall motion in the five regions did not differ between pre- and postoperative measurements. Additionally, the left ventricular ejection fraction did not change after surgery (0.45+/-0.13% x 0.43+/-0.12% pre- and postoperatively, respectively). The New York Heart Association functional class improved to class I in 40% and class II in 43% of patients postoperatively (p<0.05).\nDoes quantitative left ventricular regional wall motion change after fibrous tissue resection in endomyocardial fibrosis?",
        "answer": "no",
        "answer_rationale": "Although endomyocardial fibrosis patients have improved clinical symptoms after surgery, the global left ventricular ejection fraction and regional wall motion in these patients do not change. This finding suggests that other explanations, such as improvements in diastolic function, may be operational.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "We compared left ventricular regional wall motion, the global left ventricular ejection fraction, and the New York Heart Association functional class pre- and postoperatively.\nEndomyocardial fibrosis is characterized by fibrous tissue deposition in the endomyocardium of the apex and/or inflow tract of one or both ventricles. Although left ventricular global systolic function is preserved, patients exhibit wall motion abnormalities in the apical and inferoapical regions. Fibrous tissue resection in New York Heart Association FC III and IV endomyocardial fibrosis patients has been shown to decrease morbidity and mortality.\nWe prospectively studied 30 patients (20 female, 30+/-10 years) before and 5+/-8 months after surgery. The left ventricular ejection fraction was determined using the area-length method",
        "q2": ". Regional left ventricular motion was measured by the centerline method. Five left ventricular segments were analyzed pre- and postoperatively. Abnormality was expressed in units of standard deviation from the mean motion in a normal reference population.\nLeft ventricular wall motion in the five regions did not differ between pre- and postoperative measurements. Additionally, the left ventricular ejection fraction did not change after surgery (0.45+/-0.13% x 0.43+/-0.12% pre- and postoperatively, respectively). The New York Heart Association functional class improved to class I in 40% and class II in 43% of patients postoperatively (p<0.05).\nDoes quantitative left ventricular regional wall motion change after fibrous tissue resection in endomyocardial fibrosis?",
        "generated_text": ", and regional wall motion was assessed using the 16-segment model.\nThe mean left ventricular ejection fraction was 60+/-10% preoperatively and 62+/-10% postoperatively (p=0.1). The mean number of segments with abnormal wall motion was 5.4+/-2.4 preoperatively and 2.4+/-2.1 postoperatively (p<0.001). The number of patients with apical akinesia decreased from 28 to 10 (p<0.001). The number of patients with inferoapical akinesia decreased from 24 to 10 (p<0.001). The number of patients with",
        "levenshtein_distance": 554
    },
    {
        "realidx": "19237087",
        "question": "An unknown number of colorectal cancers could be due to missed adenomas during previous endoscopy. Data in the literature are sparse. A large cross-sectional study was done in a prospective database of all patients diagnosed with colorectal cancer.\nAll consecutive endoscopies over a period of 15 years, in which colorectal cancer was diagnosed were included. All patients who underwent more than one endoscopy and in whom ultimately cancer was diagnosed were studied separately.\nColorectal cancer was diagnosed in 835 patients. Twenty-five patients underwent a previous endoscopy without a cancer diagnosis. These 25 patients were divided into three groups according to the time between the endoscopy in which the cancer was detected and the previous endoscopy. Five out of these 25 patients underwent regular surveillance. Only 11 patients had no argument for regular follow-up. Assuming that these cancers developed from an adenoma than only 11 out of 835 (1.3%) cancers were missed in the adenoma phase. There was no difference in the size of the tumour between the three groups of patients.\nAre many colorectal cancers due to missed adenomas?",
        "answer": "no",
        "answer_rationale": "In normal daily practice, only a small number of clinically important adenomas are missed. The problem of missed adenomas probably is being exaggerated.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "An unknown number of colorectal cancers could be due to missed adenomas during previous endoscopy. Data in the literature are sparse. A large cross-sectional study was done in a prospective database of all patients diagnosed with colorectal cancer.\nAll consecutive endoscopies over a period of 15 years, in which colorectal cancer was diagnosed were included. All patients who underwent more than one endoscopy and in whom ultimately cancer was diagnosed were studied separately.\nColorectal cancer was diagnosed in 835 patients. Twenty-five patients underwent a previous endoscopy without a cancer diagnosis.",
        "q2": " These 25 patients were divided into three groups according to the time between the endoscopy in which the cancer was detected and the previous endoscopy. Five out of these 25 patients underwent regular surveillance. Only 11 patients had no argument for regular follow-up. Assuming that these cancers developed from an adenoma than only 11 out of 835 (1.3%) cancers were missed in the adenoma phase. There was no difference in the size of the tumour between the three groups of patients.\nAre many colorectal cancers due to missed adenomas?",
        "generated_text": "In 12 patients, the previous endoscopy was performed within 3 years, in 11 patients between 3 and 5 years, and in 2 patients more than 5 years before the cancer diagnosis. In 11 patients, the previous endoscopy was performed in another hospital. In 14 patients, the previous endoscopy was performed in our hospital. In 10 patients, the previous endoscopy was a colonoscopy, and in 15 patients, it was a flexible sigmoidos",
        "levenshtein_distance": 377
    },
    {
        "realidx": "19302863",
        "question": "The present study aims to compare strength, healing, and operation time of experimental intestinal anastomoses performed by polyglactin 910 (Vicryl; Ethicon, Edinburgh, United Kingdom) sutures with ethyl-2-cyanoacrylate glue (Pattex; Henkel, Dusseldorf, Germany).\nNinety-six Sprague-Dawley rats were divided into 2 (groups E and L). Each group was further subdivided into 6 subgroups (EA1, EA2, EA3, EB1, EB2, EB3, LA1, LA2, LA3, LB1, LB2, LB3), each containing 8 rats. Intestinal anastomosis was performed by polyglactin 910 sutures in A subgroups and with ethyl-2-cyanoacrylate in B subgroups. The anastomosis was end to end in A1 and B1, side to side in A2 and B2, and end to side in A3 and B3. Time for anastomosis performance (AT) was recorded. In group E, bursting pressures and hydroxyproline levels were determined on the second postoperative day, whereas in group L, the same measurements were made on the sixth postoperative day. One-way analysis of variance was used for analyses of variance in the groups. Quantitative data were analyzed with Student's t test. P value was considered significant at less than .05.\nThere was no significant difference between bursting pressures of subgroup pairs on both postoperative days 2 and 6. Hydroxyproline levels and AT were significantly better in B subgroups.\nIs the use of cyanoacrylate in intestinal anastomosis a good and reliable alternative?",
        "answer": "yes",
        "answer_rationale": "Better healing, shorter AT, and equal strength were achieved with ethyl-2-cyanoacrylate compared with polyglactin 910 sutures in intestinal anastomosis in the experimental setting.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The present study aims to compare strength, healing, and operation time of experimental intestinal anastomoses performed by polyglactin 910 (Vicryl; Ethicon, Edinburgh, United Kingdom) sutures with ethyl-2-cyanoacrylate glue (Pattex; Henkel, Dusseldorf, Germany).\nNinety-six Sprague-Dawley rats were divided into 2 (groups E and L). Each group was further subdivided into 6 subgroups (EA1, EA2, EA3, EB1, EB2, EB3, LA1, LA2, LA3, LB1, LB2, LB3), each containing 8 rats. Intestinal anastomosis was performed by polyglactin 910 sutures in A subgroups and with ethyl-2-cyanoacrylate in B subgroups.",
        "q2": " The anastomosis was end to end in A1 and B1, side to side in A2 and B2, and end to side in A3 and B3. Time for anastomosis performance (AT) was recorded. In group E, bursting pressures and hydroxyproline levels were determined on the second postoperative day, whereas in group L, the same measurements were made on the sixth postoperative day. One-way analysis of variance was used for analyses of variance in the groups. Quantitative data were analyzed with Student's t test. P value was considered significant at less than .05.\nThere was no significant difference between bursting pressures of subgroup pairs on both postoperative days 2 and 6. Hydroxyproline levels and AT were significantly better in B subgroups.\nIs the use of cyanoacrylate in intestinal anastomosis a good and reliable alternative?",
        "generated_text": "In A1 and B1 subgroups, anastomosis was performed in the first postoperative day; in A2 and B2 subgroups, in the seventh postoperative day; and in A3 and B3 subgroups, in the fourteenth postoperative day. Operation time was recorded. Tensile strength was measured by a tensiometer. Histopathologic examination was performed.\nOperation time was significantly shorter in B subgroups (P < .05). Tensile strength was higher in A subgroups in the first and seventh postoperative days (P < .05). There was no significant difference in the fourteenth postoperative day. Histopathologic examination revealed no significant difference between the groups.\nEthyl-2-cyanoacrylate glue can be used in intestinal anastomosis. It is faster and as safe as polyglactin 9",
        "levenshtein_distance": 547
    },
    {
        "realidx": "19351635",
        "question": "National guidelines and government directives have adopted policies for urgent assessment of patients with a transient ischaemic attack or minor stroke not admitted to hospital. The risk of recurrent stroke increases substantially with age, as does the potential benefit of secondary prevention. In order to develop effective strategies for older patients, it is important to identify how stroke care is currently provided for this patient group.\nBetween 2004 and 2006, older patients (>75 years) referred to a neurovascular clinic were compared with younger patients (<or =75 years). Sociodemographic details, clinical features, resource use and secondary prevention in a neurovascular clinic were collected.\nOf 379 patients referred to the clinic, 129 (34%) were given a non-stroke diagnosis. Of the remaining 250 patients, 149 (60%) were<or =75 years. Median time from symptom onset to clinic appointment was similar for the two groups (24 (IQR 15-42) vs 24 (IQR 14-43) days; p = 0.58). Older patients were more likely to be in atrial fibrillation (10.1% vs 22.8%, p<0.001) and have lacunar stroke (34.7% vs 22.1%; p = 0.04). CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75). Scans were performed more quickly in younger patients (p<0.01). MRI scan rates were higher in younger patients (26% vs 4%, p<0.01), as was carotid Doppler imaging (92% vs 77%, p<0.01). There were no differences in prescribed secondary preventive treatments. Older patients experienced less delay for carotid endarterectomy (49 vs 90 days, p<0.01). Younger patients were more likely to be given advice on weight reduction (30.2% vs 12.9%, p<0.01) and diet (46.3% vs 31.7%, p = 0.02) than older patients.\nDo older patients receive adequate stroke care?",
        "answer": "maybe",
        "answer_rationale": "Older patients were less likely to receive diagnostic investigations and lifestyle modification advice than younger patients. Guidelines need to be adopted to ensure prompt evidence-based stroke care in the outpatient setting.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "National guidelines and government directives have adopted policies for urgent assessment of patients with a transient ischaemic attack or minor stroke not admitted to hospital. The risk of recurrent stroke increases substantially with age, as does the potential benefit of secondary prevention. In order to develop effective strategies for older patients, it is important to identify how stroke care is currently provided for this patient group.\nBetween 2004 and 2006, older patients (>75 years) referred to a neurovascular clinic were compared with younger patients (<or =75 years). Sociodemographic details, clinical features, resource use and secondary prevention in a neurovascular clinic were collected.\nOf 379 patients referred to the clinic, 129 (34%) were given a non-stroke diagnosis. Of the remaining 250 patients, 149 (60%) were<or =75 years. Median time from symptom onset to clinic appointment was similar for the two groups (24 (IQR 15-42) vs 24 (IQR 14-43) days; p = 0.58). Older patients were more likely to be in atr",
        "q2": "ial fibrillation (10.1% vs 22.8%, p<0.001) and have lacunar stroke (34.7% vs 22.1%; p = 0.04). CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75). Scans were performed more quickly in younger patients (p<0.01). MRI scan rates were higher in younger patients (26% vs 4%, p<0.01), as was carotid Doppler imaging (92% vs 77%, p<0.01). There were no differences in prescribed secondary preventive treatments. Older patients experienced less delay for carotid endarterectomy (49 vs 90 days, p<0.01). Younger patients were more likely to be given advice on weight reduction (30.2% vs 12.9%, p<0.01) and diet (46.3% vs 31.7%, p = 0.02) than older patients.\nDo older patients receive adequate stroke care?",
        "generated_text": "ial fibrillation (27% vs 12%; p = 0.003), have a history of stroke (29% vs 15%; p = 0.006) and be taking warfarin (17% vs 7%; p = 0.003). Older patients were less likely to be taking aspirin (54% vs 71%; p = 0.002), have carotid imaging (54% vs 71%; p = 0.002) or be referred for carotid endarterectomy (0% vs 4%; p = 0.02). There was no difference in the proportion of patients prescribed statins (60% vs 57%; p = 0.64).\nOlder patients with transient ischaemic attack or minor stroke are less likely to receive carotid imaging and carotid endarterectomy, but are more likely to be prescribed warfarin. These differences may reflect the higher prevalence of atr",
        "levenshtein_distance": 476
    },
    {
        "realidx": "19394934",
        "question": "The incidence of large-scale urban attacks on civilian populations has significantly increased across the globe over the past decade. These incidents often result in Hospital Multiple Casualty Incidents (HMCI), which are very challenging to hospital teams. 15 years ago the Emergency and Disaster Medicine Division in the Israeli Ministry of Health defined a key of 20 percent of each hospital's bed capacity as its readiness for multiple casualties. Half of those casualties are expected to require immediate medical treatment. This study was performed to evaluate the efficacy of the current readiness guidelines based on the epidemiology of encountered HMCIs.\nA retrospective study of HMCIs was recorded in the Israeli Defense Force (IDF) home front command and the Israeli National Trauma Registry (ITR) between November 2000 and June 2003. An HMCI is defined by the Emergency and Disaster Medicine Division in the Israeli Ministry of Health as>or=10 casualties or>or=4 suffering from injuries with an ISS>or=16 arriving to a single hospital.\nThe study includes a total of 32 attacks, resulting in 62 HMCIs and 1292 casualties. The mean number of arriving casualties to a single hospital was 20.8+/-13.3 (range 4-56, median 16.5). In 95% of the HMCIs the casualty load was<or=52. Based on severity scores and ED discharges 1022 (79.2%) casualties did not necessitate immediate medical treatment.\nIsraeli hospital preparedness for terrorism-related multiple casualty incidents: can the surge capacity and injury severity distribution be better predicted?",
        "answer": "yes",
        "answer_rationale": "Hospital preparedness can be better defined by a fixed number of casualties rather than a percentile of its bed capacity. Only 20% of the arriving casualties will require immediate medical treatment. Implementation of this concept may improve the utilisation of national emergency health resources both in the preparation phase and on real time.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The incidence of large-scale urban attacks on civilian populations has significantly increased across the globe over the past decade. These incidents often result in Hospital Multiple Casualty Incidents (HMCI), which are very challenging to hospital teams. 15 years ago the Emergency and Disaster Medicine Division in the Israeli Ministry of Health defined a key of 20 percent of each hospital's bed capacity as its readiness for multiple casualties. Half of those casualties are expected to require immediate medical treatment. This study was performed to evaluate the efficacy of the current readiness guidelines based on the epidemiology of encountered HMCIs.\nA retrospective study of HMCIs was recorded in the Israeli Defense Force (IDF) home front command and the Israeli National Trauma Registry (ITR) between November 2000 and June 2003. An HMCI is",
        "q2": " defined by the Emergency and Disaster Medicine Division in the Israeli Ministry of Health as>or=10 casualties or>or=4 suffering from injuries with an ISS>or=16 arriving to a single hospital.\nThe study includes a total of 32 attacks, resulting in 62 HMCIs and 1292 casualties. The mean number of arriving casualties to a single hospital was 20.8+/-13.3 (range 4-56, median 16.5). In 95% of the HMCIs the casualty load was<or=52. Based on severity scores and ED discharges 1022 (79.2%) casualties did not necessitate immediate medical treatment.\nIsraeli hospital preparedness for terrorism-related multiple casualty incidents: can the surge capacity and injury severity distribution be better predicted?",
        "generated_text": "defined as an incident in which more than 10 casualties are admitted to a single hospital. The data was analyzed to determine the number of casualties per hospital, the number of casualties requiring immediate medical treatment, and the hospital's readiness to handle such incidents based on the current guidelines.\nDuring the study period, there were 10 HMCIs, resulting in 450 casualties admitted to hospitals. The number of casualties per hospital ranged from 10 to 100, with an average of 45 casualties per hospital. The number of casualties requiring immediate medical treatment ranged from 2 to 50, with an average of 23 per hospital. According to the current guidelines, hospitals should have 20% of their bed capacity ready for multiple casualties, with half of those beds",
        "levenshtein_distance": 567
    },
    {
        "realidx": "19398929",
        "question": "Cholecystectomy for GB polyps that are larger than 10 mm is generally recommended because of the high probability of neoplasm. In contrast, a follow-up strategy is preferred for GB polyps smaller than 10 mm. However, there are no treatment guidelines for polyps that grow in size during the follow-up period.STUDY: We retrospectively investigated 145 patients with GB polyps who underwent at least 1 ultrasonographic follow-up examination over an interval greater than 6 months, before cholecystectomy at Samsung medical center, South Korea, from 1994 to 2007. The growth rate was determined based on the change in size per time interval between 2 ultrasonographic examinations (mm/mo).\nThe median age of the patients was 48 years (range: 25 to 75). One hundred twenty-five non-neoplastic polyps and 20 neoplastic polyps were found. Neoplastic polyps were more frequently found in patients older than 60 years, those with hypertension, a polyp size greater than 10 mm, and a rapid growth rate greater than 0.6 mm/mo. On multivariate analysis, however, the growth rate was not related to the neoplastic nature of a polyp, but older age (>60 y) and large size (>10 mm) were significantly associated with neoplastic polyps.\nCan the growth rate of a gallbladder polyp predict a neoplastic polyp?",
        "answer": "no",
        "answer_rationale": "Patient's age (>60 y) and large polyp size (>10 mm) were significant predictive factors for neoplastic GB polyps. GB polyps less than 10 mm in diameter do not require surgical intervention simply because they grow.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Cholecystectomy for GB polyps that are larger than 10 mm is generally recommended because of the high probability of neoplasm. In contrast, a follow-up strategy is preferred for GB polyps smaller than 10 mm. However, there are no treatment guidelines for polyps that grow in size during the follow-up period.STUDY: We retrospectively investigated 145 patients with GB polyps who underwent at least 1 ultrasonographic follow-up examination over an interval greater than 6 months, before cholecystectomy at Samsung medical center, South Korea, from 1994 to 2007. The growth rate was determined based on the change in size per time interval between 2 ultrasonographic examinations (mm",
        "q2": "/mo).\nThe median age of the patients was 48 years (range: 25 to 75). One hundred twenty-five non-neoplastic polyps and 20 neoplastic polyps were found. Neoplastic polyps were more frequently found in patients older than 60 years, those with hypertension, a polyp size greater than 10 mm, and a rapid growth rate greater than 0.6 mm/mo. On multivariate analysis, however, the growth rate was not related to the neoplastic nature of a polyp, but older age (>60 y) and large size (>10 mm) were significantly associated with neoplastic polyps.\nCan the growth rate of a gallbladder polyp predict a neoplastic polyp?",
        "generated_text": "/year).RESULTS: The mean age was 54.2 years, and 102 (70.3%) patients were female. The mean size of the GB polyps was 7.1 mm (range, 3-15 mm). The mean follow-up period was 2.4 years (range, 0.6-13.2 years). The mean growth rate was 1.1 mm/year (range, 0.1-10.0 mm/year). The growth rate was significantly higher in patients with neoplastic polyps than in those with non-neoplastic polyps (1.7 vs 0.9 mm/year, P = 0.00",
        "levenshtein_distance": 423
    },
    {
        "realidx": "19419587",
        "question": "Sternal instability with mediastinitis is a very serious complication after median sternotomy. Biomechanical studies have suggested superiority of rigid plate fixation over wire cerclage for sternal fixation. This study tests the hypothesis that sternal closure stability can be improved by adding plate fixation in a human cadaver model.\nMidline sternotomy was performed in 18 human cadavers. Four sternal closure techniques were tested: (1) approximation with six interrupted steel wires; (2) approximation with six interrupted cables; (3) closure 1 (wires) or 2 (cables) reinforced with a transverse sternal plate at the sixth rib; (4) Closure using 4 sternal plates alone. Intrathoracic pressure was increased in all techniques while sternal separation was measured by three pairs of sonomicrometry crystals fixed at the upper, middle and lower parts of the sternum until 2.0 mm separation was detected. Differences in displacement pressures were analyzed using repeated measures ANOVA and Regression Coefficients.\nIntrathoracic pressure required to cause 2.0 mm separation increased significantly from 183.3 +/- 123.9 to 301.4 +/- 204.5 in wires/cables alone vs. wires/cables plus one plate respectively, and to 355.0 +/- 210.4 in the 4 plates group (p<0.05). Regression Coefficients (95% CI) were 120 (47-194) and 142 (66-219) respectively for the plate groups.\nSternal plating for primary and secondary sternal closure; can it improve sternal stability?",
        "answer": "yes",
        "answer_rationale": "Transverse sternal plating with 1 or 4 plates significantly improves sternal stability closure in human cadaver model. Adding a single sternal plate to primary closure improves the strength of sternal closure with traditional wiring potentially reducing the risk of sternal dehiscence and could be considered in high risk patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Sternal instability with mediastinitis is a very serious complication after median sternotomy. Biomechanical studies have suggested superiority of rigid plate fixation over wire cerclage for sternal fixation. This study tests the hypothesis that sternal closure stability can be improved by adding plate fixation in a human cadaver model.\nMidline sternotomy was performed in 18 human cadavers. Four sternal closure techniques were tested: (1) approximation with six interrupted steel wires; (2) approximation with six interrupted cables; (3) closure 1 (wires) or 2 (cables) reinforced with a transverse sternal plate at the sixth rib; (4) Closure using 4 sternal plates alone. Intrathoracic pressure was increased in all techniques while sternal separation was measured by three pairs of sonomic",
        "q2": "rometry crystals fixed at the upper, middle and lower parts of the sternum until 2.0 mm separation was detected. Differences in displacement pressures were analyzed using repeated measures ANOVA and Regression Coefficients.\nIntrathoracic pressure required to cause 2.0 mm separation increased significantly from 183.3 +/- 123.9 to 301.4 +/- 204.5 in wires/cables alone vs. wires/cables plus one plate respectively, and to 355.0 +/- 210.4 in the 4 plates group (p<0.05). Regression Coefficients (95% CI) were 120 (47-194) and 142 (66-219) respectively for the plate groups.\nSternal plating for primary and secondary sternal closure; can it improve sternal stability?",
        "generated_text": "rometry crystals placed at the upper, middle and lower sternal segments. The primary outcome was the maximum sternal separation at 20 cmH2O pressure.\nThe mean maximum sternal separation at 20 cmH2O was 1.1 mm (SD 0.4) for the plate group, 1.4 mm (SD 0.5) for the wire + plate group, 1.5 mm (SD 0.5) for the cable + plate group and 2.1 mm (SD 0.7) for the wire group. The plate group had significantly less sternal separation than the wire group (p=0.001). The cable + plate group had less sternal separation than the wire group (p=0.001).",
        "levenshtein_distance": 458
    },
    {
        "realidx": "19430778",
        "question": "To correlate magnetic resonance (MR) image findings with pain response by provocation discography in patients with discogenic low back pain, with an emphasis on the combination analysis of a high intensity zone (HIZ) and disc contour abnormalities.\nSixty-two patients (aged 17-68 years) with axial low back pain that was likely to be disc related underwent lumbar discography (178 discs tested). The MR images were evaluated for disc degeneration, disc contour abnormalities, HIZ, and endplate abnormalities. Based on the combination of an HIZ and disc contour abnormalities, four classes were determined: (1) normal or bulging disc without HIZ; (2) normal or bulging disc with HIZ; (3) disc protrusion without HIZ; (4) disc protrusion with HIZ. These MR image findings and a new combined MR classification were analyzed in the base of concordant pain determined by discography.\nDisc protrusion with HIZ [sensitivity 45.5%; specificity 97.8%; positive predictive value (PPV), 87.0%] correlated significantly with concordant pain provocation (P<0.01). A normal or bulging disc with HIZ was not associated with reproduction of pain. Disc degeneration (sensitivity 95.4%; specificity 38.8%; PPV 33.9%), disc protrusion (sensitivity 68.2%; specificity 80.6%; PPV 53.6%), and HIZ (sensitivity 56.8%; specificity 83.6%; PPV 53.2%) were not helpful in the identification of a disc with concordant pain.\nCan magnetic resonance imaging accurately predict concordant pain provocation during provocative disc injection?",
        "answer": "yes",
        "answer_rationale": "The proposed MR classification is useful to predict a disc with concordant pain. Disc protrusion with HIZ on MR imaging predicted positive discography in patients with discogenic low back pain.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To correlate magnetic resonance (MR) image findings with pain response by provocation discography in patients with discogenic low back pain, with an emphasis on the combination analysis of a high intensity zone (HIZ) and disc contour abnormalities.\nSixty-two patients (aged 17-68 years) with axial low back pain that was likely to be disc related underwent lumbar discography (178 discs tested). The MR images were evaluated for disc degeneration, disc contour abnormalities, HIZ, and endplate abnormalities. Based on the combination of an HIZ and disc contour abnormalities, four classes were determined: (1) normal or bulging disc without HIZ; (2) normal or bulging disc with HIZ; (3) disc protrusion without HIZ; (4) disc protrusion with HIZ. These MR image findings and a new combined MR classification were analyzed in",
        "q2": " the base of concordant pain determined by discography.\nDisc protrusion with HIZ [sensitivity 45.5%; specificity 97.8%; positive predictive value (PPV), 87.0%] correlated significantly with concordant pain provocation (P<0.01). A normal or bulging disc with HIZ was not associated with reproduction of pain. Disc degeneration (sensitivity 95.4%; specificity 38.8%; PPV 33.9%), disc protrusion (sensitivity 68.2%; specificity 80.6%; PPV 53.6%), and HIZ (sensitivity 56.8%; specificity 83.6%; PPV 53.2%) were not helpful in the identification of a disc with concordant pain.\nCan magnetic resonance imaging accurately predict concordant pain provocation during provocative disc injection?",
        "generated_text": "relation to the discography results.\nThe sensitivity, specificity, and positive and negative predictive values of the HIZ for discography-provoked pain were 32%, 92%, 70%, and 64%, respectively. The sensitivity, specificity, and positive and negative predictive values of the combined MR classification for discography-provoked pain were 72%, 78%, 72%, and 78%, respectively. The combined MR classification was significantly better than the HIZ alone in predicting discography-provoked pain (P < 0.001). The combined MR classification was also significantly better than the HIZ in predicting discography-provoked pain in the subgroup of patients with a single painful disc (P < 0.001). The combined MR classification was also significantly better than the HIZ in predicting disc",
        "levenshtein_distance": 602
    },
    {
        "realidx": "19468282",
        "question": "Prospective multicenter longitudinal cohort study.\nTo validate the prognostic value of the acute phase sacral sparing measurements with regard to chronic phase-independent ambulation in patients with traumatic spinal cord injury (SCI).\nEuropean Multicenter Study of Human Spinal Cord Injury (EM-SCI).\nIn 432 patients, acute phase (0-15 days) American Spinal Injury Association (ASIA)/International Spinal Cord Society neurological standard scale (AIS) grades, ASIA sacral sparing measurements, which are S4-5 light touch (LT), S4-5 pin prick (PP), anal sensation and voluntary anal contraction; and chronic phase (6 or 12 months) indoor mobility Spinal Cord Independence Measure (SCIM) measurements were analyzed. Calculations of positive and negative predictive values (PPV/NPV) as well as univariate and multivariate logistic regressions were performed in all four sacral sparing criteria. The area under the receiver-operating characteristic curve (AUC) ratios of all regression equations was calculated.\nTo achieve independent ambulation 1-year post injury, a normal S4-5 PP score showed the best PPV (96.5%, P<0.001, 95% confidence interval (95% CI): 87.9-99.6). Best NPV was reported in the S4-5 LT score (91.7%, P<0.001, 95% CI: 81.6-97.2). The use of the combination of only voluntary anal contraction and the S4-5 LT and PP sensory scores (AUC: 0.906, P<0.001, 95% CI: 0.871-0.941) showed significantly better (P<0.001, 95% CI: 0.038-0.128) discriminating results in prognosticating 1-year independent ambulation than with the use of currently used distinction between complete and incomplete SCI (AUC: 0.823, P<0.001, 95% CI: 0.781-0.864).\nIs determination between complete and incomplete traumatic spinal cord injury clinically relevant?",
        "answer": "maybe",
        "answer_rationale": "Out of the four sacral sparing criteria, the acute phase anal sensory score measurements do not contribute significantly to the prognosis of independent ambulation. The combination of the acute phase voluntary anal contraction and the S4-5 LT and PP scores, predicts significantly better chronic phase-independent ambulation outcomes than the currently used distinction between complete and incomplete SCI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Prospective multicenter longitudinal cohort study.\nTo validate the prognostic value of the acute phase sacral sparing measurements with regard to chronic phase-independent ambulation in patients with traumatic spinal cord injury (SCI).\nEuropean Multicenter Study of Human Spinal Cord Injury (EM-SCI).\nIn 432 patients, acute phase (0-15 days) American Spinal Injury Association (ASIA)/International Spinal Cord Society neurological standard scale (AIS) grades, ASIA sacral sparing measurements, which are S4-5 light touch (LT), S4-5 pin prick (PP), anal sensation and voluntary anal contraction; and chronic phase (6 or 12 months) indoor mobility Spinal Cord Independence Measure (SCIM) measurements were analyzed. Calculations of positive and negative predictive values (PPV/NPV) as well as univariate and multivariate logistic regressions were performed in all four sacral sparing criteria. The area under the receiver-operating characteristic curve (AUC) ratios of all regression equations was calculated.\nTo achieve independent ambulation 1-year post injury, a",
        "q2": " normal S4-5 PP score showed the best PPV (96.5%, P<0.001, 95% confidence interval (95% CI): 87.9-99.6). Best NPV was reported in the S4-5 LT score (91.7%, P<0.001, 95% CI: 81.6-97.2). The use of the combination of only voluntary anal contraction and the S4-5 LT and PP sensory scores (AUC: 0.906, P<0.001, 95% CI: 0.871-0.941) showed significantly better (P<0.001, 95% CI: 0.038-0.128) discriminating results in prognosticating 1-year independent ambulation than with the use of currently used distinction between complete and incomplete SCI (AUC: 0.823, P<0.001, 95% CI: 0.781-0.864).\nIs determination between complete and incomplete traumatic spinal cord injury clinically relevant?",
        "generated_text": "patient with AIS A or B must have at least one sacral sparing measurement intact. The PPV of this rule was 80.6% (95% CI 74.1-86.1%) and the NPV was 84.2% (95% CI 79.4-88.1%). The AUC of this rule was 0.87 (95% CI 0.83-0.91). The PPV of the sacral sparing measurements was higher in AIS A than in AIS B patients. The PPV of the sacral sparing measurements was higher in patients with complete motor and sensory SCI than in patients with complete motor and incomplete sensory SCI. The PPV of the sacral sparing measurements was higher in patients with thoracic SCI than in patients with cervical SCI.\nThe sacral sparing measurements are strong predictors of chronic phase-independent ambulation in patients with traumatic SCI. The sacral sparing measurements should be included in the acute phase neurological examination of patients with traumatic SCI.",
        "levenshtein_distance": 643
    },
    {
        "realidx": "19481382",
        "question": "Androgen serum levels significantly decrease in older men, causing quality of life impairment and increasing the risk of chronic disease. This disorder is defined as PADAM (Partial Androgen Deficiency of Aging Men).\nTo evaluate a PADAM screening tool and determine the prevalence of this disorder in healthy adult men.\nThis was a cross-sectional study in which 96 men aged 40 or more of the South Metropolitan Region of Santiago de Chile were surveyed with the Androgen Deficiency of Aging Men (ADAM) questionnaire of the Saint Louis University and sampled for the serum determination of total testosterone, sexual hormone binding globulin (SHBG) and albumin. Also free and bioavailable testosterone were calculated. PADAM was considered present if items 1 or 7 or any 3 other questions of the ADAM questionnaire were positive. An available testosterone of<198.4 ng/dL was used as a gold standard for the diagnosis of PADAM.\nA total of 78 men (81.3%) were identified as possible PADAM according to the ADAM questionnaire. Total testosterone levels fell from 503.6+/-180.1 ng/dL in men aged 40 to 54 years to 382.1+/-247.3 in those>70 years; however this was not statistically significant (ANOVA, p=0.06). In the same age groups, SHBG significantly increased (31.0+/-15.0 to 47.5+/-15.0 nmol/L, p<0.001) whereas free and available testosterone significantly decreased (10.6+/-3.2 to 6.4+/-3.6 ng/dL and 266.6+/-81.2 to 152.2+/-97.6 ng/dL, respectively, p<0.0001). Overall (n=96), available testosterone confirmed PADAM diagnosis in 27 cases (28.1%). The ADAM tool rendered a 83.3% sensitivity and 19.7% specificity in the detection of PADAM. Item 1 (decreased sexual desire) was a better predictor of hypogonadism than the complete questionnaire (63.3% sensitivity and 66.7% specificity).\nIs the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?",
        "answer": "no",
        "answer_rationale": "In this series, in accordance to available testosterone, the prevalence of PADAM was determined to be high, in which the ADAM questionnaire rendered a low diagnostic efficiency. PADAM diagnosis could be clinically suspected when symptoms of sexual dysfunction are present.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Androgen serum levels significantly decrease in older men, causing quality of life impairment and increasing the risk of chronic disease. This disorder is defined as PADAM (Partial Androgen Deficiency of Aging Men).\nTo evaluate a PADAM screening tool and determine the prevalence of this disorder in healthy adult men.\nThis was a cross-sectional study in which 96 men aged 40 or more of the South Metropolitan Region of Santiago de Chile were surveyed with the Androgen Deficiency of Aging Men (ADAM) questionnaire of the Saint Louis University and sampled for the serum determination of total testosterone, sexual hormone binding globulin (SHBG) and albumin. Also free and bioavailable testosterone were calculated. PADAM was considered present if items 1 or 7 or any 3 other questions of the ADAM questionnaire were positive. An available testosterone of<198.4 ng/dL was used as a gold standard for the diagnosis of PADAM.\nA total of 78 men (81.3%) were identified as possible PADAM according to the ADAM questionnaire. Total testosterone levels fell from 503.6+/-180.1 ng/dL in men aged 40 to 54 years to 382",
        "q2": ".1+/-247.3 in those>70 years; however this was not statistically significant (ANOVA, p=0.06). In the same age groups, SHBG significantly increased (31.0+/-15.0 to 47.5+/-15.0 nmol/L, p<0.001) whereas free and available testosterone significantly decreased (10.6+/-3.2 to 6.4+/-3.6 ng/dL and 266.6+/-81.2 to 152.2+/-97.6 ng/dL, respectively, p<0.0001). Overall (n=96), available testosterone confirmed PADAM diagnosis in 27 cases (28.1%). The ADAM tool rendered a 83.3% sensitivity and 19.7% specificity in the detection of PADAM. Item 1 (decreased sexual desire) was a better predictor of hypogonadism than the complete questionnaire (63.3% sensitivity and 66.7% specificity).\nIs the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?",
        "generated_text": ".1+/-140.1 ng/dL in men aged 55 to 69 years (p=0.001). The prevalence of PADAM was 40.6% (95% CI: 30.5-51.7). The ADAM questionnaire had a sensitivity of 92.3% (95% CI: 78.1-98.3), a specificity of 66.7% (95% CI: 28.6-92.9), a positive predictive value of 81.3% (95% CI: 71.1-88.7) and a negative predictive value of 83.3% (95% CI: 47.6-97.4). The area under the ROC curve was 0.82 (95% CI: 0.71-0.93).\nPADAM is a common disorder in healthy adult men. The ADAM questionnaire is a useful screening tool for PADAM.",
        "levenshtein_distance": 606
    },
    {
        "realidx": "19482903",
        "question": "Earlier studies have demonstrated low peak oxygen uptake ((.)Vo(2)peak) in children with spina bifida. Low peak heart rate and low peak respiratory exchange ratio in these studies raised questions regarding the true maximal character of (.)Vo(2)peak values obtained with treadmill testing.\nThe aim of this study was to determine whether the Vo(2)peak measured during an incremental treadmill test is a true reflection of the maximum oxygen uptake ((.)Vo(2)max) in children who have spina bifida and are ambulatory.\nA cross-sectional design was used for this study.\nTwenty children who had spina bifida and were ambulatory participated. The (.)Vo(2)peak was measured during a graded treadmill exercise test. The validity of (.)Vo(2)peak measurements was evaluated by use of previously described guidelines for maximum exercise testing in children who are healthy, as well as differences between Vo(2)peak and (.)Vo(2) during a supramaximal protocol ((.)Vo(2)supramaximal).\nThe average values for (.)Vo(2)peak and normalized (.)Vo(2)peak were, respectively, 1.23 L/min (SD=0.6) and 34.1 mL/kg/min (SD=8.3). Fifteen children met at least 2 of the 3 previously described criteria; one child failed to meet any criteria. Although there were no significant differences between (.)Vo(2)peak and Vo(2)supramaximal, 5 children did show improvement during supramaximal testing.\nThese results apply to children who have spina bifida and are at least community ambulatory.\nTreadmill testing of children who have spina bifida and are ambulatory: does peak oxygen uptake reflect maximum oxygen uptake?",
        "answer": "yes",
        "answer_rationale": "The (.)Vo(2)peak measured during an incremental treadmill test seems to reflect the true (.)Vo(2)max in children who have spina bifida and are ambulatory, validating the use of a treadmill test for these children. When confirmation of maximal effort is needed, the addition of supramaximal testing of children with disability is an easy and well-tolerated method.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Earlier studies have demonstrated low peak oxygen uptake ((.)Vo(2)peak) in children with spina bifida. Low peak heart rate and low peak respiratory exchange ratio in these studies raised questions regarding the true maximal character of (.)Vo(2)peak values obtained with treadmill testing.\nThe aim of this study was to determine whether the Vo(2)peak measured during an incremental treadmill test is a true reflection of the maximum oxygen uptake ((.)Vo(2)max) in children who have spina bifida and are ambulatory.\nA cross-sectional design was used for this study.\nTwenty children who had spina bifida and were ambulatory participated. The (.)Vo(2)peak was measured during a graded treadmill exercise test. The validity of (.)Vo(2)peak measurements was evaluated by use of previously described guidelines for maximum exercise testing in children who are healthy, as well as differences between Vo",
        "q2": "(2)peak and (.)Vo(2) during a supramaximal protocol ((.)Vo(2)supramaximal).\nThe average values for (.)Vo(2)peak and normalized (.)Vo(2)peak were, respectively, 1.23 L/min (SD=0.6) and 34.1 mL/kg/min (SD=8.3). Fifteen children met at least 2 of the 3 previously described criteria; one child failed to meet any criteria. Although there were no significant differences between (.)Vo(2)peak and Vo(2)supramaximal, 5 children did show improvement during supramaximal testing.\nThese results apply to children who have spina bifida and are at least community ambulatory.\nTreadmill testing of children who have spina bifida and are ambulatory: does peak oxygen uptake reflect maximum oxygen uptake?",
        "generated_text": "(2)peak and (.)Vo(2)max measured during a cycle ergometer test.\nThe (.)Vo(2)peak was 33.1+/-5.4 mL x kg(-1) x min(-1). The peak heart rate was 182+/-14 beats per minute, and the peak respiratory exchange ratio was 1.08+/-0.07. The (.)Vo(2)peak was significantly lower in children who had spina bifida than in children who were healthy (P<.001). The peak heart rate was significantly lower in children who had spina bifida than in children who were healthy (P<.001). The peak respiratory exchange ratio was not significantly different between the 2 groups (P=.10). The (.)Vo(2)peak measured during the treadmill test was not significantly different from",
        "levenshtein_distance": 526
    },
    {
        "realidx": "19520213",
        "question": "A list of telephone numbers of UK hospitals with a radiology department was obtained from the Royal College of Radiologists. One hundred hospitals were then randomly selected for inclusion in the survey. An 18-item questionnaire was successfully administered to consultant radiologists from 84 departments.\nSixty-one percent of departments had a named radiologist to report their skeletal surveys, 16% assigned surveys to a random radiologist, and 23% referred them elsewhere. Only 52% of departments had a dedicated paediatric radiologist, thus in a significant proportion of departments (25%) initial reports on skeletal surveys for physical abuse were provided by non-paediatric radiologists. Fifteen percent did not have ready access to a paediatric radiology opinion. Sixty-one percent thought that the service could be improved. Expert evidence was provided by 5% of respondents. Seventy-three percent would never consider providing expert evidence, even if given adequate radiology and/or legal training.\nAre UK radiologists satisfied with the training and support received in suspected child abuse?",
        "answer": "no",
        "answer_rationale": "The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "A list of telephone numbers of UK hospitals with a radiology department was obtained from the Royal College of Radiologists. One hundred hospitals were then randomly selected for inclusion in the survey. An 18-item questionnaire was successfully administered to consultant radiologists from 84 departments.\nSixty-one percent of departments had a named radiologist to report their skeletal surveys, 16% assigned surveys to a random radiologist, and 23% referred them elsewhere. Only 52% of departments had a dedicated paediatric radiologist,",
        "q2": " thus in a significant proportion of departments (25%) initial reports on skeletal surveys for physical abuse were provided by non-paediatric radiologists. Fifteen percent did not have ready access to a paediatric radiology opinion. Sixty-one percent thought that the service could be improved. Expert evidence was provided by 5% of respondents. Seventy-three percent would never consider providing expert evidence, even if given adequate radiology and/or legal training.\nAre UK radiologists satisfied with the training and support received in suspected child abuse?",
        "generated_text": "and 48% had a named radiologist with an interest in child abuse. Fifty-eight percent of departments had a written protocol for skeletal surveys, and 42% had a written protocol for interpreting skeletal surveys. Only 22% of departments had a written protocol for the timing of skeletal surveys. Seventy-one percent of departments had a written protocol for the imaging of suspected child abuse, and 55% had a written protocol for the imaging of suspected non-accidental head injury. Only 1",
        "levenshtein_distance": 418
    },
    {
        "realidx": "19546588",
        "question": "Although the mechanism of muscle wasting in end-stage renal disease is not fully understood, there is increasing evidence that acidosis induces muscle protein degradation and could therefore contribute to the loss of muscle protein stores of patients on hemodialysis, a prototypical state of chronic metabolic acidosis (CMA). Because body protein mass is controlled by the balance between synthesis and degradation, protein loss can occur as result of either increased breakdown, impaired synthesis, or both. Correction of acidosis may therefore help to maintain muscle mass and improve the health of patients with CMA. We evaluated whether alkalizing patients on hemodialysis might have a positive effect on protein synthesis and on nutritional parameters.\nEight chronic hemodialysis patients were treated daily with oral sodium bicarbonate (NaHCO(3)) supplementation for 10-14 days, yielding a pre-dialytic plasma bicarbonate concentration of 28.6 +/-1.6 mmol/l. The fractional synthesis rates (FSR) of muscle protein and albumin were obtained by the L-[(2)H(5)ring]phenylalanine flooding technique.\nOral NaHCO(3 )supplementation induced a significant increase in serum bicarbonate (21.5 +/- 3.4 vs. 28.6 +/- 1.6 mmol/l; p = 0.018) and blood pH (7.41 vs. 7.46; p = 0.041). The FSR of muscle protein and the FSR of albumin did not change significantly (muscle protein: 2.1 +/- 0.2 vs. 2.0 +/- 0.5% per day, p = 0.39; albumin: 8.3 +/- 2.2 vs. 8.6 +/- 2.5% per day, p = 0.31). Plasma concentrations of insulin-like growth factor 1 decreased significantly (33.4 +/- 21.3 vs. 25.4 +/- 12.3 nmol/l; p = 0.028), whereas thyroid-stimulating hormone, free thyroxin and free triiodothyronine did not change significantly and nutritional parameters showed no improvement.\nDoes increasing blood pH stimulate protein synthesis in dialysis patients?",
        "answer": "no",
        "answer_rationale": "In contrast to other findings, raising the blood pH of dialysis patients was not associated with a positive effect on albumin and muscle protein synthesis, or nutritional and endocrinal parameters.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Although the mechanism of muscle wasting in end-stage renal disease is not fully understood, there is increasing evidence that acidosis induces muscle protein degradation and could therefore contribute to the loss of muscle protein stores of patients on hemodialysis, a prototypical state of chronic metabolic acidosis (CMA). Because body protein mass is controlled by the balance between synthesis and degradation, protein loss can occur as result of either increased breakdown, impaired synthesis, or both. Correction of acidosis may therefore help to maintain muscle mass and improve the health of patients with CMA. We evaluated whether alkalizing patients on hemodialysis might have a positive effect on protein synthesis and on nutritional parameters.\nEight chronic hemodialysis patients were treated daily with oral sodium bicarbonate (NaHCO(3)) supplementation for 10-14 days, yielding a pre-dialytic plasma bicarbonate concentration of 28.6 +/-1.6 mmol/l. The fractional synthesis rates (FSR) of muscle protein and albumin were obtained by the L-[(2)H(5)ring]phenylalanine flooding technique.\nOral NaHCO(3 )supp",
        "q2": "lementation induced a significant increase in serum bicarbonate (21.5 +/- 3.4 vs. 28.6 +/- 1.6 mmol/l; p = 0.018) and blood pH (7.41 vs. 7.46; p = 0.041). The FSR of muscle protein and the FSR of albumin did not change significantly (muscle protein: 2.1 +/- 0.2 vs. 2.0 +/- 0.5% per day, p = 0.39; albumin: 8.3 +/- 2.2 vs. 8.6 +/- 2.5% per day, p = 0.31). Plasma concentrations of insulin-like growth factor 1 decreased significantly (33.4 +/- 21.3 vs. 25.4 +/- 12.3 nmol/l; p = 0.028), whereas thyroid-stimulating hormone, free thyroxin and free triiodothyronine did not change significantly and nutritional parameters showed no improvement.\nDoes increasing blood pH stimulate protein synthesis in dialysis patients?",
        "generated_text": "Iementation increased the FSR of muscle protein from 0.041 +/-0.004% h(-1) to 0.052 +/-0.005% h(-1) (p <0.05). The FSR of albumin was not significantly changed by NaHCO(3) supplementation. The increase in muscle protein FSR was associated with a significant increase in plasma insulin and a decrease in plasma glucagon concentrations. Plasma urea nitrogen and creatinine concentrations were not significantly changed by NaHCO(3) supplementation. Plasma amino acid concentrations were not significantly changed by NaHCO(3) supplementation, except for a significant decrease in plasma phenylalanine concentration.\nThese data suggest that correction of acidosis in patients on hemodialysis increases muscle protein synthesis, possibly via an increase in plasma insulin and a decrease in plasma glucagon concentrations. This may be a useful therapeutic approach to prevent muscle wasting in patients with CMA.",
        "levenshtein_distance": 667
    },
    {
        "realidx": "19575104",
        "question": "Fixation of foreign bodies (FB), in the mucosa, can favor its migration, giving origin to the popular saying: 'FB walk to the heart'.AIM: Describe the mechanisms involved in FB migration and how to diagnose them.\nFrom a sample of 3,000 foreign bodies, during 40 years, we analyzed four which had extra-lumen migration. We analyzed clinical, radiologic, endoscopic and ultrasound data collected at the medical documentation service.\nThree clinical histories are presented, describing two fish bones and one piece of fish cartilage. FB shifting was analyzed in all of them. Migration started in the esophagus in two, one going to the aorta and the other to the neck area. In the other two, migration started in the pharynx, and the FB moved towards the prevertebral fascia and the other externalized in the submandibular region. The mechanisms and the risks posed to the patient, by FB migration, and the way to diagnose them are hereby discussed.\nDo foreign bodies migrate through the body towards the heart?",
        "answer": "no",
        "answer_rationale": "The study allows us to determine that FB can move through the body but not towards the heart. The study also serves as a warning sign: in cases of prolonged histories of FB ingestion, imaging studies are mandatory before endoscopic examination.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Fixation of foreign bodies (FB), in the mucosa, can favor its migration, giving origin to the popular saying: 'FB walk to the heart'.AIM: Describe the mechanisms involved in FB migration and how to diagnose them.\nFrom a sample of 3,000 foreign bodies, during 40 years, we analyzed four which had extra-lumen migration. We analyzed clinical, radiologic, endoscopic and ultrasound data collected at the medical documentation service.\nThree clinical histories are presented, describing two fish bones and one piece",
        "q2": " of fish cartilage. FB shifting was analyzed in all of them. Migration started in the esophagus in two, one going to the aorta and the other to the neck area. In the other two, migration started in the pharynx, and the FB moved towards the prevertebral fascia and the other externalized in the submandibular region. The mechanisms and the risks posed to the patient, by FB migration, and the way to diagnose them are hereby discussed.\nDo foreign bodies migrate through the body towards the heart?",
        "generated_text": "of chicken bone, which migrated to the mediastinum, one to the pericardium and one to the pleural cavity. The diagnosis was made by endoscopy, radiology and ultrasound.\nThe migration of FB is a rare event, but it can be fatal. The diagnosis is difficult, but the use of endoscopy, radiology and ultrasound can help to make it.",
        "levenshtein_distance": 349
    },
    {
        "realidx": "19578820",
        "question": "Opioid-dependent patients often have co-occurring chronic illnesses requiring medications that interact with methadone. Methadone maintenance treatment (MMT) is typically provided separately from medical care. Hence, coordination of medical care and substance use treatment is important to preserve patient safety.\nTo identify potential safety risks among MMT patients engaged in medical care by evaluating the frequency that opioid dependence and MMT documentation are missing in medical records and characterizing potential medication-methadone interactions.\nAmong patients from a methadone clinic who received primary care from an affiliated, but separate, medical center, we reviewed electronic medical records for documentation of methadone, opioid dependence, and potential drug-methadone interactions. The proportions of medical records without opioid dependence and methadone documentation were estimated and potential medication-methadone interactions were identified.\nAmong the study subjects (n = 84), opioid dependence documentation was missing from the medical record in 30% (95% CI, 20%-41%) and MMT documentation was missing from either the last primary care note or the last hospital discharge summary in 11% (95% CI, 5%-19%). Sixty-nine percent of the study subjects had at least 1 medication that potentially interacted with methadone; 19% had 3 or more potentially interacting medications.\nAre opioid dependence and methadone maintenance treatment (MMT) documented in the medical record?",
        "answer": "maybe",
        "answer_rationale": "Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Opioid-dependent patients often have co-occurring chronic illnesses requiring medications that interact with methadone. Methadone maintenance treatment (MMT) is typically provided separately from medical care. Hence, coordination of medical care and substance use treatment is important to preserve patient safety.\nTo identify potential safety risks among MMT patients engaged in medical care by evaluating the frequency that opioid dependence and MMT documentation are missing in medical records and characterizing potential medication-methadone interactions.\nAmong patients from a methadone clinic who received primary care from an affiliated, but separate, medical center, we reviewed electronic medical records for documentation of methadone, opioid dependence, and potential drug-methadone interactions. The proportions",
        "q2": " of medical records without opioid dependence and methadone documentation were estimated and potential medication-methadone interactions were identified.\nAmong the study subjects (n = 84), opioid dependence documentation was missing from the medical record in 30% (95% CI, 20%-41%) and MMT documentation was missing from either the last primary care note or the last hospital discharge summary in 11% (95% CI, 5%-19%). Sixty-nine percent of the study subjects had at least 1 medication that potentially interacted with methadone; 19% had 3 or more potentially interacting medications.\nAre opioid dependence and methadone maintenance treatment (MMT) documented in the medical record?",
        "generated_text": "of patients with missing documentation and potential drug-methadone interactions were calculated.\nAmong 100 patients, 40% had no documentation of opioid dependence and 30% had no documentation of MMT in their medical records. Among 70 patients with at least one medication in their medical record, 43% had at least one potential drug-methadone interaction, including 10% with a high-risk interaction.\nOpioid-dependent patients receiving MMT and medical care at separate facilities are at risk for medication-methadone interactions and missing documentation of opioid dependence and MMT in their medical records. Improved communication between medical and substance use treatment providers is needed to ensure patient",
        "levenshtein_distance": 503
    },
    {
        "realidx": "19593710",
        "question": "ESC (Electronic Stability Control) is a crash avoidance technology that reduces the likelihood of collisions involving loss of control. Although past and emerging research indicates that ESC is effective in reducing collision rates and saving lives, and its inclusion in all vehicle platforms is encouraged, drivers may demonstrate behavioral adaptation or an overreliance on ESC that could offset or reduce its overall effectiveness. The main objective of the present study was to determine whether behavioral adaptation to ESC is likely to occur upon the widespread introduction of ESC into the Canadian vehicle fleet. Secondary objectives were to confirm the results of a previous ESC public survey and to generate a baseline measure for the future assessment of planned and ongoing ESC promotional activities in Canada.\nTwo separate telephone surveys evaluated drivers' perceptions and awareness of ESC. The first surveyed 500 randomly selected owners/drivers of passenger vehicles. The second surveyed 1017 owners/drivers of 2006-2008 ESC-equipped passenger vehicles from the provinces of Quebec and British Columbia, Canada.\nThough ESC drivers were much more likely than drivers of other vehicles to be aware of ESC (77% vs. 39%) and that their own vehicle was equipped with it (63% vs. 8%), 23 percent had never heard of it. Ninety percent of drivers who knew that their vehicle was equipped with ESC believed that ESC had made it safer to drive and reported being confident that ESC would work in an emergency. Twenty-three percent of ESC owners who knew their vehicle had ESC reported noticing long-lasting changes in their driving behavior since they began driving the vehicle.\nCould ESC (Electronic Stability Control) change the way we drive?",
        "answer": "yes",
        "answer_rationale": "Collectively, results suggest that behavioral adaptation to ESC is likely in certain drivers; however, its proven effectiveness in reducing the likelihood of being involved in a serious crash probably outweighs any potential increases in unsafe driving. To fully benefit from ESC, vehicle manufacturers are encouraged to market ESC-equipped vehicles in a realistic, safe manner. Driver training and safety organizations are also encouraged to provide balanced educational information about ESC to their members.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "ESC (Electronic Stability Control) is a crash avoidance technology that reduces the likelihood of collisions involving loss of control. Although past and emerging research indicates that ESC is effective in reducing collision rates and saving lives, and its inclusion in all vehicle platforms is encouraged, drivers may demonstrate behavioral adaptation or an overreliance on ESC that could offset or reduce its overall effectiveness. The main objective of the present study was to determine whether behavioral adaptation to ESC is likely to occur upon the widespread introduction of ESC into the Canadian vehicle fleet. Secondary objectives were to confirm the results of a previous ESC public survey and to generate a baseline measure for the future assessment of planned and ongoing ESC promotional activities in Canada.\nTwo separate telephone surveys evaluated drivers' perceptions and awareness of ESC. The first surveyed 500 randomly selected owners/drivers of",
        "q2": " passenger vehicles. The second surveyed 1017 owners/drivers of 2006-2008 ESC-equipped passenger vehicles from the provinces of Quebec and British Columbia, Canada.\nThough ESC drivers were much more likely than drivers of other vehicles to be aware of ESC (77% vs. 39%) and that their own vehicle was equipped with it (63% vs. 8%), 23 percent had never heard of it. Ninety percent of drivers who knew that their vehicle was equipped with ESC believed that ESC had made it safer to drive and reported being confident that ESC would work in an emergency. Twenty-three percent of ESC owners who knew their vehicle had ESC reported noticing long-lasting changes in their driving behavior since they began driving the vehicle.\nCould ESC (Electronic Stability Control) change the way we drive?",
        "generated_text": "vehicles with ESC, and the second surveyed 500 randomly selected owners/drivers of vehicles without ESC. The surveys were conducted in the summer of 2007.\nThe results of the two surveys were similar, with the majority of respondents indicating that they had not heard of ESC, and that they did not know whether their vehicle was equipped with ESC. The results also indicated that drivers were not likely to change their driving behavior as a result of having ESC in their vehicle. The results of the present study confirm the results of a previous survey, and suggest that the introduction of ESC into the Canadian vehicle fleet is unlikely to result in behavioral adaptation.",
        "levenshtein_distance": 540
    },
    {
        "realidx": "19640728",
        "question": "Bias against operating on patients with prosthetic valve endocarditis (PVE) who have multiple prostheses may preclude the use of life-saving valve replacement. We investigated the accuracy of the preoperative diagnosis of PVE in patients with both mitral and aortic prosthesis and the safety of single-valve replacement when only one valve seemed infected.\nPatients with a diagnosis of active PVE who had mitral and aortic prosthesis in place were assessed. We looked at the methods for diagnosis, causative agents, indication for valve replacement, operative findings and outcome.\nTwenty patients, who had both mitral and aortic prostheses and a diagnosis of PVE, were assessed. Streptococci and staphylococci caused 70% of cases. By means of echocardiography, the valves involved were: mitral (11 patients), aortic (six patients), and in three cases both prosthetic valves seemed infected. Surgery was undertaken in 17 patients (85%). The positive predictive value of transesophageal echocardiogram (TEE) for the preoperative diagnosis of the site of infection was 100%. In 13 patients, only the prosthetic valve that seemed infected was replaced. Four of these patients died within a week after the procedure. Nine patients survived the surgical procedure, completed a course of antimicrobial therapy and were followed up for 15.78 months (95% CI: 12.83-18.72). All were considered cured and relapses were not observed.\nSurgical treatment of prosthetic valve endocarditis in patients with double prostheses: is single-valve replacement safe?",
        "answer": "yes",
        "answer_rationale": "TEE allowed a diagnosis of site involvement that did correlate with the anatomic diagnosis obtained during the operation. This fact contributed to the management of patients and was of great help in guiding the surgical intervention. Echo-oriented single-valve replacement may be a safe strategy for patients with PVE and double prostheses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Bias against operating on patients with prosthetic valve endocarditis (PVE) who have multiple prostheses may preclude the use of life-saving valve replacement. We investigated the accuracy of the preoperative diagnosis of PVE in patients with both mitral and aortic prosthesis and the safety of single-valve replacement when only one valve seemed infected.\nPatients with a diagnosis of active PVE who had mitral and aortic prosthesis in place were assessed. We looked at the methods for diagnosis, causative agents, indication for valve replacement, operative findings and outcome.\nTwenty patients, who had both mitral and aortic prostheses and a diagnosis of PVE, were assessed. Streptococci and staphylococci caused 70% of cases. By means of echocardiography, the valves involved",
        "q2": " were: mitral (11 patients), aortic (six patients), and in three cases both prosthetic valves seemed infected. Surgery was undertaken in 17 patients (85%). The positive predictive value of transesophageal echocardiogram (TEE) for the preoperative diagnosis of the site of infection was 100%. In 13 patients, only the prosthetic valve that seemed infected was replaced. Four of these patients died within a week after the procedure. Nine patients survived the surgical procedure, completed a course of antimicrobial therapy and were followed up for 15.78 months (95% CI: 12.83-18.72). All were considered cured and relapses were not observed.\nSurgical treatment of prosthetic valve endocarditis in patients with double prostheses: is single-valve replacement safe?",
        "generated_text": "were identified in 17 patients (85%). In 13 patients (65%), only one valve was involved. In 7 patients (35%), both valves were involved. In 3 patients (15%), the diagnosis was not confirmed. In 13 patients, only one valve was replaced. In 7 patients, both valves were replaced. There was no mortality in the single-valve replacement group and one death in the double-valve replacement group. There was no recurrence of endocarditis in any patient.\nIn patients with both mitral and aortic prosthesis, the preoperative diagnosis of PVE is accurate in 85% of cases. In 65% of cases, only one valve is involved. In these patients, single-valve replacement is safe and",
        "levenshtein_distance": 530
    },
    {
        "realidx": "19694846",
        "question": "Although there is evidence for the influential role of transformational leadership on health outcomes, researchers have used either attitude outcomes (e.g. job satisfaction) or softer health measures, such as general well-being. Specific measures of well-being such as sleep quality have not been used, despite its association with working conditions.\nA longitudinal design was used to collect data from Danish healthcare workers at time 1 in 2005 (n = 447) and 18 months later at time 2 in 2007 (n = 274). Structural equation modelling was used to investigate the relationships between transformational leadership, self-efficacy and sleep quality at both time points independently (cross-sectionally) and longitudinally.\nFor all constructs, time 2 measures were influenced by the baseline level. Direct relationships between transformational leadership and sleep quality were found. This relationship was negative cross-sectionally at both time points, but positive between baseline and follow-up. The relationship between leadership and employees' sleep quality was not mediated by employees' self-efficacy.\nDoes self-efficacy mediate the relationship between transformational leadership behaviours and healthcare workers' sleep quality?",
        "answer": "maybe",
        "answer_rationale": "Our results indicate that training managers in transformational leadership behaviours may have a positive impact on healthcare workers' health over time. However, more research is needed to examine the mechanisms by which transformational leadership brings about improved sleep quality; self-efficacy was not found to be the explanation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Although there is evidence for the influential role of transformational leadership on health outcomes, researchers have used either attitude outcomes (e.g. job satisfaction) or softer health measures, such as general well-being. Specific measures of well-being such as sleep quality have not been used, despite its association with working conditions.\nA longitudinal design was used to collect data from Danish healthcare workers at time 1 in 2005 (n = 447) and 18 months later at time 2 in 2007 (n = 274). Structural equation modelling was used to investigate",
        "q2": " the relationships between transformational leadership, self-efficacy and sleep quality at both time points independently (cross-sectionally) and longitudinally.\nFor all constructs, time 2 measures were influenced by the baseline level. Direct relationships between transformational leadership and sleep quality were found. This relationship was negative cross-sectionally at both time points, but positive between baseline and follow-up. The relationship between leadership and employees' sleep quality was not mediated by employees' self-efficacy.\nDoes self-efficacy mediate the relationship between transformational leadership behaviours and healthcare workers' sleep quality?",
        "generated_text": "the relationship between transformational leadership and sleep quality, and the mediating role of job satisfaction and work engagement.\nTransformational leadership was positively related to job satisfaction and work engagement, and negatively related to sleep problems. Job satisfaction and work engagement were negatively related to sleep problems. The relationship between transformational leadership and sleep problems was partially mediated by job satisfaction and work engagement.\nTransformational leadership is related to better sleep quality, and this relationship is partially mediated by job satisfaction and work engagement. The results suggest that transformational leadership may be an important factor in improving sleep quality among",
        "levenshtein_distance": 470
    },
    {
        "realidx": "19836806",
        "question": "Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index.\nThe study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m(2) by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements.\nIn men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen.\nShould prostate specific antigen be adjusted for body mass index?",
        "answer": "no",
        "answer_rationale": "Consistent with prior studies, we found an inverse relationship between obesity and serum prostate specific antigen. However, the magnitude of the difference was small. Thus, adjusting prostate specific antigen for body mass index does not appear warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index.\nThe study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m(2) by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate",
        "q2": " size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements.\nIn men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen.\nShould prostate specific antigen be adjusted for body mass index?",
        "generated_text": "specific antigen.\nIn men without prostate cancer, prostate specific antigen increased with age and was inversely related to body mass index. The relationship between prostate specific antigen and body mass index was stronger in older men. In men with prostate cancer censored at diagnosis, the relationship between prostate specific antigen and body mass index was similar to that in men without prostate cancer. Percent body fat was inversely related to prostate specific antigen. Weight changes over time were not related to prostate specific antigen.\nIn men without prostate cancer, prostate specific antigen was inversely related to body mass index, with a stronger relationship in older men. This relationship was not due to weight changes over time. These findings suggest that prostate",
        "levenshtein_distance": 562
    },
    {
        "realidx": "19854401",
        "question": "The purpose of this survey was to ascertain the most common surgical practices for attaining negative (tumor-free) surgical margins in patients desiring breast-conservation treatment for breast cancer to see if a consensus exists for optimal treatment of patients.\nWe sent a survey to 1,000 surgeons interested in the treatment of breast cancer. Three hundred eighty-one surgeons responded to this survey and 351 were used for the analysis (response rate of 38%).\nAnswers showed a large variety in clinical practices among breast surgeons across the country. There was little intraoperative margin analysis; only 48% of surgeons examine the margins grossly with a pathologist and even fewer used frozen sections or imprint cytology. Decisions to reexcise specific margins varied greatly. For example, 57% of surgeons would never reexcise for a positive deep margin, but 53% would always reexcise for a positive anterior margin. Most importantly, there was a large range in answers about acceptable margins with ductal carcinoma in situ and invasive carcinoma. Fifteen percent of surgeons would accept any negative margin, 28% would accept a 1-mm negative margin, 50% would accept a 2-mm negative margin, 12% would accept a 5-mm negative margin, and 3% would accept a 10-mm negative margin.\nAttaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?",
        "answer": "no",
        "answer_rationale": "Results of this survey highlight the wide variety of practice patterns in the US for handling surgical margins in breast-conservation treatment. This issue remains controversial, with no prevailing standard of care. Consequently, additional study is needed in the modern era of multimodality treatment to examine the minimal amount of surgical treatment necessary, in conjunction with chemotherapy and radiation, to attain adequate local control rates in breast-conservation treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The purpose of this survey was to ascertain the most common surgical practices for attaining negative (tumor-free) surgical margins in patients desiring breast-conservation treatment for breast cancer to see if a consensus exists for optimal treatment of patients.\nWe sent a survey to 1,000 surgeons interested in the treatment of breast cancer. Three hundred eighty-one surgeons responded to this survey and 351 were used for the analysis (response rate of 38%).\nAnswers showed a large variety in clinical practices among breast surgeons across the country. There was little intraoperative margin analysis; only 48% of surgeons examine the margins grossly with a pathologist and even fewer used frozen sections or imprint cytology. Decisions to re",
        "q2": "excise specific margins varied greatly. For example, 57% of surgeons would never reexcise for a positive deep margin, but 53% would always reexcise for a positive anterior margin. Most importantly, there was a large range in answers about acceptable margins with ductal carcinoma in situ and invasive carcinoma. Fifteen percent of surgeons would accept any negative margin, 28% would accept a 1-mm negative margin, 50% would accept a 2-mm negative margin, 12% would accept a 5-mm negative margin, and 3% would accept a 10-mm negative margin.\nAttaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?",
        "generated_text": "-excite were based on a variety of factors, including the size of the tumor, the size of the specimen, the type of tumor, and the patient's wishes. There was a large variation in the amount of tissue removed at re-excision, with 25% of surgeons removing less than 1 cm of tissue and 25% removing more than 2 cm of tissue. There was also a large variation in the use of radiation therapy after re-excision, with 25% of surgeons always using radiation and 25% never using radiation.\nThere is no consensus among breast surgeons regarding the optimal surgical treatment for patients desiring breast-conservation treatment for breast cancer. This lack of",
        "levenshtein_distance": 496
    },
    {
        "realidx": "19913785",
        "question": "Little is known about whether a routinely inserted endoscopic nasobiliary drainage (ENBD) tube improves the clinical course in patients with choledocholithiasis-induced acute cholangitis after clearance of choledocholithiasis.\nThe aim of this study was to investigate the need for ENBD on the clinical outcomes of patients with acute cholangitis undergoing endoscopic clearance of common bile duct (CBD) stones.\nProspective, randomized study.\nTertiary referral center.\nA total of 104 patients with choledocholithiasis-induced acute cholangitis who underwent primary endoscopic treatment were compared according to insertion of an ENBD tube (51 in the ENBD group and 53 in the no-ENBD group).\nInsertion of an ENBD tube after clearance of CBD stones.\nRecurrence of cholangitis and length of hospital stay after clearance of CBD stones.\nBaseline clinical characteristics were similar between both groups. There were no significant differences in the recurrence rate of cholangitis at 24 weeks (3.9% for the ENBD group vs 3.8% for the no-ENBD group at 24 weeks; P = .99) and length of hospital stay (7.9 days [standard error = 1.2] for the ENBD group vs 7.9 days [standard error = 0.7]for the no-ENBD group; P = .98). However, procedure time was longer (26.2 [SE = 1.8] minutes vs 22.7 [SE = 1.0]minutes, respectively; P = .01) and the discomfort score was higher (4.9 [SE = 0.4] vs 2.8 [SE = 0.3], respectively; P = .02) in the ENBD group than in the no-ENBD group.\nSingle-center study.\nIs it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis?",
        "answer": "no",
        "answer_rationale": "A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Little is known about whether a routinely inserted endoscopic nasobiliary drainage (ENBD) tube improves the clinical course in patients with choledocholithiasis-induced acute cholangitis after clearance of choledocholithiasis.\nThe aim of this study was to investigate the need for ENBD on the clinical outcomes of patients with acute cholangitis undergoing endoscopic clearance of common bile duct (CBD) stones.\nProspective, randomized study.\nTertiary referral center.\nA total of 104 patients with choledocholithiasis-induced acute cholangitis who underwent primary endoscopic treatment were compared according to insertion of an ENBD tube (51 in the ENBD group and 53 in the no-ENBD group).\nInsertion of an ENBD tube after clearance of CBD stones.\nRecurrence of cholangitis and length of hospital stay after clearance of CBD stones.\nBaseline clinical characteristics were similar between both groups. There were no significant differences in the recurrence rate of cholangitis at 24 weeks (3.9% for the EN",
        "q2": "BD group vs 3.8% for the no-ENBD group at 24 weeks; P = .99) and length of hospital stay (7.9 days [standard error = 1.2] for the ENBD group vs 7.9 days [standard error = 0.7]for the no-ENBD group; P = .98). However, procedure time was longer (26.2 [SE = 1.8] minutes vs 22.7 [SE = 1.0]minutes, respectively; P = .01) and the discomfort score was higher (4.9 [SE = 0.4] vs 2.8 [SE = 0.3], respectively; P = .02) in the ENBD group than in the no-ENBD group.\nSingle-center study.\nIs it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis?",
        "generated_text": "BD group vs 1.9% for the no-ENBD group; P = .54) and the length of hospital stay (10.0 vs 9.0 days; P = .19). The rate of adverse events was similar between both groups (11.8% vs 11.3%; P = .92). In the subgroup analysis, the recurrence rate of cholangitis was similar between the ENBD and no-ENBD groups in patients with acute cholangitis with a high risk of recurrence (10.0% vs 0%; P = .20). In patients with acute cholangitis with a low risk of recurrence, the recurrence rate was also similar between both groups (0% vs 2.2%; P = .48).\nRoutine insertion of an ENBD tube after clearance of CBD stones in patients with acute cholangitis does not improve the clinical course, including the recurrence rate of cholangitis and the length of hospital stay, compared",
        "levenshtein_distance": 537
    },
    {
        "realidx": "19923859",
        "question": "The present studywas designed to investigate the possible role of T cells in spatial learning ability in mouse after toluene exposure.\nEight-week-old male wild-type (WT) and nude mice of BALB/c strain were exposed to toluene (0, 9 and 90 ppm) in a nose-only exposure chamber for 30 min per day for 3 consecutive days and then once per week for 4 weeks. Twenty-four hours after the completion of exposure, we examined the spatial learning ability in each mouse using the Morris water maze apparatus.\nIn the acquisition phase, a longer escape latency was observed in nude mice exposed to 90 ppm toluene on days 3 and 4 when compared with corresponding WT mice. However, the effect of toluene on the escape latency was not significant in nude mice. In the probe trial, WT mice exposed to 90 ppm toluene showed poor retention memory compared with the control group. In the reversal phase, we did not find any significant difference between groups.\nCan T-cell deficiency affect spatial learning ability following toluene exposure?",
        "answer": "yes",
        "answer_rationale": "These results indicate that T-cell deficiency may affect spatial learning performance following toluene exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The present studywas designed to investigate the possible role of T cells in spatial learning ability in mouse after toluene exposure.\nEight-week-old male wild-type (WT) and nude mice of BALB/c strain were exposed to toluene (0, 9 and 90 ppm) in a nose-only exposure chamber for 30 min per day for 3 consecutive days and then once per week for 4 weeks. Twenty-four hours after the completion of exposure, we examined the spatial learning ability in each mouse using the Morris water maze apparatus",
        "q2": ".\nIn the acquisition phase, a longer escape latency was observed in nude mice exposed to 90 ppm toluene on days 3 and 4 when compared with corresponding WT mice. However, the effect of toluene on the escape latency was not significant in nude mice. In the probe trial, WT mice exposed to 90 ppm toluene showed poor retention memory compared with the control group. In the reversal phase, we did not find any significant difference between groups.\nCan T-cell deficiency affect spatial learning ability following toluene exposure?",
        "generated_text": ". The expression of CD3, CD4, and CD8 in the hippocampus was detected by immunohistochemistry. The expression of IL-1\u03b2, IL-6, and TNF-\u03b1 in the hippocampus was detected by ELISA.\nThe results showed that toluene exposure significantly impaired the spatial learning ability in WT mice, but not in nude mice. The expression of CD3, CD4, and CD8 in the hippocampus was significantly increased in WT mice after toluene exposure, but not in nude mice.",
        "levenshtein_distance": 390
    },
    {
        "realidx": "20064872",
        "question": "To identify the features of PMR that may predict the duration of steroid therapy, the occurrence of relapses and the late development of GCA.\nProspective cohort study of 176 patients with PMR, followed up for 5 years. Baseline factors associated with the duration of steroids therapy were identified using Cox regression. Predictors of relapse and the late development of GCA were identified using binary logistic regression.\nA total of 176 patients with PMR were included, of whom 124 stopped steroids within 5 years. The probability of stopping steroids within 5 years was independently reduced by an elevated plasma viscosity (PV) [hazard ratio (HR) = 0.49; 95% CI 0.29, 0.82 for a PV>or = 2.00 mPa s compared with a PV<or = 1.80 mPa s; overall P = 0.024] and by starting treatment at>15 mg prednisolone (HR = 0.63; 95% CI 0.41, 0.97; P = 0.036). Either of these independently reduced the chances of stopping steroids within a given time interval between 27 and 51%. No significant predictors of relapse were identified. Predictors of late GCA on univariable analysis were female sex [odds ratio (OR) = 8.16; 95% CI 1.06, 63.13; P = 0.044], HLA-DRB1*0101 or -*0401 alleles (OR = 4.95; 95% CI 1.05, 23.34; P = 0.043), PV>or = 2.00 mPa s compared with PV<or = 1.80 mPa s (OR = 10.64; 95% CI 1.28, 88.38; P = 0.029) and initial prednisolone dose>15 mg (OR = 4.53; 95% CI 1.61, 12.79; P = 0.004).\nCan the prognosis of polymyalgia rheumatica be predicted at disease onset?",
        "answer": "yes",
        "answer_rationale": "A higher PV in PMR increases the risk of prolonged steroid therapy and late GCA. Female sex and particular HLA alleles may increase the risk of late GCA. Starting patients on>15 mg prednisolone is associated with a prolonged steroid duration.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To identify the features of PMR that may predict the duration of steroid therapy, the occurrence of relapses and the late development of GCA.\nProspective cohort study of 176 patients with PMR, followed up for 5 years. Baseline factors associated with the duration of steroids therapy were identified using Cox regression. Predictors of relapse and the late development of GCA were identified using binary logistic regression.\nA total of 176 patients with PMR were included, of whom 124 stopped steroids within 5 years. The probability of stopping steroids within 5 years was independently reduced by an elevated plasma viscosity (PV) [hazard ratio (HR) = 0.49; 95% CI 0.29, 0.82 for a PV>or = 2.00 mPa s compared with a PV<or = 1.80 mPa s; overall P = 0.024] and by starting treatment at>15 mg prednisolone (HR = 0.63; 95% CI 0.41, 0.97; P = 0.036). Either",
        "q2": " of these independently reduced the chances of stopping steroids within a given time interval between 27 and 51%. No significant predictors of relapse were identified. Predictors of late GCA on univariable analysis were female sex [odds ratio (OR) = 8.16; 95% CI 1.06, 63.13; P = 0.044], HLA-DRB1*0101 or -*0401 alleles (OR = 4.95; 95% CI 1.05, 23.34; P = 0.043), PV>or = 2.00 mPa s compared with PV<or = 1.80 mPa s (OR = 10.64; 95% CI 1.28, 88.38; P = 0.029) and initial prednisolone dose>15 mg (OR = 4.53; 95% CI 1.61, 12.79; P = 0.004).\nCan the prognosis of polymyalgia rheumatica be predicted at disease onset?",
        "generated_text": "relapse or the late development of GCA occurred in 32 patients (18%). The probability of relapse or the late development of GCA was independently increased by starting treatment at>15 mg prednisolone (odds ratio (OR) = 3.02; 95% CI 1.19, 7.67; P = 0.020), by the presence of a high erythrocyte sedimentation rate (ESR) (OR = 2.70; 95% CI 1.04, 6.99; P = 0.041) and by the presence of a high PV (OR = 3.11; 95% CI 1.18, 8.18; P = 0.021). The probability of relapse or the late development of GCA was independently reduced by stopping steroids within 5 years (OR = 0.27; 95% CI 0.11, 0.67",
        "levenshtein_distance": 440
    },
    {
        "realidx": "20084845",
        "question": "Accurate and updated information on airborne pollen in specific areas can help allergic patients. Current monitoring systems are based on a morphologic identification approach, a time-consuming method that may represent a limiting factor for sampling network enhancement.\nTo verify the feasibility of developing a real-time polymerase chain reaction (PCR) approach, an alternative to optical analysis, as a rapid, accurate, and automated tool for the detection and quantification of airborne allergenic pollen taxa.\nThe traditional cetyl trimethyl ammonium bromide-based method was modified for DNA isolation from pollen. Taxon-specific DNA sequences were identified via bioinformatics or literature searches and were PCR amplified from the matching allergenic taxa; based on the sequences of PCR products, complementary or degenerate TaqMan probes were developed. The accuracy of the quantitative real-time PCR assay was tested on 3 plant species.\nThe setup of a modified DNA extraction protocol allowed us to achieve good-quality pollen DNA. Taxon-specific nuclear gene fragments were identified and sequenced. Designed primer pairs and probes identified selected pollen taxa, mostly at the required classification level. Pollen was properly identified even when collected on routine aerobiological tape. Preliminary quantification assays on pollen grains were successfully performed on test species and in mixes.\nBiomolecular identification of allergenic pollen: a new perspective for aerobiological monitoring?",
        "answer": "yes",
        "answer_rationale": "The real-time PCR approach revealed promising results in pollen identification and quantification, even when analyzing pollen mixes. Future perspectives could concern the development of multiplex real-time PCR for the simultaneous detection of different taxa in the same reaction tube and the application of high-throughput molecular methods.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Accurate and updated information on airborne pollen in specific areas can help allergic patients. Current monitoring systems are based on a morphologic identification approach, a time-consuming method that may represent a limiting factor for sampling network enhancement.\nTo verify the feasibility of developing a real-time polymerase chain reaction (PCR) approach, an alternative to optical analysis, as a rapid, accurate, and automated tool for the detection and quantification of airborne allergenic pollen taxa.\nThe traditional cetyl trimethyl ammonium bromide-based method was modified for DNA isolation from pollen. Taxon-specific DNA sequences were identified via bioinformatics or literature searches and were PCR amplified from the matching allergenic taxa",
        "q2": "; based on the sequences of PCR products, complementary or degenerate TaqMan probes were developed. The accuracy of the quantitative real-time PCR assay was tested on 3 plant species.\nThe setup of a modified DNA extraction protocol allowed us to achieve good-quality pollen DNA. Taxon-specific nuclear gene fragments were identified and sequenced. Designed primer pairs and probes identified selected pollen taxa, mostly at the required classification level. Pollen was properly identified even when collected on routine aerobiological tape. Preliminary quantification assays on pollen grains were successfully performed on test species and in mixes.\nBiomolecular identification of allergenic pollen: a new perspective for aerobiological monitoring?",
        "generated_text": ". The PCR products were cloned and sequenced to confirm their identity. The specificity of the primers was tested against a panel of 100 pollen taxa. The sensitivity of the PCR was assessed by testing serial dilutions of cloned amplicons. The PCR was applied to pollen samples collected in the Po Valley, Italy, and the results were compared with those obtained by optical analysis.\nThe DNA extraction method was efficient and reproducible. The PCR primers were specific for the target taxa and did not cross-react with other pollen taxa. The sensitivity of the PCR was high, allowing the detection of low concentrations of pollen. The PCR results were consistent with those obtained",
        "levenshtein_distance": 558
    },
    {
        "realidx": "20121683",
        "question": "Community-based medical education is growing to meet the increased demand for quality clinical education in expanded settings, and its sustainability relies on patient participation. This study investigated patients' views on being used as an educational resource for teaching medical students.\nQuestionnaire-based survey.\nPatients attending six rural and 11 regional general practices in New South Wales over 18 teaching sessions in November 2008, who consented to student involvement in their consultation.\nPatient perceptions, expectations and acceptance of medical student involvement in consultations, assessed by surveys before and after their consultations.\n118 of 122 patients consented to medical student involvement; of these, 117 (99%) completed a survey before the consultation, and 100 (85%) after the consultation. Patients were overwhelmingly positive about their doctor and practice being involved in student teaching and felt they themselves played an important role. Pre-consultation, patients expressed reluctance to allow students to conduct some or all aspects of the consultation independently. However, after the consultation, they reported they would have accepted higher levels of involvement than actually occurred.\nAre patients willing participants in the new wave of community-based medical education in regional and rural Australia?",
        "answer": "yes",
        "answer_rationale": "Patients in regional and rural settings were willing partners in developing skills of junior medical students, who had greater involvement in patient consultations than previously reported for urban students. Our study extends the findings from urban general practice that patients are underutilised partners in community-based medical training. The support of patients from regional and rural settings could facilitate the expansion of primary care-based medical education in these areas of workforce need.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Community-based medical education is growing to meet the increased demand for quality clinical education in expanded settings, and its sustainability relies on patient participation. This study investigated patients' views on being used as an educational resource for teaching medical students.\nQuestionnaire-based survey.\nPatients attending six rural and 11 regional general practices in New South Wales over 18 teaching sessions in November 2008, who consented to student involvement in their consultation.\nPatient perceptions, expectations and acceptance of medical student involvement in consultations, assessed by surveys before and after their consultations.\n118 of 122 patients consented",
        "q2": " to medical student involvement; of these, 117 (99%) completed a survey before the consultation, and 100 (85%) after the consultation. Patients were overwhelmingly positive about their doctor and practice being involved in student teaching and felt they themselves played an important role. Pre-consultation, patients expressed reluctance to allow students to conduct some or all aspects of the consultation independently. However, after the consultation, they reported they would have accepted higher levels of involvement than actually occurred.\nAre patients willing participants in the new wave of community-based medical education in regional and rural Australia?",
        "generated_text": "to student involvement in their consultation, and 105 (97%) of these completed the survey. Most patients (92%) were willing to have a student involved in their consultation, and 89% were willing to have a student involved in future consultations. Patients' expectations of the student's role were to observe (75%), to ask questions (55%) and to examine (45%). Most patients (85%) felt that the student had contributed to their care, and 89% felt that the student had behaved appropriately. Patients'",
        "levenshtein_distance": 449
    },
    {
        "realidx": "20187289",
        "question": "Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data.\nWe replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gm\u00fcnder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006.\nIn children aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children>4 years, prevalences were found to increase with increasing age.\nPrescriptions as a proxy for asthma in children: a good choice?",
        "answer": "no",
        "answer_rationale": "When additional validation studies were taken into account, asthma medications were found to be prescribed not only for asthma but also for other respiratory diseases. In addition, not all children with current asthma had prescriptions. We therefore conclude that asthma medications are therefore not a good proxy for the disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data.\nWe replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gm\u00fcnder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006.\nIn children",
        "q2": " aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children>4 years, prevalences were found to increase with increasing age.\nPrescriptions as a proxy for asthma in children: a good choice?",
        "generated_text": "aged 0-4 years, the prevalence of asthma according to the selection procedure of Stock et al. was 12.1% in the GEK data and 10.1% in the KiGGS data. In contrast, the prevalence of asthma according to the KiGGS definition was 3.7% in the KiGGS data and 2.9% in the GEK data. The prevalence of asthma according to the KiGGS definition was higher in boys than in girls, whereas the prevalence according to the selection procedure of Stock et al. was higher in girls than in boys.\nThe selection procedure of Stock et al. identifies a large number of children with asthma, but the majority of these children do not fulfill the KiGGS",
        "levenshtein_distance": 451
    },
    {
        "realidx": "20197761",
        "question": "Guidelines emphasize that irritable bowel syndrome (IBS) is not a diagnosis of exclusion and encourage clinicians to make a positive diagnosis using the Rome criteria alone. Yet many clinicians are concerned about overlooking alternative diagnoses. We measured beliefs about whether IBS is a diagnosis of exclusion, and measured testing proclivity between IBS experts and community providers.\nWe developed a survey to measure decision-making in two standardized patients with Rome III-positive IBS, including IBS with diarrhea (D-IBS) and IBS with constipation (C-IBS). The survey elicited provider knowledge and beliefs about IBS, including testing proclivity and beliefs regarding IBS as a diagnosis of exclusion. We surveyed nurse practitioners, primary care physicians, community gastroenterologists, and IBS experts.\nExperts were less likely than nonexperts to endorse IBS as a diagnosis of exclusion (8 vs. 72%; P<0.0001). In the D-IBS vignette, experts were more likely to make a positive diagnosis of IBS (67 vs. 38%; P<0.001), to perform fewer tests (2.0 vs. 4.1; P<0.01), and to expend less money on testing (US$297 vs. $658; P<0.01). Providers who believed IBS is a diagnosis of exclusion ordered 1.6 more tests and consumed $364 more than others (P<0.0001). Experts only rated celiac sprue screening and complete blood count as appropriate in D-IBS; nonexperts rated most tests as appropriate. Parallel results were found in the C-IBS vignette.\nIs irritable bowel syndrome a diagnosis of exclusion?",
        "answer": "maybe",
        "answer_rationale": "Most community providers believe IBS is a diagnosis of exclusion; this belief is associated with increased resource use. Experts comply more closely with guidelines to diagnose IBS with minimal testing. This disconnect suggests that better implementation of guidelines is warranted to minimize variation and improve cost-effectiveness of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Guidelines emphasize that irritable bowel syndrome (IBS) is not a diagnosis of exclusion and encourage clinicians to make a positive diagnosis using the Rome criteria alone. Yet many clinicians are concerned about overlooking alternative diagnoses. We measured beliefs about whether IBS is a diagnosis of exclusion, and measured testing proclivity between IBS experts and community providers.\nWe developed a survey to measure decision-making in two standardized patients with Rome III-positive IBS, including IBS with diarrhea (D-IBS) and IBS with constipation (C-IBS). The survey elicited provider knowledge and beliefs about IBS, including testing proclivity and beliefs regarding IBS as a diagnosis of exclusion. We surveyed nurse practitioners, primary care physicians, community gastroenterologists, and IBS experts.\nExperts were less likely than nonexperts to endorse IBS as a diagnosis of exclusion (8 vs. ",
        "q2": "72%; P<0.0001). In the D-IBS vignette, experts were more likely to make a positive diagnosis of IBS (67 vs. 38%; P<0.001), to perform fewer tests (2.0 vs. 4.1; P<0.01), and to expend less money on testing (US$297 vs. $658; P<0.01). Providers who believed IBS is a diagnosis of exclusion ordered 1.6 more tests and consumed $364 more than others (P<0.0001). Experts only rated celiac sprue screening and complete blood count as appropriate in D-IBS; nonexperts rated most tests as appropriate. Parallel results were found in the C-IBS vignette.\nIs irritable bowel syndrome a diagnosis of exclusion?",
        "generated_text": "30%, p < 0.001). Experts were less likely to order tests in both D-IBS (40 vs. 65%, p < 0.001) and C-IBS (35 vs. 60%, p < 0.001). Experts were more likely to make a positive diagnosis of IBS in both D-IBS (74 vs. 45%, p < 0.001) and C-IBS (70 vs. 40%, p < 0.001). In multivariable analysis, IBS knowledge and beliefs about IBS as a diagnosis of exclusion were independently associated with testing proclivity.\nIBS experts are less likely to order tests and more likely to make",
        "levenshtein_distance": 418
    },
    {
        "realidx": "20297950",
        "question": "To investigate the effect of fenofibrate on sleep apnoea indices.\nProof-of-concept study comprising a placebo run-in period (1 week, 5 weeks if fibrate washout was required) and a 4-week randomized, double-blind treatment period. Thirty-four subjects (mean age 55 years, body mass index 34 kg/m 2 , fasting triglycerides 3.5 mmol/L) with diagnosed sleep apnoea syndrome not treated with continuous positive airways pressure were enrolled and randomized to once daily treatment with fenofibrate (145 mg NanoCrystal(R) tablet) or placebo. Overnight polysomnography, computerized attention/vigilance tests and blood sampling for measurement of lipids, insulin, fasting plasma glucose and fibrinogen were performed at the end of each study period.\nNCT00816829.\nAs this was an exploratory study, a range of sleep variables were evaluated. The apnoea/hypopnoea index (AHI) and percentage of time spent with arterial oxygen saturation (SpO(2))<90% were relevant as they have been evaluated in other clinical trials. Other variables included total apnoeas, hypopnoeas and oxygen desaturations, and non-cortical micro-awakenings related to respiratory events per hour.\nFenofibrate treatment significantly reduced the percentage of time with SpO(2)<90% (from 9.0% to 3.5% vs. 10.0% to 11.5% with placebo, p = 0.007), although there was no significant change in the AHI (reduction vs. control 14% (95%CI -47 to 40%, p = 0.533). Treatment reduced obstructive apnoeas (by 44%, from 18.5 at baseline to 15.0 at end of treatment vs. 29.0 to 30.5 on placebo, p = 0.048), and non-cortical micro-awakenings per hour (from 23.5 to 18.0 vs. 24.0 to 25.0 with placebo, p = 0.004). Other sleep variables were not significantly influenced by fenofibrate.\nExploratory study in patients with mild to moderate sleep apnoea, limited treatment duration; concomitant hypnotic treatment (35%); lack of correction for multiplicity of testing.\nProof of concept study: does fenofibrate have a role in sleep apnoea syndrome?",
        "answer": "yes",
        "answer_rationale": "The consistent direction of change in sleep indices in this proof-of-concept study may support further investigation of fenofibrate in moderate to severe sleep apnoea syndrome.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the effect of fenofibrate on sleep apnoea indices.\nProof-of-concept study comprising a placebo run-in period (1 week, 5 weeks if fibrate washout was required) and a 4-week randomized, double-blind treatment period. Thirty-four subjects (mean age 55 years, body mass index 34 kg/m 2 , fasting triglycerides 3.5 mmol/L) with diagnosed sleep apnoea syndrome not treated with continuous positive airways pressure were enrolled and randomized to once daily treatment with fenofibrate (145 mg NanoCrystal(R) tablet) or placebo. Overnight polysomnography, computerized attention/vigilance tests and blood sampling for measurement of lipids, insulin, fasting plasma glucose and fibrinogen were performed at the end of each study period.\nNCT00816829.\nAs this was an exploratory study, a range of sleep variables were evaluated. The apnoea/hypopnoea index (AHI) and percentage of time spent with arterial oxygen saturation (SpO(2))<90% were relevant as they have been evaluated in other clinical trials. Other variables included total apnoeas, hypopnoeas and oxygen desaturations, and non-cortical micro-awakenings related",
        "q2": " to respiratory events per hour.\nFenofibrate treatment significantly reduced the percentage of time with SpO(2)<90% (from 9.0% to 3.5% vs. 10.0% to 11.5% with placebo, p = 0.007), although there was no significant change in the AHI (reduction vs. control 14% (95%CI -47 to 40%, p = 0.533). Treatment reduced obstructive apnoeas (by 44%, from 18.5 at baseline to 15.0 at end of treatment vs. 29.0 to 30.5 on placebo, p = 0.048), and non-cortical micro-awakenings per hour (from 23.5 to 18.0 vs. 24.0 to 25.0 with placebo, p = 0.004). Other sleep variables were not significantly influenced by fenofibrate.\nExploratory study in patients with mild to moderate sleep apnoea, limited treatment duration; concomitant hypnotic treatment (35%); lack of correction for multiplicity of testing.\nProof of concept study: does fenofibrate have a role in sleep apnoea syndrome?",
        "generated_text": "to respiratory events. Fenofibrate treatment significantly reduced AHI (mean difference -4.1 events/h, 95% CI -7.4 to -0.8, p=0.014), percentage of time with SpO(2)<90% (mean difference -1.1%, 95% CI -2.0 to -0.2, p=0.019), total apnoeas (mean difference -1.7 events/h, 95% CI -3.1 to -0.3, p=0.018), hypopnoeas (mean difference -2.4 events/h, 95% CI -4.4 to -0.4, p=0.021), oxygen desaturations (mean difference -2.9 events/h, 95% CI -5.3 to -0.5, p=0.019) and non-cortical micro-awakenings (mean difference -1.7 events/h, 95% CI -3.1 to -0.3, p=0.018). Fenofibrate also significantly improved lipid levels and insulin sensitivity. No",
        "levenshtein_distance": 593
    },
    {
        "realidx": "20306735",
        "question": "To ascertain the perspectives of Trainee Ophthalmologist Diplomats (TOD) on the Ophthalmic Diploma Training (ODT) in West Africa with a view to improving the programme.\nA survey of set 2005 TOD on ODT was carried out in Ghana, 2006.\nThe trainees included 10 (83.35%) males and two (16.7%) females whose ages ranged between thirty-two and fifty-one years. The sponsors of the trainees included Sight Savers International, five (41.7%); Christian Blind Mission International, three (25.0%); Eye Foundation, Lagos, Nigeria two (16.7%); Ministry of Defence Nigeria, one (8.3%); and Health Authority Ghana, one (8.3%). Nine trainees (75.0%) felt the programme was well structured, training allowances were adequate eight (66.7%) and inadequate four (33.3%). Eleven (91.7%) trainees would work wherever they were posted; ten (83.3%) trainees had sense of fulfillment and three (25%) would like to proceed for residency training. All trainees were at least good in chalazion surgery and treatment of common medical eye conditions. Majority were at least good in eye surgery like cataract, eleven (91.7%); trabeculectomy nine (75.0%); pterygium 10 (83.3%); eyelid, eight (66.7%); destructive 11 (91.6%) and refraction 9 (75.0%). Some trainees' perceived problems included inadequate sponsorship (33.3%), short duration of the course four (33.3%) and poor accommodation facility two (16.7%). However, trainees' suggested increase in training posts, four (33.3); training allowance three (25.0%); and incentives for trainers/training hospitals two (16.7%).\nFulfilling human resources development goal in West Africa: can the training of ophthalmologist diplomates be improved?",
        "answer": "yes",
        "answer_rationale": "The ODT programme ensures ophthalmic manpower for secondary eye care level despite challenges. The stakeholders should look into problems facing the programme in order to improve it.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To ascertain the perspectives of Trainee Ophthalmologist Diplomats (TOD) on the Ophthalmic Diploma Training (ODT) in West Africa with a view to improving the programme.\nA survey of set 2005 TOD on ODT was carried out in Ghana, 2006.\nThe trainees included 10 (83.35%) males and two (16.7%) females whose ages ranged between thirty-two and fifty-one years. The sponsors of the trainees included Sight Savers International, five (41.7%); Christian Blind Mission International, three (25.0%); Eye Foundation, Lagos, Nigeria two (16.7%); Ministry of Defence Nigeria, one (8.3%); and Health Authority Ghana, one (8.3%). Nine trainees (75.0%) felt the programme was well structured, training allowances were adequate eight (66.7%) and inadequate four (33.3%). Eleven (91.7%) trainees would work wherever they were posted; ten (83.",
        "q2": "3%) trainees had sense of fulfillment and three (25%) would like to proceed for residency training. All trainees were at least good in chalazion surgery and treatment of common medical eye conditions. Majority were at least good in eye surgery like cataract, eleven (91.7%); trabeculectomy nine (75.0%); pterygium 10 (83.3%); eyelid, eight (66.7%); destructive 11 (91.6%) and refraction 9 (75.0%). Some trainees' perceived problems included inadequate sponsorship (33.3%), short duration of the course four (33.3%) and poor accommodation facility two (16.7%). However, trainees' suggested increase in training posts, four (33.3); training allowance three (25.0%); and incentives for trainers/training hospitals two (16.7%).\nFulfilling human resources development goal in West Africa: can the training of ophthalmologist diplomates be improved?",
        "generated_text": "3%) would work in the public sector and one (8.3%) in the private sector. The trainees were of the opinion that the programme should be extended to include a one-year fellowship in a subspecialty of ophthalmology.\nThe ODT programme is well structured and adequately funded. The trainees are willing to work in the public sector and in areas where they are needed most. The programme should be extended to include a one-year fellowship in a subspecialty of ophthalmology.\nOphthalmic Diploma Training; West Africa; Ophthalmologist; Ophthalmology\nOphthalmic Diploma Training (ODT) is a two-year postgraduate training programme in ophthalmology for medical doctors in West Africa. The programme is designed to produce ophthalmologists who can provide comprehensive eye care services in the region. The ODT programme is recognized by the West African College of Surgeons (WACS) and the Medical and Dental Council of Nigeria (MDCN).\n\nThe ODT programme was introduced in",
        "levenshtein_distance": 748
    },
    {
        "realidx": "20337202",
        "question": "To determine the duration of continuing pregnancy after antenatal corticosteroid (AC) administration and to evaluate the potential opportunity for rescue AC.\nRetrospective analysis of women at 24-32 weeks' gestation who received AC at one institution.\nSix hundred ninety-two women received AC. Two hundred forty-seven (35.7%) delivered at>or = 34 weeks' gestation. Three hundred twenty-one (46.4%) delivered within 1 week of AC; 92 of those women (13.3%) delivered within 24 hours. Only 124 (17.9%) remained pregnant 1 week after AC and delivered at<34 weeks. The latter were compared to women delivering>2 week after AC but>or = 34 weeks. More likely to deliver at<34 weeks were those women who received AC for premature preterm rupture of membranes (OR 3.83, 95% CI 2.06-7.17), twins (OR 2.90, 95% CI 1.42-5.95) or before 28 weeks (OR 2.21, 95% CI 1.38-3.52).\nContinuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue?",
        "answer": "maybe",
        "answer_rationale": "Rescue AC may apply to only 18% of cases, and we identified subsets of more likely candidates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To determine the duration of continuing pregnancy after antenatal corticosteroid (AC) administration and to evaluate the potential opportunity for rescue AC.\nRetrospective analysis of women at 24-32 weeks' gestation who received AC at one institution.\nSix hundred ninety-two women received AC. Two hundred forty-seven (35.7%) delivered at>or = 34 weeks' gestation. Three hundred twenty-one (46.4%) delivered within 1 week of AC; 92 of those women (13.3%) delivered within 24 hours. Only 124 (17.9%) remained pregnant 1 week after AC and",
        "q2": " delivered at<34 weeks. The latter were compared to women delivering>2 week after AC but>or = 34 weeks. More likely to deliver at<34 weeks were those women who received AC for premature preterm rupture of membranes (OR 3.83, 95% CI 2.06-7.17), twins (OR 2.90, 95% CI 1.42-5.95) or before 28 weeks (OR 2.21, 95% CI 1.38-3.52).\nContinuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue?",
        "generated_text": "delivered <34 weeks' gestation. Of those, 100 (80.6%) delivered within 1 week of the second course of AC. The median time from first to second AC was 10 days (range, 4-21 days). The median time from second AC to delivery was 3 days (range, 0-21 days). The median time from first AC to delivery was 13 days (range, 0-42 days). The median time from second AC to delivery was 3 days (range, 0-21 days). The median time",
        "levenshtein_distance": 334
    },
    {
        "realidx": "20354380",
        "question": "To assess gender differences among residents regarding their plans to have children during residency and determine the most influential reasons for these differences.\nUsing the Health Belief Model as a framework, the authors created an instrument to survey 424 residents from 11 residency programs at three academic medical institutions about their intentions to have children during residency. The authors developed a scale to assess the perceived career threats of having children during residency, evaluated its psychometric properties, and calculated the effect of the mediators.\nThe response rate was 77% (328/424). Forty-one percent of men versus 27% of women planned to have children during residency (P = .01). The instrument measured four career threats-extended training, loss of fellowship positions, pregnancy complications, and interference with career plans-on a five-point Likert scale. The scale had a Cronbach alpha of 0.84 and an eigenvalue of 2.2. Compared with men, women had higher scores for each item and a higher mean score (2.9 versus 2.1, P = .001), signifying greater belief in the potential of pregnancy to threaten careers. After adjusting for age, institution, postgraduate year, and knowledge of parental leave policies, women were less likely to plan to have children during residency (odds ratio 0.46 [95% confidence interval 0.25-0.84]). In mediation analysis, threats to career explained 67% of the gender variance.\nDo women residents delay childbearing due to perceived career threats?",
        "answer": "yes",
        "answer_rationale": "Women residents intentionally postpone pregnancy because of perceived threats to their careers. Medical educators should be aware of these findings when counseling female trainees.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To assess gender differences among residents regarding their plans to have children during residency and determine the most influential reasons for these differences.\nUsing the Health Belief Model as a framework, the authors created an instrument to survey 424 residents from 11 residency programs at three academic medical institutions about their intentions to have children during residency. The authors developed a scale to assess the perceived career threats of having children during residency, evaluated its psychometric properties, and calculated the effect of the mediators.\nThe response rate was 77% (328/424). Forty-one percent of men versus 27% of women planned to have children during residency (P = .01). The instrument measured four career threats-extended training, loss of fellowship positions, pregnancy complications, and interference with career",
        "q2": " plans-on a five-point Likert scale. The scale had a Cronbach alpha of 0.84 and an eigenvalue of 2.2. Compared with men, women had higher scores for each item and a higher mean score (2.9 versus 2.1, P = .001), signifying greater belief in the potential of pregnancy to threaten careers. After adjusting for age, institution, postgraduate year, and knowledge of parental leave policies, women were less likely to plan to have children during residency (odds ratio 0.46 [95% confidence interval 0.25-0.84]). In mediation analysis, threats to career explained 67% of the gender variance.\nDo women residents delay childbearing due to perceived career threats?",
        "generated_text": "goals. The most important reason for not having children during residency was the perceived threat to career goals (P < .001). Women were more likely to perceive career threats than men (P < .001). The perceived threat to career goals was the only significant mediator of the relationship between gender and intentions to have children during residency (P < .001). The authors found no significant differences in intentions to have children during residency between men and women who perceived no career threats (P = .40). The authors found no significant differences in intentions to have children during residency between men and women who perceived no career threats (P = .40).\nWomen are more likely to perceive career threats from having children during residency, and this perception is the",
        "levenshtein_distance": 582
    },
    {
        "realidx": "20537205",
        "question": "Halofantrine is a newly developed antimalarial drug used for the treatment of Plasmodium falciparum malaria. The introduction of this drug has been delayed because of its possible side effects, and due to insufficient studies on adverse reactions in humans. There have been no studies investigating its effect on hearing.\nThirty guinea pigs were divided into three groups: a control group, a halofantrine therapeutic dose group and a halofantrine double therapeutic dose group. One cochlea specimen from each animal was stained with haematoxylin and eosin and the other with toluidine blue.\nNo changes were detected in the control group. The halofantrine therapeutic dose group showed loss and distortion of inner hair cells and inner phalangeal cells, and loss of spiral ganglia cells. In the halofantrine double therapeutic dose group, the inner and outer hair cells were distorted and there was loss of spiral ganglia cells.\nIs halofantrine ototoxic?",
        "answer": "yes",
        "answer_rationale": "Halofantrine has mild to moderate pathological effects on cochlea histology, and can be considered an ototoxic drug.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Halofantrine is a newly developed antimalarial drug used for the treatment of Plasmodium falciparum malaria. The introduction of this drug has been delayed because of its possible side effects, and due to insufficient studies on adverse reactions in humans. There have been no studies investigating its effect on hearing.\nThirty guinea pigs were divided into three groups: a control group, a halofantrine therapeutic dose group and a halofantrine double therapeutic dose group. One cochlea specimen from",
        "q2": " each animal was stained with haematoxylin and eosin and the other with toluidine blue.\nNo changes were detected in the control group. The halofantrine therapeutic dose group showed loss and distortion of inner hair cells and inner phalangeal cells, and loss of spiral ganglia cells. In the halofantrine double therapeutic dose group, the inner and outer hair cells were distorted and there was loss of spiral ganglia cells.\nIs halofantrine ototoxic?",
        "generated_text": "each animal was processed for scanning electron microscopy (SEM) and the other for transmission electron microscopy (TEM). The specimens were examined for possible changes in the stereocilia of the organ of Corti and in the inner and outer hair cells.\nNo significant changes were observed in the stereocilia of the organ of Corti in any of the groups. However, in the halofantrine therapeutic dose group, there was a significant increase in the number of mitochondria in the inner hair cells,",
        "levenshtein_distance": 333
    },
    {
        "realidx": "20538207",
        "question": "It is generally considered that kidney grafts should be preserved at 4 degrees C during cold storage. However, actual temperature conditions are not known. We decided to study the temperature levels during preservation with the Biotainer storage can and Vitalpack transport pack.\nTemperature was monitored using the Thermobouton probe during preservation of pig kidneys, in the same conditions used with human grafts. The probe recorded the temperature level every 10 minutes during four days. We compared the results found with the new storage can with results obtained in the same conditions with the storage can formerly used by our team. We also studied the best position of the probe for temperature monitoring and the influence of the amount of ice within the transport pack on the temperature level. We then monitored the temperature during the conservation of actual human kidney grafts harvested at our institution from August 2007 to May 2008.\nThe temperature levels were the same regardless of the position of the probe within the transport pack. The lowest temperature was maintained during 15 hours, and the temperature level stayed below 5 degrees C for 57 hours with the new storage can. The former storage can maintained the lowest temperature level for 80 minutes, and temperature reached 5 degrees C after 10 hours 40 minutes. Temperature levels were similar when 2 or 4 kg of crushed ice were used. We observed similar results when monitoring the conservation of human grafts.\nShould temperature be monitorized during kidney allograft preservation?",
        "answer": "no",
        "answer_rationale": "The new storage can affords more stable temperature levels when compared to the formerly used can. Since temperature is stable during conservation, continuous monitoring in everyday practice does not seem warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "It is generally considered that kidney grafts should be preserved at 4 degrees C during cold storage. However, actual temperature conditions are not known. We decided to study the temperature levels during preservation with the Biotainer storage can and Vitalpack transport pack.\nTemperature was monitored using the Thermobouton probe during preservation of pig kidneys, in the same conditions used with human grafts. The probe recorded the temperature level every 10 minutes during four days. We compared the results found with the new storage can with results obtained in the same conditions with the storage can formerly used by our team. We also studied the best position of the probe for temperature monitoring and the influence of the amount of ice within the transport pack on the temperature level.",
        "q2": " We then monitored the temperature during the conservation of actual human kidney grafts harvested at our institution from August 2007 to May 2008.\nThe temperature levels were the same regardless of the position of the probe within the transport pack. The lowest temperature was maintained during 15 hours, and the temperature level stayed below 5 degrees C for 57 hours with the new storage can. The former storage can maintained the lowest temperature level for 80 minutes, and temperature reached 5 degrees C after 10 hours 40 minutes. Temperature levels were similar when 2 or 4 kg of crushed ice were used. We observed similar results when monitoring the conservation of human grafts.\nShould temperature be monitorized during kidney allograft preservation?",
        "generated_text": "The temperature was also monitored during transport of human kidneys.\nThe temperature was maintained at 4 degrees C during preservation with the new storage can, whereas it was 10 degrees C with the former can. The temperature was maintained at 4 degrees C during transport of human kidneys, but the temperature was higher in the Vitalpack transport pack than in the Biotainer storage can. The position of the probe had no influence on the temperature level. The amount of ice in the transport pack had no influence on the temperature level.\nThe Biotainer storage can allows preservation of kidneys at 4 degrees C, whereas the former can did not. The temperature is maintained at 4 degrees C during transport of human kidneys, but the temperature is higher",
        "levenshtein_distance": 523
    },
    {
        "realidx": "20549895",
        "question": "There has never been a nationally representative survey of medical students' personal health-related practices, although they are inherently of interest and may affect patient-counseling practices. This study evaluated the health practices and the vaccination status of first year residents working at the academic hospital H\u00f4tel-Dieu de France.\nThe medical files of all medicine and surgery residents in their first year of specialization between the years 2005 and 2008 were reviewed. These residents were required to go through a preventive medical visit at the University Center of Family and Community Health.\nOne hundred and nine residents (109) were included in the study; 68 (6239%) were male and 41 (37.61%) were female with a mean age of 26 years. Only 6 residents (5.50%) practiced physical activity according to international guidelines (more than three times a week for more than 30 minutes each time). Most residents (n = 76 ; 69.73%) used to skip one or two meals especially breakfast and as a consequence 30 male (44.11%) and 4 female (9.75%) students were overweight, with a statistical difference between the two sexes (Fisher test, p-value = 0.001). Twenty-eight residents (25.69%) were smokers with a male predominance. Fourteen residents of both genders (12.84%) drank alcohol regularly (>3 times a week) and 71 (65.14%) had a drink occasionally (once a month or less). Only 25 residents (23%) of the cohort had a complete and up-to-date immunization status. The immunization gap was basically against measles, mumps, rubella (MMR) and diphtheria, tetanus, poliomyelitis (dT Polio). Ninety-nine residents (90.83%) had full immunization against hepatitis B with an adequate response in 78 residents (71.56%).\nHealth habits and vaccination status of Lebanese residents: are future doctors applying the rules of prevention?",
        "answer": "no",
        "answer_rationale": "This study showed that our residents did not always have a healthy lifestyle especially when it comes to physical activity and eating habits. They also lacked an adequate vaccination. Interventions should take place in order to promote healthy life style and to improve their vaccination status.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "There has never been a nationally representative survey of medical students' personal health-related practices, although they are inherently of interest and may affect patient-counseling practices. This study evaluated the health practices and the vaccination status of first year residents working at the academic hospital H\u00f4tel-Dieu de France.\nThe medical files of all medicine and surgery residents in their first year of specialization between the years 2005 and 2008 were reviewed. These residents were required to go through a preventive medical visit at the University Center of Family and Community Health.\nOne hundred and nine residents (109) were included in the study; 68 (6239%) were male and 41 (37.61%) were female with a mean age of 26 years. Only 6 residents (5.50%) practiced physical activity according to international guidelines (more than three times a week for more than 30 minutes each time). Most residents (n = 76 ; 69.73%) used to skip one or two meals especially breakfast and as",
        "q2": " a consequence 30 male (44.11%) and 4 female (9.75%) students were overweight, with a statistical difference between the two sexes (Fisher test, p-value = 0.001). Twenty-eight residents (25.69%) were smokers with a male predominance. Fourteen residents of both genders (12.84%) drank alcohol regularly (>3 times a week) and 71 (65.14%) had a drink occasionally (once a month or less). Only 25 residents (23%) of the cohort had a complete and up-to-date immunization status. The immunization gap was basically against measles, mumps, rubella (MMR) and diphtheria, tetanus, poliomyelitis (dT Polio). Ninety-nine residents (90.83%) had full immunization against hepatitis B with an adequate response in 78 residents (71.56%).\nHealth habits and vaccination status of Lebanese residents: are future doctors applying the rules of prevention?",
        "generated_text": "many as 25 residents (22.94%) smoked. Only 12 residents (11.01%) were vaccinated against influenza and 10 residents (9.17%) against hepatitis B.\nThis study shows that the health practices of medical residents are not optimal and that their vaccination status is low. This may have an impact on their ability to counsel patients appropriately.",
        "levenshtein_distance": 643
    },
    {
        "realidx": "20571467",
        "question": "Kidneys from elderly donors tend to be implanted in recipients who are also elderly. We present the results obtained after 10 years of evolution on transplanting elderly kidneys into young recipients.\nNinety-one consecutive transplants are studied, carried out in our center with kidneys from cadaver donors older than 60 years implanted in recipients younger than 60 years. The control group is made up of 91 transplants, matched with those from the study group, whose donor and recipient were younger than 60 years.\nThere were no differences between groups with regard to recipient age, sex, cause of death and renal function of the donor, hepatitis C and cytomegalovirus serologies, cold ischemia time, tubular necrosis, immediate diuresis, need for dialysis, human leukocyte antigen incompatibilities, hypersensitized patients, acute rejection, waiting time on dialysis, and days of admission. Survival in both groups at 1, 5, and 10 years was 97.6%, 87.2%, and 76.6% vs. 98.8%, 87.5%, and 69.5% for the patient (P=0.642), 92.9%, 81.3%, and 64.2% vs. 93.9%, 76.4%, and 69.5% for the graft (P=0.980), and 94.4%, 92.6%, and 77.4% vs. 94.3%, 86.7%, and 84.4% for the graft with death censured (P=0.747), respectively. Creatininaemias at 1, 5, and 10 years were 172, 175, and 210 vs. 139, 134, and 155 (P<0.05).\nIs it appropriate to implant kidneys from elderly donors in young recipients?",
        "answer": "yes",
        "answer_rationale": "We conclude that patient and graft survival on transplanting kidneys from elderly donors to young recipients is superimposable on that obtained with young donors. However, renal function is better in the group of young donors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Kidneys from elderly donors tend to be implanted in recipients who are also elderly. We present the results obtained after 10 years of evolution on transplanting elderly kidneys into young recipients.\nNinety-one consecutive transplants are studied, carried out in our center with kidneys from cadaver donors older than 60 years implanted in recipients younger than 60 years. The control group is made up of 91 transplants, matched with those from the study group, whose donor and recipient were younger than 60 years.\nThere were no differences between groups with regard to recipient age, sex, cause of death and renal function of the donor, hepatitis C and cytomegalovirus serologies, cold ischemia time, tubular necrosis, immediate diuresis, need for dialysis, human leukocyte antigen incompatibilities, hypersensitized patients, acute rejection, waiting time on dialysis, and days of admission. Survival in both groups at 1, 5, and 10 years was",
        "q2": " 97.6%, 87.2%, and 76.6% vs. 98.8%, 87.5%, and 69.5% for the patient (P=0.642), 92.9%, 81.3%, and 64.2% vs. 93.9%, 76.4%, and 69.5% for the graft (P=0.980), and 94.4%, 92.6%, and 77.4% vs. 94.3%, 86.7%, and 84.4% for the graft with death censured (P=0.747), respectively. Creatininaemias at 1, 5, and 10 years were 172, 175, and 210 vs. 139, 134, and 155 (P<0.05).\nIs it appropriate to implant kidneys from elderly donors in young recipients?",
        "generated_text": "95%, 85%, and 70%, respectively. The mean creatinine at 1, 5, and 10 years was 1.5, 1.7, and 2.0 mg/dl, respectively, in both groups. The mean creatinine clearance at 1, 5, and 10 years was 55, 50, and 45 ml/min, respectively, in both groups.\nTransplanting elderly kidneys into young recipients does not affect the results in terms of survival and renal function.",
        "levenshtein_distance": 330
    },
    {
        "realidx": "20577124",
        "question": "Hyperleptinemia and oxidative stress play a major role in the development of cardiovascular diseases in obesity. This study aimed to investigate whether there is a relationship between plasma levels of leptin and phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and its potential relevance in the vascular remodeling in obese patients.\nThe study was performed in 164 obese and 94 normal-weight individuals (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid intima-media thickness (cIMT) was measured by ultrasonography. In addition, we performed in-vitro experiments in human peripheral blood mononuclear cells and murine macrophages.\nPhagocytic NADPH oxidase activity and leptin levels were enhanced (P<0.05) in obese patients compared with controls. NADPH oxidase activity positively correlated with leptin in obese patients. This association remained significant in a multivariate analysis. cIMT was higher (P<0.05) in obese patients compared with controls. In addition, cIMT also correlated positively with leptin and NADPH oxidase activity in obese patients. In-vitro studies showed that leptin induced NADPH oxidase activation. Inhibition of the leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide suggested a direct involvement of the phosphatidylinositol 3-kinase and protein kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation promoted macrophage proliferation.\nIs leptin involved in phagocytic NADPH oxidase overactivity in obesity?",
        "answer": "yes",
        "answer_rationale": "These findings show that phagocytic NADPH oxidase activity is increased in obesity and is related to preclinical atherosclerosis in this condition. We also suggest that hyperleptinemia may contribute to phagocytic NADPH oxidase overactivity in obesity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Hyperleptinemia and oxidative stress play a major role in the development of cardiovascular diseases in obesity. This study aimed to investigate whether there is a relationship between plasma levels of leptin and phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and its potential relevance in the vascular remodeling in obese patients.\nThe study was performed in 164 obese and 94 normal-weight individuals (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid intima-media thickness (cIMT) was measured by ultrasonography. In addition, we performed in-vitro experiments in human peripheral blood mononuclear cells and murine macrophages.\nPhagocytic NADPH oxidase activity and leptin levels were",
        "q2": " enhanced (P<0.05) in obese patients compared with controls. NADPH oxidase activity positively correlated with leptin in obese patients. This association remained significant in a multivariate analysis. cIMT was higher (P<0.05) in obese patients compared with controls. In addition, cIMT also correlated positively with leptin and NADPH oxidase activity in obese patients. In-vitro studies showed that leptin induced NADPH oxidase activation. Inhibition of the leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide suggested a direct involvement of the phosphatidylinositol 3-kinase and protein kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation promoted macrophage proliferation.\nIs leptin involved in phagocytic NADPH oxidase overactivity in obesity?",
        "generated_text": "higher in obese patients compared to controls (p < 0.001). A positive correlation was observed between leptin and NADPH oxidase activity in obese patients (r = 0.32, p < 0.001). In addition, a positive correlation was observed between NADPH oxidase activity and cIMT in obese patients (r = 0.25, p < 0.01). In vitro, leptin increased NADPH oxidase activity in human peripheral blood mononuclear cells and in murine macrophages.\nOur results suggest that leptin may be involved in the regulation of phagocytic NADPH oxidase activity, which may contribute to the development of vascular remodeling in obesity.",
        "levenshtein_distance": 498
    },
    {
        "realidx": "20602101",
        "question": "Studies have indicated that hypoalbuminemia is associated with decreased survival of patients with gastric cancer. However, the prognostic value of albumin may be secondary to an ongoing systemic inflammatory response. The aim of the study was to assess the relation between hypoalbuminemia, the systemic inflammatory response, and survival in patients with gastric cancer.\nPatients diagnosed with gastric carcinoma attending the upper gastrointestinal surgical unit in the Royal Infirmary, Glasgow between April 1997 and December 2005 and who had a pretreatment measurement of albumin and C-reactive protein (CRP) were studied.\nMost of the patients had stage III/IV disease and received palliative treatment. The minimum follow-up was 15 months. During follow-up, 157 (72%) patients died of their cancer. On univariate analysis, stage (p<0.001), treatment (p<0.001), albumin level (p<0.001), and CRP level (p<0.001) were significant predictors of survival. On multivariate analysis, stage (p<0.001), treatment (p<0.001), and CRP level (p<0.001) remained significant predictors of survival. Albumin was no longer an independent predictor of survival.\nIs hypoalbuminemia an independent prognostic factor in patients with gastric cancer?",
        "answer": "no",
        "answer_rationale": "Low albumin concentrations are associated with poorer survival in patients with gastric cancer. However, the strength of this relation with survival is dependent on the presence of a systemic inflammatory response, as evidenced by an elevated CRP level. Therefore, it appears that the relation between hypoalbuminemia and poor survival is secondary to that of the systemic inflammatory response.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Studies have indicated that hypoalbuminemia is associated with decreased survival of patients with gastric cancer. However, the prognostic value of albumin may be secondary to an ongoing systemic inflammatory response. The aim of the study was to assess the relation between hypoalbuminemia, the systemic inflammatory response, and survival in patients with gastric cancer.\nPatients diagnosed with gastric carcinoma attending the upper gastrointestinal surgical unit in the Royal Infirmary, Glasgow between April 1997 and December 2005 and who had a pretreatment measurement of albumin and C-reactive protein (CRP) were studied.\nMost of the patients had stage III/IV disease and received palliative treatment. The",
        "q2": " minimum follow-up was 15 months. During follow-up, 157 (72%) patients died of their cancer. On univariate analysis, stage (p<0.001), treatment (p<0.001), albumin level (p<0.001), and CRP level (p<0.001) were significant predictors of survival. On multivariate analysis, stage (p<0.001), treatment (p<0.001), and CRP level (p<0.001) remained significant predictors of survival. Albumin was no longer an independent predictor of survival.\nIs hypoalbuminemia an independent prognostic factor in patients with gastric cancer?",
        "generated_text": "median survival was 10 months. Hypoalbuminemia was associated with increased mortality (hazard ratio [HR], 1.4; 95% confidence interval [CI], 1.1-1.8). The relation between hypoalbuminemia and survival was modified by CRP (P = 0.001). In patients with CRP <10 mg/L, hypoalbuminemia was not associated with increased mortality (HR, 1.0; 95% CI, 0.6-1.6). In patients with CRP >10 mg/L, hypoalbuminemia was associated with increased mortality",
        "levenshtein_distance": 387
    },
    {
        "realidx": "20602784",
        "question": "This paper investigates the impact of geographic scale (census tract, zip code, and county) on the detection of disparities in breast cancer mortality among three ethnic groups in Texas (period 1995-2005). Racial disparities were quantified using both relative (RR) and absolute (RD) statistics that account for the population size and correct for unreliable rates typically observed for minority groups and smaller geographic units. Results were then correlated with socio-economic status measured by the percentage of habitants living below the poverty level.\nAfrican-American and Hispanic women generally experience higher mortality than White non-Hispanics, and these differences are especially significant in the southeast metropolitan areas and southwest border of Texas. The proportion and location of significant racial disparities however changed depending on the type of statistic (RR versus RD) and the geographic level. The largest proportion of significant results was observed for the RD statistic and census tract data. Geographic regions with significant racial disparities for African-Americans and Hispanics frequently had a poverty rate above 10.00%.\nIdentification of racial disparities in breast cancer mortality: does scale matter?",
        "answer": "yes",
        "answer_rationale": "This study investigates both relative and absolute racial disparities in breast cancer mortality between White non-Hispanic and African-American/Hispanic women at the census tract, zip code and county levels. Analysis at the census tract level generally led to a larger proportion of geographical units experiencing significantly higher mortality rates for minority groups, although results varied depending on the use of the relative versus absolute statistics. Additional research is needed before general conclusions can be formulated regarding the choice of optimal geographic regions for the detection of racial disparities.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This paper investigates the impact of geographic scale (census tract, zip code, and county) on the detection of disparities in breast cancer mortality among three ethnic groups in Texas (period 1995-2005). Racial disparities were quantified using both relative (RR) and absolute (RD) statistics that account for the population size and correct for unreliable rates typically observed for minority groups and smaller geographic units. Results were then correlated with socio-economic status measured by the percentage of habitants living below the poverty level.\nAfrican-American and Hispanic women generally",
        "q2": " experience higher mortality than White non-Hispanics, and these differences are especially significant in the southeast metropolitan areas and southwest border of Texas. The proportion and location of significant racial disparities however changed depending on the type of statistic (RR versus RD) and the geographic level. The largest proportion of significant results was observed for the RD statistic and census tract data. Geographic regions with significant racial disparities for African-Americans and Hispanics frequently had a poverty rate above 10.00%.\nIdentification of racial disparities in breast cancer mortality: does scale matter?",
        "generated_text": "had higher mortality rates than non-Hispanic whites, but the magnitude of the disparity varied by geographic scale and ethnic group. The relative disparity was higher for African-Americans at the county level, but higher for Hispanics at the census tract level. The absolute disparity was higher for Hispanics at all geographic scales. Socio-economic status was strongly associated with both relative and absolute disparities, but the strength of the association varied by ethnic group and geographic scale.\nThese findings suggest that the choice of geographic scale can influence the detection of disparities in breast cancer mortality",
        "levenshtein_distance": 468
    },
    {
        "realidx": "20605051",
        "question": "Reimbursement based on the total care of a patient during an acute episode of illness is believed to stimulate management and clinicians to reduce quality problems like waiting times and poor coordination of care delivery. Although many studies already show that this kind of case-mix based reimbursement leads to more efficiency, it remains unclear whether care coordination improved as well. This study aims to explore whether case-mix based reimbursement stimulates development of care coordination by the use of care programmes, and a process-oriented way of working.\nData for this study were gathered during the winter of 2007/2008 in a survey involving all Dutch hospitals. Descriptive and structural equation modelling (SEM) analyses were conducted.\nSEM reveals that adoption of the case-mix reimbursement within hospitals' budgeting processes stimulates hospitals to establish care programmes by the use of process-oriented performance measures. However, the implementation of care programmes is not (yet) accompanied by a change in focus from function (the delivery of independent care activities) to process (the delivery of care activities as being connected to a chain of interdependent care activities).\nDoes case-mix based reimbursement stimulate the development of process-oriented care delivery?",
        "answer": "yes",
        "answer_rationale": "This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Reimbursement based on the total care of a patient during an acute episode of illness is believed to stimulate management and clinicians to reduce quality problems like waiting times and poor coordination of care delivery. Although many studies already show that this kind of case-mix based reimbursement leads to more efficiency, it remains unclear whether care coordination improved as well. This study aims to explore whether case-mix based reimbursement stimulates development of care coordination by the use of care programmes, and a process-oriented way of working.\nData for this study were gathered during the winter of 2007/2008",
        "q2": " in a survey involving all Dutch hospitals. Descriptive and structural equation modelling (SEM) analyses were conducted.\nSEM reveals that adoption of the case-mix reimbursement within hospitals' budgeting processes stimulates hospitals to establish care programmes by the use of process-oriented performance measures. However, the implementation of care programmes is not (yet) accompanied by a change in focus from function (the delivery of independent care activities) to process (the delivery of care activities as being connected to a chain of interdependent care activities).\nDoes case-mix based reimbursement stimulate the development of process-oriented care delivery?",
        "generated_text": "in the Netherlands. A total of 100 general practitioners (GPs) and 100 practice nurses (PNs) were interviewed about their way of working and the use of care programmes. The data were analysed using multilevel logistic regression analysis.\nThe results show that case-mix based reimbursement is positively related to the use of care programmes and a process-oriented way of working. The effect is stronger for PNs than for GPs. The effect is also stronger for care programmes for chronic diseases than for acute diseases.\nThis study shows that case-m",
        "levenshtein_distance": 496
    },
    {
        "realidx": "20608141",
        "question": "Prostate-specific antigen (PSA) levels can show wide fluctuations when repeatedly measured. Here we investigatewd if: (a) biopsy timing influences the prostate cancer (PC) detection rate in patients with fluctuating PSA (flu-PSA) in comparison with patients with steadily increasing PSA (si-PSA); (b) PSA slope estimated in patients with flu-PSA predicts a different risk of cancer detection; (c) flu-PSA and si-PSA patients develop PC in topographically different sites; (d) the behaviour of pre-operative PSA is an expression of a disease with defferent characteristics to the following radical prostatectomy.\nThe study involved 211 patients who underwent at least a second biopsy after a first negative prostate biopsy. PSA Slope, PSA velocity (PSAV) and PSA doubling time (PSADT) were estimated. Flu-PSA level was defined as a PSA series with at least one PSA value lower than the one immediately preceding it.\n82 patients had flu-PSA levels and 129 si-PSA levels. There were no significant differences between the two groups in terms of cancer detection, clinical or pathological stage, but the si-PSA group with cancer had a higher Gleason score. No difference was found for PSA Slope between flu-PSA patients with cancer and those without.\nPSA repeatedly fluctuating levels are reassuring enough to avoid biopsy?",
        "answer": "no",
        "answer_rationale": "Our study demonstrates no difference in PC detection rate at repeat biopsy between patients with flu or si-PSA levels. PSA Slope, PSAV and PSADT were not found helpful tools in cancer detection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Prostate-specific antigen (PSA) levels can show wide fluctuations when repeatedly measured. Here we investigatewd if: (a) biopsy timing influences the prostate cancer (PC) detection rate in patients with fluctuating PSA (flu-PSA) in comparison with patients with steadily increasing PSA (si-PSA); (b) PSA slope estimated in patients with flu-PSA predicts a different risk of cancer detection; (c) flu-PSA and si-PSA patients develop PC in topographically different sites; (d) the behaviour of pre-operative PSA is an expression of a disease with defferent characteristics to the following radical prostatectomy.\nThe study involved 211 patients who underwent at least",
        "q2": " a second biopsy after a first negative prostate biopsy. PSA Slope, PSA velocity (PSAV) and PSA doubling time (PSADT) were estimated. Flu-PSA level was defined as a PSA series with at least one PSA value lower than the one immediately preceding it.\n82 patients had flu-PSA levels and 129 si-PSA levels. There were no significant differences between the two groups in terms of cancer detection, clinical or pathological stage, but the si-PSA group with cancer had a higher Gleason score. No difference was found for PSA Slope between flu-PSA patients with cancer and those without.\nPSA repeatedly fluctuating levels are reassuring enough to avoid biopsy?",
        "generated_text": "3 PSA measurements over a period of 12 months and underwent radical prostatectomy for PC. Patients were divided into two groups: flu-PSA (n=105) and si-PSA (n=106). The flu-PSA group had at least two PSA measurements with a difference of \u22650.5 ng/mL, while the si-PSA group had a steady increase in PSA levels over time. The primary outcome was the detection rate of PC at radical prostatectomy. Secondary outcomes included PSA slope, tumor location, and postoperative disease characteristics.\n\nResults:\n\nThe PC detection rate was similar between the flu-PSA and si-PSA groups (",
        "levenshtein_distance": 488
    },
    {
        "realidx": "20629769",
        "question": "The National Infarct Angioplasty Project assessed the feasibility of establishing a comprehensive primary angioplasty service. We aimed to compare satisfaction at intervention hospitals offering angioplasty-based care and control hospitals offering thrombolysis-based care.\nMixed methods, with postal survey of patients and their carers, supported by semi-structured interviews.\nSurvey of 682 patients and 486 carers, and interviews with 33 patients and carers, in eight English hospitals.\nPrimary angioplasty or thrombolysis.\nSatisfaction with treatment.\nResponses were received from 595/682 patients (87%) and 418/486 carers (86%). Satisfaction with overall care was high at both intervention and control sites (78% vs. 71% patients rated their care as 'excellent', P = 0.074). Patient satisfaction was higher at intervention sites for some aspects of care such as speed of treatment (80% vs. 67%'excellent', P = 0.001). Convenience of visiting was rated lower at intervention sites by carers (12% vs. 1%'poor', P = 0.001). During interviews, carers reported that they accepted the added inconvenience of visiting primary angioplasty sites in the context of this life-saving treatment. Patient satisfaction with discharge and aftercare was lower in both treatment groups than for other aspects of care.\nIs primary angioplasty an acceptable alternative to thrombolysis?",
        "answer": "yes",
        "answer_rationale": "Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The National Infarct Angioplasty Project assessed the feasibility of establishing a comprehensive primary angioplasty service. We aimed to compare satisfaction at intervention hospitals offering angioplasty-based care and control hospitals offering thrombolysis-based care.\nMixed methods, with postal survey of patients and their carers, supported by semi-structured interviews.\nSurvey of 682 patients and 486 carers, and interviews with 33 patients and carers, in eight English hospitals.\nPrimary angioplasty or thrombolysis.\nSatisfaction with treatment.\nResponses were received from 595/682 patients (87%) and 418/486 carers (86%). Satisfaction with overall care was high at both intervention and control sites (78% vs.",
        "q2": " 71% patients rated their care as 'excellent', P = 0.074). Patient satisfaction was higher at intervention sites for some aspects of care such as speed of treatment (80% vs. 67%'excellent', P = 0.001). Convenience of visiting was rated lower at intervention sites by carers (12% vs. 1%'poor', P = 0.001). During interviews, carers reported that they accepted the added inconvenience of visiting primary angioplasty sites in the context of this life-saving treatment. Patient satisfaction with discharge and aftercare was lower in both treatment groups than for other aspects of care.\nIs primary angioplasty an acceptable alternative to thrombolysis?",
        "generated_text": "79% of patients, 82% vs. 81% of carers). Patients at intervention sites were more likely to be satisfied with the information they received about their treatment (85% vs. 75%, p=0.001), and with the time taken to receive treatment (84% vs. 74%, p=0.002). Carers at intervention sites were more likely to be satisfied with the information they received about the patient's treatment (84% vs. 74%, p=0.003). Patients at intervention sites were more likely to be satisfied with the information they received about",
        "levenshtein_distance": 452
    },
    {
        "realidx": "20736672",
        "question": "To assess whether perspective-taking, which researchers in other fields have shown to induce empathy, improves patient satisfaction in encounters between student-clinicians and standardized patients (SPs).\nIn three studies, randomly assigned students (N = 608) received either a perspective-taking instruction or a neutral instruction prior to a clinical skills examination in 2006-2007. SP satisfaction was the main outcome in all three studies. Study 1 involved 245 third-year medical students from two universities. Studies 2 and 3 extended Study 1 to examine generalizability across student and SP subpopulations. Study 2 (105 physician assistant students, one university) explored the effect of perspective-taking on African American SPs' satisfaction. Study 3 (258 third-year medical students, two universities) examined the intervention's effect on students with high and low baseline perspective-taking tendencies.\nIntervention students outscored controls in patient satisfaction in all studies: Study 1: P = .01, standardized effect size = 0.16; Study 2: P = .001, standardized effect size = 0.31; Study 3: P = .009, standardized effect size = 0.13. In Study 2, perspective-taking improved African American SPs' satisfaction. In Study 3, intervention students with high baseline perspective-taking tendencies outscored controls (P = .0004, standardized effect size = 0.25), whereas those with low perspective-taking tendencies did not (P = .72, standardized effect size = 0.00).\nDoes perspective-taking increase patient satisfaction in medical encounters?",
        "answer": "maybe",
        "answer_rationale": "Perspective-taking increased patient satisfaction in all three studies, across medical schools, clinical disciplines, and racially diverse students and SPs. Perspective-taking as a means for improving patient satisfaction deserves further exploration in clinical training and practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To assess whether perspective-taking, which researchers in other fields have shown to induce empathy, improves patient satisfaction in encounters between student-clinicians and standardized patients (SPs).\nIn three studies, randomly assigned students (N = 608) received either a perspective-taking instruction or a neutral instruction prior to a clinical skills examination in 2006-2007. SP satisfaction was the main outcome in all three studies. Study 1 involved 245 third-year medical students from two universities. Studies 2 and 3 extended Study 1 to examine generalizability across student and SP subpopulations. Study 2 (105 physician assistant students, one university) explored the effect of perspective-taking on African American SPs' satisfaction. Study 3 (258 third-year medical students, two universities) examined the intervention's",
        "q2": " effect on students with high and low baseline perspective-taking tendencies.\nIntervention students outscored controls in patient satisfaction in all studies: Study 1: P = .01, standardized effect size = 0.16; Study 2: P = .001, standardized effect size = 0.31; Study 3: P = .009, standardized effect size = 0.13. In Study 2, perspective-taking improved African American SPs' satisfaction. In Study 3, intervention students with high baseline perspective-taking tendencies outscored controls (P = .0004, standardized effect size = 0.25), whereas those with low perspective-taking tendencies did not (P = .72, standardized effect size = 0.00).\nDoes perspective-taking increase patient satisfaction in medical encounters?",
        "generated_text": "effect on male SPs' satisfaction.\nIn Study 1, perspective-taking increased SP satisfaction (p < .05). In Study 2, the intervention increased satisfaction among African American SPs (p < .05). In Study 3, the intervention increased satisfaction among male SPs (p < .05).\nPerspective-taking is a promising intervention to improve patient satisfaction in clinical encounters. Future research should examine the generalizability of these findings to other student and patient subpopulations and explore the mechanisms underlying the intervention's effects.",
        "levenshtein_distance": 509
    },
    {
        "realidx": "20736887",
        "question": "A retrospective multicenter study of series of 12 patients with spinal cord sarcoidosis who underwent surgery.\nTo evaluate the postoperative outcomes of patients with cervical spinal cord sarcoidosis accompanied with compressive myelopathy and effect of decompressive surgery on the prognosis of sarcoidosis.\nSarcoidosis is a chronic, multisystem noncaseating granulomatous disease. It is difficult to differentiate spinal cord sarcoidosis from cervical compressive myelopathy. There are no studies regarding the coexistence of compressive cervical myelopathy with cervical spinal cord sarcoidosis and the effect of decompressive surgery.\nNagoya Spine Group database included 1560 cases with cervical myelopathy treated with cervical laminectomy or laminoplasty from 2001 to 2005. A total of 12 patients (0.08% of cervical myelopathy) were identified spinal cord sarcoidosis treated with decompressive surgery. As a control subject, 8 patients with spinal cord sarcoidosis without compressive lesion who underwent high-dose steroid therapy without surgery were recruited.\nIn the surgery group, enhancing lesions on magnetic resonance imaging (MRI) were mostly seen at C5-C6, coincident with the maximum compression level in all cases. Postoperative recovery rates in the surgery group at 1 week and 4 weeks were -7.4% and -1.1%, respectively. Only 5 cases had showed clinical improvement, and the condition of these 5 patients had worsened again at averaged 7.4 weeks after surgery. Postoperative oral steroid therapy was initiated at an average of 6.4 weeks and the average initial dose was 54.0 mg in the surgery group, while 51.3 mg in the nonsurgery group. The recovery rate of the Japanese Orthopedic Association score, which increased after steroid therapy, was better in the nonsurgery group (62.5%) than in the surgery group (18.6%) with significant difference (P<0.01).\nIs decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy?",
        "answer": "no",
        "answer_rationale": "The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "A retrospective multicenter study of series of 12 patients with spinal cord sarcoidosis who underwent surgery.\nTo evaluate the postoperative outcomes of patients with cervical spinal cord sarcoidosis accompanied with compressive myelopathy and effect of decompressive surgery on the prognosis of sarcoidosis.\nSarcoidosis is a chronic, multisystem noncaseating granulomatous disease. It is difficult to differentiate spinal cord sarcoidosis from cervical compressive myelopathy. There are no studies regarding the coexistence of compressive cervical myelopathy with cervical spinal cord sarcoidosis and the effect of decompressive surgery.\nNagoya Spine Group database included 1560 cases with cervical myelopathy treated with cervical laminectomy or laminoplasty from 2001 to 2005. A total of 12 patients (0.08% of cervical myelopathy) were identified spinal cord sarcoidosis treated with decompressive surgery. As a control subject, 8 patients with spinal cord sarcoidosis without compressive lesion who underwent high-dose steroid therapy without surgery",
        "q2": " were recruited.\nIn the surgery group, enhancing lesions on magnetic resonance imaging (MRI) were mostly seen at C5-C6, coincident with the maximum compression level in all cases. Postoperative recovery rates in the surgery group at 1 week and 4 weeks were -7.4% and -1.1%, respectively. Only 5 cases had showed clinical improvement, and the condition of these 5 patients had worsened again at averaged 7.4 weeks after surgery. Postoperative oral steroid therapy was initiated at an average of 6.4 weeks and the average initial dose was 54.0 mg in the surgery group, while 51.3 mg in the nonsurgery group. The recovery rate of the Japanese Orthopedic Association score, which increased after steroid therapy, was better in the nonsurgery group (62.5%) than in the surgery group (18.6%) with significant difference (P<0.01).\nIs decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy?",
        "generated_text": "were selected. The mean age was 52.5 years (range, 31-70 years). The mean follow-up period was 4.5 years (range, 2-7 years). The mean duration from onset to surgery was 1.5 years (range, 0.5-3 years). The mean duration from onset to steroid therapy was 1.2 years (range, 0.5-2 years). The mean duration from onset to diagnosis was 1.4 years (range, 0.5-3 years). The mean duration from surgery to diagnosis was 0.5 years (range, 0-1.5 years). The mean duration from steroid therapy to diagnosis was 0.5 years (range, 0-1.5 years). The mean duration from surgery to steroid therapy was 1.0 years (range, 0-2 years). The mean duration from steroid therapy to surgery was 0.5 years (range, 0-1.",
        "levenshtein_distance": 685
    },
    {
        "realidx": "20850631",
        "question": "We investigated the efficacy of ultrasound in determining megarectum and fecal load and the response to treatment in constipation and tried to specify objective criteria in this study.\nA total of 66 cases were queried and divided into 2 groups as constipated (n = 35; mean age, 6.8 \u00b1 2.9 years) and control (n = 31; mean age, 8.4 \u00b1 3.8 years) according to Rome III criteria. After the clinical evaluation, pelvic ultrasonography (US) was performed by 2 separate radiologists. The bladder capacity and the transverse rectal diameter were measured with a full bladder. Then the rectal diameter and rectal anterior wall thickness were measured, and the presence of fecal load in the rectum and sigmoid colon was recorded with an empty bladder. The examination and ultrasound were repeated after treatment for a month in these patients.\nComparison of the US measurements of the 2 radiologists performing the US tests did not show any interobserver difference (r = 0.981; P<.001). We therefore believe our results are objective and reproducible. We found a positive correlation between the rectal diameters and the age, height, weight, and bladder capacity. The posturination mean rectal diameter was thicker in the constipated group (3.02 \u00b1 1.04 cm) than in the control group (1.98 \u00b1 0.64 cm) (P<.001). The cutoff point of rectal diameter for a diagnosis of constipation was determined as 2.44 cm (71% sensitive; 76% specific; area under curve, 0.825; P<.001). The rectal anterior wall thickness and fecal load were higher in the constipated patients (P<.001). There was a significant decrease in the constipation score and fecal load after treatment for a month (P<.001), but the rectal diameter had not reached normal limits yet despite the decrease (2.71 \u00b1 0.77 cm) (P>.05).\nDiagnosis and follow-up in constipated children: should we use ultrasound?",
        "answer": "yes",
        "answer_rationale": "The use of US helps in making a correct diagnosis and in the follow-up with objective criteria and also convinces the patient and the family that the treatment needs to be continued.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We investigated the efficacy of ultrasound in determining megarectum and fecal load and the response to treatment in constipation and tried to specify objective criteria in this study.\nA total of 66 cases were queried and divided into 2 groups as constipated (n = 35; mean age, 6.8 \u00b1 2.9 years) and control (n = 31; mean age, 8.4 \u00b1 3.8 years) according to Rome III criteria. After the clinical evaluation, pelvic ultrasonography (US) was performed by 2 separate radiologists. The bladder capacity and the transverse rectal diameter were measured with a full bladder. Then the rectal diameter and rectal anterior wall thickness were measured, and the presence of fecal load in the rectum and sigmoid colon was recorded with an empty bladder. The examination and ultrasound were repeated after treatment for a month in these patients.\nComparison of the US measurements of the 2 radiologists performing the US tests did not show any interobserver difference (r = 0.981; P<.001",
        "q2": "). We therefore believe our results are objective and reproducible. We found a positive correlation between the rectal diameters and the age, height, weight, and bladder capacity. The posturination mean rectal diameter was thicker in the constipated group (3.02 \u00b1 1.04 cm) than in the control group (1.98 \u00b1 0.64 cm) (P<.001). The cutoff point of rectal diameter for a diagnosis of constipation was determined as 2.44 cm (71% sensitive; 76% specific; area under curve, 0.825; P<.001). The rectal anterior wall thickness and fecal load were higher in the constipated patients (P<.001). There was a significant decrease in the constipation score and fecal load after treatment for a month (P<.001), but the rectal diameter had not reached normal limits yet despite the decrease (2.71 \u00b1 0.77 cm) (P>.05).\nDiagnosis and follow-up in constipated children: should we use ultrasound?",
        "generated_text": "). The mean transverse rectal diameter was 1.1 \u00b1 0.3 cm in the control group and 1.7 \u00b1 0.5 cm in the constipated group (P<.001). The mean rectal diameter was 1.1 \u00b1 0.3 cm in the control group and 1.6 \u00b1 0.4 cm in the constipated group (P<.001). The mean rectal anterior wall thickness was 0.2 \u00b1 0.1 cm in the control group and 0.3 \u00b1 0.1 cm in the constipated group (P<.001). The mean fecal load was 1.1 \u00b1 0.7 cm in the control group and 2.8 \u00b1 1.1 cm in the constipated group (P<.001). The mean bladder capacity was 10.1 \u00b1 2.8 mL/kg in the control group and 11.1 \u00b1 3.1 mL/kg in the constipated group (",
        "levenshtein_distance": 579
    },
    {
        "realidx": "20971618",
        "question": "Cutaneous infections such as impetigo contagiosum (IC), molluscum contagiosum (MC) and herpes virus infection (HI) appear to be associated with atopic dermatitis (AD), but there are no reports of concrete epidemiological evidence.\nWe evaluated the association of childhood AD with these infections by conducting a population-based cross-sectional study.\nEnrolled in this study were 1117 children aged 0-6 years old attending nursery schools in Ishigaki City, Okinawa Prefecture, Japan. Physical examination was performed by dermatologists, and a questionnaire was completed on each child's history of allergic diseases including AD, asthma, allergic rhinitis and egg allergy, and that of skin infections including IC, MC and HI, as well as familial history of AD.\nIn 913 children (AD; 132), a history of IC, MC or HI was observed in 45.1%, 19.7%, and 2.5%, respectively. Multiple logistic regression analysis revealed that the odds of having a history of IC were 1.8 times higher in AD children than in non-AD children. Meanwhile, a history of MC was significantly correlated to the male gender, but not to a personal history of AD. As for HI, we found no correlated factors in this study.\nAre lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?",
        "answer": "maybe",
        "answer_rationale": "The lifetime prevalence of IC was indeed higher in young children with a history of AD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Cutaneous infections such as impetigo contagiosum (IC), molluscum contagiosum (MC) and herpes virus infection (HI) appear to be associated with atopic dermatitis (AD), but there are no reports of concrete epidemiological evidence.\nWe evaluated the association of childhood AD with these infections by conducting a population-based cross-sectional study.\nEnrolled in this study were 1117 children aged 0-6 years old attending nursery schools in Ishigaki City, Okinawa Prefecture, Japan. Physical examination was performed by dermatologists, and a questionnaire was completed on each child's history of allergic diseases including AD, asthma, allergic rhinitis and egg allergy, and that of skin infections including",
        "q2": " IC, MC and HI, as well as familial history of AD.\nIn 913 children (AD; 132), a history of IC, MC or HI was observed in 45.1%, 19.7%, and 2.5%, respectively. Multiple logistic regression analysis revealed that the odds of having a history of IC were 1.8 times higher in AD children than in non-AD children. Meanwhile, a history of MC was significantly correlated to the male gender, but not to a personal history of AD. As for HI, we found no correlated factors in this study.\nAre lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?",
        "generated_text": "IC, MC and HI. The association of AD with these infections was evaluated by multivariate logistic regression analysis.\nThe prevalence of AD was 14.1% (n=157). The prevalence of IC, MC and HI was 1.7% (n=19), 1.9% (n=21) and 0.4% (n=4), respectively. The prevalence of AD was significantly higher in children with IC (31.6%, n=6/19), MC (33.3%, n=7/21) and HI (50.0%, n=2/4) than in those without these infections (",
        "levenshtein_distance": 434
    },
    {
        "realidx": "21074975",
        "question": "The ultra high risk (UHR) for psychosis criteria have been validated in a number of studies. However, it is not known whether particular UHR criteria (Attenuated Psychotic Symptoms (APS), Brief Limited Intermittent Psychotic Symptoms (BLIPS) or Trait vulnerability criteria), or combination of criteria, is associated with a higher risk of transition to psychosis. The current study investigated this issue over a 6-month follow-up period. We hypothesised that the risk of transition would increase in the following order: Trait alone<APS alone<APS+Trait<BLIPS.\nData on UHR intake criteria and transition to psychosis status at 6 months were analysed for UHR patients seen at the PACE clinic, Orygen Youth Health between January 2000 and November 2008.\nA total of 928 new referrals were accepted into the PACE clinic over this period of whom 817 (88%) had baseline information available for analysis. The percentage of subjects who presented with APS, Trait and BLIPS were 83%, 27% and 4%, respectively. When the two intermediate groups (APS alone and APS+Trait) were combined, there was evidence that the risk of transition increased in the order of Trait alone<APS<BLIPS (p=0.024, adjusted analysis).\nUltra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?",
        "answer": "yes",
        "answer_rationale": "Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The ultra high risk (UHR) for psychosis criteria have been validated in a number of studies. However, it is not known whether particular UHR criteria (Attenuated Psychotic Symptoms (APS), Brief Limited Intermittent Psychotic Symptoms (BLIPS) or Trait vulnerability criteria), or combination of criteria, is associated with a higher risk of transition to psychosis. The current study investigated this issue over a 6-month follow-up period. We hypothesised that the risk of transition would increase in the following order: Trait alone<APS alone<APS+Trait<BLIPS.\nData on UHR intake criteria and transition to psychosis status at 6 months were analysed for UHR patients seen at the P",
        "q2": "ACE clinic, Orygen Youth Health between January 2000 and November 2008.\nA total of 928 new referrals were accepted into the PACE clinic over this period of whom 817 (88%) had baseline information available for analysis. The percentage of subjects who presented with APS, Trait and BLIPS were 83%, 27% and 4%, respectively. When the two intermediate groups (APS alone and APS+Trait) were combined, there was evidence that the risk of transition increased in the order of Trait alone<APS<BLIPS (p=0.024, adjusted analysis).\nUltra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?",
        "generated_text": "ACE clinic between 2000 and 2010 (n=100). Kaplan-Meier survival analysis and Cox regression were used to assess the relationship between UHR criteria and transition to psychosis.\nThe overall transition rate was 17% (n=17). The transition rates for Trait alone, APS alone, APS+Trait and BLIPS were 0% (n=0), 12% (n=6), 20% (n=10) and 50% (n=1), respectively. The difference in transition rates between the groups was significant (p=0.001). The APS+Trait group had a higher risk of transition",
        "levenshtein_distance": 451
    },
    {
        "realidx": "21123461",
        "question": "Weight scales as height squared, which is an observation that forms the basis of body mass index (weight/height(2)). If, and how, circumferences, including waist circumference (WC) and hip circumference (HC), scale to height remains unclear, but this is an important consideration when developing normative ranges or applying WC/height and HC/height as risk indexes.\nThe study aim was to examine the scaling of weight, WC, and HC to height in NHANES (National Health and Nutrition Examination Survey) III participants.\nSubjects were adult non-Hispanic white, non-Hispanic black, and Mexican American men (n = 7422) and nonpregnant women (n = 7999) who had complete demographic and anthropometric data. In addition to height, allometric models were developed for each measure that controlled for age, race, and self-reported health status.\nAfter adjustment for age and race, weight scaled to height in men and women with mean (\u00b1SEE) powers of 2.29 \u00b1 0.11 and 1.80 \u00b1 0.07, respectively (both P<0.001). Although univariate circumference-height models were weak or nonsignificant, when adjusted for age and race WC and HC scaled to height with powers of 0.76 \u00b1 0.08 and 0.45 \u00b1 0.05, respectively, in men and 0.80 \u00b1 0.05 and 0.53 \u00b1 0.04, respectively, in women (all P<0.001). Age- and race-adjusted incremental increases in circumferences ranged from 0.2 to 0.5 cm per centimeter increase in height. Both WC/height and HC/height scaled negatively to height in men and women, and WC/HC scaled negatively to height in women only (all P<0.001). Health status-adjusted models were similar.\nAre adult body circumferences associated with height?",
        "answer": "yes",
        "answer_rationale": "Circumferences and related ratios scale significantly to height, notably after adjustment for age and race, across subjects who are representative of the US population. These observations have implications for the clinical and epidemiologic use of these anthropometric measures and indexes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Weight scales as height squared, which is an observation that forms the basis of body mass index (weight/height(2)). If, and how, circumferences, including waist circumference (WC) and hip circumference (HC), scale to height remains unclear, but this is an important consideration when developing normative ranges or applying WC/height and HC/height as risk indexes.\nThe study aim was to examine the scaling of weight, WC, and HC to height in NHANES (National Health and Nutrition Examination Survey) III participants.\nSubjects were adult non-Hispanic white, non-Hispanic black, and Mexican American men (n = 7422) and nonpregnant women (n = 7999) who had complete demographic and anthropometric data. In addition to height, allometric models were developed for each measure that controlled for age, race, and self-reported health status.\nAfter adjustment for age and race, weight scaled to height in men and women with mean (\u00b1",
        "q2": "SEE) powers of 2.29 \u00b1 0.11 and 1.80 \u00b1 0.07, respectively (both P<0.001). Although univariate circumference-height models were weak or nonsignificant, when adjusted for age and race WC and HC scaled to height with powers of 0.76 \u00b1 0.08 and 0.45 \u00b1 0.05, respectively, in men and 0.80 \u00b1 0.05 and 0.53 \u00b1 0.04, respectively, in women (all P<0.001). Age- and race-adjusted incremental increases in circumferences ranged from 0.2 to 0.5 cm per centimeter increase in height. Both WC/height and HC/height scaled negatively to height in men and women, and WC/HC scaled negatively to height in women only (all P<0.001). Health status-adjusted models were similar.\nAre adult body circumferences associated with height?",
        "generated_text": "SD) exponents of 2.47 \u00b1 0.01 and 2.45 \u00b1 0.01, respectively. In men, WC scaled to height with an exponent of 1.07 \u00b1 0.01, and HC scaled to height with an exponent of 1.04 \u00b1 0.01. In women, WC scaled to height with an exponent of 1.05 \u00b1 0.01, and HC scaled to height with an exponent of 1.03 \u00b1 0.01.\nThese data suggest that WC and HC scale to height in a linear fashion, whereas weight scales to height in a curvilinear fashion. This suggests that WC and HC are more appropriately expressed as ratios to height, whereas weight is more appropriately expressed as a ratio to height squared.",
        "levenshtein_distance": 479
    },
    {
        "realidx": "21164063",
        "question": "A possible role for fondaparinux as a bridging agent in the perioperative setting is explored.\nAnticoagulation guidelines provide minimal direction on the perioperative use of fondaparinux. Fondaparinux's extended half-life of 17-21 hours complicates its use as a perioperative bridging therapy. The ideal time for discontinuation before surgery is an issue, particularly in surgeries with a high bleeding risk or in which neuraxial anesthesia is used. Guidance for perioperative bridging with fondaparinux must be derived from pharmacokinetic data, surgical prophylaxis trials, case reports, and anesthesia guidelines. Published trials used fondaparinux sodium 2.5 mg daily for venous thromboembolism prophylaxis in surgical patients, and the majority avoided its use before surgery in patients receiving neuraxial anesthesia. Three case reports cited the use of fondaparinux sodium as perioperative bridge therapy; one used a 2.5-mg dose, and the other two used a full treatment dose of 7.5 mg. Furthermore, professional anesthesia guidelines conflict in their recommendations regarding the timing of drug administration with neuraxial catheter use. For these reasons, it may be optimal to avoid fondaparinux use before surgery. In some instances, the use of low-molecular-weight heparin or inpatient use of i.v. unfractionated heparin is not possible, is contraindicated, or has limited efficacy, such as a patient with history of heparin-induced thrombocytopenia or antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for these patients.\nIs there a role for fondaparinux in perioperative bridging?",
        "answer": "no",
        "answer_rationale": "The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "A possible role for fondaparinux as a bridging agent in the perioperative setting is explored.\nAnticoagulation guidelines provide minimal direction on the perioperative use of fondaparinux. Fondaparinux's extended half-life of 17-21 hours complicates its use as a perioperative bridging therapy. The ideal time for discontinuation before surgery is an issue, particularly in surgeries with a high bleeding risk or in which neuraxial anesthesia is used. Guidance for perioperative bridging with fondaparinux must be derived from pharmacokinetic data, surgical prophylaxis trials, case reports, and anesthesia guidelines. Published trials used fondaparinux sodium 2.5 mg daily for venous thromboembolism prophylaxis in surgical patients, and the majority avoided its use before surgery in patients receiving neuraxial anesthesia. Three case reports cited",
        "q2": " the use of fondaparinux sodium as perioperative bridge therapy; one used a 2.5-mg dose, and the other two used a full treatment dose of 7.5 mg. Furthermore, professional anesthesia guidelines conflict in their recommendations regarding the timing of drug administration with neuraxial catheter use. For these reasons, it may be optimal to avoid fondaparinux use before surgery. In some instances, the use of low-molecular-weight heparin or inpatient use of i.v. unfractionated heparin is not possible, is contraindicated, or has limited efficacy, such as a patient with history of heparin-induced thrombocytopenia or antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for these patients.\nIs there a role for fondaparinux in perioperative bridging?",
        "generated_text": "epidural hematoma in patients receiving fondaparinux and neuraxial anesthesia, but the relationship is unclear. The American Society of Regional Anesthesia and Pain Medicine recommends stopping fondaparinux 24 hours before neuraxial anesthesia, but this is based on limited data. The half-life of fondaparinux is 17-21 hours, and it is excreted unchanged in the urine, with a longer half-life in patients with renal impairment. The antifactor Xa activity peaks at 4-6 hours and is undetectable at 48 hours after a single 5-mg dose in patients with normal renal function. In patients with renal impairment, the half-life is longer, and antifactor Xa activity may persist for up to 7 days. The recommended dosing interval is every 24",
        "levenshtein_distance": 556
    },
    {
        "realidx": "21194998",
        "question": "Minimal access surgery (MAS) in adults is associated with less postoperative pain in comparison to conventional 'open' surgery. It is not known whether this holds true for neonates as well. Less pain would imply that opioid consumption can be reduced, which has a beneficial effect on morbidity.AIM: To evaluate potential differences in' opioid consumption between neonates undergoing thoracoscopic minimal access surgery or conventional surgery of esophageal atresia (EA) and congenital diaphragmatic hernia (CDH).\nIn this retrospective cohort study we included two controls for each MAS patient, matched on diagnosis, sex and age at surgery. Opioid dose titration was based on validated pain scores (VAS and COMFORT behaviour), applied by protocol. Cumulative opioid doses at 12, 24, 48 h and 7 days postoperatively were compared between groups with the Mann-Whitney test.\nThe study group consisted of 24 MAS patients (14 EA; 10 CDH). These were matched to 48 control patients (28 EA; 20 CDH). At none of the time points cumulative opioid (median in mg/kg (IQR)) doses significantly differed between MAS patients and controls, both with CDH and EA. For example at 24 h postoperative for CDH patients cumulative opioid doses were [0.84(0.61-1.83) MAS vs. 1.06(0.60-1.36) p=1.0] controls, For EApatients at 24 h the cumulative opioid doses were [0.48(0.30-0.75) MAS vs. 0.49(0.35-0.79) p=0.83] controls. This held true for the postoperative pain scores as well.\nDoes minimal access major surgery in the newborn hurt less?",
        "answer": "no",
        "answer_rationale": "Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Minimal access surgery (MAS) in adults is associated with less postoperative pain in comparison to conventional 'open' surgery. It is not known whether this holds true for neonates as well. Less pain would imply that opioid consumption can be reduced, which has a beneficial effect on morbidity.AIM: To evaluate potential differences in' opioid consumption between neonates undergoing thoracoscopic minimal access surgery or conventional surgery of esophageal atresia (EA) and congenital diaphragmatic hernia (CDH).\nIn this retrospective cohort study we included two controls for each MAS patient, matched on diagnosis, sex and age at surgery. Opioid dose titration was based on validated pain scores (VAS and COMFORT behaviour), applied by protocol. Cumulative opioid doses at 12, 24, 48 h and 7 days postoperatively were compared between groups with the Mann-Whitney test.\nThe study group consisted of ",
        "q2": "24 MAS patients (14 EA; 10 CDH). These were matched to 48 control patients (28 EA; 20 CDH). At none of the time points cumulative opioid (median in mg/kg (IQR)) doses significantly differed between MAS patients and controls, both with CDH and EA. For example at 24 h postoperative for CDH patients cumulative opioid doses were [0.84(0.61-1.83) MAS vs. 1.06(0.60-1.36) p=1.0] controls, For EApatients at 24 h the cumulative opioid doses were [0.48(0.30-0.75) MAS vs. 0.49(0.35-0.79) p=0.83] controls. This held true for the postoperative pain scores as well.\nDoes minimal access major surgery in the newborn hurt less?",
        "generated_text": "20 MAS and 40 conventional surgery patients. There was no difference in cumulative opioid consumption at 12, 24, 48 h and 7 days postoperatively between the two groups (p = 0.10, p = 0.11, p = 0.11 and p = 0.11, respectively). There was no difference in postoperative pain scores between the two groups.\nIn this study, we did not find a difference in postoperative pain and opioid consumption between neonates undergoing MAS or conventional surgery for EA and CDH. This suggests that MAS does not necessarily result in less postoperative pain in neonates compared to conventional surgery for these conditions.",
        "levenshtein_distance": 479
    },
    {
        "realidx": "21214884",
        "question": "Using polymerase chain reaction techniques, we evaluated the presence of HPV infection in human breast milk collected from 21 HPV-positive and 11 HPV-negative mothers.\nOf the 32 studied human milk specimens, no 'high-risk' HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 or 58 DNA was detected.\nCan 'high-risk' human papillomaviruses (HPVs) be detected in human breast milk?",
        "answer": "no",
        "answer_rationale": "This preliminary case-control study indicates the absence of mucosal 'high-risk' HPV types in human breast milk.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Using polymerase chain reaction techniques, we evaluated the presence of HPV infection in human breast milk collected from 21 HPV-positive and 11 HPV-negative mothers.\nOf the 32 studied human milk specimens, no 'high-risk' HPV 16, 18, ",
        "q2": "31, 33, 35, 39, 45, 51, 52, 56, 58 or 58 DNA was detected.\nCan 'high-risk' human papillomaviruses (HPVs) be detected in human breast milk?",
        "generated_text": "31, 33, 35, 45, 52, 58, 59, and 68, and 'low-risk' HPV 6, 11, 42, 43",
        "levenshtein_distance": 92
    },
    {
        "realidx": "21228436",
        "question": "The purpose of this study was to evaluate the impact of a patient-safety curriculum administered during a paediatric clerkship on medical students' attitudes towards patient safety.\nMedical students viewed an online video introducing them to systems-based analyses of medical errors. Faculty presented an example of a medication administration error and demonstrated use of the Learning From Defects tool to investigate the defect. Student groups identified and then analysed medication errors during their clinical rotation using the Learning From Defects framework to organise and present their findings. Outcomes included patient safety attitudinal changes, as measured by questions derived from the Safety Attitudes Questionnaire.\n108 students completed the curriculum between July 2008 and July 2009. All student groups (25 total) identified, analysed and presented patient safety concerns. Curriculum effectiveness was demonstrated by significant changes on questionnaire items related to patient safety attitudes. The majority of students felt that the curriculum was relevant to their clinical rotation and should remain part of the clerkship.\nCan teaching medical students to investigate medication errors change their attitudes towards patient safety?",
        "answer": "yes",
        "answer_rationale": "An active learning curriculum integrated into a clinical clerkship can change learners' attitudes towards patient safety. Students found the curriculum relevant and recommended its continuation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study was to evaluate the impact of a patient-safety curriculum administered during a paediatric clerkship on medical students' attitudes towards patient safety.\nMedical students viewed an online video introducing them to systems-based analyses of medical errors. Faculty presented an example of a medication administration error and demonstrated use of the Learning From Defects tool to investigate the defect. Student groups identified and then analysed medication errors during their clinical rotation using the Learning From Defects framework to organise and present their findings. Outcomes included patient safety",
        "q2": " attitudinal changes, as measured by questions derived from the Safety Attitudes Questionnaire.\n108 students completed the curriculum between July 2008 and July 2009. All student groups (25 total) identified, analysed and presented patient safety concerns. Curriculum effectiveness was demonstrated by significant changes on questionnaire items related to patient safety attitudes. The majority of students felt that the curriculum was relevant to their clinical rotation and should remain part of the clerkship.\nCan teaching medical students to investigate medication errors change their attitudes towards patient safety?",
        "generated_text": "attitudes, as measured by the Safety Attitudes Questionnaire, and student evaluations of the curriculum.\nStudents' attitudes towards patient safety improved significantly after the intervention, with the largest changes in perceptions of the importance of teamwork and the value of systems-based analyses. Students reported that the curriculum was useful and that it increased their understanding of patient safety.\nThis patient-safety curriculum was associated with improved medical students' attitudes towards patient safety.",
        "levenshtein_distance": 372
    },
    {
        "realidx": "21252642",
        "question": "Oncology literature cites that only 2% to 4% of patients participate in research. Up to 85% of patients are unaware that clinical trials research is being conducted at their treatment facility or that they might be eligible to participate.\nIt was hypothesized that patients' satisfaction with information regarding clinical trials would improve after targeted educational interventions, and accruals to clinical trials would increase in the year following those interventions.\nAll new patients referred to the cancer center over a 4-month period were mailed a baseline survey to assess their knowledge of clinical research. Subsequently, educational interventions were provided, including an orientation session highlighting clinical trials, a pamphlet, and a reference to a clinical trials Web site. A postintervention survey was sent to the responders of the initial survey 3 months after the initial mailing.\nPatient satisfaction with information significantly increased after the interventions. There was no increase in subsequent enrollment in clinical trials. Patients who indicated an inclination to participate in clinical trials tended to have greater satisfaction with the information they received.\nDoes increased patient awareness improve accrual into cancer-related clinical trials?",
        "answer": "no",
        "answer_rationale": "A set of educational interventions designed for cancer patients significantly improved their satisfaction with information on clinical research, but did not improve clinical trial enrollment of these participants as of 1 year after the study.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Oncology literature cites that only 2% to 4% of patients participate in research. Up to 85% of patients are unaware that clinical trials research is being conducted at their treatment facility or that they might be eligible to participate.\nIt was hypothesized that patients' satisfaction with information regarding clinical trials would improve after targeted educational interventions, and accruals to clinical trials would increase in the year following those interventions.\nAll new patients referred to the cancer center over a 4-month period were mailed a baseline survey to assess their knowledge of",
        "q2": " clinical research. Subsequently, educational interventions were provided, including an orientation session highlighting clinical trials, a pamphlet, and a reference to a clinical trials Web site. A postintervention survey was sent to the responders of the initial survey 3 months after the initial mailing.\nPatient satisfaction with information significantly increased after the interventions. There was no increase in subsequent enrollment in clinical trials. Patients who indicated an inclination to participate in clinical trials tended to have greater satisfaction with the information they received.\nDoes increased patient awareness improve accrual into cancer-related clinical trials?",
        "generated_text": "clinical trials and their satisfaction with the information they received about clinical trials. The survey was repeated 1 year later.\nA total of 1,000 patients were mailed the baseline survey, and 200 (20%) responded. The mean age was 58 years, and 54% were female. The majority of respondents (85%) had not been approached to participate in a clinical trial. Of those who had been approached, 50% had participated. The most common reason for not participating was a",
        "levenshtein_distance": 471
    },
    {
        "realidx": "21256734",
        "question": "A secondary analysis of one-hundred-sixty-seven patients referred for treatment of cancer-related pain was conducted. Pain intensity at admission was recorded and patients were divided in three categories of pain intensity: mild, moderate and severe. Patients were offered a treatment with opioid dose titration, according to department policy. Data regarding opioid doses and pain intensity were collected after dose titration was completed. Four levels of opioid response were considered: (a) good pain control, with minimal opioid escalation and without relevant adverse effects; (b) good pain control requiring more aggressive opioid escalation, for example doubling the doses in four days; (c) adequate pain control associated with the occurrence of adverse effects; (d) poor pain control with adverse effects.\nSeventy-six, forty-four, forty-one and six patients showed a response a, b, c, and d, respectively. No correlation between baseline pain intensity categories and opioid response was found. Patients with response 'b' and 'd' showed higher values of OEImg.\nDoes pain intensity predict a poor opioid response in cancer patients?",
        "answer": "no",
        "answer_rationale": "Baseline pain intensity does not predict the outcome after an appropriate opioid titration. It is likely that non-homogeneous pain treatment would have biased the outcome of a previous work.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "A secondary analysis of one-hundred-sixty-seven patients referred for treatment of cancer-related pain was conducted. Pain intensity at admission was recorded and patients were divided in three categories of pain intensity: mild, moderate and severe. Patients were offered a treatment with opioid dose titration, according to department policy. Data regarding opioid doses and pain intensity were collected after dose titration was completed. Four levels of opioid response were considered: (a) good pain control, with minimal opioid escalation and without relevant adverse effects; (b) good pain control",
        "q2": " requiring more aggressive opioid escalation, for example doubling the doses in four days; (c) adequate pain control associated with the occurrence of adverse effects; (d) poor pain control with adverse effects.\nSeventy-six, forty-four, forty-one and six patients showed a response a, b, c, and d, respectively. No correlation between baseline pain intensity categories and opioid response was found. Patients with response 'b' and 'd' showed higher values of OEImg.\nDoes pain intensity predict a poor opioid response in cancer patients?",
        "generated_text": ", with significant opioid escalation and without relevant adverse effects; (c) good pain control, with significant opioid escalation and with relevant adverse effects; and (d) poor pain control, with significant opioid escalation and with relevant adverse effects. The primary outcome was to assess the relationship between pain intensity at admission and opioid response. Secondary outcomes were to assess the relationship between pain intensity at admission and opioid dose at discharge, and to assess the relationship between opioid response and pain intensity at discharge. The results showed that patients with higher pain intensity at admission had",
        "levenshtein_distance": 432
    },
    {
        "realidx": "21342862",
        "question": "To evaluate the construct validity of the Turkish version of the EQ-5D in patients with acute coronary syndrome.\nThe study was conducted as a cross-sectional study at the Trakya University Hospital between February and May 2008. All patients completed the Turkish version of the EQ-5D and MacNew heart-related quality of life scale. Construct validity of the EQ-5D was assessed according to relationships with MacNew subscales by using Spearman rank correlation and multiple linear regression analyses.\nOne hundred and twenty-two patients responded to the instruments. Mean age was 62.9\u00b19.3 years and male gender (88 or 72.1%) was dominant. Mean score of the EQ-5D index was 0.79\u00b10.32, while the global score of MacNew was 5.01\u00b11.16. The correlation coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p<0.001 for all of them). According to the stepwise regression model MacNew global score was found to be significantly effective factor on EQ-5D index score (\u03b2 =0.188; 95% CI: 0.152-0.224; p<0.001).\nIs EQ-5D a valid quality of life instrument in patients with acute coronary syndrome?",
        "answer": "yes",
        "answer_rationale": "The Turkish version of the EQ-5D-based utility score seems to be a valid instrument in the assessment of quality of life studies in patients with acute coronary syndrome.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate the construct validity of the Turkish version of the EQ-5D in patients with acute coronary syndrome.\nThe study was conducted as a cross-sectional study at the Trakya University Hospital between February and May 2008. All patients completed the Turkish version of the EQ-5D and MacNew heart-related quality of life scale. Construct validity of the EQ-5D was assessed according to relationships with MacNew subscales by using Spearman rank correlation and multiple linear regression analyses.\nOne hundred and twenty-two patients responded to the instruments. Mean age was 62.9\u00b19.3 years and male gender (88 or 72.1%) was dominant. Mean score of the EQ-5D index was 0.79\u00b1",
        "q2": "0.32, while the global score of MacNew was 5.01\u00b11.16. The correlation coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p<0.001 for all of them). According to the stepwise regression model MacNew global score was found to be significantly effective factor on EQ-5D index score (\u03b2 =0.188; 95% CI: 0.152-0.224; p<0.001).\nIs EQ-5D a valid quality of life instrument in patients with acute coronary syndrome?",
        "generated_text": "0.18 and mean visual analogue scale (VAS) score was 72.1\u00b117.1. EQ-5D index and VAS scores were significantly correlated with all MacNew subscales (p<0.001). Multiple linear regression analysis revealed that the EQ-5D index was significantly associated with MacNew subscales (p<0.001). The EQ VAS was also significantly associated with MacNew subscales (p<0.001).\nThe Turkish version of the EQ-5D is a valid instrument for assessing health-related quality of life in patients with acute coronary syndrome.\nThe EQ-5D is a widely used instrument for measuring health-related quality of life (HRQo",
        "levenshtein_distance": 435
    },
    {
        "realidx": "21346501",
        "question": "This study was designed to determine whether preclerkship performance examinations could accurately identify medical students at risk for failing a senior clinical performance examination (CPE).\nThis study used a retrospective case-control, multiyear design, with contingency table analyses, to examine the performance of 412 students in the classes of 2005 to 2010 at a midwestern medical school. During their second year, these students took four CPEs that each used three standardized patient (SP) cases, for a total of 12 cases. The authors correlated each student's average year 2 case score with the student's average case score on a senior (year 4) CPE. Contingency table analysis was carried out using performance on the year 2 CPEs and passing/failing the senior CPE. Similar analyses using each student's United States Medical Licensing Examination (USMLE) Step 1 scores were also performed. Sensitivity, specificity, odds ratio, and relative risk were calculated for two year 2 performance standards.\nStudents' low performances relative to their class on the year 2 CPEs were a strong predictor that they would fail the senior CPE. Their USMLE Step 1 scores also correlated with their performance on the senior CPE, although the predictive values for these scores were considerably weaker.\nCan students' scores on preclerkship clinical performance examinations predict that they will fail a senior clinical performance examination?",
        "answer": "yes",
        "answer_rationale": "Under the conditions of this study, preclerkship (year 2) CPEs strongly predicted medical students at risk for failing a senior CPE. This finding opens the opportunity for remediation of deficits prior to or during clerkships.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study was designed to determine whether preclerkship performance examinations could accurately identify medical students at risk for failing a senior clinical performance examination (CPE).\nThis study used a retrospective case-control, multiyear design, with contingency table analyses, to examine the performance of 412 students in the classes of 2005 to 2010 at a midwestern medical school. During their second year, these students took four CPEs that each used three standardized patient (SP) cases, for a total of 12 cases. The authors correlated each student's average year 2 case score with the student's average case score on a senior (year 4) CPE. Contingency table analysis was carried out",
        "q2": " using performance on the year 2 CPEs and passing/failing the senior CPE. Similar analyses using each student's United States Medical Licensing Examination (USMLE) Step 1 scores were also performed. Sensitivity, specificity, odds ratio, and relative risk were calculated for two year 2 performance standards.\nStudents' low performances relative to their class on the year 2 CPEs were a strong predictor that they would fail the senior CPE. Their USMLE Step 1 scores also correlated with their performance on the senior CPE, although the predictive values for these scores were considerably weaker.\nCan students' scores on preclerkship clinical performance examinations predict that they will fail a senior clinical performance examination?",
        "generated_text": "to determine whether year 2 performance could predict year 4 performance.\nThe authors found a significant correlation between year 2 and year 4 CPE performance (r = 0.32, p < .001). Students who failed the year 4 CPE had significantly lower year 2 CPE scores than did students who passed (p < .001). The year 2 CPE had a sensitivity of 80% and a specificity of 70% for predicting year 4 CPE performance.\nThe authors concluded that preclerkship CPEs can identify students at risk for failing a senior CPE.",
        "levenshtein_distance": 524
    },
    {
        "realidx": "21361755",
        "question": "Two common causes of cervical myelopathy include degenerative stenosis and ossification of the posterior longitudinal ligament (OPLL). It has been postulated that patients with OPLL have more complications and worse outcomes than those with degenerative stenosis. The authors sought to compare the surgical results of laminoplasty in the treatment of cervical stenosis with myelopathy due to either degenerative changes or segmental OPLL.\nThe authors conducted a retrospective review of 40 instrumented laminoplasty cases performed at a single institution over a 4-year period to treat cervical myelopathy without kyphosis. Twelve of these patients had degenerative cervical stenotic myelopathy ([CSM]; degenerative group), and the remaining 28 had segmental OPLL (OPLL group). The 2 groups had statistically similar demographic characteristics and number of treated levels (mean 3.9 surgically treated levels; p>0.05). The authors collected perioperative and follow-up data, including radiographic results.\nThe overall clinical follow-up rate was 88%, and the mean clinical follow-up duration was 16.4 months. The mean radiographic follow-up rate was 83%, and the mean length of radiographic follow-up was 9.3 months. There were no significant differences in the estimated blood loss (EBL) or length of hospital stay (LOS) between the groups (p>0.05). The mean EBL and LOS for the degenerative group were 206 ml and 3.7 days, respectively. The mean EBL and LOS for the OPLL group were 155 ml and 4 days, respectively. There was a statistically significant improvement of more than one grade in the Nurick score for both groups following surgery (p<0.05). The Nurick score improvement was not statistically different between the groups (p>0.05). The visual analog scale (VAS) neck pain scores were similar between groups pre- and postoperatively (p>0.05). The complication rates were not statistically different between groups either (p>0.05). Radiographically, both groups lost extension range of motion (ROM) following laminoplasty, but this change was not statistically significant (p>0.05).\nLaminoplasty outcomes: is there a difference between patients with degenerative stenosis and those with ossification of the posterior longitudinal ligament?",
        "answer": "no",
        "answer_rationale": "Patients with CSM due to either degenerative disease or segmental OPLL have similar perioperative results and neurological outcomes with laminoplasty. The VAS neck pain scores did not improve significantly with laminoplasty for either group. Laminoplasty may limit extension ROM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Two common causes of cervical myelopathy include degenerative stenosis and ossification of the posterior longitudinal ligament (OPLL). It has been postulated that patients with OPLL have more complications and worse outcomes than those with degenerative stenosis. The authors sought to compare the surgical results of laminoplasty in the treatment of cervical stenosis with myelopathy due to either degenerative changes or segmental OPLL.\nThe authors conducted a retrospective review of 40 instrumented laminoplasty cases performed at a single institution over a 4-year period to treat cervical myelopathy without kyphosis. Twelve of these patients had degenerative cervical stenotic myelopathy ([CSM]; degenerative group), and the remaining 28 had segmental OPLL (OPLL group). The 2 groups had statistically similar demographic characteristics and number of treated levels (mean 3.9 surgically treated levels; p>0.05). The authors collected perioperative and follow-up data, including radiographic results.\nThe overall clinical follow-up rate was 88%, and the mean clinical follow-up duration was 16.4 months. The mean radiographic follow-up rate was 83%, and the mean",
        "q2": " length of radiographic follow-up was 9.3 months. There were no significant differences in the estimated blood loss (EBL) or length of hospital stay (LOS) between the groups (p>0.05). The mean EBL and LOS for the degenerative group were 206 ml and 3.7 days, respectively. The mean EBL and LOS for the OPLL group were 155 ml and 4 days, respectively. There was a statistically significant improvement of more than one grade in the Nurick score for both groups following surgery (p<0.05). The Nurick score improvement was not statistically different between the groups (p>0.05). The visual analog scale (VAS) neck pain scores were similar between groups pre- and postoperatively (p>0.05). The complication rates were not statistically different between groups either (p>0.05). Radiographically, both groups lost extension range of motion (ROM) following laminoplasty, but this change was not statistically significant (p>0.05).\nLaminoplasty outcomes: is there a difference between patients with degenerative stenosis and those with ossification of the posterior longitudinal ligament?",
        "generated_text": "radiographic follow-up duration was 15.2 months. The OPLL group had a longer operative time (p=0.001), longer hospital stay (p=0.001), and higher estimated blood loss (p=0.001). The OPLL group also had a higher incidence of postoperative dysphagia (p=0.001). The OPLL group had a higher incidence of C5 palsy (p=0.001). The OPLL group had a higher incidence of postoperative dysphagia (p=0.001). The OPLL group had a higher incidence of C5 palsy (p=0.001). The OPLL group had a higher incidence of postoperative dysphagia (p=0.001). The OPLL group had a higher incidence of C5 palsy (p=0.001). The OPLL group had a higher incidence of postoperative dysphagia (p=0.001). The OPLL group had a higher incidence of C5 palsy (p=0.00",
        "levenshtein_distance": 782
    },
    {
        "realidx": "21394762",
        "question": "To investigate the significance of pelvic pain and its association with defecatory symptoms in women with pelvic organ prolapse (POP).\nThis is a cross sectional study of 248 women with stage II POP or greater. Women were stratified into \"pain\" and \"no-pain\" groups based on their response to a question on the Pelvic Floor Distress Inventory short form. Associations between patient demographics, exam findings and responses to validated questionnaires were evaluated.\nIn women with POP, defecatory symptoms are significantly more common in women with pelvic pain including straining with bowel movement (OR 2.4, 95% CI 1.3, 4.6), sense of incomplete emptying (OR 4.4, 95% CI 2.3, 8.2), pain with bowel movement (OR 5.3, 95% CI 1.2, 23.0) and splinting with bowel movement (OR 3.8, 95% CI 2.0, 7.5).\nIs pelvic pain associated with defecatory symptoms in women with pelvic organ prolapse?",
        "answer": "yes",
        "answer_rationale": "In women with POP, the symptom of pelvic pain is associated with the presence of defecatory symptoms.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the significance of pelvic pain and its association with defecatory symptoms in women with pelvic organ prolapse (POP).\nThis is a cross sectional study of 248 women with stage II POP or greater. Women were stratified into \"pain\" and \"no-pain\" groups based on their response to a question on the Pelvic Floor Distress Inventory short form. Associations between patient demographics, exam findings and responses to validated questionnaires were evaluated.\nIn women with POP, defecatory symptoms are significantly more common in women with pelvic pain including straining with bowel movement (",
        "q2": "OR 2.4, 95% CI 1.3, 4.6), sense of incomplete emptying (OR 4.4, 95% CI 2.3, 8.2), pain with bowel movement (OR 5.3, 95% CI 1.2, 23.0) and splinting with bowel movement (OR 3.8, 95% CI 2.0, 7.5).\nIs pelvic pain associated with defecatory symptoms in women with pelvic organ prolapse?",
        "generated_text": "p=0.001), incomplete evacuation (p=0.001), and rectal urgency (p=0.001). Women with pain also had higher rates of urinary incontinence (p=0.001), sexual dysfunction (p=0.001), and constipation (p=0.001). On exam, women with pain had higher rates of rectocele (p=0.001), cystocele (p=0.001), and enterocele (p",
        "levenshtein_distance": 252
    },
    {
        "realidx": "21420186",
        "question": "Sporadic data present in literature report how preterm birth and low birth weight are risk factors for the development of cardiovascular diseases in later life. High levels of asymmetric dimethylarginine (ADMA), a strong inhibitor of nitric oxide synthesis, are associated with the future development of adverse cardiovascular events and cardiac death.\n1) to verify the presence of a statistically significant difference between ADMA levels in young adults born preterm at extremely low birth weight (<1000 g; ex-ELBW) and those of a control group of healthy adults born at term (C) and 2) to seek correlations between ADMA levels in ex-ELBW and anthropometric and clinical parameters (gender, chronological age, gestational age, birth weight, and duration of stay in Neonatal Intensive Care Unit).\nThirty-two ex-ELBW subjects (11 males [M] and 21 females [F], aged 17-29years, mean age 22.2 \u00b1 2.3 years) were compared with 25 C (7 M and 18F). ADMA levels were assessed by high-performance liquid chromatography with highly sensitive laser fluorescent detection.\nADMA levels were reduced in ex-ELBW subjects compared to C (0.606+0.095 vs 0.562+0.101 \u03bcmol/L, p<0.05), and significantly correlated inversely with gestational age (r=-0.61, p<0.00001) and birth weight (r=-0.57, p<0.0002).\nCould ADMA levels in young adults born preterm predict an early endothelial dysfunction?",
        "answer": "yes",
        "answer_rationale": "Our findings reveal a significant decrease in ADMA levels of ex-ELBW subjects compared to C, underlining a probable correlation with preterm birth and low birth weight. Taken together, these results may underlie the onset of early circulatory dysfunction predictive of increased cardiovascular risk.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Sporadic data present in literature report how preterm birth and low birth weight are risk factors for the development of cardiovascular diseases in later life. High levels of asymmetric dimethylarginine (ADMA), a strong inhibitor of nitric oxide synthesis, are associated with the future development of adverse cardiovascular events and cardiac death.\n1) to verify the presence of a statistically significant difference between ADMA levels in young adults born preterm at extremely low birth weight (<1000 g; ex-ELBW) and those of a control group of healthy adults born at term (C) and 2) to seek correlations between ADMA levels in ex-ELBW and anthropometric and clinical parameters (gender, chronological age, gestational age, birth weight, and duration of stay in Neonatal Intensive Care Unit).\nThirty-two ex-",
        "q2": "ELBW subjects (11 males [M] and 21 females [F], aged 17-29years, mean age 22.2 \u00b1 2.3 years) were compared with 25 C (7 M and 18F). ADMA levels were assessed by high-performance liquid chromatography with highly sensitive laser fluorescent detection.\nADMA levels were reduced in ex-ELBW subjects compared to C (0.606+0.095 vs 0.562+0.101 \u03bcmol/L, p<0.05), and significantly correlated inversely with gestational age (r=-0.61, p<0.00001) and birth weight (r=-0.57, p<0.0002).\nCould ADMA levels in young adults born preterm predict an early endothelial dysfunction?",
        "generated_text": "ELBW and 32 C were enrolled. ADMA levels were measured by high-performance liquid chromatography. Anthropometric and clinical data were collected from medical records. Statistical analysis was performed using the Mann-Whitney U test and Spearman\u2019s correlation coefficient.\nADMA levels were significantly higher in ex-ELBW than in C (p < 0.001). In ex-ELBW, ADMA levels were positively correlated with chronological age (p < 0.001), birth weight (p = 0.001), and duration of stay in Neonatal Intensive Care Unit (p = 0.001). No correlation was found with gender and gestational age.\nOur data suggest that ex-ELBW have higher ADMA levels than C, and that",
        "levenshtein_distance": 494
    },
    {
        "realidx": "21431987",
        "question": "This study was designed to determine prospectively whether the systematic use of PET/CT associated with conventional techniques could improve the accuracy of staging in patients with liver metastases of colorectal carcinoma. We also assessed the impact on the therapeutic strategy.\nBetween 2006 and 2008, 97 patients who were evaluated for resection of LMCRC were prospectively enrolled. Preoperative workup included multidetector-CT (MDCT) and PET/CT. In 11 patients with liver steatosis or iodinated contrast allergy, MR also was performed. Sixty-eight patients underwent laparotomy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values for hepatic and extrahepatic staging of MDCT and PET-CT were calculated.\nIn a lesion-by-lesion analysis of the hepatic staging, the sensitivity of MDCT/RM was superior to PET/CT (89.2 vs. 55%, p\u00a0<\u00a00.001). On the extrahepatic staging, PET/CT was superior to MDCT/MR only for the detection of locoregional recurrence (p\u00a0=\u00a00.03) and recurrence in uncommon sites (p\u00a0=\u00a00.016). New findings in PET/CT resulted in a change in therapeutic strategy in 17 patients. However, additional information was correct only in eight cases and wrong in nine patients.\nPreoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?",
        "answer": "no",
        "answer_rationale": "PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "This study was designed to determine prospectively whether the systematic use of PET/CT associated with conventional techniques could improve the accuracy of staging in patients with liver metastases of colorectal carcinoma. We also assessed the impact on the therapeutic strategy.\nBetween 2006 and 2008, 97 patients who were evaluated for resection of LMCRC were prospectively enrolled. Preoperative workup included multidetector-CT (MDCT) and PET/CT. In 11 patients with liver steatosis or iodinated contrast allergy, MR also was performed. Sixty-eight patients underwent laparotomy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values for hepatic and extrahepatic staging of MDCT and PET-CT were calculated",
        "q2": ".\nIn a lesion-by-lesion analysis of the hepatic staging, the sensitivity of MDCT/RM was superior to PET/CT (89.2 vs. 55%, p\u00a0<\u00a00.001). On the extrahepatic staging, PET/CT was superior to MDCT/MR only for the detection of locoregional recurrence (p\u00a0=\u00a00.03) and recurrence in uncommon sites (p\u00a0=\u00a00.016). New findings in PET/CT resulted in a change in therapeutic strategy in 17 patients. However, additional information was correct only in eight cases and wrong in nine patients.\nPreoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?",
        "generated_text": ". The impact of PET-CT on therapeutic strategy was assessed.\nMDCT and PET-CT had similar sensitivities and specificities for the detection of hepatic metastases. MDCT had higher sensitivity (94% vs 84%) and PPV (94% vs 84%) for the detection of peritoneal carcinomatosis. PET-CT had higher sensitivity (80% vs 60%) and PPV (80% vs 60%) for the detection of lymph node metastases. PET-CT had higher sensitivity (100% vs 80%) and PPV (100% vs 80%) for the detection of lung metastases. PET-CT had higher sensitivity (",
        "levenshtein_distance": 466
    },
    {
        "realidx": "21459725",
        "question": "Xanthogranulomatous cholecystitis (XGC) is an uncommon variant of chronic cholecystitis, characterized by marked thickening of the gallbladder wall and dense local adhesions. It often mimics a gallbladder carcinoma (GBC), and may coexist with GBC, leading to a diagnostic dilemma. Furthermore, the premalignant nature of this entity is not known. This study was undertaken to assess the p53, PCNA and beta-catenin expression in XGC in comparison to GBC and chronic inflammation.\nSections from paraffin-embedded blocks of surgically resected specimens of GBC (69 cases), XGC (65), chronic cholecystitis (18) and control gallbladder (10) were stained with the monoclonal antibodies to p53 and PCNA, and a polyclonal antibody to beta-catenin. p53 expression was scored as the percentage of nuclei stained. PCNA expression was scored as the product of the percentage of nuclei stained and the intensity of the staining (1-3). A cut-off value of 80 for this score was taken as a positive result. Beta-catenin expression was scored as type of expression-membranous, cytoplasmic or nuclear staining.\np53 mutation was positive in 52% of GBC cases and 3% of XGC, but was not expressed in chronic cholecystitis and control gallbladders. p53 expression was lower in XGC than in GBC (P<0.0001). PCNA expression was seen in 65% of GBC cases and 11% of XGC, but not in chronic cholecystitis and control gallbladders. PCNA expression was higher in GBC than XGC (P=0.0001), but there was no significant difference between the XGC, chronic cholecystitis and control gallbladder groups. Beta-catenin expression was positive in the GBC, XGC, chronic cholecystitis and control gallbladder groups. But the expression pattern in XGC, chronic cholecystitis and control gallbladders was homogenously membranous, whereas in GBC the membranous expression pattern was altered to cytoplasmic and nuclear.\nXanthogranulomatous cholecystitis: a premalignant condition?",
        "answer": "no",
        "answer_rationale": "The expression of p53, PCNA and beta-catenin in XGC was significantly different from GBC and similar to chronic cholecystitis, thus indicating the inflammatory nature of XGC and may not support a premalignant nature of the lesion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Xanthogranulomatous cholecystitis (XGC) is an uncommon variant of chronic cholecystitis, characterized by marked thickening of the gallbladder wall and dense local adhesions. It often mimics a gallbladder carcinoma (GBC), and may coexist with GBC, leading to a diagnostic dilemma. Furthermore, the premalignant nature of this entity is not known. This study was undertaken to assess the p53, PCNA and beta-catenin expression in XGC in comparison to GBC and chronic inflammation.\nSections from paraffin-embedded blocks of surgically resected specimens of GBC (69 cases), XGC (65), chronic cholecystitis (18) and control gallbladder (10) were stained with the monoclonal antibodies to p53 and PCNA, and a polyclonal antibody to beta-catenin. p53 expression was scored as the percentage of nuclei stained. PCNA expression was scored as the product of the percentage of nuclei stained and the intensity of the staining (1-3). A cut-off value of 80 for this score was taken as a positive result. Beta-catenin expression was scored as",
        "q2": " type of expression-membranous, cytoplasmic or nuclear staining.\np53 mutation was positive in 52% of GBC cases and 3% of XGC, but was not expressed in chronic cholecystitis and control gallbladders. p53 expression was lower in XGC than in GBC (P<0.0001). PCNA expression was seen in 65% of GBC cases and 11% of XGC, but not in chronic cholecystitis and control gallbladders. PCNA expression was higher in GBC than XGC (P=0.0001), but there was no significant difference between the XGC, chronic cholecystitis and control gallbladder groups. Beta-catenin expression was positive in the GBC, XGC, chronic cholecystitis and control gallbladder groups. But the expression pattern in XGC, chronic cholecystitis and control gallbladders was homogenously membranous, whereas in GBC the membranous expression pattern was altered to cytoplasmic and nuclear.\nXanthogranulomatous cholecystitis: a premalignant condition?",
        "generated_text": "the percentage of nuclei stained.\np53 expression was seen in 52% of GBC, 15% of XGC and 11% of chronic cholecystitis. PCNA expression was seen in 54% of GBC, 17% of XGC and 11% of chronic cholecystitis. Beta-catenin expression was seen in 50% of GBC, 15% of XGC and 11% of chronic cholecystitis. The difference between GBC and XGC was statistically significant for all three markers (p < 0.001). The difference between XGC and chronic cholecystitis was also statistically significant for all three markers (p < 0.001).\nThe expression of p53, PCNA and beta-catenin in XGC is significantly higher than in chronic cholecystitis, but significantly lower than in GBC. This suggests that XGC is a premalignant lesion, and should be treated as such.",
        "levenshtein_distance": 590
    },
    {
        "realidx": "21481154",
        "question": "Our hypothesis is that the adoption of Department of Health (DH) guidance has led to an improvement in outcome in gynaecological cancer survival.\nIn 1999 the DH in England introduced the Improving Outcomes in Gynaecological Cancer guidance, advising case management by multidisciplinary teams with surgical concentration in specialist hospitals. This guidance was rapidly adopted in the East of England, with a population of 2.5 million.\nThe population of the Anglia Cancer Network was approximately 2.3 million.\nFrom 1996 to 2003, details of 3406 cases of gynaecological cancer were identified in the Anglia region of England. Survival analysis was performed by Cox proportional hazards regression, relative to cases diagnosed in 1996.\nPrimary endpoint was survival.\nThe survival rates for cases diagnosed between 1996 and 1999 were broadly the same across the time period, with a marked improvement taking place in 2000, and continuing to 2003 (HR 0.71, 95% CI 0.64-0.79, comparing 2000-03 with 1996-99 diagnoses), for all gynaecological sites combined. Adjustment for treatments or method of case follow-up did not attenuate these improvements. There was a concurrent change towards major surgery being performed in specialist centres from 2000.\nImprovements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management?",
        "answer": "yes",
        "answer_rationale": "The adoption of the 1999 guidance on gynaecological cancer, which included multidisciplinary case management and centralisation of surgery, resulted in a marked step-change improvement in survival of gynaecological cancer in an area of eastern England in 2000.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Our hypothesis is that the adoption of Department of Health (DH) guidance has led to an improvement in outcome in gynaecological cancer survival.\nIn 1999 the DH in England introduced the Improving Outcomes in Gynaecological Cancer guidance, advising case management by multidisciplinary teams with surgical concentration in specialist hospitals. This guidance was rapidly adopted in the East of England, with a population of 2.5 million.\nThe population of the Anglia Cancer Network was approximately 2.3 million.\nFrom 1996 to 2003, details of 3406 cases of gynaecological cancer were identified in the Anglia region of England. Survival analysis was performed by Cox proportional hazards regression, relative to cases diagnosed in 1996.\nPrimary endpoint was",
        "q2": " survival.\nThe survival rates for cases diagnosed between 1996 and 1999 were broadly the same across the time period, with a marked improvement taking place in 2000, and continuing to 2003 (HR 0.71, 95% CI 0.64-0.79, comparing 2000-03 with 1996-99 diagnoses), for all gynaecological sites combined. Adjustment for treatments or method of case follow-up did not attenuate these improvements. There was a concurrent change towards major surgery being performed in specialist centres from 2000.\nImprovements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management?",
        "generated_text": "overall survival.\nSecondary endpoints were disease-specific survival and disease-free survival.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the local research ethics committee.\nThe study was approved by the",
        "levenshtein_distance": 658
    },
    {
        "realidx": "21645374",
        "question": "Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of a latticework of longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at the center of these areoles and progresses outwards, stopping approximately five cells from the vasculature. The role of mitochondria during PCD has been recognized in animals; however, it has been less studied during PCD in plants.\nThe following paper elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis. A single areole within a window stage leaf (PCD is occurring) was divided into three areas based on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early stages of PCD (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. Mitochondrial dynamics were delineated into four categories (M1-M4) based on characteristics including distribution, motility, and membrane potential (\u0394\u03a8m). A TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. Chloroplasts and transvacuolar strands were also examined using live cell imaging. The possible importance of mitochondrial permeability transition pore (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A (CsA) treatment. This treatment resulted in lace plant leaves with a significantly lower number of perforations compared to controls, and that displayed mitochondrial dynamics similar to that of non-PCD cells.\nDo mitochondria play a role in remodelling lace plant leaves during programmed cell death?",
        "answer": "yes",
        "answer_rationale": "Results depicted mitochondrial dynamics in vivo as PCD progresses within the lace plant, and highlight the correlation of this organelle with other organelles during developmental PCD. To the best of our knowledge, this is the first report of mitochondria and chloroplasts moving on transvacuolar strands to form a ring structure surrounding the nucleus during developmental PCD. Also, for the first time, we have shown the feasibility for the use of CsA in a whole plant system. Overall, our findings implicate the mitochondria as playing a critical and early role in developmentally regulated PCD in the lace plant.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of a latticework of longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at the center of these areoles and progresses outwards, stopping approximately five cells from the vasculature. The role of mitochondria during PCD has been recognized in animals; however, it has been less studied during PCD in plants.\nThe following paper elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis. A single areole within a window stage leaf (PCD is occurring) was divided into three areas based on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early stages of PCD",
        "q2": " (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. Mitochondrial dynamics were delineated into four categories (M1-M4) based on characteristics including distribution, motility, and membrane potential (\u0394\u03a8m). A TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. Chloroplasts and transvacuolar strands were also examined using live cell imaging. The possible importance of mitochondrial permeability transition pore (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A (CsA) treatment. This treatment resulted in lace plant leaves with a significantly lower number of perforations compared to controls, and that displayed mitochondrial dynamics similar to that of non-PCD cells.\nDo mitochondria play a role in remodelling lace plant leaves during programmed cell death?",
        "generated_text": "(EPCD), and cells in late stages of PCD (LPCD). The authors used transmission electron microscopy (TEM) to observe the ultrastructure of the cells in these three areas. They also used immunogold labeling to detect the presence of specific proteins in the mitochondria of these cells.\nThe results showed that in NPCD cells, the mitochondria were elongated and had a smooth outer membrane. In EPCD cells, the mitochondria started to fragment and their outer membrane became invaginated. In LPCD cells, the mitochondria were highly fragmented and their outer membrane was highly invaginated. The authors also found that the protein Bax Inhibitor-1 (BI-1), which is known to inhibit PCD in plants, was present in the mitochondria of NPCD cells but not in EPCD or LPCD cells.\nBased on these results, the authors concluded that mitochondrial fragmentation and outer membrane",
        "levenshtein_distance": 665
    },
    {
        "realidx": "21658267",
        "question": "There are three main service delivery channels: clinical services, outreach, and family and community. To determine which delivery channels are associated with the greatest reductions in under-5 mortality rates (U5MR), we used data from sequential population-based surveys to examine the correlation between changes in coverage of clinical, outreach, and family and community services and in U5MR for 27 high-burden countries.\nHousehold survey data were abstracted from serial surveys in 27 countries. Average annual changes (AAC) between the most recent and penultimate survey were calculated for under-five mortality rates and for 22 variables in the domains of clinical, outreach, and family- and community-based services. For all 27 countries and a subset of 19 African countries, we conducted principal component analysis to reduce the variables into a few components in each domain and applied linear regression to assess the correlation between changes in the principal components and changes in under-five mortality rates after controlling for multiple potential confounding factors.\nAAC in under 5-mortality varied from 6.6% in Nepal to -0.9% in Kenya, with six of the 19 African countries all experiencing less than a 1% decline in mortality. The strongest correlation with reductions in U5MR was observed for access to clinical services (all countries: p = 0.02, r\u00b2 = 0.58; 19 African countries p<0.001, r\u00b2 = 0.67). For outreach activities, AAC U5MR was significantly correlated with antenatal care and family planning services, while AAC in immunization services showed no association. In the family- and community services domain, improvements in breastfeeding were associated with significant changes in mortality in the 30 countries but not in the African subset; while in the African countries, nutritional status improvements were associated with a significant decline in mortality.\nDo improvements in outreach, clinical, and family and community-based services predict improvements in child survival?",
        "answer": "yes",
        "answer_rationale": "Our findings support the importance of increasing access to clinical services, certain outreach services and breastfeeding and, in Africa, of improving nutritional status. Integrated programs that emphasize these services may lead to substantial mortality declines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "There are three main service delivery channels: clinical services, outreach, and family and community. To determine which delivery channels are associated with the greatest reductions in under-5 mortality rates (U5MR), we used data from sequential population-based surveys to examine the correlation between changes in coverage of clinical, outreach, and family and community services and in U5MR for 27 high-burden countries.\nHousehold survey data were abstracted from serial surveys in 27 countries. Average annual changes (AAC) between the most recent and penultimate survey were calculated for under-five mortality rates and for 22 variables in the domains of clinical, outreach, and family- and community-based services. For all 27 countries and a subset of 19 African countries, we conducted principal component analysis to reduce the variables into a few components in each domain and applied linear regression to assess the correlation between changes in the principal components and changes in under-five mortality rates after controlling for multiple potential confounding factors.\n",
        "q2": "AAC in under 5-mortality varied from 6.6% in Nepal to -0.9% in Kenya, with six of the 19 African countries all experiencing less than a 1% decline in mortality. The strongest correlation with reductions in U5MR was observed for access to clinical services (all countries: p = 0.02, r\u00b2 = 0.58; 19 African countries p<0.001, r\u00b2 = 0.67). For outreach activities, AAC U5MR was significantly correlated with antenatal care and family planning services, while AAC in immunization services showed no association. In the family- and community services domain, improvements in breastfeeding were associated with significant changes in mortality in the 30 countries but not in the African subset; while in the African countries, nutritional status improvements were associated with a significant decline in mortality.\nDo improvements in outreach, clinical, and family and community-based services predict improvements in child survival?",
        "generated_text": "We also conducted a sensitivity analysis to assess the robustness of the findings.\nIn the 27 countries, the AAC in under-five mortality rates ranged from -1.1 to -6.0 per 1000 live births per year. The AAC in the principal component of clinical services ranged from -0.05 to 0.25 standard deviations per year, and the AAC in the principal component of family and community services ranged from -0.04 to 0.14 standard deviations per year. The AAC in the principal component of outreach services ranged from -0.02 to 0.11 standard deviations per year. In the 27 countries, a one standard deviation per year increase in the principal component of clinical services was associated with a 1.1 (95% CI: 0.5, 1.7) per 1000 live births per year reduction in under-five mortality rates,",
        "levenshtein_distance": 664
    },
    {
        "realidx": "21689015",
        "question": "Canine-assisted therapy has been receiving growing attention as a means of aiding children with autism spectrum disorder (ASD). Yet, only limited studies have been done and a great deal of literature related to this intervention is anecdotal. The present study aims at providing additional quantitative evidence on the potential of dogs to positively modulate the behavior of children with ASD.SETTINGS/\nA 12-year-old boy diagnosed with ASD was exposed, at his usual treatment location (the Portuguese Association for Developmental Disorders and Autism at Vila Nova de Gaia, Portugal), to the following treatment conditions: (1) one-to-one structured activities with a therapist assisted by a certified therapy dog, and (2) one-to-one structured activities with the same therapist alone (as a control). To accurately assess differences in the behavior of the participant between these treatment conditions, the therapist followed a strict research protocol. The behavior of the participant was continuously video-recorded during both treatment conditions for further analysis and comparison. Treatment outcomes: In the presence of the dog, the participant exhibited more frequent and longer durations of positive behaviors (such as smiling and positive physical contacting) as well as less frequent and shorter durations of negative behaviors (such as aggressive manifestations).\nCan dogs prime autistic children for therapy?",
        "answer": "yes",
        "answer_rationale": "These findings are in accordance with previous experimental work and provide additional support for the assertion that dogs can prime autistic children for therapy. Ultimately, this study may contribute toward a change for full acceptance of canine-assisted therapy programs within the medical milieu. Additional studies using a similar research protocol on more autistic children will certainly help professionals to work on the most effective methods to individually serve this population through canine-assisted interventions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Canine-assisted therapy has been receiving growing attention as a means of aiding children with autism spectrum disorder (ASD). Yet, only limited studies have been done and a great deal of literature related to this intervention is anecdotal. The present study aims at providing additional quantitative evidence on the potential of dogs to positively modulate the behavior of children with ASD.SETTINGS/\nA 12-year-old boy diagnosed with ASD was exposed, at his usual treatment location (the Portuguese Association for Developmental Disorders and Autism at Vila Nova de Gaia, Portugal), to the following treatment conditions: (1) one-to-one structured activities with a therapist",
        "q2": " assisted by a certified therapy dog, and (2) one-to-one structured activities with the same therapist alone (as a control). To accurately assess differences in the behavior of the participant between these treatment conditions, the therapist followed a strict research protocol. The behavior of the participant was continuously video-recorded during both treatment conditions for further analysis and comparison. Treatment outcomes: In the presence of the dog, the participant exhibited more frequent and longer durations of positive behaviors (such as smiling and positive physical contacting) as well as less frequent and shorter durations of negative behaviors (such as aggressive manifestations).\nCan dogs prime autistic children for therapy?",
        "generated_text": "; (2) one-to-one structured activities with a therapist and a dog; and (3) one-to-one structured activities with a therapist and a stuffed dog. The order of the conditions was counterbalanced across participants. The study was conducted over a period of 6 weeks, with each condition lasting for 2 weeks. The activities included in the sessions were designed to target specific areas of difficulty for children with ASD, such as social interaction, communication, and sensory processing. The therapist used a variety of techniques, including play-based interventions, visual supports, and positive reinforcement, to engage the child in the activities. The",
        "levenshtein_distance": 520
    },
    {
        "realidx": "21712147",
        "question": "Combining various antiretroviral agents into one single dosage form has been a strategy to reduce pill burden and enhance medication adherence among human immunodeficiency virus /AIDS (HIV/AIDS) patients.\nThis is a cost-utility study from a health care system's perspective comparing coformulated fixed dose (FXD) strategy versus multiple free dose combination (FRC) in antiretroviral therapy.\nThe Medical Expenditure Panel Survey (MEPS) was used to identify HIV/AIDS patients with \u22652 active antiretroviral medications. Patients on FXD were matched in 1:1 ratio with the FRC group using propensity scores. All medical costs excluding those paid by patients and families were included. Utility was measured using SF-6D scores from the SF-12 questionnaire. Incremental cost-utility ratios (ICURs) were calculated using the mean annual estimates. A cost-effectiveness acceptability curve was determined using a Monte Carlo probabilistic simulation technique.\nNine FXD antiretroviral formulations approved by the U.S. Food and Drug Administration by 2005 was included in this study. One hundred seventy HIV/AIDS patients with \u22652 antiretroviral agents were identified from the MEPS database, of which 53% (n=92) were on FXD formulation. On matching, 70 patients from FXD had a match from the FRC group. No differences in sociodemographic and health status variables were observed between the matched groups. The mean annual cost was $15,766.15 for FXD patients and $11,875.21 for FRC patients. The mean utility gained by using FXD over FRC was 0.085; however, this difference was not statistically significant. The ICUR for the FXD treatment over FRC treatment was $45,540.49/quality-adjusted life years (QALYs). Probabilistic sensitivity analysis showed FXD to dominate FRC (>50% probability of being cost-effective) above the $40,000 threshold.\nDoes combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients?",
        "answer": "no",
        "answer_rationale": "Although the cost-effectiveness of a single-pill strategy was within the acceptable willingness-to-pay threshold, the QALY difference were minimal. Further research is recommended to explore the long-term impact of the strategy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Combining various antiretroviral agents into one single dosage form has been a strategy to reduce pill burden and enhance medication adherence among human immunodeficiency virus /AIDS (HIV/AIDS) patients.\nThis is a cost-utility study from a health care system's perspective comparing coformulated fixed dose (FXD) strategy versus multiple free dose combination (FRC) in antiretroviral therapy.\nThe Medical Expenditure Panel Survey (MEPS) was used to identify HIV/AIDS patients with \u22652 active antiretroviral medications. Patients on FXD were matched in 1:1 ratio with the FRC group using propensity scores. All medical costs excluding those paid by patients and families were included. Utility was measured using SF-6D scores from the SF-12 questionnaire. Incremental cost-utility ratios (ICURs) were calculated using the mean annual estimates. A cost-effectiveness acceptability curve was determined using a Monte Carlo probabilistic simulation technique.\nNine FXD antiretroviral formulations approved by the U.S. Food and Drug Administration by",
        "q2": " 2005 was included in this study. One hundred seventy HIV/AIDS patients with \u22652 antiretroviral agents were identified from the MEPS database, of which 53% (n=92) were on FXD formulation. On matching, 70 patients from FXD had a match from the FRC group. No differences in sociodemographic and health status variables were observed between the matched groups. The mean annual cost was $15,766.15 for FXD patients and $11,875.21 for FRC patients. The mean utility gained by using FXD over FRC was 0.085; however, this difference was not statistically significant. The ICUR for the FXD treatment over FRC treatment was $45,540.49/quality-adjusted life years (QALYs). Probabilistic sensitivity analysis showed FXD to dominate FRC (>50% probability of being cost-effective) above the $40,000 threshold.\nDoes combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients?",
        "generated_text": "December 2007 were identified. A total of 1,104 patients were included in the study, with 552 in each group. The mean age was 45.5 years, 78.4% were male, and 58.1% were black. The mean annual medical costs were $22,114 in the FXD group and $22,115 in the FRC group. The mean annual utility was 0.70 in the FXD group and 0.69 in the FRC group. The ICUR was $1,050 per quality-adjusted life year (QALY). The probability of FXD being cost-effective was 75% at a willingness-to-pay threshold of $50,000 per QALY.\nThe FXD strategy is cost-effective compared with FRC in the treatment of HIV/AIDS patients.",
        "levenshtein_distance": 612
    },
    {
        "realidx": "21726930",
        "question": "Endometrial polyp is a common cause of abnormal uterine bleeding, but the etiology and pathogenesis remain unclear. Vascular endothelial growth factor (VEGF) is angiogenic, related to thick walled vessels and transforming growth factor-beta1 (TGF-\u03b21) is related to fibrotic tissue, which are characteristics of endometrial polyps. The primary objective of this study was to find out if endometrial polyp formation is associated with increased expression of VEGF or TGF-\u03b21, or both. A secondary objective is to determine if the changes are related to steroid receptor expression.\nThis prospective study compared VEGF and TGF-\u03b21 expression of endometrial polyps and adjacent endometrial tissue in 70 premenopausal women. The comparison of results was separately made for endometrium specimens obtained in the proliferative and secretory phases. The results were correlated with the steroid receptors (estrogen receptor and progesterone receptor) expression.\nThe score of VEGF in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P<0.001) and the secretory phase (P=0.03); the score of VEGF in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium only in proliferative phase (P=0.006). The score of TGF-\u03b21 in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium in proliferative phase (P=0.02); whereas the score of TGF-\u03b21 in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P=0.006) and the secretory phase (P=0.008). There was a significant correlation between the expression of steroid receptors and VEGF and TGF-\u03b21 (Spearman's correlation P<0.001 and P<0.05, respectively).\nIs endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?",
        "answer": "yes",
        "answer_rationale": "There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Endometrial polyp is a common cause of abnormal uterine bleeding, but the etiology and pathogenesis remain unclear. Vascular endothelial growth factor (VEGF) is angiogenic, related to thick walled vessels and transforming growth factor-beta1 (TGF-\u03b21) is related to fibrotic tissue, which are characteristics of endometrial polyps. The primary objective of this study was to find out if endometrial polyp formation is associated with increased expression of VEGF or TGF-\u03b21, or both. A secondary objective is to determine if the changes are related to steroid receptor expression.\nThis prospective study compared VEGF and TGF-\u03b21 expression of endometrial polyps and adjacent endometrial tissue in 70 premenopausal women. The comparison of results was separately made for endometrium specimens obtained in the proliferative and secretory phases. The results were correlated with the steroid receptors (estrogen receptor and progesterone receptor) expression.\nThe score of VEGF in glandular cells of endometrial polyps was significantly higher than the score in adjacent",
        "q2": " endometrium, both in the proliferative phase (P<0.001) and the secretory phase (P=0.03); the score of VEGF in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium only in proliferative phase (P=0.006). The score of TGF-\u03b21 in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium in proliferative phase (P=0.02); whereas the score of TGF-\u03b21 in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P=0.006) and the secretory phase (P=0.008). There was a significant correlation between the expression of steroid receptors and VEGF and TGF-\u03b21 (Spearman's correlation P<0.001 and P<0.05, respectively).\nIs endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?",
        "generated_text": "endometrium in both proliferative and secretory phases. The score of TGF-\u03b21 in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium in both proliferative and secretory phases. The score of VEGF in glandular cells of endometrial polyps was positively correlated with the score of estrogen receptor in glandular cells of endometrial polyps in both proliferative and secretory phases. The score of TGF-\u03b21 in stromal cells of endometrial polyps was positively correlated with the score of progesterone receptor in stromal cells of endometrial polyps in both proliferative and secretory phases.\nEndometrial polyp formation is associated with increased expression of VEGF and TGF-\u03b21, which may be related to increased expression of estrogen receptor and progesterone receptor, respectively.",
        "levenshtein_distance": 467
    },
    {
        "realidx": "21789019",
        "question": "The increasingly older population confronts oncologists with an imposing challenge: older cancer patients have specific healthcare needs both independent of and associated with the diagnosis of cancer. The aim of the present study is to examine whether elderly versus younger cancer patients have different needs with respect to attendance, treatment and information.\nThis is an observational and cross-sectional study. Cancer patients aged 35 to 82 years were consecutively interviewed. The group was divided into two subgroups aged \u226465 and \u226566 years old. The Needs Evaluation Questionnaire (NEQ) was used to assess patients' needs and demographic variables were collected. Data analysis was carried out by means of cross-tabulation analyses and the chi-square test.\nThe requests most frequently expressed by the older group concerned financial-insurance information (73.9%), the need to talk to people with the same illness (71.7%), the need to receive more comprehensible information from doctors and nurses (71.7%), and the need for a better dialogue with clinicians (69.6%). Few significant differences between the two age subgroups were found, with the exception of issues such as the need for intimacy and support.\nDo elderly cancer patients have different care needs compared with younger ones?",
        "answer": "no",
        "answer_rationale": "Elderly patients have informational and relational needs similar to those of younger patients. In fact, most of the whole sample flagged up the need for higher levels of satisfaction especially concerning a better dialogue with health staff, along with a new factor: the need to talk to people with the same illness.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The increasingly older population confronts oncologists with an imposing challenge: older cancer patients have specific healthcare needs both independent of and associated with the diagnosis of cancer. The aim of the present study is to examine whether elderly versus younger cancer patients have different needs with respect to attendance, treatment and information.\nThis is an observational and cross-sectional study. Cancer patients aged 35 to 82 years were consecutively interviewed. The group was divided into two subgroups aged \u226465 and \u226566 years old. The Needs Evaluation Questionnaire (NEQ) was used to assess patients' needs and demographic variables were collected. Data",
        "q2": " analysis was carried out by means of cross-tabulation analyses and the chi-square test.\nThe requests most frequently expressed by the older group concerned financial-insurance information (73.9%), the need to talk to people with the same illness (71.7%), the need to receive more comprehensible information from doctors and nurses (71.7%), and the need for a better dialogue with clinicians (69.6%). Few significant differences between the two age subgroups were found, with the exception of issues such as the need for intimacy and support.\nDo elderly cancer patients have different care needs compared with younger ones?",
        "generated_text": "were analyzed using descriptive statistics, t-test, ANOVA and chi-square test.\nA total of 100 patients were included in the study. The mean age was 60.4 years (SD=11.1). The majority of the patients were female (56%). The most common cancer type was breast cancer (26%). The mean total score of the NEQ was 10.4 (SD=7.1). The mean total score of the NEQ was higher in the elderly group (12.4 vs. 9.1, p=",
        "levenshtein_distance": 452
    },
    {
        "realidx": "21823940",
        "question": "Research on stroke survivors' driving safety has typically used either self-reports or government records, but the extent to which the 2 may differ is not known. We compared government records and self-reports of motor vehicle collisions and driving convictions in a sample of stroke survivors.\nThe 56 participants were originally recruited for a prospective study on driving and community re-integration post-stroke; the study population consisted of moderately impaired stroke survivors without severe communication disorders who had been referred for a driving assessment. The driving records of the 56 participants for the 5 years before study entry and the 1-year study period were acquired with written consent from the Ministry of Transportation of Ontario (MTO), Canada. Self-reports of collisions and convictions were acquired via a semistructured interview and then compared with the MTO records.\nForty-three participants completed the study. For 7 (13.5%) the MTO records did not match the self-reports regarding collision involvement, and for 9 (17.3%) the MTO records did not match self-reports regarding driving convictions. The kappa coefficient for the correlation between MTO records and self-reports was 0.52 for collisions and 0.47 for convictions (both in the moderate range of agreement). When both sources of data were consulted, up to 56 percent more accidents and up to 46 percent more convictions were identified in the study population in the 5 years before study entry compared to when either source was used alone.\nDepartment of Transportation vs self-reported data on motor vehicle collisions and driving convictions for stroke survivors: do they agree?",
        "answer": "no",
        "answer_rationale": "In our population of stroke survivors, self-reports of motor vehicle collisions and driving convictions differed from government records. In future studies, the use of both government and self-reported data would ensure a more accurate picture of driving safety post-stroke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Research on stroke survivors' driving safety has typically used either self-reports or government records, but the extent to which the 2 may differ is not known. We compared government records and self-reports of motor vehicle collisions and driving convictions in a sample of stroke survivors.\nThe 56 participants were originally recruited for a prospective study on driving and community re-integration post-stroke; the study population consisted of moderately impaired stroke survivors without severe communication disorders who had been referred for a driving assessment. The driving records of the 56 participants for the 5 years before study entry and the 1-year study period were acquired with written consent from the Ministry of Transportation of Ontario (MTO), Canada. Self-reports of collisions and convictions were acquired via a semistructured interview and then compared with the MTO",
        "q2": " records.\nForty-three participants completed the study. For 7 (13.5%) the MTO records did not match the self-reports regarding collision involvement, and for 9 (17.3%) the MTO records did not match self-reports regarding driving convictions. The kappa coefficient for the correlation between MTO records and self-reports was 0.52 for collisions and 0.47 for convictions (both in the moderate range of agreement). When both sources of data were consulted, up to 56 percent more accidents and up to 46 percent more convictions were identified in the study population in the 5 years before study entry compared to when either source was used alone.\nDepartment of Transportation vs self-reported data on motor vehicle collisions and driving convictions for stroke survivors: do they agree?",
        "generated_text": "records.\nThe MTO records indicated that 10 participants had at least 1 collision in the 5 years before study entry, and 11 had at least 1 conviction. Self-reports indicated that 12 participants had at least 1 collision, and 13 had at least 1 conviction. The agreement between the 2 sources was fair for collisions (kappa=0.33) and moderate for convictions (kappa=0.55). The MTO records identified 2 collisions and 1 conviction that were not reported by the participants, and the self-reports identified 2 collisions and 2 convictions that were not recorded by the MTO.\nThe agreement between self-reports and government records for collisions and convictions was only fair to moderate in this sample of stroke",
        "levenshtein_distance": 546
    },
    {
        "realidx": "21845457",
        "question": "Trauma centers are designated to provide systematized multidisciplinary care to injured patients. Effective trauma systems reduce patient mortality by facilitating the treatment of injured patients at appropriately resourced hospitals. Several U.S. studies report reduced mortality among patients admitted directly to a level I trauma center compared with those admitted to hospitals with less resources. It has yet to be shown whether there is an outcome benefit associated with the \"level of hospital\" initially treating severely injured trauma patients in Australia. This study was designed to determine whether the level of trauma center providing treatment impacts mortality and/or hospital length of stay.\nOutcomes were evaluated for severely injured trauma patients with an Injury Severity Score (ISS)>15 using NSW Institute of Trauma and Injury Management data from 2002-2007 for our regional health service. To assess the association between trauma centers and binary outcomes, a logistic regression model was used. To assess the association between trauma centers and continuous outcomes, a multivariable linear regression model was used. Sex, age, and ISS were included as covariates in all models.\nThere were 1,986 trauma presentations during the 6-year period. Patients presenting to a level III trauma center had a significantly higher risk of death than those presenting to the level I center, regardless of age, sex, ISS, or prehospital time. Peer review of deaths at the level III center identified problems in care delivery in 15 cases associated with technical errors, delay in decision making, or errors of judgement.\nOutcomes of severely injured adult trauma patients in an Australian health service: does trauma center level make a difference?",
        "answer": "yes",
        "answer_rationale": "Severely injured patients treated at a level III center had a higher mortality rate than those treated at a level I center. Most problems identified occurred in the emergency department and were related to delays in care provision. This research highlights the importance of efficient prehospital, in-hospital, and regional trauma systems, performance monitoring, peer review, and adherence to protocols and guidelines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Trauma centers are designated to provide systematized multidisciplinary care to injured patients. Effective trauma systems reduce patient mortality by facilitating the treatment of injured patients at appropriately resourced hospitals. Several U.S. studies report reduced mortality among patients admitted directly to a level I trauma center compared with those admitted to hospitals with less resources. It has yet to be shown whether there is an outcome benefit associated with the \"level of hospital\" initially treating severely injured trauma patients in Australia. This study was designed to determine whether the level of trauma center providing treatment impacts mortality and/or hospital length of stay.\nOutcomes were evaluated for severely injured trauma patients with an Injury Severity Score (ISS)>15 using NSW Institute of Trauma and Injury Management data from 2002-2007 for our regional health service. To assess the",
        "q2": " association between trauma centers and binary outcomes, a logistic regression model was used. To assess the association between trauma centers and continuous outcomes, a multivariable linear regression model was used. Sex, age, and ISS were included as covariates in all models.\nThere were 1,986 trauma presentations during the 6-year period. Patients presenting to a level III trauma center had a significantly higher risk of death than those presenting to the level I center, regardless of age, sex, ISS, or prehospital time. Peer review of deaths at the level III center identified problems in care delivery in 15 cases associated with technical errors, delay in decision making, or errors of judgement.\nOutcomes of severely injured adult trauma patients in an Australian health service: does trauma center level make a difference?",
        "generated_text": "impact of the level of trauma center on mortality and hospital length of stay, a multivariate logistic regression model was used to adjust for age, sex, ISS, mechanism of injury, and the presence of head injury.\nA total of 1,000 patients were included in the study. The majority (70%) were male, with a mean age of 42 years. The most common mechanism of injury was motor vehicle crash (40%), followed by falls (30%). The overall in-hospital mortality was 10%. Patients treated at level I trauma centers had a lower mortality rate (8%) compared to those treated at level II (12%) and level III (15%) centers. After adjusting for confounding variables, treatment at a level I trauma center",
        "levenshtein_distance": 602
    },
    {
        "realidx": "21848798",
        "question": "In recent clinical trials (RCT) of bowel preparation, Golytely was more efficacious than MiraLAX. We hypothesised that there is a difference in adenoma detection between Golytely and MiraLAX.\nTo compare the adenoma detection rate (ADR) between these bowel preparations, and to identify independent predictors of bowel preparation quality and adenoma detection.\nThis was a post hoc analysis of an RCT that assessed efficacy and patient tolerability of Golytely vs. MiraLAX/Gatorade in average risk screening colonoscopy patients. Bowel preparation quality was measured with the Boston Bowel Preparation Scale (BBPS). An excellent/good equivalent BBPS score was defined as \u2265 7. Polyp pathology review was performed. ADR was defined as the proportion of colonoscopies with an adenoma. Univariate and multivariate analyses were conducted.\nOne hundred and ninety patients were prospectively enrolled (87 MiraLAX, 103 Golytely). Golytely had a higher rate of a BBPS score \u2265 7 (82.5% vs. MiraLAX 67.8%, P=0.02). The ADR in the Golytely cohort was 26.2% (27/103), and was 16.1% (14/87) for MiraLAX (P = 0.091). On multivariate analyses, Golytely was 2.13 \u00d7 more likely to be associated with a BBPS \u2265 7 (95% CI 1.05-4.32, P = 0.04) and 2.28 \u00d7 more likely to be associated with adenoma detection (95% CI 1.05-4.98, P = 0.04) than MiraLAX.\nMiraLAX vs. Golytely: is there a significant difference in the adenoma detection rate?",
        "answer": "yes",
        "answer_rationale": "Golytely was more efficacious than MiraLAX in bowel cleansing, and was independently associated with both bowel prep quality (BBPS \u2265 7) and higher adenoma detection. Golytely should be used as first line for bowel prep for colonoscopy. Studies with larger populations are needed to confirm these results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "In recent clinical trials (RCT) of bowel preparation, Golytely was more efficacious than MiraLAX. We hypothesised that there is a difference in adenoma detection between Golytely and MiraLAX.\nTo compare the adenoma detection rate (ADR) between these bowel preparations, and to identify independent predictors of bowel preparation quality and adenoma detection.\nThis was a post hoc analysis of an RCT that assessed efficacy and patient tolerability of Golytely vs. MiraLAX/Gatorade in average risk screening colonoscopy patients. Bowel preparation quality was measured with the Boston Bowel Preparation Scale (BBPS). An excellent/good equivalent BBPS score was defined as \u2265 7. Polyp pathology review was performed. ADR was defined as the proportion of colonoscopies with an adenoma. Univariate and multivariate analyses were conducted.\nOne hundred and ninety patients were prospectively enrolled (87 MiraLAX, 103",
        "q2": " Golytely). Golytely had a higher rate of a BBPS score \u2265 7 (82.5% vs. MiraLAX 67.8%, P=0.02). The ADR in the Golytely cohort was 26.2% (27/103), and was 16.1% (14/87) for MiraLAX (P = 0.091). On multivariate analyses, Golytely was 2.13 \u00d7 more likely to be associated with a BBPS \u2265 7 (95% CI 1.05-4.32, P = 0.04) and 2.28 \u00d7 more likely to be associated with adenoma detection (95% CI 1.05-4.98, P = 0.04) than MiraLAX.\nMiraLAX vs. Golytely: is there a significant difference in the adenoma detection rate?",
        "generated_text": "Golytely). The mean age was 54.5 years, 51% were male, and 70% were white. The mean BBPS score was higher in the Golytely group (7.8 vs. 7.1, p=0.002). The ADR was higher in the Golytely group (40% vs. 25%, p=0.03). In multivariate analysis, Golytely was independently associated with higher ADR (OR 2.3, 95% CI 1.0-5.2, p=0.04). In addition, higher BBPS score was independently associated with higher ADR (OR 1.3, 95% CI 1.1-1.6, p=0.004). In a separate multivariate analysis, Golytely",
        "levenshtein_distance": 344
    },
    {
        "realidx": "21849531",
        "question": "Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established.\nThis nationwide cohort study investigates the effect of GH treatment on all-cause and cause-specific mortality and analyzes patient characteristics influencing mortality in GHD adults.\nPatients in the Dutch National Registry of Growth Hormone Treatment in Adults were retrospectively monitored (1985-2009) and subdivided into treatment (n = 2229), primary (untreated, n = 109), and secondary control (partly treated, n = 356) groups.\nStandardized mortality ratios (SMR) were calculated for all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected mortality was obtained from cause, sex, calendar year, and age-specific death rates from national death and population counts.\nIn the treatment group, 95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 1.04-1.56)]. Mortality was higher in women than in men. After exclusion of high-risk patients, the SMR for CVD mortality remained increased in women. Mortality due to malignancies was not elevated. In the control groups mortality was not different from the background population. Univariate analyses demonstrated sex, GHD onset, age, and underlying diagnosis as influencing factors.\nDoes growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency?",
        "answer": "no",
        "answer_rationale": "GHD men receiving GH treatment have a mortality rate not different from the background population. In women, after exclusion of high-risk patients, mortality was not different from the background population except for CVD. Mortality due to malignancies was not elevated in adults receiving GH treatment. Next to gender, the heterogeneous etiology is of influence on mortality in GHD adults with GH treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established.\nThis nationwide cohort study investigates the effect of GH treatment on all-cause and cause-specific mortality and analyzes patient characteristics influencing mortality in GHD adults.\nPatients in the Dutch National Registry of Growth Hormone Treatment in Adults were retrospectively monitored (1985-2009) and subdivided into treatment (n = 2229), primary (untreated, n = 109), and secondary control (partly treated, n = 356) groups.\nStandardized mortality ratios (SMR) were calculated for all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected mortality",
        "q2": " was obtained from cause, sex, calendar year, and age-specific death rates from national death and population counts.\nIn the treatment group, 95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 1.04-1.56)]. Mortality was higher in women than in men. After exclusion of high-risk patients, the SMR for CVD mortality remained increased in women. Mortality due to malignancies was not elevated. In the control groups mortality was not different from the background population. Univariate analyses demonstrated sex, GHD onset, age, and underlying diagnosis as influencing factors.\nDoes growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency?",
        "generated_text": "was based on age- and sex-specific mortality rates in the general population.\nAll-cause mortality was increased in the treatment group (SMR 1.32, 95% CI 1.18-1.47), primary control group (SMR 1.74, 95% CI 1.14-2.51), and secondary control group (SMR 1.51, 95% CI 1.21-1.87). Malignancy mortality was increased in the treatment group (SMR 1.44, 95% CI 1.07-1.91) and secondary control",
        "levenshtein_distance": 522
    },
    {
        "realidx": "21850494",
        "question": "Hepatorenal syndrome (HRS) is the functional renal failure associated with advanced cirrhosis and has also been described in fulminant hepatic failure. Without liver transplantation its prognosis is dismal. Our study included patients with type 1 HRS associated with cirrhosis, who were not liver transplant candidates.AIM: To identify variables associated with improved survival.\nSixty-eight patients fulfilled the revised Ascites Club Criteria for type 1 HRS. None of them was suitable for liver transplantation. All the patients were treated with combinations of: albumin, midodrine and octreotide, pressors, and hemodialysis.\nMedian survival was 13 days for the whole group. Survival varied with the end-stage liver disease (ESLD) etiology: autoimmune, 49 days, cardiac cirrhosis, 22 days, idiopathic, 15.5 days, viral, 15 days, hepatitis C and alcohol, 14.5 days, alcohol 8 days, and neoplasia 4 days (p = 0.048). Survival of HRS associated with alcoholic liver disease versus other etiologies was not statistically significant (p = 0.1). Increased serum creatinine (p = 0.02) and urinary sodium 6-10 mEq/l (p = 0.027) at the initiation of therapy were prognostic factors for mortality. HRS treatment modalities (p = 0.73), use of dialysis (p = 0.56), dialysis modality (p = 0.35), use of vasopressors (p = 0.26), pre-existing renal disease (p = 0.49), gender (p = 0.90), and age (p = 0.57) were not associated with survival.\nHepatorenal syndrome: are we missing some prognostic factors?",
        "answer": "yes",
        "answer_rationale": "We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Hepatorenal syndrome (HRS) is the functional renal failure associated with advanced cirrhosis and has also been described in fulminant hepatic failure. Without liver transplantation its prognosis is dismal. Our study included patients with type 1 HRS associated with cirrhosis, who were not liver transplant candidates.AIM: To identify variables associated with improved survival.\nSixty-eight patients fulfilled the revised Ascites Club Criteria for type 1 HRS. None of them was suitable for liver transplantation. All the patients were treated with combinations of: albumin, midodrine and octreotide, pressors, and hemodialysis.\nMedian survival was 13 days for the whole group. Survival varied with the end-stage liver disease (ESLD) etiology: autoimmune, 49 days, cardiac cirrhosis, 22 days, idiopathic, 15.5 days, viral, 15 days, hepatitis C and",
        "q2": " alcohol, 14.5 days, alcohol 8 days, and neoplasia 4 days (p = 0.048). Survival of HRS associated with alcoholic liver disease versus other etiologies was not statistically significant (p = 0.1). Increased serum creatinine (p = 0.02) and urinary sodium 6-10 mEq/l (p = 0.027) at the initiation of therapy were prognostic factors for mortality. HRS treatment modalities (p = 0.73), use of dialysis (p = 0.56), dialysis modality (p = 0.35), use of vasopressors (p = 0.26), pre-existing renal disease (p = 0.49), gender (p = 0.90), and age (p = 0.57) were not associated with survival.\nHepatorenal syndrome: are we missing some prognostic factors?",
        "generated_text": "alcohol, 13 days, and cryptogenic, 10 days. Survival was better in patients with higher serum sodium levels (P = 0.0001), higher serum creatinine levels (P = 0.0001), higher serum albumin levels (P = 0.0001), higher serum bilirubin levels (P = 0.0001), higher serum alkaline phosphatase levels (P = 0.0001), higher serum gamma-glutamyl transpeptidase levels (P = 0.0001), higher serum creatinine kinase levels (P = 0.0001), higher serum lactate dehydrogenase levels (P = 0.0001), higher serum uric acid levels (P = 0.0001), higher serum glucose levels (P = 0",
        "levenshtein_distance": 467
    },
    {
        "realidx": "21864397",
        "question": "Nasopharyngeal carcinoma (NPC) with lung metastasis alone has been reported as a relatively favorable prognostic group, and combined modality treatment might be indicated for selected cases. However, the prognostic factors determining survival of this group and the indication of combined therapy have not been thoroughly studied.\nWe retrospectively reviewed 246 patients of NPC with lung metastasis(es) alone presented at diagnosis or as the first failure after primary treatment from 1993 to 2008 in an academic tertiary hospital. Univariate and multivariate survival analyses of post-metastasis survival (PMS) and overall survival (OS) were carried out to determine the prognostic factors.\nThe 3-year, 5-year, and 10-year of PMS and OS for the whole cohort were 34.3%, 17.0%, 8.6% and 67.8%, 45.4%, 18.5%, respectively. The median PMS (45.6 months vs. 23.7 months) and OS (73.7 months vs. 46.2 months) of patients treated with combined therapy was significantly longer than that of those treated with chemotherapy alone (P<0.001). Age, disease-free interval (DFI) and treatment modality were evaluated as independent prognostic factors of OS, while only age and treatment modality retain their independent significance in PMS analysis. In stratified survival analysis, compared to chemotherapy alone, combined therapy could benefit the patients with DFI>1 year, but not those with DFI \u2264 1 year.\nFactors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?",
        "answer": "yes",
        "answer_rationale": "Age \u2264 45 years, DFI>1 year, and the combined therapy were good prognostic factors for NPC patients with lung metastasis(es) alone. The combination of local therapy and the basic chemotherapy should be considered for these patients with DFI>1 year.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Nasopharyngeal carcinoma (NPC) with lung metastasis alone has been reported as a relatively favorable prognostic group, and combined modality treatment might be indicated for selected cases. However, the prognostic factors determining survival of this group and the indication of combined therapy have not been thoroughly studied.\nWe retrospectively reviewed 246 patients of NPC with lung metastasis(es) alone presented at diagnosis or as the first failure after primary treatment from 1993 to 2008 in an academic tertiary hospital. Univariate and multivariate survival analyses of post-metastasis survival (PMS) and overall survival (OS) were carried out to determine the prognostic factors.\nThe 3-year, 5-year, and 10-year of PMS and OS for the whole cohort were 34.3%, 17.0%, 8.",
        "q2": "6% and 67.8%, 45.4%, 18.5%, respectively. The median PMS (45.6 months vs. 23.7 months) and OS (73.7 months vs. 46.2 months) of patients treated with combined therapy was significantly longer than that of those treated with chemotherapy alone (P<0.001). Age, disease-free interval (DFI) and treatment modality were evaluated as independent prognostic factors of OS, while only age and treatment modality retain their independent significance in PMS analysis. In stratified survival analysis, compared to chemotherapy alone, combined therapy could benefit the patients with DFI>1 year, but not those with DFI \u2264 1 year.\nFactors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?",
        "generated_text": "1%, and 27.2%, 12.2%, 5.3%, respectively. The median PMS and OS were 2.0 years and 2.0 years, respectively. The median follow-up time was 4.0 years. In the univariate analysis, the PMS and OS were significantly better in patients with single metastasis, lower metastatic tumor burden, lower serum lactate dehydrogenase (LDH), and combined therapy. In the multivariate analysis, single metastasis, lower metastatic tumor burden, lower serum LDH, and combined therapy were independent favorable prognostic factors for PMS and OS. The 3-year PMS and OS for patients with single metastasis, lower metastatic tumor burden, lower serum LDH, and combined therapy were 55.",
        "levenshtein_distance": 524
    },
    {
        "realidx": "21889895",
        "question": "The aim of this study was to determine if educating residents about the potential effects of radiation exposure from computed tomographic (CT) imaging alters ordering patterns. This study also explored whether referring physicians are interested in radiation education and was an initial effort to address their CT ordering behavior.\nTwo to four months after a radiologist's lecture on the potential effects of radiation exposure related to CT scans, urology and orthopedic residents were surveyed regarding the number and types of CT scans they ordered, the use of alternative imaging modalities, and whether they used the lecture information to educate patients.\nTwenty-one resident lecture attendants completed the survey. The number of CT scans ordered after the lecture stayed constant for 90% (19 of 21) and decreased for 10% (two of 21). The types of CT scans ordered changed after the lecture for 14% (three of 21). Thirty-three percent (seven of 21) reported increases in alternative imaging after the lecture, including 24% (five of 21) reporting increases in magnetic resonance imaging and 19% (four of 21) reporting increases in ultrasound. Patients directed questions about radiation exposure to 57% (12 of 21); 38% (eight of 21) used the lecture information to educate patients. Referring physicians were interested in the topic, and afterward, other physician groups requested radiation education lectures.\nWill CT ordering practices change if we educate residents about the potential effects of radiation exposure?",
        "answer": "no",
        "answer_rationale": "Most clinicians did not change their CT scan ordering after receiving education about radiation from a radiologist. Radiation education allowed clinicians to discuss CT benefits and risks with their patients and to choose appropriate CT protocols. Referring physician groups are interested in this topic, and radiologists should be encouraged to give radiation lectures to them.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The aim of this study was to determine if educating residents about the potential effects of radiation exposure from computed tomographic (CT) imaging alters ordering patterns. This study also explored whether referring physicians are interested in radiation education and was an initial effort to address their CT ordering behavior.\nTwo to four months after a radiologist's lecture on the potential effects of radiation exposure related to CT scans, urology and orthopedic residents were surveyed regarding the number and types of CT scans they ordered, the use of alternative imaging modalities, and whether they used the lecture information to educate patients.\nTwenty-one resident lecture attendants completed the survey. The number of CT scans ordered after the lecture stayed constant for 90% (19 of 21) and decreased for ",
        "q2": "10% (two of 21). The types of CT scans ordered changed after the lecture for 14% (three of 21). Thirty-three percent (seven of 21) reported increases in alternative imaging after the lecture, including 24% (five of 21) reporting increases in magnetic resonance imaging and 19% (four of 21) reporting increases in ultrasound. Patients directed questions about radiation exposure to 57% (12 of 21); 38% (eight of 21) used the lecture information to educate patients. Referring physicians were interested in the topic, and afterward, other physician groups requested radiation education lectures.\nWill CT ordering practices change if we educate residents about the potential effects of radiation exposure?",
        "generated_text": "10% (2 of 21). The number of magnetic resonance imaging (MRI) scans ordered increased for 43% (9 of 21), decreased for 19% (4 of 21), and stayed constant for 38% (8 of 21). The number of plain radiographs ordered increased for 14% (3 of 21), decreased for 10% (2 of 21), and stayed constant for 76% (16 of 21). The number of ultrasound examinations ordered increased for 10% (2 of 21), decreased for 10% (2 of 21), and stayed constant",
        "levenshtein_distance": 504
    },
    {
        "realidx": "21946341",
        "question": "Ablation of persistent atrial fibrillation (AF) may require adjunctive methods of substrate modification. Both ablation-targeting complex fractionated atrial electrograms (CFAEs) recorded during AF and fractionated electrograms recorded during sinus rhythm (sinus rhythm fractionation [SRF]) have been described. However, the relationship of CFAEs with SRF is unclear.\nTwenty patients (age 62 \u00b1 9 years, 13 males) with persistent AF and 9 control subjects without organic heart disease or AF (age 36 \u00b1 6 years, 4 males) underwent detailed CFAE and SRF left atrial electroanatomic maps. The overlap in left atrial regions with CFAEs and SRF was compared in the AF population, and the distribution of SRF was compared among patients with AF and normal controls. Propagation maps were analyzed to identify the activation patterns associated with SR fractionation.\nSRF (338 \u00b1 150 points) and CFAE (418 \u00b1 135 points) regions comprised 29% \u00b1 14% and 25% \u00b1 15% of the left atrial surface area, respectively. There was no significant correlation between SRF and CFAE maps (r = .2; P = NS). On comparing patients with AF and controls, no significant difference was found in the distribution of SRF between groups (P = .74). Regions of SRF overlapped areas of wave-front collision 75% \u00b1 13% of the time.\nIs there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation?",
        "answer": "no",
        "answer_rationale": "(1) There is little overlap between regions of CFAEs during AF and regions of SRF measured in the time domain or the frequency domain, (2) the majority of SRF appears to occur in regions with wave-front collision, (3) the distribution of SRF is similar in patients with AF and normal controls, suggesting that this may not have an important role in AF maintenance and may not be a suitable ablation target.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Ablation of persistent atrial fibrillation (AF) may require adjunctive methods of substrate modification. Both ablation-targeting complex fractionated atrial electrograms (CFAEs) recorded during AF and fractionated electrograms recorded during sinus rhythm (sinus rhythm fractionation [SRF]) have been described. However, the relationship of CFAEs with SRF is unclear.\nTwenty patients (age 62 \u00b1 9 years, 13 males) with persistent AF and 9 control subjects without organic heart disease or AF (age 36 \u00b1 6 years, 4 males) underwent detailed CFAE and SRF left atrial electroanatomic maps. The overlap in left atrial regions with CFAEs and SRF was compared in the AF population, and the distribution of SRF was compared among",
        "q2": " patients with AF and normal controls. Propagation maps were analyzed to identify the activation patterns associated with SR fractionation.\nSRF (338 \u00b1 150 points) and CFAE (418 \u00b1 135 points) regions comprised 29% \u00b1 14% and 25% \u00b1 15% of the left atrial surface area, respectively. There was no significant correlation between SRF and CFAE maps (r = .2; P = NS). On comparing patients with AF and controls, no significant difference was found in the distribution of SRF between groups (P = .74). Regions of SRF overlapped areas of wave-front collision 75% \u00b1 13% of the time.\nIs there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation?",
        "generated_text": "the AF and control groups.\nIn the AF population, 42% of the left atrial surface had CFAEs, and 22% had SRF. There was a significant overlap between CFAE and SRF regions (p <0.001). In the control group, 1% of the left atrial surface had SRF, which was significantly less than in the AF group (p <0.001). The SRF regions in the AF group were significantly larger in the posterior left atrial wall (p <0.001) and in the left atrial appendage (p <0.001) compared with the control group.\nIn patients with persistent AF, CFAE and SRF regions significantly overlap, and SRF is increased",
        "levenshtein_distance": 492
    },
    {
        "realidx": "21952349",
        "question": "Myocardial damage that is associated with percutaneous coronary intervention (PCI) partially affects the results of the procedure, and is related to medium-term cardiovascular death. Remote postischemic conditioning might reduce the myocardial lesions that are associated with PCI, but perhaps less so in diabetics. The aim of this study was to evaluate the protective effect of remote postischemic conditioning in patients undergoing elective PCI for stable angina or non-ST elevation acute coronary syndrome with troponin<1 ng/ml at the time of randomization.\nThis randomized single-blinded single-center clinical trial involved 320 patients undergoing elective PCI who were randomized to either receive three 5-min cycles of ischemia by inflation of a cuff on the non-dominant arm to 200 mm Hg (remote postischemic conditioning) or to placebo (uninflated cuff). The primary outcome variable was the maximum increase in troponin in the first 24 h. The secondary outcome variable was readmission due to heart failure or cardiovascular mortality after 1 year of follow-up. In addition, a diabetic population was studied.\nRemote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization?",
        "answer": "yes",
        "answer_rationale": "This clinical trial evaluated the possible reduction in intervention-related myocardial damage that was attributable to remote postischemic conditioning.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Myocardial damage that is associated with percutaneous coronary intervention (PCI) partially affects the results of the procedure, and is related to medium-term cardiovascular death. Remote postischemic conditioning might reduce the myocardial lesions that are associated with PCI, but perhaps less so in diabetics. The aim of this study was to evaluate the protective effect of remote postischemic conditioning in patients undergoing elective PCI for stable angina or non-ST elevation acute coronary syndrome with troponin<1 ng/ml at the time of randomization.\nThis randomized single-blinded single-center clinical trial involved 320 patients undergoing elective",
        "q2": " PCI who were randomized to either receive three 5-min cycles of ischemia by inflation of a cuff on the non-dominant arm to 200 mm Hg (remote postischemic conditioning) or to placebo (uninflated cuff). The primary outcome variable was the maximum increase in troponin in the first 24 h. The secondary outcome variable was readmission due to heart failure or cardiovascular mortality after 1 year of follow-up. In addition, a diabetic population was studied.\nRemote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization?",
        "generated_text": "PCI for stable angina or non-ST elevation acute coronary syndrome with troponin<1 ng/ml at the time of randomization. Patients were randomized to receive remote postischemic conditioning or no remote postischemic conditioning. The primary endpoint was the area under the curve of creatine kinase-MB (CK-MB) from 0 to 72 h after PCI. Secondary endpoints included the area under the curve of troponin I from 0 to 72 h after PCI, the incidence of major adverse cardiovascular events at 1 year, and the incidence of cardiovascular",
        "levenshtein_distance": 416
    },
    {
        "realidx": "22011946",
        "question": "Many insurance payors mandate that bariatric surgery candidates undergo a medically supervised weight management (MSWM) program as a prerequisite for surgery. However, there is little evidence to support this requirement. We evaluated in a randomized controlled trial the hypothesis that participation in a MSWM program does not predict outcomes after laparoscopic adjustable gastric banding (LAGB) in a publicly insured population.\nThis pilot randomized trial was conducted in a large academic urban public hospital. Patients who met NIH consensus criteria for bariatric surgery and whose insurance did not require a mandatory 6-month MSWM program were randomized to a MSWM program with monthly visits over 6 months (individual or group) or usual care for 6 months and then followed for bariatric surgery outcomes postoperatively. Demographics, weight, and patient behavior scores, including patient adherence, eating behavior, patient activation, and physical activity, were collected at baseline and at 6 months (immediately preoperatively and postoperatively).\nA total of 55 patients were enrolled in the study with complete follow-up on 23 patients. Participants randomized to a MSWM program attended an average of 2 sessions preoperatively. The majority of participants were female and non-Caucasian, mean age was 46 years, average income was less than $20,000/year, and most had Medicaid as their primary insurer, consistent with the demographics of the hospital's bariatric surgery program. Data analysis included both intention-to-treat and completers' analyses. No significant differences in weight loss and most patient behaviors were found between the two groups postoperatively, suggesting that participation in a MSWM program did not improve weight loss outcomes for LAGB. Participation in a MSWM program did appear to have a positive effect on physical activity postoperatively.\nDoes a preoperative medically supervised weight loss program improve bariatric surgery outcomes?",
        "answer": "no",
        "answer_rationale": "MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Many insurance payors mandate that bariatric surgery candidates undergo a medically supervised weight management (MSWM) program as a prerequisite for surgery. However, there is little evidence to support this requirement. We evaluated in a randomized controlled trial the hypothesis that participation in a MSWM program does not predict outcomes after laparoscopic adjustable gastric banding (LAGB) in a publicly insured population.\nThis pilot randomized trial was conducted in a large academic urban public hospital. Patients who met NIH consensus criteria for bariatric surgery and whose insurance did not require a mandatory 6-month MSWM program were randomized to a MSWM program with monthly visits over 6 months (individual or group) or usual care for 6 months and then followed for bariatric surgery outcomes postoperatively. Demographics, weight, and patient behavior scores, including patient adherence, eating behavior, patient activation, and physical activity, were collected at baseline and at 6 months (im",
        "q2": "mediately preoperatively and postoperatively).\nA total of 55 patients were enrolled in the study with complete follow-up on 23 patients. Participants randomized to a MSWM program attended an average of 2 sessions preoperatively. The majority of participants were female and non-Caucasian, mean age was 46 years, average income was less than $20,000/year, and most had Medicaid as their primary insurer, consistent with the demographics of the hospital's bariatric surgery program. Data analysis included both intention-to-treat and completers' analyses. No significant differences in weight loss and most patient behaviors were found between the two groups postoperatively, suggesting that participation in a MSWM program did not improve weight loss outcomes for LAGB. Participation in a MSWM program did appear to have a positive effect on physical activity postoperatively.\nDoes a preoperative medically supervised weight loss program improve bariatric surgery outcomes?",
        "generated_text": "mediately before surgery). The primary outcome was excess weight loss (EWL) at 12 months after LAGB. Secondary outcomes included EWL at 24 months, percentage of excess weight loss (%EWL), and remission of comorbidities.\nA total of 100 patients were randomized, 50 to the MSWM group and 50 to the usual care group. The MSWM group had a higher proportion of patients who were Black (62% vs 44%, P = .04). There was no difference in EWL at 12 months (22.1 vs 21.4 kg, P = .80) or 24 months (24.1 vs 22.4 kg, P = .60) between the MSWM and usual care groups, respectively. There was no difference in %EWL at",
        "levenshtein_distance": 728
    },
    {
        "realidx": "22012962",
        "question": "Men appear to benefit more from being married than women with respect to mortality in middle age. However, there is some uncertainty about gender differences in mortality risks in older individuals, widowed, divorced and single individuals and about the impact of living arrangements.\nLongitudinal data with 1990 census records being linked to mortality data up to 2005 were used (Swiss National Cohort). The sample comprised all residents over age 44 years in Switzerland (n=2,440,242). All-cause mortality HRs for marital status and living arrangements were estimated by Cox regression for men and women and different age groups with adjustment for education and socio-professional category.\nThe benefit of being married was stronger for men than for women; however, mortality patterns were similar, with higher mortality in divorced and single individuals compared with widowed individuals (<80 years). After adjustment for living arrangements, the gender difference by marital status disappeared. Stratification by living arrangement revealed that mortality risks were highest for 45-64-year-old divorced (HR 1.72 (95% CI 1.67 to 1.76)) and single men (HR 1.67 (95% CI 1.63 to 1.71)) who lived alone. In women of the same age, the highest mortality risk was observed for those who were single and living with a partner (HR 1.70 (95% CI 1.58 to 1.82)). In older age groups, the impact of marital status decreased.\nMarital status, living arrangement and mortality: does the association vary by gender?",
        "answer": "yes",
        "answer_rationale": "Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Men appear to benefit more from being married than women with respect to mortality in middle age. However, there is some uncertainty about gender differences in mortality risks in older individuals, widowed, divorced and single individuals and about the impact of living arrangements.\nLongitudinal data with 1990 census records being linked to mortality data up to 2005 were used (Swiss National Cohort). The sample comprised all residents over age 44 years in Switzerland (n=2,440,242). All-cause mortality HRs for marital status and living arrangements were estimated by Cox regression for men and women and different age groups with adjustment for education and socio-professional category.\nThe benefit of being married was stronger for men than for women; however, mortality patterns were similar, with higher mortality in divorced and single",
        "q2": " individuals compared with widowed individuals (<80 years). After adjustment for living arrangements, the gender difference by marital status disappeared. Stratification by living arrangement revealed that mortality risks were highest for 45-64-year-old divorced (HR 1.72 (95% CI 1.67 to 1.76)) and single men (HR 1.67 (95% CI 1.63 to 1.71)) who lived alone. In women of the same age, the highest mortality risk was observed for those who were single and living with a partner (HR 1.70 (95% CI 1.58 to 1.82)). In older age groups, the impact of marital status decreased.\nMarital status, living arrangement and mortality: does the association vary by gender?",
        "generated_text": "individuals and lower mortality in widowed individuals. The gender difference was most pronounced in the 45-64 age group (HR 0.71 vs. 0.84). The gender difference decreased with age and disappeared in the oldest age group (HR 0.95 vs. 0.95). The gender difference was most pronounced in the 45-64 age group (HR 0.71 vs. 0.84). The gender difference decreased with age and disappeared in the oldest age group (HR 0.95 vs. 0.95). The gender difference was most pronounced in the 45-64 age group (HR 0.71 vs. 0.84). The gender difference",
        "levenshtein_distance": 481
    },
    {
        "realidx": "22023714",
        "question": "To explore the impact of delivery mode on women's postpartum quality of life in rural China and probe factors influencing postnatal quality of life.\nChildbirth significantly affects puerpera's physical, psychological and social domains of quality of life. Under the circumstance of increasing high caesarean section rate in rural China, the impact of delivery mode on postnatal quality of life remains unclear.\nCross-sectional study design.\nWomen residing in rural areas and in their 0-12 months after childbirth from 30 rural townships participated in a household survey. A structured questionnaire was used to evaluate women's socio-demographic characteristics, previous pregnant experiences, foetal characteristics and use of maternal health services. The scale for rural postnatal quality of life was adopted to assess postnatal quality of life from six dimensions: physical complaints and pain, sleep and energy, sex satisfaction, interpersonal communication, self-evaluated living stress and perceived life satisfaction.\nThe overall caeserean section rate was 70\u00b70% (962/1375), and most of them (59\u00b77%) were selected by maternal request. None of six dimensions and total score of quality of life displayed significant difference between women with normal delivery and cesaerean section. It was found that postnatal home visit related to good postnatal quality of life and lower husband education level, male gender of infant were associated with poor quality of life.\nDoes delivery mode affect women's postpartum quality of life in rural China?",
        "answer": "no",
        "answer_rationale": "Delivery mode did not affect postpartum quality of life in rural China. Socio-cultural determinants may contribute more in influencing postnatal quality of life.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To explore the impact of delivery mode on women's postpartum quality of life in rural China and probe factors influencing postnatal quality of life.\nChildbirth significantly affects puerpera's physical, psychological and social domains of quality of life. Under the circumstance of increasing high caesarean section rate in rural China, the impact of delivery mode on postnatal quality of life remains unclear.\nCross-sectional study design.\nWomen residing in rural areas and in their 0-12 months after childbirth from 30 rural townships participated in a household survey. A structured questionnaire was used to evaluate women's socio-demographic characteristics, previous pregnant experiences, foetal characteristics and use of maternal health services. The scale for rural postnatal quality of life was adopted",
        "q2": " to assess postnatal quality of life from six dimensions: physical complaints and pain, sleep and energy, sex satisfaction, interpersonal communication, self-evaluated living stress and perceived life satisfaction.\nThe overall caeserean section rate was 70\u00b70% (962/1375), and most of them (59\u00b77%) were selected by maternal request. None of six dimensions and total score of quality of life displayed significant difference between women with normal delivery and cesaerean section. It was found that postnatal home visit related to good postnatal quality of life and lower husband education level, male gender of infant were associated with poor quality of life.\nDoes delivery mode affect women's postpartum quality of life in rural China?",
        "generated_text": "to measure postnatal quality of life. Multivariate linear regression was used to explore the association between delivery mode and postnatal quality of life, and to identify factors influencing postnatal quality of life.\nA total of 1,494 women were included in the analysis. The mean score of postnatal quality of life was 102.02 (SD=15.12). The mean score of postnatal quality of life in vaginal delivery group was higher than that in caesarean section group (103.12 vs. 100.50, p=0.001). Multivariate linear regression analysis showed that vaginal delivery was positively associated with postnatal quality of life",
        "levenshtein_distance": 507
    },
    {
        "realidx": "22042121",
        "question": "Demonstrate that the rabbit may be used in the training of surgery, in addition to present its perioperative care.\nThirty two animals, with age and weight, respectively, from 3 to 5.5 months old and 3000 to 4200 grams, were undergone different periods of pre-operative fasting, exclusive intramuscular anesthesia (ketamine+xylazine), laparotomy with total gastrectomy and total splenectomy. It was dosed the pre-operative (initial) and post-surgical (end) serum blood glucose, in addition to quantify the gastric content after the resection of the part.\nThe anesthetical-surgical procedure presented a mortality rate of 3.125% (1:32) and a morbidity rate of 6.25% (2:32). It was evidenced an initial mean blood glucose = 199.4 mg/dl and the end = 326.1 mg/dl. In spite of extended fasting (minimum of 2 hours for the absolute fasting and maximum of 8.5 hours for liquids, and 20.5 hours for solids) all animals presented at the end of the surgical procedure any gastric content and a blood glucose increase. Those with fasting for liquids and solids when compared to the quantity of solid gastric content, presented a moderate negative degree of correlation.\nPerioperative care in an animal model for training in abdominal surgery: is it necessary a preoperative fasting?",
        "answer": "no",
        "answer_rationale": "The rabbit is a good model to be used in training of surgery, with a low morbi-mortality, able to be anesthetized intramuscularly, with no need of pre-operative fasting and does not present hypoglycemia even with the extended fasting period.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Demonstrate that the rabbit may be used in the training of surgery, in addition to present its perioperative care.\nThirty two animals, with age and weight, respectively, from 3 to 5.5 months old and 3000 to 4200 grams, were undergone different periods of pre-operative fasting, exclusive intramuscular anesthesia (ketamine+xylazine), laparotomy with total gastrectomy and total splenectomy. It was dosed the pre-operative (initial) and post-surgical (end) serum blood glucose, in addition to quantify the gastric content after the resection of the part.\nThe anesthetical-surgical procedure presented a mortality rate of 3.125% (1:32",
        "q2": ") and a morbidity rate of 6.25% (2:32). It was evidenced an initial mean blood glucose = 199.4 mg/dl and the end = 326.1 mg/dl. In spite of extended fasting (minimum of 2 hours for the absolute fasting and maximum of 8.5 hours for liquids, and 20.5 hours for solids) all animals presented at the end of the surgical procedure any gastric content and a blood glucose increase. Those with fasting for liquids and solids when compared to the quantity of solid gastric content, presented a moderate negative degree of correlation.\nPerioperative care in an animal model for training in abdominal surgery: is it necessary a preoperative fasting?",
        "generated_text": "). The pre-operative fasting periods of 12, 18 and 24 hours, respectively, presented a mean of 12.0, 12.5 and 12.0 mmol/L of blood glucose, and 0.0, 0.0 and 0.0 mL of gastric content. The pre-operative fasting period of 6 hours presented a mean of 11.0 mmol/L of blood glucose and 1.0 mL of gastric content. The pre-operative fasting period of 6 hours presented a mean of 11.0 mmol/L of blood glucose and 1.0 mL of gastric content. The pre-operative fasting period of",
        "levenshtein_distance": 457
    },
    {
        "realidx": "22075911",
        "question": "Figures from the British Defence Dental Services reveal that serving personnel in the British Army have a persistently lower level of dental fitness than those in the Royal Navy or the Royal Air Force. No research had been undertaken to ascertain if this reflects the oral health of recruits joining each Service. This study aimed to pilot a process for collecting dental and sociodemographic data from new recruits to each Service and examine the null hypothesis that no differences in dental health existed.\nDiagnostic criteria were developed, a sample size calculated and data collected at the initial training establishments of each Service.\nData for 432 participants were entered into the analysis. Recruits in the Army sample had a significantly greater prevalence of dental decay and greater treatment resource need than either of the other two Services. Army recruits had a mean number of 2.59 (2.08, 3.09) decayed teeth per recruit, compared to 1.93 (1.49, 2.39 p<0.01) in Royal Navy recruits and 1.26 (0.98, 1.53 p<0.001) in Royal Air Force recruits. Among Army recruits 62.7% were from the two most deprived quintiles of the Index of Multiple Deprivation compared to 42.5% of Royal Naval recruits and 36.6% of Royal Air Force recruits.\nIs there a differential in the dental health of new recruits to the British Armed Forces?",
        "answer": "yes",
        "answer_rationale": "A significant difference in dental health between recruits to each Service does exist and is a likely to be a reflection of the sociodemographic background from which they are drawn.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Figures from the British Defence Dental Services reveal that serving personnel in the British Army have a persistently lower level of dental fitness than those in the Royal Navy or the Royal Air Force. No research had been undertaken to ascertain if this reflects the oral health of recruits joining each Service. This study aimed to pilot a process for collecting dental and sociodemographic data from new recruits to each Service and examine the null hypothesis that no differences in dental health existed.\nDiagnostic criteria were developed, a sample size calculated and data collected at the initial training establishments of each Service.\nData for 432 participants were entered into the analysis. Recruits in the Army sample had a significantly greater prevalence of dental decay and greater treatment resource need than either of",
        "q2": " the other two Services. Army recruits had a mean number of 2.59 (2.08, 3.09) decayed teeth per recruit, compared to 1.93 (1.49, 2.39 p<0.01) in Royal Navy recruits and 1.26 (0.98, 1.53 p<0.001) in Royal Air Force recruits. Among Army recruits 62.7% were from the two most deprived quintiles of the Index of Multiple Deprivation compared to 42.5% of Royal Naval recruits and 36.6% of Royal Air Force recruits.\nIs there a differential in the dental health of new recruits to the British Armed Forces?",
        "generated_text": "the other Services. The Royal Navy sample had the lowest prevalence of dental decay and the lowest treatment resource need.\nThe null hypothesis was rejected. The results suggest that the lower level of dental fitness in the Army is, in part, due to the oral health of recruits joining the Army. The findings have implications for the recruitment and training of new personnel in the British Armed Forces.",
        "levenshtein_distance": 339
    },
    {
        "realidx": "22117569",
        "question": "An effective advance care planning programme involves an organizational wide commitment and preparedness for health service reform to embed advance care planning into routine practice. Internationally, such programmes have been implemented predominantly in aged and acute care with more recent work in primary care.\nA multi-site action research was conducted over a 16-month period in 2007-2009 with three Victorian community palliative care services. Using mixed method data collection strategies to assess feasibility, we conducted a baseline audit of staff and clients; analysed relevant documents (client records, policies, procedures and quality improvement strategies) pre-implementation and post-implementation and conducted key informant interviews (n\u2003=\u20039).\nThree community palliative care services: one regional and two metropolitan services in Victoria, Australia.\nThe services demonstrated that it was feasible to embed the Model into their organizational structures. Advance care planning conversations and involvement of family was an important outcome measure rather than completion rate of advance care planning documents in community settings. Services adapted and applied their own concept of community, which widened the impact of the model. Changes to quality audit processes were essential to consolidate the model into routine palliative care practice.\nIs an advance care planning model feasible in community palliative care?",
        "answer": "yes",
        "answer_rationale": "An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "An effective advance care planning programme involves an organizational wide commitment and preparedness for health service reform to embed advance care planning into routine practice. Internationally, such programmes have been implemented predominantly in aged and acute care with more recent work in primary care.\nA multi-site action research was conducted over a 16-month period in 2007-2009 with three Victorian community palliative care services. Using mixed method data collection strategies to assess feasibility, we conducted a baseline audit of staff and clients; analysed relevant documents (client records, policies, procedures and quality improvement strategies) pre-implementation and post-implementation and",
        "q2": " conducted key informant interviews (n\u2003=\u20039).\nThree community palliative care services: one regional and two metropolitan services in Victoria, Australia.\nThe services demonstrated that it was feasible to embed the Model into their organizational structures. Advance care planning conversations and involvement of family was an important outcome measure rather than completion rate of advance care planning documents in community settings. Services adapted and applied their own concept of community, which widened the impact of the model. Changes to quality audit processes were essential to consolidate the model into routine palliative care practice.\nIs an advance care planning model feasible in community palliative care?",
        "generated_text": "conducted focus groups with staff and clients.\nThe findings suggest that advance care planning is feasible in community palliative care and that it is acceptable to clients and staff. The programme was implemented in three stages: (1) preparation and planning; (2) implementation; and (3) evaluation and sustainability. The programme was implemented in three community palliative care services in Victoria, Australia. The programme involved the development of a standardised advance care planning process, including the use of advance care planning forms and training for staff. The programme was evaluated using a mixed-methods approach, including surveys, interviews, and analysis",
        "levenshtein_distance": 539
    },
    {
        "realidx": "22154448",
        "question": "To study the risks of haemodynamic instability, and the possible occurrence of spinal haematoma, meningitis and epidural abscess when epidural analgesia is performed for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).\nWe retrospectively analyzed the data of 35 patients treated by HIPEC with oxaliplatin or cisplatin. An epidural catheter was inserted before induction of general anaesthesia. Postoperatively, a continuous epidural infusion of ropivacain, then a patient-controlled epidural analgesia were started.\nThe epidural catheter was used peroperatively before HIPEC in 12 subjects (34%), and after HIPEC in 23 subjects (66%). The median dose of ropivacain given peroperatively in the epidural catheter was 40 mg (30-75). Norepinephrin was used in two subjects (6%) peroperatively (median infusion rate 0.325 \u03bcg/kg per minute [0.32-0.33]), and in four subjects (11%) in the postoperative 24 hours. No spinal haematoma, meningitis or epidural abscess were noted. Five subjects (14%) had a thrombopenia or a prothrombin time less than 60% before catheter removal. Two subjects (6%) had a leukopenia before catheter removal. No thrombopenia or blood coagulation disorders were recorded the day of catheter removal.\nEpidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique?",
        "answer": "no",
        "answer_rationale": "In this series of 35 patients, the use of epidural analgesia for HIPEC does not seem to be associated with a worse risk of haemodynamic instability, spinal haematoma, meningitis or epidural abscess. HIPEC with platinum salt is not incompatible with the safety of epidural analgesia, with an optimized fluid management peroperatively and the following of perimedullary anesthesia practice guidelines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To study the risks of haemodynamic instability, and the possible occurrence of spinal haematoma, meningitis and epidural abscess when epidural analgesia is performed for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).\nWe retrospectively analyzed the data of 35 patients treated by HIPEC with oxaliplatin or cisplatin. An epidural catheter was inserted before induction of general anaesthesia. Postoperatively, a continuous epidural infusion of ropivacain, then a patient-controlled epidural analgesia were started.\nThe epidural catheter was used peroperatively before HIPEC in 12 subjects (34%), and after HIPEC in 23 subjects (66%). The median dose of ropivacain given peroperatively",
        "q2": " in the epidural catheter was 40 mg (30-75). Norepinephrin was used in two subjects (6%) peroperatively (median infusion rate 0.325 \u03bcg/kg per minute [0.32-0.33]), and in four subjects (11%) in the postoperative 24 hours. No spinal haematoma, meningitis or epidural abscess were noted. Five subjects (14%) had a thrombopenia or a prothrombin time less than 60% before catheter removal. Two subjects (6%) had a leukopenia before catheter removal. No thrombopenia or blood coagulation disorders were recorded the day of catheter removal.\nEpidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique?",
        "generated_text": "was 10 mg/h (range 5-15). The median dose of ropivacain given postoperatively was 10 mg/h (range 5-15). The median duration of epidural analgesia was 4 days (range 2-10). The median duration of hospital stay was 10 days (range 7-20). There was no case of haemodynamic instability, spinal haematoma, meningitis or epidural abscess.\nEpidural analgesia is a safe and effective method for postoperative pain control in patients undergoing HIPEC.",
        "levenshtein_distance": 465
    },
    {
        "realidx": "22188074",
        "question": "To investigate whether problems in instrumental activities of daily living (IADL) can add to conventionally used clinical measurements in helping to predict a diagnosis of dementia at 1- and 2-year follow-up.\nMulticenter prospective cohort study.\nMemory clinics in Europe.\nIndividuals aged 55 and older without dementia.\nIADLs were measured using pooled activities from five informant-based questionnaires. Structural equation modeling (SEM) was used to investigate the relation between IADLs and dementia. Age, sex, education, depression, and cognitive measures (Mini-Mental State Examination and verbal memory) were included in the model.\nFive hundred thirty-one participants had baseline and 1-year follow-up assessments; 69 (13.0%) of these had developed dementia at 1-year follow-up. At 2-year follow-up, 481 participants were seen, of whom 100 (20.8%) had developed dementia. Participants with IADL disabilities at baseline had a higher conversion rate (24.4%) than participants without IADL disabilities (16.7%) (chi-square\u00a0=\u00a04.28, degrees of freedom\u00a0=\u00a01, P\u00a0=\u00a0.04). SEM showed that IADL disability could help predict dementia in addition to the measured variables at 1-year follow-up (odds ratio (OR)\u00a0=\u00a02.20, 95% confidence interval (CI)\u00a0= 1.51-3.13) and 2-year follow-up (OR\u00a0=\u00a02.11, 95% CI\u00a0=\u00a01.33-3.33).\nDo instrumental activities of daily living predict dementia at 1- and 2-year follow-up?",
        "answer": "yes",
        "answer_rationale": "IADL disability is a useful addition to the diagnostic process in a memory clinic setting, indicating who is at higher risk of developing dementia at 1- and 2-year follow-up.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate whether problems in instrumental activities of daily living (IADL) can add to conventionally used clinical measurements in helping to predict a diagnosis of dementia at 1- and 2-year follow-up.\nMulticenter prospective cohort study.\nMemory clinics in Europe.\nIndividuals aged 55 and older without dementia.\nIADLs were measured using pooled activities from five informant-based questionnaires. Structural equation modeling (SEM) was used to investigate the relation between IADLs and dementia. Age, sex, education, depression, and cognitive measures (Mini-Mental State Examination and verbal memory) were included in the model.\nFive hundred thirty-one participants had baseline and 1-year follow-up assessments; 69 (13.0%) of these had developed dementia at 1-year follow-up. At 2-year follow-up, 481 participants were seen, of",
        "q2": " whom 100 (20.8%) had developed dementia. Participants with IADL disabilities at baseline had a higher conversion rate (24.4%) than participants without IADL disabilities (16.7%) (chi-square\u00a0=\u00a04.28, degrees of freedom\u00a0=\u00a01, P\u00a0=\u00a0.04). SEM showed that IADL disability could help predict dementia in addition to the measured variables at 1-year follow-up (odds ratio (OR)\u00a0=\u00a02.20, 95% confidence interval (CI)\u00a0= 1.51-3.13) and 2-year follow-up (OR\u00a0=\u00a02.11, 95% CI\u00a0=\u00a01.33-3.33).\nDo instrumental activities of daily living predict dementia at 1- and 2-year follow-up?",
        "generated_text": "whom 101 (21.0%) had developed dementia. The SEM model showed that IADLs were associated with dementia at 1- and 2-year follow-up, independent of age, sex, education, depression, and cognitive measures. The model explained 42% and 45% of the variance in dementia at 1- and 2-year follow-up, respectively.\nIADLs are associated with dementia at 1- and 2-year follow-up, independent of age, sex, education, depression, and cognitive measures. IADLs may be a useful addition to clinical assessment in memory clinics to help predict dementia.",
        "levenshtein_distance": 423
    },
    {
        "realidx": "22227642",
        "question": "The aim of this work is to assess a previously described slit-lamp biomicroscopy-based method (SLBM) for measuring pupil diameter and compare it to Colvard infrared pupillometry (CIP).\nTwo examiners performed three repeated measurements with each instrument in 40 healthy eyes. We determined the agreement of SLBM and CIP, intraobserver and interobserver repeatabilities, and interobserver concordance (kappa) and SLBM ability for detecting pupil sizes over 6.0\u00a0mm.\nThe mean (\u00b1standard deviation [SD]) pupil diameter was 5.81 \u00b1 0.70\u00a0mm with SLBM and 6.26 \u00b1 0.68\u00a0mm with CIP (p\u2009=\u20090.01) averaging both examiner's results. Mean differences between the SLBM and CIP were -0.60\u00a0mm and -0.30\u00a0mm for each examiner using the average of the three readings (p\u2009=\u20090.02), and they were very similar using the first reading. Intraobserver reproducibility: the width of the 95% LoA ranged from 1.79 to 2.30\u00a0mm. The ICCs were 0.97 and 0.92 for SLBM, and 0.96 and 0.90 for CIP. Interobserver reproducibility: the width of the LoA ranged from 1.82 to 2.09\u00a0mm. Kappa statistics were 0.39 and 0.49 for the first and mean SLBM readings, respectively, and 0.45 for both the first and mean CIP readings. Sensitivity and specificity of SLBM for detection of pupils larger than 6\u00a0mm ranged from 55.56% to 73.68% and from 76.19% to 95.45%, respectively. The best trade-off between sensitivity and specificity ranged from 5.4\u00a0mm to 6.2\u00a0mm.\nCan we measure mesopic pupil size with the cobalt blue light slit-lamp biomicroscopy method?",
        "answer": "no",
        "answer_rationale": "Although the SLBM is quite repeatable, it underestimates mesopic pupil size and shows a too wide range of agreement with CIP. SLBM shows low sensitivity in detecting pupils larger than 6\u00a0mm, which may be misleading when planning anterior segment surgery. Previous grading-consensus training strategies may increase interrater reproducibility, and compensation for the systematic underestimation could improve accuracy of the SLBM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The aim of this work is to assess a previously described slit-lamp biomicroscopy-based method (SLBM) for measuring pupil diameter and compare it to Colvard infrared pupillometry (CIP).\nTwo examiners performed three repeated measurements with each instrument in 40 healthy eyes. We determined the agreement of SLBM and CIP, intraobserver and interobserver repeatabilities, and interobserver concordance (kappa) and SLBM ability for detecting pupil sizes over 6.0\u00a0mm.\nThe mean (\u00b1standard deviation [SD]) pupil diameter was 5.81 \u00b1 0.70\u00a0mm with SLBM and 6.26 \u00b1 0.68\u00a0mm with CIP (p\u2009=\u20090.01) averaging both examiner's results. Mean differences between the SLBM and CIP were -0.60\u00a0mm and -0.30\u00a0mm for each examiner using the average of the three readings (p\u2009=\u20090.02), and they were very similar using the first reading. Intra",
        "q2": "observer reproducibility: the width of the 95% LoA ranged from 1.79 to 2.30\u00a0mm. The ICCs were 0.97 and 0.92 for SLBM, and 0.96 and 0.90 for CIP. Interobserver reproducibility: the width of the LoA ranged from 1.82 to 2.09\u00a0mm. Kappa statistics were 0.39 and 0.49 for the first and mean SLBM readings, respectively, and 0.45 for both the first and mean CIP readings. Sensitivity and specificity of SLBM for detection of pupils larger than 6\u00a0mm ranged from 55.56% to 73.68% and from 76.19% to 95.45%, respectively. The best trade-off between sensitivity and specificity ranged from 5.4\u00a0mm to 6.2\u00a0mm.\nCan we measure mesopic pupil size with the cobalt blue light slit-lamp biomicroscopy method?",
        "generated_text": "observer repeatability was 0.20\u00a0mm for SLBM and 0.15\u00a0mm for CIP, and interobserver repeatability was 0.25\u00a0mm for SLBM and 0.15\u00a0mm for CIP. The kappa for interobserver concordance was 0.78 for SLBM and 0.85 for CIP. The sensitivity and specificity of SLBM for detecting pupils larger than 6.0\u00a0mm were 88% and 80%, respectively.\nSLBM is a feasible and repeatable method for measuring pupil diameter, but it underestimates the pupil size compared to CIP. The agreement between the two methods is acceptable for clinical purposes, but CIP is more accurate and precise.",
        "levenshtein_distance": 469
    },
    {
        "realidx": "22233470",
        "question": "The 58th World Health Assembly called for all health systems to move towards universal coverage where everyone has access to key promotive, preventive, curative and rehabilitative health interventions at an affordable cost. Universal coverage involves ensuring that health care benefits are distributed on the basis of need for care and not on ability to pay. The distribution of health care benefits is therefore an important policy question, which health systems should address. The aim of this study is to assess the distribution of health care benefits in the Kenyan health system, compare changes over two time periods and demonstrate the extent to which the distribution meets the principles of universal coverage.\nTwo nationally representative cross-sectional households surveys conducted in 2003 and 2007 were the main sources of data. A comprehensive analysis of the entire health system is conducted including the public sector, private-not-for-profit and private-for-profit sectors. Standard benefit incidence analysis techniques were applied and adopted to allow application to private sector services.\nThe three sectors recorded similar levels of pro-rich distribution in 2003, but in 2007, the private-not-for-profit sector was pro-poor, public sector benefits showed an equal distribution, while the private-for-profit sector remained pro-rich. Larger pro-rich disparities were recorded for inpatient compared to outpatient benefits at the hospital level, but primary health care services were pro-poor. Benefits were distributed on the basis of ability to pay and not on need for care.\nDoes the distribution of health care benefits in Kenya meet the principles of universal coverage?",
        "answer": "no",
        "answer_rationale": "The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The 58th World Health Assembly called for all health systems to move towards universal coverage where everyone has access to key promotive, preventive, curative and rehabilitative health interventions at an affordable cost. Universal coverage involves ensuring that health care benefits are distributed on the basis of need for care and not on ability to pay. The distribution of health care benefits is therefore an important policy question, which health systems should address. The aim of this study is to assess the distribution of health care benefits in the Kenyan health system, compare changes over two time periods and demonstrate the extent to which the distribution meets the principles of universal coverage.\nTwo nationally representative cross-sectional households surveys conducted in 2003 and 2007 were the main sources of data. A comprehensive",
        "q2": " analysis of the entire health system is conducted including the public sector, private-not-for-profit and private-for-profit sectors. Standard benefit incidence analysis techniques were applied and adopted to allow application to private sector services.\nThe three sectors recorded similar levels of pro-rich distribution in 2003, but in 2007, the private-not-for-profit sector was pro-poor, public sector benefits showed an equal distribution, while the private-for-profit sector remained pro-rich. Larger pro-rich disparities were recorded for inpatient compared to outpatient benefits at the hospital level, but primary health care services were pro-poor. Benefits were distributed on the basis of ability to pay and not on need for care.\nDoes the distribution of health care benefits in Kenya meet the principles of universal coverage?",
        "generated_text": "list of health care benefits was constructed from the two surveys and used to measure the distribution of health care benefits. The concentration index was used to measure the extent to which the distribution of health care benefits was pro-poor. The concentration index is a summary measure of inequality that is based on the entire distribution of health care benefits. It is twice the area between the concentration curve and the line of equality. The concentration curve plots the cumulative proportion of health care benefits received against the cumulative proportion of the population ranked by socioeconomic status, starting with the poorest. A concentration index of zero indicates equality in the distribution of health care benefits across the socioeconomic scale. A negative concentration index indicates that health care benefits are concentrated among the poor, while a positive concentration index indicates that",
        "levenshtein_distance": 680
    },
    {
        "realidx": "22236315",
        "question": "Distance to provider might be an important barrier to timely diagnosis and treatment for cancer patients who qualify for Medicaid coverage. Whether driving time or driving distance is a better indicator of travel burden is also of interest.\nDriving distances and times from patient residence to primary care provider were calculated for 3,917 breast, colorectal (CRC) and lung cancer Medicaid patients in Washington State from 1997 to 2003 using MapQuest.com. We fitted regression models of stage at diagnosis and time-to-treatment (number of days between diagnosis and surgery) to test the hypothesis that travel burden is associated with timely diagnosis and treatment of cancer.\nLater stage at diagnosis for breast cancer Medicaid patients is associated with travel burden (OR = 1.488 per 100 driving miles, P= .037 and OR = 1.270 per driving hour, P= .016). Time-to-treatment after diagnosis of CRC is also associated with travel burden (14.57 days per 100 driving miles, P= .002 and 5.86 days per driving hour, P= .018).\nIs distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer?",
        "answer": "no",
        "answer_rationale": "Although travel burden is associated with timely diagnosis and treatment for some types of cancer, we did not find evidence that driving time was, in general, better at predicting timeliness of cancer diagnosis and treatment than driving distance. More intensive efforts at early detection of breast cancer and early treatment of CRC for Medicaid patients who live in remote areas may be needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Distance to provider might be an important barrier to timely diagnosis and treatment for cancer patients who qualify for Medicaid coverage. Whether driving time or driving distance is a better indicator of travel burden is also of interest.\nDriving distances and times from patient residence to primary care provider were calculated for 3,917 breast, colorectal (CRC) and lung cancer Medicaid patients in Washington State from 1997 to 2003 using MapQuest.com. We fitted regression models of stage at diagnosis and time-to-treatment (number of days between diagnosis and surgery) to test the hypothesis that travel burden is associated with timely",
        "q2": " diagnosis and treatment of cancer.\nLater stage at diagnosis for breast cancer Medicaid patients is associated with travel burden (OR = 1.488 per 100 driving miles, P= .037 and OR = 1.270 per driving hour, P= .016). Time-to-treatment after diagnosis of CRC is also associated with travel burden (14.57 days per 100 driving miles, P= .002 and 5.86 days per driving hour, P= .018).\nIs distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer?",
        "generated_text": "diagnosis and treatment.\nMedian driving time to primary care provider was 15 minutes (interquartile range: 10-25 minutes). Median driving distance was 7.5 miles (interquartile range: 4.5-12.5 miles). In multivariate analysis, neither driving time nor driving distance was associated with stage at diagnosis or time-to-treatment for any of the three cancers.\nTravel burden is not a significant barrier to timely diagnosis and treatment for Medicaid patients in Washington State.",
        "levenshtein_distance": 352
    },
    {
        "realidx": "22237146",
        "question": "Epidermal growth factor receptor (EGFR) mutations as prognostic or predictive marker in patients with non-small cell lung cancer (NSCLC) have been used widely. However, it may be difficult to get tumor tissue for analyzing the status of EGFR mutation status in large proportion of patients with advanced disease.\nWe obtained pairs of tumor and serum samples from 57 patients with advanced NSCLC, between March 2006 and January 2009. EGFR mutation status from tumor samples was analyzed by genomic polymerase chain reaction and direct sequence and EGFR mutation status from serum samples was determined by the peptide nucleic acid locked nucleic acid polymerase chain reaction clamp.\nEGFR mutations were detected in the serum samples of 11 patients and in the tumor samples of 12 patients. EGFR mutation status in the serum and tumor samples was consistent in 50 of the 57 pairs (87.7%). There was a high correlation between the mutations detected in serum sample and the mutations detected in the matched tumor sample (correlation index 0.62; P<0.001). Twenty-two of 57 patients (38.5%) received EGFR-tyrosine kinase inhibitors as any line therapy. The response for EGFR-tyrosine kinase inhibitors was significantly associated with EGFR mutations in both tumor samples and serum samples (P<0.05). There was no significant differences in overall survival according to the status of EGFR mutations in both serum and tumor samples (P>0.05).\nCan serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?",
        "answer": "yes",
        "answer_rationale": "Serum sample might be alternatively used in the difficult time of getting tumor tissue for analyzing the status of EGFR mutation status in patients with advanced NSCLC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Epidermal growth factor receptor (EGFR) mutations as prognostic or predictive marker in patients with non-small cell lung cancer (NSCLC) have been used widely. However, it may be difficult to get tumor tissue for analyzing the status of EGFR mutation status in large proportion of patients with advanced disease.\nWe obtained pairs of tumor and serum samples from 57 patients with advanced NSCLC, between March 2006 and January 2009. EGFR mutation status from tumor samples was analyzed by genomic polymerase chain reaction and direct sequence and EGFR mutation status from serum samples was determined by the peptide nucleic acid locked nucleic acid polymerase chain reaction clamp.\nEGFR mutations were detected in the serum samples of 11 patients and in the tumor samples of 12 patients. EGFR mutation status in",
        "q2": " the serum and tumor samples was consistent in 50 of the 57 pairs (87.7%). There was a high correlation between the mutations detected in serum sample and the mutations detected in the matched tumor sample (correlation index 0.62; P<0.001). Twenty-two of 57 patients (38.5%) received EGFR-tyrosine kinase inhibitors as any line therapy. The response for EGFR-tyrosine kinase inhibitors was significantly associated with EGFR mutations in both tumor samples and serum samples (P<0.05). There was no significant differences in overall survival according to the status of EGFR mutations in both serum and tumor samples (P>0.05).\nCan serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?",
        "generated_text": "serum samples was concordant with that in tumor samples in 10 patients (83.3%). The sensitivity and specificity of EGFR mutation status in serum samples were 83.3% and 100%, respectively. The positive and negative predictive values were 100% and 96.4%, respectively. The overall survival of patients with EGFR mutations in serum samples was significantly longer than that of patients without EGFR mutations in serum samples (22.1 vs. 10.1 months, p=0.001). The progression-free survival of patients with EGFR mutations in serum samples was also significantly longer than that of patients without EGFR mutations in serum samples (10.1 vs. 5.1 months, p=0.",
        "levenshtein_distance": 485
    },
    {
        "realidx": "22251324",
        "question": "This study investigated associations between the performance of dental students in each of the three components of the selection procedure [academic average, Undergraduate Medicine and Health Sciences Admission Test (UMAT) and structured interview], socio-demographic characteristics and their academic success in an undergraduate dental surgery programme.\nLongitudinal review of admissions data relating to students entering dental education at the University of Otago, New Zealand, between 2004 and 2009 was compared with academic performance throughout the dental programme.\nAfter controlling for variables, pre-admission academic average, UMAT scores and interview performance did not predict performance as a dental student. Class place in second year, however, was a strong predictor of class place in final year. Multivariate analysis demonstrated that the best predictors of higher class placement in the final year were New Zealand European ethnicity and domestic (rather than international) student status. Other socio-demographic characteristics were not associated with performance. These interim findings provide a sound base for the ongoing study.\nDoes performance in selection processes predict performance as a dental student?",
        "answer": "no",
        "answer_rationale": "The study found important socio-demographic differences in pre-admission test scores, but those scores did not predict performance in the dental programme, whether measured in second year or in final year.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "This study investigated associations between the performance of dental students in each of the three components of the selection procedure [academic average, Undergraduate Medicine and Health Sciences Admission Test (UMAT) and structured interview], socio-demographic characteristics and their academic success in an undergraduate dental surgery programme.\nLongitudinal review of admissions data relating to students entering dental education at the University of Otago, New Zealand, between 2004 and 2009 was compared with academic performance throughout the dental programme.\nAfter controlling for variables, pre-admission",
        "q2": " academic average, UMAT scores and interview performance did not predict performance as a dental student. Class place in second year, however, was a strong predictor of class place in final year. Multivariate analysis demonstrated that the best predictors of higher class placement in the final year were New Zealand European ethnicity and domestic (rather than international) student status. Other socio-demographic characteristics were not associated with performance. These interim findings provide a sound base for the ongoing study.\nDoes performance in selection processes predict performance as a dental student?",
        "generated_text": "academic average was the only significant predictor of academic success in the dental programme. The UMAT and interview scores were not significant predictors of academic success in the dental programme.\nThe results of this study suggest that the academic average is the only significant predictor of academic success in the dental programme. The UMAT and interview scores did not significantly predict academic success in this context.",
        "levenshtein_distance": 420
    },
    {
        "realidx": "22266735",
        "question": "The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recently recommended new criteria for diagnosing gestational diabetes mellitus (GDM). This study was undertaken to determine whether adopting the IADPSG criteria would be cost-effective, compared with the current standard of care.\nWe developed a decision analysis model comparing the cost-utility of three strategies to identify GDM: 1) no screening, 2) current screening practice (1-h 50-g glucose challenge test between 24 and 28 weeks followed by 3-h 100-g glucose tolerance test when indicated), or 3) screening practice proposed by the IADPSG. Assumptions included that 1) women diagnosed with GDM received additional prenatal monitoring, mitigating the risks of preeclampsia, shoulder dystocia, and birth injury; and 2) GDM women had opportunity for intensive postdelivery counseling and behavior modification to reduce future diabetes risks. The primary outcome measure was the incremental cost-effectiveness ratio (ICER).\nOur model demonstrates that the IADPSG recommendations are cost-effective only when postdelivery care reduces diabetes incidence. For every 100,000 women screened, 6,178 quality-adjusted life-years (QALYs) are gained, at a cost of $125,633,826. The ICER for the IADPSG strategy compared with the current standard was $20,336 per QALY gained. When postdelivery care was not accomplished, the IADPSG strategy was no longer cost-effective. These results were robust in sensitivity analyses.\nScreening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective?",
        "answer": "yes",
        "answer_rationale": "The IADPSG recommendation for glucose screening in pregnancy is cost-effective. The model is most sensitive to the likelihood of preventing future diabetes in patients identified with GDM using postdelivery counseling and intervention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recently recommended new criteria for diagnosing gestational diabetes mellitus (GDM). This study was undertaken to determine whether adopting the IADPSG criteria would be cost-effective, compared with the current standard of care.\nWe developed a decision analysis model comparing the cost-utility of three strategies to identify GDM: 1) no screening, 2) current screening practice (1-h 50-g glucose challenge test between 24 and 28 weeks followed by 3-h 100-g glucose tolerance test when indicated), or 3) screening practice proposed by the IADPSG. Assumptions included that 1) women diagnosed with GDM received additional prenatal monitoring, mitigating the risks of preeclampsia, shoulder dystocia, and birth injury; and 2)",
        "q2": " GDM women had opportunity for intensive postdelivery counseling and behavior modification to reduce future diabetes risks. The primary outcome measure was the incremental cost-effectiveness ratio (ICER).\nOur model demonstrates that the IADPSG recommendations are cost-effective only when postdelivery care reduces diabetes incidence. For every 100,000 women screened, 6,178 quality-adjusted life-years (QALYs) are gained, at a cost of $125,633,826. The ICER for the IADPSG strategy compared with the current standard was $20,336 per QALY gained. When postdelivery care was not accomplished, the IADPSG strategy was no longer cost-effective. These results were robust in sensitivity analyses.\nScreening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective?",
        "generated_text": "infants of mothers with GDM received additional monitoring for hypoglycemia and jaundice. We used published data to estimate the costs and health outcomes of each strategy.\nThe IADPSG strategy would identify 12.1% of pregnant women as having GDM, compared with 1.7% under current practice. The IADPSG strategy would prevent 1.1 cases of preeclampsia, 1.1 cases of shoulder dystocia, and 1.1 cases of birth injury per 1000 women screened, at an incremental cost of $10,000 per quality-adjusted life-year (QALY) gained, compared with current practice. The IADPSG strategy would prevent 1.1 cases of preeclampsia, 1.1 cases of",
        "levenshtein_distance": 632
    },
    {
        "realidx": "22302761",
        "question": "It has been shown in vitro that pretreatment of skin with fractional lasers enhances transdermal delivery of drugs. The aim of this study is to demonstrate in vivo firstly that laser enhances transdermal drug absorption and secondly that this can be manipulated by altering laser settings.STUDY DESIGN/\nFour pigs were used in the IACUC approved animal study. On day 0, 5 g of 4% topical lidocaine was applied under occlusion for 60 minutes to a 400 cm(2) area on the abdomen. Blood was drawn at 0, 60, 90, 120, 180, and 240 minutes. On day 7, the Er:YAG laser was used at 500, 250, 50, and 25 \u00b5m ablative depth, respectively, over a 400 cm(2) area on the abdomen. Five grams of 4% topical lidocaine was applied immediately with occlusion for 60 minutes, and then removed. Blood was drawn at 0, 60, 90, 120, 180, and 240 minutes. The serum was extracted and analyzed for lidocaine and its metabolite monoethylglycinexylidide (MEGX).\nSerum levels of lidocaine and MEGX were undetectable in untreated skin. Following laser treatment both lidocaine and MEGX were detectable. Peak levels of lidocaine were significantly higher (P = 0.0002) at 250 \u00b5m (0.62 mg/L), compared to 500 \u00b5m (0.45 mg/L), 50 \u00b5m (0.48 mg/L), and 25 \u00b5m (0.3 mg/L). Peak levels of MEGX were significantly higher (P \u2264 0.0001) at 250 \u00b5m (0.048 mg/L), compared to 500 \u00b5m (0.018 mg/L), 50 \u00b5m (0.036 mg/L), and 25 \u00b5m (0.0144 mg/L).\nCan fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model?",
        "answer": "yes",
        "answer_rationale": "This study demonstrates that laser pretreatment significantly increases absorption of topical lidocaine so that it is detectable in the blood and that manipulating laser settings can affect drug absorption. Future work will look at translating this effect into clinical benefit.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "It has been shown in vitro that pretreatment of skin with fractional lasers enhances transdermal delivery of drugs. The aim of this study is to demonstrate in vivo firstly that laser enhances transdermal drug absorption and secondly that this can be manipulated by altering laser settings.STUDY DESIGN/\nFour pigs were used in the IACUC approved animal study. On day 0, 5 g of 4% topical lidocaine was applied under occlusion for 60 minutes to a 400 cm(2) area on the abdomen. Blood was drawn at 0, 60, 90, 120, 180, and 240 minutes. On day 7, the Er:YAG laser was used at 500, 250, 50, and 25 \u00b5m ablative depth, respectively, over a 400 cm(2) area on the abdomen. Five grams of 4% topical lidocaine was applied immediately with occlusion for 60 minutes, and then removed. Blood was drawn at 0, 60, 90,",
        "q2": " 120, 180, and 240 minutes. The serum was extracted and analyzed for lidocaine and its metabolite monoethylglycinexylidide (MEGX).\nSerum levels of lidocaine and MEGX were undetectable in untreated skin. Following laser treatment both lidocaine and MEGX were detectable. Peak levels of lidocaine were significantly higher (P = 0.0002) at 250 \u00b5m (0.62 mg/L), compared to 500 \u00b5m (0.45 mg/L), 50 \u00b5m (0.48 mg/L), and 25 \u00b5m (0.3 mg/L). Peak levels of MEGX were significantly higher (P \u2264 0.0001) at 250 \u00b5m (0.048 mg/L), compared to 500 \u00b5m (0.018 mg/L), 50 \u00b5m (0.036 mg/L), and 25 \u00b5m (0.0144 mg/L).\nCan fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model?",
        "generated_text": "120, 180, and 240 minutes. On day 14, the same procedure was repeated with the addition of 1% tetracaine to the lidocaine. On day 21, the same procedure was repeated with the addition of 1% tetracaine and 1% prilocaine to the lidocaine. Lidocaine levels were measured by high-performance liquid chromatography. The area under the curve (AUC) was calculated for each time point and compared with the control using the Student t test.RESULTS/\nThe AUC for the control was 10.1 \u00b1 1.4 ng/mL per minute. The AUC for the 500, 250, 50, and 25 \u00b5m ablative depth was 14.1 \u00b1 1.4, 13.1 \u00b1 1.4, 12.1 \u00b1 1.4, and 11.1 \u00b1 1.",
        "levenshtein_distance": 518
    },
    {
        "realidx": "22348433",
        "question": "The optimum protocol for expander volume adjustment with respect to the timing and application of radiotherapy remains controversial.\nEighteen New Zealand rabbits were divided into three groups. Metallic port integrated anatomic breast expanders of 250 cc were implanted on the back of each animal and controlled expansion was performed. Group I underwent radiotherapy with full expanders while in Group II, expanders were partially deflated immediately prior to radiotherapy. Control group did not receive radiotherapy.The changes in blood flow at different volume adjustments were investigated in Group II by laser Doppler flowmetry. Variations in the histopathologic properties of the irradiated tissues including the skin, capsule and the pocket floor, were compared in the biopsy specimens taken from different locations in each group.\nA significant increase in skin blood flow was detected in Group II with partial expander deflation. Overall, histopathologic exam revealed aggravated findings of chronic radiodermatitis (epidermal atrophy, dermal inflammation and fibrosis, neovascularisation and vascular changes as well as increased capsule thickness) especially around the lower expander pole, in Group II.\nDoes partial expander deflation exacerbate the adverse effects of radiotherapy in two-stage breast reconstruction?",
        "answer": "yes",
        "answer_rationale": "Expander deflation immediately prior to radiotherapy, may augment the adverse effects, especially in the lower expander pole, possibly via enhanced radiosensitization due to a relative increase in the blood flow and tissue oxygenation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The optimum protocol for expander volume adjustment with respect to the timing and application of radiotherapy remains controversial.\nEighteen New Zealand rabbits were divided into three groups. Metallic port integrated anatomic breast expanders of 250 cc were implanted on the back of each animal and controlled expansion was performed. Group I underwent radiotherapy with full expanders while in Group II, expanders were partially deflated immediately prior to radiotherapy. Control group did not receive radiotherapy.The changes in blood flow at different volume adjustments were investigated in Group II by laser Doppler flowmetry. Variations in the histopathologic properties",
        "q2": " of the irradiated tissues including the skin, capsule and the pocket floor, were compared in the biopsy specimens taken from different locations in each group.\nA significant increase in skin blood flow was detected in Group II with partial expander deflation. Overall, histopathologic exam revealed aggravated findings of chronic radiodermatitis (epidermal atrophy, dermal inflammation and fibrosis, neovascularisation and vascular changes as well as increased capsule thickness) especially around the lower expander pole, in Group II.\nDoes partial expander deflation exacerbate the adverse effects of radiotherapy in two-stage breast reconstruction?",
        "generated_text": "of the tissue were evaluated in all groups.\nIn Group I, the mean blood flow was 12.5\u00b11.5 perfusion units (PU) and in Group II, it was 14.5\u00b11.5 PU (p=0.001). In Group I, the mean thickness of the fibrous capsule was 1.5\u00b10.5 mm and in Group II, it was 1.0\u00b10.5 mm (p=0.001). In the control group, the mean thickness of the fibrous capsule was 0",
        "levenshtein_distance": 485
    },
    {
        "realidx": "22350859",
        "question": "The objective of this study was to determine the most effective content of pictorial health warning labels (HWLs) and whether educational attainment moderates these effects.\nField experiments were conducted with 529 adult smokers and 530 young adults (258 nonsmokers; 271 smokers). Participants reported responses to different pictorial HWLs printed on cigarette packages. One experiment involved manipulating textual form (testimonial narrative vs. didactic) and the other involved manipulating image type (diseased organs vs. human suffering).\nTests of mean ratings and rankings indicated that pictorial HWLs with didactic textual forms had equivalent or significantly higher credibility, relevance, and impact than pictorial HWLs with testimonial forms. Results from mixed-effects models confirmed these results. However, responses differed by participant educational attainment: didactic forms were consistently rated higher than testimonials among participants with higher education, whereas the difference between didactic and testimonial narrative forms was weaker or not statistically significant among participants with lower education. In the second experiment, with textual content held constant, greater credibility, relevance, and impact was found for graphic imagery of diseased organs than imagery of human suffering.\nCan pictorial warning labels on cigarette packages address smoking-related health disparities?",
        "answer": "yes",
        "answer_rationale": "Pictorial HWLs with didactic textual forms seem to work better than those with testimonial narratives. Future research should determine which pictorial HWL content has the greatest real-world impact among consumers from disadvantaged groups, including assessment of how HWL content should change to maintain its impact as tobacco control environments strengthen and consumer awareness of smoking-related risks increases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The objective of this study was to determine the most effective content of pictorial health warning labels (HWLs) and whether educational attainment moderates these effects.\nField experiments were conducted with 529 adult smokers and 530 young adults (258 nonsmokers; 271 smokers). Participants reported responses to different pictorial HWLs printed on cigarette packages. One experiment involved manipulating textual form (testimonial narrative vs. didactic) and the other involved manipulating image type (diseased organs vs. human suffering).\nTests of mean ratings and rankings indicated that pictorial HWLs with didactic textual forms had equivalent",
        "q2": " or significantly higher credibility, relevance, and impact than pictorial HWLs with testimonial forms. Results from mixed-effects models confirmed these results. However, responses differed by participant educational attainment: didactic forms were consistently rated higher than testimonials among participants with higher education, whereas the difference between didactic and testimonial narrative forms was weaker or not statistically significant among participants with lower education. In the second experiment, with textual content held constant, greater credibility, relevance, and impact was found for graphic imagery of diseased organs than imagery of human suffering.\nCan pictorial warning labels on cigarette packages address smoking-related health disparities?",
        "generated_text": "or higher impact than those with testimonial narratives. Pictorial HWLs with diseased organs had higher impact than those with human suffering images. Educational attainment did not moderate the effects of textual form or image type.\nThese findings suggest that didactic textual forms and diseased organs are more effective in pictorial HWLs, regardless of educational attainment.",
        "levenshtein_distance": 543
    },
    {
        "realidx": "22365295",
        "question": "To determine the rate of early infection for totally implantable venous access devices (TIVADs) placed without antibiotic prophylaxis.\nA list of patients who underwent TIVAD placement in 2009 was obtained from the patient archiving and communication system (PACS). This list was cross-referenced to all patients who underwent TIVAD removal from January 1, 2009, through January 30, 2010, to identify TIVADs that were removed within 30 days of placement. Retrospective chart review was performed to record patient demographics, including age, sex, cancer diagnosis, and indication for removal. Concurrent antibiotic therapy, chemotherapy, and laboratory data before and within 30 days of placement were recorded. Central line-associated bloodstream infections (CLABSIs) were identified using U.S. Centers for Disease Control and Prevention (CDC) criteria.\nThere were 1,183 ports placed and 13 removed. CLABSIs occurred in seven (0.6%) patients within 30 days of placement. At the time of TIVAD placement, 81 (7%) patients were receiving antibiotics incidental to the procedure. One patient who received an antibiotic the day of implantation developed a CLABSI. Chemotherapy was administered to 148 (13%) patients on the day of placement.\nTotally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?",
        "answer": "no",
        "answer_rationale": "The rate of early infection without antibiotic prophylaxis before TIVAD placement in the interventional radiology suite is<1%. Based on these data, use of prophylactic antibiotics for TIVAD placement is not recommended.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine the rate of early infection for totally implantable venous access devices (TIVADs) placed without antibiotic prophylaxis.\nA list of patients who underwent TIVAD placement in 2009 was obtained from the patient archiving and communication system (PACS). This list was cross-referenced to all patients who underwent TIVAD removal from January 1, 2009, through January 30, 2010, to identify TIVADs that were removed within 30 days of placement. Retrospective chart review was performed to record patient demographics, including age, sex, cancer diagnosis, and indication for removal. Concurrent antibiotic therapy, chemotherapy, and laboratory data before and within ",
        "q2": "30 days of placement were recorded. Central line-associated bloodstream infections (CLABSIs) were identified using U.S. Centers for Disease Control and Prevention (CDC) criteria.\nThere were 1,183 ports placed and 13 removed. CLABSIs occurred in seven (0.6%) patients within 30 days of placement. At the time of TIVAD placement, 81 (7%) patients were receiving antibiotics incidental to the procedure. One patient who received an antibiotic the day of implantation developed a CLABSI. Chemotherapy was administered to 148 (13%) patients on the day of placement.\nTotally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?",
        "generated_text": "30 days of TIVAD placement were recorded. The primary outcome was early TIVAD infection, defined as TIVAD removal for infection within 30 days of placement. The secondary outcome was TIVAD removal for any reason within 30 days of placement. The rate of early TIVAD infection was calculated as the number of TIVADs removed for infection within 30 days divided by the total number of TIVADs placed in 2009. The rate of TIVAD removal for any reason within 30 days was calculated as the number of TIVADs removed for any reason within 30 days divided by the total number of TIV",
        "levenshtein_distance": 470
    },
    {
        "realidx": "22382608",
        "question": "The differential diagnosis between essential tremor (ET) and Parkinson's disease (PD) may be, in some cases, very difficult on clinical grounds alone. In addition, it is accepted that a small percentage of ET patients presenting symptoms and signs of possible PD may progress finally to a typical pattern of parkinsonism. Ioflupane, N-u-fluoropropyl-2a-carbomethoxy-3a-(4-iodophenyl) nortropane, also called FP-CIT, labelled with (123)I (commercially known as DaTSCAN) has been proven to be useful in the differential diagnosis between PD and ET and to confirm dopaminergic degeneration in patients with parkinsonism. The aim of this study is to identify dopaminergic degeneration in patients with PD and distinguish them from others with ET using semi-quantitative SPECT (123)I-Ioflupane (DaTSCAN) data in comparison with normal volunteers (NV), in addition with the respective ones of patients referred as suffering from ET, as well as, of patients with a PD diagnosis at an initial stage with a unilateral presentation of motor signs.\nTwenty-eight patients suffering from ET (10 males plus 18 females) and 28 NV (12 males and 16 females) were enroled in this study. In addition, 33 patients (11 males and 22 females) with an established diagnosis of PD with unilateral limb involvement (12 left hemi-body and 21 right hemi-body) were included for comparison with ET. We used DaTSCAN to obtain SPECT images and measure the radiopharmaceutical uptake in the striatum (S), as well as the caudate nucleus (CN) and putamen (P) in all individuals.\nQualitative (Visual) interpretation of the SPECT data did not find any difference in the uptake of the radiopharmaceutical at the level of the S, CN and P between NV and ET patients. Reduced accumulation of the radiopharmaceutical uptake was found in the P of all PD patients. Semiquantitative analysis revealed significant differences between NV and ET patients in the striatum, reduced in the latter. There was also a significant reduction in the tracer accumulation in the left putamen of patients with right hemi-parkinsonism compared to ET and NV. Patients with left hemi-parkinsonism, demonstrated reduced radioligand uptake in the right putamen in comparison with ET and NV. Clinical follow-up of 20 patients with ET at (so many months afterwards) revealed no significant change in clinical presentation, particularly no signs of PD. Follow-up DaTSCAN performed in 10 of them (so many months afterwards) was negative in all but one. This one had an equivocal baseline study which deteriorated 12\u00a0months later.\nSPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?",
        "answer": "no",
        "answer_rationale": "Our results do not support the hypothesis of a link between essential tremor and Parkinson's disease. However, it appears that ET patients have a small degree of striatal dopaminergic degeneration. If this is due to alterations in the nigrostriatl pathway or of other origin it is not clear. Follow-up studies of essential tremor patients are warranted to assess progression of disease and to understand better the possible cause for striatal dopaminergic degeneration.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The differential diagnosis between essential tremor (ET) and Parkinson's disease (PD) may be, in some cases, very difficult on clinical grounds alone. In addition, it is accepted that a small percentage of ET patients presenting symptoms and signs of possible PD may progress finally to a typical pattern of parkinsonism. Ioflupane, N-u-fluoropropyl-2a-carbomethoxy-3a-(4-iodophenyl) nortropane, also called FP-CIT, labelled with (123)I (commercially known as DaTSCAN) has been proven to be useful in the differential diagnosis between PD and ET and to confirm dopaminergic degeneration in patients with parkinsonism. The aim of this study is to identify dopaminergic degeneration in patients with PD and distinguish them from others with ET using semi-quantitative SPECT (123)I-Ioflupane (DaTSCAN) data in comparison with normal volunteers (NV), in addition with the respective ones of patients referred as suffering from ET, as well as, of patients with a PD diagnosis at an initial stage with a unilateral presentation of motor signs.\nTwenty-eight patients suffering from ET (10 males plus 18 females) and 28 NV (12 males and 16 females) were enroled in this study. In addition, 33 patients (11 males and 22 females) with an established diagnosis of PD with unilateral limb involvement (12 left hemi-body and",
        "q2": " 21 right hemi-body) were included for comparison with ET. We used DaTSCAN to obtain SPECT images and measure the radiopharmaceutical uptake in the striatum (S), as well as the caudate nucleus (CN) and putamen (P) in all individuals.\nQualitative (Visual) interpretation of the SPECT data did not find any difference in the uptake of the radiopharmaceutical at the level of the S, CN and P between NV and ET patients. Reduced accumulation of the radiopharmaceutical uptake was found in the P of all PD patients. Semiquantitative analysis revealed significant differences between NV and ET patients in the striatum, reduced in the latter. There was also a significant reduction in the tracer accumulation in the left putamen of patients with right hemi-parkinsonism compared to ET and NV. Patients with left hemi-parkinsonism, demonstrated reduced radioligand uptake in the right putamen in comparison with ET and NV. Clinical follow-up of 20 patients with ET at (so many months afterwards) revealed no significant change in clinical presentation, particularly no signs of PD. Follow-up DaTSCAN performed in 10 of them (so many months afterwards) was negative in all but one. This one had an equivocal baseline study which deteriorated 12\u00a0months later.\nSPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?",
        "generated_text": "21 right hemi-body) were also included. All patients underwent a brain SPECT examination with (123)I-Ioflupane. The striatal uptake of the tracer was quantified by calculating the striatal to cerebellar uptake ratio (S/C ratio). The S/C ratio was calculated for the whole striatum and for the left and right striatum separately. The S/C ratio was compared between the three groups (NV, ET and PD). The S/C ratio was also compared between the left and right striatum in the PD group.\nThe S/C ratio was significantly lower in the PD group compared to the NV and ET groups (p < 0.001). There was no significant difference in the S/C ratio between the NV and ET groups (p = 0.45). In the PD group, the S/C ratio was significantly lower in the affected side compared to the unaffected side (p < 0.001).\nThese results suggest that (123)I-Ioflupane SPECT can be a useful tool in differentiating PD from ET, even in the early stages of PD when the disease is unilateral. The technique can help identify dopaminergic degeneration in PD patients, which is not present in ET patients. This can aid in making an accurate diagnosis and initiating appropriate treatment early in the disease process.\n\n**Key Points:**\n\n1. **Differentiation Challenge:** Distinguishing between essential trem",
        "levenshtein_distance": 1002
    },
    {
        "realidx": "22453060",
        "question": "Bystander resuscitation plays an important role in lifesaving cardiopulmonary resuscitation (CPR). A significant reduction in the \"no-flow-time\", quantitatively better chest compressions and an improved quality of ventilation can be demonstrated during CPR using supraglottic airway devices (SADs). Previous studies have demonstrated the ability of inexperienced persons to operate SADs after brief instruction. The aim of this pilot study was to determine whether an instruction manual consisting of four diagrams enables laypersons to operate a Laryngeal Mask Supreme\u00ae (LMAS) in the manikin.\nAn instruction manual of four illustrations with speech bubbles displaying the correct use of the LMAS was designed. Laypersons were handed a bag containing a LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the instruction sheet, and were asked to perform and ventilate the manikin as displayed. Time to ventilation was recorded and degree of success evaluated.\nA total of 150 laypersons took part. Overall 145 participants (96.7%) inserted the LMAS in the manikin in the right direction. The device was inserted inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized this and corrected the position. Within the first 2 minutes 119 (79.3%) applicants were able to insert the LMAS and provide tidal volumes greater than 150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 \u00b1 29 s. No significant difference related to previous BLS training (P = 0.85), technical education (P = 0.07) or gender could be demonstrated (P = 0.25).\nDoes a 4 diagram manual enable laypersons to operate the Laryngeal Mask Supreme\u00ae?",
        "answer": "yes",
        "answer_rationale": "In manikin laypersons could insert LMAS in the correct direction after onsite instruction by a simple manual with a high success rate. This indicates some basic procedural understanding and intellectual transfer in principle. Operating errors (n = 91) were frequently not recognized and corrected (n = 77). Improvements in labeling and the quality of instructional photographs may reduce individual error and may optimize understanding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Bystander resuscitation plays an important role in lifesaving cardiopulmonary resuscitation (CPR). A significant reduction in the \"no-flow-time\", quantitatively better chest compressions and an improved quality of ventilation can be demonstrated during CPR using supraglottic airway devices (SADs). Previous studies have demonstrated the ability of inexperienced persons to operate SADs after brief instruction. The aim of this pilot study was to determine whether an instruction manual consisting of four diagrams enables laypersons to operate a Laryngeal Mask Supreme\u00ae (LMAS) in the manikin.\nAn instruction manual of four illustrations with speech bubbles displaying the correct use of the LMAS was designed. Laypersons were handed a bag containing a LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the instruction sheet, and were asked to perform and ventilate the manikin as displayed.",
        "q2": " Time to ventilation was recorded and degree of success evaluated.\nA total of 150 laypersons took part. Overall 145 participants (96.7%) inserted the LMAS in the manikin in the right direction. The device was inserted inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized this and corrected the position. Within the first 2 minutes 119 (79.3%) applicants were able to insert the LMAS and provide tidal volumes greater than 150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 \u00b1 29 s. No significant difference related to previous BLS training (P = 0.85), technical education (P = 0.07) or gender could be demonstrated (P = 0.25).\nDoes a 4 diagram manual enable laypersons to operate the Laryngeal Mask Supreme\u00ae?",
        "generated_text": "The primary endpoint was the correct placement of the LMAS. Secondary endpoints were the time to successful placement, the number of attempts, and the quality of ventilation.\nA total of 100 laypersons (50% female, mean age 32.5 years) were included. The LMAS was correctly placed in 98% of the cases. The mean time to successful placement was 102.5 s (SD 42.5 s). The mean number of attempts was 1.1 (SD 0.3). The mean ventilation volume was 570 ml (SD 110 ml). The mean inspiratory pressure was 21 cm H2O (SD 5 cm H2O). The mean inspiratory time was 1.5 s (SD 0.4 s). The mean respiratory rate was 12/min (SD",
        "levenshtein_distance": 571
    },
    {
        "realidx": "22491528",
        "question": "To determine if composite measures based on process indicators are consistent with short-term outcome indicators in surgical colorectal cancer care.\nLongitudinal analysis of consistency between composite measures based on process indicators and outcome indicators for 85 Dutch hospitals.\nThe Dutch Surgical Colorectal Audit database, the Netherlands.\n4732 elective patients with colon carcinoma and 2239 with rectum carcinoma treated in 85 hospitals were included in the analyses.\nAll available process indicators were aggregated into five different composite measures. The association of the different composite measures with risk-adjusted postoperative mortality and morbidity was analysed at the patient and hospital level.\nAt the patient level, only one of the composite measures was negatively associated with morbidity for rectum carcinoma. At the hospital level, a strong negative association was found between composite measures and hospital mortality and morbidity rates for rectum carcinoma (p<0.05), and hospital morbidity rates for colon carcinoma.\nCombining process indicators to evaluate quality of care for surgical patients with colorectal cancer: are scores consistent with short-term outcome?",
        "answer": "maybe",
        "answer_rationale": "For individual patients, a high score on the composite measures based on process indicators is not associated with better short-term outcome. However, at the hospital level, a good score on the composite measures based on process indicators was consistent with more favourable risk-adjusted short-term outcome rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To determine if composite measures based on process indicators are consistent with short-term outcome indicators in surgical colorectal cancer care.\nLongitudinal analysis of consistency between composite measures based on process indicators and outcome indicators for 85 Dutch hospitals.\nThe Dutch Surgical Colorectal Audit database, the Netherlands.\n4732 elective patients with colon carcinoma and 2239 with rectum carcinoma treated in 85 hospitals were included in the analyses.\nAll available process indicators were aggregated into five different composite measures. The association of the different composite measures",
        "q2": " with risk-adjusted postoperative mortality and morbidity was analysed at the patient and hospital level.\nAt the patient level, only one of the composite measures was negatively associated with morbidity for rectum carcinoma. At the hospital level, a strong negative association was found between composite measures and hospital mortality and morbidity rates for rectum carcinoma (p<0.05), and hospital morbidity rates for colon carcinoma.\nCombining process indicators to evaluate quality of care for surgical patients with colorectal cancer: are scores consistent with short-term outcome?",
        "generated_text": "with short-term outcome indicators was assessed using multilevel logistic regression analysis.\nThe composite measures based on process indicators were not consistently associated with the outcome indicators. For colon cancer, the composite measures were not associated with the outcome indicators. For rectum cancer, the composite measures were associated with the outcome indicators, but the strength of the associations varied.\nComposite measures based on process indicators are not consistently associated with short-term outcome indicators in surgical colorectal cancer care. This suggests that composite measures based on process indicators may",
        "levenshtein_distance": 456
    },
    {
        "realidx": "22497340",
        "question": "To clarify whether horizontal canal ocular reflex is influenced by otolith organs input.\nThe subjects were seven healthy humans. The right ear was stimulated using ice-water. Each subject was kept in a left-ear-down position for 20 s and then repositioned to a prone position, a right-ear-down position and a supine position with 20 s intervals. Nystagmus was analysed using three-dimensional video-oculography.\nEye movements in the supine position and the prone position were not in a symmetric fashion. Nystagmus in the left-ear-down position and the right-ear-down position were not symmetric either. These phenomena indicate that the axis of the eyeball rotation was affected by the shift of the direction of gravity exerted on the head.\nIs horizontal semicircular canal ocular reflex influenced by otolith organs input?",
        "answer": "yes",
        "answer_rationale": "Otolith organs input influences the axis of horizontal semicircular canal ocular reflex; therefore, the plane of compensatory eye movements induced by the horizontal canal stimulation is not always parallel to the canal.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To clarify whether horizontal canal ocular reflex is influenced by otolith organs input.\nThe subjects were seven healthy humans. The right ear was stimulated using ice-water. Each subject was kept in a left-ear-down position for 20 s and then repositioned to a prone position, a right-ear-down position and a supine position with 20 s intervals. Nystagmus was analysed using three-dimensional video-oc",
        "q2": "ulography.\nEye movements in the supine position and the prone position were not in a symmetric fashion. Nystagmus in the left-ear-down position and the right-ear-down position were not symmetric either. These phenomena indicate that the axis of the eyeball rotation was affected by the shift of the direction of gravity exerted on the head.\nIs horizontal semicircular canal ocular reflex influenced by otolith organs input?",
        "generated_text": "ulography.\nIn the left-ear-down position, the slow-phase velocity (SPV) of horizontal nystagmus was 1.1\u00b0/s (range 0.4-2.0\u00b0/s). In the prone position, the SPV was 1.0\u00b0/s (range 0.3-1.7\u00b0/s). In the right-ear-down",
        "levenshtein_distance": 322
    },
    {
        "realidx": "22504515",
        "question": "The study was performed to evaluate the clinical and technical efficacy of endovenous laser ablation (EVLA) of small saphenous varicosities, particularly in relation to the site of endovenous access.\nTotally 59 patients with unilateral saphenopopliteal junction incompetence and small saphenous vein reflux underwent EVLA (810 nm, 14 W diode laser) with ambulatory phlebectomies. Small saphenous vein access was gained at the lowest site of truncal reflux. Patients were divided into 2 groups: access gained above mid-calf (AMC, n = 33) and below mid-calf (BMC, n = 26) levels. Outcomes included Venous Clinical Severity Scores (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), patient satisfaction, complications, and recurrence rates.\nBoth groups demonstrated significant improvement in VCSS, AVVQ, generic quality of life Short Form 36, and EuroQol scores (P<.05) up to 1 year. No differences were seen between AMC and BMC groups for complications (phlebitis: 2 [6%] and 1 [3.8%], P>.05; paresthesia: 2 [6%] and 5 [19%], P = .223) and recurrence (3 [9%] and 1 [3.8%], P = .623), respectively.\nEndovenous laser ablation in the treatment of small saphenous varicose veins: does site of access influence early outcomes?",
        "answer": "no",
        "answer_rationale": "The site of access in our study does not appear to influence complications specifically neural injury or recurrence rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The study was performed to evaluate the clinical and technical efficacy of endovenous laser ablation (EVLA) of small saphenous varicosities, particularly in relation to the site of endovenous access.\nTotally 59 patients with unilateral saphenopopliteal junction incompetence and small saphenous vein reflux underwent EVLA (810 nm, 14 W diode laser) with ambulatory phlebectomies. Small saphenous vein access was gained at the lowest site of truncal reflux. Patients were divided into 2 groups: access gained above mid-calf (AMC, n = 33) and below mid-calf (BMC, n = 26) levels. Outcomes included Venous Clinical Severity Scores (VCSS), Aberdeen Varicose Vein",
        "q2": " Questionnaire (AVVQ), patient satisfaction, complications, and recurrence rates.\nBoth groups demonstrated significant improvement in VCSS, AVVQ, generic quality of life Short Form 36, and EuroQol scores (P<.05) up to 1 year. No differences were seen between AMC and BMC groups for complications (phlebitis: 2 [6%] and 1 [3.8%], P>.05; paresthesia: 2 [6%] and 5 [19%], P = .223) and recurrence (3 [9%] and 1 [3.8%], P = .623), respectively.\nEndovenous laser ablation in the treatment of small saphenous varicose veins: does site of access influence early outcomes?",
        "generated_text": "Questionnaire (AVVQ), and venous duplex ultrasound (VDU) at 12 months.\nAt 12 months, VCSS and AVVQ scores improved significantly in both groups (P < .001). There was no significant difference in VCSS and AVVQ scores between the 2 groups. VDU showed that 29 of 33 (87.9%) patients in the AMC group and 23 of 26 (88.5%) in the BMC group had complete occlusion of the small saphenous vein (P = .94). There was no significant difference in the number of phlebectomies performed between the 2 groups (P = .12). There was no major complication in either group.\nEVLA",
        "levenshtein_distance": 433
    },
    {
        "realidx": "22513023",
        "question": "To assess whether Indigenous Australians age prematurely compared with other Australians, as implied by Australian Government aged care policy, which uses age 50 years and over for population-based planning for Indigenous people compared with 70 years for non-indigenous people.\nCross-sectional analysis of aged care assessment, hospital and health survey data comparing Indigenous and non-indigenous age-specific prevalence of health conditions. Analysis of life tables for Indigenous and non-indigenous populations comparing life expectancy at different ages.\nAt age 63 for women and age 65 for men, Indigenous people had the same life expectancy as non-indigenous people at age 70. There is no consistent pattern of a 20-year lead in age-specific prevalence of age-associated conditions for Indigenous compared with other Australians. There is high prevalence from middle-age onwards of some conditions, particularly diabetes (type unspecified), but there is little or no lead for others.\nDo Indigenous Australians age prematurely?",
        "answer": "no",
        "answer_rationale": "The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To assess whether Indigenous Australians age prematurely compared with other Australians, as implied by Australian Government aged care policy, which uses age 50 years and over for population-based planning for Indigenous people compared with 70 years for non-indigenous people.\nCross-sectional analysis of aged care assessment, hospital and health survey data comparing Indigenous and non-indigenous age-specific prevalence of health conditions. Analysis of life tables for Indigenous and non-indigenous populations comparing life expectancy at different ages",
        "q2": ".\nAt age 63 for women and age 65 for men, Indigenous people had the same life expectancy as non-indigenous people at age 70. There is no consistent pattern of a 20-year lead in age-specific prevalence of age-associated conditions for Indigenous compared with other Australians. There is high prevalence from middle-age onwards of some conditions, particularly diabetes (type unspecified), but there is little or no lead for others.\nDo Indigenous Australians age prematurely?",
        "generated_text": ".\nIndigenous Australians have higher age-specific prevalence of health conditions and higher mortality rates compared with non-indigenous Australians. However, Indigenous Australians do not age prematurely compared with non-indigenous Australians. Indigenous Australians have higher mortality rates at all ages, but the relative risk of mortality does not increase with age. Indigenous Australians have higher rates of chronic disease and disability at younger ages, but this is not due to premature ageing. The higher rates of chronic disease and disability",
        "levenshtein_distance": 405
    },
    {
        "realidx": "22522271",
        "question": "Forty obese patients with T2DM without clinical features of Cushing's syndrome were recruited. Plasma, urinary and salivary cortisol were measured directly by an enzyme-linked immunosorbent assay using monoclonal antibodies. The specificities of the three tests using various cutoffs were calculated and compared, employing the assumption that none of the patients had hypercortisolism.\nThe patients had a mean age and BMI of 56 years (range 31-75) and 37 kg/m\u00b2 (31-56) respectively. All 40 provided late-night salivary cortisol samples. Thirty-eight patients completed all three tests. Two patients only completed two screening tests. The specificities of late-night salivary cortisol (cutoff 10 nmol/L), 24hr UFC (400 nmol) and 1mg DST (50 nmol/L) were 70% (95% CI 53-83%), 90% (76-97%) and 72% (55-85%) respectively. The specificity of late-night salivary cortisol was significantly less than 24 hr UFC (P=0.039) but not 1mg DST (P>0.99).\nIs late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?",
        "answer": "no",
        "answer_rationale": "Late-night salivary cortisol has a poor specificity for cortisol excess in obese patients with T2DM with 24 hr UFC showing significantly better specificity in our population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Forty obese patients with T2DM without clinical features of Cushing's syndrome were recruited. Plasma, urinary and salivary cortisol were measured directly by an enzyme-linked immunosorbent assay using monoclonal antibodies. The specificities of the three tests using various cutoffs were calculated and compared, employing the assumption that none of the patients had hypercortisolism.\nThe patients had a mean age and BMI of 56 years (range 31-75) and 37 kg/m\u00b2 (31-56) respectively. All 40 provided late-night salivary cortisol samples. Thirty-eight patients completed all three tests. Two patients only completed two screening tests.",
        "q2": " The specificities of late-night salivary cortisol (cutoff 10 nmol/L), 24hr UFC (400 nmol) and 1mg DST (50 nmol/L) were 70% (95% CI 53-83%), 90% (76-97%) and 72% (55-85%) respectively. The specificity of late-night salivary cortisol was significantly less than 24 hr UFC (P=0.039) but not 1mg DST (P>0.99).\nIs late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?",
        "generated_text": "The mean plasma cortisol was 217 nmol/L (range 50-500), urinary free cortisol 114 nmol/24 h (range 20-300), and salivary cortisol 1.1 nmol/L (range 0.1-4.0). The specificities of the three tests using various cutoffs were calculated and compared, employing the assumption that none of the patients had hypercortisolism. The specificity of the salivary cortisol test was higher than that of the plasma cortisol test at all cutoffs, and higher than that of the UFC test at cutoffs up to",
        "levenshtein_distance": 363
    },
    {
        "realidx": "22532370",
        "question": "To provide insight into the factors by which obesity in itself may directly lead to early arterial damage, we aimed to determine early sonographic markers of obesity-related vascular dysfunction in young obese males.\nThirty-five young obese males and 23 age-matched healthy male volunteers were recruited into the study. Common carotid artery pulsatility index and resistance index were calculated from blood flow velocities curves obtained by pulsed Doppler ultrasonography.\nThe mean pulsatility index, resistance index, body mass index, waist circumference, systolic and diastolic blood pressure, homeostasis model assessment for insulin resistance, plasma fasting glucose, insulin, C-peptide, triglycerides, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were statistically higher in obese subjects than in healthy controls.\nAre increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males?",
        "answer": "yes",
        "answer_rationale": "Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To provide insight into the factors by which obesity in itself may directly lead to early arterial damage, we aimed to determine early sonographic markers of obesity-related vascular dysfunction in young obese males.\nThirty-five young obese males and 23 age-matched healthy male volunteers were recruited into the study. Common carotid artery pulsatility index and resistance index were calculated from blood flow velocities curves obtained by pulsed Doppler ultrasonography.\nThe mean pulsatility",
        "q2": " index, resistance index, body mass index, waist circumference, systolic and diastolic blood pressure, homeostasis model assessment for insulin resistance, plasma fasting glucose, insulin, C-peptide, triglycerides, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were statistically higher in obese subjects than in healthy controls.\nAre increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males?",
        "generated_text": "index and resistance index values were significantly higher in the obese group compared with the control group (p < 0.001 and p < 0.001, respectively). There was a significant positive correlation between pulsatility index and body mass index (r = 0.51, p < 0.001), waist circumference (r = 0.47, p < 0.00",
        "levenshtein_distance": 355
    },
    {
        "realidx": "22534881",
        "question": "The correlation between radiographic transition zone on contrast enema in Hirschsprung's disease and the total length of aganglionosis is known to be inaccurate. The aim of our study was to analyse this correlation more precisely to improve preoperative planning of the corrective surgery.\nFrom 1998 to 2009, 79 patients were operated on for Hirschsprung's disease. All available preoperative contrast enemas (n = 61) had been single blind reviewed by the same radiologist who defined the radiographic transition zone when present in vertebral level. Four groups were determined (rectal, rectosigmoid, long segment, and absence of transition zone) and by Kappa coefficient of agreement correlated to the length of aganglionosis in the pathological report.\nRadiological findings were concordant with the specimen in pathology in 8 cases of 19 in rectal form (42 %), in 20 cases of 35 in rectosigmoid form (57 %), in all 6 cases of long-segment form (100 %), in the 2 cases of total colonic form (100 %) with a global agreement of 58.1 %, \u03ba = 0.39 CI [0.24; 0.57].\nDoes the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease?",
        "answer": "no",
        "answer_rationale": "Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The correlation between radiographic transition zone on contrast enema in Hirschsprung's disease and the total length of aganglionosis is known to be inaccurate. The aim of our study was to analyse this correlation more precisely to improve preoperative planning of the corrective surgery.\nFrom 1998 to 2009, 79 patients were operated on for Hirschsprung's disease. All available preoperative contrast enemas (n = 61) had been single blind reviewed by the same radiologist who defined the radiographic transition zone when present in vertebral level. Four groups were determined (rectal, rectosigmoid, long segment, and absence of transition zone) and by Kappa",
        "q2": " coefficient of agreement correlated to the length of aganglionosis in the pathological report.\nRadiological findings were concordant with the specimen in pathology in 8 cases of 19 in rectal form (42 %), in 20 cases of 35 in rectosigmoid form (57 %), in all 6 cases of long-segment form (100 %), in the 2 cases of total colonic form (100 %) with a global agreement of 58.1 %, \u03ba = 0.39 CI [0.24; 0.57].\nDoes the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease?",
        "generated_text": "statistics the interobserver agreement was determined. The radiographic transition zone was compared with the total length of aganglionosis as determined by histology.\nThe interobserver agreement was 0.78 (95% CI 0.67-0.89). The radiographic transition zone was present in 52 patients (85%). The radiographic transition zone was located in the rectum in 14 patients (27%), in the rectosigmoid in 24 patients (46%), and in the descending colon in 14 patients (27%). The histological length of aganglionosis was rectal in 10 patients (1",
        "levenshtein_distance": 416
    },
    {
        "realidx": "22537902",
        "question": "Synchronous liver metastases (SLM) occur in 20% of colorectal cancers (CRC). Resection of SLM and CLC can be undertaken at different centres (separate management, SM) or at the same centre (global management, GM).\nRetrospective study of SLM and CRC resections carried out during 01/2000 - 12/2006 by SM or GM, using a combined or delayed strategy.\nMorphologic characteristics and type of CRC and SLM resection were similar for the GM (n = 45) or SM (n = 66) groups. In patients with delayed liver resection (62 SM, 17 GM), chemotherapy prior to liver surgery was used in 92% and 38% of SM and GM patients (P<0.0001) and the median delay between procedures was 212 and 182 days, respectively (P = 0.04). First step of liver resection was more often performed during colorectal surgery in the GM group (62 vs. 6% for SM, P<0.0001) and the mean number of procedures (CRC+SLM) was lower (1.6 vs. 2.3, P = 0.003). Three-month mortality was 3% for GM and 0% for SM (n.s.). Overall survival rates were 67% and 51% for SM and GM at 3 years (n.s.), and 35 and 31% at 5 years (n.s.). Disease-free survival to 5 years was higher in SM patients (14% vs. 11%, P = 0.009).\nColorectal cancer with synchronous liver metastases: does global management at the same centre improve results?",
        "answer": "no",
        "answer_rationale": "GM of CRC and SLM was associated with fewer procedures but did not influence overall survival. SM was associated with a longer delay and increased use of chemotherapy between procedures, suggesting that more rigorous selection of SM patients for surgery may explain the higher disease-free survival after SLM resection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Synchronous liver metastases (SLM) occur in 20% of colorectal cancers (CRC). Resection of SLM and CLC can be undertaken at different centres (separate management, SM) or at the same centre (global management, GM).\nRetrospective study of SLM and CRC resections carried out during 01/2000 - 12/2006 by SM or GM, using a combined or delayed strategy.\nMorphologic characteristics and type of CRC and SLM resection were similar for the GM (n = 45) or SM (n = 66) groups. In patients with delayed liver resection (62 SM, 17 GM), chemotherapy prior to liver surgery was used in 92% and 38% of SM and GM patients (P<0.0001) and the median delay between procedures was 212 and 182 days",
        "q2": ", respectively (P = 0.04). First step of liver resection was more often performed during colorectal surgery in the GM group (62 vs. 6% for SM, P<0.0001) and the mean number of procedures (CRC+SLM) was lower (1.6 vs. 2.3, P = 0.003). Three-month mortality was 3% for GM and 0% for SM (n.s.). Overall survival rates were 67% and 51% for SM and GM at 3 years (n.s.), and 35 and 31% at 5 years (n.s.). Disease-free survival to 5 years was higher in SM patients (14% vs. 11%, P = 0.009).\nColorectal cancer with synchronous liver metastases: does global management at the same centre improve results?",
        "generated_text": ", respectively (P=0.12). In the combined group (4 SM, 28 GM), the median time between procedures was 1 and 0 days, respectively (P=0.0001). The 5-year overall survival (OS) was 52% and 57% for SM and GM, respectively (P=0.57). The 5-year OS for the delayed group was 52% and 57% for SM and GM, respectively (P=0.64). The 5-year OS for the combined group was 50% and 57% for SM and GM, respectively (P=0.74). The 5-year OS for patients with R0 resection was 60% and 63% for SM and GM, respectively (P=0.8",
        "levenshtein_distance": 421
    },
    {
        "realidx": "22540518",
        "question": "To analyze the reliability of micro-computed tomography (micro-CT) to assess bone density and the microstructure of the maxillary bones at the alveolar process in human clinics by direct comparison with conventional stereologic-based histomorphometry.\nAnalysis of osseous microstructural variables including bone volumetric density (BV/TV) of 39 biopsies from the maxillary alveolar bone was performed by micro-CT. Conventional stereologic-based histomorphometry of 10 bone biopsies was performed by optic microscopy (OM) and low-vacuum surface electronic microscopy (SEM). Percentages of bone between micro-CT and conventional stereologic-based histomorphometry were compared.\nSignificant positive correlations were observed between BV/TV and the percentage of bone (%Bone) analyzed by SEM (r\u00a0=\u00a00.933, P\u00a0<\u00a00.001), by toluidine blue staining OM (r\u00a0=\u00a00.950, P\u00a0<\u00a00.001) and by dark field OM (r\u00a0=\u00a00.667, P\u00a0=\u00a00.05). The high positive correlation coefficient between BV/TV and trabecular thickness illustrates that a value of BV/TV upper than 50% squares with a bone presenting most of their trabecules thicker than 0.2\u00a0mm. The high negative correlation between BV/TV and trabecular separation shows that values of BV/TV upper than 50% squares with a bone presenting most of their trabecules separated less than 0.3\u00a0mm each other.\nIs micro-computed tomography reliable to determine the microstructure of the maxillary alveolar bone?",
        "answer": "yes",
        "answer_rationale": "BV/TV assessed by micro-CT correlates with the percentage of bone assessed by conventional stereologic-based histomorphometry. Micro-CT is a reliable technique to determine the bone density and the microstructure of the maxillary alveolar bone at the site of dental implant insertion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To analyze the reliability of micro-computed tomography (micro-CT) to assess bone density and the microstructure of the maxillary bones at the alveolar process in human clinics by direct comparison with conventional stereologic-based histomorphometry.\nAnalysis of osseous microstructural variables including bone volumetric density (BV/TV) of 39 biopsies from the maxillary alveolar bone was performed by micro-CT. Conventional stereologic-based histomorphometry of 10 bone biopsies was performed by optic microscopy (OM) and low-vacuum surface electronic microscopy (SEM). Percentages of bone between micro-CT and conventional stereologic-based histomorphometry were compared.\nSignificant positive correlations were observed between BV/TV and the percentage of bone (%Bone) analyzed by SEM (r\u00a0=\u00a00.933",
        "q2": ", P\u00a0<\u00a00.001), by toluidine blue staining OM (r\u00a0=\u00a00.950, P\u00a0<\u00a00.001) and by dark field OM (r\u00a0=\u00a00.667, P\u00a0=\u00a00.05). The high positive correlation coefficient between BV/TV and trabecular thickness illustrates that a value of BV/TV upper than 50% squares with a bone presenting most of their trabecules thicker than 0.2\u00a0mm. The high negative correlation between BV/TV and trabecular separation shows that values of BV/TV upper than 50% squares with a bone presenting most of their trabecules separated less than 0.3\u00a0mm each other.\nIs micro-computed tomography reliable to determine the microstructure of the maxillary alveolar bone?",
        "generated_text": ", p\u00a0<\u00a00.001) and OM (r\u00a0=\u00a00.981, p\u00a0<\u00a00.001). The mean difference between BV/TV and %Bone was 0.002 (95% CI: \u22120.001 to 0.005) for SEM and \u22120.001 (95% CI: \u22120.002 to 0.001) for OM. The mean difference between BV/TV and %Bone was 0.001 (95% CI: \u22120.001 to 0.003) for SEM and \u22120.001 (95% CI: \u22120.002 to 0.001)",
        "levenshtein_distance": 472
    },
    {
        "realidx": "22617083",
        "question": "To examine age-related differences in the relationship between personality and coping strategies in an Australian population of psychiatric inpatients.\nConsenting eligible adults (N=238) from 18-100 years of age consecutively admitted to inpatient psychiatry units were assessed using the SCID I and II, the Coping Orientations to Problems Experienced Scale (COPE), the Brief Psychiatric Rating Scale (BPRS), the Global Assessment of Functioning Scale (GAF), the Social and Occupational Functioning Assessment Scale (SOFAS), the 12 Item Short-Form Heath Survey (SF12), the Sarason Social Support Questionnaire, and the NEO Five Factor Inventory (NEO-FFI) (cognitively impaired, and non-English speaking patients were excluded).\nOlder adults reported less symptomatology than younger patients and younger patients described more personality dysfunction than older patients. As assessed by the COPE, older adults reported lower levels of dysfunctional coping strategies than younger adults. Personality traits, social supports, gender, and age predicted coping strategies, while Axis I diagnosis, education, personality disorder, and symptom severity were not significant predictors of coping strategies.\nDoes age moderate the effect of personality disorder on coping style in psychiatric inpatients?",
        "answer": "yes",
        "answer_rationale": "This study found that influences on coping were multifactorial and moderated by age. These factors have implications for interventions designed to enhance coping strategies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To examine age-related differences in the relationship between personality and coping strategies in an Australian population of psychiatric inpatients.\nConsenting eligible adults (N=238) from 18-100 years of age consecutively admitted to inpatient psychiatry units were assessed using the SCID I and II, the Coping Orientations to Problems Experienced Scale (COPE), the Brief Psychiatric Rating Scale (BPRS), the Global Assessment of Functioning Scale (GAF), the Social and Occupational Functioning Assessment Scale (SOFAS), the 12 Item Short-Form Heath Survey (SF12), the Sarason Social Support Questionnaire",
        "q2": ", and the NEO Five Factor Inventory (NEO-FFI) (cognitively impaired, and non-English speaking patients were excluded).\nOlder adults reported less symptomatology than younger patients and younger patients described more personality dysfunction than older patients. As assessed by the COPE, older adults reported lower levels of dysfunctional coping strategies than younger adults. Personality traits, social supports, gender, and age predicted coping strategies, while Axis I diagnosis, education, personality disorder, and symptom severity were not significant predictors of coping strategies.\nDoes age moderate the effect of personality disorder on coping style in psychiatric inpatients?",
        "generated_text": "(SSQ), and the NEO Five Factor Inventory (NEO-FFI). Hierarchical multiple regression analyses were used to examine the relationship between personality and coping, controlling for age, gender, diagnosis, and symptom severity.\nPersonality was significantly related to coping, with age and gender accounting for some of the variance. Neuroticism was positively related to emotion-focused coping and negatively related to problem-focused coping. Extraversion was positively related to positive reinterpretation and growth, and negatively related to behavioral disengagement. Openness was positively related to positive reinterpretation and growth, and negatively related to behavioral dis",
        "levenshtein_distance": 509
    },
    {
        "realidx": "22644412",
        "question": "To evaluate retrospectively whether technical factors of hepatic arterial embolization affect the prognosis of patients with hepatocellular carcinoma (HCC).\nInclusion criteria of this study were the following: (1) patients received embolization as the initial treatment during 2003-2004, (2) Child A or B liver profile, (3) five or fewer HCCs with maximum diameter of 7 cm or smaller, and (4) no extrahepatic metastasis. Patient data were gathered from 43 centers. Prognostic factors were evaluated using univariate and multivariate analyses.\nEight hundred fifteen patients were enrolled. The 1-, 3-, 5-, and 7-year overall survival rates were 92.0 % (95 % CI 90.1-93.9), 62.9 % (95 % CI 59.3-66.6), 39.0 % (95 % CI 35.1-43.0), and 26.7 % (95 % CI 22.6-30.8) in all patients. Univariate analysis showed a Child-Pugh class-A, alpha-fetoprotein level lower than 100 ng/ml, tumor size of 3 cm or smaller, tumor number of 3 or fewer, one-lobe tumor distribution, nodular tumor type, within the Milan criteria, stage I or II, no portal venous invasion, use of iodized oil, and selective embolization were significantly better prognostic factors. In the multivariate Cox model, the benefit to survival of selective embolization remained significant (hazard ratio 0.68; 95 % CI 0.48-0.97; p = 0.033).\nHepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?",
        "answer": "yes",
        "answer_rationale": "Selective embolization contributes to survival in patients with HCCs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate retrospectively whether technical factors of hepatic arterial embolization affect the prognosis of patients with hepatocellular carcinoma (HCC).\nInclusion criteria of this study were the following: (1) patients received embolization as the initial treatment during 2003-2004, (2) Child A or B liver profile, (3) five or fewer HCCs with maximum diameter of 7 cm or smaller, and (4) no extrahepatic metastasis. Patient data were gathered from 43 centers. Prognostic factors were evaluated using univariate and multivariate analyses.\nEight hundred fifteen patients were enrolled. The 1-, 3-, 5-, and 7-year overall survival rates were 92.0 % (95 % CI 90.1-93.9), 62.9 % (95 % CI 59.3-66.6), 39.0 % (95 %",
        "q2": " CI 35.1-43.0), and 26.7 % (95 % CI 22.6-30.8) in all patients. Univariate analysis showed a Child-Pugh class-A, alpha-fetoprotein level lower than 100 ng/ml, tumor size of 3 cm or smaller, tumor number of 3 or fewer, one-lobe tumor distribution, nodular tumor type, within the Milan criteria, stage I or II, no portal venous invasion, use of iodized oil, and selective embolization were significantly better prognostic factors. In the multivariate Cox model, the benefit to survival of selective embolization remained significant (hazard ratio 0.68; 95 % CI 0.48-0.97; p = 0.033).\nHepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?",
        "generated_text": "CI 35.1-43.0), and 24.1 % (95 % CI 20.6-27.8), respectively. The 1-, 3-, 5-, and 7-year disease-free survival rates were 70.5 % (95 % CI 67.4-73.6), 32.1 % (95 % CI 28.8-35.5), 18.1 % (95 % CI 15.3-21.1), and 10.1 % (95 % CI 7.9-12.6), respectively. Multivariate analysis revealed that the following factors were independent prognostic factors for overall survival: age, performance status, Child-Pugh class, alpha-fetoprotein, des-gamma-carboxy",
        "levenshtein_distance": 503
    },
    {
        "realidx": "22656647",
        "question": "Preventive home visits are offered to community dwelling older people in Denmark aimed at maintaining their functional ability for as long as possible, but only two thirds of older people accept the offer from the municipalities. The purpose of this study is to investigate 1) whether socioeconomic status was associated with acceptance of preventive home visits among older people and 2) whether municipality invitational procedures for the preventive home visits modified the association.\nThe study population included 1,023 community dwelling 80-year-old individuals from the Danish intervention study on preventive home visits. Information on preventive home visit acceptance rates was obtained from questionnaires. Socioeconomic status was measured by financial assets obtained from national registry data, and invitational procedures were identified through the municipalities. Logistic regression analyses were used, adjusted by gender.\nOlder persons with high financial assets accepted preventive home visits more frequently than persons with low assets (adjusted OR = 1.5 (CI95%: 1.1-2.0)). However, the association was attenuated when adjusted by the invitational procedures. The odds ratio for accepting preventive home visits was larger among persons with low financial assets invited by a letter with a proposed date than among persons with high financial assets invited by other procedures, though these estimates had wide confidence intervals.\nAre acceptance rates of a national preventive home visit programme for older people socially imbalanced?",
        "answer": "yes",
        "answer_rationale": "High socioeconomic status was associated with a higher acceptance rate of preventive home visits, but the association was attenuated by invitational procedures. The results indicate that the social inequality in acceptance of publicly offered preventive services might decrease if municipalities adopt more proactive invitational procedures.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Preventive home visits are offered to community dwelling older people in Denmark aimed at maintaining their functional ability for as long as possible, but only two thirds of older people accept the offer from the municipalities. The purpose of this study is to investigate 1) whether socioeconomic status was associated with acceptance of preventive home visits among older people and 2) whether municipality invitational procedures for the preventive home visits modified the association.\nThe study population included 1,023 community dwelling 80-year-old individuals from the Danish intervention study on preventive home visits. Information on preventive home visit acceptance rates was obtained from questionnaires. Socioeconomic status was measured by financial assets obtained from national registry data, and",
        "q2": " invitational procedures were identified through the municipalities. Logistic regression analyses were used, adjusted by gender.\nOlder persons with high financial assets accepted preventive home visits more frequently than persons with low assets (adjusted OR = 1.5 (CI95%: 1.1-2.0)). However, the association was attenuated when adjusted by the invitational procedures. The odds ratio for accepting preventive home visits was larger among persons with low financial assets invited by a letter with a proposed date than among persons with high financial assets invited by other procedures, though these estimates had wide confidence intervals.\nAre acceptance rates of a national preventive home visit programme for older people socially imbalanced?",
        "generated_text": "categorized into quartiles. Municipality invitational procedures were categorized into three groups: 1) municipalities that invited all 80-year-olds to a preventive home visit, 2) municipalities that invited 80-year-olds who had been in contact with the municipality in the past year, and 3) municipalities that invited 80-year-olds who had been in contact with the municipality in the past year and had a low socioeconomic status.\nMultivariable logistic regression analyses were performed to estimate the association between socioeconomic status and acceptance of preventive home visits, adjusted for age, sex, and comorbidity. Interaction terms were included to assess whether the association between socioeconomic status and",
        "levenshtein_distance": 576
    },
    {
        "realidx": "22668712",
        "question": "The aim of this study was to assess the diagnostic value of articular sounds, standardized clinical examination, and standardized articular ultrasound in the detection of internal derangements of the temporomandibular joint.\nForty patients and 20 asymptomatic volunteers underwent a standardized interview, physical examination, and static and dynamic articular ultrasound. Sensitivity, specificity, and predictive values were calculated using magnetic resonance as the reference test.\nA total of 120 temporomandibular joints were examined. Based on our findings, the presence of articular sounds and physical signs are often insufficient to detect disk displacement. Imaging by static and dynamic high-resolution ultrasound demonstrates considerably lower sensitivity when compared with magnetic resonance. Some of the technical difficulties resulted from a limited access because of the presence of surrounding bone structures.\nInternal derangement of the temporomandibular joint: is there still a place for ultrasound?",
        "answer": "no",
        "answer_rationale": "The present study does not support the recommendation of ultrasound as a conclusive diagnostic tool for internal derangements of the temporomandibular joint.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The aim of this study was to assess the diagnostic value of articular sounds, standardized clinical examination, and standardized articular ultrasound in the detection of internal derangements of the temporomandibular joint.\nForty patients and 20 asymptomatic volunteers underwent a standardized interview, physical examination, and static and dynamic articular ultrasound. Sensitivity, specificity, and predictive values were calculated using magnetic resonance as the reference test.\nA total of ",
        "q2": "120 temporomandibular joints were examined. Based on our findings, the presence of articular sounds and physical signs are often insufficient to detect disk displacement. Imaging by static and dynamic high-resolution ultrasound demonstrates considerably lower sensitivity when compared with magnetic resonance. Some of the technical difficulties resulted from a limited access because of the presence of surrounding bone structures.\nInternal derangement of the temporomandibular joint: is there still a place for ultrasound?",
        "generated_text": "120 joints were evaluated. The sensitivity of the clinical examination was 50%, and the specificity was 90%. The sensitivity of the ultrasound examination was 80%, and the specificity was 95%. The sensitivity of the articular sounds was 50%, and the specificity was 95%. The combination of clinical examination and ultrasound increased the sensitivity to 80% and the specificity to 95%",
        "levenshtein_distance": 372
    },
    {
        "realidx": "22668852",
        "question": "The high prevalence of obesity in African American (AA) women may result, in part, from a lower resting metabolic rate (RMR) than non-AA women. If true, AA women should require fewer calories than non-AA women to maintain weight. Our objective was to determine in the setting of a controlled feeding study, if AA women required fewer calories than non-AA women to maintain weight.\nThis analysis includes 206 women (73% AA), aged 22-75 years, who participated in the Dietary Approaches to Stop Hypertension (DASH) trial-a multicenter, randomized, controlled, feeding study comparing the effects of 3 dietary patterns on blood pressure in individuals with prehypertension or stage 1 hypertension. After a 3-week run-in, participants were randomized to 1 of 3 dietary patterns for 8 weeks. Calorie intake was adjusted during feeding to maintain stable weight. The primary outcome of this analysis was average daily calorie (kcal) intake during feeding.\nAA women had higher baseline weight and body mass index than non-AA women (78.4 vs 72.4 kg, P<.01; 29.0 vs 27.6 kg/m(2), P<.05, respectively). During intervention feeding, mean (SD) kcal was 2168 (293) in AA women and 2073 (284) in non-AA women. Mean intake was 94.7 kcal higher in AA women than in non-AA women (P<.05). After adjustment for potential confounders, there was no difference in caloric intake between AA and non-AA women (\u0394 = -2.8 kcal, P = .95).\nDo African American women require fewer calories to maintain weight?",
        "answer": "no",
        "answer_rationale": "These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The high prevalence of obesity in African American (AA) women may result, in part, from a lower resting metabolic rate (RMR) than non-AA women. If true, AA women should require fewer calories than non-AA women to maintain weight. Our objective was to determine in the setting of a controlled feeding study, if AA women required fewer calories than non-AA women to maintain weight.\nThis analysis includes 206 women (73% AA), aged 22-75 years, who participated in the Dietary Approaches to Stop Hypertension (DASH) trial-a multicenter, randomized, controlled, feeding study comparing the effects of 3 dietary patterns on blood pressure in individuals with prehypertension or stage 1 hypertension. After a 3-week run-in, participants were randomized to 1 of 3 dietary patterns for 8 weeks. Calorie intake was adjusted during",
        "q2": " feeding to maintain stable weight. The primary outcome of this analysis was average daily calorie (kcal) intake during feeding.\nAA women had higher baseline weight and body mass index than non-AA women (78.4 vs 72.4 kg, P<.01; 29.0 vs 27.6 kg/m(2), P<.05, respectively). During intervention feeding, mean (SD) kcal was 2168 (293) in AA women and 2073 (284) in non-AA women. Mean intake was 94.7 kcal higher in AA women than in non-AA women (P<.05). After adjustment for potential confounders, there was no difference in caloric intake between AA and non-AA women (\u0394 = -2.8 kcal, P = .95).\nDo African American women require fewer calories to maintain weight?",
        "generated_text": "the run-in to achieve weight stability, and then maintained for the 8-week intervention. We used linear regression to assess the association between race and calories required to maintain weight, adjusting for age, body mass index, and center.\nAA women required 124 fewer calories per day (95% CI: -225, -23) than non-AA women to maintain weight. This difference was not explained by differences in RMR, as RMR did not differ by race. However, AA women had higher fasting insulin levels and a trend toward higher homeostasis model assessment of insulin resistance (HOMA-IR) scores, which may have contributed to the lower calorie requirements.\nIn this controlled feeding study, AA women required fewer calories than non-AA women to maintain weight, which may be due to differences in insulin sensitivity or other factors not measured in this",
        "levenshtein_distance": 605
    },
    {
        "realidx": "22680064",
        "question": "To determine the ability of early sonogram to predict the presentation of twin A at birth.\nA retrospective cohort study was conducted on all twin pregnancies evaluated at our Fetal Evaluation Unit from 2007 to 2009. Sonogram records were reviewed for the presentation of twin A at seven gestational age intervals and inpatient medical records were reviewed for the presentation of twin A at delivery. The positive predictive value, sensitivity, and specificity of presentation as determined by ultrasound, at each gestational age interval, for the same presentation at delivery were calculated.\nTwo hundred and thirty-eight twin pregnancies met inclusion criteria. A total of 896 ultrasounds were reviewed. The positive predictive value of cephalic presentation of twin A as determined by ultrasound for the persistence of cephalic presentation at delivery reached 95% after 28 weeks gestation. The positive predictive value for noncephalic presentation as established by sonogram for noncephalic at delivery was>90% after 32 weeks gestation.\nCan third trimester ultrasound predict the presentation of the first twin at delivery?",
        "answer": "yes",
        "answer_rationale": "The presentation of the first twin at delivery can be determined by sonogram by the 32nd week of gestation in over 90% of twin pregnancies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine the ability of early sonogram to predict the presentation of twin A at birth.\nA retrospective cohort study was conducted on all twin pregnancies evaluated at our Fetal Evaluation Unit from 2007 to 2009. Sonogram records were reviewed for the presentation of twin A at seven gestational age intervals and inpatient medical records were reviewed for the presentation of twin A at delivery. The positive predictive value, sensitivity, and specificity of presentation as determined by ultrasound, at each gestational age interval, for the same presentation at delivery",
        "q2": " were calculated.\nTwo hundred and thirty-eight twin pregnancies met inclusion criteria. A total of 896 ultrasounds were reviewed. The positive predictive value of cephalic presentation of twin A as determined by ultrasound for the persistence of cephalic presentation at delivery reached 95% after 28 weeks gestation. The positive predictive value for noncephalic presentation as established by sonogram for noncephalic at delivery was>90% after 32 weeks gestation.\nCan third trimester ultrasound predict the presentation of the first twin at delivery?",
        "generated_text": "were calculated.\nA total of 100 twin pregnancies were included in the study. The positive predictive value of a cephalic presentation on sonogram for a cephalic presentation at delivery was 88% at 20-23 weeks, 92% at 24-27 weeks, 94% at 28-31 weeks, 94% at 32-35 weeks, 94% at 36-39 weeks, and",
        "levenshtein_distance": 348
    },
    {
        "realidx": "22683044",
        "question": "Some studies suggest that open access articles are more often cited than non-open access articles. However, the relationship between open access and citations count in a discipline such as intensive care medicine has not been studied to date. The present article analyzes the effect of open access publishing of scientific articles in intensive care medicine journals in terms of citations count.\nWe evaluated a total of 161 articles (76% being non-open access articles) published in Intensive Care Medicine in the year 2008. Citation data were compared between the two groups up until April 30, 2011. Potentially confounding variables for citation counts were adjusted for in a linear multiple regression model.\nThe median number (interquartile range) of citations of non-open access articles was 8 (4-12) versus 9 (6-18) in the case of open access articles (p=0.084). In the highest citation range (>8), the citation count was 13 (10-16) and 18 (13-21) (p=0.008), respectively. The mean follow-up was 37.5 \u00b1 3 months in both groups. In the 30-35 months after publication, the average number (mean \u00b1 standard deviation) of citations per article per month of non-open access articles was 0.28 \u00b1 0.6 versus 0.38 \u00b1 0.7 in the case of open access articles (p=0.043). Independent factors for citation advantage were the Hirsch index of the first signing author (\u03b2=0.207; p=0.015) and open access status (\u03b2=3.618; p=0.006).\nDoes open access publishing increase the impact of scientific articles?",
        "answer": "yes",
        "answer_rationale": "Open access publishing and the Hirsch index of the first signing author increase the impact of scientific articles. The open access advantage is greater for the more highly cited articles, and appears in the 30-35 months after publication.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Some studies suggest that open access articles are more often cited than non-open access articles. However, the relationship between open access and citations count in a discipline such as intensive care medicine has not been studied to date. The present article analyzes the effect of open access publishing of scientific articles in intensive care medicine journals in terms of citations count.\nWe evaluated a total of 161 articles (76% being non-open access articles) published in Intensive Care Medicine in the year 2008. Citation data were compared between the two groups up until April 30, 2011. Potentially confounding variables for citation counts were adjusted for in a linear multiple regression model.\nThe median number (interquartile range) of citations of non-open access articles was 8 (4-12) versus 9 (6-18) in the case of open access articles (p=0",
        "q2": ".084). In the highest citation range (>8), the citation count was 13 (10-16) and 18 (13-21) (p=0.008), respectively. The mean follow-up was 37.5 \u00b1 3 months in both groups. In the 30-35 months after publication, the average number (mean \u00b1 standard deviation) of citations per article per month of non-open access articles was 0.28 \u00b1 0.6 versus 0.38 \u00b1 0.7 in the case of open access articles (p=0.043). Independent factors for citation advantage were the Hirsch index of the first signing author (\u03b2=0.207; p=0.015) and open access status (\u03b2=3.618; p=0.006).\nDoes open access publishing increase the impact of scientific articles?",
        "generated_text": ".14). The adjusted difference in citations between open access and non-open access articles was 1.1 (95% CI: -0.7 to 2.9; p=0.23). The adjusted difference in citations per month was 0.1 (95% CI: -0.1 to 0.2; p=0.31). The adjusted difference in citations per month per author was 0.01 (95% CI: -0.01 to 0.03; p=0.25). The adjusted difference in citations per month per reference was 0.01 (95% CI: -0.01 to 0.03; p=0.31). The adjusted difference in citations per month per page was 0.01",
        "levenshtein_distance": 459
    },
    {
        "realidx": "22694248",
        "question": "Although the retroperitoneal approach has been the preferred choice for open urological procedures, retroperitoneoscopy is not the preferred approach for laparoscopy. This study aims to develop a training model for retroperitoneoscopy and to establish an experimental learning curve.\nFifteen piglets were operated on to develop a standard retroperitoneoscopic nephrectomy (RPN) training model. All procedures were performed with three ports. Intraoperative data (side, operative time, blood loss, peritoneal opening) were recorded. Animals were divided into groups A, the first eight, and B, the last seven cases. Data were statistically analyzed.\nWe performed fifteen RPNs. The operative time varied from 15 to 50 minutes (median 30 minutes). Blood loss varied from 5 to 100 mL (median 20 mL). We experienced five peritoneal openings; we had two surgical vascular complications managed laparoscopically. There was statistical difference between groups A and B for peritoneal opening (p = 0.025), operative time (p = 0.0037), and blood loss (p = 0.026).\nRPN in a porcine model could simulate the whole procedure, from creating the space to nephrectomy completion. Experimental learning curve was eight cases, after statistical data analysis.\nIs there a model to teach and practice retroperitoneoscopic nephrectomy?",
        "answer": "yes",
        "answer_rationale": "RPN in a porcine model is feasible and could be very useful for teaching and practicing retroperitoneoscopy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Although the retroperitoneal approach has been the preferred choice for open urological procedures, retroperitoneoscopy is not the preferred approach for laparoscopy. This study aims to develop a training model for retroperitoneoscopy and to establish an experimental learning curve.\nFifteen piglets were operated on to develop a standard retroperitoneoscopic nephrectomy (RPN) training model. All procedures were performed with three ports. Intraoperative data (side, operative time, blood loss, peritoneal opening) were recorded. Animals were divided into groups A, the first eight, and B, the last seven cases. Data were statistically analyzed.\nWe performed fifteen RPNs. The operative time varied from",
        "q2": " 15 to 50 minutes (median 30 minutes). Blood loss varied from 5 to 100 mL (median 20 mL). We experienced five peritoneal openings; we had two surgical vascular complications managed laparoscopically. There was statistical difference between groups A and B for peritoneal opening (p = 0.025), operative time (p = 0.0037), and blood loss (p = 0.026).\nRPN in a porcine model could simulate the whole procedure, from creating the space to nephrectomy completion. Experimental learning curve was eight cases, after statistical data analysis.\nIs there a model to teach and practice retroperitoneoscopic nephrectomy?",
        "generated_text": "100 to 240 minutes, with a mean of 150 minutes. The mean blood loss was 100 mL. The peritoneum was opened in two cases. There was a significant difference in operative time between groups A and B (p < 0.05). There was no significant difference in blood loss between the two groups (p > 0.05). There was no mortality.\nRetroperitoneoscopy is a feasible approach for laparoscopic urological procedures. A standard training model for RPN can be developed in piglets. The learning curve for RPN is 8 cases.",
        "levenshtein_distance": 437
    },
    {
        "realidx": "22720085",
        "question": "Several studies have shown associations between hyperglycemia and risk of cardiovascular disease (CVD) and mortality, yet glucose-lowering treatment does little to mitigate this risk. We examined whether associations between hyperglycemia and CVD risk were explained by underlying insulin resistance.\nIn 60 middle-aged individuals without diabetes we studied the associations of fasting plasma glucose, 2-hour post oral glucose tolerance test plasma glucose, insulin sensitivity as well as body fat percentage with CVD risk. Insulin sensitivity was measured as the glucose infusion rate during a euglycemic hyperinsulinemic clamp, body fat percentage was measured by dual X-ray absorptiometry, and CVD risk was estimated using the Framingham risk score. Associations of fasting plasma glucose, 2-hour plasma glucose, insulin sensitivity and body fat percentage with the Framingham risk score were assessed in linear regression models.\nBoth fasting and 2-hour plasma glucose levels were associated with higher Framingham risk score (fasting glucose: r(2) = 0.21; 2-hour glucose: r(2) = 0.24; P<0.001 for both), and insulin sensitivity with lower Framingham risk score (r(2) = 0.36; P<0.001). However, adjustment for insulin sensitivity and 2-hour glucose made the effect of fasting glucose non-significant (P = 0.060). Likewise, when adjusting for insulin sensitivity and fasting glucose, the association between 2-hour glucose and Framingham risk score disappeared (P = 0.143). In contrast, insulin sensitivity was still associated with Framingham risk score after adjusting for glucose levels (P<0.001). Body fat was not associated with Framingham risk score when taking insulin sensitivity into account (P = 0.550).\nDoes insulin resistance drive the association between hyperglycemia and cardiovascular risk?",
        "answer": "yes",
        "answer_rationale": "The association between plasma glucose levels and CVD risk is mainly explained by insulin resistance, which raises the question of whether glucose lowering per se without changes in the processes that underlie hyperglycemia should be the sole clinical paradigm in the treatment of type 2 diabetes or its prevention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Several studies have shown associations between hyperglycemia and risk of cardiovascular disease (CVD) and mortality, yet glucose-lowering treatment does little to mitigate this risk. We examined whether associations between hyperglycemia and CVD risk were explained by underlying insulin resistance.\nIn 60 middle-aged individuals without diabetes we studied the associations of fasting plasma glucose, 2-hour post oral glucose tolerance test plasma glucose, insulin sensitivity as well as body fat percentage with CVD risk. Insulin sensitivity was measured as the glucose infusion rate during a euglycemic hyperinsulinemic clamp, body fat percentage was measured by dual X-ray absorptiometry, and CVD risk was estimated using the Framingham risk score. Associations of fasting plasma glucose, 2-hour plasma glucose, insulin sensitivity and body fat percentage with the Framingham risk score were assessed in linear regression models.\nBoth fasting and 2-hour plasma glucose levels were associated with higher Framingham risk",
        "q2": " score (fasting glucose: r(2) = 0.21; 2-hour glucose: r(2) = 0.24; P<0.001 for both), and insulin sensitivity with lower Framingham risk score (r(2) = 0.36; P<0.001). However, adjustment for insulin sensitivity and 2-hour glucose made the effect of fasting glucose non-significant (P = 0.060). Likewise, when adjusting for insulin sensitivity and fasting glucose, the association between 2-hour glucose and Framingham risk score disappeared (P = 0.143). In contrast, insulin sensitivity was still associated with Framingham risk score after adjusting for glucose levels (P<0.001). Body fat was not associated with Framingham risk score when taking insulin sensitivity into account (P = 0.550).\nDoes insulin resistance drive the association between hyperglycemia and cardiovascular risk?",
        "generated_text": "score (\u03b2=0.11, p=0.001 and \u03b2=0.10, p=0.002, respectively). Insulin sensitivity was inversely associated with the Framingham risk score (\u03b2=-0.10, p=0.003). Body fat percentage was also positively associated with the Framingham risk score (\u03b2=0.09, p=0.006). In multivariable models adjusted for age, sex, smoking, hypertension, and dyslipidemia, the associations of fasting and 2-hour plasma glucose with the Framingham risk score were attenuated and became non-significant (\u03b2=0.05, p=0.14 and \u03b2=0.04, p=0.23, respectively), while the association of insulin sensitivity remained significant (\u03b2=-0.07, p=0.04). Body",
        "levenshtein_distance": 550
    },
    {
        "realidx": "22758782",
        "question": "Hip fracture in geriatric patients has a substantial economic impact and represents a major cause of morbidity and mortality in this population. At our institution, a regional anesthesia program was instituted for patients undergoing surgery for hip fracture. This retrospective cohort review examines the effects of regional anesthesia (from mainly after July 2007) vs general anesthesia (mainly prior to July 2007) on morbidity, mortality and hospitalization costs.\nThis retrospective cohort study involved data collection from electronic and paper charts of 308 patients who underwent surgery for hip fracture from September 2006 to December 2008. Data on postoperative morbidity, in-patient mortality, and cost of hospitalization (as estimated from data on hospital charges) were collected and analyzed. Seventy-three patients received regional anesthesia and 235 patients received general anesthesia. During July 2007, approximately halfway through the study period, a regional anesthesia and analgesia program was introduced.\nThe average cost of hospitalization in patients who received surgery for hip fracture was no different between patients who receive regional or general anesthesia ($16,789 + 631 vs $16,815 + 643, respectively, P = 0.9557). Delay in surgery and intensive care unit (ICU) admission resulted in significantly higher hospitalization costs. Age, male gender, African American race and ICU admission were associated with increased in-hospital mortality. In-hospital mortality and rates of readmission are not statistically different between the two anesthesia groups.\nRegional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs?",
        "answer": "no",
        "answer_rationale": "There is no difference in postoperative morbidity, rates of rehospitalization, in-patient mortality or hospitalization costs in geriatric patients undergoing regional or general anesthesia for repair of hip fracture. Delay in surgery beyond 3 days and ICU admission both increase cost of hospitalization.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Hip fracture in geriatric patients has a substantial economic impact and represents a major cause of morbidity and mortality in this population. At our institution, a regional anesthesia program was instituted for patients undergoing surgery for hip fracture. This retrospective cohort review examines the effects of regional anesthesia (from mainly after July 2007) vs general anesthesia (mainly prior to July 2007) on morbidity, mortality and hospitalization costs.\nThis retrospective cohort study involved data collection from electronic and paper charts of 308 patients who underwent surgery for hip fracture from September 2006 to December 2008. Data on postoperative morbidity, in-patient mortality, and cost of hospitalization (as estimated from data on hospital charges) were collected and analyzed. Seventy-three patients received regional anesthesia and 235 patients received general anesthesia. During",
        "q2": " July 2007, approximately halfway through the study period, a regional anesthesia and analgesia program was introduced.\nThe average cost of hospitalization in patients who received surgery for hip fracture was no different between patients who receive regional or general anesthesia ($16,789 + 631 vs $16,815 + 643, respectively, P = 0.9557). Delay in surgery and intensive care unit (ICU) admission resulted in significantly higher hospitalization costs. Age, male gender, African American race and ICU admission were associated with increased in-hospital mortality. In-hospital mortality and rates of readmission are not statistically different between the two anesthesia groups.\nRegional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs?",
        "generated_text": "the study period, the proportion of patients receiving regional anesthesia increased from 10% in 2006 to 50% in 2008. The mean age of patients was 83 years, and 65% were female. The mean American Society of Anesthesiologists (ASA) physical status score was 3.1. The mean duration of surgery was 70 minutes, and the mean estimated blood loss was 150 mL. The mean duration of hospitalization was 12 days. The overall in-patient mortality rate was 10%. The incidence of postoperative delirium was 12%, and the incidence of postoperative pneumonia was 10%. The mean hospital charges per patient were $22,0",
        "levenshtein_distance": 606
    },
    {
        "realidx": "22825590",
        "question": "Longitudinal cohort studies in sub-Saharan Africa are urgently needed to understand cardiovascular disease development. We, therefore, explored health behaviours and conventional risk factors of African individuals with optimal blood pressure (BP) (\u2264 120/80 mm Hg), and their 5-year prediction for the development of hypertension.\nThe Prospective Urban Rural Epidemiology study in the North West Province, South Africa, started in 2005 and included African volunteers (n = 1994; aged>30 years) from a sample of 6000 randomly selected households in rural and urban areas.\nAt baseline, 48% of the participants were hypertensive (\u2265 140/90 mmHg). Those with optimal BP (n = 478) were followed at a success rate of 70% for 5 years (213 normotensive, 68 hypertensive, 57 deceased). Africans that became hypertensive smoked more than the normotensive individuals (68.2% vs 49.8%), and they also had a greater waist circumference [ratio of geometric means of 0.94 cm (95% CI: 0.86-0.99)] and greater amount of \u03b3-glutamyltransferase [0.74 U/l (95% CI: 0.62-0.88)]at baseline. The 5-year change in BP was independently explained by baseline \u03b3-glutamyltransferase [R(2) = 0.23, \u03b2 = 0.13 U/l (95% CI: 0.01-0.19)]. Alcohol intake also predicted central systolic BP and carotid cross-sectional wall area (CSWA) at follow-up. Waist circumference was another predictor of BP changes [\u03b2 = 0.18 cm (95% CI: 0.05-0.24)]and CSWA. HIV infection was inversely associated with increased BP.\nAre behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans?",
        "answer": "yes",
        "answer_rationale": "During the 5 years, 24% of Africans with optimal BP developed hypertension. The surge in hypertension in Africa is largely explained by modifiable risk factors. Public health strategies should focus aggressively on lifestyle to prevent a catastrophic burden on the national health system.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Longitudinal cohort studies in sub-Saharan Africa are urgently needed to understand cardiovascular disease development. We, therefore, explored health behaviours and conventional risk factors of African individuals with optimal blood pressure (BP) (\u2264 120/80 mm Hg), and their 5-year prediction for the development of hypertension.\nThe Prospective Urban Rural Epidemiology study in the North West Province, South Africa, started in 2005 and included African volunteers (n = 1994; aged>30 years) from a sample of 6000 randomly selected households in rural and urban areas.\nAt baseline, 48% of the participants were hypertensive (\u2265 140/90 mmHg). Those with optimal BP (n = 478) were followed at a success rate of 70% for 5 years (213 normotensive, 68 hypertensive, 57 deceased). Africans that became hypertensive smoked more than the normotensive individuals (68.2% vs 49.8%), and they also had a",
        "q2": " greater waist circumference [ratio of geometric means of 0.94 cm (95% CI: 0.86-0.99)] and greater amount of \u03b3-glutamyltransferase [0.74 U/l (95% CI: 0.62-0.88)]at baseline. The 5-year change in BP was independently explained by baseline \u03b3-glutamyltransferase [R(2) = 0.23, \u03b2 = 0.13 U/l (95% CI: 0.01-0.19)]. Alcohol intake also predicted central systolic BP and carotid cross-sectional wall area (CSWA) at follow-up. Waist circumference was another predictor of BP changes [\u03b2 = 0.18 cm (95% CI: 0.05-0.24)]and CSWA. HIV infection was inversely associated with increased BP.\nAre behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans?",
        "generated_text": "higher prevalence of diabetes mellitus (10.3% vs 2.8%). The normotensive group had a higher prevalence of obesity (40.4% vs 27.7%) and central obesity (60.1% vs 44.1%). The hypertensive group had a higher prevalence of metabolic syndrome (44.1% vs 24.4%). The 5-year incidence of hypertension was 32.4% (95% CI: 26.1\u201339.2). The strongest predictors of hypertension were age (OR 1.07; 95% CI: 1.04\u20131.10), male sex (OR 2.14; 95% CI: 1.18\u20133.87), and smoking (OR 1.81; 95% CI: 1.07\u20133.06). The 5-year mortality",
        "levenshtein_distance": 554
    },
    {
        "realidx": "22876568",
        "question": "Celiac disease (CD) is an autoimmune enteropathy characterized by villus atrophy and malabsorption of essential nutrients. Vitamin D deficiency has been described in autoimmune diseases, but its status in prepubertal children with CD has not been adequately studied.\nTo determine the vitamin D status of prepubertal children with CD.\nA retrospective study of prepubertal children aged 3-12 years with CD (n=24) who were compared to prepubertal, non-CD children of the same age (n=50). Children were included in the study if they had a diagnosis of CD by intestinal biopsy, and were not on a gluten-free diet (GFD). Patients were excluded if they had diseases of calcium or vitamin D metabolism, or were receiving calcium or vitamin D supplementation or had other autoimmune diseases. All subjects had their serum 25-hydroxyvitamin D [25(OH)D] level measured.\nThere was no difference in 25(OH)D level between the CD and non-CD children (27.58 +/- 9.91 versus 26.20 +/- 10.45, p = 0.59). However, when the patients were subdivided into obese and non-obese groups, the non-obese CD patients had a significantly higher 25(OH)D level than the obese normal children (28.39 +/- 10.26 versus 21.58 +/- 5.67, p = 0.009). In contrast, there was no difference in 25(OH)D level between non-obese CD patients and non-obese normal children (28.39 +/- 10.26 versus 30.64 +/-12.08, p = 0.52). The season of 25(OH)D measurement was not a significant confounder (p =0.7).\nIs vitamin D deficiency a feature of pediatric celiac disease?",
        "answer": "no",
        "answer_rationale": "Our data showed no difference in 25(OH) D levels between normal children and those with CD when adjusted for body mass index.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Celiac disease (CD) is an autoimmune enteropathy characterized by villus atrophy and malabsorption of essential nutrients. Vitamin D deficiency has been described in autoimmune diseases, but its status in prepubertal children with CD has not been adequately studied.\nTo determine the vitamin D status of prepubertal children with CD.\nA retrospective study of prepubertal children aged 3-12 years with CD (n=24) who were compared to prepubertal, non-CD children of the same age (n=50). Children were included in the study if they had a diagnosis of CD by intestinal biopsy, and were not on a gluten-free diet (GFD). Patients were excluded if they had diseases of calcium or vitamin D metabolism, or were receiving calcium or vitamin D supplementation or had other autoimmune diseases. All subjects had their serum 25-hydroxyvitamin D [25(OH)D] level measured.\nThere was no difference in 25",
        "q2": "(OH)D level between the CD and non-CD children (27.58 +/- 9.91 versus 26.20 +/- 10.45, p = 0.59). However, when the patients were subdivided into obese and non-obese groups, the non-obese CD patients had a significantly higher 25(OH)D level than the obese normal children (28.39 +/- 10.26 versus 21.58 +/- 5.67, p = 0.009). In contrast, there was no difference in 25(OH)D level between non-obese CD patients and non-obese normal children (28.39 +/- 10.26 versus 30.64 +/-12.08, p = 0.52). The season of 25(OH)D measurement was not a significant confounder (p =0.7).\nIs vitamin D deficiency a feature of pediatric celiac disease?",
        "generated_text": "(OH)D levels between the CD and non-CD groups (p=0.12). The mean 25(OH)D level in the CD group was 27.9 ng/mL (SD 10.1) and in the non-CD group was 31.1 ng/mL (SD 10.1). Vitamin D insufficiency was defined as 25(OH)D levels <30 ng/mL and deficiency as <20 ng/mL. There was no difference in the prevalence of vitamin D insufficiency or deficiency between the two groups (p=0.12 and p=0.32, respectively). In the CD group, 46% had vitamin D insufficiency compared to 38% in the non-CD group, and 8% had vitamin D deficiency compared to 4% in the non-CD group.\nIn this study of pre",
        "levenshtein_distance": 454
    },
    {
        "realidx": "22902073",
        "question": "The purpose of this study was to investigate whether knowledge of ultrasound-obtained estimated fetal weight (US-EFW) is a risk factor for cesarean delivery (CD).\nRetrospective cohort from a single center in 2009-2010 of singleton, term live births. CD rates were compared for women with and without US-EFW within 1 month of delivery and adjusted for potential confounders.\nOf the 2329 women in our cohort, 50.2% had US-EFW within 1 month of delivery. CD was significantly more common for women with US-EFW (15.7% vs 10.2%; P<.001); after we controlled for confounders, US-EFW remained an independent risk factor for CD (odds ratio, 1.44; 95% confidence interval, 1.1-1.9). The risk increased when US-EFW was>3500 g (odds ratio, 1.8; 95% confidence interval, 1.3-2.7).\nEstimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery?",
        "answer": "yes",
        "answer_rationale": "Knowledge of US-EFW, above and beyond the impact of fetal size itself, increases the risk of CD. Acquisition of US-EFW near term appears to be an independent and potentially modifiable risk factor for CD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study was to investigate whether knowledge of ultrasound-obtained estimated fetal weight (US-EFW) is a risk factor for cesarean delivery (CD).\nRetrospective cohort from a single center in 2009-2010 of singleton, term live births. CD rates were compared for women with and without US-EFW within 1 month of delivery and adjusted for potential confounders.\nOf the 2329 women in our cohort, 50.2% had US-EFW within 1 month of delivery. CD was significantly more common for women",
        "q2": " with US-EFW (15.7% vs 10.2%; P<.001); after we controlled for confounders, US-EFW remained an independent risk factor for CD (odds ratio, 1.44; 95% confidence interval, 1.1-1.9). The risk increased when US-EFW was>3500 g (odds ratio, 1.8; 95% confidence interval, 1.3-2.7).\nEstimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery?",
        "generated_text": "with US-EFW (25.1% vs. 17.4%, p < 0.001). After adjustment for potential confounders, US-EFW was associated with a 1.7-fold increased risk of CD (95% CI 1.3-2.2). The association was stronger for women with US-EFW \u22654000 g (aOR 2.4, 95% CI 1.4-4.0) and for nulliparous women (aOR 2.1",
        "levenshtein_distance": 244
    },
    {
        "realidx": "23025584",
        "question": "That alcohol consumption is strongly influenced by the drinking behavior of social company has been demonstrated in observational research. However, not everyone is equally vulnerable to other people's drinking, and it is important to unravel which factors underlie these individual differences. This study focuses on the role of psychosocial stress in attempting to explain individual differences in the propensity to imitate alcohol consumption.\nWith a 2 (confederate's drinking condition: alcohol vs. soda) \u00d7 2 (participant's stress condition: stress vs. no stress) experimental design, we tested whether the tendency to imitate other people's drinking was related to participants' induced stress levels. The young male adults (N = 106) were randomly assigned to each of the conditions. In each session, directly after the stress or no-stress period, confederates and participants entered a bar laboratory where we observed their drinking behavior. Prior to entering the session, confederates were instructed to drink alcohol or soda.\nParticipants in both stress and no-stress conditions consumed substantially more alcohol when confederates drank alcohol than when they drank soda. There was no difference in alcohol consumed between stress and no-stress conditions. No moderating effect of stress on the tendency to drink along with peers was found.\nDoes stress increase imitation of drinking behavior?",
        "answer": "no",
        "answer_rationale": "Generally, it appears that among young male adults, imitation of alcohol consumption is a robust phenomenon not dependent on individual stress levels.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "That alcohol consumption is strongly influenced by the drinking behavior of social company has been demonstrated in observational research. However, not everyone is equally vulnerable to other people's drinking, and it is important to unravel which factors underlie these individual differences. This study focuses on the role of psychosocial stress in attempting to explain individual differences in the propensity to imitate alcohol consumption.\nWith a 2 (confederate's drinking condition: alcohol vs. soda) \u00d7 2 (participant's stress condition: stress vs. no stress) experimental design, we tested whether the tendency to imitate other people's drinking was related to participants' induced stress levels. The young male",
        "q2": " adults (N = 106) were randomly assigned to each of the conditions. In each session, directly after the stress or no-stress period, confederates and participants entered a bar laboratory where we observed their drinking behavior. Prior to entering the session, confederates were instructed to drink alcohol or soda.\nParticipants in both stress and no-stress conditions consumed substantially more alcohol when confederates drank alcohol than when they drank soda. There was no difference in alcohol consumed between stress and no-stress conditions. No moderating effect of stress on the tendency to drink along with peers was found.\nDoes stress increase imitation of drinking behavior?",
        "generated_text": "participants (N = 100) were randomly assigned to one of the four experimental conditions. In the stress condition, participants were exposed to the Trier Social Stress Test (TSST) before the drinking session, whereas in the no stress condition, participants were not exposed to the TSST. During the drinking session, participants and their confederate were instructed to drink either an alcoholic beverage or a non-alcoholic beverage. The amount of alcohol consumed by the participant was measured.\nParticipants in the stress condition drank more alcohol than participants in the no stress condition, but only when the confederate drank alcohol. No differences in alcohol consumption",
        "levenshtein_distance": 464
    },
    {
        "realidx": "23076787",
        "question": "To explain China's cigarette pricing mechanism and the role of the Chinese State Tobacco Monopoly Administration (STMA) on cigarette pricing and taxation.\nPublished government tobacco tax documentation and statistics published by the Chinese STMA are used to analyse the interrelations among industry profits, taxes and retail price of cigarettes in China.\nThe 2009 excise tax increase on cigarettes in China has not translated into higher retail prices because the Chinese STMA used its policy authority to ensure that retail cigarette prices did not change. The government tax increase is being collected at both the producer and wholesale levels. As a result, the 2009 excise tax increase in China has resulted in higher tax revenue for the government and lower profits for the tobacco industry, with no increase in the retail price of cigarettes for consumers.\nCan increases in the cigarette tax rate be linked to cigarette retail prices?",
        "answer": "no",
        "answer_rationale": "Numerous studies have found that taxation is one of the most effective policy instruments for tobacco control. However, these findings come from countries that have market economies where market forces determine prices and influence how cigarette taxes are passed to the consumers in retail prices. China's tobacco industry is not a market economy; therefore, non-market forces and the current Chinese tobacco monopoly system determine cigarette prices. The result is that tax increases do not necessarily get passed on to the retail price.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To explain China's cigarette pricing mechanism and the role of the Chinese State Tobacco Monopoly Administration (STMA) on cigarette pricing and taxation.\nPublished government tobacco tax documentation and statistics published by the Chinese STMA are used to analyse the interrelations among industry profits, taxes and retail price of cigarettes in China.\nThe 2009 excise tax increase on cigarettes in China has not translated into higher retail prices because the Chinese STMA used",
        "q2": " its policy authority to ensure that retail cigarette prices did not change. The government tax increase is being collected at both the producer and wholesale levels. As a result, the 2009 excise tax increase in China has resulted in higher tax revenue for the government and lower profits for the tobacco industry, with no increase in the retail price of cigarettes for consumers.\nCan increases in the cigarette tax rate be linked to cigarette retail prices?",
        "generated_text": "the tax increase to subsidise the industry and to increase its own profits.\nThe Chinese STMA has been using the tax increase to subsidise the industry and to increase its own profits, rather than passing the increased tax burden onto consumers through higher retail prices.\nThis has resulted in a decrease in the real price of cigarettes in China, which may have contributed to the continued high prevalence of smoking in the country.\nThe Chinese government should",
        "levenshtein_distance": 334
    },
    {
        "realidx": "23149821",
        "question": "A higher prevalence of cardiovascular risk factors (CRFs) in HIV-infected patients, together with chronic infection and treatments, has resulted in an increased risk of silent myocardial ischaemia (SMI). The objective of this study was to evaluate whether myocardial SPECT should be used for screening HIV-infected patients with no clinical symptoms of coronary artery disease.\nThe prevalence of SMI detected by myocardial SPECT was determined in 94 HIV-infected patients with a normal clinical cardiovascular examination in relation to anthropomorphic parameters, CRFs, inflammatory and HIV infection status, and treatment.\nCoronary artery disease was detected in nine patients (eight with ischaemia, one with myocardial infarction), corresponding to 9.6 % positivity. All but two of the scintigraphic diagnoses of ischaemia were confirmed by coronarography. Univariate analysis revealed that the overall number of CRFs and the combination of gender and age were associated with a diagnosis of SMI (p<0.05). According to multivariate analysis, the only independent parameter significantly associated with the scintigraphic diagnosis of SMI was the combination of gender and age (p = 0.01). All the positive myocardial SPECT scans were in men older than 52 years with at least two other CRFs. In this subpopulation of 47 patients, the prevalence of SMI detected by myocardial SPECT reached 19.2 %.\nShould HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?",
        "answer": "maybe",
        "answer_rationale": "In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "A higher prevalence of cardiovascular risk factors (CRFs) in HIV-infected patients, together with chronic infection and treatments, has resulted in an increased risk of silent myocardial ischaemia (SMI). The objective of this study was to evaluate whether myocardial SPECT should be used for screening HIV-infected patients with no clinical symptoms of coronary artery disease.\nThe prevalence of SMI detected by myocardial SPECT was determined in 94 HIV-infected patients with a normal clinical cardiovascular examination in relation to anthropomorphic parameters, CRFs, inflammatory and HIV infection status, and treatment.\nCoronary artery disease was detected in nine patients (eight with ischaemia, one with myocardial infarction), corresponding to 9.6 % positivity. All but two of the scint",
        "q2": "igraphic diagnoses of ischaemia were confirmed by coronarography. Univariate analysis revealed that the overall number of CRFs and the combination of gender and age were associated with a diagnosis of SMI (p<0.05). According to multivariate analysis, the only independent parameter significantly associated with the scintigraphic diagnosis of SMI was the combination of gender and age (p = 0.01). All the positive myocardial SPECT scans were in men older than 52 years with at least two other CRFs. In this subpopulation of 47 patients, the prevalence of SMI detected by myocardial SPECT reached 19.2 %.\nShould HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?",
        "generated_text": "igraphic abnormalities were reversible. The prevalence of SMI was higher in patients with a higher number of CRFs (p = 0.001). The presence of SMI was associated with older age (p = 0.001), higher body mass index (p = 0.001), higher waist circumference (p = 0.001), higher total cholesterol (p = 0.001), higher low-density lipoprotein cholesterol (p = 0.001), higher triglycerides (p = 0.001), higher C-reactive protein (p = 0.001), higher interleukin-6 (p = 0.001",
        "levenshtein_distance": 519
    },
    {
        "realidx": "23177368",
        "question": "Immediate breast reconstruction (IBR) provides psychological benefit to many early breast cancer patients however concerns persist regarding its potential impact on chemotherapy delivery. We investigated the association between IBR, complications and adjuvant chemotherapy delivery.\nRetrospective analysis of patients in an academic breast service, who underwent mastectomy, with or without reconstruction, and received adjuvant chemotherapy.\nComparisons were made between 107 patients who received IBR and 113 who received mastectomy alone. Those receiving IBR were on average younger, with lower body mass index (BMI) and better prognoses. Overall complication rates were comparable (mastectomy alone: 45.1% versus IBR: 35.5%, p = 0.2). There was more return to surgery in the IBR group with 11.5% of tissue expanders requiring removal, whilst more seromas occurred in the mastectomy group. There was no significant difference in the median time to chemotherapy.\nDoes immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?",
        "answer": "no",
        "answer_rationale": "We found no evidence that IBR compromised the delivery of adjuvant chemotherapy, although there was a significant incidence of implant infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Immediate breast reconstruction (IBR) provides psychological benefit to many early breast cancer patients however concerns persist regarding its potential impact on chemotherapy delivery. We investigated the association between IBR, complications and adjuvant chemotherapy delivery.\nRetrospective analysis of patients in an academic breast service, who underwent mastectomy, with or without reconstruction, and received adjuvant chemotherapy.\nComparisons were made between 107 patients who received IBR and 113 who received mastectomy alone. Those receiving IBR were on average younger, with",
        "q2": " lower body mass index (BMI) and better prognoses. Overall complication rates were comparable (mastectomy alone: 45.1% versus IBR: 35.5%, p = 0.2). There was more return to surgery in the IBR group with 11.5% of tissue expanders requiring removal, whilst more seromas occurred in the mastectomy group. There was no significant difference in the median time to chemotherapy.\nDoes immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?",
        "generated_text": "higher body mass index (BMI), more likely to be smokers, have larger tumours and higher grade disease. IBR patients were more likely to receive anthracycline-based chemotherapy (p=0.001). There was no difference in the proportion of patients who received chemotherapy as intended (p=0.12). There was no difference in the proportion of patients who received chemotherapy as intended (p=0.12). There was no difference in the proportion of patients who received chemotherapy as intended (p",
        "levenshtein_distance": 351
    },
    {
        "realidx": "23224030",
        "question": "Individuals with type 1 diabetes have a high risk of developing cardiovascular diseases, and it has been reported that they consume a high atherogenic diet. We examined how nutrient intake and adherence to current European nutritional recommendations evolved in a large cohort of European individuals with type 1 diabetes over a period of 7 years.SUBJECTS/\nWe analysed data from the EURODIAB Prospective Complications Study, a European multicentre prospective cohort study. Standardized 3-day dietary records were employed in individuals with type 1 diabetes. One thousand one hundred and two patients (553 men, 549 women, baseline age 33 \u00b1 10 years, duration 15 \u00b1 9 years) had complete nutritional data available at baseline and after 7 years. We calculated mean differences in reported nutrients over time and adjusted these for age, gender, HbA1c and BMI with ANOVA models.\nCompared to baseline, there were minor changes in nutrients. Reported protein (-0.35% energy (en), fat (-1.07% en), saturated fat (-0.25% en) and cholesterol (-7.42 mg/1000 kcal) intakes were lower, whereas carbohydrate (+1.23% en) and fibre (+0.46 g/1000 kcal) intakes were higher at the 7-year follow-up. European recommendations for adequate nutrient intakes were followed in individuals with type 1 diabetes for protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 2.4%) and saturated fat (11, 13%).\nDo European people with type 1 diabetes consume a high atherogenic diet?",
        "answer": "yes",
        "answer_rationale": "European individuals with type 1 diabetes consume a high atherogenic diet as few patients met recommendations for dietary fibre and saturated fat. This study showed minor changes in dietary nutrients and energy intakes over a period of 7 years. Nutrition education needs particular focus on strategies to increase dietary fibre and reduce saturated fat to exploit their potential benefit.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Individuals with type 1 diabetes have a high risk of developing cardiovascular diseases, and it has been reported that they consume a high atherogenic diet. We examined how nutrient intake and adherence to current European nutritional recommendations evolved in a large cohort of European individuals with type 1 diabetes over a period of 7 years.SUBJECTS/\nWe analysed data from the EURODIAB Prospective Complications Study, a European multicentre prospective cohort study. Standardized 3-day dietary records were employed in individuals with type 1 diabetes. One thousand one hundred and two patients (553 men, 549 women, baseline age 33 \u00b1 10 years, duration 15 \u00b1 9 years) had complete nutritional data available at baseline and after 7 years. We calculated mean differences in reported nutrients over time and adjusted these for age, gender, HbA1c and BMI with ANOVA models.\nCompared to baseline",
        "q2": ", there were minor changes in nutrients. Reported protein (-0.35% energy (en), fat (-1.07% en), saturated fat (-0.25% en) and cholesterol (-7.42 mg/1000 kcal) intakes were lower, whereas carbohydrate (+1.23% en) and fibre (+0.46 g/1000 kcal) intakes were higher at the 7-year follow-up. European recommendations for adequate nutrient intakes were followed in individuals with type 1 diabetes for protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 2.4%) and saturated fat (11, 13%).\nDo European people with type 1 diabetes consume a high atherogenic diet?",
        "generated_text": ", the cohort reported a significant increase in energy intake (100 kcal/day, P < 0.001), protein (2.5 g/day, P < 0.001), fat (5.5 g/day, P < 0.001), saturated fatty acids (1.5 g/day, P < 0.001), cholesterol (15 mg/day, P < 0.001), and a decrease in carbohydrate (5.5 g/day, P < 0.001), fibre (0.5 g/day, P < 0.001), and alcohol (1.5 g/day, P < 0.001). The proportion of patients who met the recommendations for saturated fatty acids, cholesterol, and fibre decreased over time, whereas the proportion who met the recommendations for carbohydrate and",
        "levenshtein_distance": 500
    },
    {
        "realidx": "23283159",
        "question": "To investigate the effect of obesity at the start of adolescence on the prevalence, incidence and maintenance of chest wheezing among individuals aged 11-15 years in a birth cohort in a developing country.\nThe seventh follow-up of the 1993 Pelotas birth cohort occurred in 2004 (individuals aged 10-11 years). Between January and August 2008, the eighth follow-up of the cohort was conducted. All the individuals of the original cohort who were alive (who were then adolescents aged between 14 and 15 years) were targets for the study. The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire was used to define wheezing. In addition to the body mass index (BMI), used to define obesity by the World Health Organization (WHO) criteria, we assessed skinfold thickness.\nFrom the original cohort, 4,349 individuals were located (85.7% follow-up rate). The prevalence of chest wheezing at 11 and 15 years were 13.5% (95% CI: 12.5%-14.5%) and 12.1% (95% CI: 11.1%-13.1%), respectively. The prevalence of wheezing at both times was 4.5% (95% CI: 3.9%-5.1%) and the incidence of wheezing was 7.5% (95% CI: 6.7%-8.3%). Independent of the effect of various confounding variables, the prevalence of wheezing at 15 years was 50% greater among obese individuals than among eutrophic individuals at 11 years (RR 1.53; 95% CI: 1.14-2.05). The greater the skinfold tertile at 11 years, the higher the prevalence of wheezing at 15 years was (p = .011). Weight status and skinfolds did not present any association with incident wheezing. After controlling for confounding factors, the risk of persistent wheezing among obese individuals at 11 years was 1.82 (95% CI: 1.30-2.54).\nIs obesity a risk factor for wheezing among adolescents?",
        "answer": "yes",
        "answer_rationale": "Since obesity at the start of adolescence is associated with asthma symptom persistence, prevention and treatment of obesity may reduce avoidable healthcare costs and disease burden.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the effect of obesity at the start of adolescence on the prevalence, incidence and maintenance of chest wheezing among individuals aged 11-15 years in a birth cohort in a developing country.\nThe seventh follow-up of the 1993 Pelotas birth cohort occurred in 2004 (individuals aged 10-11 years). Between January and August 2008, the eighth follow-up of the cohort was conducted. All the individuals of the original cohort who were alive (who were then adolescents aged between 14 and 15 years) were targets for the study. The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire was used to define wheezing. In addition to the body mass index (BMI), used to define obesity by the World Health Organization (WHO) criteria, we assessed skinfold thickness.\nFrom the original cohort, 4,349 individuals were located (85.7% follow-up rate). The prevalence of chest wheezing at 11 and 15 years were 13.5% (95% CI: 12.5%-14.5%) and 12",
        "q2": ".1% (95% CI: 11.1%-13.1%), respectively. The prevalence of wheezing at both times was 4.5% (95% CI: 3.9%-5.1%) and the incidence of wheezing was 7.5% (95% CI: 6.7%-8.3%). Independent of the effect of various confounding variables, the prevalence of wheezing at 15 years was 50% greater among obese individuals than among eutrophic individuals at 11 years (RR 1.53; 95% CI: 1.14-2.05). The greater the skinfold tertile at 11 years, the higher the prevalence of wheezing at 15 years was (p = .011). Weight status and skinfolds did not present any association with incident wheezing. After controlling for confounding factors, the risk of persistent wheezing among obese individuals at 11 years was 1.82 (95% CI: 1.30-2.54).\nIs obesity a risk factor for wheezing among adolescents?",
        "generated_text": ".4% (95% CI: 11.5%-13.3%), respectively. The incidence of chest wheezing between 11 and 15 years was 5.1% (95% CI: 4.5%-5.7%). Obesity at 11 years was associated with chest wheezing at 15 years (OR = 1.52; 95% CI: 1.07-2.16). Obesity at 11 years was associated with the incidence of chest wheezing between 11 and 15 years (OR = 1.52; 95% CI: 1.07-2.16). Obesity at 11 years was associated with the maintenance of chest wheezing between 11 and 15 years (OR = 1.71; 95% CI: 1.01-2.90). The association between obesity and chest wheezing was stronger in males.\nObesity at the start of adolescence",
        "levenshtein_distance": 500
    },
    {
        "realidx": "23321509",
        "question": "To evaluate surgical outcome and survival benefit after quaternary cytoreduction (QC) in epithelial ovarian cancer (EOC) relapse.\nWe systematically evaluated all consecutive patients undergoing QC in our institution over a 12-year period (October 2000-January 2012). All relevant surgical and clinical outcome parameters were systematically assessed.\nForty-nine EOC patients (median age: 57; range: 28-76) underwent QC; in a median of 16 months (range:2-142) after previous chemotherapy. The majority of the patients had an initial FIGO stage III (67.3%), peritoneal carcinomatosis (77.6%) and no ascites (67.3%). At QC, patients presented following tumour pattern: lower abdomen 85.7%; middle abdomen 79.6% and upper abdomen 42.9%. Median duration of surgery was 292 min (range: a total macroscopic tumour clearance could be achieved. Rates of major operative morbidity and 30-day mortality were 28.6% and 2%, respectively.Mean follow-up from QC was 18.41 months (95% confidence interval (CI):12.64-24.18) and mean overall survival (OS) 23.05 months (95% CI: 15.5-30.6). Mean OS for patients without vs any tumour residuals was 43 months (95% CI: 26.4-59.5) vs 13.4 months (95% CI: 7.42-19.4); P=0.001. Mean OS for patients who received postoperative chemotherapy (n=18; 36.7%) vs those who did not was 40.5 months (95% CI: 27.4-53.6) vs 12.03 months (95% CI: 5.9-18.18); P<0.001.Multivariate analysis indentified multifocal tumour dissemination to be of predictive significance for incomplete tumour resection, higher operative morbidity and lower survival, while systemic chemotherapy subsequent to QC had a protective significant impact on OS. No prognostic impact had ascites, platinum resistance, high grading and advanced age.\nQuaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?",
        "answer": "yes",
        "answer_rationale": "Even in this highly advanced setting of the third EOC relapse, maximal therapeutic effort combining optimal surgery and chemotherapy appear to significantly prolong survival in a selected patients 'group'.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate surgical outcome and survival benefit after quaternary cytoreduction (QC) in epithelial ovarian cancer (EOC) relapse.\nWe systematically evaluated all consecutive patients undergoing QC in our institution over a 12-year period (October 2000-January 2012). All relevant surgical and clinical outcome parameters were systematically assessed.\nForty-nine EOC patients (median age: 57; range: 28-76) underwent QC; in a median of 16 months (range:2-142) after previous chemotherapy. The majority of the patients had an initial FIGO stage III (67.3%), peritoneal carcinomatosis (77.6%) and no ascites (67.3%). At QC, patients presented following tumour pattern: lower abdomen 85.7%; middle abdomen 79.6% and upper abdomen 42.9%. Median duration of surgery was 292 min (range: a total macroscopic tumour clearance could be achieved. Rates of major operative morbidity and 30-day mortality were 28.6% and 2%, respectively.Mean follow-up from QC was 18.41 months (95% confidence interval",
        "q2": " (CI):12.64-24.18) and mean overall survival (OS) 23.05 months (95% CI: 15.5-30.6). Mean OS for patients without vs any tumour residuals was 43 months (95% CI: 26.4-59.5) vs 13.4 months (95% CI: 7.42-19.4); P=0.001. Mean OS for patients who received postoperative chemotherapy (n=18; 36.7%) vs those who did not was 40.5 months (95% CI: 27.4-53.6) vs 12.03 months (95% CI: 5.9-18.18); P<0.001.Multivariate analysis indentified multifocal tumour dissemination to be of predictive significance for incomplete tumour resection, higher operative morbidity and lower survival, while systemic chemotherapy subsequent to QC had a protective significant impact on OS. No prognostic impact had ascites, platinum resistance, high grading and advanced age.\nQuaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?",
        "generated_text": "[CI]: 14.1-22.7). The median progression-free survival (PFS) and overall survival (OS) from QC were 10.1 months (95% CI: 7.1-13.1) and 21.1 months (95% CI: 15.1-27.1), respectively. In multivariate analysis, the only independent prognostic factor for PFS was the number of previous lines of chemotherapy (p=0.001). For OS, the only independent prognostic factor was the achievement of a total macroscopic tumour clearance (p=0.001).\nQC in EOC relapse is feasible and safe, with acceptable morbidity and mortality rates. The achievement of a total macroscopic tumour clearance is associated with a significant survival benefit.",
        "levenshtein_distance": 605
    },
    {
        "realidx": "23347337",
        "question": "To provide equality of cancer care to rural patients, Townsville Cancer Centre administers intensive chemotherapy regimens to rural patients with node-positive breast and metastatic colorectal cancers at the same doses as urban patients. Side-effects were usually managed by rural general practitioners locally.AIM: The aim is to determine the safety of this practice by comparing the profile of serious adverse events and dose intensities between urban and rural patients at the Townsville Cancer Centre.\nA retrospective audit was conducted in patients with metastatic colorectal and node-positive breast cancers during a 24-month period. Fisher's exact test was used for analysis. Rurality was determined as per rural, remote and metropolitan classification.\nOf the 121 patients included, 70 and 51 patients had breast and colon cancers respectively. The urban versus rural patient split among all patients, breast and colorectal cancer subgroups was 68 versus 53, 43 versus 27 and 25 versus 26 respectively. A total of 421 cycles was given with dose intensity of>95% for breast cancer in both groups (P>0.05). Rate of febrile neutropenia was 9.3% versus 7.4% (P = 0.56). For XELOX, rate of diarrhoea was 20% versus 19% (P = 0.66) and rate of vomiting was 20% versus 11% (P = 0.11). Only two patients were transferred to Townsville for admission. No toxic death occurred in either group.\nIs intensive chemotherapy safe for rural cancer patients?",
        "answer": "yes",
        "answer_rationale": "It appears safe to administer intensive chemotherapy regimens at standard doses to rural patients without increased morbidity or mortality. Support for general practitioners through phone or videoconferencing may reduce the safety concerns.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To provide equality of cancer care to rural patients, Townsville Cancer Centre administers intensive chemotherapy regimens to rural patients with node-positive breast and metastatic colorectal cancers at the same doses as urban patients. Side-effects were usually managed by rural general practitioners locally.AIM: The aim is to determine the safety of this practice by comparing the profile of serious adverse events and dose intensities between urban and rural patients at the Townsville Cancer Centre.\nA retrospective audit was conducted in patients with metastatic colorectal and node-positive breast cancers during a 24-month period. Fisher's exact test was used for analysis. Rurality was determined as per rural, remote and metropolitan classification.\nOf the 121 patients included, 70 and 51 patients had breast and colon cancers respectively. The urban versus rural patient split among all",
        "q2": " patients, breast and colorectal cancer subgroups was 68 versus 53, 43 versus 27 and 25 versus 26 respectively. A total of 421 cycles was given with dose intensity of>95% for breast cancer in both groups (P>0.05). Rate of febrile neutropenia was 9.3% versus 7.4% (P = 0.56). For XELOX, rate of diarrhoea was 20% versus 19% (P = 0.66) and rate of vomiting was 20% versus 11% (P = 0.11). Only two patients were transferred to Townsville for admission. No toxic death occurred in either group.\nIs intensive chemotherapy safe for rural cancer patients?",
        "generated_text": "patients was 54% versus 46%. The median age was 59 years (range 27-84 years). The median number of cycles was 6 (range 1-24 cycles). The median relative dose intensity was 94% (range 40-110%). The median time to first dose reduction was 4 months (range 1-12 months). The median time to first treatment delay was 2 months (range 1-12 months). The median time to first treatment discontinuation was 4 months (range 1-12 months). The median time to first hospitalisation was 2 months (range 1-12 months). The median time to first emergency department presentation was 2",
        "levenshtein_distance": 432
    },
    {
        "realidx": "23359100",
        "question": "Heterotopic ossification is a common complication after total hip arthroplasty. Non-steroidal anti-inflammatory drugs (NSAIDs) are known to prevent heterotopic ossifications effectively, however gastrointestinal complaints are reported frequently. In this study, we investigated whether etoricoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor that produces fewer gastrointestinal side effects, is an effective alternative for the prevention of heterotopic ossification.\nWe investigated the effectiveness of oral etoricoxib 90 mg for seven days in a prospective two-stage study design for phase-2 clinical trials in a small sample of patients (n\u2009=\u200942). A cemented primary total hip arthroplasty was implanted for osteoarthritis. Six months after surgery, heterotopic ossification was determined on anteroposterior pelvic radiographs using the Brooker classification.\nNo heterotopic ossification was found in 62 % of the patients that took etoricoxib; 31 % of the patients had Brooker grade 1 and 7 % Brooker grade 2 ossification.\nIs etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?",
        "answer": "yes",
        "answer_rationale": "Etoricoxib seems effective in preventing heterotopic ossification after total hip arthroplasty. This finding further supports the use of COX-2 inhibitors for the prevention of heterotopic ossification following total hip arthroplasty.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Heterotopic ossification is a common complication after total hip arthroplasty. Non-steroidal anti-inflammatory drugs (NSAIDs) are known to prevent heterotopic ossifications effectively, however gastrointestinal complaints are reported frequently. In this study, we investigated whether etoricoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor that produces fewer gastrointestinal side effects, is an effective alternative for the prevention of heterotopic ossification.\nWe investigated the effectiveness of oral etoricoxib 90 mg for seven days in a prospective two-stage study design for phase-2 clinical",
        "q2": " trials in a small sample of patients (n\u2009=\u200942). A cemented primary total hip arthroplasty was implanted for osteoarthritis. Six months after surgery, heterotopic ossification was determined on anteroposterior pelvic radiographs using the Brooker classification.\nNo heterotopic ossification was found in 62 % of the patients that took etoricoxib; 31 % of the patients had Brooker grade 1 and 7 % Brooker grade 2 ossification.\nIs etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?",
        "generated_text": "trials. The primary endpoint was the incidence of heterotopic ossification, which was assessed by radiographs and the Brooker classification. The secondary endpoints were the incidence of gastrointestinal complaints and the functional outcome, which was assessed by the Harris hip score.\nA total of 100 patients were included in the study. The incidence of heterotopic ossification was 12% in the etoricoxib group and 14% in the control group (p = 0.74). The incidence of gastrointestinal complaints was 12% in the etoricoxib group and 16",
        "levenshtein_distance": 416
    },
    {
        "realidx": "23361217",
        "question": "There are a number of factors responsible for the longevity of unicompartmental knee replacements (UKR). These include the magnitude of postoperative alignment and the type of material used. The effect of component design and material on postoperative alignment, however, has not been explored.\nWe retrospectively reviewed 89 patients who underwent UKR with robotic guidance. Patients were divided into two groups, according to whether they had received an all-polyethylene inlay component (Inlay group) or a metal-backed onlay component (Onlay group). We explored the magnitude of mechanical alignment correction obtained in both groups.\nMean postoperative mechanical alignment was significantly closer to neutral in the Onlay group (mean=2.8\u00b0; 95% CI=2.4\u00b0, 3.2\u00b0) compared to the Inlay group (mean=3.9\u00b0; 95% CI=3.4\u00b0, 4.4\u00b0) (R2=0.65; P=0.003), adjusting for gender, BMI, age, side and preoperative mechanical alignment (Fig. 2). Further exploration revealed that the thickness of the tibial polyethyelene insert had a significant effect on postoperative alignment when added to the model (R2=0.68; P=0.01).\nDoes the type of tibial component affect mechanical alignment in unicompartmental knee replacement?",
        "answer": "yes",
        "answer_rationale": "Patients who received a metal-backed Onlay tibial component obtained better postoperative mechanical alignment compared to those who received all-polyethylene Inlay prostheses. The thicker overall construct of Onlay prostheses appears to be an important determinant of postoperative alignment. Considering their higher survivorship rates and improved postoperative mechanical alignment, Onlay prostheses should be the first option when performing medial UKR.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "There are a number of factors responsible for the longevity of unicompartmental knee replacements (UKR). These include the magnitude of postoperative alignment and the type of material used. The effect of component design and material on postoperative alignment, however, has not been explored.\nWe retrospectively reviewed 89 patients who underwent UKR with robotic guidance. Patients were divided into two groups, according to whether they had received an all-polyethylene inlay component (Inlay group) or a metal-backed onlay component (Onlay group). We explored the magnitude of mechanical alignment correction obtained in both groups.\nMean postoperative mechanical alignment was significantly closer to neutral in the Onlay group (mean=2.8",
        "q2": "\u00b0; 95% CI=2.4\u00b0, 3.2\u00b0) compared to the Inlay group (mean=3.9\u00b0; 95% CI=3.4\u00b0, 4.4\u00b0) (R2=0.65; P=0.003), adjusting for gender, BMI, age, side and preoperative mechanical alignment (Fig. 2). Further exploration revealed that the thickness of the tibial polyethyelene insert had a significant effect on postoperative alignment when added to the model (R2=0.68; P=0.01).\nDoes the type of tibial component affect mechanical alignment in unicompartmental knee replacement?",
        "generated_text": "\u00b0, SD=2.1\u00b0) compared to the Inlay group (mean=4.1\u00b0, SD=2.4\u00b0) (p=0.002). The Onlay group also had a significantly higher proportion of patients with postoperative mechanical alignment within 3\u00b0 of neutral (75% vs. 47%, p=0.004). There was no significant difference in the magnitude of mechanical alignment correction between the two groups (p=0.11).\nThe type of component used in UKR affects the magnitude of postoperative alignment correction. The use of a metal-backed onlay component allows for greater correction of mechanical alignment compared to",
        "levenshtein_distance": 367
    },
    {
        "realidx": "23375036",
        "question": "To determine whether the OraQuick\u00ae HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem, PA, USA) in sputum is a valid tool for HIV surveillance among TB patients.\nA cross sectional study was carried out on sputa of patients diagnosed with tuberculosis. Sputa were tested for antibodies to HIV using OraQuick\u00ae HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem, PA, USA). The results were compared with results of serum ELISA.\nCompared to serum ELISA, the OraQuick\u00ae HIV-1/2 Assay in sputum specimens reported 90% sensitivity (9/10) and 100% specificity (307/307), with a positive predictive value of 100% (95%CI: 66.37%-100.00%) and a negative predictive value of 99.68% (95%CI: 98.20%-99.99%).\nAn HIV1/2 point of care test on sputum for screening TB/HIV co-infection in Central India - Will it work?",
        "answer": "yes",
        "answer_rationale": "This testing method may provide a useful strategy for conducting HIV surveillance in possible co-infected TB patients at peripheral centres. Since there is no investment on infrastructure, it may be possible for paramedical health professionals to carry out the test, particularly in areas with low HIV endemicity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine whether the OraQuick\u00ae HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem, PA, USA) in sputum is a valid tool for HIV surveillance among TB patients.\nA cross sectional study was carried out on sputa of patients diagnosed with tuberculosis. Sputa were tested for antibodies to HIV using OraQuick\u00ae HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem, PA, USA). The results were compared with results of serum ELISA.\nCompared to serum ELISA, the OraQuick",
        "q2": "\u00ae HIV-1/2 Assay in sputum specimens reported 90% sensitivity (9/10) and 100% specificity (307/307), with a positive predictive value of 100% (95%CI: 66.37%-100.00%) and a negative predictive value of 99.68% (95%CI: 98.20%-99.99%).\nAn HIV1/2 point of care test on sputum for screening TB/HIV co-infection in Central India - Will it work?",
        "generated_text": "\u00ae HIV-1/2 Assay in sputum had a sensitivity of 97.1% (95% CI: 92.1-99.3), specificity of 98.2% (95% CI: 94.4-99.6), positive predictive value of 97.1% (95% CI: 92.1-99.3), negative predictive value of 98.2% (95% CI: 9",
        "levenshtein_distance": 205
    },
    {
        "realidx": "23379759",
        "question": "The aims of the study were to report the rates of recurrent and residual cholesteatoma following primary CAT surgery and to report the rate of conversion to a modified radical mastoidectomy.\nThis was a retrospective review of a single surgeon series between 2006 and 2012.\nIn total 132 second-look operations were undertaken, with a mean interval between primary surgery and second-look procedures of 6 months. The rate of cholesteatoma at second-look surgery was 19.7%, which was split into residual disease (10.6%) and recurrent disease (9.09%). New tympanic membrane defects with cholesteatoma were considered as recurrent disease. Residual disease was defined as cholesteatoma present behind an intact tympanic membrane. The majority of recurrent and residual disease was easily removed at second look (73.1%). Only four cases were converted to a modified radical mastoidectomy (3%) and three cases required a third-look procedure.\nCan early second-look tympanoplasty reduce the rate of conversion to modified radical mastoidectomy?",
        "answer": "yes",
        "answer_rationale": "Combined approach tympanoplasty (CAT) allows for successful treatment of cholesteatoma with rates of recurrent and residual disease comparable to open mastoid surgery. Early timing of second-look procedures allows easier removal of any recurrent or residual disease, which reduces the conversion rate to open mastoidectomy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The aims of the study were to report the rates of recurrent and residual cholesteatoma following primary CAT surgery and to report the rate of conversion to a modified radical mastoidectomy.\nThis was a retrospective review of a single surgeon series between 2006 and 2012.\nIn total 132 second-look operations were undertaken, with a mean interval between primary surgery and second-look procedures of 6 months. The rate of cholesteatoma at second-look surgery was 19.7%, which was split into residual disease (",
        "q2": "10.6%) and recurrent disease (9.09%). New tympanic membrane defects with cholesteatoma were considered as recurrent disease. Residual disease was defined as cholesteatoma present behind an intact tympanic membrane. The majority of recurrent and residual disease was easily removed at second look (73.1%). Only four cases were converted to a modified radical mastoidectomy (3%) and three cases required a third-look procedure.\nCan early second-look tympanoplasty reduce the rate of conversion to modified radical mastoidectomy?",
        "generated_text": "10.6%) and recurrent disease (9.1%). The rate of conversion to a modified radical mastoidectomy was 1.5%.\nThe rate of residual and recurrent cholesteatoma at second-look surgery was 19.7%. The rate of conversion to a modified radical mastoidectomy was 1.5%.",
        "levenshtein_distance": 346
    },
    {
        "realidx": "23412195",
        "question": "This study was designed to compare clinical effectiveness of operative with nonoperative treatment for displaced midshaft clavicular fractures (DMCF).\nWe systematically searched electronic databases (MEDILINE, EMBASE, CLINICAL, OVID, BIOSIS and Cochrane registry of controlled clinical trials) to identify randomized controlled trials (RCTs) in which operative treatment was compared with nonoperative treatment for DMCF from 1980 to 2012. The methodologic quality of trials was assessed. Data from chosen studies were pooled with using of fixed-effects and random-effects models with mean differences and risk ratios for continuous and dichotomous variables, respectively.\nFour RCTs with a total of 321 patients were screened for the present study. Results showed that the operative treatment was superior to the nonoperative treatment regarding the rate of nonunion [95\u00a0% confidence interval (CI) (0.05, 0.43), P\u00a0=\u00a00.0004], malunion [95\u00a0% CI (0.06, 0.34), P\u00a0<\u00a00.00001] and overall complication [95\u00a0% CI (0.43-0.76), P\u00a0=\u00a00.0001]. Subgroup analyses of complications revealed that significant differences were existed in the incidence of neurologic symptoms [95\u00a0% CI (0.20, 0.74), P\u00a0=\u00a00.004] and dissatisfaction with appearance [95\u00a0% CI (0.19, 0.65), P\u00a0=\u00a00.001]. Lack of consistent and standardized assessment data, insufficiency analysis that carried out showed improved functional outcomes (P\u00a0<\u00a00.05) in operative treatment.\nShould displaced midshaft clavicular fractures be treated surgically?",
        "answer": "yes",
        "answer_rationale": "The available evidence suggests that the operative treatment for DMCF is associated with a lower rate of nonunion, malunion and complication than nonoperative treatment. This study supports traditional primary operative treatment for DMCF in active adults.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study was designed to compare clinical effectiveness of operative with nonoperative treatment for displaced midshaft clavicular fractures (DMCF).\nWe systematically searched electronic databases (MEDILINE, EMBASE, CLINICAL, OVID, BIOSIS and Cochrane registry of controlled clinical trials) to identify randomized controlled trials (RCTs) in which operative treatment was compared with nonoperative treatment for DMCF from 1980 to 2012. The methodologic quality of trials was assessed. Data from chosen studies were pooled with using of fixed-effects and random-effects models with mean differences and risk ratios for continuous and dichotomous variables, respectively.\nFour RCTs with a total of 321 patients were screened for the present study. Results showed that the operative treatment was superior to the nonoperative treatment regarding the rate of nonunion [95\u00a0% confidence interval (CI) (0.",
        "q2": "05, 0.43), P\u00a0=\u00a00.0004], malunion [95\u00a0% CI (0.06, 0.34), P\u00a0<\u00a00.00001] and overall complication [95\u00a0% CI (0.43-0.76), P\u00a0=\u00a00.0001]. Subgroup analyses of complications revealed that significant differences were existed in the incidence of neurologic symptoms [95\u00a0% CI (0.20, 0.74), P\u00a0=\u00a00.004] and dissatisfaction with appearance [95\u00a0% CI (0.19, 0.65), P\u00a0=\u00a00.001]. Lack of consistent and standardized assessment data, insufficiency analysis that carried out showed improved functional outcomes (P\u00a0<\u00a00.05) in operative treatment.\nShould displaced midshaft clavicular fractures be treated surgically?",
        "generated_text": "02, 0.22), P\u2009=\u20090.001], the Constant score (95\u00a0% CI 4.11, 11.29, P\u2009<\u20090.00001), the DASH score (95\u00a0% CI 6.11, 14.29, P\u2009<\u20090.00001), the SF-36 score (95\u00a0% CI 4.11, 11.29, P\u2009<\u20090.00001), the University of California Los Angeles (UCLA) score (95\u00a0% CI 0.41, 1.29, P\u2009=\u20090.006), the time to return to",
        "levenshtein_distance": 454
    },
    {
        "realidx": "23422012",
        "question": "Vancomycin is the primary treatment for infections caused by methicilin-resistant Staphylococcus aureus (MRSA). The association of vancomycin treatment failures with increased vancomycin minimum inhibitory concentration (MIC) is a well-recognized problem. A number of single-centre studies have identified progressive increases in glycopeptide MICs for S. aureus strains over recent years - a phenomenon known as vancomycin MIC creep. It is unknown if this is a worldwide phenomenon or if it is localized to specific centers.\nThe aim of this study was to evaluate the trend of vancomycin MIC for isolates of MRSA over a 3-year period in a tertiary university hospital in Portugal. MRSA isolates from samples of patients admitted from January 2007 to December 2009 were assessed. Etest method was used to determine the respective vancomycin MIC. Only one isolate per patient was included in the final analysis.\nA total of 93 MRSA isolates were studied. The vancomycin MICs were 0.75, 1, 1.5 and 2 mg/L for 1 (1.1%), 19 (20.4%), 38 (40.9%), 35 (37.6%) isolates, respectively. During the 3 year period, we observed a significant fluctuation in the rate of MRSA with a vancomycin MIC\u2009>\u20091 mg/L (2007: 86.2%; 2008: 93.3%; 2009: 58.8%, p\u2009=\u20090.002). No MRSA isolate presented a MIC\u2009>\u20092 mg/L.\nIs vancomycin MIC creep a worldwide phenomenon?",
        "answer": "no",
        "answer_rationale": "We were unable to find in our institution data compatible to the presence of vancomycin MIC creep during the study period. This phenomenon seems not to be generalized; as a result each institution should systematically monitor MRSA vancomycin MIC over time.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Vancomycin is the primary treatment for infections caused by methicilin-resistant Staphylococcus aureus (MRSA). The association of vancomycin treatment failures with increased vancomycin minimum inhibitory concentration (MIC) is a well-recognized problem. A number of single-centre studies have identified progressive increases in glycopeptide MICs for S. aureus strains over recent years - a phenomenon known as vancomycin MIC creep. It is unknown if this is a worldwide phenomenon or if it is localized to specific centers.\nThe aim of this study was to evaluate the trend of vancomycin MIC for isolates of MRSA over a 3-year period in a tertiary university hospital in Portugal. MRSA isolates from samples of patients admitted from January 2007 to December 2009 were assessed. Etest method was used to determine the respective vancom",
        "q2": "ycin MIC. Only one isolate per patient was included in the final analysis.\nA total of 93 MRSA isolates were studied. The vancomycin MICs were 0.75, 1, 1.5 and 2 mg/L for 1 (1.1%), 19 (20.4%), 38 (40.9%), 35 (37.6%) isolates, respectively. During the 3 year period, we observed a significant fluctuation in the rate of MRSA with a vancomycin MIC\u2009>\u20091 mg/L (2007: 86.2%; 2008: 93.3%; 2009: 58.8%, p\u2009=\u20090.002). No MRSA isolate presented a MIC\u2009>\u20092 mg/L.\nIs vancomycin MIC creep a worldwide phenomenon?",
        "generated_text": "ycin MICs. The data was analyzed using the chi-square test and the Mann-Whitney test.\nA total of 1,020 MRSA isolates were included in the study. The mean vancomycin MIC was 1.5 mg/L (range 0.5-8 mg/L). There was a significant increase in the proportion of isolates with vancomycin MIC \u22652 mg/L over the study period (p=0.001). In 2007, 10.5% of isolates had a MIC \u22652 mg/L, increasing to 14.3% in 2008 and 18.2% in 2009. There was no significant difference in the vancomycin MIC between isolates from blood and non-blood sources (p=0.12",
        "levenshtein_distance": 377
    },
    {
        "realidx": "23448747",
        "question": "To examine whether a history of cancer increased the likelihood of a fall in community-dwelling older adults, and if cancer type, stage, or time since diagnosis increased falls.\nA longitudinal, retrospective, cohort study.\nA home- and community-based waiver program in Michigan.\n862 older adults aged 65 years or older with cancer compared to 8,617 older adults without cancer using data from the Minimum Data Set-Home Care and Michigan cancer registry.\nReports of falls were examined for 90-180 days. Generalized estimating equations were used to compare differences between the groups.\nCancer, falls, patient characteristics, comorbidities, medications, pain, weight loss, vision, memory recall, and activities, as well as cancer type, stage, and time since diagnosis.\nA fall occurred at a rate of 33% in older adults with cancer compared to 29% without cancer (p<0.00). Those with a history of cancer were more likely to fall than those without cancer (adjusted odds ratio 1.16; 95% confidence interval [1.02, 1.33]; p = 0.03). No differences in fall rates were determined by cancer type or stage, and the odds of a fall did not increase when adding time since cancer diagnosis.\nDo older adults with cancer fall more often?",
        "answer": "yes",
        "answer_rationale": "The fall rate was higher in older adults with cancer than in older adults without cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To examine whether a history of cancer increased the likelihood of a fall in community-dwelling older adults, and if cancer type, stage, or time since diagnosis increased falls.\nA longitudinal, retrospective, cohort study.\nA home- and community-based waiver program in Michigan.\n862 older adults aged 65 years or older with cancer compared to 8,617 older adults without cancer using data from the Minimum Data Set-Home Care and Michigan cancer registry.\nReports of falls were examined for 90-180 days. Generalized estimating equations were used to compare differences between the groups.\nCancer, falls, patient characteristics, comorbidities, medications, pain, weight loss,",
        "q2": " vision, memory recall, and activities, as well as cancer type, stage, and time since diagnosis.\nA fall occurred at a rate of 33% in older adults with cancer compared to 29% without cancer (p<0.00). Those with a history of cancer were more likely to fall than those without cancer (adjusted odds ratio 1.16; 95% confidence interval [1.02, 1.33]; p = 0.03). No differences in fall rates were determined by cancer type or stage, and the odds of a fall did not increase when adding time since cancer diagnosis.\nDo older adults with cancer fall more often?",
        "generated_text": "and functional status.\nCancer was associated with a 1.2-fold increased risk of falls (odds ratio [OR] = 1.2, 95% confidence interval [CI] = 1.0-1.4). The risk of falls was higher in those with lung cancer (OR = 1.5, 95% CI = 1.1-2.0), blood cancer (OR = 1.4, 95% CI = 1.1-1.9), and prostate cancer (OR = 1.4, 95% CI = 1.0-1.9",
        "levenshtein_distance": 411
    },
    {
        "realidx": "23455575",
        "question": "The so-called \"globulomaxillary cyst\", described as a fissural cyst, caused by entrapped epithelium between the nasal and maxillary process, is no longer considered for its own entity. Nevertheless, cystic lesions, which correspond to the previous image of globulomaxillary cysts, do still occur in daily practice. This raises the question to which entities pathological processes in this particular region actually belong to.\nIn a retrospective study, 17 cases (12 men and 5 women, 12-59\u00a0years old) of primarily diagnosed globulomaxillary cysts are analysed according to clinical, radiological and histological aspects, catamnestic processed and assigned to a new entity. The results are compared with the international literature and draws conclusions on the diagnostic and therapeutic procedure.\nSeven lateral periodontal cysts, four radicular cysts, two keratocystic odontogenic tumours, one adenomatoid odontogenic tumour, one periapical granuloma, one residual cyst and one undefined jaw cyst were determined.\nGlobulomaxillary cysts--do they really exist?",
        "answer": "no",
        "answer_rationale": "According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The so-called \"globulomaxillary cyst\", described as a fissural cyst, caused by entrapped epithelium between the nasal and maxillary process, is no longer considered for its own entity. Nevertheless, cystic lesions, which correspond to the previous image of globulomaxillary cysts, do still occur in daily practice. This raises the question to which entities pathological processes in this particular region actually belong to.\nIn a retrospective study, 17 cases (12 men and 5 women, 12-59\u00a0years old) of",
        "q2": " primarily diagnosed globulomaxillary cysts are analysed according to clinical, radiological and histological aspects, catamnestic processed and assigned to a new entity. The results are compared with the international literature and draws conclusions on the diagnostic and therapeutic procedure.\nSeven lateral periodontal cysts, four radicular cysts, two keratocystic odontogenic tumours, one adenomatoid odontogenic tumour, one periapical granuloma, one residual cyst and one undefined jaw cyst were determined.\nGlobulomaxillary cysts--do they really exist?",
        "generated_text": "cystic lesions in the globulomaxillary region were evaluated. The lesions were located in the maxillary sinus floor (n\u2009=\u200910), the canine fossa (n\u2009=\u20094), the pterygomaxillary fissure (n\u2009=\u20092), and the infratemporal fossa (n\u2009=\u20091). The lesions were classified according to their histopathological features and their location.\nThe lesions were classified as follows: 10 (59%) were diagnosed as nas",
        "levenshtein_distance": 405
    },
    {
        "realidx": "23495128",
        "question": "The aim of the present study was to explore patients' views on the acceptability and feasibility of using colour to describe osteoarthritis (OA) pain, and whether colour could be used to communicate pain to healthcare professionals.\nSix group interviews were conducted with 17 patients with knee OA. Discussion topics included first impressions about using colour to describe pain, whether participants could associate their pain with colour, how colours related to changes to intensity and different pain qualities, and whether they could envisage using colour to describe pain to healthcare professionals.\nThe group interviews indicated that, although the idea of using colour was generally acceptable, it did not suit all participants as a way of describing their pain. The majority of participants chose red to describe high-intensity pain; the reasons given were because red symbolized inflammation, fire, anger and the stop signal in a traffic light system. Colours used to describe the absence of pain were chosen because of their association with positive emotional feelings, such as purity, calmness and happiness. A range of colours was chosen to represent changes in pain intensity. Aching pain was consistently identified as being associated with colours such as grey or black, whereas sharp pain was described using a wider selection of colours. The majority of participants thought that they would be able to use colour to describe their pain to healthcare professionals, although issues around the interpretability and standardization of colour were raised.\nThe colour of pain: can patients use colour to describe osteoarthritis pain?",
        "answer": "yes",
        "answer_rationale": "For some patients, using colour to describe their pain experience may be a useful tool to improve doctor-patient communication.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The aim of the present study was to explore patients' views on the acceptability and feasibility of using colour to describe osteoarthritis (OA) pain, and whether colour could be used to communicate pain to healthcare professionals.\nSix group interviews were conducted with 17 patients with knee OA. Discussion topics included first impressions about using colour to describe pain, whether participants could associate their pain with colour, how colours related to changes to intensity and different pain qualities, and whether they could envisage using colour to describe pain to healthcare professionals.\nThe group interviews indicated that, although the idea of using colour was generally acceptable, it did not suit all participants as a way of describing their pain. The majority of participants chose red to describe high-intensity",
        "q2": " pain; the reasons given were because red symbolized inflammation, fire, anger and the stop signal in a traffic light system. Colours used to describe the absence of pain were chosen because of their association with positive emotional feelings, such as purity, calmness and happiness. A range of colours was chosen to represent changes in pain intensity. Aching pain was consistently identified as being associated with colours such as grey or black, whereas sharp pain was described using a wider selection of colours. The majority of participants thought that they would be able to use colour to describe their pain to healthcare professionals, although issues around the interpretability and standardization of colour were raised.\nThe colour of pain: can patients use colour to describe osteoarthritis pain?",
        "generated_text": "pain, and blue for low-intensity pain. Some participants associated different colours with different pain qualities, for example, red for sharp pain and blue for aching pain. Participants who had difficulty associating their pain with colour found it difficult to imagine using colour to communicate their pain to healthcare professionals. However, those who did find it easy to associate their pain with colour thought that it could be a useful way of communicating their pain to healthcare professionals, particularly if they had difficulty describing their pain in words.\nUsing colour to describe pain may be a useful adjunct to existing pain assessment tools, but it is unlikely to replace them. Further research is needed to explore the acceptability and feasibility of using colour to describe pain in different patient groups",
        "levenshtein_distance": 625
    },
    {
        "realidx": "23497210",
        "question": "Although record linkage of routinely collected health datasets is a valuable research resource, most datasets are established for administrative purposes and not for health outcomes research. In order for meaningful results to be extrapolated to specific populations, the limitations of the data and linkage methodology need to be investigated and clarified. It is the objective of this study to investigate the differences in ascertainment which may arise between a hospital admission dataset and a dispensing claims dataset, using major depression in pregnancy as an example. The safe use of antidepressants in pregnancy is an ongoing issue for clinicians with around 10% of pregnant women suffer from depression. As the birth admission will be the first admission to hospital during their pregnancy for most women, their use of antidepressants, or their depressive condition, may not be revealed to the attending hospital clinicians. This may result in adverse outcomes for the mother and infant.\nPopulation-based de-identified data were provided from the Western Australian Data Linkage System linking the administrative health records of women with a delivery to related records from the Midwives' Notification System, the Hospital Morbidity Data System and the national Pharmaceutical Benefits Scheme dataset. The women with depression during their pregnancy were ascertained in two ways: women with dispensing records relating to dispensed antidepressant medicines with an WHO ATC code to the 3rd level, pharmacological subgroup, 'N06A Antidepressants'; and, women with any hospital admission during pregnancy, including the birth admission, if a comorbidity was recorded relating to depression.\nFrom 2002 to 2005, there were 96698 births in WA. At least one antidepressant was dispensed to 4485 (4.6%) pregnant women. There were 3010 (3.1%) women with a comorbidity related to depression recorded on their delivery admission, or other admission to hospital during pregnancy. There were a total of 7495 pregnancies identified by either set of records. Using data linkage, we determined that these records represented 6596 individual pregnancies. Only 899 pregnancies were found in both groups (13.6% of all cases). 80% of women dispensed an antidepressant did not have depression recorded as a comorbidity on their hospital records. A simple capture-recapture calculation suggests the prevalence of depression in this population of pregnant women to be around 16%.\nAre women with major depression in pregnancy identifiable in population health data?",
        "answer": "no",
        "answer_rationale": "No single data source is likely to provide a complete health profile for an individual. For women with depression in pregnancy and dispensed antidepressants, the hospital admission data do not adequately capture all cases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Although record linkage of routinely collected health datasets is a valuable research resource, most datasets are established for administrative purposes and not for health outcomes research. In order for meaningful results to be extrapolated to specific populations, the limitations of the data and linkage methodology need to be investigated and clarified. It is the objective of this study to investigate the differences in ascertainment which may arise between a hospital admission dataset and a dispensing claims dataset, using major depression in pregnancy as an example. The safe use of antidepressants in pregnancy is an ongoing issue for clinicians with around 10% of pregnant women suffer from depression. As the birth admission will be the first admission to hospital during their pregnancy for most women, their use of antidepressants, or their depressive condition, may not be revealed to the attending hospital clinicians. This may result in adverse outcomes for the mother and infant.\nPopulation-based de-identified data were provided from the Western Australian Data Linkage System linking the administrative health records of women with a delivery to related records from the Midwives' Notification System, the Hospital Morbidity Data System and the national Pharmaceutical Benefits Scheme dataset. The women with depression during their pregnancy were ascertained in two ways: women with dispensing",
        "q2": " records relating to dispensed antidepressant medicines with an WHO ATC code to the 3rd level, pharmacological subgroup, 'N06A Antidepressants'; and, women with any hospital admission during pregnancy, including the birth admission, if a comorbidity was recorded relating to depression.\nFrom 2002 to 2005, there were 96698 births in WA. At least one antidepressant was dispensed to 4485 (4.6%) pregnant women. There were 3010 (3.1%) women with a comorbidity related to depression recorded on their delivery admission, or other admission to hospital during pregnancy. There were a total of 7495 pregnancies identified by either set of records. Using data linkage, we determined that these records represented 6596 individual pregnancies. Only 899 pregnancies were found in both groups (13.6% of all cases). 80% of women dispensed an antidepressant did not have depression recorded as a comorbidity on their hospital records. A simple capture-recapture calculation suggests the prevalence of depression in this population of pregnant women to be around 16%.\nAre women with major depression in pregnancy identifiable in population health data?",
        "generated_text": "claims for antidepressants during their pregnancy and women with a hospital admission for depression during their pregnancy. The two groups were compared for demographic and clinical characteristics.\nA total of 100,101 women with a delivery between 1993 and 2009 were identified. Of these, 10,010 (10.0%) had a dispensing claim for antidepressants and 1,101 (1.1%) had a hospital admission for depression during their pregnancy. The two groups were similar in terms of age, parity, marital status, remoteness of residence and socioeconomic status. However, the women with a hospital admission for depression were more likely to have a previous hospital admission for depression (22.4% vs. 1.9%, p < 0.001), a previous dispensing claim for antidepressants (41.5% vs. 12.4%, p < 0.001), a previous hospital admission for substance abuse (10.1% vs. 1.1%, p < 0.001), a previous dispensing claim for a substance abuse",
        "levenshtein_distance": 819
    },
    {
        "realidx": "23517744",
        "question": "To our knowledge there are no evidence-based medicine data to date to critically judge the vulnerability of a solitary kidney to warm ischemia compared to paired kidneys.\nTen dogs were exposed to open right nephrectomy to create a solitary kidney model (group 1). Ten dogs with both kidneys were considered group 2. All dogs underwent warm ischemia by open occlusion of the left renal artery for 90 minutes. Dogs were sacrificed at different intervals (3 days to 4 weeks). All dogs were reevaluated by renogram before sacrifice and histopathology of the investigated kidney. The proinflammatory markers CD95 and tumor necrosis factor-\u03b1 were assessed using real-time polymerase chain reaction.\nIn group 1 clearance decreased by 20% at 1 week but basal function was regained starting at week 2. In group 2 clearance decreased more than 90% up to week 2. Recovery started at week 3 and by 4 weeks there was a 23% clearance reduction. Histopathological examination in group 1 revealed significant tubular necrosis (60%) at 3 days with regeneration starting at 1 week. In group 2 there was more pronounced tubular necrosis (90%) with regeneration starting at 2 weeks. The expression of proinflammatory markers was up-regulated in each group with higher, more sustained expression in group 2.\nIs solitary kidney really more resistant to ischemia?",
        "answer": "yes",
        "answer_rationale": "Solitary kidney in a canine model is more resistant to ischemia than paired kidneys based on radiological, pathological and genetic evidence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To our knowledge there are no evidence-based medicine data to date to critically judge the vulnerability of a solitary kidney to warm ischemia compared to paired kidneys.\nTen dogs were exposed to open right nephrectomy to create a solitary kidney model (group 1). Ten dogs with both kidneys were considered group 2. All dogs underwent warm ischemia by open occlusion of the left renal artery for 90 minutes. Dogs were sacrificed at different intervals (3 days to 4 weeks). All dogs were reevaluated by renogram before sacrifice and histopathology of the investigated kidney. The proinflammatory markers CD95 and tumor necrosis factor-\u03b1 were assessed using real-time polymerase chain reaction.\nIn group ",
        "q2": "1 clearance decreased by 20% at 1 week but basal function was regained starting at week 2. In group 2 clearance decreased more than 90% up to week 2. Recovery started at week 3 and by 4 weeks there was a 23% clearance reduction. Histopathological examination in group 1 revealed significant tubular necrosis (60%) at 3 days with regeneration starting at 1 week. In group 2 there was more pronounced tubular necrosis (90%) with regeneration starting at 2 weeks. The expression of proinflammatory markers was up-regulated in each group with higher, more sustained expression in group 2.\nIs solitary kidney really more resistant to ischemia?",
        "generated_text": "1, the renogram showed a significant decrease in the renal function at 3 days and 1 week after ischemia, with a significant improvement at 2 and 4 weeks. In group 2, the renogram showed a significant decrease in the renal function at 3 days and 1 week after ischemia, with a significant improvement at 2 and 4 weeks. Histopathology showed a significant improvement in the renal function in group 1 at 2 and 4 weeks after ischemia, with a significant improvement in the renal function in group 2 at 2 and 4 weeks after ischemia. The expression of CD95 and tumor necrosis factor-\u03b1 was significantly higher in",
        "levenshtein_distance": 476
    },
    {
        "realidx": "23539689",
        "question": "To characterize the use and delivery of cough and cold medicines in children younger than 6 presenting to an inner-city pediatric emergency department (PED) following 2007 FDA warnings.\nA cross-sectional observational study was performed using a convenience sampling of PED patients during the fall of 2010. Caregivers were presented with 6 commonly used cough medicine preparations and were asked to demonstrate if and how they would administer these to their children.\nIn all, 65 patients and their caregivers consented and participated in the study. During the demonstration, 82% (53/65) stated that they would treat with cough or cold medicines, and 72% (38/53) incorrectly dosed the medication they desired to give.\nCold preparation use in young children after FDA warnings: do concerns still exist?",
        "answer": "yes",
        "answer_rationale": "Despite current recommendations, cough and cold medicines are still used in children younger than 6 years of age. A significant portion of caregivers report that they are still unaware of public warnings, potential side effects, and interactions with other medications.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To characterize the use and delivery of cough and cold medicines in children younger than 6 presenting to an inner-city pediatric emergency department (PED) following 2007 FDA warnings.\nA cross-sectional observational study was performed using a convenience sampling of PED patients during the fall of 2010. Caregivers were presented with 6 commonly used cough medicine preparations and were asked to demonstrate if and how they would",
        "q2": " administer these to their children.\nIn all, 65 patients and their caregivers consented and participated in the study. During the demonstration, 82% (53/65) stated that they would treat with cough or cold medicines, and 72% (38/53) incorrectly dosed the medication they desired to give.\nCold preparation use in young children after FDA warnings: do concerns still exist?",
        "generated_text": "administer the medicine to their child. The primary outcome was the proportion of caregivers who would administer the medicine correctly. Secondary outcomes included the proportion of caregivers who would administer the medicine incorrectly and the proportion who would not administer the medicine at all.\nA total of 100 caregivers were enrolled. The mean age of the caregivers was 30.2 years, and 82% were female.",
        "levenshtein_distance": 285
    },
    {
        "realidx": "23568387",
        "question": "Bicompartmental knee arthroplasty features bone and ligament sparing as unicompartmental knee arthroplasty and is presumably better in the recovery of muscle strength and function compared to total knee arthroplasty (TKA) though not previously reported in the literature. The aim of the study was to compare isokinetic knee muscle strength and physical performance in patients who underwent either bicompartmental knee arthroplasty or TKA.\nEach of 24 patients (31 knees) was prospectively examined preoperatively, at 6 and 12 months after each surgery. Isokinetic knee extensor and flexor strength as well as position sense were measured using the Biodex system. Timed up and go test, stair climbing test, and the 6-min walk test were used to assess physical performance. The results of each group were also compared with those from the corresponding healthy control, respectively.\nDemography showed significant difference in the mean age between bicompartment (54.8 \u00b1 5.6 years) and TKA groups (65.7 \u00b1 6.7 years). Comparing between the two groups, knee extensor and flexor torque, hamstring/Quadriceps ratio, position sense, and physical performance were not significantly different preoperatively, at 6 and 12 months after surgery. In intra-group analysis, muscle strength and position sense at each time point were not different in both groups. In physical performance, both groups resulted in improvement in the 6-min walk test, and only TKA group showed enhancement in stair climbing test.\nIs bicompartmental knee arthroplasty more favourable to knee muscle strength and physical performance compared to total knee arthroplasty?",
        "answer": "no",
        "answer_rationale": "Although theoretically plausible, bicompartmental knee arthroplasty was not superior in knee muscle strength and physical performance at 1 year compared with total knee arthroplasty.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Bicompartmental knee arthroplasty features bone and ligament sparing as unicompartmental knee arthroplasty and is presumably better in the recovery of muscle strength and function compared to total knee arthroplasty (TKA) though not previously reported in the literature. The aim of the study was to compare isokinetic knee muscle strength and physical performance in patients who underwent either bicompartmental knee arthroplasty or TKA.\nEach of 24 patients (31 knees) was prospectively examined preoperatively, at 6 and 12 months after each surgery. Isokinetic knee extensor and flexor strength as well as position sense were measured using the Biodex system. Timed up and go test, stair climbing test, and the 6-min walk test were used to assess physical performance. The results of each group",
        "q2": " were also compared with those from the corresponding healthy control, respectively.\nDemography showed significant difference in the mean age between bicompartment (54.8 \u00b1 5.6 years) and TKA groups (65.7 \u00b1 6.7 years). Comparing between the two groups, knee extensor and flexor torque, hamstring/Quadriceps ratio, position sense, and physical performance were not significantly different preoperatively, at 6 and 12 months after surgery. In intra-group analysis, muscle strength and position sense at each time point were not different in both groups. In physical performance, both groups resulted in improvement in the 6-min walk test, and only TKA group showed enhancement in stair climbing test.\nIs bicompartmental knee arthroplasty more favourable to knee muscle strength and physical performance compared to total knee arthroplasty?",
        "generated_text": "were compared with the contralateral side and between the groups.\nAt 12 months, both groups had improved in isokinetic knee extensor and flexor strength, position sense, and physical performance compared to preoperative values (p < 0.05). However, the bicompartmental group had significantly better isokinetic knee extensor and flexor strength at 60\u00b0/s (p < 0.05), position sense (p < 0.05), and physical performance (p < 0.05) compared to the TKA group.\nBicompartmental knee arthroplasty is superior to TKA in the recovery of isokinetic knee muscle strength, position sense, and physical performance at 12 months after surgery.",
        "levenshtein_distance": 548
    },
    {
        "realidx": "23571528",
        "question": "This study aims to examine the accuracy of a new sternal skin conductance (SSC) device in measuring hot flashes and to assess the acceptability of the device by women.\nThree small descriptive pilot studies were performed using two sequential prototypes of the SSC device developed by an engineering device company in the Midwest. The devices were worn either in a monitored setting for 24 hours or in an ambulatory setting for 5 weeks. During the study period, women recorded hot flashes in a prospective hot flash diary and answered questions about the acceptability of wearing the SSC device.\nThe first prototype was not able to collect any analyzable skin conductance data owing to various malfunction issues, including poor conductance and battery failure. However, 16 women wore the device for 5 weeks and reported that wearing the device was acceptable, although 31% stated that it interfered with daily activities. Hot flash data from the second prototype revealed a 24% concordance rate between self-reported and device-recorded hot flashes.\nSternal skin conductance: a reasonable surrogate for hot flash measurement?",
        "answer": "no",
        "answer_rationale": "Findings from these studies support discordance between device-recorded and self-reported hot flashes. In addition, the studies reveal further limitations of SSC monitoring, including difficulties with data collection and lack of consistency in interpretation. Based on these results and other recent trials identifying issues with SSC methodology, it is time to find a better physiologic surrogate measure for hot flashes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "This study aims to examine the accuracy of a new sternal skin conductance (SSC) device in measuring hot flashes and to assess the acceptability of the device by women.\nThree small descriptive pilot studies were performed using two sequential prototypes of the SSC device developed by an engineering device company in the Midwest. The devices were worn either in a monitored setting for 24 hours or in an ambulatory setting for 5 weeks. During the study period, women recorded hot flashes in a prospective hot flash diary and answered questions about the acceptability of wearing",
        "q2": " the SSC device.\nThe first prototype was not able to collect any analyzable skin conductance data owing to various malfunction issues, including poor conductance and battery failure. However, 16 women wore the device for 5 weeks and reported that wearing the device was acceptable, although 31% stated that it interfered with daily activities. Hot flash data from the second prototype revealed a 24% concordance rate between self-reported and device-recorded hot flashes.\nSternal skin conductance: a reasonable surrogate for hot flash measurement?",
        "generated_text": "the device.\nIn the first study, 10 women wore the device for 24 hours in a monitored setting. The device detected 80% of the hot flashes reported in the diary. In the second study, 15 women wore the device for 5 weeks in an ambulatory setting. The device detected 75% of the hot flashes reported in the diary. In the third study, 20 women wore the device for 5 weeks in an ambulatory setting. The device detected 85%",
        "levenshtein_distance": 370
    },
    {
        "realidx": "23621776",
        "question": "Unintended pregnancy has been significantly associated with subsequent female sterilization. Whether women who are sterilized after experiencing an unintended pregnancy are less likely to express desire for sterilization reversal is unknown.\nThis study used national, cross-sectional data collected by the 2006-2010 National Survey of Family Growth. The study sample included women ages 15-44 who were surgically sterile from a tubal sterilization at the time of interview. Multivariable logistic regression was used to examine the relationship between a history of unintended pregnancy and desire for sterilization reversal while controlling for potential confounders.\nIn this nationally representative sample of 1,418 women who were sterile from a tubal sterilization, 78% had a history of at least one unintended pregnancy and 28% expressed a desire to have their sterilization reversed. In unadjusted analysis, having a prior unintended pregnancy was associated with higher odds of expressing desire for sterilization reversal (odds ratio [OR]: 1.80; 95% confidence interval [CI]: 1.15-2.79). In adjusted analysis controlling for sociodemographic factors, unintended pregnancy was no longer significantly associated with desire for reversal (OR: 1.46; 95% CI: 0.91-2.34).\nDoes a history of unintended pregnancy lessen the likelihood of desire for sterilization reversal?",
        "answer": "no",
        "answer_rationale": "Among women who had undergone tubal sterilization, a prior history of unintended pregnancy did not decrease desire for sterilization reversal.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Unintended pregnancy has been significantly associated with subsequent female sterilization. Whether women who are sterilized after experiencing an unintended pregnancy are less likely to express desire for sterilization reversal is unknown.\nThis study used national, cross-sectional data collected by the 2006-2010 National Survey of Family Growth. The study sample included women ages 15-44 who were surgically sterile from a tubal sterilization at the time of interview. Multivariable logistic regression was used to examine the relationship between a history of unintended pregnancy and desire for sterilization reversal while controlling for potential confounders.\nIn this nationally representative sample of 1,418 women who were sterile from a tubal sterilization",
        "q2": ", 78% had a history of at least one unintended pregnancy and 28% expressed a desire to have their sterilization reversed. In unadjusted analysis, having a prior unintended pregnancy was associated with higher odds of expressing desire for sterilization reversal (odds ratio [OR]: 1.80; 95% confidence interval [CI]: 1.15-2.79). In adjusted analysis controlling for sociodemographic factors, unintended pregnancy was no longer significantly associated with desire for reversal (OR: 1.46; 95% CI: 0.91-2.34).\nDoes a history of unintended pregnancy lessen the likelihood of desire for sterilization reversal?",
        "generated_text": ", 38% reported that their pregnancy was unintended. Women who had an unintended pregnancy were less likely to desire sterilization reversal (adjusted odds ratio [aOR] 0.5, 95% confidence interval [CI] 0.3-0.8). Women who had an unintended pregnancy were more likely to have had a sterilization within 6 months of delivery (aOR 2.1, 95% CI 1.4-3.1). Women who had a sterilization within 6 months of delivery were less likely to desire sterilization reversal (aOR 0.4, 95% CI 0.3-0",
        "levenshtein_distance": 384
    },
    {
        "realidx": "23677366",
        "question": "Anteroposterior, lateral, and right and left oblique lumbar spine radiographs are often a standard part of the evaluation of children who are clinically suspected of having spondylolysis. Recent concerns regarding radiation exposure and costs have brought the value of oblique radiographs into question. The purpose of the present study was to determine the diagnostic value of oblique views in the diagnosis of spondylolysis.\nRadiographs of fifty adolescents with L5 spondylolysis without spondylolisthesis and fifty controls were retrospectively reviewed. All controls were confirmed not to have spondylolysis on the basis of computed tomographic scanning, magnetic resonance imaging, or bone scanning. Anteroposterior, lateral, and right and left oblique radiographs of the lumbar spine were arranged into two sets of slides: one showing four views (anteroposterior, lateral, right oblique, and left oblique) and one showing two views (anteroposterior and lateral only). The slides were randomly presented to four pediatric spine surgeons for diagnosis, with four-view slides being presented first, followed by two-view slides. The slides for twenty random patients were later reanalyzed in order to calculate of intra-rater agreement. A power analysis demonstrated that this study was adequately powered. Inter-rater and intra-rater agreement were assessed on the basis of the percentage of overall agreement and intraclass correlation coefficients (ICCs). PCXMC software was used to generate effective radiation doses. Study charges were determined from radiology billing data.\nThere was no significant difference in sensitivity and specificity between four-view and two-view radiographs in the diagnosis of spondylolysis. The sensitivity was 0.59 for two-view studies and 0.53 for four-view studies (p = 0.33). The specificity was 0.96 for two-view studies and 0.94 for four-view studies (p = 0.60). Inter-rater agreement, intra-rater agreement, and agreement with gold-standard ICC values were in the moderate range and also demonstrated no significant differences. Percent overall agreement was 78% for four-view studies and 82% for two-view studies. The radiation effective dose was 1.26 mSv for four-view studies and 0.72 mSv for two-view studies (difference, 0.54 mSv). The charge for four-view studies was $145 more than that for two-view studies.\nDo oblique views add value in the diagnosis of spondylolysis in adolescents?",
        "answer": "no",
        "answer_rationale": "There is no difference in sensitivity and specificity between four-view and two-view studies. Although oblique views have long been considered standard practice by some, our data could not identify a diagnostic benefit that might outweigh the additional cost and radiation exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Anteroposterior, lateral, and right and left oblique lumbar spine radiographs are often a standard part of the evaluation of children who are clinically suspected of having spondylolysis. Recent concerns regarding radiation exposure and costs have brought the value of oblique radiographs into question. The purpose of the present study was to determine the diagnostic value of oblique views in the diagnosis of spondylolysis.\nRadiographs of fifty adolescents with L5 spondylolysis without spondylolisthesis and fifty controls were retrospectively reviewed. All controls were confirmed not to have spondylolysis on the basis of computed tomographic scanning, magnetic resonance imaging, or bone scanning. Anteroposterior, lateral, and right and left oblique radiographs of the lumbar spine were arranged into two sets of slides: one showing four views (anteroposterior, lateral, right oblique, and left oblique) and one showing two views (anteroposterior and lateral only). The slides were randomly presented to four pediatric spine surgeons for diagnosis, with four-view slides being presented first, followed by two-view slides. The slides for twenty random patients were later reanalyzed in order to calculate of intra-rater agreement. A power analysis demonstrated that",
        "q2": " this study was adequately powered. Inter-rater and intra-rater agreement were assessed on the basis of the percentage of overall agreement and intraclass correlation coefficients (ICCs). PCXMC software was used to generate effective radiation doses. Study charges were determined from radiology billing data.\nThere was no significant difference in sensitivity and specificity between four-view and two-view radiographs in the diagnosis of spondylolysis. The sensitivity was 0.59 for two-view studies and 0.53 for four-view studies (p = 0.33). The specificity was 0.96 for two-view studies and 0.94 for four-view studies (p = 0.60). Inter-rater agreement, intra-rater agreement, and agreement with gold-standard ICC values were in the moderate range and also demonstrated no significant differences. Percent overall agreement was 78% for four-view studies and 82% for two-view studies. The radiation effective dose was 1.26 mSv for four-view studies and 0.72 mSv for two-view studies (difference, 0.54 mSv). The charge for four-view studies was $145 more than that for two-view studies.\nDo oblique views add value in the diagnosis of spondylolysis in adolescents?",
        "generated_text": "a sample size of fifty patients per group would be sufficient to detect a difference in sensitivity of 10% or greater between the two-view and four-view groups with a power of 80%.\nThe sensitivity of the two-view group was 88% (44 of fifty patients), and the sensitivity of the four-view group was 94% (47 of fifty patients). The difference in sensitivity was not statistically significant (p = 0.31). The specificity of the two-view group was 98% (49 of fifty patients), and the specificity of the four-view group was 100% (fifty of fifty patients). The difference in specificity was not statistically significant (p = 0.31). The intra-rater agreement was 85%.\nThe addition of oblique views to anteroposterior and lateral radiographs of the lumbar spine does not significantly improve the sensitivity or specificity of the diagnosis of spondylolysis in adolescents. The use of oblique views may therefore be unnecessary in the evaluation of spondylolysis in adolescents.",
        "levenshtein_distance": 810
    },
    {
        "realidx": "23690198",
        "question": "Social and cultural factors combined with little information may prevent the diffusion of epidural analgesia for pain relief during childbirth. The present study was launched contemporarily to the implementation of analgesia for labor in our Department in order to perform a 2 years audit on its use. The goal is to evaluate the epidural acceptance and penetration into hospital practice by women and care givers and safety and efficacy during childbirth.\nThis audit cycle measured epidural analgesia performance against 4 standards: (1) Implementation of epidural analgesia for labor to all patients; (2) Acceptance and good satisfaction level reported by patients and caregivers. (3) Effectiveness of labor analgesia; (4) No maternal or fetal side effects.\nDuring the audit period epidural analgesia increased from 15.5% of all labors in the first trimester of the study to 51% in the last trimester (p<0.005). Satisfaction levels reported by patients and care givers were good. A hierarchical clustering analysis identified two clusters based on VAS (Visual Analogue Scale) time course: in 226 patients (cluster 1) VAS decreased from 8.5\u00b11.4 before to 4.1\u00b11.3 after epidural analgesia; in 1002 patients (cluster 2) VAS decreased from 8.12\u00b11.7 before (NS vs cluster 1), to 0.76\u00b10.79 after (p<0.001 vs before and vs cluster 2 after). No other differences between clusters were observed.\nImplementation of epidural analgesia for labor: is the standard of effective analgesia reachable in all women?",
        "answer": "yes",
        "answer_rationale": "Present audit shows that the process of implementation of labor analgesia was quick, successful and safe, notwithstanding the identification of one cluster of women with suboptimal response to epidural analgesia that need to be further studies, overall pregnant womens'adhesion to labor analgesia was satisfactory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Social and cultural factors combined with little information may prevent the diffusion of epidural analgesia for pain relief during childbirth. The present study was launched contemporarily to the implementation of analgesia for labor in our Department in order to perform a 2 years audit on its use. The goal is to evaluate the epidural acceptance and penetration into hospital practice by women and care givers and safety and efficacy during childbirth.\nThis audit cycle measured epidural analgesia performance against 4 standards: (1) Implementation of epidural analgesia for labor to all patients; (2) Acceptance and good satisfaction level reported by patients and caregivers. (3) Effectiveness of labor analgesia; (4) No maternal or fetal side effects.\nDuring the audit period epidural analgesia increased from 15.5% of all labors in the first trimester of the",
        "q2": " study to 51% in the last trimester (p<0.005). Satisfaction levels reported by patients and care givers were good. A hierarchical clustering analysis identified two clusters based on VAS (Visual Analogue Scale) time course: in 226 patients (cluster 1) VAS decreased from 8.5\u00b11.4 before to 4.1\u00b11.3 after epidural analgesia; in 1002 patients (cluster 2) VAS decreased from 8.12\u00b11.7 before (NS vs cluster 1), to 0.76\u00b10.79 after (p<0.001 vs before and vs cluster 2 after). No other differences between clusters were observed.\nImplementation of epidural analgesia for labor: is the standard of effective analgesia reachable in all women?",
        "generated_text": "first year to 40% in the last trimester of the second year. The mean satisfaction level was 8.5/10. The mean pain score decreased from 8.5/10 to 2.5/10. No maternal or fetal side effects were reported.\nThe audit cycle showed that epidural analgesia for labor is safe and effective. The acceptance and satisfaction level is high. The penetration into hospital practice is increasing. The audit cycle is a useful tool to evaluate the performance of a new practice and to improve the quality of care.",
        "levenshtein_distance": 454
    },
    {
        "realidx": "23736032",
        "question": "A multidisciplinary team (MDT) approach to breast cancer management is the gold standard. The aim is to evaluate MDT decision making in a modern breast unit.\nAll referrals to the breast MDT where breast cancer was diagnosed from 1 July 2009 to 30 June 2011 were included. Multidisciplinary team decisions were compared with subsequent patient management and classified as concordant or discordant.\nOver the study period, there were 3230 MDT decisions relating to 705 patients. Overall, 91.5% (2956 out of 3230) of decisions were concordant, 4.5% (146 out of 3230), were discordant and 4% (128 out of 3230) had no MDT decision. Of 146 discordant decisions, 26 (17.8%) were considered 'unjustifiable' as there was no additional information available after the MDT to account for the change in management. The remaining 120 discordant MDT decisions were considered 'justifiable', as management was altered due to patient choice (n=61), additional information available after MDT (n=54) or MDT error (n=5).\nMultidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?",
        "answer": "yes",
        "answer_rationale": "The vast majority of MDT decisions are implemented. Management alteration was most often due to patient choice or additional information available after the MDT. A minority of management alterations were 'unjustifiable' and the authors recommend that any patient whose treatment is subsequently changed should have MDT rediscussion prior to treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "A multidisciplinary team (MDT) approach to breast cancer management is the gold standard. The aim is to evaluate MDT decision making in a modern breast unit.\nAll referrals to the breast MDT where breast cancer was diagnosed from 1 July 2009 to 30 June 2011 were included. Multidisciplinary team decisions were compared with subsequent patient management and classified as concordant or discordant.\nOver the study period, there were 3230 MDT decisions relating to 705 patients. Overall, 91.5% (2956 out of 3230) of decisions were concordant, 4.5% (146 out",
        "q2": " of 3230), were discordant and 4% (128 out of 3230) had no MDT decision. Of 146 discordant decisions, 26 (17.8%) were considered 'unjustifiable' as there was no additional information available after the MDT to account for the change in management. The remaining 120 discordant MDT decisions were considered 'justifiable', as management was altered due to patient choice (n=61), additional information available after MDT (n=54) or MDT error (n=5).\nMultidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?",
        "generated_text": "of 3230) were partially discordant and 4% (128 out of 3230) were completely discordant. The most common discordant decisions were for surgery (32.8%), radiotherapy (25.7%) and chemotherapy (20.3%). The most common reason for discordance was patient choice (40.2%), followed by medical reasons (21.7%) and patient factors (15.5%).\nMultidisciplinary team decision making in a modern breast unit is highly concordant with patient management. Discordance is most commonly due to",
        "levenshtein_distance": 380
    },
    {
        "realidx": "23761381",
        "question": "Testosterone measurement by liquid chromatography tandem mass spectrometry (LC-MS/MS) is well accepted as the preferred technique for the analysis of testosterone. Variation is seen between assays and this may be due to differences in calibration as commercial calibrators for this assay are not readily available. We investigated the effects calibration in routine clinical LC-MS/MS assays.\nAll LC-MS/MS users that were registered with the UKNEQAS external quality assurance scheme for testosterone were invited to take part in the study. A set of seven serum samples and serum-based calibrators were sent to all laboratories that expressed an interest. The laboratories were instructed to analyse all samples using there own calibrators and return the results and a method questionnaire for analysis.\nFifteen laboratories took part in the study. There was no consensus on supplier of testosterone or matrix for the preparation of calibrators and all were prepared in-house. Also, a wide variety of mass spectrometers, internal standards, chromatography conditions and sample extractions were used. The variation in results did not improve when the results were corrected with a common calibrator.\nIs calibration the cause of variation in liquid chromatography tandem mass spectrometry testosterone measurement?",
        "answer": "no",
        "answer_rationale": "The variation in results obtained could not be attributed to variations in calibrators. The differences in methodologies between laboratories must be the reason for this variation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Testosterone measurement by liquid chromatography tandem mass spectrometry (LC-MS/MS) is well accepted as the preferred technique for the analysis of testosterone. Variation is seen between assays and this may be due to differences in calibration as commercial calibrators for this assay are not readily available. We investigated the effects calibration in routine clinical LC-MS/MS assays.\nAll LC-MS/MS users that were registered with the UKNEQAS external quality assurance scheme for testosterone were invited to take part in the study. A set of seven serum samples and serum-based calibrators were sent to all laboratories that expressed an",
        "q2": " interest. The laboratories were instructed to analyse all samples using there own calibrators and return the results and a method questionnaire for analysis.\nFifteen laboratories took part in the study. There was no consensus on supplier of testosterone or matrix for the preparation of calibrators and all were prepared in-house. Also, a wide variety of mass spectrometers, internal standards, chromatography conditions and sample extractions were used. The variation in results did not improve when the results were corrected with a common calibrator.\nIs calibration the cause of variation in liquid chromatography tandem mass spectrometry testosterone measurement?",
        "generated_text": "interest in taking part in the study. The samples were analysed using the laboratories\u2019 routine LC-MS/MS assay and the results were returned to UKNEQAS for analysis.\nA total of 12 laboratories took part in the study. The calibrators were prepared using pooled serum from 10 male donors. The calibrators were assigned values using the mean of the results from the 12 participating laboratories. The results from the seven samples were compared to the mean of the 12 laboratories using the calibrators provided. The results were also compared to",
        "levenshtein_distance": 427
    },
    {
        "realidx": "23794696",
        "question": "To investigate the effect of bracket-ligature combination on the amount of orthodontic space closure over three months.\nRandomized clinical trial with three parallel groups.\nA hospital orthodontic department (Chesterfield Royal Hospital, UK).\nForty-five patients requiring upper first premolar extractions.\nInformed consent was obtained and participants were randomly allocated into one of three groups: (1) conventional pre-adjusted edgewise brackets and elastomeric ligatures; (2) conventional pre-adjusted edgewise brackets and Super Slick(\u00ae) low friction elastomeric ligatures; (3) Damon 3MX(\u00ae) passive self-ligating brackets. Space closure was undertaken on 0\u00b7019\u00d70\u00b7025-inch stainless steel archwires with nickel-titanium coil springs. Participants were recalled at four weekly intervals. Upper alginate impressions were taken at each visit (maximum three). The primary outcome measure was the mean amount of space closure in a 3-month period.\nA one-way ANOVA was undertaken [dependent variable: mean space closure (mm); independent variable: group allocation]. The amount of space closure was very similar between the three groups (1 mm per 28 days); however, there was a wide variation in the rate of space closure between individuals. The differences in the amount of space closure over three months between the three groups was very small and non-significant (P\u200a=\u200a0\u00b7718).\nDoes the bracket-ligature combination affect the amount of orthodontic space closure over three months?",
        "answer": "no",
        "answer_rationale": "The hypothesis that reducing friction by modifying the bracket/ligature interface increases the rate of space closure was not supported. The major determinant of orthodontic tooth movement is probably the individual patient response.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To investigate the effect of bracket-ligature combination on the amount of orthodontic space closure over three months.\nRandomized clinical trial with three parallel groups.\nA hospital orthodontic department (Chesterfield Royal Hospital, UK).\nForty-five patients requiring upper first premolar extractions.\nInformed consent was obtained and participants were randomly allocated into one of three groups: (1) conventional pre-adjusted edgewise brackets and elastomeric ligatures; (2) conventional pre-adjusted edgewise brackets and Super Slick(\u00ae) low friction elastomeric ligatures; (3) Damon 3MX(\u00ae) passive self-ligating brackets. Space closure was undertaken on 0\u00b7019\u00d70\u00b7025-inch stainless steel archwires with nickel-t",
        "q2": "itanium coil springs. Participants were recalled at four weekly intervals. Upper alginate impressions were taken at each visit (maximum three). The primary outcome measure was the mean amount of space closure in a 3-month period.\nA one-way ANOVA was undertaken [dependent variable: mean space closure (mm); independent variable: group allocation]. The amount of space closure was very similar between the three groups (1 mm per 28 days); however, there was a wide variation in the rate of space closure between individuals. The differences in the amount of space closure over three months between the three groups was very small and non-significant (P\u200a=\u200a0\u00b7718).\nDoes the bracket-ligature combination affect the amount of orthodontic space closure over three months?",
        "generated_text": "itanium coil springs. The amount of space closure was measured on lateral cephalometric radiographs at baseline and three months.\nThe mean (standard deviation) space closure at three months was 4\u00b71 (1\u00b74) mm, 4\u00b72 (1\u00b74) mm and 4\u00b74 (1\u00b74) mm for groups 1, 2 and 3, respectively. There was no statistically significant difference between the groups (P=0\u00b787).\nThere was no difference in the amount of orthodontic space closure over three months between the three bracket-ligature combinations.\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f\n\u115f",
        "levenshtein_distance": 508
    },
    {
        "realidx": "23806388",
        "question": "To examine the ability of various postoperative nomograms to predict prostate cancer-specific mortality (PCSM) and to validate that they could predict aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, and stage are the classic triad used to predict BCR after radical prostatectomy (RP). Multiple nomograms use these to predict risk of BCR. A previous study showed that several nomograms could predict aggressive BCR (prostate-specific antigen doubling time [PSADT]\u00a0<9 months) more accurately than BCR. However, it remains unknown if they can predict more definitive endpoints, such as PCSM.\nWe performed Cox analyses to examine the ability of 4 postoperative nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the joint Center for Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in the Shared Equal Access Regional Cancer Hospital (SEARCH) database who underwent RP between 1990 and 2009. We also compared their ability to predict BCR and aggressive BCR in a subset of men. We calculated the c-index for each nomogram to determine its predictive accuracy for estimating actual outcomes.\nWe found that each nomogram could predict aggressive BCR and PCSM in a statistically significant manner and that they all predicted PCSM more accurately than they predicted BCR (ie, with higher c-index values).\nDo nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?",
        "answer": "yes",
        "answer_rationale": "Currently available nomograms used to predict BCR accurately predict PCSM and other more clinically relevant endpoints. Moreover, not only do they significantly predict PCSM, but do so with generally greater accuracy than BCR.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To examine the ability of various postoperative nomograms to predict prostate cancer-specific mortality (PCSM) and to validate that they could predict aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, and stage are the classic triad used to predict BCR after radical prostatectomy (RP). Multiple nomograms use these to predict risk of BCR. A previous study showed that several nomograms could predict aggressive BCR (prostate-specific antigen doubling time [PSADT]\u00a0<9 months) more accurately than BCR. However, it remains unknown if they can predict more definitive endpoints, such as PCSM.\nWe performed Cox analyses to examine the ability of 4 postoperative nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the",
        "q2": " joint Center for Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in the Shared Equal Access Regional Cancer Hospital (SEARCH) database who underwent RP between 1990 and 2009. We also compared their ability to predict BCR and aggressive BCR in a subset of men. We calculated the c-index for each nomogram to determine its predictive accuracy for estimating actual outcomes.\nWe found that each nomogram could predict aggressive BCR and PCSM in a statistically significant manner and that they all predicted PCSM more accurately than they predicted BCR (ie, with higher c-index values).\nDo nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?",
        "generated_text": "Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram, to predict PCSM in 1,000 men who underwent RP at our institution between 1987 and 2009. We also examined the ability of these nomograms to predict aggressive BCR (PSADT\u00a0<9 months). We then compared the ability of the nomograms to predict aggressive BCR and PCSM using the C-statistic.\nThe DPC nomogram was the only nomogram that was a significant predictor of PCSM (hazard ratio [HR] 1.04, 95% confidence interval [CI] 1.01-1.07, p=0.005). The Kattan nomogram was not a significant predictor of PCSM (HR 1.01,",
        "levenshtein_distance": 564
    },
    {
        "realidx": "23810330",
        "question": "Intraoperative neuromonitoring (IONM) aims to control nerve-sparing total mesorectal excision (TME) for rectal cancer in order to improve patients' functional outcome. This study was designed to compare the urogenital and anorectal functional outcome of TME with and without IONM of innervation to the bladder and the internal anal sphincter.\nA consecutive series of 150 patients with primary rectal cancer were analysed. Fifteen match pairs with open TME and combined urogenital and anorectal functional assessment at follow up were established identical regarding gender, tumour site, tumour stage, neoadjuvant radiotherapy and type of surgery. Urogenital and anorectal function was evaluated prospectively on the basis of self-administered standardized questionnaires, measurement of residual urine volume and longterm-catheterization rate.\nNewly developed urinary dysfunction after surgery was reported by 1 of 15 patients in the IONM group and by 6 of 15 in the control group (p\u00a0=\u00a00.031). Postoperative residual urine volume was significantly higher in the control group. At follow up impaired anorectal function was present in 1 of 15 patients undergoing TME with IONM and in 6 of 15 without IONM (p\u00a0=\u00a00.031). The IONM group showed a trend towards a lower rate of sexual dysfunction after surgery.\nIs intraoperative neuromonitoring associated with better functional outcome in patients undergoing open TME?",
        "answer": "yes",
        "answer_rationale": "In this study TME with IONM was associated with significant lower rates of urinary and anorectal dysfunction. Prospective randomized trials are mandatory to evaluate the definite role of IONM in rectal cancer surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Intraoperative neuromonitoring (IONM) aims to control nerve-sparing total mesorectal excision (TME) for rectal cancer in order to improve patients' functional outcome. This study was designed to compare the urogenital and anorectal functional outcome of TME with and without IONM of innervation to the bladder and the internal anal sphincter.\nA consecutive series of 150 patients with primary rectal cancer were analysed. Fifteen match pairs with open TME and combined urogenital and anorectal functional assessment at follow up were established identical regarding gender, tumour site, tumour stage, neoadjuvant radiotherapy and type of surgery. Urogenital and anorectal function was evaluated prospectively on the basis of self",
        "q2": "-administered standardized questionnaires, measurement of residual urine volume and longterm-catheterization rate.\nNewly developed urinary dysfunction after surgery was reported by 1 of 15 patients in the IONM group and by 6 of 15 in the control group (p\u00a0=\u00a00.031). Postoperative residual urine volume was significantly higher in the control group. At follow up impaired anorectal function was present in 1 of 15 patients undergoing TME with IONM and in 6 of 15 without IONM (p\u00a0=\u00a00.031). The IONM group showed a trend towards a lower rate of sexual dysfunction after surgery.\nIs intraoperative neuromonitoring associated with better functional outcome in patients undergoing open TME?",
        "generated_text": "-administered questionnaires (IPSS, ICIQ-FLUTS, ICIQ-SF, ICIQ-LUTS-M, Fecal Incontinence Severity Index, Wexner Incontinence Score, Cleveland Clinic Constipation Score, Patient Assessment of Constipation Symptom Score, St Mark's score) and urodynamic and anorectal manometric investigations.\nPatients with IONM had a significantly better urogenital and anorectal functional outcome compared to patients without IONM. The mean IPSS was 5.4 vs. 10.2 (p=0.001), the mean ICIQ-FLUTS 10.2 vs. 15.4 (p=",
        "levenshtein_distance": 507
    },
    {
        "realidx": "23848044",
        "question": "This study represents a subset of a complete data set, considering only those children aged admitted to the Pediatric Surgery and Pediatric Nephrology Clinics during the period January 2011 to July 2012.\nIn this study, we have determined that the QT interval changes significantly depending on the use of oxybutynin. The QT changes increased cardiac arrhythmia in children.\nDoes oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?",
        "answer": "yes",
        "answer_rationale": "For this reason, children using such drugs should be closely monitored for cardiac arrhythmia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study represents a subset of a complete data set, considering only those children aged admitted to the Pediatric Surgery and Pediatric Nephrology Clinics during the period January 2011 to July 2012.\nIn this study, we",
        "q2": " have determined that the QT interval changes significantly depending on the use of oxybutynin. The QT changes increased cardiac arrhythmia in children.\nDoes oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?",
        "generated_text": "aimed to evaluate the frequency of urinary tract infections (UTIs) in children admitted to the Pediatric Surgery and Pediatric Nephrology Clinics at the University Hospital Center of Split, Croatia, from January 2011 to",
        "levenshtein_distance": 190
    },
    {
        "realidx": "23870157",
        "question": "Precursor events are undesirable events that can lead to a subsequent adverse event and have been associated with postoperative mortality. The purpose of the present study was to determine whether precursor events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting population. These events might be targets for strategies aimed at quality improvement.\nThe present study was a retrospective cohort design performed at the Queen Elizabeth Health Science Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by 5 surgeons to determine the frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of \u22651 precursor events in the matched groups was performed.\nA total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently in the MACE group than in the non-MACE group (33% vs 24%; P\u00a0=\u00a0.015). The incidence of the individual events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater prevalence of other important postoperative outcomes.\nAre intraoperative precursor events associated with postoperative major adverse events?",
        "answer": "yes",
        "answer_rationale": "Patients undergoing cardiac surgery who are exposed to intraoperative precursor events were more likely to experience a postoperative MACE. Quality improvement techniques aimed at mitigating the consequences of precursor events might improve the surgical outcomes for cardiac surgical patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Precursor events are undesirable events that can lead to a subsequent adverse event and have been associated with postoperative mortality. The purpose of the present study was to determine whether precursor events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting population. These events might be targets for strategies aimed at quality improvement.\nThe present study was a retrospective cohort design performed at the Queen Elizabeth Health Science Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by 5 surgeons to determine the",
        "q2": " frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of \u22651 precursor events in the matched groups was performed.\nA total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently in the MACE group than in the non-MACE group (33% vs 24%; P\u00a0=\u00a0.015). The incidence of the individual events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater prevalence of other important postoperative outcomes.\nAre intraoperative precursor events associated with postoperative major adverse events?",
        "generated_text": "presence of precursor events. The primary outcome was the presence of precursor events in the MACE group compared with the non-MACE group. Secondary outcomes included the type and number of precursor events in the MACE group compared with the non-MACE group.\nA total of 100 patients were included in the study (50 in the MACE group and 50 in the non-MACE group). The MACE group had a significantly higher number of precursor events compared with the non-MACE group (mean 2.4 vs 1.1, P < .001). The most common precursor events in the MACE group were prolonged cross-clamp time, prolonged aortic cross-clamp time, and prolonged cardiopulmonary bypass time. The MACE group also had",
        "levenshtein_distance": 538
    },
    {
        "realidx": "23916653",
        "question": "Recently, orthostatic myoclonus (OM) has been suggested as a cause of gait impairment and unsteadiness in neurodegenerative diseases. The aim of this study was to investigate the frequency of orthostatic myoclonus, its clinical characteristics and the underlying associated neurological disorders.\nA retrospective analysis of clinical data and electromyogram surface recordings from subjects with unexplained unsteadiness/gait impairment was performed. Diagnosis of OM was made when a pattern of non-rhythmic bursts was observed (duration range 20-100 ms; bursts per second \u226416).\nAmong 93 subjects studied, OM was the most frequent disorder (n = 16; 17.2%), followed by orthostatic tremor (13.9%) and low frequency tremors during orthostatism (12.9%). All patients with OM complained about unsteadiness during orthostatism and/or during gait. Leg jerking was only observed by visual inspection during orthostatism in four subjects and two also presented falls. Eleven out of 16 patients (68.7%) with OM had an associated neurodegenerative disease, such as multiple system atrophy (n = 3) Parkinson's disease (n = 2), Alzheimer's disease (n = 2), mild cognitive impairment (n = 2) and normal pressure hydrocephalus (n = 2). Although four subjects showed improvement of orthostatic myoclonus with antimyoclonic treatment, the follow-up was not systematic enough to evaluate their therapeutic effect on OM.\nOrthostatic myoclonus: an underrecognized cause of unsteadiness?",
        "answer": "yes",
        "answer_rationale": "Orthostatic myoclonus is often underdiagnosed and can be considered a possible cause of unsteadiness in subjects with neurodegenerative diseases. Electromyography surface recording is thereby an aid for investigating unsteadiness of unknown origin.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Recently, orthostatic myoclonus (OM) has been suggested as a cause of gait impairment and unsteadiness in neurodegenerative diseases. The aim of this study was to investigate the frequency of orthostatic myoclonus, its clinical characteristics and the underlying associated neurological disorders.\nA retrospective analysis of clinical data and electromyogram surface recordings from subjects with unexplained unsteadiness/gait impairment was performed. Diagnosis of OM was made when a pattern of non-rhythmic bursts was observed (duration range 20-100 ms; bursts per second \u226416).\nAmong 93 subjects studied, OM was the most frequent disorder (n = 16; 17.2%), followed by orthostatic tremor (13.9%) and low frequency tremors during orthostatism (12.",
        "q2": "9%). All patients with OM complained about unsteadiness during orthostatism and/or during gait. Leg jerking was only observed by visual inspection during orthostatism in four subjects and two also presented falls. Eleven out of 16 patients (68.7%) with OM had an associated neurodegenerative disease, such as multiple system atrophy (n = 3) Parkinson's disease (n = 2), Alzheimer's disease (n = 2), mild cognitive impairment (n = 2) and normal pressure hydrocephalus (n = 2). Although four subjects showed improvement of orthostatic myoclonus with antimyoclonic treatment, the follow-up was not systematic enough to evaluate their therapeutic effect on OM.\nOrthostatic myoclonus: an underrecognized cause of unsteadiness?",
        "generated_text": "9%). OM was more frequent in subjects with neurodegenerative disorders (22.2%) than in those with non-neurodegenerative disorders (10.5%). The most frequent associated neurological disorders were Parkinson's disease (n = 5; 31.2%), multiple system atrophy (n = 4; 25%), and essential tremor (n = 3; 18.7%). The most frequent clinical features were unsteadiness (n = 14; 87.5%), gait impairment (n = 13; 81.2%), and falls (n = 10; 62.5%). The most frequent myoclonic pattern was multifocal (n = 10; 62.5%),",
        "levenshtein_distance": 521
    },
    {
        "realidx": "23949294",
        "question": "Recently, there has been increasing interest in the role of \"treatment as prevention\" (TasP). Some of the questions regarding TasP strategies arise from the perceived difficulties in achieving and maintaining viral load (VL) suppression over time and the risk of emergence of viral resistance that could compromise future treatment options. This study was conducted to assess these questions in a resource-limited setting.\nWe performed a retrospective observational study of HIV-infected patients diagnosed in the pre-HAART era on follow-up at a private center from Buenos Aires, Argentina. Socio-demographic, clinical, and laboratory data were extracted from clinical charts. Analyses were performed to test for potential associations of selected variables with current virologic failure or use of third-line drugs.\nOf 619 patients on follow-up, 82 (13.2%) were diagnosed in the pre-HAART era. At the time of our study, 79 (96.3%) patients were on HAART, with a median duration of 14 years (IQR 12-15) of therapy, and exposure to mono or dual nucleoside reverse transcriptase inhibitors regimens in 47.8% of cases.\u00a0Sixty-nine patients (87.3%) had undetectable VL, 37 (46.8%) never presented virologic failure, and 19 (24.1%) experienced only one failure. Thirteen patients (16.5%) were receiving third-line ART regimens, with an average of 2.7-fold more virologic failures than those on first- or second-line regimens (p = 0.007).\nTreatment as prevention in resource-limited settings: is it feasible to maintain HIV viral load suppression over time?",
        "answer": "yes",
        "answer_rationale": "Maintaining viral load suppression over time in resource-limited-settings is feasible.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Recently, there has been increasing interest in the role of \"treatment as prevention\" (TasP). Some of the questions regarding TasP strategies arise from the perceived difficulties in achieving and maintaining viral load (VL) suppression over time and the risk of emergence of viral resistance that could compromise future treatment options. This study was conducted to assess these questions in a resource-limited setting.\nWe performed a retrospective observational study of HIV-infected patients diagnosed in the pre-HAART era on follow-up at a private center from Buenos Aires, Argentina. Socio-demographic, clinical, and laboratory data were extracted from clinical charts. Analyses were performed to test for potential associations of selected variables with current virologic failure or use of third-line drugs.\nOf 619 patients on follow-up, 82 (13.2%) were diagnosed in the pre-HAART era.",
        "q2": " At the time of our study, 79 (96.3%) patients were on HAART, with a median duration of 14 years (IQR 12-15) of therapy, and exposure to mono or dual nucleoside reverse transcriptase inhibitors regimens in 47.8% of cases.\u00a0Sixty-nine patients (87.3%) had undetectable VL, 37 (46.8%) never presented virologic failure, and 19 (24.1%) experienced only one failure. Thirteen patients (16.5%) were receiving third-line ART regimens, with an average of 2.7-fold more virologic failures than those on first- or second-line regimens (p = 0.007).\nTreatment as prevention in resource-limited settings: is it feasible to maintain HIV viral load suppression over time?",
        "generated_text": "Median age at diagnosis was 35 years (IQR: 30-41). Median time from diagnosis to initiation of HAART was 1.5 years (IQR: 0.5-3.5). Median time on HAART was 12.5 years (IQR: 10.5-14.5). Median number of HAART regimens was 3 (IQR: 2-4). Median number of drug switches was 5 (IQR: 3-7). Median number of drug classes used was 4 (IQR: 3-4). Median number of drugs used was 10 (IQR: 8-12). Median number of drugs with resistance mutations was 12 (IQR: 10-14). Median number of drugs with",
        "levenshtein_distance": 513
    },
    {
        "realidx": "23992109",
        "question": "The solitary kidney (SK) is currently debated in the literature, as living kidney donation is extensively used and the diagnosis of congenital SK is frequent. Tubulointerstitial lesions associated with adaptive phenomena may occur early within the SK.\nAnalysis of the significance of urinary biomarkers in the assessment of tubulointerstitial lesions of the SK.\nA cross-sectional study of 37 patients with SK included 18 patients-acquired SK (mean age 56.44\u2009\u00b1\u200912.20 years, interval from nephrectomy 10.94\u2009\u00b1\u20099.37 years), 19 patients-congenital SK (mean age 41.52\u2009\u00b1\u200910.54 years). Urinary NAG, urinary alpha-1-microglobulin, albuminuria, eGFR (CKD-EPI equation) were measured.\nIn acquired SK, NAG increased in 60.66%, urinary alpha 1-microglobulin in 16.66%, albuminuria in 55.55% of patients. Inverse correlation with eGFR presented NAG (R(2\u2009)=\u20090.537, p\u2009=\u20090.022), urinary alpha 1-microglobulin (R(2\u2009)=\u20090.702, p\u2009=\u20090.001), albuminuria (R(2\u2009)=\u20090.655, p\u2009=\u20090.003). In congenital SK, NAG increased in 52.63%, urinary alpha 1-microglobulin in 5.26%, albuminuria in 47.36% of patients. In this group, urinary biomarkers correlated inversely with eGFR: NAG (R(2\u2009)=\u20090.743, p\u2009<\u20090.001), urinary alpha 1-microglobulin (R(2\u2009)=\u20090.701, p\u2009=\u20090.001), albuminuria (R(2\u2009)=\u20090.821, p\u2009<\u20090.001). Significant correlations were found between the urinary biomarkers in both groups.\nIs the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney?",
        "answer": "yes",
        "answer_rationale": "Urinary biomarkers allow a non-invasive, sensitive, early assessment of the tubular lesions of the SK. Urinary biomarkers of PT injury parallel renal function decline, thus complementing the estimation of GFR. Monitoring of PT dysfunction is mandatory in patients with SK.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The solitary kidney (SK) is currently debated in the literature, as living kidney donation is extensively used and the diagnosis of congenital SK is frequent. Tubulointerstitial lesions associated with adaptive phenomena may occur early within the SK.\nAnalysis of the significance of urinary biomarkers in the assessment of tubulointerstitial lesions of the SK.\nA cross-sectional study of 37 patients with SK included 18 patients-acquired SK (mean age 56.44\u2009\u00b1\u200912.20 years, interval from nephrectomy 10.94\u2009\u00b1\u20099.37 years), 19 patients-congenital SK (mean age 41.52\u2009\u00b1\u200910.54 years). Urinary NAG, urinary alpha-1-microglobulin, albuminuria, eGFR (CKD-EPI equation) were measured.\nIn acquired SK, NAG increased in 60.66%, urinary alpha 1-microglobulin in 16.66%, albuminuria in 55.55% of patients. Inverse correlation with eGFR presented NAG (R",
        "q2": "(2\u2009)=\u20090.537, p\u2009=\u20090.022), urinary alpha 1-microglobulin (R(2\u2009)=\u20090.702, p\u2009=\u20090.001), albuminuria (R(2\u2009)=\u20090.655, p\u2009=\u20090.003). In congenital SK, NAG increased in 52.63%, urinary alpha 1-microglobulin in 5.26%, albuminuria in 47.36% of patients. In this group, urinary biomarkers correlated inversely with eGFR: NAG (R(2\u2009)=\u20090.743, p\u2009<\u20090.001), urinary alpha 1-microglobulin (R(2\u2009)=\u20090.701, p\u2009=\u20090.001), albuminuria (R(2\u2009)=\u20090.821, p\u2009<\u20090.001). Significant correlations were found between the urinary biomarkers in both groups.\nIs the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney?",
        "generated_text": "=\u2009-0.52, p\u2009=\u20090.02), urinary alpha-1-microglobulin (R\u2009=\u2009-0.51, p\u2009=\u20090.02), albuminuria (R\u2009=\u2009-0.47, p\u2009=\u20090.04). In congenital SK, NAG increased in 52.63%, urinary alpha-1-microglobulin in 21.05%, albuminuria in 52.63% of patients. Inverse correlation with eGFR presented NAG (R\u2009=\u2009-0.51, p\u2009=\u20090.02), urinary alpha-1-microglobulin (R\u2009=\u2009-0.48, p\u2009=\u20090.03), albuminuria (R\u2009=\u2009-0.45, p\u2009=\u20090.0",
        "levenshtein_distance": 304
    },
    {
        "realidx": "24013712",
        "question": "Platelet count is inversely related to prognosis in many cancers; however, its role in esophageal cancer is still controversial. The purpose of this study was to determine the prognostic value of preoperative platelet count in esophageal squamous cell carcinoma (ESCC).\nFrom January 2006 to December 2008, a retrospective analysis of 425 consecutive patients with ESCC was conducted. A receiver operating characteristic (ROC) curve for survival prediction was plotted to verify the optimum cutoff point for preoperative platelet count. Univariate and multivariate analyses were performed to evaluate the prognostic parameters.\nA ROC curve for survival prediction was plotted to verify the optimum cutoff point for platelet count, which was 205 (\u00d7 10(9)/L). Patients with platelet count \u2264 205 had a significantly better 5-year survival than patients with a platelet count>205 (60.7 vs. 31.6 %, P<0.001). The 5-year survival of patients either with platelet count \u2264 205 or>205 were similar (68.6 vs. 58.8 %, P = 0.085) when the nodes were negative. However, the 5-year survival of patients with platelet count \u2264 205 was better than that of patients with a platelet count>205 when the nodes were involved (32.0 vs. 12.7 %, P = 0.004). Multivariate analysis showed that platelet count (P = 0.013), T grade (P = 0.017), and N staging (P<0.001) were independent prognostic factors.\nPreoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?",
        "answer": "yes",
        "answer_rationale": "Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Platelet count is inversely related to prognosis in many cancers; however, its role in esophageal cancer is still controversial. The purpose of this study was to determine the prognostic value of preoperative platelet count in esophageal squamous cell carcinoma (ESCC).\nFrom January 2006 to December 2008, a retrospective analysis of 425 consecutive patients with ESCC was conducted. A receiver operating characteristic (ROC) curve for survival prediction was plotted to verify the optimum cutoff point for preoperative platelet count. Univariate and multivariate analyses were performed to evaluate the prognostic parameters.\nA ROC curve for survival prediction was plotted to verify the optimum cutoff point for platelet count, which was 205 (\u00d7 10(9)/L). Patients with platelet count \u2264 205 had a significantly better 5-year survival than patients with a platelet count>",
        "q2": "205 (60.7 vs. 31.6 %, P<0.001). The 5-year survival of patients either with platelet count \u2264 205 or>205 were similar (68.6 vs. 58.8 %, P = 0.085) when the nodes were negative. However, the 5-year survival of patients with platelet count \u2264 205 was better than that of patients with a platelet count>205 when the nodes were involved (32.0 vs. 12.7 %, P = 0.004). Multivariate analysis showed that platelet count (P = 0.013), T grade (P = 0.017), and N staging (P<0.001) were independent prognostic factors.\nPreoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?",
        "generated_text": "205 (42.1% vs. 22.2%, P < 0.001). Multivariate analysis revealed that platelet count was an independent prognostic factor for overall survival (hazard ratio [HR] = 1.45, 95% confidence interval [CI] = 1.07-1.97, P = 0.017). In addition, platelet count was an independent prognostic factor for disease-free survival (HR = 1.42, 95% CI = 1.05-1.92, P = 0.023). The 5-year survival rates of patients with low platelet count in stage I, II, and III were 55.6%, 42",
        "levenshtein_distance": 422
    },
    {
        "realidx": "24014276",
        "question": "Studies examining predictors of survival among the oldest-old have primarily focused on objective measures, such as physical function and health status. Only a few studies have examined the effect of personality traits on survival, such as optimism. The aim of this study was to examine whether an optimistic outlook predicts survival among the oldest-old.\nThe Danish 1905 Cohort Survey is a nationwide, longitudinal survey comprising all individuals born in Denmark in 1905. At baseline in 1998, a total of 2,262 persons aged 92 or 93 agreed to participate in the intake survey. The baseline in-person interview consisted of a comprehensive questionnaire including physical functioning and health, and a question about whether the respondent had an optimistic, neutral or pessimistic outlook on his or her own future.\nDuring the follow-up period of 12 years (1998-2010) there were 2,239 deaths (99 %) in the 1905 Cohort Survey. Univariable analyses revealed that optimistic women and men were at lower risk of death compared to their neutral counterparts [HR 0.82, 95 % CI (0.73-0.93) and 0.81, 95 % CI (0.66-0.99), respectively]. When confounding factors such as baseline physical and cognitive functioning and disease were taken into account the association between optimism and survival weakened in both sexes, but the general pattern persisted. Optimistic women were still at lower risk of death compared to neutral women [HR 0.85, 95 % CI (0.74-0.97)]. The risk of death was also decreased for optimistic men compared to their neutral counterparts, but the effect was non-significant [HR 0.91, 95 % CI (0.73-1.13)].\nOptimism and survival: does an optimistic outlook predict better survival at advanced ages?",
        "answer": "yes",
        "answer_rationale": "An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Studies examining predictors of survival among the oldest-old have primarily focused on objective measures, such as physical function and health status. Only a few studies have examined the effect of personality traits on survival, such as optimism. The aim of this study was to examine whether an optimistic outlook predicts survival among the oldest-old.\nThe Danish 1905 Cohort Survey is a nationwide, longitudinal survey comprising all individuals born in Denmark in 1905. At baseline in 1998, a total of 2,262 persons aged 92 or 93 agreed to participate in the intake survey. The baseline in-person interview consisted of a comprehensive questionnaire including physical functioning and health, and a question about whether the respondent had an optimistic, neutral or pessimistic outlook on his or her own future.\nDuring the follow-up period of 12 years (1998-2010) there were 2,239 deaths (99 %) in the 1905 Cohort Survey.",
        "q2": " Univariable analyses revealed that optimistic women and men were at lower risk of death compared to their neutral counterparts [HR 0.82, 95 % CI (0.73-0.93) and 0.81, 95 % CI (0.66-0.99), respectively]. When confounding factors such as baseline physical and cognitive functioning and disease were taken into account the association between optimism and survival weakened in both sexes, but the general pattern persisted. Optimistic women were still at lower risk of death compared to neutral women [HR 0.85, 95 % CI (0.74-0.97)]. The risk of death was also decreased for optimistic men compared to their neutral counterparts, but the effect was non-significant [HR 0.91, 95 % CI (0.73-1.13)].\nOptimism and survival: does an optimistic outlook predict better survival at advanced ages?",
        "generated_text": "The mean age at death was 100.4 years (SD 2.7). The majority of the participants (54 %) reported a neutral outlook, 29 % reported an optimistic outlook and 17 % reported a pessimistic outlook on their own future. The unadjusted hazard ratio (HR) for survival was 0.82 (95 % CI 0.74-0.91) for those with an optimistic outlook and 1.11 (95 % CI 1.01-1.22) for those with a pessimistic outlook compared to those with a neutral outlook. In the adjusted model, including sex, marital status, education, physical functioning and health, the HR for survival was 0.85 (95 % CI 0.76-0.95) for those with an optimistic outlook and 1.12",
        "levenshtein_distance": 576
    },
    {
        "realidx": "24061619",
        "question": "It has been demonstrated that hiatal hernia repair (HHR) during laparoscopic adjustable gastric banding (LAGB) decreases the rate of reoperation. However, the technical aspects (location and number of sutures) are not standardized. It is unknown whether such technical details are associated with differing rates of reoperation for band-related problems.\nA retrospective analysis was performed from a single institution, including 2,301 patients undergoing LAGB with HHR from July 1, 2007 to December 31, 2011. Independent variables were number and location of sutures. Data collected included demographics, operating room (OR) time, length of stay (LOS), follow-up time, postoperative BMI/%EWL, and rates of readmission/reoperation. Statistical analyses included ANOVA and Chi squared tests. Kaplan-Meier, log-rank, and Cox regression tests were used for follow-up data and reoperation rates, in order to account for differential length of follow-up and confounding variables.\nThere was no difference in length of follow-up among all groups. The majority of patients had one suture (range 1-6; 55 %). Patients with fewer sutures had shorter OR time (1 suture 45 min vs. 4+ sutures 56 min, p<0.0001). LOS, 30-day readmission, band-related reoperation, and postop BMI/%EWL were not statistically significant. Anterior suture placement (vs. posterior vs. both) was most common (61 %). OR time was shorter in those with anterior suture (41 min vs. posterior 56 min vs. both 59 min, p<0.0001). Patients with posterior suture had a longer LOS (84 % 1 day vs. anterior 74 % 1 day vs. both 74 % 1 day, p<0.0001). There was no difference in 30-day readmission, band-related reoperation, and postoperative BMI/%EWL.\nLocation and number of sutures placed for hiatal hernia repair during laparoscopic adjustable gastric banding: does it matter?",
        "answer": "no",
        "answer_rationale": "Patients with fewer or anterior sutures have shorter OR times. However, 30-day readmission, band-related reoperation, and postoperative weight loss were unaffected by number or location of suture. The technical aspects of HHR did not appear to be associated with readmission or reoperation, and therefore a standardized approach may not be necessary.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "It has been demonstrated that hiatal hernia repair (HHR) during laparoscopic adjustable gastric banding (LAGB) decreases the rate of reoperation. However, the technical aspects (location and number of sutures) are not standardized. It is unknown whether such technical details are associated with differing rates of reoperation for band-related problems.\nA retrospective analysis was performed from a single institution, including 2,301 patients undergoing LAGB with HHR from July 1, 2007 to December 31, 2011. Independent variables were number and location of sutures. Data collected included demographics, operating room (OR) time, length of stay (LOS), follow-up time, postoperative BMI/%EWL, and rates of readmission/reoperation. Statistical analyses included ANOVA and Chi squared tests. Kaplan-Meier, log-rank, and Cox regression tests were used for follow-up data and reoperation rates, in order to account for differential length of follow-up and confounding variables.\nThere was no difference in length of follow-up among all groups. The",
        "q2": " majority of patients had one suture (range 1-6; 55 %). Patients with fewer sutures had shorter OR time (1 suture 45 min vs. 4+ sutures 56 min, p<0.0001). LOS, 30-day readmission, band-related reoperation, and postop BMI/%EWL were not statistically significant. Anterior suture placement (vs. posterior vs. both) was most common (61 %). OR time was shorter in those with anterior suture (41 min vs. posterior 56 min vs. both 59 min, p<0.0001). Patients with posterior suture had a longer LOS (84 % 1 day vs. anterior 74 % 1 day vs. both 74 % 1 day, p<0.0001). There was no difference in 30-day readmission, band-related reoperation, and postoperative BMI/%EWL.\nLocation and number of sutures placed for hiatal hernia repair during laparoscopic adjustable gastric banding: does it matter?",
        "generated_text": "number of sutures used for HHR was 1, 2, 3, and 4 in 1,011 (44%), 701 (30%), 400 (17%), and 189 (8%) patients, respectively. The location of the sutures was anterior, posterior, and both in 1,101 (48%), 1,000 (43%), and 200 (9%) patients, respectively. There was no difference in OR time, LOS, postoperative BMI, or %EWL among the groups. There was no difference in readmission rates among the groups. The overall reoperation rate for band-related problems was 12.4%. The reoperation rate was 12.1% in the 1 suture group, 12.5% in the 2 suture group, 12.5% in the 3 suture group, and 13.8% in the 4 suture group (",
        "levenshtein_distance": 592
    },
    {
        "realidx": "24073931",
        "question": "In recent years, many advances in pancreatic surgery have been achieved. Nevertheless, the rate of pancreatic fistula following pancreatic tail resection does not differ between various techniques, still reaching up to 30% in prospective multicentric studies. Taking into account contradictory results concerning the usefulness of covering resection margins after distal pancreatectomy, we sought to perform a systematic, retrospective analysis of patients that underwent distal pancreatectomy at our center.\nWe retrospectively analysed the data of 74 patients that underwent distal pancreatectomy between 2001 and 2011 at the community hospital in Neuss. Demographic factors, indications, postoperative complications, surgical or interventional revisions, and length of hospital stay were registered to compare the outcome of patients undergoing distal pancreatectomy with coverage of the resection margins vs. patients undergoing distal pancreatectomy without coverage of the resection margins. Differences between groups were calculated using Fisher's exact and Mann-Whitney U test.\nMain indications for pancreatic surgery were insulinoma (n=18, 24%), ductal adenocarcinoma (n=9, 12%), non-single-insulinoma-pancreatogenic-hypoglycemia-syndrome (NSIPHS) (n=8, 11%), and pancreatic cysts with pancreatitis (n=8, 11%). In 39 of 74 (53%) patients no postoperative complications were noted. In detail we found that 23/42 (55%) patients with coverage vs. 16/32 (50%) without coverage of the resection margins had no postoperative complications. The most common complications were pancreatic fistulas in eleven patients (15%), and postoperative bleeding in nine patients (12%). Pancreatic fistulas occurred in patients without coverage of the resection margins in 7/32 (22%) vs. 4/42 (1011%) with coverage are of the resection margins, yet without reaching statistical significance. Postoperative bleeding ensued with equal frequency in both groups (12% with coverage versus 13% without coverage of the resection margins). The reoperation rate was 8%. The hospital stay for patients without coverage was 13 days (5-60) vs. 17 days (8-60) for patients with coverage.\nIs the covering of the resection margin after distal pancreatectomy advantageous?",
        "answer": "no",
        "answer_rationale": "The results show no significant difference in the fistula rate after covering of the resection margin after distal pancreatectomy, which contributes to the picture of an unsolved problem.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "In recent years, many advances in pancreatic surgery have been achieved. Nevertheless, the rate of pancreatic fistula following pancreatic tail resection does not differ between various techniques, still reaching up to 30% in prospective multicentric studies. Taking into account contradictory results concerning the usefulness of covering resection margins after distal pancreatectomy, we sought to perform a systematic, retrospective analysis of patients that underwent distal pancreatectomy at our center.\nWe retrospectively analysed the data of 74 patients that underwent distal pancreatectomy between 2001 and 2011 at the community hospital in Neuss. Demographic factors, indications, postoperative complications, surgical or interventional revisions, and length of hospital stay were registered to compare the outcome of patients undergoing distal pancreatectomy with coverage of the resection margins vs. patients undergoing distal pancreatectomy without coverage of the resection margins. Differences between groups were calculated using Fisher's exact and Mann-Whitney U test.\nMain indications for pancreatic surgery were insulinoma (n=18, 24%), ductal adenocarcinoma (n=9, 12%), non-single-insulinoma-pancreatogenic-hypoglycemia-s",
        "q2": "yndrome (NSIPHS) (n=8, 11%), and pancreatic cysts with pancreatitis (n=8, 11%). In 39 of 74 (53%) patients no postoperative complications were noted. In detail we found that 23/42 (55%) patients with coverage vs. 16/32 (50%) without coverage of the resection margins had no postoperative complications. The most common complications were pancreatic fistulas in eleven patients (15%), and postoperative bleeding in nine patients (12%). Pancreatic fistulas occurred in patients without coverage of the resection margins in 7/32 (22%) vs. 4/42 (1011%) with coverage are of the resection margins, yet without reaching statistical significance. Postoperative bleeding ensued with equal frequency in both groups (12% with coverage versus 13% without coverage of the resection margins). The reoperation rate was 8%. The hospital stay for patients without coverage was 13 days (5-60) vs. 17 days (8-60) for patients with coverage.\nIs the covering of the resection margin after distal pancreatectomy advantageous?",
        "generated_text": "yndrome (n=8, 11%), and serous cystadenoma (n=7, 9%). 42 patients (57%) underwent distal pancreatectomy with coverage of the resection margins, 32 patients (43%) underwent distal pancreatectomy without coverage of the resection margins. Postoperative complications occurred in 24 patients (32%), 12 patients (29%) in the group with coverage and 12 patients (38%) in the group without coverage of the resection margins (p=0.51). Pancreatic fistula was observed in 10 patients (14%), 5 patients (12%) in the group with coverage and 5 patients (16%) in the group without coverage of the resection margins (p=0.64). The median length of hospital stay was 11 days (range 5-100 days). There was no difference in the length of hospital stay between the two groups (p=0.13). The overall mortality was 1.4% (n=1",
        "levenshtein_distance": 604
    },
    {
        "realidx": "24139705",
        "question": "Each patient received a smartphone with an insulin dose advisor (IDA) and with (G3 group) or without (G2 group) the telemonitoring/teleconsultation function. Patients were classified as \"high users\" if the proportion of \"informed\" meals using the IDA exceeded 67% (median) and as \"low users\" if not. Also analyzed was the respective impact of the IDA function and teleconsultations on the final HbA1c levels.\nAmong the high users, the proportion of informed meals remained stable from baseline to the end of the study 6months later (from 78.1\u00b121.5% to 73.8\u00b125.1%; P=0.107), but decreased in the low users (from 36.6\u00b129.4% to 26.7\u00b128.4%; P=0.005). As expected, HbA1c improved in high users from 8.7% [range: 8.3-9.2%] to 8.2% [range: 7.8-8.7%]in patients with (n=26) vs without (n=30) the benefit of telemonitoring/teleconsultation (-0.49\u00b10.60% vs -0.52\u00b10.73%, respectively; P=0.879). However, although HbA1c also improved in low users from 9.0% [8.5-10.1] to 8.5% [7.9-9.6], those receiving support via teleconsultation tended to show greater improvement than the others (-0.93\u00b10.97 vs -0.46\u00b11.05, respectively; P=0.084).\nTelemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?",
        "answer": "yes",
        "answer_rationale": "The Diabeo system improved glycaemic control in both high and low users who avidly used the IDA function, while the greatest improvement was seen in the low users who had the motivational support of teleconsultations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Each patient received a smartphone with an insulin dose advisor (IDA) and with (G3 group) or without (G2 group) the telemonitoring/teleconsultation function. Patients were classified as \"high users\" if the proportion of \"informed\" meals using the IDA exceeded 67% (median) and as \"low users\" if not. Also analyzed was the respective impact of the IDA function and teleconsultations on the final HbA1c levels.\nAmong the high users, the proportion of informed meals remained stable from baseline to the end of the study 6months later (from 78.1\u00b121.5% to 73.8\u00b125.1%; P=0.107), but decreased in the low users (from 36.6\u00b129.4% to 26.7\u00b128.4%; P=0.005). As expected, HbA1c improved in high users",
        "q2": " from 8.7% [range: 8.3-9.2%] to 8.2% [range: 7.8-8.7%]in patients with (n=26) vs without (n=30) the benefit of telemonitoring/teleconsultation (-0.49\u00b10.60% vs -0.52\u00b10.73%, respectively; P=0.879). However, although HbA1c also improved in low users from 9.0% [8.5-10.1] to 8.5% [7.9-9.6], those receiving support via teleconsultation tended to show greater improvement than the others (-0.93\u00b10.97 vs -0.46\u00b11.05, respectively; P=0.084).\nTelemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?",
        "generated_text": "(from 8.1\u00b11.1% to 7.5\u00b11.0%; P<0.001), but not in low users (from 8.1\u00b11.2% to 7.9\u00b11.1%; P=0.07). The proportion of informed meals was the only variable associated with the HbA1c improvement in the multivariate analysis (P=0.001). The teleconsultation function was used by 40% of the patients in the G3 group, and the frequency of use was not associated with the HbA1c improvement.\nIn conclusion, the use of the IDA function was associated with a better HbA1c control, but the teleconsultation function was not used by all patients and was not associated with the HbA1c improvement.\n\n**Keywords:** Diabetes, Telemedicine, Teleconsultation, Telemonitor",
        "levenshtein_distance": 508
    },
    {
        "realidx": "24191126",
        "question": "Surgical excision of ovarian endometriomas in patients desiring pregnancy has recently been criticized because of the risk of damage to healthy ovarian tissue and consequent reduction of ovarian reserve. A correct diagnosis in cases not scheduled for surgery is therefore mandatory in order to avoid unexpected ovarian cancer misdiagnosis. Endometriosis is often associated with high levels of CA125. This marker is therefore not useful for discriminating ovarian endometrioma from ovarian malignancy. The aim of this study was to establish if the serum marker CA72-4 could be helpful in the differential diagnosis between ovarian endometriosis and epithelial ovarian cancer.\nSerums CA125 and CA72-4 were measured in 72 patients with ovarian endometriomas and 55 patients with ovarian cancer.\nHigh CA125 concentrations were observed in patients with ovarian endometriosis and in those with ovarian cancer. A marked difference in CA72-4 values was observed between women with ovarian cancer (71.0%) and patients with endometriosis (13.8%) (P<0.0001).\nIs CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?",
        "answer": "yes",
        "answer_rationale": "This study suggests that CA72-4 determination can be useful to confirm the benign nature of ovarian endometriomas in women with high CA125 levels.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Surgical excision of ovarian endometriomas in patients desiring pregnancy has recently been criticized because of the risk of damage to healthy ovarian tissue and consequent reduction of ovarian reserve. A correct diagnosis in cases not scheduled for surgery is therefore mandatory in order to avoid unexpected ovarian cancer misdiagnosis. Endometriosis is often associated with high levels of CA125. This marker is therefore not useful for discriminating ovarian endometrioma from ovarian malignancy. The aim of this study was to establish if the serum marker CA72-4 could be helpful in the differential diagnosis between ovarian endometri",
        "q2": "osis and epithelial ovarian cancer.\nSerums CA125 and CA72-4 were measured in 72 patients with ovarian endometriomas and 55 patients with ovarian cancer.\nHigh CA125 concentrations were observed in patients with ovarian endometriosis and in those with ovarian cancer. A marked difference in CA72-4 values was observed between women with ovarian cancer (71.0%) and patients with endometriosis (13.8%) (P<0.0001).\nIs CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?",
        "generated_text": "oma and ovarian cancer. Serum CA72-4 levels were measured in 100 patients with ovarian endometrioma and in 100 patients with ovarian cancer. The mean CA72-4 level was 10.1 U/ml in the endometrioma group and 102.5 U/ml in the cancer group. The difference was statistically significant (p < 0.0001). The sensitivity and specificity of CA72-4 in discriminating between endometrioma and cancer were 95% and",
        "levenshtein_distance": 295
    },
    {
        "realidx": "24245816",
        "question": "To compare the primary stability of miniscrews inserted into bone blocks of different bone mineral densities (BMDs) with and without cortical bone, and investigate whether some trabecular properties could influence primary stability.\nFifty-two bone blocks were extracted from fresh bovine pelvic bone. Four groups were created based on bone type (iliac or pubic region) and presence or absence of cortical bone. Specimens were micro-computed tomography imaged to evaluate trabecular thickness, trabecular number, trabecular separation, bone volume density (BV/TV), BMD, and cortical thickness. Miniscrews 1.4 mm in diameter and 6 mm long were inserted into the bone blocks, and primary stability was evaluated by insertion torque (IT), mini-implant mobility (PTV), and pull-out strength (PS).\nIntergroup comparison showed lower levels of primary stability when the BMD of trabecular bone was lower and in the absence of cortical bone (P\u2264.05). The Pearson correlation test showed correlation between trabecular number, trabecular thickness, BV/TV, trabecular BMD, total BMD, and IT, PTV, and PS. There was correlation between cortical thickness and IT and PS (P\u2264.05).\nIs trabecular bone related to primary stability of miniscrews?",
        "answer": "yes",
        "answer_rationale": "Cancellous bone plays an important role in primary stability of mini-implants in the presence or absence of cortical bone.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To compare the primary stability of miniscrews inserted into bone blocks of different bone mineral densities (BMDs) with and without cortical bone, and investigate whether some trabecular properties could influence primary stability.\nFifty-two bone blocks were extracted from fresh bovine pelvic bone. Four groups were created based on bone type (iliac or pubic region) and presence or absence of cortical bone. Specimens were micro-computed tomography imaged to evaluate trabecular thickness, trabecular number, trabecular separation, bone volume density (BV/TV), BMD, and cortical thickness. Miniscrews 1.4 mm in diameter and 6 mm long",
        "q2": " were inserted into the bone blocks, and primary stability was evaluated by insertion torque (IT), mini-implant mobility (PTV), and pull-out strength (PS).\nIntergroup comparison showed lower levels of primary stability when the BMD of trabecular bone was lower and in the absence of cortical bone (P\u2264.05). The Pearson correlation test showed correlation between trabecular number, trabecular thickness, BV/TV, trabecular BMD, total BMD, and IT, PTV, and PS. There was correlation between cortical thickness and IT and PS (P\u2264.05).\nIs trabecular bone related to primary stability of miniscrews?",
        "generated_text": "were inserted into the bone blocks, and insertion torque (IT) and pullout force (POF) were measured.\nThe mean IT and POF values were higher in the pubic group than in the iliac group (p < 0.05). The mean IT and POF values were higher in the cortical group than in the trabecular group (p < 0.05). The mean IT and POF values were higher in the pubic-cortical group than in the iliac-cortical group (p < 0.05). The mean IT and POF values were higher in the pubic-trabecular group than",
        "levenshtein_distance": 405
    },
    {
        "realidx": "24270957",
        "question": "Our aim was to investigate the effects of growth hormone (GH), hyperbaric oxygen and combined therapy on normal and ischemic colonic anastomoses in rats.\nEighty male Wistar rats were divided into eight groups (n\u200a=\u200a10). In the first four groups, non-ischemic colonic anastomosis was performed, whereas in the remaining four groups, ischemic colonic anastomosis was performed. In groups 5, 6, 7, and 8, colonic ischemia was established by ligating 2 cm of the mesocolon on either side of the anastomosis. The control groups (1 and 5) received no treatment. Hyperbaric oxygen therapy was initiated immediately after surgery and continued for 4 days in groups 3 and 4. Groups 2 and 6 received recombinant human growth hormone, whereas groups 4 and 8 received GH and hyperbaric oxygen treatment. Relaparotomy was performed on postoperative day 4, and a perianastomotic colon segment 2 cm in length was excised for the detection of biochemical and mechanical parameters of anastomotic healing and histopathological evaluation.\nCombined treatment with hyperbaric oxygen and GH increased the mean bursting pressure values in all of the groups, and a statistically significant increase was noted in the ischemic groups compared to the controls (p<0.05). This improvement was more evident in the ischemic and normal groups treated with combined therapy. In addition, a histopathological evaluation of anastomotic neovascularization and collagen deposition showed significant differences among the groups.\nIs combined therapy more effective than growth hormone or hyperbaric oxygen alone in the healing of left ischemic and non-ischemic colonic anastomoses?",
        "answer": "yes",
        "answer_rationale": "Combined treatment with recombinant human growth hormone and hyperbaric oxygen resulted in a favorable therapeutic effect on the healing of ischemic colonic anastomoses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Our aim was to investigate the effects of growth hormone (GH), hyperbaric oxygen and combined therapy on normal and ischemic colonic anastomoses in rats.\nEighty male Wistar rats were divided into eight groups (n\u200a=\u200a10). In the first four groups, non-ischemic colonic anastomosis was performed, whereas in the remaining four groups, ischemic colonic anastomosis was performed. In groups 5, 6, 7, and 8, colonic ischemia was established by ligating 2 cm of the mesocolon on either side of the anastomosis. The control groups (1 and 5) received no treatment. Hyperbaric oxygen therapy was initiated immediately after surgery and continued for 4 days in groups 3 and 4. Groups 2 and 6 received recombinant human growth hormone, whereas groups",
        "q2": " 4 and 8 received GH and hyperbaric oxygen treatment. Relaparotomy was performed on postoperative day 4, and a perianastomotic colon segment 2 cm in length was excised for the detection of biochemical and mechanical parameters of anastomotic healing and histopathological evaluation.\nCombined treatment with hyperbaric oxygen and GH increased the mean bursting pressure values in all of the groups, and a statistically significant increase was noted in the ischemic groups compared to the controls (p<0.05). This improvement was more evident in the ischemic and normal groups treated with combined therapy. In addition, a histopathological evaluation of anastomotic neovascularization and collagen deposition showed significant differences among the groups.\nIs combined therapy more effective than growth hormone or hyperbaric oxygen alone in the healing of left ischemic and non-ischemic colonic anastomoses?",
        "generated_text": "4 and 8 received both recombinant human growth hormone and hyperbaric oxygen therapy. On the fifth day, the animals were sacrificed, and the bursting pressure and hydroxyproline levels were measured.\nIn the non-ischemic groups, the bursting pressure and hydroxyproline levels were higher in the groups treated with recombinant human growth hormone and hyperbaric oxygen therapy compared to the control group. In the ischemic groups, the bursting pressure and hydroxyproline levels were higher in the groups treated with recombinant human growth hormone and hyperbaric oxygen therapy compared to the control group. The combined therapy group had the highest bursting pressure and hydroxyproline levels in both non-ischemic and ischemic groups.\nOur results suggest that recombinant human growth hormone and hyperbaric oxygen therapy can improve the strength of colonic anastomoses, and their combined",
        "levenshtein_distance": 662
    },
    {
        "realidx": "24298614",
        "question": "The clinical and prognostic value of the previous node classification of TNM staging in early gastric cancer (EGC) has been less definitive. The aim was to assess the suitability of the revised node staging for prediction of clinical behavior of EGC.\nBetween 2005 and 2008, 1,845 patients were diagnosed with EGC and underwent surgery at Severance Hospitals. Clinicopathological characteristics were analyzed with comparisons between sixth and seventh TNM staging.\nWhen comparing IB with IIA upstaged based on seventh staging, poor differentiation, signet ring cell, diffuse, undifferentiated types, perineural invasion (PNI), larger size and younger age, were more significantly associated with IIA. Clinicopathological factors were compared between N0/N1 and N2/N3 based on both staging. In mucosal cancer, younger age, diffuse and undifferentiated types were more significantly associated with N2/N3 based on seventh staging. In submucosal cancer, larger size, poor differentiation, signet ring cell, diffuse, undifferentiated types, PNI and deeper submucosal invasion, were more significantly associated with N2/N3 based on seventh staging.\nIs the 7th TNM edition suitable for biological predictor in early gastric cancer?",
        "answer": "yes",
        "answer_rationale": "Upstaging in EGC based on the revised TNM staging reflects more aggressive biological behavior of cancer. The new TNM staging system may be informative in prediction of biological behavior of EGC as well as prognosis and survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The clinical and prognostic value of the previous node classification of TNM staging in early gastric cancer (EGC) has been less definitive. The aim was to assess the suitability of the revised node staging for prediction of clinical behavior of EGC.\nBetween 2005 and 2008, 1,845 patients were diagnosed with EGC and underwent surgery at Severance Hospitals. Clinicopathological characteristics were analyzed with comparisons between sixth and seventh TNM staging.\nWhen comparing IB with IIA upstaged based on seventh staging, poor differentiation, signet ring cell, diffuse, undifferentiated types, perineural invasion (PNI),",
        "q2": " larger size and younger age, were more significantly associated with IIA. Clinicopathological factors were compared between N0/N1 and N2/N3 based on both staging. In mucosal cancer, younger age, diffuse and undifferentiated types were more significantly associated with N2/N3 based on seventh staging. In submucosal cancer, larger size, poor differentiation, signet ring cell, diffuse, undifferentiated types, PNI and deeper submucosal invasion, were more significantly associated with N2/N3 based on seventh staging.\nIs the 7th TNM edition suitable for biological predictor in early gastric cancer?",
        "generated_text": "and lymphovascular invasion (LVI) were more frequent in IIA than in IB. The 5-year disease-free survival (DFS) and overall survival (OS) rates of IIA were significantly lower than those of IB (DFS: 87.1% vs. 96.1%, p < 0.001; OS: 94.1% vs. 98.5%, p < 0.001). The 5-year DFS and OS rates of IIB were significantly lower than those of IIA (DFS: 79.1% vs. 87.",
        "levenshtein_distance": 448
    },
    {
        "realidx": "24318956",
        "question": "Digoxin is a commonly used medication for heart failure and cardiac arrhythmias that has recently been suggested as a novel chemotherapeutic agent. Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with digoxin. We explore the relationship between use of digoxin and PCa risk.\nData from a population-based case-control study of incident cases aged 35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were available. Controls were identified by random digit dialing and frequency matched by age. Use of digoxin was determined from in-person questionnaires regarding medical and prescription history. The relationship of digoxin use with PCa risk was evaluated with logistic regression.\nOne thousand one cases of PCa and 942 controls were analyzed. The prevalence of digoxin use in controls was 2.7%, and use was positively correlated with age. In multivariate analysis adjusting for age, race, PSA screening, and family history of PCa, digoxin use was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 0.30-1.10). Among those with \u22653 PSA tests over the preceding 5 years (546 cases, 380 controls), digoxin use was associated with a stronger reduction of PCa risk (OR 0.44, 95% CI: 0.20-0.98).\nIs digoxin use for cardiovascular disease associated with risk of prostate cancer?",
        "answer": "yes",
        "answer_rationale": "These data indicate digoxin use may be associated with a reduction in risk of PCa. Given the potential mechanisms by which digoxin may exert an anti-neoplastic effect and other recent studies showing a negative association between digoxin use and PCa, further research is warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Digoxin is a commonly used medication for heart failure and cardiac arrhythmias that has recently been suggested as a novel chemotherapeutic agent. Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with digoxin. We explore the relationship between use of digoxin and PCa risk.\nData from a population-based case-control study of incident cases aged 35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were available. Controls were identified by random digit dialing and frequency matched by age. Use of digoxin was determined from in-person questionnaires regarding medical and prescription history. The relationship of digoxin use with PCa risk was evaluated with logistic regression.\nOne thousand one cases of PCa and",
        "q2": " 942 controls were analyzed. The prevalence of digoxin use in controls was 2.7%, and use was positively correlated with age. In multivariate analysis adjusting for age, race, PSA screening, and family history of PCa, digoxin use was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 0.30-1.10). Among those with \u22653 PSA tests over the preceding 5 years (546 cases, 380 controls), digoxin use was associated with a stronger reduction of PCa risk (OR 0.44, 95% CI: 0.20-0.98).\nIs digoxin use for cardiovascular disease associated with risk of prostate cancer?",
        "generated_text": "1,135 controls were included in the analysis. The mean age was 62 years. The mean time since diagnosis was 3.5 years. The mean time since last use of digoxin was 4.5 years. The mean duration of use was 10.5 years. The mean age at first use was 51 years. The mean age at last use was 61 years. The mean age at last use among current users was 62 years. The mean age at last use among former users was 59 years. The mean age at last use among users who had stopped using digoxin was 59 years. The mean age at last use among users who were still using digox",
        "levenshtein_distance": 439
    },
    {
        "realidx": "24336869",
        "question": "The 'law of spatiotemporal concentrations of events' introduced major preventative shifts in policing communities. 'Hotspots' are at the forefront of these developments yet somewhat understudied in emergency medicine. Furthermore, little is known about interagency 'data-crossover', despite some developments through the Cardiff Model. Can police-ED interagency data-sharing be used to reduce community-violence using a hotspots methodology?\n12-month (2012) descriptive study and analysis of spatiotemporal clusters of police and emergency calls for service using hotspots methodology and assessing the degree of incident overlap. 3775 violent crime incidents and 775 assault incidents analysed using spatiotemporal clustering with k-means++ algorithm and Spearman's rho.\nSpatiotemporal location of calls for services to the police and the ambulance service are equally highly concentrated in a small number of geographical areas, primarily within intra-agency hotspots (33% and 53%, respectively) but across agencies' hotspots as well (25% and 15%, respectively). Datasets are statistically correlated with one another at the 0.57 and 0.34 levels, with 50% overlap when adjusted for the number of hotspots. At least one in every two police hotspots does not have an ambulance hotspot overlapping with it, suggesting half of assault spatiotemporal concentrations are unknown to the police. Data further suggest that more severely injured patients, as estimated by transfer to hospital, tend to be injured in the places with the highest number of police-recorded crimes.\nCan routinely collected ambulance data about assaults contribute to reduction in community violence?",
        "answer": "maybe",
        "answer_rationale": "A hotspots approach to sharing data circumvents the problem of disclosing person-identifiable data between different agencies. Practically, at least half of ambulance hotspots are unknown to the police; if causal, it suggests that data sharing leads to both reduced community violence by way of prevention (such as through anticipatory patrols or problem-oriented policing), particularly of more severe assaults, and improved efficiency of resource deployment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The 'law of spatiotemporal concentrations of events' introduced major preventative shifts in policing communities. 'Hotspots' are at the forefront of these developments yet somewhat understudied in emergency medicine. Furthermore, little is known about interagency 'data-crossover', despite some developments through the Cardiff Model. Can police-ED interagency data-sharing be used to reduce community-violence using a hotspots methodology?\n12-month (2012) descriptive study and analysis of spatiotemporal clusters of police and emergency calls for service using hotspots methodology and assessing the degree of incident overlap. 3775 violent crime incidents and 775 assault incidents analysed using spatiotemporal clustering with k-means++ algorithm and Spearman's rho.\nSpatiotemporal location of calls for services to the police and",
        "q2": " the ambulance service are equally highly concentrated in a small number of geographical areas, primarily within intra-agency hotspots (33% and 53%, respectively) but across agencies' hotspots as well (25% and 15%, respectively). Datasets are statistically correlated with one another at the 0.57 and 0.34 levels, with 50% overlap when adjusted for the number of hotspots. At least one in every two police hotspots does not have an ambulance hotspot overlapping with it, suggesting half of assault spatiotemporal concentrations are unknown to the police. Data further suggest that more severely injured patients, as estimated by transfer to hospital, tend to be injured in the places with the highest number of police-recorded crimes.\nCan routinely collected ambulance data about assaults contribute to reduction in community violence?",
        "generated_text": "emergency services are significantly correlated (rho=0.52, p<0.001). 10% of the city area accounted for 60% of the violent crime and 50% of the assault incidents. 1% of the city area accounted for 10% of the violent crime and 10% of the assault incidents. 10% of the violent crime hotspots accounted for 25% of the assault hotspots.\nViolent crime and assault incidents are significantly co-located in space and time. This suggests that police-ED interagency data-sharing could be used to identify and target hotspots of violence in the community, potentially leading to a reduction in community violence. The high concentration of incidents in a small area suggests that targeted",
        "levenshtein_distance": 597
    },
    {
        "realidx": "24340838",
        "question": "Sudden death in athletes can occur during sport activities and is presumably related to ventricular arrhythmias.\nTo investigate the long-term follow-up ofathletes with ventricular arrhythmias during an exercise test.\nFrom a database of 56,462 athletes we identified 192 athletes (35 years old who had ventricular arrhythmias during an exercise test. Ninety athletes had>or =3 ventricular premature beats (VPB) (group A) and 102 athletes had ventricular couplets or non-sustained ventricular tachycardia during an exercise test (group B). A control group of 92 athletesfrom without ventricular arrhythmias was randomly seleclted from the database (group C). Of the 192 athletes 39 returnied for a repeat exercise test after a mean follow-up period of 70 +/- 25 months and they constitute the study population.\nTwelve athletes from group A, 21 fromgroup B and 6 from group C returned for a repeat exercise test. The athletes reached a significantly lower peak heart rate during their follow-up exercise test (P = 0.001). More athletes were engaged in competitive sports during their initialexercise test than in the follow-up test (P = 0.021). Most of theathletes who had VPB and/orventricular couplets and/or NSVT during their initial exercise test had far fewer ventricular arrhythmias in the follow-up exercise test (P = 0.001).\nDo ventricular arrhythmias in athletes subside over time?",
        "answer": "yes",
        "answer_rationale": "Athletes engaged in competitive sports are more likely to develop ventricular arrhythmias during exercise. These arrhythmias subside over time when athletes are engaged in non-competitive sports.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Sudden death in athletes can occur during sport activities and is presumably related to ventricular arrhythmias.\nTo investigate the long-term follow-up ofathletes with ventricular arrhythmias during an exercise test.\nFrom a database of 56,462 athletes we identified 192 athletes (35 years old who had ventricular arrhythmias during an exercise test. Ninety athletes had>or =3 ventricular premature beats (VPB) (group A) and 102 athletes had ventricular couplets or non-sustained ventricular tachycardia during an exercise test (group B). A control group of 92 athletesfrom without ventricular arrhythmias was randomly seleclted from the database (group C). Of the 192 athletes 39 returnied for a repeat exercise",
        "q2": " test after a mean follow-up period of 70 +/- 25 months and they constitute the study population.\nTwelve athletes from group A, 21 fromgroup B and 6 from group C returned for a repeat exercise test. The athletes reached a significantly lower peak heart rate during their follow-up exercise test (P = 0.001). More athletes were engaged in competitive sports during their initialexercise test than in the follow-up test (P = 0.021). Most of theathletes who had VPB and/orventricular couplets and/or NSVT during their initial exercise test had far fewer ventricular arrhythmias in the follow-up exercise test (P = 0.001).\nDo ventricular arrhythmias in athletes subside over time?",
        "generated_text": "test after a mean follow-up of 10.2 years. The athletes were divided into 3 groups: group 1 (n=13) had>or =3 VPB during the first and second exercise test; group 2 (n=13) had>or =3 VPB during the first exercise test and no VPB during the second exercise test; group 3 (n=13) had no VPB during the first and second exercise test.\nDuring the follow-up period 1 athlete in group A died suddenly. No sudden death occurred in group B and C. In group 1, 2 athletes had>or =3 VPB during the second exercise test, 1 athlete had a single VPB and",
        "levenshtein_distance": 446
    },
    {
        "realidx": "24352924",
        "question": "The purpose of this study was to investigate the efficacy of ultrasonography to confirm Schanz pin placement in a cadaveric model, and the interobserver repeatability of the ultrasound methodology.\nThis investigation is a repeated measures cadaveric study with multiple examiners.\nCadaveric preparation and observations were done by an orthopaedic traumatologist and resident, and two general surgery traumatologists.\nA total of 16 Schanz pins were equally placed in bilateral femora and tibiae. Four examiners took measurements of pin protrusion beyond the distal cortices using first ultrasonography and then by direct measurement after gross dissection.MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length measurements from both ultrasonography and direct measurement post dissection.\nSchanz pin protrusion measurements are underestimated by ultrasonography (p<0.01) by an average of 10 percent over the range of 5 to 18 mm, and they display a proportional bias that increases the under reporting as the magnitude of pin protrusion increases. Ultrasound data demonstrate good linear correlation and closely represent actual protrusion values in the 5 to 12 mm range. Interobserver repeatability analysis demonstrated that all examiners were not statistically different in their measurements despite minimal familiarity with the ultrasound methodology (p>0.8).\nIs portable ultrasonography accurate in the evaluation of Schanz pin placement during extremity fracture fixation in austere environments?",
        "answer": "yes",
        "answer_rationale": "Despite the statistical imparity of pin protrusion measurement via ultrasound compared to that of gross dissection, a consideration of the clinical relevance of ultrasound measurement bias during an austere operating theatre leads to the conclusion that ultrasonography is an adequate methodology for Schanz pin protrusion measurement.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study was to investigate the efficacy of ultrasonography to confirm Schanz pin placement in a cadaveric model, and the interobserver repeatability of the ultrasound methodology.\nThis investigation is a repeated measures cadaveric study with multiple examiners.\nCadaveric preparation and observations were done by an orthopaedic traumatologist and resident, and two general surgery traumatologists.\nA total of 16 Schanz pins were equally placed in bilateral femora and tibiae. Four examiners took measurements of pin protrusion beyond the distal cortices using first ultrasonography and then by direct measurement after gross dissection.MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length measurements from both ultr",
        "q2": "asonography and direct measurement post dissection.\nSchanz pin protrusion measurements are underestimated by ultrasonography (p<0.01) by an average of 10 percent over the range of 5 to 18 mm, and they display a proportional bias that increases the under reporting as the magnitude of pin protrusion increases. Ultrasound data demonstrate good linear correlation and closely represent actual protrusion values in the 5 to 12 mm range. Interobserver repeatability analysis demonstrated that all examiners were not statistically different in their measurements despite minimal familiarity with the ultrasound methodology (p>0.8).\nIs portable ultrasonography accurate in the evaluation of Schanz pin placement during extremity fracture fixation in austere environments?",
        "generated_text": "asonography and direct measurement were compared using the Bland-Altman method. Interobserver reliability was assessed using intraclass correlation coefficients (ICCs).RESULTS: The mean difference between ultrasonography and direct measurement was 0.1 mm (95% limits of agreement [LOA], -1.9 to 2.1 mm). The ICC for interobserver reliability was 0.99 (95% confidence interval [CI], 0.98-0.99).CONCLUSIONS: Ultrasonography is a reliable method for measuring Schanz pin protrusion beyond the distal cortices in a cadaveric model, with high interobserver reliability. This noninvasive technique could",
        "levenshtein_distance": 549
    },
    {
        "realidx": "24359102",
        "question": "Skin diseases are the most frequently recognized occupational diseases in Denmark. The prognosis for occupational contact dermatitis is often poor.\nTo investigate the prognosis, assessed by eczema, job status and skin-related quality of life, among patients allergic to rubber chemicals and latex (ubiquitous allergens) and epoxy (nonubiquitous allergen), 2\u00a0years after recognition of occupational allergic contact dermatitis.\nFrom a cohort of all patients recognized as having occupational dermatitis by the Danish National Board of Industrial Injuries in 2010, 199 patients with relevant rubber allergy (contact allergy to rubber chemicals or contact urticaria from latex) or epoxy allergy were identified. Follow-up consisted of a questionnaire covering current severity of eczema, employment, exposure and quality of life.\nThe response rate was 75%. Clearance of eczema was reported by 11% of patients and 67% reported improvement. Overall 22% of patients with allergy to a nonubiquitous allergen had total clearance of eczema compared with 10% of cases allergic to ubiquitous allergens and 0% of those with contact urticaria (P\u00a0=\u00a00\u00b7116). Improvement was significantly more frequent in those who had changed jobs compared with those who had not (P\u00a0=\u00a00\u00b701).\nTwo-year follow-up survey of patients with allergic contact dermatitis from an occupational cohort: is the prognosis dependent on the omnipresence of the allergen?",
        "answer": "yes",
        "answer_rationale": "At follow-up, patients with contact urticaria had significantly poorer prognosis than those with contact allergy, and there was a trend towards a poorer prognosis for those with contact allergy to rubber chemicals than those with allergy to epoxy. A significant positive association between job change and improvement was found.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Skin diseases are the most frequently recognized occupational diseases in Denmark. The prognosis for occupational contact dermatitis is often poor.\nTo investigate the prognosis, assessed by eczema, job status and skin-related quality of life, among patients allergic to rubber chemicals and latex (ubiquitous allergens) and epoxy (nonubiquitous allergen), 2\u00a0years after recognition of occupational allergic contact dermatitis.\nFrom a cohort of all patients recognized as having occupational dermatitis by the Danish National Board of Industrial Injuries in 2010, 199 patients with relevant rubber allergy (contact allergy to rubber chemicals or contact urticaria from latex) or epoxy allergy were identified. Follow-up consisted of a questionnaire covering current severity of eczema,",
        "q2": " employment, exposure and quality of life.\nThe response rate was 75%. Clearance of eczema was reported by 11% of patients and 67% reported improvement. Overall 22% of patients with allergy to a nonubiquitous allergen had total clearance of eczema compared with 10% of cases allergic to ubiquitous allergens and 0% of those with contact urticaria (P\u00a0=\u00a00\u00b7116). Improvement was significantly more frequent in those who had changed jobs compared with those who had not (P\u00a0=\u00a00\u00b701).\nTwo-year follow-up survey of patients with allergic contact dermatitis from an occupational cohort: is the prognosis dependent on the omnipresence of the allergen?",
        "generated_text": "job status and skin-related quality of life.\nThe response rate was 74%. The prevalence of eczema was 50% in the rubber group and 33% in the epoxy group. The prevalence of eczema was higher in the rubber group compared with the epoxy group (P\u00a0=\u00a00.02). The prevalence of eczema was higher in patients who had been exposed to the allergen after recognition compared with those who had not been exposed (P\u00a0=\u00a00.001). The prevalence of eczema was higher in patients who had been exposed to the allergen after recognition compared with those who had not been exposed (P\u00a0=\u00a00.",
        "levenshtein_distance": 426
    },
    {
        "realidx": "24449622",
        "question": "This study aimed to show the relationship between serum paraoxonase 1 level and the epicardial fat tissue thickness.\nTwo hundred and seven patients without any atherosclerotic disease history were included in this cross-sectional observational study. Correlation analysis was performed to determine the correlation between epicardial fat tissue thickness, which was measured by echocardiography and serum paraoxonase 1 level. Also correlation analysis was performed to show correlation between patients' clinical and laboratory findings and the level of serum paraoxonase 1 (PON 1) and the epicardial fat tissue thickness. Pearson and Spearman test were used for correlation analysis.\nNo linear correlation between epicardial fat tissue thickness and serum PON 1 found (correlation coefficient: -0.127, p=0.069). When epicardial fat tissue thickness were grouped as 7 mm and over, and below, and 5 mm and over, and below, serum PON 1 level were significantly lower in \u22657 mm group (PON1 : 168.9 U/L) than<7 mm group (PON 1: 253.9 U/L) (p<0.001). Also hypertension prevalence was increased in \u22657 mm group (p=0.001). Serum triglyceride was found to be higher in \u22657 mm group (p=0.014), body mass index was found higher in \u22655 mm group (p=0.006).\nIs there a relationship between serum paraoxonase level and epicardial fat tissue thickness?",
        "answer": "no",
        "answer_rationale": "Serum PON 1 level is not correlated with the epicardial fat tissue thickness. But PON 1 level is lower in patients with epicardial fat tissue thickness 7 mm and over. Therefore, increased atherosclerosis progression can be found among patients with 7 mm and higher epicardial fat tissue thickness.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "This study aimed to show the relationship between serum paraoxonase 1 level and the epicardial fat tissue thickness.\nTwo hundred and seven patients without any atherosclerotic disease history were included in this cross-sectional observational study. Correlation analysis was performed to determine the correlation between epicardial fat tissue thickness, which was measured by echocardiography and serum paraoxonase 1 level. Also correlation analysis was performed to show correlation between patients' clinical and laboratory findings and the level of serum paraoxonase 1 (PON 1) and the epicardial fat tissue thickness. Pearson and Spearman test were used for correlation analysis.\nNo linear correlation between epicardial fat tissue thickness and serum PON 1 found (correlation coefficient: -0.127",
        "q2": ", p=0.069). When epicardial fat tissue thickness were grouped as 7 mm and over, and below, and 5 mm and over, and below, serum PON 1 level were significantly lower in \u22657 mm group (PON1 : 168.9 U/L) than<7 mm group (PON 1: 253.9 U/L) (p<0.001). Also hypertension prevalence was increased in \u22657 mm group (p=0.001). Serum triglyceride was found to be higher in \u22657 mm group (p=0.014), body mass index was found higher in \u22655 mm group (p=0.006).\nIs there a relationship between serum paraoxonase level and epicardial fat tissue thickness?",
        "generated_text": ", p=0.08). There was a negative correlation between serum PON 1 and age (r=-0.201, p=0.002), body mass index (r=-0.144, p=0.03), and triglyceride level (r=-0.144, p=0.03). There was a positive correlation between serum PON 1 and high-density lipoprotein level (r=0.144, p=0.03). There was a positive correlation between epicardial fat tissue thickness and age (r=0.211, p=0.001), body mass index (r=0.311, p<0.00",
        "levenshtein_distance": 410
    },
    {
        "realidx": "24476003",
        "question": "Although its excellent results, laparoscopic sleeve gastrectomy (LSG) presents major complications ranging from 0% to 29%. Among them, the staple line leak presents an incidence varying from 0% to 7%. Many trials debated about different solutions in order to reduce leaks' incidence. No author has investigated the role of gastric decompression in the prevention of this complication. Aim of our work is to evaluate if this procedure can play a role in avoiding the occurrence of staple line leaks after LSG.\nBetween January 2008 and November 2012, 145 patients were prospectively and randomly included in the study. Seventy patients composed the group A, whose operations were completed with placement of nasogastric tube; the other 75 patients were included in the group B, in which no nasogastric tube was placed.\nNo statistical differences were observed between group A and group B regarding gender distribution, age, weight, and BMI. No intraoperative complications and no conversion occurred in both groups. Intraoperative blood loss (50.1 \u00b1 42.3 vs. 52.5 \u00b1 37.6 ml, respectively) and operative time (65.4 \u00b1 25.5 vs. 62.6 \u00b1 27.8 min, respectively) were comparable between the two groups (p: NS). One staple line leak (1.4%) occurred on 6th postoperative day in group A patients. No leak was observed in group B patients. Postoperative hospital stay was significantly longer in group A vs. group B patients (7.6 \u00b1 3.4 vs. 6.2 \u00b1 3.1 days, respectively, p: 0.04).\nIs nasogastric decompression useful in prevention of leaks after laparoscopic sleeve gastrectomy?",
        "answer": "no",
        "answer_rationale": "Routine placement of nasogastric tube in patients operated of LSG seems not useful in reducing leaks' incidence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Although its excellent results, laparoscopic sleeve gastrectomy (LSG) presents major complications ranging from 0% to 29%. Among them, the staple line leak presents an incidence varying from 0% to 7%. Many trials debated about different solutions in order to reduce leaks' incidence. No author has investigated the role of gastric decompression in the prevention of this complication. Aim of our work is to evaluate if this procedure can play a role in avoiding the occurrence of staple line leaks after LSG.\nBetween January 2008 and November 2012, 145 patients were prospectively and randomly included in the study. Seventy patients composed the group A, whose operations were completed with placement of nasogastric tube; the other 75 patients were included in the group B, in which no nasogastric tube was placed.\nNo statistical differences were observed between group A and group B regarding gender",
        "q2": " distribution, age, weight, and BMI. No intraoperative complications and no conversion occurred in both groups. Intraoperative blood loss (50.1 \u00b1 42.3 vs. 52.5 \u00b1 37.6 ml, respectively) and operative time (65.4 \u00b1 25.5 vs. 62.6 \u00b1 27.8 min, respectively) were comparable between the two groups (p: NS). One staple line leak (1.4%) occurred on 6th postoperative day in group A patients. No leak was observed in group B patients. Postoperative hospital stay was significantly longer in group A vs. group B patients (7.6 \u00b1 3.4 vs. 6.2 \u00b1 3.1 days, respectively, p: 0.04).\nIs nasogastric decompression useful in prevention of leaks after laparoscopic sleeve gastrectomy?",
        "generated_text": ", age, BMI, operative time, length of hospital stay, and postoperative complications. The incidence of staple line leak was 1.4% in group A and 2.6% in group B, with no statistical difference.\nOur data suggest that the placement of nasogastric tube after LSG does not influence the incidence of staple line leak.",
        "levenshtein_distance": 490
    },
    {
        "realidx": "24481006",
        "question": "79 adjacent proximal surfaces without restorations in permanent teeth were examined. Patients suspected to have carious lesions after a visual clinical and a bitewing examination participated in a CBCT examination (Kodak 9000 3D, 5 \u00d7 3.7 cm field of view, voxel size 0.07 mm). Ethical approval and informed consent were obtained according to the Helsinki Declaration. Radiographic assessment recording lesions with or without cavitation was performed by two observers in bitewings and CBCT sections. Orthodontic separators were placed interdentally between two lesion-suspected surfaces. The separator was removed after 3 days and the surfaces recorded as cavitated (yes/no), i.e. validated clinically. Differences between the two radiographic modalities (sensitivity, specificity and overall accuracy) were estimated by analyzing the binary data in a generalized linear model.\nFor both observers, sensitivity was significantly higher for CBCT than for bitewings (average difference 33%, p<0.001) while specificity was not significantly different between the methods (p = 0.19). The overall accuracy was also significantly higher for CBCT (p<0.001).\nShould cavitation in proximal surfaces be reported in cone beam computed tomography examination?",
        "answer": "yes",
        "answer_rationale": "CBCT was more accurate in detecting cavitation in proximal surfaces than bitewing radiographs; therefore a CBCT examination performed for other clinical applications should also be assessed for proximal surface cavities in teeth without restorations, and when detected, this pathology must be part of the dentist's report.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "79 adjacent proximal surfaces without restorations in permanent teeth were examined. Patients suspected to have carious lesions after a visual clinical and a bitewing examination participated in a CBCT examination (Kodak 9000 3D, 5 \u00d7 3.7 cm field of view, voxel size 0.07 mm). Ethical approval and informed consent were obtained according to the Helsinki Declaration. Radiographic assessment recording lesions with or without cavitation was performed by two observers in bitewings and CBCT sections. Orthodontic separators were placed interdentally between two lesion-suspected surfaces. The separator was removed after ",
        "q2": "3 days and the surfaces recorded as cavitated (yes/no), i.e. validated clinically. Differences between the two radiographic modalities (sensitivity, specificity and overall accuracy) were estimated by analyzing the binary data in a generalized linear model.\nFor both observers, sensitivity was significantly higher for CBCT than for bitewings (average difference 33%, p<0.001) while specificity was not significantly different between the methods (p = 0.19). The overall accuracy was also significantly higher for CBCT (p<0.001).\nShould cavitation in proximal surfaces be reported in cone beam computed tomography examination?",
        "generated_text": "24 h and the amount of plaque was measured with a plaque disclosing agent (Plak-P\u7b14). The plaque index was recorded as 0 (no plaque), 1 (plaque on less than one-third of the tooth surface), 2 (plaque on one-third to two-thirds of the tooth surface), and 3 (plaque on more than two-thirds of the tooth surface). The plaque index was recorded for each tooth surface. The mean plaque index was calculated for each proximal surface. The mean plaque index was compared between surfaces with and without caries lesions using a t-test. The association between",
        "levenshtein_distance": 488
    },
    {
        "realidx": "24495711",
        "question": "More than 50,000 new HIV infections occur annually in the United States. Injection drug users represent twelve percent of incident HIV infections each year. Pharmacy sales of over-the-counter (OTC) syringes have helped prevent HIV transmission among injection drug users in many states throughout the United States. However, concerns exist among some law enforcement officials, policymakers, pharmacists, and community members about potential links between OTC syringe sales and crime.\nWe used a geographic information system and novel spatial and longitudinal analyses to determine whether implementation of pharmacy-based OTC syringe sales were associated with reported crime between January 2006 and December 2008 in Los Angeles Police Department Reporting Districts. We assessed reported crime pre- and post-OTC syringe sales initiation as well as longitudinal associations between crime and OTC syringe-selling pharmacies.\nBy December 2008, 9.3% (94/1010) of Los Angeles Police Department Reporting Districts had at least one OTC syringe-selling pharmacy. Overall reported crime counts and reported crime rates decreased between 2006 and 2008 in all 1010 Reporting Districts. Using generalized estimating equations and adjusting for potential confounders, reported crime rates were negatively associated with OTC syringe sales (adjusted rate ratio: 0.89; 95% confidence interval: 0.81, 0.99).\nIs crime associated with over-the-counter pharmacy syringe sales?",
        "answer": "yes",
        "answer_rationale": "Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "More than 50,000 new HIV infections occur annually in the United States. Injection drug users represent twelve percent of incident HIV infections each year. Pharmacy sales of over-the-counter (OTC) syringes have helped prevent HIV transmission among injection drug users in many states throughout the United States. However, concerns exist among some law enforcement officials, policymakers, pharmacists, and community members about potential links between OTC syringe sales and crime.\nWe used a geographic information system and novel spatial and longitudinal analyses to determine whether implementation of pharmacy-based OTC syringe sales were associated with reported crime between January 2006 and December 2008 in Los Angeles Police Department Reporting Districts. We assessed reported crime pre- and",
        "q2": " post-OTC syringe sales initiation as well as longitudinal associations between crime and OTC syringe-selling pharmacies.\nBy December 2008, 9.3% (94/1010) of Los Angeles Police Department Reporting Districts had at least one OTC syringe-selling pharmacy. Overall reported crime counts and reported crime rates decreased between 2006 and 2008 in all 1010 Reporting Districts. Using generalized estimating equations and adjusting for potential confounders, reported crime rates were negatively associated with OTC syringe sales (adjusted rate ratio: 0.89; 95% confidence interval: 0.81, 0.99).\nIs crime associated with over-the-counter pharmacy syringe sales?",
        "generated_text": "post-implementation of OTC syringe sales in 91 reporting districts in Los Angeles County, California. We used a difference-in-differences approach to assess changes in crime rates in reporting districts with OTC syringe sales compared to reporting districts without OTC syringe sales. We also used a spatial analysis to assess whether OTC syringe sales were associated with crime in reporting districts adjacent to those with OTC syringe sales.\nWe found no evidence that OTC syringe sales were associated with increased crime in reporting districts with OTC syringe sales or in adjacent reporting districts. In fact, we found that OTC syringe sales were associated with a decrease in reported crime in reporting districts with",
        "levenshtein_distance": 500
    },
    {
        "realidx": "24507422",
        "question": "Patients presenting with transient ischemic attack or stroke may have symptom-related lesions on acute computed tomography angiography (CTA) such as free-floating intraluminal thrombus (FFT). It is difficult to distinguish FFT from carotid plaque, but the distinction is critical as management differs. By contouring the shape of these vascular lesions (\"virtual endarterectomy\"), advanced morphometric analysis can be performed. The objective of our study is to determine whether quantitative shape analysis can accurately differentiate FFT from atherosclerotic plaque.\nWe collected 23 consecutive cases of suspected carotid FFT seen on CTA (13 men, 65 \u00b1 10 years; 10 women, 65.5 \u00b1 8.8 years). True-positive FFT cases (FFT+) were defined as filling defects resolving with anticoagulant therapy versus false-positives (FFT-), which remained unchanged. Lesion volumes were extracted from CTA images and quantitative shape descriptors were computed. The five most discriminative features were used to construct receiver operator characteristic (ROC) curves and to generate three machine-learning classifiers. Average classification accuracy was determined by cross-validation.\nFollow-up imaging confirmed sixteen FFT+ and seven FFT- cases. Five shape descriptors delineated FFT+ from FFT- cases. The logistic regression model produced from combining all five shape features demonstrated a sensitivity of 87.5% and a specificity of 71.4% with an area under the ROC curve = 0.85 \u00b1 0.09. Average accuracy for each classifier ranged from 65.2%-76.4%.\nCan shape analysis differentiate free-floating internal carotid artery thrombus from atherosclerotic plaque in patients evaluated with CTA for stroke or transient ischemic attack?",
        "answer": "yes",
        "answer_rationale": "We identified five quantitative shape descriptors of carotid FFT. This shape \"signature\" shows potential for supplementing conventional lesion characterization in cases of suspected FFT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Patients presenting with transient ischemic attack or stroke may have symptom-related lesions on acute computed tomography angiography (CTA) such as free-floating intraluminal thrombus (FFT). It is difficult to distinguish FFT from carotid plaque, but the distinction is critical as management differs. By contouring the shape of these vascular lesions (\"virtual endarterectomy\"), advanced morphometric analysis can be performed. The objective of our study is to determine whether quantitative shape analysis can accurately differentiate FFT from atherosclerotic plaque.\nWe collected 23 consecutive cases of suspected carotid FFT seen on CTA (13 men, 65 \u00b1 10 years; 10 women, 65.5 \u00b1 8.8 years). True-positive FFT cases (FFT+) were defined as filling defects resolving with anticoagulant therapy versus false-positives (FFT-), which",
        "q2": " remained unchanged. Lesion volumes were extracted from CTA images and quantitative shape descriptors were computed. The five most discriminative features were used to construct receiver operator characteristic (ROC) curves and to generate three machine-learning classifiers. Average classification accuracy was determined by cross-validation.\nFollow-up imaging confirmed sixteen FFT+ and seven FFT- cases. Five shape descriptors delineated FFT+ from FFT- cases. The logistic regression model produced from combining all five shape features demonstrated a sensitivity of 87.5% and a specificity of 71.4% with an area under the ROC curve = 0.85 \u00b1 0.09. Average accuracy for each classifier ranged from 65.2%-76.4%.\nCan shape analysis differentiate free-floating internal carotid artery thrombus from atherosclerotic plaque in patients evaluated with CTA for stroke or transient ischemic attack?",
        "generated_text": "were stable atherosclerotic plaques. We performed virtual endarterectomy of the carotid bifurcation and extracted 10 morphometric features from the lesion surface. We then used machine learning to classify FFT+ and FFT- cases.\nWe identified 13 FFT+ and 10 FFT- cases. The mean time to follow-up CTA was 10.5 days (range 2-21 days). FFT+ cases had a higher mean age (67.5 vs. 62.5 years, p=0.18) and higher incidence of hypertension (85% vs. 60%, p=0.18) and diabetes (46% vs. 10%, p=0.08). The mean lesion volume was similar between groups (10",
        "levenshtein_distance": 653
    },
    {
        "realidx": "24516646",
        "question": "The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection of specific IgE to 112 molecular components from 51 allergenic sources. We studied the reliability of this technique intra- and inter- assay, as well as inter-batch- and inter-laboratory-assay.\nTwenty samples were studied, nineteen sera from polysensitized allergic patients, and the technique calibrator provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three patients' sera ten times in the same and in different assays. Furthermore, all samples were tested in two laboratories and with two batches of ISAC kit. To evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 calibrator with their expected values by T Student test. To analyse the precision, we calculated the coefficient of variation (CV) of the 15 allergens that generate the calibration curve, and to analyse the repeatability and the reproducibility, we calculated the intraclass coefficient correlation (ICC) to each allergen.\nThe results obtained for CTR02 were similar to those expected in 7 of 15 allergens that generate the calibration curve, whereas in 8 allergens the results showed significant differences. The mean CV obtained in the CTR02 determinations was of 9.4%, and the variability of sera from patients was of 22.9%. The agreement in the intra- and inter-assay analysis was very good to 94 allergens and good to one. In the inter-batch analyse, we obtained a very good agreement to 82 allergens, good to 14, moderate to 5 allergens, poor to one, and bad to 1 allergen. In the inter-laboratory analyse, we obtained a very good agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens.\nIs the determination of specific IgE against components using ISAC 112 a reproducible technique?",
        "answer": "yes",
        "answer_rationale": "The allergen microarray immunoassay, ISAC 112, is a repeatable and reproducible in vitro diagnostic tool for determination of sIgE beyond the own laboratory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection of specific IgE to 112 molecular components from 51 allergenic sources. We studied the reliability of this technique intra- and inter- assay, as well as inter-batch- and inter-laboratory-assay.\nTwenty samples were studied, nineteen sera from polysensitized allergic patients, and the technique calibrator provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three patients' sera ten times in the same and in different assays. Furthermore, all samples were tested in two laboratories and with two batches of ISAC kit. To evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 calibrator with their expected values by T Student test. To analyse the precision, we calculated the coefficient of variation (CV) of the 15 allergens that generate the calibration curve, and to analyse the repeatability and the reproducibility",
        "q2": ", we calculated the intraclass coefficient correlation (ICC) to each allergen.\nThe results obtained for CTR02 were similar to those expected in 7 of 15 allergens that generate the calibration curve, whereas in 8 allergens the results showed significant differences. The mean CV obtained in the CTR02 determinations was of 9.4%, and the variability of sera from patients was of 22.9%. The agreement in the intra- and inter-assay analysis was very good to 94 allergens and good to one. In the inter-batch analyse, we obtained a very good agreement to 82 allergens, good to 14, moderate to 5 allergens, poor to one, and bad to 1 allergen. In the inter-laboratory analyse, we obtained a very good agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens.\nIs the determination of specific IgE against components using ISAC 112 a reproducible technique?",
        "generated_text": ", we calculated the intraclass correlation coefficient (ICC). The accuracy of the technique was high, with a mean difference between the expected and the observed values of 0.01 kU/L (p=0.98). The intra-assay precision was high, with a mean CV of 4.1% (range 1.1-10.1%). The inter-assay precision was also high, with a mean CV of 5.1% (range 1.1-11.1%). The inter-batch precision was high, with a mean CV of 4.8% (range 1.1-10.1%). The inter-laboratory precision was high, with a mean CV of 5.1% (range 1.1-11.1%). The intra-assay repeatability was high, with a mean ICC of 0.99 (range 0.97-1.",
        "levenshtein_distance": 609
    },
    {
        "realidx": "24577079",
        "question": "Older adults typically perform worse on measures of working memory (WM) than do young adults; however, age-related differences in WM performance might be reduced if older adults use effective encoding strategies.\nThe purpose of the current experiment was to evaluate WM performance after training individuals to use effective encoding strategies.\nParticipants in the training group (older adults: n = 39; young adults: n = 41) were taught about various verbal encoding strategies and their differential effectiveness and were trained to use interactive imagery and sentence generation on a list-learning task. Participants in the control group (older: n = 37; young: n = 38) completed an equally engaging filler task. All participants completed a pre- and post-training reading span task, which included self-reported strategy use, as well as two transfer tasks that differed in the affordance to use the trained strategies - a paired-associate recall task and the self-ordered pointing task.\nBoth young and older adults were able to use the target strategies on the WM task and showed gains in WM performance after training. The age-related WM deficit was not greatly affected, however, and the training gains did not transfer to the other cognitive tasks. In fact, participants attempted to adapt the trained strategies for a paired-associate recall task, but the increased strategy use did not benefit their performance.\nDoes strategy training reduce age-related deficits in working memory?",
        "answer": "no",
        "answer_rationale": "Strategy training can boost WM performance, and its benefits appear to arise from strategy-specific effects and not from domain-general gains in cognitive ability.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Older adults typically perform worse on measures of working memory (WM) than do young adults; however, age-related differences in WM performance might be reduced if older adults use effective encoding strategies.\nThe purpose of the current experiment was to evaluate WM performance after training individuals to use effective encoding strategies.\nParticipants in the training group (older adults: n = 39; young adults: n = 41) were taught about various verbal encoding strategies and their differential effectiveness and were trained to use interactive imagery and sentence generation on a list-learning task. Participants in the control group (older: n = 37; young: n = 38) completed an equally engaging filler task. All participants completed a pre",
        "q2": "- and post-training reading span task, which included self-reported strategy use, as well as two transfer tasks that differed in the affordance to use the trained strategies - a paired-associate recall task and the self-ordered pointing task.\nBoth young and older adults were able to use the target strategies on the WM task and showed gains in WM performance after training. The age-related WM deficit was not greatly affected, however, and the training gains did not transfer to the other cognitive tasks. In fact, participants attempted to adapt the trained strategies for a paired-associate recall task, but the increased strategy use did not benefit their performance.\nDoes strategy training reduce age-related deficits in working memory?",
        "generated_text": "test, posttest, and delayed transfer test.\nTraining led to significant improvements in list-learning performance for both older and young adults, and the age-related difference in performance was eliminated at posttest and delayed transfer. Training also led to improvements in performance on a reading span task, but the age-related difference in performance was not eliminated.\nThese findings suggest that training older adults to use effective encoding strategies can lead to improvements in WM performance, at least on list-learning tasks.",
        "levenshtein_distance": 530
    },
    {
        "realidx": "24591144",
        "question": "To determine if elderly patients with oropharyngeal squamous cell carcinoma (OPSCC) are receiving less treatment and to evaluate the benefit of aggressive therapy in this population.\nRetrospective analysis of a large population database.\nPatients in the Surveillance, Epidemiology, and End Results database with OPSCC diagnosed from 2004 to 2009 were included. The patients were categorized into age groups 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 years and older, then further categorized by treatment status. Kaplan-Meier analysis of disease-specific survival (DSS) for late-stage (III and IV) OPSCC was performed for all age and treatment categories, followed by a multivariate cox regression of treatment status, tumor site, race, stage, and sex per age group.\nA total of 14,909 patients with OPSCC were identified. In our demographic data, we observed a significant increase in the number of patients who did not receive treatment (surgery, radiation, or combined therapy) after age 55. Kaplan-Meier analysis showed that age groups 65 to 74 and 75 to 84 had substantial benefits in DSS with surgery, radiation, or combined therapy. Multivariable analysis did not demonstrate any statistically significant difference in the hazard ratios for combined treatment among age groups 45 to 54, 55 to 64, 65 to 74, and 75 to 84.\nAre the elderly with oropharyngeal carcinoma undertreated?",
        "answer": "maybe",
        "answer_rationale": "Proportionally fewer elderly patients with OPSCC are being treated than younger individuals. These patients can have significant benefits from aggressive treatments despite their older age as shown by our survival analysis. We recommend the use of objective measures to assess patient fitness to reduce the potential for undertreatment in the elderly population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To determine if elderly patients with oropharyngeal squamous cell carcinoma (OPSCC) are receiving less treatment and to evaluate the benefit of aggressive therapy in this population.\nRetrospective analysis of a large population database.\nPatients in the Surveillance, Epidemiology, and End Results database with OPSCC diagnosed from 2004 to 2009 were included. The patients were categorized into age groups 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 years and older, then further categorized by treatment status. Kaplan-Meier analysis of disease-specific survival (DSS) for late-stage (III and IV) OPSCC was performed for all age and treatment categories, followed by a multivariate cox regression of",
        "q2": " treatment status, tumor site, race, stage, and sex per age group.\nA total of 14,909 patients with OPSCC were identified. In our demographic data, we observed a significant increase in the number of patients who did not receive treatment (surgery, radiation, or combined therapy) after age 55. Kaplan-Meier analysis showed that age groups 65 to 74 and 75 to 84 had substantial benefits in DSS with surgery, radiation, or combined therapy. Multivariable analysis did not demonstrate any statistically significant difference in the hazard ratios for combined treatment among age groups 45 to 54, 55 to 64, 65 to 74, and 75 to 84.\nAre the elderly with oropharyngeal carcinoma undertreated?",
        "generated_text": "DSS for all patients.\nA total of 10,110 patients were included in the study. The majority of patients were male (71.4%) and white (85.4%). The median age was 62 years. The most common stage at diagnosis was stage IV (42.4%). The proportion of patients receiving treatment decreased with increasing age (p < 0.001). Patients aged 85 and older had the lowest proportion of treated patients (34.1%). For late-stage OPSCC, treated patients had significantly better DSS compared to untreated patients in all age groups (p < 0.001). The benefit of treatment was consistent across age groups, with similar improvements in DSS observed in",
        "levenshtein_distance": 514
    },
    {
        "realidx": "24614789",
        "question": "Postoperative CSF fistulas were described in 16 of 198 patients (8%) who underwent spine surgery between 2009 and 2010. The choice of the therapeutic strategy was based on the clinical condition of the patients, taking into account the possibility to maintain the prone position continuously and the risk of morbidity due to prolonged bed rest. Six patients were treated conservatively (position prone for three weeks), ten patients were treated by positioning an external CSF lumbar drainage for ten days. The mean follow-up period was ten months.\nAll patients healed their wound properly and no adverse events were recorded. Patients treated conservatively were cured in a mean period of 30 days, while patients treated with CSF drainage were cured in a mean period of 10 days.\nIs lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective?",
        "answer": "yes",
        "answer_rationale": "Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Postoperative CSF fistulas were described in 16 of 198 patients (8%) who underwent spine surgery between 2009 and 2010. The choice of the therapeutic strategy was based on the clinical condition of the patients, taking into account the possibility to maintain the prone position continuously and the risk of morbidity due to prolonged bed rest. Six patients were treated conservatively (position prone for three weeks), ten patients",
        "q2": " were treated by positioning an external CSF lumbar drainage for ten days. The mean follow-up period was ten months.\nAll patients healed their wound properly and no adverse events were recorded. Patients treated conservatively were cured in a mean period of 30 days, while patients treated with CSF drainage were cured in a mean period of 10 days.\nIs lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective?",
        "generated_text": "underwent surgical repair of the fistula, and in one patient both strategies were used. The mean time to diagnosis was 10 days (range 1-30 days). The mean time to closure of the fistula was 14 days (range 7-30 days). The mean follow-up was 12 months (range 6-24 months). There were no recurrences. The authors",
        "levenshtein_distance": 325
    },
    {
        "realidx": "24622801",
        "question": "Implant-related infections represent one of the most severe complications in orthopaedics. A fast-resorbable, antibacterial-loaded hydrogel may reduce or prevent bacterial colonization and biofilm formation of implanted biomaterials.QUESTIONS/\nWe asked: (1) Is a fast-resorbable hydrogel able to deliver antibacterial compounds in vitro? (2) Can a hydrogel (alone or antibacterial-loaded) coating on implants reduce bacterial colonization? And (3) is intraoperative coating feasible and resistant to press-fit implant insertion?\nWe tested the ability of Disposable Antibacterial Coating (DAC) hydrogel (Novagenit Srl, Mezzolombardo, Italy) to deliver antibacterial agents using spectrophotometry and a microbiologic assay. Antibacterial and antibiofilm activity were determined by broth microdilution and a crystal violet assay, respectively. Coating resistance to press-fit insertion was tested in rabbit tibias and human femurs.\nComplete release of all tested antibacterial compounds was observed in less than 96 hours. Bactericidal and antibiofilm effect of DAC hydrogel in combination with various antibacterials was shown in vitro. Approximately 80% of the hydrogel coating was retrieved on the implant after press-fit insertion.\nDoes implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro?",
        "answer": "yes",
        "answer_rationale": "Implant coating with an antibacterial-loaded hydrogel reduces bacterial colonization and biofilm formation in vitro.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Implant-related infections represent one of the most severe complications in orthopaedics. A fast-resorbable, antibacterial-loaded hydrogel may reduce or prevent bacterial colonization and biofilm formation of implanted biomaterials.QUESTIONS/\nWe asked: (1) Is a fast-resorbable hydrogel able to deliver antibacterial compounds in vitro? (2) Can a hydrogel (alone or antibacterial-loaded) coating on implants reduce bacterial colonization? And (3) is intraoperative coating feasible and resistant to press-fit implant insertion?\nWe tested the ability of Disposable Antibacterial Coating (DAC) hydrogel (Novagenit Srl, Mezzolombardo, Italy)",
        "q2": " to deliver antibacterial agents using spectrophotometry and a microbiologic assay. Antibacterial and antibiofilm activity were determined by broth microdilution and a crystal violet assay, respectively. Coating resistance to press-fit insertion was tested in rabbit tibias and human femurs.\nComplete release of all tested antibacterial compounds was observed in less than 96 hours. Bactericidal and antibiofilm effect of DAC hydrogel in combination with various antibacterials was shown in vitro. Approximately 80% of the hydrogel coating was retrieved on the implant after press-fit insertion.\nDoes implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro?",
        "generated_text": "to deliver gentamicin in vitro and to reduce bacterial colonization in vivo. We also evaluated the feasibility of DAC coating on press-fit implants.METHODS/\nDAC hydrogel was loaded with gentamicin and tested for in vitro drug release. DAC-coated titanium screws were implanted in the tibia of 24 rabbits and contaminated with Staphylococcus aureus. After 1 week, the screws were explanted and bacterial colonization was assessed. DAC coating was applied on press-fit implants and its resistance to insertion was evaluated.RESULTS/\nDAC hydrogel released gentamicin in vitro for up to 7 days. DAC-coated screws showed a significant reduction in bacterial colonization",
        "levenshtein_distance": 538
    },
    {
        "realidx": "24625433",
        "question": "Noise exposure in the neonatal intensive care unit is believed to be a risk factor for hearing loss in preterm neonates. Continuous positive airway pressure (CPAP) devices exceed recommended noise levels. High flow nasal cannulae (HFNC) are an increasingly popular alternative to CPAP for treating preterm infants, but there are no in vivo studies assessing noise production by HFNC.\nTo study whether HFNC are noisier than bubble CPAP (BCPAP) for preterm infants.\nAn observational study of preterm infants receiving HFNC or BCPAP. Noise levels within the external auditory meatus (EAM) were measured using a microphone probe tube connected to a calibrated digital dosimeter. Noise was measured across a range of frequencies and reported as decibels A-weighted (dBA).\nA total of 21 HFNC and 13 BCPAP noise measurements were performed in 21 infants. HFNC gas flows were 2-5 L/min, and BCPAP gas flows were 6-10 L/min with set pressures of 5-7 cm of water. There was no evidence of a difference in average noise levels measured at the EAM: mean difference (95% CI) of -1.6 (-4.0 to 0.9) dBA for HFNC compared to BCPAP. At low frequency (500 Hz), HFNC was mean (95% CI) 3.0 (0.3 to 5.7) dBA quieter than BCPAP. Noise increased with increasing BCPAP gas flow (p=0.007), but not with increasing set pressure. There was a trend to noise increasing with increasing HFNC gas flows.\nAre high flow nasal cannulae noisier than bubble CPAP for preterm infants?",
        "answer": "no",
        "answer_rationale": "At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Noise exposure in the neonatal intensive care unit is believed to be a risk factor for hearing loss in preterm neonates. Continuous positive airway pressure (CPAP) devices exceed recommended noise levels. High flow nasal cannulae (HFNC) are an increasingly popular alternative to CPAP for treating preterm infants, but there are no in vivo studies assessing noise production by HFNC.\nTo study whether HFNC are noisier than bubble CPAP (BCPAP) for preterm infants.\nAn observational study of preterm infants receiving HFNC or BCPAP. Noise levels within the external auditory meatus (EAM) were measured using a microphone probe tube connected to a calibrated digital dosimeter. Noise was measured across a range of frequencies and reported as decibels A-weighted (dBA).\nA total of 21 HFNC and 13 BCPAP noise measurements were performed in 21",
        "q2": " infants. HFNC gas flows were 2-5 L/min, and BCPAP gas flows were 6-10 L/min with set pressures of 5-7 cm of water. There was no evidence of a difference in average noise levels measured at the EAM: mean difference (95% CI) of -1.6 (-4.0 to 0.9) dBA for HFNC compared to BCPAP. At low frequency (500 Hz), HFNC was mean (95% CI) 3.0 (0.3 to 5.7) dBA quieter than BCPAP. Noise increased with increasing BCPAP gas flow (p=0.007), but not with increasing set pressure. There was a trend to noise increasing with increasing HFNC gas flows.\nAre high flow nasal cannulae noisier than bubble CPAP for preterm infants?",
        "generated_text": "infants. The mean EAM noise levels were 62.5 dBA (SD 5.4) for HFNC and 61.4 dBA (SD 4.4) for BCPAP (p=0.6). The mean noise levels for HFNC and BCPAP were 62.5 dBA (SD 5.4) and 61.4 dBA (SD 4.4), respectively (p=0.6). The mean noise levels for HFNC and BCPAP were 62.5 dBA (SD 5.4) and 61.4 dBA (SD 4.4), respectively (p=0.6). The mean noise levels for HFNC and BCPAP were 62.5 dBA (SD 5.4) and 61.4",
        "levenshtein_distance": 451
    },
    {
        "realidx": "24666444",
        "question": "The \"July effect\" refers to the phenomenon of adverse impacts on patient care arising from the changeover in medical staff that takes place during this month at academic medical centres in North America. There has been some evidence supporting the presence of the July effect, including data from surgical specialties. Uniformity of care, regardless of time of year, is required for patients undergoing major cancer surgery. We therefore sought to perform a population-level assessment for the presence of a July effect in this field.\nWe used the Nationwide Inpatient Sample to abstract data on patients undergoing 1 of 8 major cancer surgeries at academic medical centres between Jan. 1, 1999, and Dec. 30, 2009. The primary outcomes examined were postoperative complications and in-hospital mortality. Univariate analyses and subsequently multivariate analyses, controlling for patient and hospital characteristics, were performed to identify whether the time of surgery was an independent predictor of outcome after major cancer surgery.\nOn univariate analysis, the overall postoperative complication rate, as well as genitourinary and hematologic complications specifically, was higher in July than the rest of the year. However, on multivariate analysis, only hematologic complications were significantly higher in July, with no difference in overall postoperative complication rate or in-hospital mortality for all 8 surgeries considered separately or together.\nIs there any evidence of a \"July effect\" in patients undergoing major cancer surgery?",
        "answer": "no",
        "answer_rationale": "On the whole, the data confirm an absence of a July effect in patients undergoing major cancer surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The \"July effect\" refers to the phenomenon of adverse impacts on patient care arising from the changeover in medical staff that takes place during this month at academic medical centres in North America. There has been some evidence supporting the presence of the July effect, including data from surgical specialties. Uniformity of care, regardless of time of year, is required for patients undergoing major cancer surgery. We therefore sought to perform a population-level assessment for the presence of a July effect in this field.\nWe used the Nationwide Inpatient Sample to abstract data on patients undergoing 1 of 8 major cancer surgeries at academic medical centres between Jan. 1, 1999, and Dec. 30, 2009.",
        "q2": " The primary outcomes examined were postoperative complications and in-hospital mortality. Univariate analyses and subsequently multivariate analyses, controlling for patient and hospital characteristics, were performed to identify whether the time of surgery was an independent predictor of outcome after major cancer surgery.\nOn univariate analysis, the overall postoperative complication rate, as well as genitourinary and hematologic complications specifically, was higher in July than the rest of the year. However, on multivariate analysis, only hematologic complications were significantly higher in July, with no difference in overall postoperative complication rate or in-hospital mortality for all 8 surgeries considered separately or together.\nIs there any evidence of a \"July effect\" in patients undergoing major cancer surgery?",
        "generated_text": "We compared the rates of postoperative complications, in-hospital mortality and length of stay between July and the preceding and following months (June and August). We used multivariable logistic regression to adjust for patient and hospital characteristics.\nWe identified 1 040 115 patients who underwent 1 of the 8 major cancer surgeries at academic medical centres during the study period. The overall complication rate was 14.5%, with a mortality rate of 2.1%. There was no significant difference in the rates of complications (odds ratio [OR] 1.00, 95% confidence interval [CI] 0.97\u20131.03",
        "levenshtein_distance": 579
    },
    {
        "realidx": "24669960",
        "question": "Women have been reported to show more frequent recanalization and better recovery after intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment for acute stroke compared with men. To investigate this we studied a series of stroke patients receiving IV rt-PA and undergoing acute transcranial doppler (TCD) examination.\nAcute stroke patients received IV rt-PA and had acute TCD examination within 4 hours of symptom onset at 4 major stroke centers. TCD findings were interpreted using the Thrombolysis in Brain Ischemia (TIBI) flow grading system. The recanalization rates, and poor 3-month outcomes (modified Rankin scale>2) of men and women were compared using the chi-square test. Multiple regression analysis was used to assess sex as a predictor of recanalization and poor 3-month outcome after controlling for age, baseline NIH Stroke Scale (NIHSS), time to treatment, hypertension, and blood glucose.\n369 patients had TCD examinations before or during IV rt-PA treatment. The 199 (53.9%) men and 170 (46.1%) women had mean ages of 67\u2009\u00b1\u200913 and 70\u2009\u00b1\u200914 years, respectively. The sexes did not differ significantly in baseline stroke severity, time to TCD examination, or time to thrombolysis. Of the men, 68 (34.2%) had complete recanalization, 58 (29.1%) had partial recanalization, and 73 (36.6%) had no recanalization. Of the women, 53 (31.2%) had complete recanalization, 46 (27%) had partial recanalization, and 71 (41.8%) had no recanalization (p\u2009=\u20090.6). Multiple regression analyses showed no difference between the sexes in recanalization rate, time to recanalization, or clinical outcome at 3 months.\nDoes the sex of acute stroke patients influence the effectiveness of rt-PA?",
        "answer": "no",
        "answer_rationale": "In our study; sex is not a significant predictor of recanalization rate, time to recanalization or 3-month outcome in stroke patients following IV rt-PA.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Women have been reported to show more frequent recanalization and better recovery after intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment for acute stroke compared with men. To investigate this we studied a series of stroke patients receiving IV rt-PA and undergoing acute transcranial doppler (TCD) examination.\nAcute stroke patients received IV rt-PA and had acute TCD examination within 4 hours of symptom onset at 4 major stroke centers. TCD findings were interpreted using the Thrombolysis in Brain Ischemia (TIBI) flow grading system. The recanalization rates, and poor 3-month outcomes (modified Rankin scale>2) of men and women were compared using the chi-square test. Multiple regression analysis was used to assess sex as a predictor of recanalization and poor 3-month outcome after controlling for age, baseline NIH Stroke Scale (NIHSS), time to treatment, hypertension, and blood glucose.\n369 patients had TCD examinations before or",
        "q2": " during IV rt-PA treatment. The 199 (53.9%) men and 170 (46.1%) women had mean ages of 67\u2009\u00b1\u200913 and 70\u2009\u00b1\u200914 years, respectively. The sexes did not differ significantly in baseline stroke severity, time to TCD examination, or time to thrombolysis. Of the men, 68 (34.2%) had complete recanalization, 58 (29.1%) had partial recanalization, and 73 (36.6%) had no recanalization. Of the women, 53 (31.2%) had complete recanalization, 46 (27%) had partial recanalization, and 71 (41.8%) had no recanalization (p\u2009=\u20090.6). Multiple regression analyses showed no difference between the sexes in recanalization rate, time to recanalization, or clinical outcome at 3 months.\nDoes the sex of acute stroke patients influence the effectiveness of rt-PA?",
        "generated_text": "during IV rt-PA treatment. 192 (52%) were women and 177 (48%) were men. The mean age was 67.2 years and the mean NIHSS was 14.2. The recanalization rate was higher in women (51.0% vs. 40.1%, p=0.04). The poor 3-month outcome rate was lower in women (40.1% vs. 51.4%, p=0.02). In multivariate analysis, female sex was independently associated with higher recanalization rate (OR 1.62, 95% CI 1.02-2.57, p=0.04) and lower poor 3-month outcome rate (OR 0.59, 95% CI 0.37-0.94, p=0.03).\nIn this study, women had higher recanal",
        "levenshtein_distance": 523
    },
    {
        "realidx": "24671913",
        "question": "SYNTAX score (SxS) has been demonstrated to predict long-term outcomes in stable patients with coronary artery disease. But its prognostic value for patients with acute coronary syndrome remains unknown.AIM: To evaluate whether SxS could predict in-hospital outcomes for patients admitted with ST elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI).\nThe study included 538 patients with STEMI who underwent pPCI between January 2010 and December 2012. The patients were divided into two groups: low SxS (<22) and high SxS (>22). The SxS of all patients was calculated from aninitial angiogram and TIMI flow grade of infarct related artery was calculated after pPCI. Left ventricular systolic functions of the patients were evaluated with an echocardiogram in the following week. The rates of reinfarction and mortality during hospitalisation were obtained from the medical records of our hospital.\nThe high SxS group had more no-reflow (41% and 25.1%, p<0.001, respectively), lower ejection fraction (38.2 \u00b1 7.5% and 44.6 \u00b1 8.8%, p<0.001, respectively), and greater rates of re-infarction (9.5% and 7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, respectively) during hospitalisation compared to the low SxS group. On multivariate logistic regression analysis including clinical variables, SxS was an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001).\nDoes SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?",
        "answer": "yes",
        "answer_rationale": "SxS is a useful tool that can predict in-hospital outcomes of patients with STEMI undergoing pPCI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "SYNTAX score (SxS) has been demonstrated to predict long-term outcomes in stable patients with coronary artery disease. But its prognostic value for patients with acute coronary syndrome remains unknown.AIM: To evaluate whether SxS could predict in-hospital outcomes for patients admitted with ST elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI).\nThe study included 538 patients with STEMI who underwent pPCI between January 2010 and December 2012. The patients were divided into two groups: low SxS (<22) and high SxS (>22). The SxS of all patients was calculated from aninitial angiogram and TIMI flow grade of infarct related artery was calculated after pPCI. Left ventricular systolic functions of the patients were evaluated with an echocardiogram in the following week. The rates of reinfarction and mortality during hospitalisation were obtained from the medical records of our hospital",
        "q2": ".\nThe high SxS group had more no-reflow (41% and 25.1%, p<0.001, respectively), lower ejection fraction (38.2 \u00b1 7.5% and 44.6 \u00b1 8.8%, p<0.001, respectively), and greater rates of re-infarction (9.5% and 7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, respectively) during hospitalisation compared to the low SxS group. On multivariate logistic regression analysis including clinical variables, SxS was an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001).\nDoes SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?",
        "generated_text": ". The primary endpoint was a composite of in-hospital mortality and reinfarction.\nThe mean age of the patients was 59.1\u00b112.1 years and 78.4% were male. The mean SxS was 21.1\u00b14.1. The patients were divided into two groups according to SxS: low SxS (<22) and high SxS (>22). The in-hospital mortality and reinfarction rates were higher in the high SxS group (p=0.001 and p=0.002, respectively). The multivariate analysis revealed that SxS was an independent predictor of in-hospital mortality and reinfarction (OR: 1.11, 95% CI: 1.04-1.19, p=0.002). The area under the receiver operating characteristic curve for",
        "levenshtein_distance": 505
    },
    {
        "realidx": "24698298",
        "question": "To assess pain intensity with and without subcutaneous local anesthesia prior to intraarticular administration of contrast medium for magnetic resonance arthrography (MRa) of the shoulder.\nThis single-center study was conducted after an IRB waiver of authorization, between January 2010 and December 2012. All patients provided written, informed consent for the procedure. Our prospectively populated institutional database was searched, based on our inclusion criteria. There were 249 outpatients (178 men and 71 women; mean age, 44.4 years \u00b1 14.6; range, 15-79) who underwent MRa and were enrolled in this study. Patients were excluded if they had received surgery of the shoulder before MRa, had undergone repeated MRa of the same shoulder, and/or had undergone MRa of both shoulders on the same day. Patients were randomly assigned into one of three groups. Patients in group A (n=61) received skin infiltration with local anesthesia. Patients in control group B (n=92) and group C (n=96) did not receive local anesthesia. Pain levels were immediately assessed after the injection for MRa using a horizontal visual analog scale (VAS) that ranged from 0 to 10. To compare the pain scores of the three groups for male and female patients, a two-way analysis of variance was used. A p-value equal to or less than 0.05 was considered to indicate a significant result.\nPatients who received local anesthesia (group A) showed a mean pain level on the VAS of 2.6 \u00b1 2.3. In patients who did not receive local anesthetics (groups B and C), a mean pain level on the VAS of 2.6 \u00b1 2.2 and 2.7 \u00b1 2.4 were detected, respectively. Between the three groups, no statistically significant difference in pain intensity was detected (p=.960). There were significant differences in subjective pain perception between men and women (p=.009). Moreover, the sex difference in all three groups was equal (p=.934).\nMR arthrography of the shoulder: do we need local anesthesia?",
        "answer": "no",
        "answer_rationale": "Local anesthesia is not required to lower a patient's pain intensity when applying intra-articular contrast media for MR arthrography of the shoulder. This could result in reduced costs and a reduced risk of adverse reactions, without an impact on patient comfort.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To assess pain intensity with and without subcutaneous local anesthesia prior to intraarticular administration of contrast medium for magnetic resonance arthrography (MRa) of the shoulder.\nThis single-center study was conducted after an IRB waiver of authorization, between January 2010 and December 2012. All patients provided written, informed consent for the procedure. Our prospectively populated institutional database was searched, based on our inclusion criteria. There were 249 outpatients (178 men and 71 women; mean age, 44.4 years \u00b1 14.6; range, 15-79) who underwent MRa and were enrolled in this study. Patients were excluded if they had received surgery of the shoulder before MRa, had undergone repeated MRa of the same shoulder, and/or had undergone MRa of both shoulders on the same day. Patients were randomly assigned into one of three groups. Patients in group A (n=61) received skin infiltration with local anesthesia. Patients in control group B (n=92) and group C (n=96) did not receive local",
        "q2": " anesthesia. Pain levels were immediately assessed after the injection for MRa using a horizontal visual analog scale (VAS) that ranged from 0 to 10. To compare the pain scores of the three groups for male and female patients, a two-way analysis of variance was used. A p-value equal to or less than 0.05 was considered to indicate a significant result.\nPatients who received local anesthesia (group A) showed a mean pain level on the VAS of 2.6 \u00b1 2.3. In patients who did not receive local anesthetics (groups B and C), a mean pain level on the VAS of 2.6 \u00b1 2.2 and 2.7 \u00b1 2.4 were detected, respectively. Between the three groups, no statistically significant difference in pain intensity was detected (p=.960). There were significant differences in subjective pain perception between men and women (p=.009). Moreover, the sex difference in all three groups was equal (p=.934).\nMR arthrography of the shoulder: do we need local anesthesia?",
        "generated_text": "anesthesia. Patients in group C received a placebo injection of saline. Pain was assessed using a 100-mm visual analog scale (VAS). The primary outcome was the difference in pain intensity between group A and group B. The secondary outcome was the difference in pain intensity between group B and group C.\nThe mean VAS score was 22.1 mm (95% CI: 17.8-26.4) in group A, 34.1 mm (95% CI: 29.4-38.8) in group B, and 33.4 mm (95% CI: 28.7-38.1) in group C. The difference in pain intensity between group A and group B was 12.0 mm (95% CI: 5.1-18.9; p=0.001). The difference in pain intensity between group B and group C was 0.7 mm (95% CI: -4.6 to",
        "levenshtein_distance": 661
    },
    {
        "realidx": "24739448",
        "question": "In January 2008, the Food and Drug Administration (FDA) communicated concerns and, in May 2009, issued a warning about an increased risk of suicidality for all antiepileptic drugs (AEDs). This research evaluated the association between the FDA suicidality communications and the AED prescription claims among members with epilepsy and/or psychiatric disorder.\nA longitudinal interrupted time-series design was utilized to evaluate Oklahoma Medicaid claims data from January 2006 through December 2009. The study included 9289 continuously eligible members with prevalent diagnoses of epilepsy and/or psychiatric disorder and at least one AED prescription claim. Trends, expressed as monthly changes in the log odds of AED prescription claims, were compared across three time periods: before (January 2006 to January 2008), during (February 2008 to May 2009), and after (June 2009 to December 2009) the FDA warning.\nBefore the FDA warning period, a significant upward trend of AED prescription claims of 0.01% per month (99% CI: 0.008% to 0.013%, p<0.0001) was estimated. In comparison to the prewarning period, no significant change in trend was detected during (-20.0%, 99% CI: -70.0% to 30.0%, p=0.34) or after (80.0%, 99% CI: -20.0% to 200.0%, p=0.03) the FDA warning period. After stratification, no diagnostic group (i.e., epilepsy alone, epilepsy and comorbid psychiatric disorder, and psychiatric disorder alone) experienced a significant change in trend during the entire study period (p>0.01).\nHave antiepileptic drug prescription claims changed following the FDA suicidality warning?",
        "answer": "no",
        "answer_rationale": "During the time period considered, the FDA AED-related suicidality warning does not appear to have significantly affected prescription claims of AED medications for the study population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "In January 2008, the Food and Drug Administration (FDA) communicated concerns and, in May 2009, issued a warning about an increased risk of suicidality for all antiepileptic drugs (AEDs). This research evaluated the association between the FDA suicidality communications and the AED prescription claims among members with epilepsy and/or psychiatric disorder.\nA longitudinal interrupted time-series design was utilized to evaluate Oklahoma Medicaid claims data from January 2006 through December 2009. The study included 9289 continuously eligible members with prevalent diagnoses of epilepsy and/or psychiatric disorder and at least one AED prescription claim. Trends, expressed as monthly changes in the log odds of AED prescription claims, were compared across three time periods: before (January 2006 to January 2008), during (February 2008 to May 2009), and after (June 2009 to December 2009) the FDA warning.\n",
        "q2": "Before the FDA warning period, a significant upward trend of AED prescription claims of 0.01% per month (99% CI: 0.008% to 0.013%, p<0.0001) was estimated. In comparison to the prewarning period, no significant change in trend was detected during (-20.0%, 99% CI: -70.0% to 30.0%, p=0.34) or after (80.0%, 99% CI: -20.0% to 200.0%, p=0.03) the FDA warning period. After stratification, no diagnostic group (i.e., epilepsy alone, epilepsy and comorbid psychiatric disorder, and psychiatric disorder alone) experienced a significant change in trend during the entire study period (p>0.01).\nHave antiepileptic drug prescription claims changed following the FDA suicidality warning?",
        "generated_text": "The primary outcome was the monthly proportion of AED prescription claims.\nThe monthly proportion of AED prescription claims decreased from 0.022 in January 2006 to 0.017 in December 2009 (p < 0.001). The FDA warning was associated with a significant decrease in the monthly proportion of AED prescription claims (p < 0.001). The largest decrease was observed in the first month after the warning (May 2009), with a 12% reduction in AED prescription claims compared to the expected trend.\nThe FDA warning about the increased risk of suicidality for AEDs was associated with a significant decrease in AED prescription claims among Oklahoma Medicaid members with epilepsy and/or psychiatric disorder. This finding suggests that healthcare providers may have altered their prescribing practices in response to the FDA warning, potentially leading to changes in",
        "levenshtein_distance": 621
    },
    {
        "realidx": "24751724",
        "question": "Ageing is a growing issue for people from UK black, Asian and minority ethnic (BAME) groups. The health experiences of these groups are recognised as a 'tracer' to measure success in end of life patient-preferred outcomes that includes place of death (PoD).AIM: To examine patterns in PoD among BAME groups who died of cancer.\nMortality data for 93,375 cancer deaths of those aged \u226565 years in London from 2001-2010 were obtained from the UK Office for National Statistics (ONS). Decedent's country of birth was used as a proxy for ethnicity. Linear regression examined trends in place of death across the eight ethnic groups and Poisson regression examined the association between country of birth and place of death.\n76% decedents were born in the UK, followed by Ireland (5.9%), Europe(5.4%) and Caribbean(4.3%). Most deaths(52.5%) occurred in hospital, followed by home(18.7%). During the study period, deaths in hospital declined with an increase in home deaths; trend for time analysis for those born in UK(0.50%/yr[0.36-0.64%]p<0.001), Europe (1.00%/yr[0.64-1.30%]p<0.001), Asia(1.09%/yr[0.94-1.20%]p<0.001) and Caribbean(1.03%/yr[0.72-1.30%]p<0.001). However, time consistent gaps across the geographical groups remained. Following adjustment hospital deaths were more likely for those born in Asia(Proportion ratio(PR)1.12[95%CI1.08-1.15]p<0.001) and Africa(PR 1.11[95%CI1.07-1.16]p<0.001). Hospice deaths were less likely for those born in Asia(PR 0.73 [0.68-0.80] p<0.001), Africa (PR 0.83[95%CI0.74-0.93]p<0.001), and 'other' geographical regions (PR0.90[95% 0.82-0.98]p<0.001). Home deaths were less likely for those born in the Caribbean(PR0.91[95%CI 0.85-0.98]p<0.001).\nDoes ethnicity affect where people with cancer die?",
        "answer": "yes",
        "answer_rationale": "Location of death varies by country of birth. BAME groups are more likely to die in a hospital and less likely to die at home or in a hospice. Further investigation is needed to determine whether these differences result from patient-centred preferences, or other environment or service-related factors. This knowledge will enable strategies to be developed to improve access to relevant palliative care and related services, where necessary.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Ageing is a growing issue for people from UK black, Asian and minority ethnic (BAME) groups. The health experiences of these groups are recognised as a 'tracer' to measure success in end of life patient-preferred outcomes that includes place of death (PoD).AIM: To examine patterns in PoD among BAME groups who died of cancer.\nMortality data for 93,375 cancer deaths of those aged \u226565 years in London from 2001-2010 were obtained from the UK Office for National Statistics (ONS). Decedent's country of birth was used as a proxy for ethnicity. Linear regression examined trends in place of death across the eight ethnic groups and Poisson regression examined the association between country of birth and place of death.\n76% decedents were born in the UK, followed by Ireland (5.9%), Europe(5.4%) and Caribbean(4.3%). Most deaths(52.5%) occurred in hospital, followed by home(18.7%). During the study period, deaths in hospital declined with an increase in home deaths; trend for time analysis for those born in UK(0.50%/yr[0.36-0.64%]p<0.001), Europe (1.00%/yr[0",
        "q2": ".64-1.30%]p<0.001), Asia(1.09%/yr[0.94-1.20%]p<0.001) and Caribbean(1.03%/yr[0.72-1.30%]p<0.001). However, time consistent gaps across the geographical groups remained. Following adjustment hospital deaths were more likely for those born in Asia(Proportion ratio(PR)1.12[95%CI1.08-1.15]p<0.001) and Africa(PR 1.11[95%CI1.07-1.16]p<0.001). Hospice deaths were less likely for those born in Asia(PR 0.73 [0.68-0.80] p<0.001), Africa (PR 0.83[95%CI0.74-0.93]p<0.001), and 'other' geographical regions (PR0.90[95% 0.82-0.98]p<0.001). Home deaths were less likely for those born in the Caribbean(PR0.91[95%CI 0.85-0.98]p<0.001).\nDoes ethnicity affect where people with cancer die?",
        "generated_text": ".40-1.60%]p=0.001), Caribbean (1.00%/yr[0.10-1.90%]p=0.027), and Africa (1.00%/yr[0.10-1.90%]p=0.027). In multivariable analysis, compared to those born in the UK, those born in Europe (adjusted rate ratio [aRR] 1.12 [1.04-1.21]), Caribbean (aRR 1.14 [1.03-1.26]), and Africa (aRR 1.14 [1.02-1.27]) were more likely to die at home.CONCLUSION: There is a shift in place of death from hospital to home for all ethnic groups. However, those born in Europe, Caribbean and Africa are more likely to die at home compared to those born in the UK. This suggests that the current policy of promoting home deaths may not be equally effective for all ethnic groups.",
        "levenshtein_distance": 497
    },
    {
        "realidx": "24799031",
        "question": "The objective was to evaluate the efficacy of diffusion-weighted imaging (DWI) in predicting the development of vascularization in hypovascular hepatocellular lesions (HHLs).\nForty-two HHLs that were diagnosed by computed tomographic (CT) arteriography were evaluated retrospectively. The lesion on DWI was classified as isointense, hypointense, or hyperintense. Follow-up studies that included intravenous dynamic CT or magnetic resonance imaging were performed.\nThe 730-day cumulative developments of vascularization in hypointense, isointense, and hyperintense lesions were 17%, 30%, and 40%, respectively. The differences among these developments were not statistically significant.\nIs diffusion-weighted imaging a significant indicator of the development of vascularization in hypovascular hepatocellular lesions?",
        "answer": "no",
        "answer_rationale": "The signal intensity on DWI showed no significant difference in the development of vascularization.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The objective was to evaluate the efficacy of diffusion-weighted imaging (DWI) in predicting the development of vascularization in hypovascular hepatocellular lesions (HHLs).\nForty-two HHLs that were diagnosed by computed tomographic (CT) arteriography were evaluated retrospectively. The lesion on DWI was classified as isointense, hypointense, or hyperintense. Follow",
        "q2": "-up studies that included intravenous dynamic CT or magnetic resonance imaging were performed.\nThe 730-day cumulative developments of vascularization in hypointense, isointense, and hyperintense lesions were 17%, 30%, and 40%, respectively. The differences among these developments were not statistically significant.\nIs diffusion-weighted imaging a significant indicator of the development of vascularization in hypovascular hepatocellular lesions?",
        "generated_text": "-up CT scans were performed in 30 lesions, and the development of vascularization was evaluated. The relationship between the DWI signal intensity and the development of vascularization was analyzed.\nThe mean apparent diffusion coefficient (ADC) value of the HHLs was 1.22 \u00b1 0.28 \u00d7 10(-3) mm(2)/s, which was significantly lower than that",
        "levenshtein_distance": 321
    },
    {
        "realidx": "24809662",
        "question": "Midurethral sling (MUS) can improve overactive bladder (OAB) symptoms. It is unclear if anterior/apical prolapse (AA) repair provides additional benefit. We hypothesized that women with mixed urinary incontinence (MUI) experience greater improvement in the OAB component of their symptoms after concomitant MUS and AA repair compared with MUS alone.\nThis is a retrospective cohort study of women with bothersome MUI (defined by objective stress test and validated questionnaire) undergoing MUS alone (\"MUS-only\") or concomitant MUS and AA repair (\"MUS + AA\"). Our primary outcome was the Overactive Bladder Questionnaire Symptom Severity (OAB-q SS) change score 6\u00a0weeks after surgery.\nOf 151 women, 67 (44\u00a0%) underwent MUS-only and 84 (56\u00a0%) underwent MUS + AA. The MUS-only cohort was younger and had less severe baseline prolapse (p\u2009<\u20090.05 for both). Postoperative complications (predominantly UTI) occurred in 35 (23\u00a0%) patients and were similar between cohorts. For all subjects mean OAB-q SS scores significantly improved postoperatively (p\u2009<\u20090.05). Our primary outcome, OAB-q SS change score, showed no significant differences between cohorts (30\u2009\u00b1\u200926 MUS-only vs 25\u2009\u00b1\u200925 MUS + AA, p\u2009=\u20090.20), indicating similar improvements in OAB symptoms. Multivariate linear regression analysis revealed no difference in OAB-q SS change score between cohorts; however, OAB-q SS change scores were lower for women with a postoperative complication (\u03b2\u2009=\u2009-19, 95\u00a0% CI -31 to -6; p\u2009<\u20090.01).\nDoes concomitant anterior/apical repair during midurethral sling improve the overactive bladder component of mixed incontinence?",
        "answer": "no",
        "answer_rationale": "In women with bothersome MUI, concomitant AA repair does not result in additional improvement in OAB symptoms over MUS alone. Patients with postoperative complications exhibit less improvement in OAB symptoms.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Midurethral sling (MUS) can improve overactive bladder (OAB) symptoms. It is unclear if anterior/apical prolapse (AA) repair provides additional benefit. We hypothesized that women with mixed urinary incontinence (MUI) experience greater improvement in the OAB component of their symptoms after concomitant MUS and AA repair compared with MUS alone.\nThis is a retrospective cohort study of women with bothersome MUI (defined by objective stress test and validated questionnaire) undergoing MUS alone (\"MUS-only\") or concomitant MUS and AA repair (\"MUS + AA\"). Our primary outcome was the Overactive Bladder Questionnaire Symptom Severity (OAB-q SS) change score 6\u00a0weeks after surgery.\nOf 151 women, 67 (44\u00a0%) underwent MUS-only and 84 (56\u00a0%) underwent MUS + AA. The MUS-only cohort was younger and had less severe baseline prolapse (p\u2009<\u2009",
        "q2": "0.05 for both). Postoperative complications (predominantly UTI) occurred in 35 (23\u00a0%) patients and were similar between cohorts. For all subjects mean OAB-q SS scores significantly improved postoperatively (p\u2009<\u20090.05). Our primary outcome, OAB-q SS change score, showed no significant differences between cohorts (30\u2009\u00b1\u200926 MUS-only vs 25\u2009\u00b1\u200925 MUS + AA, p\u2009=\u20090.20), indicating similar improvements in OAB symptoms. Multivariate linear regression analysis revealed no difference in OAB-q SS change score between cohorts; however, OAB-q SS change scores were lower for women with a postoperative complication (\u03b2\u2009=\u2009-19, 95\u00a0% CI -31 to -6; p\u2009<\u20090.01).\nDoes concomitant anterior/apical repair during midurethral sling improve the overactive bladder component of mixed incontinence?",
        "generated_text": "0.05). The MUS + AA cohort had higher baseline OAB-q SS (p\u2009=\u20090.002). There was no difference in OAB-q SS change score between the two cohorts (p\u2009=\u20090.14). In multivariable analysis, MUS + AA was not associated with greater OAB-q SS improvement (p\u2009=\u20090.14). There was no difference in OAB-q SS change score between the two cohorts in subgroup analysis of women with baseline OAB-q SS\u2009>\u20093 (p\u2009=\u20090.14) or those with baseline OAB-q SS\u2009>\u20096 (p\u2009=\u20090.14). There was no difference in OAB-q SS change score between the two cohorts in subgroup analysis of women with baseline OAB-q SS\u2009>",
        "levenshtein_distance": 561
    },
    {
        "realidx": "24922528",
        "question": "To explore the extent to which parent-adolescent emotional closeness, family conflict, and parental permissiveness moderate the association of puberty and alcohol use in adolescents (aged 10-14).\nCross-sectional survey of 7631 adolescents from 231 Australian schools. Measures included pubertal status, recent (30day) alcohol use, parent-adolescent emotional closeness, family conflict, parental permissiveness of alcohol use and peer alcohol use. The analysis was based on a two-level (individuals nested within schools) logistic regression model, with main effects entered first, and interaction terms added second.\nThe interaction of family factors and pubertal stage did not improve the fit of the model, so a main effect model of family factors and pubertal stage was adopted. There were significant main effects for pubertal stage with boys in middle puberty at increased odds of alcohol use, and girls in advanced puberty at increased odds of alcohol use.\nThe association of puberty and young adolescent alcohol use: do parents have a moderating role?",
        "answer": "no",
        "answer_rationale": "Puberty and family factors were strong predictors of adolescent alcohol use, but family factors did not account for variation in the association of pubertal stage and alcohol use.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To explore the extent to which parent-adolescent emotional closeness, family conflict, and parental permissiveness moderate the association of puberty and alcohol use in adolescents (aged 10-14).\nCross-sectional survey of 7631 adolescents from 231 Australian schools. Measures included pubertal status, recent (30day) alcohol use, parent-adolescent emotional closeness, family conflict, parental permissiveness of alcohol use and peer alcohol use. The analysis was based on a two-level (individuals nested within schools",
        "q2": ") logistic regression model, with main effects entered first, and interaction terms added second.\nThe interaction of family factors and pubertal stage did not improve the fit of the model, so a main effect model of family factors and pubertal stage was adopted. There were significant main effects for pubertal stage with boys in middle puberty at increased odds of alcohol use, and girls in advanced puberty at increased odds of alcohol use.\nThe association of puberty and young adolescent alcohol use: do parents have a moderating role?",
        "generated_text": ") multilevel model.\nPubertal status was associated with increased alcohol use in both boys and girls, but the association was stronger in girls. Parent-adolescent emotional closeness and family conflict moderated the association between pubertal status and alcohol use in girls only. Parental permissiveness of alcohol use moderated the association between pubertal status and alcohol use in boys only.\nThe findings suggest that puberty is associated with increased alcohol use in both boys and girls, but the association is stronger",
        "levenshtein_distance": 400
    },
    {
        "realidx": "24977765",
        "question": "Concussions are commonly diagnosed in pediatric patients presenting to the emergency department (ED). The primary objective of this study was to evaluate compliance with ED discharge instructions for concussion management.\nA prospective cohort study was conducted from November 2011 to November 2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 pediatric patients per year. Subjects were aged 8 years to 17 years and were discharged from the ED with a diagnosis of concussion. Exclusion criteria included recent (past 3 months) diagnosis of head injury, hospital admission, intracranial injury, skull fracture, suspected nonaccidental trauma, or preexisting neurologic condition. Subjects were administered a baseline survey in the ED and were given standardized discharge instructions for concussion by the treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 weeks after ED visit.\nA total of 150 patients were enrolled. The majority (67%) of concussions were sports related. Among sports-related concussions, soccer (30%), football (11%), lacrosse (8%), and basketball (8%) injuries were most common. More than one third (39%) reported return to play (RTP) on the day of the injury. Physician follow-up was equivalent for sport and nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 0.06; 4 weeks, 29% vs. 8%, p<0.01). Of the patients who did RTP or normal activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most (58%) did not receive medical clearance. Of the patients who had returned to activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, and most (54%) received medical clearance.\nAre pediatric concussion patients compliant with discharge instructions?",
        "answer": "yes",
        "answer_rationale": "Pediatric patients discharged from the ED are mostly compliant with concussion instructions. However, a significant number of patients RTP on the day of injury, while experiencing symptoms or without medical clearance.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Concussions are commonly diagnosed in pediatric patients presenting to the emergency department (ED). The primary objective of this study was to evaluate compliance with ED discharge instructions for concussion management.\nA prospective cohort study was conducted from November 2011 to November 2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 pediatric patients per year. Subjects were aged 8 years to 17 years and were discharged from the ED with a diagnosis of concussion. Exclusion criteria included recent (past 3 months) diagnosis of head injury, hospital admission, intracranial injury, skull fracture, suspected nonaccidental trauma, or preexisting neurologic condition. Subjects were administered a baseline survey in the ED and were given standardized discharge instructions for concussion by the treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 weeks after ED visit.\nA total of 150 patients were enrolled. The majority (67%) of concussions were sports related. Among sports-related concussions",
        "q2": ", soccer (30%), football (11%), lacrosse (8%), and basketball (8%) injuries were most common. More than one third (39%) reported return to play (RTP) on the day of the injury. Physician follow-up was equivalent for sport and nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 0.06; 4 weeks, 29% vs. 8%, p<0.01). Of the patients who did RTP or normal activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most (58%) did not receive medical clearance. Of the patients who had returned to activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, and most (54%) received medical clearance.\nAre pediatric concussion patients compliant with discharge instructions?",
        "generated_text": ", 40% were from football, 13% from soccer, and 11% from basketball. At 2 weeks, 70% of patients reported following all discharge instructions, and 20% reported following most instructions. At 4 weeks, 80% reported following all instructions, and 15% reported following most instructions. The most common reason for not following instructions was that the patient felt better and did not need to follow them. There was no significant difference in compliance between sports-related and non\u2013sports-related concussions.\nCompliance with ED discharge instructions for concussion management is high, with most patients reporting adherence to all instructions at both 2 weeks and 4 weeks post-ED visit. This suggests that standardized discharge instructions are effective in guiding patient management after concussion. However, some patients do not fully comply, often because they feel better, which may indicate a need for clearer communication about the importance of adhering to the full recovery protocol.",
        "levenshtein_distance": 738
    },
    {
        "realidx": "24995509",
        "question": "To investigate the association between age-related macular degeneration (AMD) and the polymorphisms of HIF1A, a major vascular epithelial growth factor regulator under hypoxic conditions. The associations of AMD and polymorphisms of genes CFH, SKIV2L and MYRIP were also studied.\nProspective study.\nEighty-seven AMD patients and 80 healthy subjects admitted to the Department of Ophthalmology at Pamukkale University Hospital, Denizli, Turkey, were included: 45 (52%) had wet type AMD, and 42 (48%) had dry type AMD.\nPolymorphisms rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) were investigated in DNA isolated from peripheral blood samples of the cases and controls by dye-termination DNA sequencing.\nGenotype distribution of rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) in AMD cases and healthy controls; association between genotypes and AMD subtypes.\nGiven the significant difference between the mean age of case and control groups (72.13\u2009\u00b1\u20095.77 vs. 62.80\u2009\u00b1\u20095.22, respectively) (P\u2009=\u2009.000), subsequent analyses were adjusted for age. We found that having at least one C allele for polymorphism rs1061170 increases AMD risk independent of age (OR\u2009=\u20092.42, 95% confidence interval [CI], 1.22-4.81). The ancestral T allele for polymorphism rs1061170 has a protective effect for AMD (OR\u2009=\u20090.53, 95% CI, 0.34-0.83). No statistically significant difference for distributions of other single nucleotide polymorphisms (SNPs) emerged between patients and healthy subjects.\nHIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration?",
        "answer": "maybe",
        "answer_rationale": "No associations appeared between HIF1A SNPs and AMD, which were studied here for the first time; however, polymorphism rs1061170 of the CFH gene is associated with AMD in our population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To investigate the association between age-related macular degeneration (AMD) and the polymorphisms of HIF1A, a major vascular epithelial growth factor regulator under hypoxic conditions. The associations of AMD and polymorphisms of genes CFH, SKIV2L and MYRIP were also studied.\nProspective study.\nEighty-seven AMD patients and 80 healthy subjects admitted to the Department of Ophthalmology at Pamukkale University Hospital, Denizli, Turkey, were included: 45 (52%) had wet type AMD, and 42 (48%) had dry type AMD.\nPolymorphisms rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) were investigated in DNA isolated from peripheral blood samples of the cases and controls by dye-termination DNA sequencing.\nGenotype distribution of rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs115494",
        "q2": "65 and rs11549467 (HIF1A) in AMD cases and healthy controls; association between genotypes and AMD subtypes.\nGiven the significant difference between the mean age of case and control groups (72.13\u2009\u00b1\u20095.77 vs. 62.80\u2009\u00b1\u20095.22, respectively) (P\u2009=\u2009.000), subsequent analyses were adjusted for age. We found that having at least one C allele for polymorphism rs1061170 increases AMD risk independent of age (OR\u2009=\u20092.42, 95% confidence interval [CI], 1.22-4.81). The ancestral T allele for polymorphism rs1061170 has a protective effect for AMD (OR\u2009=\u20090.53, 95% CI, 0.34-0.83). No statistically significant difference for distributions of other single nucleotide polymorphisms (SNPs) emerged between patients and healthy subjects.\nHIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration?",
        "generated_text": "65 and rs11549467 (HIF1A) were in Hardy-Weinberg equilibrium in both groups. The frequency of the T allele of rs11549465 (HIF1A) was higher in AMD patients than in controls (p=0.001, OR=2.40, 95% CI=1.40-4.12). The frequency of the C allele of rs11549467 (HIF1A) was higher in AMD patients than in controls (p=0.001, OR=2.40, 95% CI=1.40-4.12). The frequency of the T allele of rs1061170 (CFH) was higher in AMD patients than in controls (p=0.001, OR=4.10, 95% CI=1.90-8.80). The frequency of the C allele of rs4",
        "levenshtein_distance": 650
    },
    {
        "realidx": "24996865",
        "question": "Reconstructing the natural joint line in knee revision surgery improves clinical and functional outcome but may be challenging when both cartilage and bone were removed during previous operations. Assessing joint lines (JLs) by means of bony landmarks is inadvisable because of large variations in human anatomy. Because of the inherent symmetry of the human body, we hypothesised that JLs may be directly assessed by measuring the distances from the bony landmarks to the JL of the contralateral knee by means of radiographic images.\nUsing scaled weight-bearing radiographs in anteroposterior view of both knees, two independent observers measured the distances from the fibular head, the medial and lateral epicondyle, and the adductor tubercle to the JL. A two-sided p value of \u22640.05 was considered statistically significant.\nTwo hundred knees of 100 patients (50 men and 50 women) were examined. For the fibular head, the mean difference between the treated and the control knee was 0.0 mm with narrow confidence limits ranging from -1.1 to 1.1.\nAssessing joint line positions by means of the contralateral knee: a new approach for planning knee revision surgery?",
        "answer": "yes",
        "answer_rationale": "As a new assessment method, we have suggested to assess the JL by means of radiographs of the contralateral knee. The most precise parameter was found to be the distance between the fibular head and the JL. The level of arthritis, age, gender, visibility of the landmarks, and misalignment did not influence measurement accuracy. This parameter is the first tibia-related landmark for assessing the JL, which advantageously corresponds to the tibia-first technique in revision surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Reconstructing the natural joint line in knee revision surgery improves clinical and functional outcome but may be challenging when both cartilage and bone were removed during previous operations. Assessing joint lines (JLs) by means of bony landmarks is inadvisable because of large variations in human anatomy. Because of the inherent symmetry of the human body, we hypothesised that JLs may be directly assessed by measuring the distances from the bony landmarks to the JL of the contralateral knee by means of radiographic images.\nUsing scaled weight-bearing radiographs in anteroposterior view of both knees, two independent",
        "q2": " observers measured the distances from the fibular head, the medial and lateral epicondyle, and the adductor tubercle to the JL. A two-sided p value of \u22640.05 was considered statistically significant.\nTwo hundred knees of 100 patients (50 men and 50 women) were examined. For the fibular head, the mean difference between the treated and the control knee was 0.0 mm with narrow confidence limits ranging from -1.1 to 1.1.\nAssessing joint line positions by means of the contralateral knee: a new approach for planning knee revision surgery?",
        "generated_text": "observers measured the distances from the JL to the medial and lateral tibial tubercles (TTs), the medial and lateral tibial plateaus (TPs), and the medial and lateral femoral condyles (FCs). The mean values of the distances from the JL to the bony landmarks of the contralateral knee were used to reconstruct the JL of the operated knee. The JLs were reconstructed by means of the mean values of the distances from the bony landmarks to the JL of the contralateral knee. The JLs were reconstructed by means of the mean values of the distances from",
        "levenshtein_distance": 366
    },
    {
        "realidx": "25007420",
        "question": "Francophones may experience poorer health due to social status, cultural differences in lifestyle and attitudes, and language barriers to health care. Our study sought to compare mental health indicators between Francophones and non-Francophones living in the province of Manitoba.\nTwo populations were used: one from administrative datasets housed at the Manitoba Centre for Health Policy and the other from representative survey samples. The administrative datasets contained data from physician billings, hospitalizations, prescription drug use, education, and social services use, and surveys included indicators on language variables and on self-rated health.\nOutside urban areas, Francophones had lower rates of diagnosed substance use disorder (rate ratio [RR] = 0.80; 95% CI 0.68 to 0.95) and of suicide and suicide attempts (RR = 0.59; 95% CI 0.43 to 0.79), compared with non-Francophones, but no differences were found between the groups across the province in rates of diagnosed mood disorders, anxiety disorders, dementia, or any mental disorders after adjusting for age, sex, and geographic area. When surveyed, Francophones were less likely than non-Francophones to report that their mental health was excellent, very good, or good (66.9%, compared with 74.2%).\nAre there mental health differences between francophone and non-francophone populations in manitoba?",
        "answer": "maybe",
        "answer_rationale": "The discrepancy in how Francophones view their mental health and their rates of diagnosed mental disorders may be related to health seeking behaviours in the Francophone population. Community and government agencies should try to improve the mental health of this population through mental health promotion and by addressing language and cultural barriers to health services.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Francophones may experience poorer health due to social status, cultural differences in lifestyle and attitudes, and language barriers to health care. Our study sought to compare mental health indicators between Francophones and non-Francophones living in the province of Manitoba.\nTwo populations were used: one from administrative datasets housed at the Manitoba Centre for Health Policy and the other from representative survey samples. The administrative datasets contained data from physician billings, hospitalizations, prescription drug use, education, and social services use, and surveys included indicators on language variables and on self-rated health.\nOutside urban areas, Francophones had lower rates of diagnosed substance use disorder (rate ratio [RR] = 0.80; 95% CI ",
        "q2": "0.68 to 0.95) and of suicide and suicide attempts (RR = 0.59; 95% CI 0.43 to 0.79), compared with non-Francophones, but no differences were found between the groups across the province in rates of diagnosed mood disorders, anxiety disorders, dementia, or any mental disorders after adjusting for age, sex, and geographic area. When surveyed, Francophones were less likely than non-Francophones to report that their mental health was excellent, very good, or good (66.9%, compared with 74.2%).\nAre there mental health differences between francophone and non-francophone populations in manitoba?",
        "generated_text": ": 0.70-0.92) and depression (RR = 0.82; 95% CI: 0.74-0.91). In urban areas, Francophones had higher rates of diagnosed substance use disorder (RR = 1.21; 95% CI: 1.05-1.40) and depression (RR = 1.14; 95% CI: 1.05-1.24). Francophones in both urban and rural areas had higher rates of diagnosed anxiety (RR = 1.15; 95% CI: 1",
        "levenshtein_distance": 429
    },
    {
        "realidx": "25043083",
        "question": "Recently, increasing number of literature has identified the posterior tibial slope (PTS) as one of the risk factors of primary anterior cruciate ligament (ACL) injury. However, few studies concerning the association between failure of ACL reconstruction (ACLR) and PTS have been published. The objective of this study was to explore the association between the failure of ACLR and PTS at a minimum of two years follow-up.\nTwo hundred and thirty eight eligible patients from June 2009 to October 2010 were identified from our database. A total of 20 failure cases of ACLR and 20 randomly selected controls were included in this retrospective study. The demographic data and the results of manual maximum side-to-side difference with KT-1000 arthrometer at 30\u00b0 of knee flexion and pivot-shift test before the ACLR and at the final follow-up were collected. The medial and lateral PTSs were measured using the magnetic resonance imaging (MRI) scan, based on Hudek's measurement. A comparison of PTS between the two groups was performed.\nThe overall failure rate of the present study was 8.4%. Of the 40 participants, the mean medial PTS was 4.1\u00b0 \u00b1 3.2\u00b0 and the mean lateral PTS was 4.6\u00b0 \u00b1 2.6\u00b0. The medial PTS of the ACLR failure group was significantly steeper than the control group (3.5\u00b0 \u00b1 2.5\u00b0 vs. 6.1\u00b0 \u00b1 2.1\u00b0, P = 0.000). Similarly, the lateral PTS of the ACLR failure group was significantly steeper than the control group (2.9\u00b0 \u00b1 2.1\u00b0 vs. 5.5\u00b0 \u00b1 3.0\u00b0, P = 0.006). For medial PTS \u2265 5\u00b0, the odds ratio of ACLR failure was 6.8 (P = 0.007); for lateral PTS \u22655\u00b0, the odds ratio of ACLR failure was 10.8 (P = 0.000).\nAre failures of anterior cruciate ligament reconstruction associated with steep posterior tibial slopes?",
        "answer": "yes",
        "answer_rationale": "Both medial and lateral PTS were significantly steeper in failures of ACLR than the control group. Medial or lateral PTS \u22655\u00b0 was a new risk factor of ACLR failure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Recently, increasing number of literature has identified the posterior tibial slope (PTS) as one of the risk factors of primary anterior cruciate ligament (ACL) injury. However, few studies concerning the association between failure of ACL reconstruction (ACLR) and PTS have been published. The objective of this study was to explore the association between the failure of ACLR and PTS at a minimum of two years follow-up.\nTwo hundred and thirty eight eligible patients from June 2009 to October 2010 were identified from our database. A total of 20 failure cases of ACLR and 20 randomly selected controls were included in this retrospective study. The demographic data and the results of manual maximum side-to-side difference with KT-1000 arthrometer at 30\u00b0 of knee flexion and pivot-shift test before the ACLR and at the final follow-up were collected. The medial and lateral PTSs were measured using the magnetic resonance imaging (MRI) scan, based on Hudek's measurement. A comparison of PTS between the two groups was performed.\nThe overall failure rate of the",
        "q2": " present study was 8.4%. Of the 40 participants, the mean medial PTS was 4.1\u00b0 \u00b1 3.2\u00b0 and the mean lateral PTS was 4.6\u00b0 \u00b1 2.6\u00b0. The medial PTS of the ACLR failure group was significantly steeper than the control group (3.5\u00b0 \u00b1 2.5\u00b0 vs. 6.1\u00b0 \u00b1 2.1\u00b0, P = 0.000). Similarly, the lateral PTS of the ACLR failure group was significantly steeper than the control group (2.9\u00b0 \u00b1 2.1\u00b0 vs. 5.5\u00b0 \u00b1 3.0\u00b0, P = 0.006). For medial PTS \u2265 5\u00b0, the odds ratio of ACLR failure was 6.8 (P = 0.007); for lateral PTS \u22655\u00b0, the odds ratio of ACLR failure was 10.8 (P = 0.000).\nAre failures of anterior cruciate ligament reconstruction associated with steep posterior tibial slopes?",
        "generated_text": "ACLR was 8.4%. The mean age of the failure group was 24.5 years (range, 16-38 years), and 18 (90%) were male. The mean age of the control group was 23.5 years (range, 16-38 years), and 17 (85%) were male. There was no significant difference in age and gender between the two groups (p > 0.05). The mean follow-up time was 35.2 months (range, 24-54 months). The mean medial PTS was 10.1\u00b0 (range, 5.5\u00b0-14.5\u00b0) in the failure group and 7.1\u00b0 (range, 4.5\u00b0-10.5\u00b0) in the control group (p < 0.05). The mean lateral PTS was 10.5\u00b0 (range, 6.5\u00b0-14.5\u00b0) in the failure group and",
        "levenshtein_distance": 490
    },
    {
        "realidx": "25079920",
        "question": "As parents of young children are often unaware their child is overweight, screening provides the opportunity to inform parents and provide the impetus for behaviour change. We aimed to determine if parents could recall and understand the information they received about their overweight child after weight screening.\nRandomised controlled trial of different methods of feedback.\nParticipants were recruited through primary and secondary care but appointments took place at a University research clinic.\n1093 children aged 4-8\u2005years were screened. Only overweight children (n=271, 24.7%) are included in this study. Parents of overweight children were randomised to receive feedback regarding their child's weight using best practice care (BPC) or motivational interviewing (MI) at face-to-face interviews typically lasting 20-40\u2005min. 244 (90%) parents participated in a follow-up interview 2\u2005weeks later to assess recall and understanding of information from the feedback session.\nInterviews were audio-taped and transcribed verbatim before coding for amount and accuracy of recall. Scores were calculated for total recall and sub-categories of interest.\nOverall, 39% of the information was recalled (mean score 6.3 from possible score of 16). Parents given feedback via BPC recalled more than those in the MI group (difference in total score 0.48; 95% CI 0.05 to 0.92). Although 94% of parents were able to correctly recall their child's weight status, fewer than 10 parents could accurately describe what the measurements meant. Maternal education (0.81; 0.25 to 1.37) and parental ratings of how useful they found the information (0.19; 0.04 to 0.35) were significant predictors of recall score in multivariate analyses.\nDo parents recall and understand children's weight status information after BMI screening?",
        "answer": "maybe",
        "answer_rationale": "While parents remember that their child's body mass index is higher than recommended, they are unable to remember much of the information and advice provided about the result.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "As parents of young children are often unaware their child is overweight, screening provides the opportunity to inform parents and provide the impetus for behaviour change. We aimed to determine if parents could recall and understand the information they received about their overweight child after weight screening.\nRandomised controlled trial of different methods of feedback.\nParticipants were recruited through primary and secondary care but appointments took place at a University research clinic.\n1093 children aged 4-8\u2005years were screened. Only overweight children (n=271, 24.7%) are included in this study. Parents of overweight children were randomised to receive feedback regarding their child's weight using best practice care (BPC) or motivational interviewing (MI) at face-to-face interviews typically lasting 20-40\u2005min. 244 (90%) parents participated in a follow-up interview 2\u2005weeks later to assess recall and understanding of information from the feedback session.\nInterviews were audio-t",
        "q2": "aped and transcribed verbatim before coding for amount and accuracy of recall. Scores were calculated for total recall and sub-categories of interest.\nOverall, 39% of the information was recalled (mean score 6.3 from possible score of 16). Parents given feedback via BPC recalled more than those in the MI group (difference in total score 0.48; 95% CI 0.05 to 0.92). Although 94% of parents were able to correctly recall their child's weight status, fewer than 10 parents could accurately describe what the measurements meant. Maternal education (0.81; 0.25 to 1.37) and parental ratings of how useful they found the information (0.19; 0.04 to 0.35) were significant predictors of recall score in multivariate analyses.\nDo parents recall and understand children's weight status information after BMI screening?",
        "generated_text": "aped and transcribed verbatim. Transcripts were analysed using thematic analysis.\nParents in both groups reported high levels of recall and understanding of the information they received. Parents in the MI group were more likely to recall the information in a positive way and to report that the information was relevant to their child. Parents in the BPC group were more likely to recall the information in a negative way and to report that the information was not relevant to their child.\nParents of overweight children can recall and understand the information they receive about their child's weight after screening. The way in which the information is presented affects how it is recalled and understood. MI may be a more effective way to provide feedback to parents about their child's weight than BPC.",
        "levenshtein_distance": 599
    },
    {
        "realidx": "25103647",
        "question": "To examine whether government-funded, low-income vision care programs improve use of eye care services by low-income individuals in Canada.\nCross-sectional survey.\n27,375 white respondents to the Canadian Community Health Survey (CCHS) Healthy Aging 2008/2009.\nGovernment-funded, low-income vision care programs were reviewed. The amount of assistance provided was compared with professional fee schedules for general/routine eye examinations and market prices for eyeglasses. The utilization of eye care providers was derived from the CCHS.\nTo receive low-income vision care assistance, individuals must be in receipt of social assistance. Criteria for receiving social assistance are stringent. The Canadian Financial Capability Survey revealed that 7.9% of Canadians aged 45 to 64 years and 5.5% aged \u226565 years received social assistance in 2009. The CCHS found in 2008/2009 that 12.5% of citizens aged 45 to 64 years and 13.2% of those aged \u226565 years had difficulty paying for basic expenses such as food. In 5 provinces, low-income vision care assistance fully covers a general/routine eye examination. In the remainder, the assistance provided is insufficient for a general/routine eye examination. The assistance for eyeglasses is inadequate in 5 provinces, requiring out-of-pocket copayments. Among middle-aged whites who self-reported not having glaucoma, cataracts, diabetes, or vision problems not corrected by lenses, utilization of eye care providers was 28.1% among those with financial difficulty versus 41.9% among those without (p<0.05), giving a prevalence ratio 0.68 (95% CI 0.57-0.80) adjusted for age, sex and education.\nDoes government assistance improve utilization of eye care services by low-income individuals?",
        "answer": "maybe",
        "answer_rationale": "Despite government assistance, low-income individuals use vision care services less often than wealthy individuals.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To examine whether government-funded, low-income vision care programs improve use of eye care services by low-income individuals in Canada.\nCross-sectional survey.\n27,375 white respondents to the Canadian Community Health Survey (CCHS) Healthy Aging 2008/2009.\nGovernment-funded, low-income vision care programs were reviewed. The amount of assistance provided was compared with professional fee schedules for general/routine eye examinations and market prices for eyeglasses. The utilization of eye care providers was derived from the CCHS.\nTo receive low-income vision care assistance, individuals must be in receipt of social assistance. Criteria for receiving social assistance are stringent. The Canadian Financial Capability Survey revealed that 7.9% of Canadians aged 45 to 64 years and 5.5% aged \u226565 years received social assistance in 2009. The CCHS found in 2008/2009 that 12.5% of",
        "q2": " citizens aged 45 to 64 years and 13.2% of those aged \u226565 years had difficulty paying for basic expenses such as food. In 5 provinces, low-income vision care assistance fully covers a general/routine eye examination. In the remainder, the assistance provided is insufficient for a general/routine eye examination. The assistance for eyeglasses is inadequate in 5 provinces, requiring out-of-pocket copayments. Among middle-aged whites who self-reported not having glaucoma, cataracts, diabetes, or vision problems not corrected by lenses, utilization of eye care providers was 28.1% among those with financial difficulty versus 41.9% among those without (p<0.05), giving a prevalence ratio 0.68 (95% CI 0.57-0.80) adjusted for age, sex and education.\nDoes government assistance improve utilization of eye care services by low-income individuals?",
        "generated_text": "Canadians aged \u226545 years had an annual household income <$20,000. The amount of assistance provided for general/routine eye examinations and eyeglasses was less than the professional fee schedules and market prices, respectively, in all provinces and territories. The CCHS found that 12.5% of Canadians aged \u226545 years had not had an eye examination in the previous 12 months. The percentage was higher in those with an annual household income <$20,000 (16.4%) compared with those with an annual household income \u2265$20,000 (11.7%).\nGovernment-funded, low-income vision care programs in Canada are limited in scope and do not appear to be effective in improving access to eye care services by low-income individuals.",
        "levenshtein_distance": 583
    },
    {
        "realidx": "25277731",
        "question": "Sternal fractures in childhood are rare. The aim of the study was to investigate the accident mechanism, the detection of radiological and sonographical criteria and consideration of associated injuries.\nIn the period from January 2010 to December 2012 all inpatients and outpatients with sternal fractures were recorded according to the documentation.\nA total of 4 children aged 5-14\u00a0years with a sternal fracture were treated in 2\u00a0years, 2\u00a0children were hospitalized for pain management and 2 remained in outpatient care.\nSternal fracture in growing children : A rare and often overlooked fracture?",
        "answer": "maybe",
        "answer_rationale": "Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Sternal fractures in childhood are rare. The aim of the study was to investigate the accident mechanism, the detection of radiological and sonographical criteria and consideration of associated injuries.\nIn the period from January 2010 to December 2012 all inpatients and outpatients with sternal fractures were recorded according",
        "q2": " to the documentation.\nA total of 4 children aged 5-14\u00a0years with a sternal fracture were treated in 2\u00a0years, 2\u00a0children were hospitalized for pain management and 2 remained in outpatient care.\nSternal fracture in growing children : A rare and often overlooked fracture?",
        "generated_text": "to the ICD-10 code S22.0. The data were collected retrospectively from the hospital information system and the radiological information system. The data were evaluated with regard to age, gender, accident mechanism, associated injuries, radiological and sonographical criteria.\nIn the study period,",
        "levenshtein_distance": 229
    },
    {
        "realidx": "25280365",
        "question": "Clinical pathologists (CPs) report RBC morphologic (RBC-M) changes to assist clinicians in prioritizing differential diagnoses. However, reporting is subjective, semiquantitative, and potentially biased. Reporting decisions vary among CPs, and reports may not be interpreted by clinicians as intended.\nThe aims of this study were to survey clinicians and CPs about RBC-M terms and their clinical value, and identify areas of agreement and discordance.\nOnline surveys were distributed to small animal clinicians via the Veterinary Information Network and to CPs via the ASVCP listserv. A quiz assessed understanding of RBC-M terms among respondent groups. Descriptive statistics were used to analyze responses to survey questions, and quiz scores were compared among groups.\nAnalyzable responses were obtained from 1662 clinicians and 82 CPs. Both clinicians and CPs considered some terms, e.g., agglutination, useful, whereas only CPs considered other terms, e.g., ghost cells, useful. All groups interpreted certain terms, e.g., Heinz bodies, correctly, whereas some clinicians misinterpreted others, e.g., eccentrocytes. Responses revealed that CPs often do not report RBC-M they consider insignificant, when present in low numbers. Twenty-eight percent of clinicians think CPs review all blood smears while only 19% of CPs report reviewing all smears.\nReporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians?",
        "answer": "yes",
        "answer_rationale": "Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Clinical pathologists (CPs) report RBC morphologic (RBC-M) changes to assist clinicians in prioritizing differential diagnoses. However, reporting is subjective, semiquantitative, and potentially biased. Reporting decisions vary among CPs, and reports may not be interpreted by clinicians as intended.\nThe aims of this study were to survey clinicians and CPs about RBC-M terms and their clinical value, and identify areas of agreement and discordance.\nOnline surveys were distributed to small animal clinicians via the Veterinary Information Network and to CPs via the ASVCP listserv. A quiz assessed understanding of RBC-M terms among respondent groups. Descriptive statistics were used to analyze responses to survey questions, and quiz scores were compared among groups.\nAnalyz",
        "q2": "able responses were obtained from 1662 clinicians and 82 CPs. Both clinicians and CPs considered some terms, e.g., agglutination, useful, whereas only CPs considered other terms, e.g., ghost cells, useful. All groups interpreted certain terms, e.g., Heinz bodies, correctly, whereas some clinicians misinterpreted others, e.g., eccentrocytes. Responses revealed that CPs often do not report RBC-M they consider insignificant, when present in low numbers. Twenty-eight percent of clinicians think CPs review all blood smears while only 19% of CPs report reviewing all smears.\nReporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians?",
        "generated_text": "able surveys were received from 112 clinicians and 100 CPs. Clinicians and CPs agreed that RBC-M terms are important for clinical decision-making, but disagreed on the importance of some terms. Clinicians and CPs had similar understanding of RBC-M terms, but some terms were misinterpreted by both groups. Clinicians and CPs had different opinions about the clinical value of RBC-M terms, with clinicians placing more importance on some terms than CPs.\nThese findings suggest that there is room for improvement in the reporting of RBC-M changes by CPs, and that better communication and education may be needed to ensure that reports are interpreted as intended by clinicians.",
        "levenshtein_distance": 484
    },
    {
        "realidx": "25311479",
        "question": "It is uncertain whether the inverse equity hypothesis-the idea that new health interventions are initially primarily accessed by the rich, but that inequalities narrow with diffusion to the poor-holds true for cancer screening in low and middle income countries (LMICs).This study examines the relationship between overall coverage and economic inequalities in coverage of cancer screening in four middle-income countries.\nSecondary analyses of cross-sectional data from the WHO study on Global Ageing and Adult Health in China, Mexico, Russia and South Africa (2007-2010). Three regression-based methods were used to measure economic inequalities: (1) Adjusted OR; (2) Relative Index of Inequality (RII); and (3) Slope Index of Inequality.\nCoverage for breast cancer screening was 10.5% in South Africa, 19.3% in China, 33.8% in Russia and 43% in Mexico, and coverage for cervical cancer screening was 24% in South Africa, 27.2% in China, 63.7% in Mexico and 81.5% in Russia. Economic inequalities in screening participation were substantially lower or non-existent in countries with higher aggregate coverage, for both breast cancer screening (RII: 14.57 in South Africa, 4.90 in China, 2.01 in Mexico, 1.04 in Russia) and cervical cancer screening (RII: 3.60 in China, 2.47 in South Africa, 1.39 in Mexico, 1.12 in Russia).\nThe inverse equity hypothesis: does it apply to coverage of cancer screening in middle-income countries?",
        "answer": "yes",
        "answer_rationale": "Economic inequalities in breast and cervical cancer screening are low in LMICs with high screening coverage. These findings are consistent with the inverse equity hypothesis and indicate that high levels of equity in cancer screening are feasible even in countries with high income inequality.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "It is uncertain whether the inverse equity hypothesis-the idea that new health interventions are initially primarily accessed by the rich, but that inequalities narrow with diffusion to the poor-holds true for cancer screening in low and middle income countries (LMICs).This study examines the relationship between overall coverage and economic inequalities in coverage of cancer screening in four middle-income countries.\nSecondary analyses of cross-sectional data from the WHO study on Global Ageing and Adult Health in China, Mexico, Russia and South Africa (2007-2010). Three regression-based methods were used to measure economic inequalities: (1) Adjusted OR; (2) Relative Index of Inequality (RII); and (3) Slope Index of Inequality.\nCoverage for breast cancer screening was 10.5% in South Africa, 19.3% in",
        "q2": " China, 33.8% in Russia and 43% in Mexico, and coverage for cervical cancer screening was 24% in South Africa, 27.2% in China, 63.7% in Mexico and 81.5% in Russia. Economic inequalities in screening participation were substantially lower or non-existent in countries with higher aggregate coverage, for both breast cancer screening (RII: 14.57 in South Africa, 4.90 in China, 2.01 in Mexico, 1.04 in Russia) and cervical cancer screening (RII: 3.60 in China, 2.47 in South Africa, 1.39 in Mexico, 1.12 in Russia).\nThe inverse equity hypothesis: does it apply to coverage of cancer screening in middle-income countries?",
        "generated_text": "China, 22.5% in Mexico and 24.5% in Russia. Coverage for cervical cancer screening was 20.5% in China, 22.5% in Mexico, 24.5% in Russia and 30.5% in South Africa. In all countries, the rich had higher coverage than the poor for both types of screening. The magnitude of inequalities was largest in South Africa for breast cancer screening (RII=2.4, 95% CI 1.7 to 3.4) and in China for cervical cancer screening (RII=2.1, 95% CI 1.5 to 2.9). Inequalities in coverage decreased with increasing overall coverage in breast cancer screening (p=0",
        "levenshtein_distance": 366
    },
    {
        "realidx": "25371231",
        "question": "The aetiology of osteochondritis dissecans is still unclear. The aim of this prospective pilot study was to analyse whether vitamin D insufficiency, or deficiency, might be a contributing etiological factor in the development of an OCD lesion.\nThe serum level of vitamin D3 in 23 consecutive patients (12 male and 11 female) suffering from a stage III, or stages III and IV, OCD lesion (mostly stage III) admitted for surgery was measured.\nThe patients' mean age was 31.3\u00a0years and most of them already exhibited closed epiphyseal plates. In the majority of patients (18/23), a distinct vitamin D3 deficiency was found, two patients were vitamin D3-insufficient and, in three patients, the vitamin D3 level reached the lowest normal value.\nIs vitamin D insufficiency or deficiency related to the development of osteochondritis dissecans?",
        "answer": "maybe",
        "answer_rationale": "These first data show that a vitamin D3 deficiency rather than an insufficiency may be involved in the development of OCD lesions. Probably, with a vitamin D3 substitution, the development of an advanced OCD stage could be avoided. Further analyses, including morphological analyses regarding a possible osteomalacia, and examination of the PTH and other determinants of the bone metabolism, should be undertaken to either confirm or refute these data.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The aetiology of osteochondritis dissecans is still unclear. The aim of this prospective pilot study was to analyse whether vitamin D insufficiency, or deficiency, might be a contributing etiological factor in the development of an OCD lesion.\nThe serum level of vitamin D3 in 23 consecutive patients (12 male and 11 female) suffering from a stage III, or stages III and IV, OCD lesion (mostly stage III) admitted for",
        "q2": " surgery was measured.\nThe patients' mean age was 31.3\u00a0years and most of them already exhibited closed epiphyseal plates. In the majority of patients (18/23), a distinct vitamin D3 deficiency was found, two patients were vitamin D3-insufficient and, in three patients, the vitamin D3 level reached the lowest normal value.\nIs vitamin D insufficiency or deficiency related to the development of osteochondritis dissecans?",
        "generated_text": "arthroscopic treatment was measured. The mean age was 15.5 years (range 11-21 years). The control group consisted of 23 age- and sex-matched healthy volunteers. The serum level of vitamin D3 was measured by radioimmunoassay.\nThe mean vitamin D3 level in the OCD group was 19.1 ng/ml (range 7-32 ng/ml). The mean vitamin",
        "levenshtein_distance": 303
    },
    {
        "realidx": "25394614",
        "question": "To compare two treatment strategies in preterm infants with or at risk of respiratory distress syndrome: early surfactant administration (within one hour of birth) versus late surfactant administration, in a geographically defined population.\nThe primary outcome was chronic lung disease (CLD) and mortality before/at 36 weeks. Secondary outcomes included: duration of mechanical ventilation and continuous positive airway pressure (CPAP), post-natal steroids for CLD and major neonatal morbidities.\nPremature infants born at 22-32 weeks' gestation between January 2006 and December 2009.\nTen neonatal intensive care units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.\nRetrospective analysis of prospectively collected data from the regional NICU database in NSW and ACT.\nOf the 2170 infants who received surfactant, 1182 (54.5%) and 988 (45.5%) received early and late surfactant, respectively. The early surfactant group was less mature (27.1\u2009\u00b1\u20092.1 versus 29.4\u2009\u00b1\u20092.1 weeks) and had more CLD and mortality (40.2% versus 20.0%). The multivariable analysis showed early surfactant to be associated with less duration of ventilation, longer duration of CPAP and longer hospital stay but had little or no impact on CLD/mortality.\nDoes timing of initial surfactant treatment make a difference in rates of chronic lung disease or mortality in premature infants?",
        "answer": "maybe",
        "answer_rationale": "Early surfactant administration is associated with shorter duration of ventilation but does not appear to be significantly protective against CLD/mortality among premature infants. This may support the growing evidence for consideration of CPAP as an alternative to routine intubation and early surfactant administration. Further investigation from large randomized clinical trials is warranted to confirm these results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To compare two treatment strategies in preterm infants with or at risk of respiratory distress syndrome: early surfactant administration (within one hour of birth) versus late surfactant administration, in a geographically defined population.\nThe primary outcome was chronic lung disease (CLD) and mortality before/at 36 weeks. Secondary outcomes included: duration of mechanical ventilation and continuous positive airway pressure (CPAP), post-natal steroids for CLD and major neonatal morbidities.\nPremature infants born at 22-32 weeks' gestation between January 2006 and December 2009.\nTen neonatal intensive care units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.\nRetrospective analysis of prospectively collected data from the regional NICU",
        "q2": " database in NSW and ACT.\nOf the 2170 infants who received surfactant, 1182 (54.5%) and 988 (45.5%) received early and late surfactant, respectively. The early surfactant group was less mature (27.1\u2009\u00b1\u20092.1 versus 29.4\u2009\u00b1\u20092.1 weeks) and had more CLD and mortality (40.2% versus 20.0%). The multivariable analysis showed early surfactant to be associated with less duration of ventilation, longer duration of CPAP and longer hospital stay but had little or no impact on CLD/mortality.\nDoes timing of initial surfactant treatment make a difference in rates of chronic lung disease or mortality in premature infants?",
        "generated_text": "database.\nOf 2,114 infants, 1,414 (67%) received early surfactant and 700 (33%) received late surfactant. Infants in the early surfactant group had lower gestational age (27.4 vs. 28.1 weeks, p < 0.001), lower birth weight (934 vs. 1,021 g, p < 0.001), higher proportion of male infants (54% vs. 49%, p = 0.002), higher proportion of multiple births (34% vs. 27%, p < 0.001), higher proportion of antenatal",
        "levenshtein_distance": 414
    },
    {
        "realidx": "25475395",
        "question": "For women, the correlation between circulating androgens and sexual desire is inconclusive. Substitution with androgens at physiological levels improves sexual function in women who experience decreased sexual desire and androgen deficiency from surgical menopause, pituitary disease, and age-related decline in androgen production in the ovaries. Measuring bioactive testosterone is difficult and new methods have been proposed, including measuring the primary androgen metabolite androsterone glucuronide (ADT-G).AIM: The aim of this study was to investigate a possible correlation between serum levels of androgens and sexual desire in women and whether the level of ADT-G is better correlated than the level of circulating androgens with sexual desire.\nThis was a cross-sectional study including 560 healthy women aged 19-65 years divided into three age groups. Correlations were considered to be statistically significant at P<0.05.\nSexual desire was determined as the total score of the sexual desire domain of the Female Sexual Function Index. Total testosterone (TT), calculated free testosterone (FT), androstenedione, dehydroepiandrosterone sulfate (DHEAS), and ADT-G were analyzed using mass spectrometry.\nSexual desire correlated overall with FT and androstenedione in the total cohort of women. In a subgroup of women aged 25-44 years with no use of systemic hormonal contraception, sexual desire correlated with TT, FT, androstenedione, and DHEAS. In women aged 45-65 years, androstenedione correlated with sexual desire. No correlations between ADT-G and sexual desire were identified.\nIs there a correlation between androgens and sexual desire in women?",
        "answer": "yes",
        "answer_rationale": "In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "For women, the correlation between circulating androgens and sexual desire is inconclusive. Substitution with androgens at physiological levels improves sexual function in women who experience decreased sexual desire and androgen deficiency from surgical menopause, pituitary disease, and age-related decline in androgen production in the ovaries. Measuring bioactive testosterone is difficult and new methods have been proposed, including measuring the primary androgen metabolite androsterone glucuronide (ADT-G).AIM: The aim of this study was to investigate a possible correlation between serum levels of androgens and sexual desire in women and whether the level of ADT-G is better correlated than the level of circulating androgens with sexual desire.\nThis was a cross-sectional study including 560 healthy women aged 19-65 years divided into three age groups. Correlations were considered to be statistically",
        "q2": " significant at P<0.05.\nSexual desire was determined as the total score of the sexual desire domain of the Female Sexual Function Index. Total testosterone (TT), calculated free testosterone (FT), androstenedione, dehydroepiandrosterone sulfate (DHEAS), and ADT-G were analyzed using mass spectrometry.\nSexual desire correlated overall with FT and androstenedione in the total cohort of women. In a subgroup of women aged 25-44 years with no use of systemic hormonal contraception, sexual desire correlated with TT, FT, androstenedione, and DHEAS. In women aged 45-65 years, androstenedione correlated with sexual desire. No correlations between ADT-G and sexual desire were identified.\nIs there a correlation between androgens and sexual desire in women?",
        "generated_text": "significant at p < 0.05.\nThe mean age of the participants was 40.2 years. The mean levels of testosterone, androstenedione, and ADT-G were 0.59 ng/mL, 1.42 ng/mL, and 1.12 ng/mL, respectively. The mean levels of sexual desire were 2.85. There was a significant positive correlation between testosterone and sexual desire (r = 0.23, p < 0.001). There was a significant positive correlation between androstenedione and sexual desire (r = 0.21, p < 0.001). There was a significant positive correlation between ADT-G and sexual desire (r = 0.25, p < 0.0",
        "levenshtein_distance": 497
    },
    {
        "realidx": "25481573",
        "question": "To assess the extent to which the title and font of participant information sheets (PISs) can influence pregnant women's and trainee midwives' perceptions of an antenatal intervention.\nPregnant women (n=35) and trainee midwives (n=36) were randomly presented with one of four PISs where the title and font of the PIS had been manipulated to create four experimental conditions (i.e., Double Fluent; Double Awkward; Fluent Title-Awkward Font; Awkward Title-Fluent Font). After reading the PIS, participants rated their perceptions of the intervention (i.e., Attractiveness, Complexity, Expected Risk, Required Effort) using five-point Likert scales.\nA 4\u00d72 factorial multivariate analysis of variance revealed that pregnant women rated the Double Awkward condition as significantly more complex than the Double Fluent (p=.024) and Awkward Title-Fluent Font (p=.021) conditions.\nProcessing fluency effects: can the content and presentation of participant information sheets influence recruitment and participation for an antenatal intervention?",
        "answer": "yes",
        "answer_rationale": "Font influenced pregnant women's ratings of intervention complexity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To assess the extent to which the title and font of participant information sheets (PISs) can influence pregnant women's and trainee midwives' perceptions of an antenatal intervention.\nPregnant women (n=35) and trainee midwives (n=36) were randomly presented with one of four PISs where the title and font of the PIS had been manipulated to create four experimental conditions (i.e., Double Fluent; Double Awkward; Fluent Title-Awkward Font; Awkward Title-Fluent Font). After reading",
        "q2": " the PIS, participants rated their perceptions of the intervention (i.e., Attractiveness, Complexity, Expected Risk, Required Effort) using five-point Likert scales.\nA 4\u00d72 factorial multivariate analysis of variance revealed that pregnant women rated the Double Awkward condition as significantly more complex than the Double Fluent (p=.024) and Awkward Title-Fluent Font (p=.021) conditions.\nProcessing fluency effects: can the content and presentation of participant information sheets influence recruitment and participation for an antenatal intervention?",
        "generated_text": "the PIS, participants completed a questionnaire assessing their perceptions of the intervention.\nPregnant women and trainee midwives perceived the intervention as more beneficial and less risky when the PIS had a fluent title and font (Double Fluent condition) compared to when the PIS had an awkward title and font (Double Awkward condition). The other two conditions (Fluent Title-Awkward Font; Awkward Title-Fluent Font) did not differ from the Double Awkward condition.\nThe title and font of PISs can",
        "levenshtein_distance": 390
    },
    {
        "realidx": "25488308",
        "question": "The proper angle of miniscrew insertion is important for cortical anchorage, patient safety, and biomechanical control. The purposes of this study are to report the alveolar process thickness and inter-radicular space in the posterior region of the mandible, to assess the impact of different miniscrew insertion angle protocols, and to identify differences between the genders or types of malocclusion.\nIn this retrospective study, 100 individuals were selected for orthodontic treatment at a radiology clinic. Cone-beam computed tomography data were imported into 3-dimensional software. The predictor variable was the location in the mandible and insertion angle. The demographic variables collected included age, gender, and malocclusion (Angle Classes I and II). The primary outcome variables were bone thickness and inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the cement-enamel junction. The bone thicknesses were taken at 45\u00b0, 60\u00b0, and 90\u00b0 in relation to the alveolar ridge, simulating a miniscrew insertion. These factors were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). Sexual dimorphism and malocclusion were evaluated with t tests. To compare the inter-radicular space and the thickness of bone between areas, an analysis of variance for repeated measures was used.\nThe sample was composed of 100 patients with a mean age of 17.4 \u00b1 6.74 years. There were 61 female and 39 male patients and 60 Class I and 40 Class II molar relationships. The inter-radicular space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 to 13.77 mm. The thickness tended to decrease with the increase in insertion angle from 45\u00b0 to 90\u00b0. No significant differences between the genders or types of malocclusion were found.\nCan bone thickness and inter-radicular space affect miniscrew placement in posterior mandibular sites?",
        "answer": "no",
        "answer_rationale": "The results of this study suggest that the safest areas for the placement of miniscrews are between the first and second premolars and between the first and second molars, regardless of the angle of insertion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The proper angle of miniscrew insertion is important for cortical anchorage, patient safety, and biomechanical control. The purposes of this study are to report the alveolar process thickness and inter-radicular space in the posterior region of the mandible, to assess the impact of different miniscrew insertion angle protocols, and to identify differences between the genders or types of malocclusion.\nIn this retrospective study, 100 individuals were selected for orthodontic treatment at a radiology clinic. Cone-beam computed tomography data were imported into 3-dimensional software. The predictor variable was the location in the mandible and insertion angle. The demographic variables collected included age, gender, and malocclusion (Angle Classes I and II). The primary outcome variables were bone thickness and inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the cement-enamel junction. The bone thicknesses were taken at 45\u00b0, 60\u00b0, and 90\u00b0 in relation to the alveolar ridge, sim",
        "q2": "ulating a miniscrew insertion. These factors were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). Sexual dimorphism and malocclusion were evaluated with t tests. To compare the inter-radicular space and the thickness of bone between areas, an analysis of variance for repeated measures was used.\nThe sample was composed of 100 patients with a mean age of 17.4 \u00b1 6.74 years. There were 61 female and 39 male patients and 60 Class I and 40 Class II molar relationships. The inter-radicular space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 to 13.77 mm. The thickness tended to decrease with the increase in insertion angle from 45\u00b0 to 90\u00b0. No significant differences between the genders or types of malocclusion were found.\nCan bone thickness and inter-radicular space affect miniscrew placement in posterior mandibular sites?",
        "generated_text": "ulating the insertion angle of the miniscrew. The data were analyzed using the Kruskal-Wallis test, Mann-Whitney U test, and Spearman correlation test.\nThe mean bone thickness was 2.12 mm at 45\u00b0, 1.97 mm at 60\u00b0, and 1.71 mm at 90\u00b0. The mean inter-radicular space was 4.12 mm. The bone thickness was significantly different between the insertion angles (P < .001). The bone thickness was significantly different between the genders (P < .001). The bone thickness was significantly different between the malocclusions (P < .001). The inter-radicular space was significantly different between the genders (P < .001). The inter-radicular space was significantly different between the malocclusions (P < .001).\nThe bone thickness and inter-radicular space in the posterior region of the mand",
        "levenshtein_distance": 612
    },
    {
        "realidx": "25499207",
        "question": "Current evidence suggests that neck pain is negatively associated with health-related quality of life (HRQoL). However, these studies are cross-sectional and do not inform the association between neck pain and future HRQoL.\nThe purpose of this study was to investigate the association between increasing grades of neck pain severity and HRQoL 6 months later. In addition, this longitudinal study examines the crude association between the course of neck pain and HRQoL.\nThis is a population-based cohort study.\nEleven hundred randomly sampled Saskatchewan adults were included.\nOutcome measures were the mental component summary (MCS) and physical component summary (PCS) of the Short-Form-36 (SF-36) questionnaire.\nWe formed a cohort of 1,100 randomly sampled Saskatchewan adults in September 1995. We used the Chronic Pain Questionnaire to measure neck pain and its related disability. The SF-36 questionnaire was used to measure physical and mental HRQoL 6 months later. Multivariable linear regression was used to measure the association between graded neck pain and HRQoL while controlling for confounding. Analysis of variance and t tests were used to measure the crude association among four possible courses of neck pain and HRQoL at 6 months. The neck pain trajectories over 6 months were no or mild neck pain, improving neck pain, worsening neck pain, and persistent neck pain. Finally, analysis of variance was used to examine changes in baseline to 6-month PCS and MCS scores among the four neck pain trajectory groups.\nThe 6-month follow-up rate was 74.9%. We found an exposure-response relationship between neck pain and physical HRQoL after adjusting for age, education, arthritis, low back pain, and depressive symptomatology. Compared with participants without neck pain at baseline, those with mild (\u03b2=-1.53, 95% confidence interval [CI]=-2.83, -0.24), intense (\u03b2=-3.60, 95% CI=-5.76, -1.44), or disabling (\u03b2=-8.55, 95% CI=-11.68, -5.42) neck pain had worse physical HRQoL 6 months later. We did not find an association between neck pain and mental HRQoL. A worsening course of neck pain and persistent neck pain were associated with worse physical HRQoL.\nIs neck pain associated with worse health-related quality of life 6 months later?",
        "answer": "yes",
        "answer_rationale": "We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Current evidence suggests that neck pain is negatively associated with health-related quality of life (HRQoL). However, these studies are cross-sectional and do not inform the association between neck pain and future HRQoL.\nThe purpose of this study was to investigate the association between increasing grades of neck pain severity and HRQoL 6 months later. In addition, this longitudinal study examines the crude association between the course of neck pain and HRQoL.\nThis is a population-based cohort study.\nEleven hundred randomly sampled Saskatchewan adults were included.\nOutcome measures were the mental component summary (MCS) and physical component summary (PCS) of the Short-Form-36 (SF-36) questionnaire.\nWe formed a cohort of 1,100 randomly sampled Saskatchewan adults in September 1995. We used the Chronic Pain Questionnaire to measure neck pain and its related disability. The SF-36 questionnaire was used to measure physical and mental HRQoL 6 months later. Multivariable linear regression was used to measure the association between graded neck pain and HRQoL while controlling for confounding. Analysis of variance and t tests were used to measure the crude association among four possible courses of neck pain and HRQoL at 6 months.",
        "q2": " The neck pain trajectories over 6 months were no or mild neck pain, improving neck pain, worsening neck pain, and persistent neck pain. Finally, analysis of variance was used to examine changes in baseline to 6-month PCS and MCS scores among the four neck pain trajectory groups.\nThe 6-month follow-up rate was 74.9%. We found an exposure-response relationship between neck pain and physical HRQoL after adjusting for age, education, arthritis, low back pain, and depressive symptomatology. Compared with participants without neck pain at baseline, those with mild (\u03b2=-1.53, 95% confidence interval [CI]=-2.83, -0.24), intense (\u03b2=-3.60, 95% CI=-5.76, -1.44), or disabling (\u03b2=-8.55, 95% CI=-11.68, -5.42) neck pain had worse physical HRQoL 6 months later. We did not find an association between neck pain and mental HRQoL. A worsening course of neck pain and persistent neck pain were associated with worse physical HRQoL.\nIs neck pain associated with worse health-related quality of life 6 months later?",
        "generated_text": "All analyses were adjusted for age and sex.\nThe mean age of the cohort was 45.2 years (SD=15.7), and 54% were women. Neck pain was reported by 42% of the cohort at baseline. The mean PCS and MCS scores were 49.4 (SD=10.1) and 51.1 (SD=9.1), respectively. After controlling for confounding, neck pain was associated with lower PCS (\u03b2=\u22122.1, 95% confidence interval [CI]=\u22123.4 to \u22120.8) and lower MCS (\u03b2=\u22121.5, 95% CI=\u22122.8 to \u22120.2) scores. The crude analysis showed that those who had persistent neck pain had the lowest PCS and MCS scores, whereas those who had no neck pain at baseline and follow-up had the highest PCS and MCS scores.\nThis study suggests that neck pain is associated with lower HRQoL 6 months later. The results also suggest that the course of neck pain is associated with HRQoL. These findings suggest that neck pain is a risk factor for poor HRQ",
        "levenshtein_distance": 740
    },
    {
        "realidx": "25503376",
        "question": "Obstructive sleep apnea (OSA) is tightly linked to increased cardiovascular disease. Surgery is an important method to treat OSA, but its effect on serum lipid levels in OSA patients is unknown. We aimed to evaluate the effect of upper airway surgery on lipid profiles.\nWe performed a retrospective review of 113 adult patients with OSA who underwent surgery (nasal or uvulopalatopharyngoplasty [UPPP]) at a major, urban, academic hospital in Beijing from 2012 to 2013 who had preoperative and postoperative serum lipid profiles.\nSerum TC (4.86\u00b10.74 to 4.69\u00b10.71) and LP(a) (median 18.50 to 10.90) all decreased significantly post-operatively (P<0.01, 0.01, respectively), with no changes in serum HDL, LDL, or TG (P>0.05, all). For UPPP patients (n=51), serum TC, HDL and LP(a) improved (P=0.01, 0.01,<0.01, respectively). For nasal patients (n=62), only the serum LP(a) decreased (P<0.01). In patients with normal serum lipids at baseline, only serum LP(a) decreased (P<0.01). In contrast, in patients with isolated hypertriglyceridemia, the serum HDL, TG and LP(a) showed significant improvements (P=0.02, 0.03,<0.01, respectively). In patients with isolated hypercholesterolemia, the serum LP(a) decreased significantly (P=0.01), with a similar trend for serum TC (P=0.06). In patients with mixed hyperlipidemia, the serum TC and LDL also decreased (P=0.02, 0.03, respectively).\nDoes airway surgery lower serum lipid levels in obstructive sleep apnea patients?",
        "answer": "yes",
        "answer_rationale": "Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Obstructive sleep apnea (OSA) is tightly linked to increased cardiovascular disease. Surgery is an important method to treat OSA, but its effect on serum lipid levels in OSA patients is unknown. We aimed to evaluate the effect of upper airway surgery on lipid profiles.\nWe performed a retrospective review of 113 adult patients with OSA who underwent surgery (nasal or uvulopalatopharyngoplasty [UPPP]) at a major, urban, academic hospital in Beijing from 2012 to 2013 who had preoperative and postoperative serum lipid profiles.\nSerum TC (4.86\u00b10.74 to 4.69\u00b10.71) and LP(a) (median 18.50 to 10.90) all decreased significantly post-operatively (P<0.01, 0.01, respectively), with no changes in serum HDL, LDL, or TG (P>0.05, all). For UPPP patients (n=51",
        "q2": "), serum TC, HDL and LP(a) improved (P=0.01, 0.01,<0.01, respectively). For nasal patients (n=62), only the serum LP(a) decreased (P<0.01). In patients with normal serum lipids at baseline, only serum LP(a) decreased (P<0.01). In contrast, in patients with isolated hypertriglyceridemia, the serum HDL, TG and LP(a) showed significant improvements (P=0.02, 0.03,<0.01, respectively). In patients with isolated hypercholesterolemia, the serum LP(a) decreased significantly (P=0.01), with a similar trend for serum TC (P=0.06). In patients with mixed hyperlipidemia, the serum TC and LDL also decreased (P=0.02, 0.03, respectively).\nDoes airway surgery lower serum lipid levels in obstructive sleep apnea patients?",
        "generated_text": "), serum TC (4.91\u00b10.74 to 4.72\u00b10.71) and LP(a) (median 18.50 to 10.90) decreased significantly (P=0.01, 0.01, respectively), with no changes in serum HDL, LDL, or TG (P>0.05, all). For nasal surgery patients (n=62), serum TC (4.82\u00b10.74 to 4.67\u00b10.71) decreased significantly (P=0.01), with no changes in serum HDL, LDL, TG, or LP(a) (P>0.05, all). In UPPP patients, serum TC and LP(a) decreased significantly in patients with severe OSA (AHI\u226530) (P=0.01, 0.01, respectively), but not",
        "levenshtein_distance": 491
    },
    {
        "realidx": "25521278",
        "question": "Identifying eating behaviors which contribute to excess weight gain will inform obesity prevention strategies. A tendency to clear one's plate when eating may be a risk factor for obesity in an environment where food is plentiful. Whether plate clearing is associated with increased body weight in a cohort of US participants was examined.\nNine hundred and ninety-three US adults (60% male, 80% American European, mean age=31 years) completed self-report measures of habitual plate clearing together with behavioral and demographic characteristics known to be associated with obesity.\nPlate clearing tendencies were positively associated with BMI and remained so after accounting for a large number of other demographic and behavioral predictors of BMI in analyses (\u03b2=0.18, 95% CIs=0.07, 0.29, P<0.001); an increased tendency to plate clear was associated with a significantly higher body weight.\nIs plate clearing a risk factor for obesity?",
        "answer": "yes",
        "answer_rationale": "The tendency to clear one's plate when eating is associated with increased body weight and may constitute a risk factor for weight gain.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Identifying eating behaviors which contribute to excess weight gain will inform obesity prevention strategies. A tendency to clear one's plate when eating may be a risk factor for obesity in an environment where food is plentiful. Whether plate clearing is associated with increased body weight in a cohort of US participants was examined.\nNine hundred and ninety-three US adults (60% male, 80% American European, mean age=31 years) completed self-report measures of habitual plate clearing together",
        "q2": " with behavioral and demographic characteristics known to be associated with obesity.\nPlate clearing tendencies were positively associated with BMI and remained so after accounting for a large number of other demographic and behavioral predictors of BMI in analyses (\u03b2=0.18, 95% CIs=0.07, 0.29, P<0.001); an increased tendency to plate clear was associated with a significantly higher body weight.\nIs plate clearing a risk factor for obesity?",
        "generated_text": "with measures of height and weight. Participants were categorized into four groups based on their plate clearing frequency (never, sometimes, often, always). The association between plate clearing frequency and BMI was examined using linear regression, adjusting for age, sex, and ethnicity.\nParticipants who reported always clearing their plate had higher BMI (mean=27.7 kg/m2) compared to those who never cleared their plate (mean=24.7 kg/m2).",
        "levenshtein_distance": 349
    },
    {
        "realidx": "25571931",
        "question": "Among patients with acute stroke symptoms, delay in hospital admission is the main obstacle for the use of thrombolytic therapy and other interventions associated with decreased mortality and disability. The primary aim of this study was to assess whether an elderly clinical population correctly endorsed the response to call for emergency services when presented with signs and symptoms of stroke using a standardized questionnaire.\nWe performed a cross-sectional study among elderly out-patients (\u226560 years) in Buenos Aires, Argentina randomly recruited from a government funded health clinic. The correct endorsement of intention to call 911 was assessed with the Stroke Action Test and the cut-off point was set at \u226575%. Knowledge of stroke and clinical and socio-demographic indicators were also collected and evaluated as predictors of correct endorsement using logistic regression.\nAmong 367 elderly adults, 14% correctly endorsed intention to call 911. Presented with the most typical signs and symptoms, only 65% reported that they would call an ambulance. Amaurosis Fugax was the symptom for which was called the least (15%). On average, the correct response was chosen only 37% of the time. Compared to lower levels of education, higher levels were associated to correctly endorsed intention to call 911 (secondary School adjusted OR 3.53, 95% CI 1.59-7.86 and Tertiary/University adjusted OR 3.04, 95% CI 1.12-8.21).\nDo elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke?",
        "answer": "maybe",
        "answer_rationale": "These results suggest the need to provide interventions that are specifically designed to increase awareness of potential stroke signs and symptoms and appropriate subsequent clinical actions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Among patients with acute stroke symptoms, delay in hospital admission is the main obstacle for the use of thrombolytic therapy and other interventions associated with decreased mortality and disability. The primary aim of this study was to assess whether an elderly clinical population correctly endorsed the response to call for emergency services when presented with signs and symptoms of stroke using a standardized questionnaire.\nWe performed a cross-sectional study among elderly out-patients (\u226560 years) in Buenos Aires, Argentina randomly recruited from a government funded health clinic. The correct endorsement of intention to call 911 was assessed with the Stroke Action Test and the cut-off point was set at \u226575%. Knowledge of stroke and clinical and socio-demographic indicators were also collected and evaluated as predictors of correct endorsement using logistic regression.\nAmong ",
        "q2": "367 elderly adults, 14% correctly endorsed intention to call 911. Presented with the most typical signs and symptoms, only 65% reported that they would call an ambulance. Amaurosis Fugax was the symptom for which was called the least (15%). On average, the correct response was chosen only 37% of the time. Compared to lower levels of education, higher levels were associated to correctly endorsed intention to call 911 (secondary School adjusted OR 3.53, 95% CI 1.59-7.86 and Tertiary/University adjusted OR 3.04, 95% CI 1.12-8.21).\nDo elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke?",
        "generated_text": "100 participants, 52% were female, mean age was 69.5 years (SD 6.5), 40% had hypertension, 20% diabetes, 15% hypercholesterolemia and 10% had a previous stroke. The mean score of the Stroke Action Test was 67.5% (SD 17.5). Only 38% of the participants correctly endorsed the intention to call 911 in all stroke scenarios. In the multivariate analysis, higher education (OR 1.12; 95% CI 1.01-1.24; p=0.03) and higher knowledge of stroke (",
        "levenshtein_distance": 436
    },
    {
        "realidx": "25588461",
        "question": "Disorders of consciousness (DOC) diagnosis relies on the presence or absence of purposeful motor responsiveness, which characterizes the minimally conscious state (MCS) and the unresponsive wakefulness syndrome (UWS), respectively. Functional neuroimaging studies have raised the question of possible residual conscious awareness also in clinically-defined UWS patients. The aim of our study was to identify electrophysiological parameters, by means of a transcranial magnetic stimulation approach, which might potentially express the presence of residual networks sustaining fragmentary behavioral patterns, even when no conscious behavior can be observed.\nWe enrolled 25 severe DOC patients, following post-anoxic or traumatic brain injury and 20 healthy individuals (HC) as control group. Baseline electrophysiological evaluation evidenced, in comparison to HC, a partial preservation of cortical effective connectivity and excitability in clinically defined MCS, whereas these components were absent in clinically defined UWS. Then, we applied an anodal transcranial direct current stimulation (a-tDCS) protocol over the orbitofrontal cortex.\na-tDCS was able to boost cortical connectivity and excitability in all HC, MCS, and to unmask such excitability/connectivity in some UWS patients.\nCan transcranial direct current stimulation be useful in differentiating unresponsive wakefulness syndrome from minimally conscious state patients?",
        "answer": "yes",
        "answer_rationale": "a-tDCS could be useful in identifying residual connectivity markers in clinically-defined UWS, who may lack of purposeful behavior as a result of a motor-output failure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Disorders of consciousness (DOC) diagnosis relies on the presence or absence of purposeful motor responsiveness, which characterizes the minimally conscious state (MCS) and the unresponsive wakefulness syndrome (UWS), respectively. Functional neuroimaging studies have raised the question of possible residual conscious awareness also in clinically-defined UWS patients. The aim of our study was to identify electrophysiological parameters, by means of a transcranial magnetic stimulation approach, which might potentially express the presence of residual networks sustaining fragmentary behavioral patterns, even when no conscious behavior can be observed.\nWe enrolled 25 severe DOC patients, following post-anoxic or traumatic brain injury and 20 healthy",
        "q2": " individuals (HC) as control group. Baseline electrophysiological evaluation evidenced, in comparison to HC, a partial preservation of cortical effective connectivity and excitability in clinically defined MCS, whereas these components were absent in clinically defined UWS. Then, we applied an anodal transcranial direct current stimulation (a-tDCS) protocol over the orbitofrontal cortex.\na-tDCS was able to boost cortical connectivity and excitability in all HC, MCS, and to unmask such excitability/connectivity in some UWS patients.\nCan transcranial direct current stimulation be useful in differentiating unresponsive wakefulness syndrome from minimally conscious state patients?",
        "generated_text": "controls. All patients underwent a standardized neurobehavioral assessment, according to the Coma Recovery Scale-Revised (CRS-R). We applied a paired-pulse transcranial magnetic stimulation protocol, consisting of a conditioning stimulus over the contralateral motor cortex and a test stimulus over the primary motor cortex, to assess cortico-cortical inhibition (CCI). We recorded motor evoked potentials (MEPs) from the contralateral first dorsal interosseus muscle.\nWe found that the CCI index was significantly higher in UWS patients compared to MCS patients and healthy controls. Moreover, the CCI index was inversely correlated with the CRS-R total score in",
        "levenshtein_distance": 546
    },
    {
        "realidx": "25604390",
        "question": "Dickkopf-3 (DKK3) may act as a tumor suppressor as it is down-regulated in various types of cancer. This study assessed the DKK3 protein expression in gastric cancer and its potential value as a prognostic marker.\nDKK3 expression was evaluated by immunohistochemistry in 158 gastric cancer samples from patients who underwent gastrectomy from 2002 to 2008. Clinicopathological parameters and survival data were analyzed.\nLoss of DKK3 expression was found in 64 of 158 (40.5%) samples, and it was associated with advanced T stage (p<0.001), lymph node metastasis (p<0.001), UICC TNM stage (p<0.001), tumor location (p = 0.029), lymphovascular invasion (p = 0.035), and perineural invasion (p = 0.032). Patients without DKK3 expression in tumor cells had a significantly worse disease-free and overall survival than those with DKK3 expression (p<0.001, and p = 0.001, respectively). TNM stage (p = 0.028 and p<0.001, respectively) and residual tumor (p<0.001 and p = 0.003, respectively) were independent predictors of disease-free and overall survival. Based on the preoperative clinical stage assessed by computed tomography (CT), loss of DKK3 expression was predominantly associated with worse prognosis in patients with clinically node-negative advanced gastric cancer (AGC). The combination of DKK3 expression status and CT increased the accuracy of CT staging for predicting lymph node involvement from 71.5 to 80.0% in AGC patients.\nAberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node metastasis preoperatively?",
        "answer": "yes",
        "answer_rationale": "Loss of DKK3 protein expression was significantly associated with poor survival in patients with gastric cancer and was strongly correlated with the TNM stage. DKK3 might be a potential biomarker of lymph node involvement that can improve the predictive power of CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Dickkopf-3 (DKK3) may act as a tumor suppressor as it is down-regulated in various types of cancer. This study assessed the DKK3 protein expression in gastric cancer and its potential value as a prognostic marker.\nDKK3 expression was evaluated by immunohistochemistry in 158 gastric cancer samples from patients who underwent gastrectomy from 2002 to 2008. Clinicopathological parameters and survival data were analyzed.\nLoss of DKK3 expression was found in 64 of 158 (40.5%) samples, and it was associated with advanced T stage (p<0.001), lymph node metastasis (p<0.001), UICC TNM stage (p<0.001), tumor location (p = 0.029), lymphovascular invasion (p = 0.035), and perineural invasion (p = 0.032). Patients",
        "q2": " without DKK3 expression in tumor cells had a significantly worse disease-free and overall survival than those with DKK3 expression (p<0.001, and p = 0.001, respectively). TNM stage (p = 0.028 and p<0.001, respectively) and residual tumor (p<0.001 and p = 0.003, respectively) were independent predictors of disease-free and overall survival. Based on the preoperative clinical stage assessed by computed tomography (CT), loss of DKK3 expression was predominantly associated with worse prognosis in patients with clinically node-negative advanced gastric cancer (AGC). The combination of DKK3 expression status and CT increased the accuracy of CT staging for predicting lymph node involvement from 71.5 to 80.0% in AGC patients.\nAberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node metastasis preoperatively?",
        "generated_text": "with DKK3 loss had a significantly shorter overall survival (p = 0.001) and disease-free survival (p = 0.001). Multivariate analysis revealed that DKK3 loss was an independent prognostic factor for overall survival (p = 0.001) and disease-free survival (p = 0.001).\nDKK3 loss is associated with aggressive clinicopathological features and poor prognosis in gastric cancer, suggesting its potential as a prognostic marker.",
        "levenshtein_distance": 574
    },
    {
        "realidx": "25614468",
        "question": "The aim of this study was to prospectively compare the diagnostic performance of magnetic resonance imaging (MRI), multidetector computed tomography (MDCT) and endoscopic ultrasonography (EUS) in the preoperative locoregional staging of gastric cancer.\nThis study had Institutional Review Board approval, and informed consent was obtained from all patients. Fifty-two patients with biopsy-proven gastric cancer underwent preoperative 1.5-T MRI, 64-channel MDCT and EUS. All images were analysed blind, and the results were compared with histopathological findings according to the seventh edition of the TNM classification. After the population had been divided on the basis of the local invasion (T1-3 vs T4a-b) and nodal involvement (N0 vs N+), sensitivity, specificity, positive and negative predictive value, and accuracy were calculated and diagnostic performance measures were assessed using the McNemar test.\nFor T staging, EUS showed higher sensitivity (94%) than MDCT and MRI (65 and 76%; p = 0.02 and p = 0.08). MDCT and MRI had significantly higher specificity (91 and 89%) than EUS (60%) (p = 0.0009 and p = 0.003). Adding MRI to MDCT or EUS did not result in significant differences for sensitivity. For N staging, EUS showed higher sensitivity (92%) than MRI and MDCT (69 and 73%; p = 0.01 and p = 0.02). MDCT showed better specificity (81%) than EUS and MRI (58 and 73%; p = 0.03 and p = 0.15).\nPreoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging?",
        "answer": "no",
        "answer_rationale": "Our prospective study confirmed the leading role of EUS and MDCT in the staging of gastric cancer and did not prove, at present, the value of the clinical use of MRI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The aim of this study was to prospectively compare the diagnostic performance of magnetic resonance imaging (MRI), multidetector computed tomography (MDCT) and endoscopic ultrasonography (EUS) in the preoperative locoregional staging of gastric cancer.\nThis study had Institutional Review Board approval, and informed consent was obtained from all patients. Fifty-two patients with biopsy-proven gastric cancer underwent preoperative 1.5-T MRI, 64-channel MDCT and EUS. All images were analysed blind, and the results were compared with histopathological findings according to the seventh edition of the TNM classification. After the population had been divided on the basis of the local invasion (T1-3 vs T4a-b) and nodal involvement (N0 vs N+), sensitivity, specificity, positive and negative predictive value, and accuracy were calculated and diagnostic performance measures were assessed using the McNem",
        "q2": "ar test.\nFor T staging, EUS showed higher sensitivity (94%) than MDCT and MRI (65 and 76%; p = 0.02 and p = 0.08). MDCT and MRI had significantly higher specificity (91 and 89%) than EUS (60%) (p = 0.0009 and p = 0.003). Adding MRI to MDCT or EUS did not result in significant differences for sensitivity. For N staging, EUS showed higher sensitivity (92%) than MRI and MDCT (69 and 73%; p = 0.01 and p = 0.02). MDCT showed better specificity (81%) than EUS and MRI (58 and 73%; p = 0.03 and p = 0.15).\nPreoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging?",
        "generated_text": "ar test.\nIn the T staging, MRI had higher sensitivity (83.3% vs 66.7%, P=0.047) and accuracy (84.6% vs 71.2%, P=0.049) than MDCT, and higher sensitivity (83.3% vs 50.0%, P=0.006) and accuracy (84.6% vs 67.3%, P=0.011) than EUS. In the N staging, MRI had higher sensitivity (88.9% vs 77.8%, P=0.035) and accuracy (86.5% vs 76.9%, P=0.032) than MDCT, and higher sensitivity (88.9% vs 66.",
        "levenshtein_distance": 422
    },
    {
        "realidx": "25669733",
        "question": "To test the predictive value of distal ureteral diameter (UD) on reflux resolution after endoscopic injection in children with primary vesicoureteral reflux (VUR).\nThis was a retrospective review of patients diagnosed with primary VUR between 2009 and 2012 who were managed by endoscopic injection. Seventy preoperative and postoperative voiding cystourethrograms were reviewed. The largest UD within the false pelvis was measured. The UD was divided by the L1-L3 vertebral body distance to get the UD ratio (UDR). One radiologist interpreted the findings of voiding cystourethrography in all patients. Clinical outcome was defined as reflux resolution.\nSeventy patients were enrolled in this series (17 boys and 53 girls). Mean age was 5.9 years (1.2-13 years). Grade III presented in 37 patients (53%), and 33 patients (47%) were of grade IV. Mean distal UD was 5.5\u00a0mm (2.5-13\u00a0mm). Mean UDR was 37.8% (18%-70%). Macroplastique injection was performed in all. Subureteric injection was performed in 60 patients (86%), whereas intraureteric injection was performed in 10 patients. No postoperative complications were detected. The effect of grade, UD, and UDR on success after endoscopic injection was tested. UD and UDR were significant predictors of reflux resolution on logistic regression analysis (P\u00a0<.007 and .001, respectively).\nCan distal ureteral diameter predict reflux resolution after endoscopic injection?",
        "answer": "yes",
        "answer_rationale": "UDR provides an objective measurement of VUR and appears as a predictive tool of success after endoscopic injection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To test the predictive value of distal ureteral diameter (UD) on reflux resolution after endoscopic injection in children with primary vesicoureteral reflux (VUR).\nThis was a retrospective review of patients diagnosed with primary VUR between 2009 and 2012 who were managed by endoscopic injection. Seventy preoperative and postoperative voiding cystourethrograms were reviewed. The largest UD within the false pelvis was measured. The UD was divided by the L1-L3 vertebral body distance to get the UD ratio (UDR). One radiologist interpreted the findings of voiding cystourethrography in all patients. Clinical outcome was defined as reflux resolution.\nSeventy patients were enrolled in this series (17 boys and 53 girls). Mean age was 5.9 years",
        "q2": " (1.2-13 years). Grade III presented in 37 patients (53%), and 33 patients (47%) were of grade IV. Mean distal UD was 5.5\u00a0mm (2.5-13\u00a0mm). Mean UDR was 37.8% (18%-70%). Macroplastique injection was performed in all. Subureteric injection was performed in 60 patients (86%), whereas intraureteric injection was performed in 10 patients. No postoperative complications were detected. The effect of grade, UD, and UDR on success after endoscopic injection was tested. UD and UDR were significant predictors of reflux resolution on logistic regression analysis (P\u00a0<.007 and .001, respectively).\nCan distal ureteral diameter predict reflux resolution after endoscopic injection?",
        "generated_text": "(range, 1-14 years). The mean UD was 1.1 cm (range, 0.4-2.1 cm). The mean UDR was 0.13 (range, 0.04-0.24). The mean follow-up was 24 months (range, 12-48 months). The mean number of voiding cystourethrograms per patient was 2.5 (range, 1-5). Reflux resolution was achieved in 50 patients (71.4%). The mean UD in the resolution group was 1.2 cm (range, 0.4-2.1 cm) and 0.9 cm (range, 0.5-1.5 cm) in the",
        "levenshtein_distance": 502
    },
    {
        "realidx": "25675614",
        "question": "Diabetes mellitus (DM) is undiagnosed in approximately half of the patients actually suffering from the disease. In addition, the prevalence of DM is more than twice as high as in patients with periodontitis when compared to periodontally healthy subjects. Thus, a high number of patients with periodontitis may have undiagnosed DM. The purpose of the present study was to evaluate whether blood oozing from a gingival crevice during routine periodontal examination can be used for determining glucose levels.\nObservational cross-sectional studies were carried out in 75 patients (43 males and 32 females) with chronic periodontitis who were divided into two groups: Group I and Group II, respectively. Blood oozing from the gingival crevices of anterior teeth following periodontal probing was collected with the stick of glucose self-monitoring device, and the blood glucose levels were measured. At the same time, finger-prick blood was taken for glucometric analysis and subsequent readings were recorded.\nThe patient's blood glucose values ranged from 74 to 256 mg/dl. The comparison between gingival crevicular blood and finger-prick blood showed a very strong correlation, with a t value of 3.97 (at P value = 0.001).\nCan gingival crevicular blood be relied upon for assessment of blood glucose level?",
        "answer": "yes",
        "answer_rationale": "The data from this study has shown that GCB collected during diagnostic periodontal examination can be an excellent source of blood for glucometric analysis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Diabetes mellitus (DM) is undiagnosed in approximately half of the patients actually suffering from the disease. In addition, the prevalence of DM is more than twice as high as in patients with periodontitis when compared to periodontally healthy subjects. Thus, a high number of patients with periodontitis may have undiagnosed DM. The purpose of the present study was to evaluate whether blood oozing from a gingival crevice during routine periodontal examination can be used for determining glucose levels.\nObservational cross-sectional studies were carried out in 75 patients (43 males and 32 females) with chronic periodontitis who were divided into two groups: Group I and",
        "q2": " Group II, respectively. Blood oozing from the gingival crevices of anterior teeth following periodontal probing was collected with the stick of glucose self-monitoring device, and the blood glucose levels were measured. At the same time, finger-prick blood was taken for glucometric analysis and subsequent readings were recorded.\nThe patient's blood glucose values ranged from 74 to 256 mg/dl. The comparison between gingival crevicular blood and finger-prick blood showed a very strong correlation, with a t value of 3.97 (at P value = 0.001).\nCan gingival crevicular blood be relied upon for assessment of blood glucose level?",
        "generated_text": "Group II. Group I consisted of 38 patients with periodontitis and known DM, and Group II consisted of 37 patients with periodontitis and no history of DM. Blood was collected from the gingival crevice of the deepest pocket in each quadrant and was used to measure the blood glucose level using a glucometer. The results were compared with the blood glucose levels obtained from the finger prick method.\nThe mean blood glucose level in Group I was 162.13 \u00b1 51.12 mg/dl, and in Group II, it was 101.08 \u00b1 17.12 mg/dl",
        "levenshtein_distance": 451
    },
    {
        "realidx": "25699562",
        "question": "Our previous work demonstrated that the Transmissible Liability Index (TLI), an instrument designed as an index of liability for substance use disorder (SUD), is associated with risk of substance use disorder. This longitudinal study assessed whether TLI measured in 10-12-year-olds (late childhood) predicts suicidal behavior from age 12-14 (preadolescence) to age 25 (young adulthood). We hypothesized that TLI would predict number and severity of suicide attempts.\nSubjects were sons of men who had lifetime history of SUD (n\u2009=\u2009250), called the High Average Risk (HAR) group, and sons of men with no lifetime history of a SUD (n\u2009=\u2009250), called the Low Average Risk (LAR) group. The TLI was delineated at baseline (age 10-12), and age-specific versions were administered at 12-14, 16, 19, 22, and 25 years of age.\nTLI was significantly associated with number and severity of lifetime suicide attempts.\nDoes the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?",
        "answer": "yes",
        "answer_rationale": "These findings confirm the hypothesis that TLI assessed at late childhood is a predictor of frequency and severity of suicidal behavior from preadolescence to young adulthood.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Our previous work demonstrated that the Transmissible Liability Index (TLI), an instrument designed as an index of liability for substance use disorder (SUD), is associated with risk of substance use disorder. This longitudinal study assessed whether TLI measured in 10-12-year-olds (late childhood) predicts suicidal behavior from age 12-14 (preadolescence) to age 25 (young adulthood). We hypothesized that TLI would predict number and severity of suicide attempts.\nSubjects were sons of men who had lifetime history of SUD (n\u2009=\u2009250), called the",
        "q2": " High Average Risk (HAR) group, and sons of men with no lifetime history of a SUD (n\u2009=\u2009250), called the Low Average Risk (LAR) group. The TLI was delineated at baseline (age 10-12), and age-specific versions were administered at 12-14, 16, 19, 22, and 25 years of age.\nTLI was significantly associated with number and severity of lifetime suicide attempts.\nDoes the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?",
        "generated_text": "high-risk group, and sons of men with no history of SUD (n\u2009=\u2009150), called the low-risk group. TLI was measured at age 10-12, and suicidal behavior was assessed at ages 12-14, 15-17, 18-20, and 21-25. We used negative binomial regression to model the number of suicide attempts and ordinal logistic regression to model the severity of the most severe attempt.\nTLI was significantly associated with number of suicide attempts",
        "levenshtein_distance": 287
    },
    {
        "realidx": "25725704",
        "question": "Clinical supervision is widely recognised as a mechanism for providing professional support, professional development and clinical governance for healthcare workers. There have been limited studies about the effectiveness of clinical supervision for allied health and minimal studies conducted within the Australian health context. The aim of the present study was to identify whether clinical supervision was perceived to be effective by allied health professionals and to identify components that contributed to effectiveness. Participants completed an anonymous online questionnaire, administered through the health service's intranet.\nA cross-sectional study was conducted with community allied health workers (n = 82) 8 months after implementation of structured clinical supervision. Demographic data (age, gender), work-related history (profession employment level, years of experience), and supervision practice (number and length of supervision sessions) were collected through an online survey. The outcome measure, clinical supervision effectiveness, was operationalised using the Manchester Clinical Supervision Scale-26 (MCSS-26). Data were analysed with Pearson correlation (r) and independent sample t-tests (t) with significance set at 0.05 (ie the probability of significant difference set at P<0.05).\nThe length of the supervision sessions (r(s) \u2265 0.44), the number of sessions (r(s) \u2265 0.35) and the total period supervision had been received (r(s) \u2265 0.42) were all significantly positively correlated with the MCSS-26 domains of clinical supervision effectiveness. Three individual variables, namely 'receiving clinical supervision', 'having some choice in the allocation of clinical supervisor' and 'having a completed clinical supervision agreement', were also significantly associated with higher total MCSS-26 scores (P(s)<0.014).\nCan clinical supervision sustain our workforce in the current healthcare landscape?",
        "answer": "yes",
        "answer_rationale": "The results of the study demonstrate that when clinical supervision uses best practice principles, it can provide professional support for allied health workers, even during times of rapid organisational change.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Clinical supervision is widely recognised as a mechanism for providing professional support, professional development and clinical governance for healthcare workers. There have been limited studies about the effectiveness of clinical supervision for allied health and minimal studies conducted within the Australian health context. The aim of the present study was to identify whether clinical supervision was perceived to be effective by allied health professionals and to identify components that contributed to effectiveness. Participants completed an anonymous online questionnaire, administered through the health service's intranet.\nA cross-sectional study was conducted with community allied health workers (n = 82) 8 months after implementation of structured clinical supervision. Demographic data (age, gender), work-related history (profession employment level, years of experience), and supervision practice (number and length of supervision sessions) were collected through an online survey. The outcome measure, clinical supervision effectiveness, was operationalised using the Manchester Clinical Supervision Scale",
        "q2": "-26 (MCSS-26). Data were analysed with Pearson correlation (r) and independent sample t-tests (t) with significance set at 0.05 (ie the probability of significant difference set at P<0.05).\nThe length of the supervision sessions (r(s) \u2265 0.44), the number of sessions (r(s) \u2265 0.35) and the total period supervision had been received (r(s) \u2265 0.42) were all significantly positively correlated with the MCSS-26 domains of clinical supervision effectiveness. Three individual variables, namely 'receiving clinical supervision', 'having some choice in the allocation of clinical supervisor' and 'having a completed clinical supervision agreement', were also significantly associated with higher total MCSS-26 scores (P(s)<0.014).\nCan clinical supervision sustain our workforce in the current healthcare landscape?",
        "generated_text": "(MCSS). The MCSS is a 20-item scale that measures the effectiveness of clinical supervision in terms of the supervisor's role, the supervisee's role and the supervisory relationship. The MCSS has been validated in the United Kingdom and has been used in other countries, including Australia. The MCSS was chosen for this study because it is a well-established and validated tool for measuring clinical supervision effectiveness. The MCSS has good psychometric properties, including high internal consistency and test-retest reliability. The MCSS has also been used in a variety of healthcare settings, including allied health, making it a suitable measure for this study. The MCSS was administered online, and participants were asked to rate their agreement with each item on a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The total",
        "levenshtein_distance": 665
    },
    {
        "realidx": "25752725",
        "question": "Schizophrenia patients are typically found to have low IQ both pre- and post-onset, in comparison to the general population. However, a subgroup of patients displays above average IQ pre-onset. The nature of these patients' illness and its relationship to typical schizophrenia is not well understood. The current study sought to investigate the symptom profile of high-IQ schizophrenia patients.\nWe identified 29 schizophrenia patients of exceptionally high pre-morbid intelligence (mean estimated pre-morbid intelligence quotient (IQ) of 120), of whom around half also showed minimal decline (less than 10 IQ points) from their estimated pre-morbid IQ. We compared their symptom scores (SAPS, SANS, OPCRIT, MADRS, GAF, SAI-E) with a comparison group of schizophrenia patients of typical IQ using multinomial logistic regression.\nThe patients with very high pre-morbid IQ had significantly lower scores on negative and disorganised symptoms than typical patients (RRR=0.019; 95% CI=0.001, 0.675, P=0.030), and showed better global functioning and insight (RRR=1.082; 95% CI=1.020, 1.148; P=0.009). Those with a minimal post-onset IQ decline also showed higher levels of manic symptoms (RRR=8.213; 95% CI=1.042, 64.750, P=0.046).\nSchizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia?",
        "answer": "yes",
        "answer_rationale": "These findings provide evidence for the existence of a high-IQ variant of schizophrenia that is associated with markedly fewer negative symptoms than typical schizophrenia, and lends support to the idea of a psychosis spectrum or continuum over boundaried diagnostic categories.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Schizophrenia patients are typically found to have low IQ both pre- and post-onset, in comparison to the general population. However, a subgroup of patients displays above average IQ pre-onset. The nature of these patients' illness and its relationship to typical schizophrenia is not well understood. The current study sought to investigate the symptom profile of high-IQ schizophrenia patients.\nWe identified 29 schizophrenia patients of exceptionally high pre-morbid intelligence (mean estimated pre-morbid intelligence quotient (IQ) of 120), of whom around half also showed minimal decline (less than 10 IQ points) from their estimated pre-morbid IQ. We compared their symptom scores (SAPS, SANS, OPCRIT, MADRS, GAF, SAI-E) with a comparison group",
        "q2": " of schizophrenia patients of typical IQ using multinomial logistic regression.\nThe patients with very high pre-morbid IQ had significantly lower scores on negative and disorganised symptoms than typical patients (RRR=0.019; 95% CI=0.001, 0.675, P=0.030), and showed better global functioning and insight (RRR=1.082; 95% CI=1.020, 1.148; P=0.009). Those with a minimal post-onset IQ decline also showed higher levels of manic symptoms (RRR=8.213; 95% CI=1.042, 64.750, P=0.046).\nSchizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia?",
        "generated_text": "of 29 schizophrenia patients with average pre-morbid IQ (mean estimated pre-morbid IQ of 100). The two groups were matched for age, gender, and years of education.\nThe high-IQ group had significantly lower positive symptom scores (SAPS, p=0.001; OPCRIT, p=0.001), and higher negative symptom scores (SANS, p=0.001; OPCRIT, p=0.001). They also had higher depression scores (MADRS, p=0.001), and higher global functioning scores (GAF, p=0.001). There was no difference in estimated pre- or post-morbid IQ between the two groups",
        "levenshtein_distance": 426
    },
    {
        "realidx": "25752912",
        "question": "To compare the probability of prenatal diagnosis (PND) and termination of pregnancy for fetal anomaly (TOPFA) between fetuses conceived by assisted reproductive techniques (ART) and spontaneously-conceived fetuses with congenital heart defects (CHD).\nPopulation-based observational study.\nParis and surrounding suburbs.\nFetuses with CHD in the Paris registry of congenital malformations and cohort of children with CHD (Epicard).\nComparison of ART-conceived and spontaneously conceived fetuses taking into account potential confounders (maternal characteristics, multiplicity and year of birth or TOPFA).\nProbability and gestational age at PND and TOPFA for ART-conceived versus spontaneously conceived fetuses.\nThe probability of PND (28.1% versus 34.6%, P = 0.077) and TOPFA (36.2% versus 39.2%, P = 0.677) were not statistically different between ART-conceived (n = 171) and spontaneously conceived (n = 4620) fetuses. Estimates were similar after adjustment for potential confounders. Gestational age at PND tended to be earlier for ART fetuses (23.1 versus 24.8 weeks, P = 0.05) but no statistical difference was found after adjustment for confounders. Gestational age at TOPFA was comparable between ART-conceived and spontaneously conceived fetuses.\nIs the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques?",
        "answer": "no",
        "answer_rationale": "In our population, ART conception was not significantly associated with the probability of PND or TOPFA for CHD. One implication of our results is that live births may be adequate for assessing the overall risk of CHD related to ART. However, total prevalence, in particular of severe CHD, would not be adequately assessed if TOPFA are not included.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To compare the probability of prenatal diagnosis (PND) and termination of pregnancy for fetal anomaly (TOPFA) between fetuses conceived by assisted reproductive techniques (ART) and spontaneously-conceived fetuses with congenital heart defects (CHD).\nPopulation-based observational study.\nParis and surrounding suburbs.\nFetuses with CHD in the Paris registry of congenital malformations and cohort of children with CHD (Epicard).\nComparison of ART-conceived and spontaneously conceived fetuses taking into account potential confounders (maternal characteristics, multiplicity and year of birth or TOPFA).\nProbability and gestational age at PND and TOPFA for ART-conceived versus spontaneously conceived fetuses.\nThe probability of PND (28.1% versus 34.6%,",
        "q2": " P = 0.077) and TOPFA (36.2% versus 39.2%, P = 0.677) were not statistically different between ART-conceived (n = 171) and spontaneously conceived (n = 4620) fetuses. Estimates were similar after adjustment for potential confounders. Gestational age at PND tended to be earlier for ART fetuses (23.1 versus 24.8 weeks, P = 0.05) but no statistical difference was found after adjustment for confounders. Gestational age at TOPFA was comparable between ART-conceived and spontaneously conceived fetuses.\nIs the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques?",
        "generated_text": "p=0.001) and TOPFA (14.1% versus 20.1%, p=0.001) was lower in ART-conceived fetuses. The gestational age at PND was higher in ART-conceived fetuses (21.1 versus 19.9 weeks, p=0.001). The probability of TOPFA was lower in ART-conceived fetuses with PND (35.5% versus 50.0%, p=0.001). The probability of PND was lower in ART-conceived fetuses with isolated CHD (25.0% versus 32.1%, p=0.001)",
        "levenshtein_distance": 452
    },
    {
        "realidx": "25756710",
        "question": "To validate a clinical diagnostic tool, used by emergency physicians (EPs), to diagnose the central cause of patients presenting with vertigo, and to determine interrater reliability of this tool.\nA convenience sample of adult patients presenting to a single academic ED with isolated vertigo (i.e. vertigo without other neurological deficits) was prospectively evaluated with STANDING (SponTAneousNystagmus, Direction, head Impulse test, standiNG) by five trained EPs. The first step focused on the presence of spontaneous nystagmus, the second on the direction of nystagmus, the third on head impulse test and the fourth on gait. The local standard practice, senior audiologist evaluation corroborated by neuroimaging when deemed appropriate, was considered the reference standard. Sensitivity and specificity of STANDING were calculated. On the first 30 patients, inter-observer agreement among EPs was also assessed.\nFive EPs with limited experience in nystagmus assessment volunteered to participate in the present study enrolling 98 patients. Their average evaluation time was 9.9 \u00b1 2.8\u2009min (range 6-17). Central acute vertigo was suspected in 16 (16.3%) patients. There were 13 true positives, three false positives, 81 true negatives and one false negative, with a high sensitivity (92.9%, 95% CI 70-100%) and specificity (96.4%, 95% CI 93-38%) for central acute vertigo according to senior audiologist evaluation. The Cohen's kappas of the first, second, third and fourth steps of the STANDING were 0.86, 0.93, 0.73 and 0.78, respectively. The whole test showed a good inter-observer agreement (k = 0.76, 95% CI 0.45-1).\nCan emergency physicians accurately and reliably assess acute vertigo in the emergency department?",
        "answer": "yes",
        "answer_rationale": "In the hands of EPs, STANDING showed a good inter-observer agreement and accuracy validated against the local standard of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To validate a clinical diagnostic tool, used by emergency physicians (EPs), to diagnose the central cause of patients presenting with vertigo, and to determine interrater reliability of this tool.\nA convenience sample of adult patients presenting to a single academic ED with isolated vertigo (i.e. vertigo without other neurological deficits) was prospectively evaluated with STANDING (SponTAneousNystagmus, Direction, head Impulse test, standiNG) by five trained EPs. The first step focused on the presence of spontaneous nystagmus, the second on the direction of nystagmus, the third on head impulse test and the fourth on gait. The local standard practice, senior audiologist evaluation corroborated by neuroimaging when deemed appropriate, was considered the reference standard. Sensitivity and specificity of STANDING were calculated. On the first 30 patients, inter-observer agreement among EPs was also assessed.\nFive EPs with limited experience in nystagmus assessment",
        "q2": " volunteered to participate in the present study enrolling 98 patients. Their average evaluation time was 9.9 \u00b1 2.8\u2009min (range 6-17). Central acute vertigo was suspected in 16 (16.3%) patients. There were 13 true positives, three false positives, 81 true negatives and one false negative, with a high sensitivity (92.9%, 95% CI 70-100%) and specificity (96.4%, 95% CI 93-38%) for central acute vertigo according to senior audiologist evaluation. The Cohen's kappas of the first, second, third and fourth steps of the STANDING were 0.86, 0.93, 0.73 and 0.78, respectively. The whole test showed a good inter-observer agreement (k = 0.76, 95% CI 0.45-1).\nCan emergency physicians accurately and reliably assess acute vertigo in the emergency department?",
        "generated_text": "evaluated 100 patients with isolated vertigo. The reference standard identified 40 patients with peripheral vestibular disorders and 60 with central disorders. STANDING had a sensitivity of 95% (95% CI 84-99%) and a specificity of 97% (95% CI 89-99%) for peripheral vestibular disorders. Interrater reliability was high, with a kappa coefficient of 0.85 (95% CI 0.75-0.95).\nSTANDING is a simple, reliable, and accurate tool for EPs to diagnose peripheral vestibular disorders in patients presenting with isolated vertigo. This tool could help EPs to quickly and accurately identify the cause of vertigo, leading to better patient care and potentially reducing the need for unnecessary tests and treatments.",
        "levenshtein_distance": 578
    },
    {
        "realidx": "25779009",
        "question": "There is no standard protocol for the evaluation of antiseptics used for skin and mucous membranes in the presence of interfering substances. Our objective was to suggest trial conditions adapted from the NF EN 13727 standard, for the evaluation of antiseptics used in gynecology and dermatology.\nThree antiseptic solutions were tested in vitro: a chlorhexidine-benzalkonium (CB) combination, a hexamidine-chlorhexidine-chlorocresol (HCC) combination, and povidone iodine (P). The adaptation of trial conditions to the standard involved choosing dilutions, solvent, and interfering substances. The activity of solutions was assessed on the recommended strains at concentrations of 97% (pure solution), 50%, and 10% (diluted solution), and 1%. A logarithmic reduction \u2265 5 was expected after 60seconds of contact, to meet requirements of bactericidal activity.\nHCC did not present any bactericidal activity except on P. aeruginosa at a concentration of 97%. P was not bactericidal on E. hirae at any concentration and on S. aureus at 97%. CB had the most homogeneous bactericidal activity with a reduction>5 log on the 4 bacterial strains at concentrations of 97%, 50% and 10%.\nBactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?",
        "answer": "maybe",
        "answer_rationale": "Adapting the NF EN 13727 standard allowed assessing the 3 tested solutions: only CB was bactericidal in dirty conditions. This study proved the possibility of validating antiseptic choice in vitro, in current practice conditions, for adjunctive treatment of skin and mucous membranes disorders, primarily of bacterial origin or with a potential of superinfection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "There is no standard protocol for the evaluation of antiseptics used for skin and mucous membranes in the presence of interfering substances. Our objective was to suggest trial conditions adapted from the NF EN 13727 standard, for the evaluation of antiseptics used in gynecology and dermatology.\nThree antiseptic solutions were tested in vitro: a chlorhexidine-benzalkonium (CB) combination, a hexamidine-chlorhexidine-chlorocresol (HCC) combination, and povidone iodine (P). The adaptation of trial conditions to the standard involved choosing dilutions, solvent, and interfering substances. The activity of solutions was assessed on the recommended strains at concentrations of 97% (pure solution), 50%, and ",
        "q2": "10% (diluted solution), and 1%. A logarithmic reduction \u2265 5 was expected after 60seconds of contact, to meet requirements of bactericidal activity.\nHCC did not present any bactericidal activity except on P. aeruginosa at a concentration of 97%. P was not bactericidal on E. hirae at any concentration and on S. aureus at 97%. CB had the most homogeneous bactericidal activity with a reduction>5 log on the 4 bacterial strains at concentrations of 97%, 50% and 10%.\nBactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?",
        "generated_text": "25% in the presence of interfering substances (blood, serum, and mucous). The activity of the solutions was determined by the reduction in the number of colony-forming units (CFU) after 5 min of contact.\nThe CB and HCC combinations were active in the presence of blood, serum, and mucous at 97% and 50% concentrations, but not at 25%. P was active only at 97% in the presence of blood and serum, but not in the presence of mucous. The CB and HCC combinations were more active than P in the presence of interfering substances.\nThe trial conditions proposed in this study make it possible to evaluate the activity of antiseptics in the presence of",
        "levenshtein_distance": 501
    },
    {
        "realidx": "25793749",
        "question": "Although the Internet is commonly used to recruit samples in studies of human immunodeficiency virus (HIV)-related risk behaviors, it has not been used to measure patient-reported well-being. As the burden of long-term chronic HIV infection rises, the Internet may offer enormous potential for recruitment to research and interventions.\nThis study aimed to compare two samples of gay men living with HIV, one recruited via the Web and the other recruited in outpatient settings, in terms of self-reported physical and psychological symptom burden.\nThe Internet sample was recruited from a UK-wide Web-based survey of gay men with diagnosed HIV. Of these, 154 respondents identified themselves as resident in London and were included in this analysis. The HIV clinic sample was recruited from five HIV outpatient clinics. Of these participants, 400 gay men recruited in London clinics were included in this analysis.\nThe Web-based sample was younger than the clinic sample (37.3 years, SD 7.0 vs 40.9 years, SD 8.3), more likely to be in paid employment (72.8%, 99/136 vs 60.1%, 227/378), less likely to be on antiretroviral therapy (ART) (58.4%, 90/154 vs 68.0%, 266/391), and had worse mean psychological symptom burden compared to the clinic sample (mean scores: 1.61, SD 1.09 vs 1.36, SD 0.96) but similar physical symptom burden (mean scores: 0.78, SD 0.65 vs 0.70, SD 0.74). In multivariable logistic regression, for the physical symptom burden model, adjusted for age, ethnicity, employment status, and ART use, the recruitment setting (ie, Web-based vs clinic) was not significantly associated with high physical symptom score. The only variable that remained significantly associated with high physical symptom score was employment status, with those in employment being less likely to report being in the upper (worst) physical symptom tertile versus the other two tertiles (adjusted OR 0.41, 95% CI 0.28-0.62, P<.001). For the psychological symptom burden model, those recruited via the Web were significantly more likely to report being in the upper (worst) tertile (adjusted OR 2.20, 95% CI 1.41-3.44, P=.001). In addition, those in employment were less likely to report being in the upper (worst) psychological symptom tertile compared to those not in employment (adjusted OR 0.32, 95% CI 0.21-0.49, P<.001).\nDo Web-based and clinic samples of gay men living with HIV differ on self-reported physical and psychological symptoms?",
        "answer": "maybe",
        "answer_rationale": "Our data have revealed a number of differences. Compared to the clinic sample, the Web-based sample had worse psychological symptom burden, younger average age, higher prevalence of employment, and a lower proportion on ART. For future research, we recommend that Web-based data collection should include the demographic variables that we note differed between samples. In addition, we recognize that each recruitment method may bring inherent sampling bias, with clinic populations differing by geographical location and reflecting those accessing regular medical care, and Web-based sampling recruiting those with greater Internet access and identifying survey materials through specific searches and contact with specific websites.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Although the Internet is commonly used to recruit samples in studies of human immunodeficiency virus (HIV)-related risk behaviors, it has not been used to measure patient-reported well-being. As the burden of long-term chronic HIV infection rises, the Internet may offer enormous potential for recruitment to research and interventions.\nThis study aimed to compare two samples of gay men living with HIV, one recruited via the Web and the other recruited in outpatient settings, in terms of self-reported physical and psychological symptom burden.\nThe Internet sample was recruited from a UK-wide Web-based survey of gay men with diagnosed HIV. Of these, 154 respondents identified themselves as resident in London and were included in this analysis. The HIV clinic sample was recruited from five HIV outpatient clinics. Of these participants, 400 gay men recruited in London clinics were included in this analysis.\nThe Web-based sample was younger than the clinic sample (37.3 years, SD 7.0 vs 40.9 years, SD 8.3), more likely to be in paid employment (72.8%, 99/136 vs 60.1%, 227/378), less likely to be on antiretroviral therapy (ART) (58.4%, 90/154 vs 68.0%, 266/391), and had worse mean psychological symptom burden compared to the clinic sample (mean scores: 1.61, SD 1.09 vs ",
        "q2": "1.36, SD 0.96) but similar physical symptom burden (mean scores: 0.78, SD 0.65 vs 0.70, SD 0.74). In multivariable logistic regression, for the physical symptom burden model, adjusted for age, ethnicity, employment status, and ART use, the recruitment setting (ie, Web-based vs clinic) was not significantly associated with high physical symptom score. The only variable that remained significantly associated with high physical symptom score was employment status, with those in employment being less likely to report being in the upper (worst) physical symptom tertile versus the other two tertiles (adjusted OR 0.41, 95% CI 0.28-0.62, P<.001). For the psychological symptom burden model, those recruited via the Web were significantly more likely to report being in the upper (worst) tertile (adjusted OR 2.20, 95% CI 1.41-3.44, P=.001). In addition, those in employment were less likely to report being in the upper (worst) psychological symptom tertile compared to those not in employment (adjusted OR 0.32, 95% CI 0.21-0.49, P<.001).\nDo Web-based and clinic samples of gay men living with HIV differ on self-reported physical and psychological symptoms?",
        "generated_text": "1.32, SD 1.02; p=0.01). There was no difference in mean physical symptom burden between the two samples (mean scores: 1.40, SD 1.04 vs 1.34, SD 1.01; p=0.50).\nThe Web-based sample had higher psychological symptom burden than the clinic sample, but similar physical symptom burden. The Internet may be a useful tool for recruiting people with HIV who are not in regular contact with HIV clinics and who may have higher psychological symptom burden.",
        "levenshtein_distance": 894
    },
    {
        "realidx": "25810292",
        "question": "Traditional resectional techniques and chordal transfer are difficult to apply in video-assisted mitral valve repair. Using artificial chords appears easier in this setting. The purpose of this study was to review the effectiveness and reproducibility of neochordal repair as a routine approach to minimally invasive mitral repair, and to assess the stability of neochord implantation using the figure-of-eight suture without pledgets in this setting.\nThis is a retrospective review of all patients who underwent minimally invasive video-assisted mitral valve repair from 2008 to 2013. The primary endpoints were recurrent mitral regurgitation and reoperation.\nA total of 426 consecutive patients were included during the study period, with a mean age of 55 \u00b1 18 years. Neochords were used in all patients, and in association with leaflet resection in 47 patients. One patient was not repairable and underwent valve replacement (repair rate, 99.8%). Fifteen patients had Grade I (3.5%) regurgitation, whereas the remainder had none. Patients were fast-tracked, with 25% extubated in the operation theatre and the remainder within 6 h. There were 5 deaths within 30 days (1.2%). Follow-up ranged 3-60 months, during which all of the patients remained with no or trace mitral regurgitation. No de-insertion or rupture of any neochords was found, and no patients required a reoperation.\nIs minimally invasive mitral valve repair with artificial chords reproducible and applicable in routine surgery?",
        "answer": "yes",
        "answer_rationale": "Minimally invasive mitral valve repair using neochords provided a high rate of repair, reproducible results in a routine cardiac surgery setting and stable repair during follow-up. This has become our preferred technique for mitral valve surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Traditional resectional techniques and chordal transfer are difficult to apply in video-assisted mitral valve repair. Using artificial chords appears easier in this setting. The purpose of this study was to review the effectiveness and reproducibility of neochordal repair as a routine approach to minimally invasive mitral repair, and to assess the stability of neochord implantation using the figure-of-eight suture without pledgets in this setting.\nThis is a retrospective review of all patients who underwent minimally invasive video-assisted mitral valve repair from 2008 to 2013. The primary endpoints were recurrent mitral regurgitation and reoperation.\nA total of 426 consecutive patients were included during the study period, with a mean age of 55 \u00b1 18 years. Neochords were used in all",
        "q2": " patients, and in association with leaflet resection in 47 patients. One patient was not repairable and underwent valve replacement (repair rate, 99.8%). Fifteen patients had Grade I (3.5%) regurgitation, whereas the remainder had none. Patients were fast-tracked, with 25% extubated in the operation theatre and the remainder within 6 h. There were 5 deaths within 30 days (1.2%). Follow-up ranged 3-60 months, during which all of the patients remained with no or trace mitral regurgitation. No de-insertion or rupture of any neochords was found, and no patients required a reoperation.\nIs minimally invasive mitral valve repair with artificial chords reproducible and applicable in routine surgery?",
        "generated_text": "patients, with a mean of 2.4 \u00b1 1.1 chords per patient. The mean follow-up was 3.5 \u00b1 1.5 years. The mean left ventricular end-diastolic diameter decreased from 54 \u00b1 8 mm preoperatively to 51 \u00b1 7 mm postoperatively (p < 0.001). The mean left ventricular ejection fraction increased from 58% \u00b1 12% preoperatively to 62% \u00b1 10% postoperatively (p < 0.001). The mean mitral valve area increased from 1.5 \u00b1 0.5 cm2 preoperatively to 2.2 \u00b1 0.5 cm2 postoper",
        "levenshtein_distance": 518
    },
    {
        "realidx": "25887165",
        "question": "Patients usually complain about numbness in the nasal tip after microfat injections. The present study evaluated the severity of the numbness in the nasal tip after the procedure.\nTo address the research question, a prospective study of young women was designed and performed at the Beijing Anzhen Hospital. Time was the primary predictor variable. The nasal tip sensation, which was evaluated using objective and subjective assessments, was used as the primary outcome variable. The McNemar-Bowker test (time vs nasal tip sensation) was used to detect statistical significance.\nA total of 30 young women (age 20.04 \u00b1 3.63 years) were recruited for the present study. The preoperative mean touch threshold value was 3.60 units. One week after the injection, the women experienced a decrease in the touch threshold value by 2.50 units. However, the sensation recovered gradually during the follow-up period (1.51 units at week 2, 2.39 units at week 4, 3.01 units at week 8, and 3.35 units at week 12). Significant differences were detected between multiple different measurement points (P<.05). The percentage of those experiencing paresthesia after the microfat injections also gradually diminished to none.\nDoes Sensation Return to the Nasal Tip After Microfat Grafting?",
        "answer": "yes",
        "answer_rationale": "Postoperative numbness occurs in most patients receiving nasal microfat injections. Partial to complete recovery of nasal tip sensation can be expected to occur over a 3-month period.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Patients usually complain about numbness in the nasal tip after microfat injections. The present study evaluated the severity of the numbness in the nasal tip after the procedure.\nTo address the research question, a prospective study of young women was designed and performed at the Beijing Anzhen Hospital. Time was the primary predictor variable. The nasal tip sensation, which was evaluated using objective and subjective assessments, was used as the primary outcome variable. The McNemar-Bowker test (time vs nasal tip sensation) was used to detect statistical significance.\nA total of 30 young women (age 20.04 \u00b1 3.63 years) were recruited for the present study. The",
        "q2": " preoperative mean touch threshold value was 3.60 units. One week after the injection, the women experienced a decrease in the touch threshold value by 2.50 units. However, the sensation recovered gradually during the follow-up period (1.51 units at week 2, 2.39 units at week 4, 3.01 units at week 8, and 3.35 units at week 12). Significant differences were detected between multiple different measurement points (P<.05). The percentage of those experiencing paresthesia after the microfat injections also gradually diminished to none.\nDoes Sensation Return to the Nasal Tip After Microfat Grafting?",
        "generated_text": "mean follow-up time was 12.00 \u00b1 1.15 months. The objective assessment of nasal tip sensation was significantly different between the preoperative and postoperative periods (P < 0.001). The subjective assessment of nasal tip sensation was significantly different between the preoperative and postoperative periods (P < 0.001). The objective assessment of nasal tip sensation was significantly different between the preoperative and postoperative periods (P < 0.001). The subjective assessment of nasal tip sensation was significantly different between the preoperative and postoperative periods (P < 0.001). The objective assessment of nasal tip",
        "levenshtein_distance": 486
    },
    {
        "realidx": "25940336",
        "question": "More than 1000 candidates applied for orthopaedic residency positions in 2014, and the competition is intense; approximately one-third of the candidates failed to secure a position in the match. However, the criteria used in the selection process often are subjective and studies have differed in terms of which criteria predict either objective measures or subjective ratings of resident performance by faculty.QUESTIONS/\nDo preresidency selection factors serve as predictors of success in residency? Specifically, we asked which preresidency selection factors are associated or correlated with (1) objective measures of resident knowledge and performance; and (2) subjective ratings by faculty.\nCharts of 60 orthopaedic residents from our institution were reviewed. Preresidency selection criteria examined included United States Medical Licensing Examination (USMLE) Step 1 and Step 2 scores, Medical College Admission Test (MCAT) scores, number of clinical clerkship honors, number of letters of recommendation, number of away rotations, Alpha Omega Alpha (AOA) honor medical society membership, fourth-year subinternship at our institution, and number of publications. Resident performance was assessed using objective measures including American Board of Orthopaedic Surgery (ABOS) Part I scores and Orthopaedics In-Training Exam (OITE) scores and subjective ratings by faculty including global evaluation scores and faculty rankings of residents. We tested associations between preresidency criteria and the subsequent objective and subjective metrics using linear correlation analysis and Mann-Whitney tests when appropriate.\nObjective measures of resident performance namely, ABOS Part I scores, had a moderate linear correlation with the USMLE Step 2 scores (r = 0.55, p<0.001) and number of clinical honors received in medical school (r = 0.45, p<0.001). OITE scores had a weak linear correlation with the number of clinical honors (r = 0.35, p = 0.009) and USMLE Step 2 scores (r = 0.29, p = 0.02). With regards to subjective outcomes, AOA membership was associated with higher scores on the global evaluation (p = 0.005). AOA membership also correlated with higher global evaluation scores (r = 0.60, p = 0.005) with the strongest correlation existing between AOA membership and the \"interpersonal and communication skills\" subsection of the global evaluations.\nDoes Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency?",
        "answer": "yes",
        "answer_rationale": "We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "More than 1000 candidates applied for orthopaedic residency positions in 2014, and the competition is intense; approximately one-third of the candidates failed to secure a position in the match. However, the criteria used in the selection process often are subjective and studies have differed in terms of which criteria predict either objective measures or subjective ratings of resident performance by faculty.QUESTIONS/\nDo preresidency selection factors serve as predictors of success in residency? Specifically, we asked which preresidency selection factors are associated or correlated with (1) objective measures of resident knowledge and performance; and (2) subjective ratings by faculty.\nCharts of 60 orthopaedic residents from our institution were reviewed. Preresidency selection criteria examined included United States Medical Licensing Examination (USMLE) Step 1 and Step 2 scores, Medical College Admission Test (MCAT) scores, number of clinical clerkship honors, number of letters of recommendation, number of away rotations, Alpha Omega Alpha (AOA) honor medical society membership, fourth-year subinternship at our institution, and number of publications. Resident performance was assessed using objective measures including American Board of Orthopaedic Surgery (ABOS) Part I scores and Orthopaedics In-Training Exam",
        "q2": " (OITE) scores and subjective ratings by faculty including global evaluation scores and faculty rankings of residents. We tested associations between preresidency criteria and the subsequent objective and subjective metrics using linear correlation analysis and Mann-Whitney tests when appropriate.\nObjective measures of resident performance namely, ABOS Part I scores, had a moderate linear correlation with the USMLE Step 2 scores (r = 0.55, p<0.001) and number of clinical honors received in medical school (r = 0.45, p<0.001). OITE scores had a weak linear correlation with the number of clinical honors (r = 0.35, p = 0.009) and USMLE Step 2 scores (r = 0.29, p = 0.02). With regards to subjective outcomes, AOA membership was associated with higher scores on the global evaluation (p = 0.005). AOA membership also correlated with higher global evaluation scores (r = 0.60, p = 0.005) with the strongest correlation existing between AOA membership and the \"interpersonal and communication skills\" subsection of the global evaluations.\nDoes Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency?",
        "generated_text": "(OITE) scores, and subjective measures including resident evaluations by faculty. Correlations between preresidency selection factors and resident performance measures were assessed using Spearman rank correlation coefficients. Multiple linear regression was used to assess the relationship between preresidency selection factors and resident performance measures, controlling for potential confounding variables. RESULTS/\nOf the 60 residents, 50 (83%) were male and 10 (17%) were female. The mean age at the time of residency was 28.5 years (range, 25-34 years). The mean number of years in residency was 3.5 years (range, 1-5 years). The mean USMLE Step 1 score was 234.5 (range, 210-264), and the mean USMLE Step 2 score was 244.5 (range, 220-270). The mean MCAT score was 35.5 (range, 30-40). The mean number of clinical clerkship honors was 3.5 (range, 0-6), and the mean number of letters of recommendation was 5.5 (",
        "levenshtein_distance": 806
    },
    {
        "realidx": "25986020",
        "question": "Adoption and implementation of evidence-based measures for catheter care leads to reductions in central line-associated bloodstream infection (CLABSI) rates in the NICU. The purpose of this study is to evaluate whether this rate reduction is sustainable for at least 1 year and to identify key determinants of this sustainability at the NICU of the Floating Hospital for Children at Tufts Medical Center.\nWe reviewed the incidence of CLABSIs in the NICU temporally to the implementation of new practice policies and procedures, from July 2008 to December 2013.\nAdoption of standardized care practices, including bundles and checklists, was associated with a significant reduction of the CLABSI rate to zero for>370 consecutive days in our NICU in 2012. Overall, our CLABSI rates decreased from 4.1 per 1000 line days in 2009 (13 infections; 3163 line days) to 0.94 in 2013 (2 infections; 2115 line days), which represents a 77% reduction over a 5-year period. In the first quarter of 2013, there was a brief increase in CLABSI rate to 3.3 per 1000 line days; after a series of interventions, the CLABSI rate was maintained at zero for>600 days. Ongoing training, surveillance, and vigilance with catheter insertion and maintenance practices and improved documentation were identified as key drivers for success.\nIs zero central line-associated bloodstream infection rate sustainable?",
        "answer": "yes",
        "answer_rationale": "High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Adoption and implementation of evidence-based measures for catheter care leads to reductions in central line-associated bloodstream infection (CLABSI) rates in the NICU. The purpose of this study is to evaluate whether this rate reduction is sustainable for at least 1 year and to identify key determinants of this sustainability at the NICU of the Floating Hospital for Children at Tufts Medical Center.\nWe reviewed the incidence of CLABSIs in the NICU temporally to the implementation of new practice policies and procedures, from July 2008 to December 2013.\nAdoption of standardized care practices, including bundles and checklists, was associated with a significant reduction of the CLABSI rate to zero for>370 consecutive days in our NICU in 2012.",
        "q2": " Overall, our CLABSI rates decreased from 4.1 per 1000 line days in 2009 (13 infections; 3163 line days) to 0.94 in 2013 (2 infections; 2115 line days), which represents a 77% reduction over a 5-year period. In the first quarter of 2013, there was a brief increase in CLABSI rate to 3.3 per 1000 line days; after a series of interventions, the CLABSI rate was maintained at zero for>600 days. Ongoing training, surveillance, and vigilance with catheter insertion and maintenance practices and improved documentation were identified as key drivers for success.\nIs zero central line-associated bloodstream infection rate sustainable?",
        "generated_text": "This rate reduction was sustained for 1 year, with only 1 CLABSI in 2013.\nSustainability of CLABSI rate reduction in the NICU is achievable and can be maintained for at least 1 year. The key determinants of this sustainability include the adoption of evidence-based measures, the use of standardized care practices such as bundles and checklists, and the commitment of the healthcare team to maintaining high standards of care.",
        "levenshtein_distance": 461
    },
    {
        "realidx": "26037986",
        "question": "Emergency surgery is associated with poorer outcomes and higher mortality with recent studies suggesting the 30-day mortality to be 14-15%. The aim of this study was to analyse the 30-day mortality, age-related 30-day mortality and 1-year mortality following emergency laparotomy. We hope this will encourage prospective data collection, improvement of care and initiate strategies to establish best practice in this area.\nThis was a retrospective study of patients who underwent emergency laparotomy from June 2010 to May 2012. The primary end point of the study was 30-day mortality, age-related 30-day mortality and 1-year all-cause mortality.\n477 laparotomies were performed in 446 patients. 57% were aged<70 and 43% aged>70 years. 30-day mortality was 12, 4% in those aged<70 years and 22% in those>70 years (p<0.001). 1-year mortality was 25, 15% in those aged under 70 years and 38% in those aged>70 years (p<0.001).\n30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement?",
        "answer": "maybe",
        "answer_rationale": "Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Emergency surgery is associated with poorer outcomes and higher mortality with recent studies suggesting the 30-day mortality to be 14-15%. The aim of this study was to analyse the 30-day mortality, age-related 30-day mortality and 1-year mortality following emergency laparotomy. We hope this will encourage prospective data collection, improvement of care and initiate strategies to establish best practice in this area.\nThis was a retrospective study of patients who underwent emergency laparotomy from June 2010 to May 2012. The primary end point of the study was 30-day mortality, age-related 30-day mortality and 1",
        "q2": "-year all-cause mortality.\n477 laparotomies were performed in 446 patients. 57% were aged<70 and 43% aged>70 years. 30-day mortality was 12, 4% in those aged<70 years and 22% in those>70 years (p<0.001). 1-year mortality was 25, 15% in those aged under 70 years and 38% in those aged>70 years (p<0.001).\n30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement?",
        "generated_text": "-year mortality. Data were collected from the hospital database and analysed using SPSS version 20.0.\nA total of 200 patients underwent emergency laparotomy during the study period. The mean age was 62.5 years (range 18-94 years). The overall 30-day mortality was 10% (n=20). The 30-day mortality was 10% (n=12) in patients aged <65 years and 10% (n=8) in patients aged \u226565 years. The 1-year mortality",
        "levenshtein_distance": 319
    },
    {
        "realidx": "26113007",
        "question": "Orthodontic patients show high prevalence of tooth-size discrepancy. This study investigates the possible association between arch form, clinically significant tooth-size discrepancy, and sagittal molar relationship.\nPretreatment orthodontic casts of 230 Saudi patients were classified into one of three arch form types (tapered, ovoid, and square) using digitally scanned images of the mandibular arches. Bolton ratio was calculated, sagittal molar relationship was defined according to Angle classification, and correlations were analyzed using ANOVA, chi-square, and t-tests.\nNo single arch form was significantly more common than the others. Furthermore, no association was observed between the presence of significant Bolton discrepancy and the sagittal molar relationship or arch form. Overall Bolton discrepancy is significantly more prevalent in males.\nIs arch form influenced by sagittal molar relationship or Bolton tooth-size discrepancy?",
        "answer": "no",
        "answer_rationale": "Arch form in a Saudi patient group is independent of gender, sagittal molar relationship, and Bolton discrepancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Orthodontic patients show high prevalence of tooth-size discrepancy. This study investigates the possible association between arch form, clinically significant tooth-size discrepancy, and sagittal molar relationship.\nPretreatment orthodontic casts of 230 Saudi patients were classified into one of three arch form types (tapered, ovoid, and square) using digitally scanned images of the mandibular arches. Bolton ratio was calculated, sagittal molar",
        "q2": " relationship was defined according to Angle classification, and correlations were analyzed using ANOVA, chi-square, and t-tests.\nNo single arch form was significantly more common than the others. Furthermore, no association was observed between the presence of significant Bolton discrepancy and the sagittal molar relationship or arch form. Overall Bolton discrepancy is significantly more prevalent in males.\nIs arch form influenced by sagittal molar relationship or Bolton tooth-size discrepancy?",
        "generated_text": "relationship was determined, and the presence of clinically significant tooth-size discrepancy was determined.\nThe most common arch form was the tapered type (44.8%), followed by the ovoid type (35.7%) and the square type (19.6%). The most common sagittal molar relationship was Class I (60.4%), followed by Class II (28.7%) and Class III (1",
        "levenshtein_distance": 354
    },
    {
        "realidx": "26126304",
        "question": "To compare in vitro fertilization (IVF) outcomes in low responders stimulated with microdose leuprolide protocol (ML) following pretreatment with either oral contraceptive pill (OCP) or luteal estradiol (E2) + GnRH antagonist (E2 + antag) for follicular synchronization prior to controlled ovarian hyperstimulation (COH).\nThis was a retrospective study of 130 women, who were poor responders, undergoing IVF with either OCP/ML or E2+ antag/ML protocols. The main outcome measures were ongoing pregnancy rates, number of oocytes retrieved, and cancellation rate.\nBoth groups were similar in baseline characteristics. There were no significant differences in gonadotropin requirement, cancellation rate, and number of embryos transferred. Ongoing pregnancy rates (40% vs. 15%) were significantly higher in the OCP/ML group. Trends toward greater number of oocytes retrieved (7.7 \u00b1 3.4 vs. 5.9 \u00b1 4.2) and improved implantation rates (20% vs. 12%) were also noted, but these did not reach statistical significance.\nEstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?",
        "answer": "no",
        "answer_rationale": "E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To compare in vitro fertilization (IVF) outcomes in low responders stimulated with microdose leuprolide protocol (ML) following pretreatment with either oral contraceptive pill (OCP) or luteal estradiol (E2) + GnRH antagonist (E2 + antag) for follicular synchronization prior to controlled ovarian hyperstimulation (COH).\nThis was a retrospective study of 130 women, who were poor responders, undergoing IVF with either OCP/ML or E2+ antag/ML protocols. The main outcome measures were ongoing pregnancy rates, number of oocytes retrieved, and cancellation rate.\nBoth groups were similar in baseline characteristics. There were",
        "q2": " no significant differences in gonadotropin requirement, cancellation rate, and number of embryos transferred. Ongoing pregnancy rates (40% vs. 15%) were significantly higher in the OCP/ML group. Trends toward greater number of oocytes retrieved (7.7 \u00b1 3.4 vs. 5.9 \u00b1 4.2) and improved implantation rates (20% vs. 12%) were also noted, but these did not reach statistical significance.\nEstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?",
        "generated_text": "no significant differences in the number of oocytes retrieved, fertilization rates, and ongoing pregnancy rates between the two groups. The cancellation rate was higher in the OCP/ML group (14.3% vs. 0%, p=0.02). The OCP/ML group had a higher number of days of stimulation (12.1 vs. 10.5, p=0.001), higher total dose of gonadotropins (2,040 vs. 1,650 IU, p=0.001), and higher cost of treatment ($5,100 vs. $4,",
        "levenshtein_distance": 399
    },
    {
        "realidx": "26134053",
        "question": "Outcome feedback is the process of learning patient outcomes after their care within the emergency department. We conducted a national survey of Canadian Royal College emergency medicine (EM) residents and program directors to determine the extent to which active outcome feedback and follow-up occurred. We also compared the perceived educational value of outcome feedback between residents and program directors.\nWe distributed surveys to all Royal College-accredited adult and pediatric EM training programs using a modified Dillman method. We analyzed the data using student's t-test for continuous variables and Fisher's exact test for categorical variables.\nWe received 210 completed surveys from 260 eligible residents (80.8%) and 21 of 24 program directors (87.5%) (overall 81.3%). Mandatory active outcome feedback was not present in any EM training program for admitted or discharged patients (0/21). Follow-up was performed electively by 89.4% of residents for patients admitted to the hospital, and by 44.2% of residents for patients discharged home. A majority of residents (76.9%) believed that patient follow-up should be mandatory compared to 42.9% of program directors (p=0.002). The perceived educational value of outcome feedback was 5.8/7 for residents and 5.1/7 for program directors (difference 0.7; p=0.002) based on a seven-point Likert scale (1=not important; 7=very important).\nOutcome Feedback within Emergency Medicine Training Programs: An Opportunity to Apply the Theory of Deliberate Practice?",
        "answer": "maybe",
        "answer_rationale": "While Canadian EM training programs do not mandate follow-up, it is performed electively by the majority of residents surveyed. Residents place a significantly greater educational value on outcome feedback than their program directors, and believe that follow-up should be a mandatory component of EM residencies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Outcome feedback is the process of learning patient outcomes after their care within the emergency department. We conducted a national survey of Canadian Royal College emergency medicine (EM) residents and program directors to determine the extent to which active outcome feedback and follow-up occurred. We also compared the perceived educational value of outcome feedback between residents and program directors.\nWe distributed surveys to all Royal College-accredited adult and pediatric EM training programs using a modified Dillman method. We analyzed the data using student's t-test for continuous variables and Fisher's exact test for categorical variables.\nWe received 210 completed surveys from 260 eligible residents (80.8%) and 21 of 24 program directors (87.5%) (overall 81.3%). Mandatory active outcome feedback was not present in any EM training program for",
        "q2": " admitted or discharged patients (0/21). Follow-up was performed electively by 89.4% of residents for patients admitted to the hospital, and by 44.2% of residents for patients discharged home. A majority of residents (76.9%) believed that patient follow-up should be mandatory compared to 42.9% of program directors (p=0.002). The perceived educational value of outcome feedback was 5.8/7 for residents and 5.1/7 for program directors (difference 0.7; p=0.002) based on a seven-point Likert scale (1=not important; 7=very important).\nOutcome Feedback within Emergency Medicine Training Programs: An Opportunity to Apply the Theory of Deliberate Practice?",
        "generated_text": "adult or pediatric patients. Only 10.5% of residents and 14.3% of program directors reported receiving active outcome feedback for adult patients, and 11.4% of residents and 14.3% of program directors reported receiving active outcome feedback for pediatric patients. The majority of residents (85.7%) and program directors (85.7%) reported that active outcome feedback was important for educational purposes. Residents and program directors agreed that outcome feedback was important for educational purposes (p = 0.99). However, residents (80.0%) were more likely than program directors (52.4%) to believe that outcome feedback was important for patient safety (p = 0.007).\nActive outcome feedback",
        "levenshtein_distance": 502
    },
    {
        "realidx": "26163474",
        "question": "Sublingual varices have earlier been related to ageing, smoking and cardiovascular disease. The aim of this study was to investigate whether sublingual varices are related to presence of hypertension.\nIn an observational clinical study among 431 dental patients tongue status and blood pressure were documented. Digital photographs of the lateral borders of the tongue for grading of sublingual varices were taken, and blood pressure was measured. Those patients without previous diagnosis of hypertension and with a noted blood pressure \u2265 140 mmHg and/or \u2265 90 mmHg at the dental clinic performed complementary home blood pressure during one week. Those with an average home blood pressure \u2265 135 mmHg and/or \u2265 85 mmHg were referred to the primary health care centre, where three office blood pressure measurements were taken with one week intervals. Two independent blinded observers studied the photographs of the tongues. Each photograph was graded as none/few (grade 0) or medium/severe (grade 1) presence of sublingual varices. Pearson's Chi-square test, Student's t-test, and multiple regression analysis were applied. Power calculation stipulated a study population of 323 patients.\nAn association between sublingual varices and hypertension was found (OR = 2.25, p<0.002). Mean systolic blood pressure was 123 and 132 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.0001, CI 95 %). Mean diastolic blood pressure was 80 and 83 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.005, CI 95 %). Sublingual varices indicate hypertension with a positive predictive value of 0.5 and a negative predictive value of 0.80.\nIs there a connection between sublingual varices and hypertension?",
        "answer": "yes",
        "answer_rationale": "An association was found between sublingual varices and hypertension. Examining the lateral borders of the tongue is easily done, causes no harm and could be a valuable method for the dental profession to take active part in preventive healthcare.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Sublingual varices have earlier been related to ageing, smoking and cardiovascular disease. The aim of this study was to investigate whether sublingual varices are related to presence of hypertension.\nIn an observational clinical study among 431 dental patients tongue status and blood pressure were documented. Digital photographs of the lateral borders of the tongue for grading of sublingual varices were taken, and blood pressure was measured. Those patients without previous diagnosis of hypertension and with a noted blood pressure \u2265 140 mmHg and/or \u2265 90 mmHg at the dental clinic performed complementary home blood pressure during one week. Those with an average home blood pressure \u2265 135 mmHg and/or \u2265 85 mmHg were referred to the primary health care centre, where three office blood pressure measurements were taken with one week intervals. Two independent blinded observers studied the photographs of the tongues. Each photograph was graded as none/few (grade 0) or medium/severe (grade",
        "q2": " 1) presence of sublingual varices. Pearson's Chi-square test, Student's t-test, and multiple regression analysis were applied. Power calculation stipulated a study population of 323 patients.\nAn association between sublingual varices and hypertension was found (OR = 2.25, p<0.002). Mean systolic blood pressure was 123 and 132 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.0001, CI 95 %). Mean diastolic blood pressure was 80 and 83 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.005, CI 95 %). Sublingual varices indicate hypertension with a positive predictive value of 0.5 and a negative predictive value of 0.80.\nIs there a connection between sublingual varices and hypertension?",
        "generated_text": "1) sublingual varices.\nA total of 431 patients were included in the study. The mean age was 51.4 years (SD 15.4), 52% were women. The prevalence of sublingual varices was 22.5%. The prevalence of hypertension was 31.1%. Patients with sublingual varices had a higher prevalence of hypertension (41.1% vs. 27.1%, p = 0.002). In a multivariate logistic regression analysis sublingual varices were associated with hypertension (OR 1.78, 95% CI 1.12-2.83, p = 0.015). The sensitivity of sublingual varices for hypertension was 29.1% and the specificity 64.1%.\nSublingual varices are associated",
        "levenshtein_distance": 527
    },
    {
        "realidx": "26200172",
        "question": "In recent years, biofeedback has become increasingly popular for its proven success in peak performance training - the psychophysiological preparation of athletes for high-stakes sport competitions, such as the Olympic games. The aim of this research was to test whether an 8-week period of exposure to biofeedback training could improve the psychophysiological control over competitive anxiety and enhance athletic performance in participating subjects.\nParticipants of this study were highly competent athletes, each training in different sport disciplines. The experimental group consisted of 18 athletes (4 women, 14 men), whereas the Control group had 21 athletes (4 women, 17 men). All athletes were between 16 and 34 years old. The biofeedback device, Nexus 10, was used to detect and measure the psychophysiological responses of athletes. Athletes from both groups (control and experimental) were subjected to stress tests at the beginning of the study and once again at its conclusion. In between, the experimental group received training in biofeedback techniques. We then calculated the overall percentage of athletes in the experimental group compared with those in the control group who were able to control respiration, skin conductance, heart rate, blood flow amplitude, heart rate variability, and heart respiration coherence. One year following completion of the initial study, we questioned athletes from the experimental group, to determine whether they continued to use these skills and if they could detect any subsequent enhancement in their athletic performance.\nWe demonstrated that a greater number of participants in the experimental group were able to successfully control their psychophysiological parameters, in comparison to their peers in the control group. Significant results (p<0.05) were noted in regulation of GSR following short stress test conditions (p = 0.037), in regulation of HR after exposure to STROOP stressor (p = 0.037), in regulation of GSR following the Math and GSR stressors (p = 0.033, p = 0.409) and in achieving HR - breathing coherence following the math stressor (p = 0.042).\nCan biofeedback training of psychophysiological responses enhance athletes' sport performance?",
        "answer": "yes",
        "answer_rationale": "One year following completion of the training program, all participants from the experimental group indicated that they were still using the biofeedback - psycho-regulation skills. Furthermore, these participants uniformly reported believing that these skills had enhanced their athletic performance and general well-being.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "In recent years, biofeedback has become increasingly popular for its proven success in peak performance training - the psychophysiological preparation of athletes for high-stakes sport competitions, such as the Olympic games. The aim of this research was to test whether an 8-week period of exposure to biofeedback training could improve the psychophysiological control over competitive anxiety and enhance athletic performance in participating subjects.\nParticipants of this study were highly competent athletes, each training in different sport disciplines. The experimental group consisted of 18 athletes (4 women, 14 men), whereas the Control group had 21 athletes (4 women, 17 men). All athletes were between 16 and 34 years old. The biofeedback device, Nexus 10, was used to detect and measure the psychophysiological responses of athletes. Athletes from both groups (control and experimental) were subjected to stress tests at the beginning of the study and once again at its conclusion. In between, the experimental group received training in biofeedback techniques. We then calculated the overall percentage of athletes in the experimental group compared with",
        "q2": " those in the control group who were able to control respiration, skin conductance, heart rate, blood flow amplitude, heart rate variability, and heart respiration coherence. One year following completion of the initial study, we questioned athletes from the experimental group, to determine whether they continued to use these skills and if they could detect any subsequent enhancement in their athletic performance.\nWe demonstrated that a greater number of participants in the experimental group were able to successfully control their psychophysiological parameters, in comparison to their peers in the control group. Significant results (p<0.05) were noted in regulation of GSR following short stress test conditions (p = 0.037), in regulation of HR after exposure to STROOP stressor (p = 0.037), in regulation of GSR following the Math and GSR stressors (p = 0.033, p = 0.409) and in achieving HR - breathing coherence following the math stressor (p = 0.042).\nCan biofeedback training of psychophysiological responses enhance athletes' sport performance?",
        "generated_text": "the control group who showed improvement in their psychophysiological control over competitive anxiety and enhancement in athletic performance.\n\n## Final Solution\nTo solve this problem, we need to determine the percentage of athletes in the experimental group who showed improvement in psychophysiological control over competitive anxiety and enhancement in athletic performance compared to the control group after an 8-week biofeedback training period.\n\n### Approach\n\n1. **Identify the groups and their sizes:**\n   - Experimental group: 18 athletes (4 women, 14 men)\n   - Control group: 21 athletes (4 women, 17 men)\n\n2. **Understand the procedure:**\n   - Both groups underwent stress tests at the beginning and end of the study.\n   - The experimental group received biofeedback training in between.\n\n3. **Determine the outcome:**\n   - Calculate the percentage of athletes in the experimental group who showed improvement compared to the control group.\n\n4. **Assumptions:**\n   - We need to assume that the improvement is measured based on the stress test results before and after",
        "levenshtein_distance": 797
    },
    {
        "realidx": "26209118",
        "question": "Children with sickle cell disease (SCD) are at risk of bone infarcts and acute osteomyelitis. The clinical differentiation between a bone infarct and acute osteomyelitis is a diagnostic challenge. Unenhanced T1-W fat-saturated MR images have been proposed as a potential tool to differentiate bone infarcts from osteomyelitis.\nTo evaluate the reliability of unenhanced T1-W fat-saturated MRI for differentiation between bone infarcts and acute osteomyelitis in children with SCD.\nWe retrospectively reviewed the records of 31 children (20 boys, 11 girls; mean age 10.6 years, range 1.1-17.9 years) with SCD and acute bone pain who underwent MR imaging including unenhanced T1-W fat-saturated images from 2005 to 2010. Complete clinical charts were reviewed by a pediatric hematologist with training in infectious diseases to determine a clinical standard to define the presence or absence of osteomyelitis. A pediatric radiologist reviewed all MR imaging and was blinded to clinical information. Based on the signal intensity in T1-W fat-saturated images, the children were further classified as positive for osteomyelitis (low bone marrow signal intensity) or positive for bone infarct (high bone marrow signal intensity).\nBased on the clinical standard, 5 children were classified as positive for osteomyelitis and 26 children as positive for bone infarct (negative for osteomyelitis). The bone marrow signal intensity on T1-W fat-saturated imaging was not significant for the differentiation between bone infarct and osteomyelitis (P\u2009=\u20090.56). None of the additional evaluated imaging parameters on unenhanced MRI proved reliable in differentiating these diagnoses.\nUtility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease -- can it differentiate bone infarcts from acute osteomyelitis?",
        "answer": "no",
        "answer_rationale": "The bone marrow signal intensity on unenhanced T1-W fat-saturated MR images is not a reliable criterion to differentiate bone infarcts from osteomyelitis in children.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Children with sickle cell disease (SCD) are at risk of bone infarcts and acute osteomyelitis. The clinical differentiation between a bone infarct and acute osteomyelitis is a diagnostic challenge. Unenhanced T1-W fat-saturated MR images have been proposed as a potential tool to differentiate bone infarcts from osteomyelitis.\nTo evaluate the reliability of unenhanced T1-W fat-saturated MRI for differentiation between bone infarcts and acute osteomyelitis in children with SCD.\nWe retrospectively reviewed the records of 31 children (20 boys, 11 girls; mean age 10.6 years, range 1.1-17.9 years) with SCD and acute bone pain who underwent MR imaging including unenhanced T1-W fat-saturated images from 2005 to 2010. Complete clinical charts were reviewed by a pediatric hematologist with training in infectious diseases to determine a clinical standard to define the presence",
        "q2": " or absence of osteomyelitis. A pediatric radiologist reviewed all MR imaging and was blinded to clinical information. Based on the signal intensity in T1-W fat-saturated images, the children were further classified as positive for osteomyelitis (low bone marrow signal intensity) or positive for bone infarct (high bone marrow signal intensity).\nBased on the clinical standard, 5 children were classified as positive for osteomyelitis and 26 children as positive for bone infarct (negative for osteomyelitis). The bone marrow signal intensity on T1-W fat-saturated imaging was not significant for the differentiation between bone infarct and osteomyelitis (P\u2009=\u20090.56). None of the additional evaluated imaging parameters on unenhanced MRI proved reliable in differentiating these diagnoses.\nUtility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease -- can it differentiate bone infarcts from acute osteomyelitis?",
        "generated_text": "or absence of osteomyelitis. Two radiologists independently reviewed the MR images and recorded the presence or absence of bone marrow edema, bone infarct, and osteomyelitis. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of unenhanced T1-W fat-saturated images for the diagnosis of osteomyelitis were calculated.\nThe clinical standard defined 14 patients with osteomyelitis and 17 with bone infarcts. The interobserver agreement for the diagnosis of osteomyelitis was excellent (kappa = 0.87). The sensitivity, specificity, PPV, NPV, and accuracy of unenhanced T1-W fat-saturated images for the diagnosis of osteomyelitis were 85.7%, 100%, 100%, 94.1%, and 96.8%, respectively.\nUnenhanced T",
        "levenshtein_distance": 655
    },
    {
        "realidx": "26215326",
        "question": "The objective of the study was to determine whether risk of recurrent preterm birth differs based on the clinical presentation of a prior spontaneous preterm birth (SPTB): advanced cervical dilatation (ACD), preterm premature rupture of membranes (PPROM), or preterm labor (PTL).\nThis retrospective cohort study included singleton pregnancies from 2009 to 2014 complicated by a history of prior SPTB. Women were categorized based on the clinical presentation of their prior preterm delivery as having ACD, PPROM, or PTL. Risks for sonographic short cervical length and recurrent SPTB were compared between women based on the clinical presentation of their prior preterm birth. Log-linear regression was used to control for confounders.\nOf 522 patients included in this study, 96 (18.4%) had prior ACD, 246 (47.1%) had prior PPROM, and 180 (34.5%) had prior PTL. Recurrent PTB occurred in 55.2% of patients with a history of ACD compared with 27.2% of those with PPROM and 32.2% with PTL (P = .001). The mean gestational age at delivery was significantly lower for those with a history of ACD (34.0 weeks) compared with women with prior PPROM (37.2 weeks) or PTL (37.0 weeks) (P = .001). The lowest mean cervical length prior to 24 weeks was significantly shorter in patients with a history of advanced cervical dilation when compared with the other clinical presentations.\nDoes the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy?",
        "answer": "yes",
        "answer_rationale": "Patients with a history of ACD are at an increased risk of having recurrent preterm birth and cervical shortening in a subsequent pregnancy compared with women with prior preterm birth associated PPROM or PTL.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The objective of the study was to determine whether risk of recurrent preterm birth differs based on the clinical presentation of a prior spontaneous preterm birth (SPTB): advanced cervical dilatation (ACD), preterm premature rupture of membranes (PPROM), or preterm labor (PTL).\nThis retrospective cohort study included singleton pregnancies from 2009 to 2014 complicated by a history of prior SPTB. Women were categorized based on the clinical presentation of their prior preterm delivery as having ACD, PPROM, or PTL. Risks for sonographic short cervical length and recurrent SPTB were compared between women based on the clinical presentation of their prior preterm birth. Log-linear regression was used to control for confounders.\nOf 522 patients included in this study, 96 (18.4%) had prior ACD",
        "q2": ", 246 (47.1%) had prior PPROM, and 180 (34.5%) had prior PTL. Recurrent PTB occurred in 55.2% of patients with a history of ACD compared with 27.2% of those with PPROM and 32.2% with PTL (P = .001). The mean gestational age at delivery was significantly lower for those with a history of ACD (34.0 weeks) compared with women with prior PPROM (37.2 weeks) or PTL (37.0 weeks) (P = .001). The lowest mean cervical length prior to 24 weeks was significantly shorter in patients with a history of advanced cervical dilation when compared with the other clinical presentations.\nDoes the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy?",
        "generated_text": ", 124 (23.8%) had prior PPROM, and 302 (57.8%) had prior PTL. Women with prior ACD had a higher risk of recurrent SPTB compared to women with prior PPROM (adjusted odds ratio [aOR], 2.1; 95% confidence interval [CI], 1.1-4.1) and prior PTL (aOR, 2.1; 95% CI, 1.2-3.7). Women with prior PPROM had a higher risk of recurrent SPTB compared to women with prior PTL (aOR, 1.5; 95% CI, 1.0-2.4). Women with prior ACD had a higher risk of sonographic short cerv",
        "levenshtein_distance": 460
    },
    {
        "realidx": "26304701",
        "question": "The effect of preoperative education on anxiety and postoperative outcomes of cardiac surgery patients remains unclear.AIM: The aim of the study was to estimate the effectiveness of a nurse-led preoperative education on anxiety and postoperative outcomes.\nA randomised controlled study was designed. All the patients who were admitted for elective cardiac surgery in a general hospital in Athens with knowledge of the Greek language were eligible to take part in the study. Patients in the intervention group received preoperative education by specially trained nurses. The control group received the standard information by the ward personnel. Measurements of anxiety were conducted on admission-A, before surgery-B and before discharge-C by the state-trait anxiety inventory.\nThe sample consisted of 395 patients (intervention group: 205, control group: 190). The state anxiety on the day before surgery decreased only in the intervention group (34.0 (8.4) versus 36.9 (10.7); P=0.001). The mean decrease in state score during the follow-up period was greater in the intervention group (P=0.001). No significant difference was found in the length of stay or readmission. Lower proportions of chest infection were found in the intervention group (10 (5.3) versus 1 (0.5); P=0.004). Multivariate linear regression revealed that education and score in trait anxiety scale on admission are independent predictors of a reduction in state anxiety.\nCan nurse-led preoperative education reduce anxiety and postoperative complications of patients undergoing cardiac surgery?",
        "answer": "yes",
        "answer_rationale": "Preoperative education delivered by nurses reduced anxiety and postoperative complications of patients undergoing cardiac surgery, but it was not effective in reducing readmissions or length of stay.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The effect of preoperative education on anxiety and postoperative outcomes of cardiac surgery patients remains unclear.AIM: The aim of the study was to estimate the effectiveness of a nurse-led preoperative education on anxiety and postoperative outcomes.\nA randomised controlled study was designed. All the patients who were admitted for elective cardiac surgery in a general hospital in Athens with knowledge of the Greek language were eligible to take part in the study. Patients in the intervention group received preoperative education by specially trained nurses. The control group received the standard information by the ward personnel. Measurements of anxiety were conducted on admission-A, before surgery-B and before discharge-C by the state-trait anxiety inventory.\nThe sample consisted of 395 patients (intervention group: 205, control group: 190",
        "q2": "). The state anxiety on the day before surgery decreased only in the intervention group (34.0 (8.4) versus 36.9 (10.7); P=0.001). The mean decrease in state score during the follow-up period was greater in the intervention group (P=0.001). No significant difference was found in the length of stay or readmission. Lower proportions of chest infection were found in the intervention group (10 (5.3) versus 1 (0.5); P=0.004). Multivariate linear regression revealed that education and score in trait anxiety scale on admission are independent predictors of a reduction in state anxiety.\nCan nurse-led preoperative education reduce anxiety and postoperative complications of patients undergoing cardiac surgery?",
        "generated_text": "). The intervention group had lower anxiety scores at all three time points (A: 40.1 vs 42.1, p=0.001; B: 42.1 vs 44.1, p=0.001; C: 39.1 vs 41.1, p=0.001). The intervention group had a lower incidence of postoperative complications (12.7% vs 18.4%, p=0.04), shorter hospital stay (10.1 vs 11.1 days, p=0.001) and lower hospital costs (\u20ac10,100 vs \u20ac11,",
        "levenshtein_distance": 533
    },
    {
        "realidx": "26348845",
        "question": "Rapid prescreening (RPS) is one of the quality assurance (QA) methods used in gynecologic cytology. The efficacy of RPS has been previously studied but mostly with respect to squamous lesions; in fact, there has been no study so far specifically looking at the sensitivity of RPS for detecting glandular cell abnormalities.\nA total of 80,565 Papanicolaou (Pap) smears underwent RPS during a 25-month period. A sample was designated as \"review for abnormality\" (R) if any abnormal cells (at the threshold of atypical squamous cells of undetermined significance/atypical glandular cells [AGC]) were thought to be present or was designated as negative (N) if none were detected. Each sample then underwent full screening (FS) and was designated as either R or N and also given a cytologic interpretation.\nThe final cytologic interpretation was a glandular cell abnormality (\u2265AGC) in 107 samples (0.13%); 39 of these (36.4%) were flagged as R on RPS. Twenty-four patients (33.8%) out of 71 who had histologic follow-up were found to harbor a high-grade squamous intraepithelial lesion or carcinoma; 13 of those 24 Pap smears (54.2%) had been flagged as R on RPS. Notably, 11 AGC cases were picked up by RPS only and not by FS and represented false-negative cases; 2 of these showed endometrial adenocarcinoma on histologic follow-up.\nPap smears with glandular cell abnormalities: Are they detected by rapid prescreening?",
        "answer": "yes",
        "answer_rationale": "Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Rapid prescreening (RPS) is one of the quality assurance (QA) methods used in gynecologic cytology. The efficacy of RPS has been previously studied but mostly with respect to squamous lesions; in fact, there has been no study so far specifically looking at the sensitivity of RPS for detecting glandular cell abnormalities.\nA total of 80,565 Papanicolaou (Pap) smears underwent RPS during a 25-month period. A sample was designated as \"review for abnormality\" (R) if any abnormal cells (at the threshold of atypical squamous cells of undetermined significance/atypical glandular cells [AGC]) were thought to be present or was designated as negative (N) if none were detected. Each sample then underwent full screening (FS) and was designated as either R",
        "q2": " or N and also given a cytologic interpretation.\nThe final cytologic interpretation was a glandular cell abnormality (\u2265AGC) in 107 samples (0.13%); 39 of these (36.4%) were flagged as R on RPS. Twenty-four patients (33.8%) out of 71 who had histologic follow-up were found to harbor a high-grade squamous intraepithelial lesion or carcinoma; 13 of those 24 Pap smears (54.2%) had been flagged as R on RPS. Notably, 11 AGC cases were picked up by RPS only and not by FS and represented false-negative cases; 2 of these showed endometrial adenocarcinoma on histologic follow-up.\nPap smears with glandular cell abnormalities: Are they detected by rapid prescreening?",
        "generated_text": "or N. The final diagnosis was based on the FS result. The RPS and FS results were compared with the final diagnosis to calculate the sensitivity and specificity of RPS for glandular cell abnormalities.\nA total of 79,915 samples were included in the study. The sensitivity of RPS for glandular cell abnormalities was 87.5% (95% confidence interval [CI], 81.1-92.1), and the specificity was 99.9% (95% CI, 99.9-99.9). The positive predictive value was 92.3% (95% CI, 85.4-96.4), and the negative predictive value was 99.9% (95% CI, 99.9-",
        "levenshtein_distance": 519
    },
    {
        "realidx": "26370095",
        "question": "To investigate the cost-effectiveness of up to \u00a3400 worth of financial incentives for smoking cessation in pregnancy as an adjunct to routine health care.\nCost-effectiveness analysis based on a Phase II randomized controlled trial (RCT) and a cost-utility analysis using a life-time Markov model.\nThe RCT was undertaken in Glasgow, Scotland. The economic analysis was undertaken from the UK National Health Service (NHS) perspective.\nA total of 612 pregnant women randomized to receive usual cessation support plus or minus financial incentives of up to \u00a3400 vouchers (US $609), contingent upon smoking cessation.\nComparison of usual support and incentive interventions in terms of cotinine-validated quitters, quality-adjusted life years (QALYs) and direct costs to the NHS.\nThe incremental cost per quitter at 34-38 weeks pregnant was \u00a31127 ($1716).This is similar to the standard look-up value derived from Stapleton&West's published ICER tables, \u00a31390 per quitter, by looking up the Cessation in Pregnancy Incentives Trial (CIPT) incremental cost (\u00a3157) and incremental 6-month quit outcome (0.14). The life-time model resulted in an incremental cost of \u00a317 [95% confidence interval (CI)\u2009=\u2009-\u00a393, \u00a3107] and a gain of 0.04 QALYs (95% CI\u2009=\u2009-0.058, 0.145), giving an ICER of \u00a3482/QALY ($734/QALY). Probabilistic sensitivity analysis indicates uncertainty in these results, particularly regarding relapse after birth. The expected value of perfect information was \u00a330 million (at a willingness to pay of \u00a330\u2009000/QALY), so given current uncertainty, additional research is potentially worthwhile.\nAre financial incentives cost-effective to support smoking cessation during pregnancy?",
        "answer": "yes",
        "answer_rationale": "Financial incentives for smoking cessation in pregnancy are highly cost-effective, with an incremental cost per quality-adjusted life years of \u00a3482, which is well below recommended decision thresholds.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the cost-effectiveness of up to \u00a3400 worth of financial incentives for smoking cessation in pregnancy as an adjunct to routine health care.\nCost-effectiveness analysis based on a Phase II randomized controlled trial (RCT) and a cost-utility analysis using a life-time Markov model.\nThe RCT was undertaken in Glasgow, Scotland. The economic analysis was undertaken from the UK National Health Service (NHS) perspective.\nA total of 612 pregnant women randomized to receive usual cessation support plus or minus financial incentives of up to \u00a3400 vouchers (US $609), contingent upon smoking cessation.\nComparison of usual support and incentive interventions in terms of cotinine-validated quitters, quality-adjusted life years (QALYs) and direct costs to the NHS.\nThe incremental cost per quitter at 34-38 weeks pregnant was \u00a31127 ($1716).This is similar to the standard look-up value derived from Stapleton&",
        "q2": "West's published ICER tables, \u00a31390 per quitter, by looking up the Cessation in Pregnancy Incentives Trial (CIPT) incremental cost (\u00a3157) and incremental 6-month quit outcome (0.14). The life-time model resulted in an incremental cost of \u00a317 [95% confidence interval (CI)\u2009=\u2009-\u00a393, \u00a3107] and a gain of 0.04 QALYs (95% CI\u2009=\u2009-0.058, 0.145), giving an ICER of \u00a3482/QALY ($734/QALY). Probabilistic sensitivity analysis indicates uncertainty in these results, particularly regarding relapse after birth. The expected value of perfect information was \u00a330 million (at a willingness to pay of \u00a330\u2009000/QALY), so given current uncertainty, additional research is potentially worthwhile.\nAre financial incentives cost-effective to support smoking cessation during pregnancy?",
        "generated_text": "rsquo;s meta-analysis of smoking cessation interventions. The incremental cost per QALY was \u00a310,100 ($15,340). This is below the commonly used threshold of \u00a320,000 ($30,400) per QALY.\nFinancial incentives are a cost-effective intervention for smoking cessation in pregnancy, and should be considered as part of a comprehensive smoking cessation strategy for pregnant women.\nThe study you're referring to investigates the cost-effectiveness of providing financial incentives up to \u00a3400 for smoking cessation in pregnant women, in addition to standard healthcare support. The research is based on a Phase II randomized controlled trial (RCT) and a cost-utility analysis using a lifetime Markov model. The trial was conducted in Glasgow, Scotland, and the economic analysis was from the perspective of the UK National Health Service (NHS).\n\nA total of 612",
        "levenshtein_distance": 683
    },
    {
        "realidx": "26418441",
        "question": "Polyps identified at colonoscopy are predominantly diminutive (<5\u2009mm) with a small risk (>1%) of high-grade dysplasia or carcinoma; however, the cost of histological assessment is substantial.AIM: The aim of this study was to determine whether prediction of colonoscopy surveillance intervals based on real-time endoscopic assessment of polyp histology is accurate and cost effective.\nA prospective cohort study was conducted across a tertiary care and private community hospital. Ninety-four patients underwent colonoscopy and polypectomy of diminutive (\u22645\u2009mm) polyps from October 2012 to July 2013, yielding a total of 159 polyps. Polyps were examined and classified according to the Sano-Emura classification system. The endoscopic assessment (optical diagnosis) of polyp histology was used to predict appropriate colonoscopy surveillance intervals. The main outcome measure was the accuracy of optical diagnosis of diminutive colonic polyps against the gold standard of histological assessment.\nOptical diagnosis was correct in 105/108 (97.2%) adenomas. This yielded a sensitivity, specificity and positive and negative predictive values (with 95%CI) of 97.2% (92.1-99.4%), 78.4% (64.7-88.7%), 90.5% (83.7-95.2%) and 93% (80.9-98.5%) respectively. Ninety-two (98%) patients were correctly triaged to their repeat surveillance colonoscopy. Based on these findings, a cut and discard approach would have resulted in a saving of $319.77 per patient.\nCan we ease the financial burden of colonoscopy?",
        "answer": "yes",
        "answer_rationale": "Endoscopists within a tertiary care setting can accurately predict diminutive polyp histology and confer an appropriate surveillance interval with an associated financial benefit to the healthcare system. However, limitations to its application in the community setting exist, which may improve with further training and high-definition colonoscopes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Polyps identified at colonoscopy are predominantly diminutive (<5\u2009mm) with a small risk (>1%) of high-grade dysplasia or carcinoma; however, the cost of histological assessment is substantial.AIM: The aim of this study was to determine whether prediction of colonoscopy surveillance intervals based on real-time endoscopic assessment of polyp histology is accurate and cost effective.\nA prospective cohort study was conducted across a tertiary care and private community hospital. Ninety-four patients underwent colonoscopy and polypectomy of diminutive (\u22645\u2009mm) polyps from October 2012 to July 2013, yielding a total of 159 polyps. Polyps were examined and classified according to the Sano-Emura classification system. The endoscopic assessment (optical diagnosis) of polyp histology was used to predict appropriate colonoscopy surveillance intervals",
        "q2": ". The main outcome measure was the accuracy of optical diagnosis of diminutive colonic polyps against the gold standard of histological assessment.\nOptical diagnosis was correct in 105/108 (97.2%) adenomas. This yielded a sensitivity, specificity and positive and negative predictive values (with 95%CI) of 97.2% (92.1-99.4%), 78.4% (64.7-88.7%), 90.5% (83.7-95.2%) and 93% (80.9-98.5%) respectively. Ninety-two (98%) patients were correctly triaged to their repeat surveillance colonoscopy. Based on these findings, a cut and discard approach would have resulted in a saving of $319.77 per patient.\nCan we ease the financial burden of colonoscopy?",
        "generated_text": ". The histological diagnosis was used as the gold standard. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the optical diagnosis were calculated. The cost of histological assessment was compared with the cost of surveillance colonoscopy.\nThe sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the optical diagnosis were 94.1%, 97.6%, 97.6%, 94.1%, and 96.3%, respectively. The cost of histological assessment was $10,200, whereas the cost of surveillance colonoscopy was $10,200 for the 94 patients. The cost savings from avoiding unnecessary histological assessment was $10,200.\nThe optical diagnosis of diminutive polyps is accurate and cost effective.",
        "levenshtein_distance": 498
    },
    {
        "realidx": "26419377",
        "question": "The purpose of this study was to evaluate safe depth for suture anchor insertion during acetabular labral repair and to determine the neighbouring structures at risk during drilling and anchor insertion.\nTen human cadaveric hips (six males and four females) were obtained. Acetabular labral surface was prepared and marked for right hips as 12, 1 and 3 o'clock positions, for left hips 12, 11 and 9 o'clock positions. Those were defined as anterior, anterior-superior and superior zones, respectively. These labral positions were drilled at defined zones. After measurements, depth of the bone at 10\u00b0 and 20\u00b0 drill angles on zones was compared statistically.\nAcetabular bone widths at investigated labral insertion points did not statistically differ. A total of 14 injuries in 60 penetrations occurred (23.3\u00a0%) with free drill penetrations, and no injuries occurred with stopped drill penetrations. The bone depth was gradually decreasing from 10\u00b0 to 20\u00b0 drill angles and from anterior to superior inserting zones without significant importance. The risk of perforation to the pelvic cavity started with 20\u00a0mm drill depth, and the mean depth for all insertions was calculated as 31.7\u00a0mm (SD 2.6).\nAre pelvic anatomical structures in danger during arthroscopic acetabular labral repair?",
        "answer": "yes",
        "answer_rationale": "It is anatomically possible that some pelvic structures sustain iatrogenic injury during acetabular drilling for anchor placement. Being aware of mean pelvic vault is important in which drilling after excessive pincer rim trimming could easily decrease the depth of acetabular bone without a standard. Careful drilling by using stopped drill bit is crucial to prevent iatrogenic injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The purpose of this study was to evaluate safe depth for suture anchor insertion during acetabular labral repair and to determine the neighbouring structures at risk during drilling and anchor insertion.\nTen human cadaveric hips (six males and four females) were obtained. Acetabular labral surface was prepared and marked for right hips as 12, 1 and 3 o'clock positions, for left hips 12, 11 and 9 o'clock positions. Those were defined as anterior, anterior-superior and superior zones, respectively. These labral positions were drilled at defined zones. After measurements, depth of the bone at 10\u00b0 and 20\u00b0 drill angles on zones was",
        "q2": " compared statistically.\nAcetabular bone widths at investigated labral insertion points did not statistically differ. A total of 14 injuries in 60 penetrations occurred (23.3\u00a0%) with free drill penetrations, and no injuries occurred with stopped drill penetrations. The bone depth was gradually decreasing from 10\u00b0 to 20\u00b0 drill angles and from anterior to superior inserting zones without significant importance. The risk of perforation to the pelvic cavity started with 20\u00a0mm drill depth, and the mean depth for all insertions was calculated as 31.7\u00a0mm (SD 2.6).\nAre pelvic anatomical structures in danger during arthroscopic acetabular labral repair?",
        "generated_text": "measured. The neighbouring structures at risk were identified.\nThe mean safe depth for anchor insertion was 12.1 mm (range 10.5-13.5 mm) at 10\u00b0 drill angle and 11.1 mm (range 9.5-12.5 mm) at 20\u00b0 drill angle. The mean safe depth for anchor insertion was 11.1 mm (range 9.5-12.5 mm) at 10\u00b0 drill angle and 10.1 mm (range 8.5-11.5 mm) at 20\u00b0 drill angle. The mean safe depth",
        "levenshtein_distance": 478
    },
    {
        "realidx": "26460153",
        "question": "We retrospectively identified 84 consecutive patients aged \u226580 years, who underwent a cardiac reoperation at the department for Cardiothoracic Surgery in the Heart&Vessel Center Bad Bevensen between January 2007 and 2013. Demographic profiles as well as operative data were analyzed, and the patients were prospectively followed. Patient's functional status and quality of life were assessed with the Barthel Index, New York Heart Association class and the short form-12 questionnaire.\nThe mean age of the study group (61 men, 23 women) was 81.9\u2009\u00b1\u20091.9 years. Most redo-procedures were carried out after primary coronary artery bypass grafting (65%), primary aortic valve replacement (21%) and primary mitral valve replacement (6%). The most frequent actual surgical procedures were combined coronary artery bypass grafting and aortic valve replacement (26%), isolated coronary artery bypass grafting (19%), and isolated aortic valve replacement (19%). The mean length of hospital stay was 17\u2009\u00b1\u200915 days. In-hospital mortality counted for 32.1%. During follow up (29\u2009\u00b1\u200920 months) a further 19.0% of the patients died. The Barthel Index of the survivors was 89\u2009\u00b1\u200917 and their mean New York Heart Association class was 2\u2009\u00b1\u20091. A total of 93% of the patients were living at home. Summary scores of physical and mental health of the short form-12 questionnaire equalled those of an age- and sex-matched normative population.\nCardiac reoperations in octogenarians: Do they really benefit?",
        "answer": "yes",
        "answer_rationale": "Despite high perioperative mortality, results document a sustainable recovery of the survivors offering the prospect of a highly independent and satisfying life. Therefore, advanced age alone should not be a contraindication for redo cardiac interventions. Geriatr Gerontol Int 2016; 16: 1138-1144.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We retrospectively identified 84 consecutive patients aged \u226580 years, who underwent a cardiac reoperation at the department for Cardiothoracic Surgery in the Heart&Vessel Center Bad Bevensen between January 2007 and 2013. Demographic profiles as well as operative data were analyzed, and the patients were prospectively followed. Patient's functional status and quality of life were assessed with the Barthel Index, New York Heart Association class and the short form-12 questionnaire.\nThe mean age of the study group (61 men, 23 women) was 81.9\u2009\u00b1\u20091.9 years. Most redo-procedures were carried out after primary coronary artery bypass grafting (65%), primary aortic valve replacement (21%) and primary mitral valve replacement (6%). The most frequent actual surgical procedures were",
        "q2": " combined coronary artery bypass grafting and aortic valve replacement (26%), isolated coronary artery bypass grafting (19%), and isolated aortic valve replacement (19%). The mean length of hospital stay was 17\u2009\u00b1\u200915 days. In-hospital mortality counted for 32.1%. During follow up (29\u2009\u00b1\u200920 months) a further 19.0% of the patients died. The Barthel Index of the survivors was 89\u2009\u00b1\u200917 and their mean New York Heart Association class was 2\u2009\u00b1\u20091. A total of 93% of the patients were living at home. Summary scores of physical and mental health of the short form-12 questionnaire equalled those of an age- and sex-matched normative population.\nCardiac reoperations in octogenarians: Do they really benefit?",
        "generated_text": "aortic valve replacement (41%), coronary artery bypass grafting (34%) and mitral valve replacement (14%). The mean duration of cardiopulmonary bypass was 124\u2009\u00b1\u200953 minutes, and the mean cross-clamp time was 74\u2009\u00b1\u200940 minutes. The overall in-hospital mortality was 10.7%. The mean follow-up was 3.2\u2009\u00b1\u20091.4 years. The 1-, 3- and 5-year survival rates were 89.3%, 77.4% and 65.5%, respectively. The Barthel Index and the New York Heart Association class improved significantly after surgery. The physical component summary of the short form-12 questionnaire improved significantly,",
        "levenshtein_distance": 475
    },
    {
        "realidx": "26471488",
        "question": "Limited and conflicting data exist on an association between mammographic density (MD) and re-excision rates after breast-conserving surgery (BCS). Additionally, the correlation of MD with resection of unnecessary margins during initial BCS is unknown.\nAll women with a diagnosis of breast cancer from 2003 to 2012 and enrolled in a larger study on MD were evaluated. Operative and pathology reports were reviewed to determine margin resection and involvement. Mammographic density was determined both by breast imaging-reporting and data system (BI-RADS) classification and by an automated software program (Volpara Solutions). Additional margins were deemed unnecessary if the lumpectomy specimen margin was free of invasive tumor [\u22652 mm for ductal carcinoma in situ (DCIS)] or if further re-excision was needed.\nOf 655 patients, 398 (60.8%) had BCS, whereas 226 (34.5%) underwent initial mastectomy. The women with denser breasts (BI-RADS 3 or 4) underwent initial mastectomy more frequently than the women with less dense breasts (40.0 vs. 30.5%, respectively; p = 0.0118). Of the patients with BCS, 166 (41.7%) required separate re-excision. Additional margins were taken during BCS in 192 (48.2%) patients, with 151 (78.6%) proving to be unnecessary. In the bivariable analysis, the patients with denser breasts according to BI-RADS classification and volumetric density showed a trend toward requiring more frequent re-excision, but this association was not seen in the multivariable analysis. The rate of unnecessary margins did not differ by breast density. In the multivariate analysis, the re-excision rates increased with DCIS (p<0.0003) and decreased with resection of additional margins (p = 0.0043).\nDoes Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?",
        "answer": "no",
        "answer_rationale": "Mammographic density is not associated with an increased need for re-excision or resection of unnecessary margins at initial BCS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Limited and conflicting data exist on an association between mammographic density (MD) and re-excision rates after breast-conserving surgery (BCS). Additionally, the correlation of MD with resection of unnecessary margins during initial BCS is unknown.\nAll women with a diagnosis of breast cancer from 2003 to 2012 and enrolled in a larger study on MD were evaluated. Operative and pathology reports were reviewed to determine margin resection and involvement. Mammographic density was determined both by breast imaging-reporting and data system (BI-RADS) classification and by an automated software program (Volpara Solutions). Additional margins were deemed unnecessary if the lumpectomy specimen margin was free of invasive tumor [\u22652 mm for ductal carcinoma in situ (DCIS)] or if further re-excision was needed.\nOf 655 patients, 398 (60.8%) had BCS, whereas 226 (34.5%) underwent initial mastectomy. The women with denser breasts (BI-RADS 3 or ",
        "q2": "4) underwent initial mastectomy more frequently than the women with less dense breasts (40.0 vs. 30.5%, respectively; p = 0.0118). Of the patients with BCS, 166 (41.7%) required separate re-excision. Additional margins were taken during BCS in 192 (48.2%) patients, with 151 (78.6%) proving to be unnecessary. In the bivariable analysis, the patients with denser breasts according to BI-RADS classification and volumetric density showed a trend toward requiring more frequent re-excision, but this association was not seen in the multivariable analysis. The rate of unnecessary margins did not differ by breast density. In the multivariate analysis, the re-excision rates increased with DCIS (p<0.0003) and decreased with resection of additional margins (p = 0.0043).\nDoes Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?",
        "generated_text": "4) were more likely to have BCS (P = 0.001). Among the 398 women who had BCS, 122 (30.6%) had re-excision. Women with higher MD (BI-RADS 4 vs. 1-2) had higher re-excision rates (36.4% vs. 25.0%, P = 0.02). The re-excision rate was higher in women with DCIS (40.0% vs. 28.7%, P = 0.04). The re-excision rate was higher in women with higher MD (Volpara density \u226550% vs. <50%, 35.4% vs. 26.7%, P = 0.04). The re-excision rate was higher in women with higher MD (Volpara density \u226550% vs. <50%, 35.4%",
        "levenshtein_distance": 646
    },
    {
        "realidx": "26516021",
        "question": "Evidence-based practice (EBP) is widely promoted, but does EBP produce better patient outcomes? We report a natural experiment when part of the internal medicine service in a hospital was reorganized in 2003 to form an EBP unit, the rest of the service remaining unchanged. The units attended similar patients until 2012 permitting comparisons of outcomes and activity.\nWe used routinely collected statistics (2004-11) to compare the two different methods of practice and test whether patients being seen by the EBP unit differed from standard practice (SP) patients. Data were available by doctor and year. To check for differences between the EBP and SP doctors prior to reorganization, we used statistics from 2000 to 2003. We looked for changes in patient outcomes or activity following reorganization and whether the EBP unit was achieving significantly different results from SP. Data across the periods were combined and tested using Mann-Whitney test.\nNo statistically significant differences in outcomes were detected between the EBP and the SP doctors prior to reorganization. Following the unit's establishment, the mortality of patients being treated by EBP doctors compared with their previous performance dropped from 7.4% to 6.3% (P\u2009<\u20090.02) and length of stay from 9.15 to 6.01 days (P\u2009=\u20090.002). No statistically significant improvements were seen in SP physicians' performance. No differences in the proportion of patients admitted or their complexity between the services were detected. Despite this, EBP patients had a clinically significantly lower risk of death 6.27% versus 7.75% (P\u2009<\u20090.001) and a shorter length of stay 6.01 versus 8.46 days (P\u2009<\u20090.001) than SP patients. Readmission rates were similar: 14.4% (EBP); 14.5% (SP). EBP doctors attended twice as many patients/doctor as SP doctors.\nDoes evidence-based practice improve patient outcomes?",
        "answer": "yes",
        "answer_rationale": "The EBP unit was associated with better patient outcomes and more efficient performance than achieved by the same physicians previously or by SP concurrently.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Evidence-based practice (EBP) is widely promoted, but does EBP produce better patient outcomes? We report a natural experiment when part of the internal medicine service in a hospital was reorganized in 2003 to form an EBP unit, the rest of the service remaining unchanged. The units attended similar patients until 2012 permitting comparisons of outcomes and activity.\nWe used routinely collected statistics (2004-11) to compare the two different methods of practice and test whether patients being seen by the EBP unit differed from standard practice (SP) patients. Data were available by doctor and year. To check for differences between the EBP and SP doctors prior to reorganization, we used statistics from 2000 to 2003. We looked for changes in patient outcomes or activity following reorganization and whether the EBP unit was achieving significantly different results from SP. Data across the periods were combined and tested using Mann-Whitney test.\nNo statistically significant differences in outcomes were detected between the EBP and the SP doctors prior to",
        "q2": " reorganization. Following the unit's establishment, the mortality of patients being treated by EBP doctors compared with their previous performance dropped from 7.4% to 6.3% (P\u2009<\u20090.02) and length of stay from 9.15 to 6.01 days (P\u2009=\u20090.002). No statistically significant improvements were seen in SP physicians' performance. No differences in the proportion of patients admitted or their complexity between the services were detected. Despite this, EBP patients had a clinically significantly lower risk of death 6.27% versus 7.75% (P\u2009<\u20090.001) and a shorter length of stay 6.01 versus 8.46 days (P\u2009<\u20090.001) than SP patients. Readmission rates were similar: 14.4% (EBP); 14.5% (SP). EBP doctors attended twice as many patients/doctor as SP doctors.\nDoes evidence-based practice improve patient outcomes?",
        "generated_text": "reorganization. Following reorganization, the EBP unit had significantly higher mortality rates (p=0.001), higher readmission rates (p=0.001), higher bed days per patient (p=0.001), higher bed occupancy (p=0.001), higher bed turnover (p=0.001), higher bed occupancy per doctor (p=0.001), higher bed turnover per doctor (p=0.001), higher number of patients per doctor (p=0.001), higher number of discharges per doctor (p=0.001), higher number of readmissions per doctor (p=0.001), higher number of bed days per doctor (p=0.001), higher number of bed days per patient (p=0.001), higher number of bed days per discharge (p=0.001), higher number of bed days per readmission",
        "levenshtein_distance": 595
    },
    {
        "realidx": "26536001",
        "question": "It is unknown whether tumoral somatostatin receptor subtype 2a (sst2a) immunohistochemistry (IHC) has additional value compared to somatostatin receptor scintigraphy (SRS) uptake using OctreoScan\u00ae in predicting response to peptide receptor radiotherapy using 177Lu-octreotate (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aims of this study were: (1) to establish the percentage of sst2a immunopositivity in GEP-NET samples of PRRT-treated patients, (2) to determine the relationship between best GEP-NET response using RECIST 1.0 criteria 1 year after PRRT and tumoral sst2a IHC, and (3) to compare characteristics of patients with sst2a IHC-negative and -positive tumors.\nAll 73 consecutive patients were selected for PRRT based on a positive SRS. Radiological response was scored according to RECIST 1.0 criteria. sst2a status was detected on tumor samples by IHC.\nIn total, 93% of GEP-NET samples showed sst2a IHC positivity. No statistically significant relationship was observed between in vitro sst2a expression and in vivo best GEP-NET response 1 year after PRRT (p = 0.47). Sex, primary tumor site, disease stage, ENETS TNM classification, Ki-67 index, highest serum chromogranin-A level, and highest neuron-specific enolase level were not significantly different between patients with negative and positive sst2a tumoral IHC with the exception of age at diagnosis (p = 0.007).\nIs There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?",
        "answer": "no",
        "answer_rationale": "sst2a IHC of tumor samples has no additional value compared to SRS uptake using OctreoScan\u00ae in predicting tumor response after PRRT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "It is unknown whether tumoral somatostatin receptor subtype 2a (sst2a) immunohistochemistry (IHC) has additional value compared to somatostatin receptor scintigraphy (SRS) uptake using OctreoScan\u00ae in predicting response to peptide receptor radiotherapy using 177Lu-octreotate (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aims of this study were: (1) to establish the percentage of sst2a immunopositivity in GEP-NET samples of PRRT-treated patients, (2) to determine the relationship between best GEP-NET response using RECIST 1.0 criteria 1 year after PRRT and tumoral sst2a IHC, and (3) to compare characteristics of patients with sst2a IHC-negative and -positive tumors.\nAll 73 consecutive patients were selected for PRRT based on a positive SRS. Radiological response",
        "q2": " was scored according to RECIST 1.0 criteria. sst2a status was detected on tumor samples by IHC.\nIn total, 93% of GEP-NET samples showed sst2a IHC positivity. No statistically significant relationship was observed between in vitro sst2a expression and in vivo best GEP-NET response 1 year after PRRT (p = 0.47). Sex, primary tumor site, disease stage, ENETS TNM classification, Ki-67 index, highest serum chromogranin-A level, and highest neuron-specific enolase level were not significantly different between patients with negative and positive sst2a tumoral IHC with the exception of age at diagnosis (p = 0.007).\nIs There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?",
        "generated_text": "was assessed using RECIST 1.0 criteria 1 year after PRRT. Tumor samples were stained for sst2a using immunohistochemistry. The relationship between sst2a IHC and response to PRRT was determined using logistic regression analysis.\nSst2a IHC was positive in 54% of the patients. The percentage of sst2a IHC-positive patients was higher in patients with a positive response to PRRT compared to patients with stable disease or progressive disease (67% vs. 47%, p=0.04). In multivariate analysis, sst2a IHC positivity was independently associated with a positive response to PRRT (OR 2.7, 95% CI 1.1-6.8, p=0.03). Patients with sst2a IHC-negative tumors had a higher Ki-67 index (p=0.001), more often had liver metastases (p=",
        "levenshtein_distance": 613
    },
    {
        "realidx": "26548832",
        "question": "Longitudinally following patients requires a full-time employee (FTE)-dependent data inflow infrastructure. There are efforts to capture patient-reported outcomes (PROs) by the use of non-FTE-dependent methodologies. In this study, we set out to assess the reliability of PRO data captured via FTE-dependent compared with non-FTE-dependent methodologies.\nA total of 119 adult patients (65 men) who underwent 1-and 2-level lumbar fusions at Duke University Medical Center were enrolled in this prospective study. Enrollment criteria included available demographic, clinical, and PRO data. All patients completed 2 sets of questionnaires--the first a phone interviews and the second a self-survey. There was at least a 2-week period between the phone interviews and self-survey. Questionnaires included the Oswestry Disability Index (ODI), the visual analog scale for back pain (VAS-BP), and the visual analog scale for leg pain (VAS-LP). Repeated-measures analysis of variance was used to compare the reliability of baseline PRO data captured.\nA total of 39.49% of patients were smokers, 21.00% had diabetes, and 11.76% had coronary artery disease; 26.89% reported history of anxiety disorder, and 28.57% reported history of depression. A total of 97.47% of patients had a high-school diploma or General Education Development, and 49.57% attained a 4-year college degree or postgraduate degree. We observed a high correlation between baseline PRO data captured between FTE-dependent versus non-FTE dependent methodologies (ODI: r = -0.89, VAS-BP: r = 0.74, VAS-LP: r = 0.70). There was no difference in PROs of baseline pain and functional disability between FTE-dependent and non-FTE-dependent methodologies: baseline ODI (FTE-dependent: 47.73 \u00b1 16.77 [mean \u00b1 SD] vs. non-FTE-dependent: 45.81 \u00b1 12.11, P = 0.39), VAS-LP (FTE-dependent: 6.13 \u00b1 2.78 vs. non-FTE-dependent: 6.46 \u00b1 2.79, P = 0.36) and VAS-BP (FTE-dependent: 6.33 \u00b1 2.90 vs. non-FTE-dependent: 6.53 \u00b1 2.48, P = 0.57).\nAssessing Patient Reported Outcomes Measures via Phone Interviews Versus Patient Self-Survey in the Clinic: Are We Measuring the Same Thing?",
        "answer": "yes",
        "answer_rationale": "Our study suggests that there is great reliability between PRO data captured between FTE-dependent and non-FTE-dependent methodologies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Longitudinally following patients requires a full-time employee (FTE)-dependent data inflow infrastructure. There are efforts to capture patient-reported outcomes (PROs) by the use of non-FTE-dependent methodologies. In this study, we set out to assess the reliability of PRO data captured via FTE-dependent compared with non-FTE-dependent methodologies.\nA total of 119 adult patients (65 men) who underwent 1-and 2-level lumbar fusions at Duke University Medical Center were enrolled in this prospective study. Enrollment criteria included available demographic, clinical, and PRO data. All patients completed 2 sets of questionnaires--the first a phone interviews and the second a self-survey. There was at least a 2-week period between the phone interviews and self-survey. Questionnaires included the Oswestry Disability Index (ODI), the visual analog scale for back pain (VAS-BP), and the visual analog scale for leg pain (VAS-LP). Repeated-measures analysis of variance was used to compare the reliability of baseline PRO data captured.\nA total of 39.49% of patients were smokers, 21.00% had diabetes, and 11.76% had coronary artery disease; 26.89% reported history of anxiety disorder, and 28.57% reported history of depression. A total",
        "q2": " of 97.47% of patients had a high-school diploma or General Education Development, and 49.57% attained a 4-year college degree or postgraduate degree. We observed a high correlation between baseline PRO data captured between FTE-dependent versus non-FTE dependent methodologies (ODI: r = -0.89, VAS-BP: r = 0.74, VAS-LP: r = 0.70). There was no difference in PROs of baseline pain and functional disability between FTE-dependent and non-FTE-dependent methodologies: baseline ODI (FTE-dependent: 47.73 \u00b1 16.77 [mean \u00b1 SD] vs. non-FTE-dependent: 45.81 \u00b1 12.11, P = 0.39), VAS-LP (FTE-dependent: 6.13 \u00b1 2.78 vs. non-FTE-dependent: 6.46 \u00b1 2.79, P = 0.36) and VAS-BP (FTE-dependent: 6.33 \u00b1 2.90 vs. non-FTE-dependent: 6.53 \u00b1 2.48, P = 0.57).\nAssessing Patient Reported Outcomes Measures via Phone Interviews Versus Patient Self-Survey in the Clinic: Are We Measuring the Same Thing?",
        "generated_text": "of 100 patients (84.03%) completed both the phone interview and self-survey. The mean ODI was 42.02 (SD, 16.12) and 41.57 (SD, 16.12), respectively, for the phone interview and self-survey (P = .72). The mean VAS-BP was 5.71 (SD, 2.71) and 5.62 (SD, 2.71), respectively, for the phone interview and self-survey (P = .77). The mean VAS-LP was 5.41 (SD, 3.11) and 5.32 (SD, 3.11), respectively, for the phone interview and self-survey (P = .80). There was no significant difference in the ODI, VAS-BP, and VAS-LP between the phone interview and self-survey.\nThis study suggests that PRO data captured via non-FTE-dependent methodologies are reliable and comparable to FTE-dependent methodologies. This may allow for a more efficient and cost-effective way to collect PRO data in clinical practice.",
        "levenshtein_distance": 698
    },
    {
        "realidx": "26556589",
        "question": "Achilles tendon structure deteriorates 2-days after maximal loading in elite athletes. The load-response behaviour of tendons may be altered in type 1 diabetes mellitus (T1DM) as hyperglycaemia accelerates collagen cross-linking. This study compared Achilles tendon load-response in participants with T1DM and controls.\nAchilles tendon structure was quantified at day-0, day-2 and day-4 after a 10\u00a0km run. Ultrasound tissue characterisation (UTC) measures tendon structural integrity by classifying pixels as echo-type I, II, III or IV. Echo-type I has the most aligned collagen fibrils and IV has the least.\nParticipants were 7 individuals with T1DM and 10 controls. All regularly ran distances greater than 5\u00a0km and VISA-A scores indicated good tendon function (T1DM\u2009=\u200994\u2009\u00b1\u200911, control\u2009=\u200994\u2009\u00b1\u200910). There were no diabetic complications and HbA1c was 8.7\u2009\u00b1\u20092.6\u00a0mmol/mol for T1DM and 5.3\u2009\u00b1\u20090.4\u00a0mmol/mol for control groups. Baseline tendon structure was similar in T1DM and control groups - UTC echo-types (I-IV) and anterior-posterior thickness were all p\u2009>\u20090.05. No response to load was seen in either T1DM or control group over the 4-days post exercise.\nDoes type 1 diabetes mellitus affect Achilles tendon response to a 10\u00a0km run?",
        "answer": "no",
        "answer_rationale": "Active individuals with T1DM do not have a heightened Achilles tendon response to load, which suggests no increased risk of tendon injury. We cannot extrapolate these findings to sedentary individuals with T1DM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Achilles tendon structure deteriorates 2-days after maximal loading in elite athletes. The load-response behaviour of tendons may be altered in type 1 diabetes mellitus (T1DM) as hyperglycaemia accelerates collagen cross-linking. This study compared Achilles tendon load-response in participants with T1DM and controls.\nAchilles tendon structure was quantified at day-0, day-2 and day-4 after a 10\u00a0km run. Ultrasound tissue characterisation (UTC) measures tendon structural integrity by classifying pixels as echo-type I, II, III or IV. Echo-type I has the most aligned collagen fibrils and IV has the least.\nParticipants were 7 individuals with T1DM and 10 controls. All regularly ran distances greater than 5\u00a0",
        "q2": "km and VISA-A scores indicated good tendon function (T1DM\u2009=\u200994\u2009\u00b1\u200911, control\u2009=\u200994\u2009\u00b1\u200910). There were no diabetic complications and HbA1c was 8.7\u2009\u00b1\u20092.6\u00a0mmol/mol for T1DM and 5.3\u2009\u00b1\u20090.4\u00a0mmol/mol for control groups. Baseline tendon structure was similar in T1DM and control groups - UTC echo-types (I-IV) and anterior-posterior thickness were all p\u2009>\u20090.05. No response to load was seen in either T1DM or control group over the 4-days post exercise.\nDoes type 1 diabetes mellitus affect Achilles tendon response to a 10\u00a0km run?",
        "generated_text": "km. At day-0, there was no difference in echo-type I between T1DM and controls (p\u00a0=\u00a00.12). At day-2, echo-type I was lower in T1DM compared to controls (p\u00a0=\u00a00.04). At day-4, echo-type I was similar between groups (p\u00a0=\u00a00.12). There was no difference in echo-type IV between groups at any time point (p\u00a0>\u00a00.05).\nIn conclusion, the Achilles tendon load-response was altered in T1DM compared to controls. This may be due to differences in tendon structure and/or collagen cross-linking. Further research is needed to understand the mechanisms underlying these differences and their implications for tendon health in",
        "levenshtein_distance": 464
    },
    {
        "realidx": "26561905",
        "question": "To compare the dose intensity and toxicity profiles for patients undergoing chemotherapy at the Townsville Cancer Centre (TCC), a tertiary cancer centre in northern Queensland, with those for patients treated in Mount Isa, supervised by the same medical oncologists via teleoncology.\nA quasi-experimental design comparing two patient groups.\nTCC and Mount Isa Hospital, which both operate under the auspices of the Townsville Teleoncology Network (TTN).\nEligible patients who received chemotherapy at TCC or Mt Isa Hospital between 1 May 2007 and 30 April 2012.\nTeleoncology model for managing cancer patients in rural towns.\nDose intensity (doses, number of cycles and lines of treatment) and toxicity rates (rate of serious side effects, hospital admissions and mortality).\nOver 5 years, 89 patients received a total of 626 cycles of various chemotherapy regimens in Mount Isa. During the same period, 117 patients who received a total of 799 cycles of chemotherapy at TCC were eligible for inclusion in the comparison group. There were no significant differences between the Mount Isa and TCC patients in most demographic characteristics, mean numbers of treatment cycles, dose intensities, proportions of side effects, and hospital admissions. There were no toxicity-related deaths in either group.\nDo teleoncology models of care enable safe delivery of chemotherapy in rural towns?",
        "answer": "yes",
        "answer_rationale": "It appears safe to administer chemotherapy in rural towns under the supervision of medical oncologists from larger centres via teleoncology, provided that rural health care resources and governance arrangements are adequate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To compare the dose intensity and toxicity profiles for patients undergoing chemotherapy at the Townsville Cancer Centre (TCC), a tertiary cancer centre in northern Queensland, with those for patients treated in Mount Isa, supervised by the same medical oncologists via teleoncology.\nA quasi-experimental design comparing two patient groups.\nTCC and Mount Isa Hospital, which both operate under the auspices of the Townsville Teleoncology Network (TTN).\nEligible patients who received chemotherapy at TCC or Mt Isa Hospital between 1 May 2007 and 30 April 2012.\nTeleoncology model for managing cancer patients in rural towns.\nDose intensity (doses, number of cycles and",
        "q2": " lines of treatment) and toxicity rates (rate of serious side effects, hospital admissions and mortality).\nOver 5 years, 89 patients received a total of 626 cycles of various chemotherapy regimens in Mount Isa. During the same period, 117 patients who received a total of 799 cycles of chemotherapy at TCC were eligible for inclusion in the comparison group. There were no significant differences between the Mount Isa and TCC patients in most demographic characteristics, mean numbers of treatment cycles, dose intensities, proportions of side effects, and hospital admissions. There were no toxicity-related deaths in either group.\nDo teleoncology models of care enable safe delivery of chemotherapy in rural towns?",
        "generated_text": "days of treatment) and toxicity profiles (haematological and non-haematological toxicities).\nA total of 102 patients were included in the study: 51 in each group. There was no significant difference in the dose intensity of chemotherapy between the two groups. The mean number of cycles was 5.8 for the TCC group and 5.7 for the Mt Isa group (P = 0.87). The mean number of days of treatment was 174 for the TCC group and 175 for the Mt Isa group (P = 0.92). There was no significant difference in the incidence of",
        "levenshtein_distance": 491
    },
    {
        "realidx": "26578404",
        "question": "Breathlessness is one of the most distressing symptoms experienced by patients with advanced cancer and noncancer diagnoses alike. Often, severity of breathlessness increases quickly, calling for rapid symptom control. Oral, buccal, and parenteral routes of provider-controlled drug administration have been described. It is unclear whether patient-controlled therapy (PCT) systems would be an additional treatment option.\nTo investigate whether intravenous opioid PCT can be an effective therapeutic method to reduce breathlessness in patients with advanced disease. Secondary aims were to study the feasibility and acceptance of opioid PCT in patients with refractory breathlessness.\nThis was a pilot observational study with 18 inpatients with advanced disease and refractory breathlessness receiving opioid PCT. Breathlessness was measured on a self-reported numeric rating scale. Richmond Agitation Sedation Scale scores, Palliative Performance Scale scores, vital signs, and a self-developed patient satisfaction questionnaire were used for measuring secondary outcomes. Descriptive and interference analyses (Friedman test) and post hoc analyses (Wilcoxon tests and Bonferroni corrections) were performed.\nEighteen of 815 patients (advanced cancer; median age\u00a0=\u00a057.5\u00a0years [range 36-81]; 77.8% female) received breathlessness symptom control with opioid PCT; daily morphine equivalent dose at Day 1 was median\u00a0=\u00a020.3\u00a0mg (5.0-49.6\u00a0mg); Day 2: 13.0\u00a0mg (1.0-78.5\u00a0mg); Day 3: 16.0\u00a0mg (8.3-47.0\u00a0mg). Numeric rating scale of current breathlessness decreased (baseline: median\u00a0=\u00a05 [range 1-10]; Day 1: median\u00a0=\u00a04 [range 0-8], P\u00a0<\u00a00.01; Day 2: median\u00a0=\u00a04 [range 0-5], P\u00a0<\u00a00.01). Physiological parameters were stable over time. On Day 3, 12/12 patients confirmed that this mode of application provided relief of breathlessness.\nPatient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?",
        "answer": "yes",
        "answer_rationale": "Opioid PCT is a feasible and acceptable therapeutic method to reduce refractory breathlessness in palliative care patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Breathlessness is one of the most distressing symptoms experienced by patients with advanced cancer and noncancer diagnoses alike. Often, severity of breathlessness increases quickly, calling for rapid symptom control. Oral, buccal, and parenteral routes of provider-controlled drug administration have been described. It is unclear whether patient-controlled therapy (PCT) systems would be an additional treatment option.\nTo investigate whether intravenous opioid PCT can be an effective therapeutic method to reduce breathlessness in patients with advanced disease. Secondary aims were to study the feasibility and acceptance of opioid PCT in patients with refractory breathlessness.\nThis was a pilot observational study with 18 inpatients with advanced disease and refractory breathlessness receiving opioid PCT. Breathlessness was measured on a self-reported numeric rating scale. Richmond Agitation Sedation Scale scores, Palliative Performance Scale scores, vital signs, and a self-developed patient satisfaction questionnaire were used for measuring secondary outcomes. Descriptive and interference analyses (Friedman test) and post hoc analyses (Wilcoxon tests and Bonferroni corrections) were performed.\nEighteen of 815 patients (advanced cancer;",
        "q2": " median age\u00a0=\u00a057.5\u00a0years [range 36-81]; 77.8% female) received breathlessness symptom control with opioid PCT; daily morphine equivalent dose at Day 1 was median\u00a0=\u00a020.3\u00a0mg (5.0-49.6\u00a0mg); Day 2: 13.0\u00a0mg (1.0-78.5\u00a0mg); Day 3: 16.0\u00a0mg (8.3-47.0\u00a0mg). Numeric rating scale of current breathlessness decreased (baseline: median\u00a0=\u00a05 [range 1-10]; Day 1: median\u00a0=\u00a04 [range 0-8], P\u00a0<\u00a00.01; Day 2: median\u00a0=\u00a04 [range 0-5], P\u00a0<\u00a00.01). Physiological parameters were stable over time. On Day 3, 12/12 patients confirmed that this mode of application provided relief of breathlessness.\nPatient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?",
        "generated_text": "n = 12; noncancer; n = 6) with refractory breathlessness received opioid PCT. The mean age was 64 years (range, 41-84 years). The mean Palliative Performance Scale score was 30 (range, 10-60). The mean Richmond Agitation Sedation Scale score was 0 (range, -2 to +2). The mean numeric rating scale score for breathlessness was 7.5 (range, 4-10). The mean numeric rating scale score for breathlessness decreased to 4.5 (range, 0-8) after 1 hour (P < .001). The mean numeric rating scale score for breathlessness decreased to 3.5 (range, 0-8) after 2 hours (P < .001). The mean numeric rating scale score for breathlessness decreased to 3.0 (range, 0-8) after 4 hours (P < .001). The mean numeric rating scale score for breathlessness decreased to 2.5 (",
        "levenshtein_distance": 569
    },
    {
        "realidx": "26601554",
        "question": "To investigate the role of viral infection in benign paroxysmal positional vertigo (BPPV).\nIn this retrospective study, 483 patients with BPPV were included in the study group. The control group consisted of 461 healthy subjects. In both groups, serologic analysis of viral agents (HSV1, HSV2, Herpes zoster, EBV, CMV, adenovirus, influenza, and parainfluenza virus) was performed.\nWith the exception of influenza and parainfluenza, all viral serology values were higher in the BBPV group than the control group. We also observed seasonal variation. The BPPV group exhibited elevated values for HSV1 and adenovirus in March and May, for Herpes zoster, adenovirus, and influenza in April, for HSV1 in June, and for HSV1 and CMV in September, compared to the control group. In October, the BPPV group showed increased values for all of the viruses studied, compared to the control group.\nDo viral infections have a role in benign paroxysmal positional vertigo?",
        "answer": "yes",
        "answer_rationale": "BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the role of viral infection in benign paroxysmal positional vertigo (BPPV).\nIn this retrospective study, 483 patients with BPPV were included in the study group. The control group consisted of 461 healthy subjects. In both groups, serologic analysis of viral agents (HSV1, HSV2, Herpes zoster, EBV, CMV, adenovirus, influenza, and parainfluenza virus) was performed.\nWith the exception of influenza and parainfluenza, all viral serology values were higher",
        "q2": " in the BBPV group than the control group. We also observed seasonal variation. The BPPV group exhibited elevated values for HSV1 and adenovirus in March and May, for Herpes zoster, adenovirus, and influenza in April, for HSV1 in June, and for HSV1 and CMV in September, compared to the control group. In October, the BPPV group showed increased values for all of the viruses studied, compared to the control group.\nDo viral infections have a role in benign paroxysmal positional vertigo?",
        "generated_text": "in the BPPV group compared to the control group. The difference was statistically significant for HSV1, HSV2, Herpes zoster, EBV, and CMV (p < 0.05). The highest seropositivity was observed for HSV1 in both groups. The seropositivity of HSV1 was higher in the BPPV group compared to the control group (p < 0.05). The seropositivity of HSV2 was higher in the BPPV group compared to the control group (",
        "levenshtein_distance": 332
    },
    {
        "realidx": "26606599",
        "question": "To determine the relationship between injury severity surrogates and other patient factors with the development and severity of heterotopic ossification (HO) following open reduction internal fixation of acetabular fractures treated with a posterior approach.\nRetrospective review.\nAcademic level 1 trauma center.\nTwo hundred forty-one patients who were treated through a posterior approach with a minimum of 6-month radiographic follow-up were identified from an acetabular fracture database.\nNone.\nThe occurrence and severity (Brooker Grade III/IV) of HO 6 months postsurgery.\nLength of stay (LOS) in the intensive care unit (ICU), non-ICU LOS>10 days, and HO prophylaxis with external radiation beam therapy (XRT) were significantly associated with the development of HO in a multivariate model [\n1-2 days, odds ratio (OR) = 4.33, 95% confidence interval (CI): 1.03-18.25; 3-6 days, OR = 4.1, 95% CI, 1.27-13.27;>6 days, OR = 11.7, 95% CI, 3.24-42.22; non-ICU LOS>10 days (vs. 0-6 days): OR = 7.6, 95% CI, 2.6-22.25; XRT HO prophylaxis: OR = 0.29, 95% CI, 0.10-0.85]. Other variables evaluated in multivariate modeling not significantly associated with development and severity of HO included age, gender, mechanism of injury, injury severity score, presence of neurologic injury, Letournel fracture type, occurrence of hip dislocation, interval from injury to surgery, operative time, and estimated blood loss.\nDo Surrogates of Injury Severity Influence the Occurrence of Heterotopic Ossification in Fractures of the Acetabulum?",
        "answer": "maybe",
        "answer_rationale": "Surrogates of injury severity, including days in the ICU and non-ICU hospital LOS>10 days, were associated with the development of HO in our cohort of acetabular fracture patients. Prophylaxis with XRT was significantly protective against the development of HO, and the ability to provide prophylaxis is very likely related to the severity of injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "To determine the relationship between injury severity surrogates and other patient factors with the development and severity of heterotopic ossification (HO) following open reduction internal fixation of acetabular fractures treated with a posterior approach.\nRetrospective review.\nAcademic level 1 trauma center.\nTwo hundred forty-one patients who were treated through a posterior approach with a minimum of 6-month radiographic follow-up were identified from an acetabular fracture database.\nNone.\nThe occurrence and severity (Brooker Grade III/IV) of HO 6 months postsurgery.\nLength of stay (LOS) in the intensive care unit (ICU), non-ICU LOS>10 days, and HO prophylaxis with external radiation beam therapy (XRT) were significantly associated with the development of HO in a multivariate model [\n1-2 days, odds ratio (OR) = 4.33, 95% confidence interval (CI): 1.03-18.25; 3-6 days,",
        "q2": " OR = 4.1, 95% CI, 1.27-13.27;>6 days, OR = 11.7, 95% CI, 3.24-42.22; non-ICU LOS>10 days (vs. 0-6 days): OR = 7.6, 95% CI, 2.6-22.25; XRT HO prophylaxis: OR = 0.29, 95% CI, 0.10-0.85]. Other variables evaluated in multivariate modeling not significantly associated with development and severity of HO included age, gender, mechanism of injury, injury severity score, presence of neurologic injury, Letournel fracture type, occurrence of hip dislocation, interval from injury to surgery, operative time, and estimated blood loss.\nDo Surrogates of Injury Severity Influence the Occurrence of Heterotopic Ossification in Fractures of the Acetabulum?",
        "generated_text": "OR = 10.00, 95% CI: 2.14-47.22; >6 days, OR = 12.00, 95% CI: 2.49-57.92; P = 0.003], [\nOR = 3.00, 95% CI: 1.21-7.43; P = 0.018], and [\nOR = 2.90, 95% CI: 1.17-7.21; P = 0.021], respectively. The presence of a pelvic ring injury was also associated with HO development [\nOR = 2.40, 95% CI: 1.04-5.55; P = 0.040]. The presence of a pelvic ring injury was also associated with the development",
        "levenshtein_distance": 457
    },
    {
        "realidx": "26708803",
        "question": "Treatment of neonatal testicular torsion has two objectives: salvage of the involved testicle (which is rarely achieved) and preservation of the contralateral gonad. The second goal universally involves contralateral testicular scrotal fixation to prevent the future occurrence of contralateral torsion. However, there is controversy with regards to management of a synchronous contralateral hydrocele. It has been our policy not to address the contralateral hydrocele through an inguinal incision to minimize potential injury to the spermatic cord. Our objective in this study was to determine whether the decision to manage a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal approach is safe and effective.\nWe reviewed all cases of neonatal testicular torsion occurring at our institution between the years 1999 and 2006. Age at presentation, physical examination, ultrasonographic and intraoperative findings were recorded. Patients were followed after initial surgical intervention to determine the likelihood of developing a subsequent hydrocele or hernia.\nThirty-seven patients were identified as presenting with neonatal torsion. Age of presentation averaged 3.5 days (range 1-14 days). Left-sided pathology was seen more commonly than the right, with a 25:12 distribution. All torsed testicles were nonviable. Twenty-two patients were noted to have a contralateral hydrocele at presentation. All hydroceles were opened through a scrotal approach at the time of contralateral scrotal fixation. No patient underwent an inguinal exploration to examine for a patent process vaginalis. None of the patients who presented with a hydrocele have developed a clinical hydrocele or hernia after an average 7.5 years (range 4.3-11.2) follow-up.\nTreatment of contralateral hydrocele in neonatal testicular torsion: Is less more?",
        "answer": "maybe",
        "answer_rationale": "We have demonstrated that approaching a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal incision is safe and effective. Inguinal exploration was not performed in our study and our long-term results demonstrate that such an approach would have brought no additional benefit. In avoiding an inguinal approach we did not subject our patients to unnecessary risk of testicular or vasal injury. Contralateral hydrocele is commonly seen in cases of neonatal testicular torsion. In our experience this is a condition of minimal clinical significance and does not warrant formal inguinal exploration for treatment. This conservative management strategy minimizes the potential of contralateral spermatic cord injury in the neonate. The aims of the study were met.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Treatment of neonatal testicular torsion has two objectives: salvage of the involved testicle (which is rarely achieved) and preservation of the contralateral gonad. The second goal universally involves contralateral testicular scrotal fixation to prevent the future occurrence of contralateral torsion. However, there is controversy with regards to management of a synchronous contralateral hydrocele. It has been our policy not to address the contralateral hydrocele through an inguinal incision to minimize potential injury to the spermatic cord. Our objective in this study was to determine whether the decision to manage a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal approach is safe and effective.\nWe reviewed all cases of neonatal testicular torsion occurring at our institution between the years 1999 and 2006. Age at presentation, physical examination, ultrasonographic and intraoperative findings were recorded. Patients were followed",
        "q2": " after initial surgical intervention to determine the likelihood of developing a subsequent hydrocele or hernia.\nThirty-seven patients were identified as presenting with neonatal torsion. Age of presentation averaged 3.5 days (range 1-14 days). Left-sided pathology was seen more commonly than the right, with a 25:12 distribution. All torsed testicles were nonviable. Twenty-two patients were noted to have a contralateral hydrocele at presentation. All hydroceles were opened through a scrotal approach at the time of contralateral scrotal fixation. No patient underwent an inguinal exploration to examine for a patent process vaginalis. None of the patients who presented with a hydrocele have developed a clinical hydrocele or hernia after an average 7.5 years (range 4.3-11.2) follow-up.\nTreatment of contralateral hydrocele in neonatal testicular torsion: Is less more?",
        "generated_text": "for a minimum of 12 months.\nA total of 12 patients were identified. The mean age at presentation was 2.5 months (range 1-5 months). All patients presented with a scrotal mass. The involved testicle was always the right side. The contralateral testicle was always normal. All patients underwent high orchiectomy of the involved testicle. In 10 patients, a contralateral hydrocele was present. In all 10 patients, the hydrocele was managed through a scrotal approach. There were no complications related to the hydrocelectomy. All patients were followed for a mean of 24 months (range 12-48 months). There were no recurrences of hydrocele or testicular torsion.\nIn cases of neonatal testicular torsion, management of a synchronous contralateral hydrocele through a scrotal approach is safe and effective",
        "levenshtein_distance": 596
    },
    {
        "realidx": "26778755",
        "question": "Although dose-volume parameters in image-guided brachytherapy have become a standard, the use of posterior-inferior border of the pubic symphysis (PIBS) points has been recently proposed in the reporting of vaginal doses. The aim was to evaluate their pertinence.\nNineteen patients who received image-guided brachytherapy after concurrent radiochemotherapy were included. Per treatment, CT scans were performed at Days 2 and 3, with reporting of the initial dwell positions and times. Doses delivered to the PIBS points were evaluated on each plan, considering that they were representative of one-third of the treatment. The movements of the applicator according to the PIBS point were analysed.\nMean prescribed doses at PIBS -2, PIBS, PIBS +2 were, respectively, 2.23 \u00b1 1.4, 6.39 \u00b1 6.6, and 31.85 \u00b1 36.06 Gy. Significant differences were observed between the 5 patients with vaginal involvement and the remaining 14 at the level of PIBS +2 and PIBS: +47.60 Gy and +7.46 Gy, respectively (p = 0.023 and 0.03). The variations between delivered and prescribed doses at PIBS points were not significant. However, at International commission on radiation units and measurements rectovaginal point, the delivered dose was decreased by 1.43 \u00b1 2.49 Gy from the planned dose (p = 0.019). The delivered doses at the four points were strongly correlated with the prescribed doses with R(2) ranging from 0.93 to 0.95. The movements of the applicator in regard of the PIBS point assessed with the Digital Imaging and Communications in Medicine coordinates were insignificant.\nVaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?",
        "answer": "maybe",
        "answer_rationale": "The doses evaluated at PIBS points are not impacted by intrafractional movements. PIBS and PIBS +2 dose points allow distinguishing the plans of patients with vaginal infiltration. Further studies are needed to correlate these parameters with vaginal morbidity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Although dose-volume parameters in image-guided brachytherapy have become a standard, the use of posterior-inferior border of the pubic symphysis (PIBS) points has been recently proposed in the reporting of vaginal doses. The aim was to evaluate their pertinence.\nNineteen patients who received image-guided brachytherapy after concurrent radiochemotherapy were included. Per treatment, CT scans were performed at Days 2 and 3, with reporting of the initial dwell positions and times. Doses delivered to the PIBS points were evaluated on each plan, considering that they were representative of one-third of the treatment. The movements of the applicator according to the PIBS point were analysed.\nMean prescribed doses at PIBS -2, PIBS, PIBS +2 were, respectively, 2.23 \u00b1 1.4, 6.39 \u00b1 6.6, and 31.85 \u00b1 36.06 Gy. Significant",
        "q2": " differences were observed between the 5 patients with vaginal involvement and the remaining 14 at the level of PIBS +2 and PIBS: +47.60 Gy and +7.46 Gy, respectively (p = 0.023 and 0.03). The variations between delivered and prescribed doses at PIBS points were not significant. However, at International commission on radiation units and measurements rectovaginal point, the delivered dose was decreased by 1.43 \u00b1 2.49 Gy from the planned dose (p = 0.019). The delivered doses at the four points were strongly correlated with the prescribed doses with R(2) ranging from 0.93 to 0.95. The movements of the applicator in regard of the PIBS point assessed with the Digital Imaging and Communications in Medicine coordinates were insignificant.\nVaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?",
        "generated_text": "differences were observed between PIBS -2 and PIBS (p < 0.001), PIBS and PIBS +2 (p < 0.001), and PIBS -2 and PIBS +2 (p < 0.001). The mean dose at PIBS +2 was higher than at PIBS -2 (p < 0.001). The mean dose at PIBS +2 was higher than at PIBS (p < 0.001). The mean dose at PIBS was higher than at PIBS -2 (p < 0.001). The mean dose at PIBS +2 was higher than at PIBS (p < 0.001). The mean dose at PIBS was higher than at PIBS -2 (p < 0.001",
        "levenshtein_distance": 616
    },
    {
        "realidx": "26820719",
        "question": "The incidence of colorectal cancer in young patients is increasing. It remains unclear if the disease has unique features in this age group.\nThis was a single-center, retrospective cohort study which included patients diagnosed with colorectal cancer at age \u226440\u00a0years in 1997-2013 matched 1:2 by year of diagnosis with consecutive colorectal cancer patients diagnosed at age>50\u00a0years during the same period. Patients aged 41-50\u00a0years were not included in the study, to accentuate potential age-related differences. Clinicopathological characteristics, treatment, and outcome were compared between groups.\nThe cohort included 330 patients, followed for a median time of 65.9\u00a0months (range 4.7-211). Several significant differences were noted. The younger group had a different ethnic composition. They had higher rates of family history of colorectal cancer (p\u00a0=\u00a00.003), hereditary colorectal cancer syndromes (p\u00a0<\u00a00.0001), and inflammatory bowel disease (p\u00a0=\u00a00.007), and a lower rate of polyps (p\u00a0<\u00a00.0001). They were more likely to present with stage III or IV disease (p\u00a0=\u00a00.001), angiolymphatic invasion, signet cell ring adenocarcinoma, and rectal tumors (p\u00a0=\u00a00.02). Younger patients more frequently received treatment. Young patients had a worse estimated 5-year disease-free survival rate (57.6\u00a0 vs. 70\u00a0%, p\u00a0=\u00a00.039), but this did not retain significance when analyzed by stage (p\u00a0=\u00a00.092). Estimated 5-year overall survival rates were 59.1 and 62.1\u00a0% in the younger and the control group, respectively (p\u00a0=\u00a00.565).\nColorectal cancer in young patients: is it a distinct clinical entity?",
        "answer": "yes",
        "answer_rationale": "Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The incidence of colorectal cancer in young patients is increasing. It remains unclear if the disease has unique features in this age group.\nThis was a single-center, retrospective cohort study which included patients diagnosed with colorectal cancer at age \u226440\u00a0years in 1997-2013 matched 1:2 by year of diagnosis with consecutive colorectal cancer patients diagnosed at age>50\u00a0years during the same period. Patients aged 41-50\u00a0years were not included in the study, to accentuate potential age-related differences. Clinicopathological characteristics, treatment, and outcome were compared between groups.\nThe cohort included 330 patients, followed for a median time of 65.9\u00a0months (range 4.7-211). Several significant differences were noted. The younger group had a different ethnic composition. They had higher rates of family history of colorectal cancer (p\u00a0=\u00a00.003), hereditary colorectal cancer syndromes (p\u00a0<\u00a00.",
        "q2": "0001), and inflammatory bowel disease (p\u00a0=\u00a00.007), and a lower rate of polyps (p\u00a0<\u00a00.0001). They were more likely to present with stage III or IV disease (p\u00a0=\u00a00.001), angiolymphatic invasion, signet cell ring adenocarcinoma, and rectal tumors (p\u00a0=\u00a00.02). Younger patients more frequently received treatment. Young patients had a worse estimated 5-year disease-free survival rate (57.6\u00a0 vs. 70\u00a0%, p\u00a0=\u00a00.039), but this did not retain significance when analyzed by stage (p\u00a0=\u00a00.092). Estimated 5-year overall survival rates were 59.1 and 62.1\u00a0% in the younger and the control group, respectively (p\u00a0=\u00a00.565).\nColorectal cancer in young patients: is it a distinct clinical entity?",
        "generated_text": "001), and advanced stage at diagnosis (p\u00a0=\u00a00.001). They had higher rates of right-sided tumors (p\u00a0<\u00a00.001), and more frequent mucinous histology (p\u00a0=\u00a00.001). They had higher rates of emergency surgery (p\u00a0<\u00a00.001), and more frequent use of adjuvant chemotherapy (p\u00a0=\u00a00.001). The 5-year overall survival was 64% in the younger group and 75% in the older group (p\u00a0=\u00a00.001). In multivariate analysis, age \u226440\u00a0years was an independent predictor of worse overall survival (HR 1.58, 95% CI 1.07-2.33, p\u00a0=\u00a00.021).\nColorectal cancer in young patients has unique",
        "levenshtein_distance": 451
    },
    {
        "realidx": "26852225",
        "question": "Anchoring vignettes are brief texts describing a hypothetical character who illustrates a certain fixed level of a trait under evaluation. This research uses vignettes to elucidate factors associated with sleep disorders in adult Japanese before and after adjustment for reporting heterogeneity in self-reports. This study also evaluates the need for adjusting for reporting heterogeneity in the management of sleep and energy related problems in Japan.\nWe investigated a dataset of 1002 respondents aged 18 years and over from the Japanese World Health Survey, which collected information through face-to-face interview from 2002 to 2003. The ordered probit model and the Compound Hierarchical Ordered Probit (CHOPIT) model, which incorporated anchoring vignettes, were employed to estimate and compare associations of sleep and energy with socio-demographic and life-style factors before and after adjustment for differences in response category cut-points for each individual.\nThe prevalence of self-reported problems with sleep and energy was 53 %. Without correction of cut-point shifts, age, sex, and the number of comorbidities were significantly associated with a greater severity of sleep-related problems. After correction, age, the number of comorbidities, and regular exercise were significantly associated with a greater severity of sleep-related problems; sex was no longer a significant factor. Compared to the ordered probit model, the CHOPIT model provided two changes with a subtle difference in the magnitude of regression coefficients after correction for reporting heterogeneity.\nIs adjustment for reporting heterogeneity necessary in sleep disorders?",
        "answer": "no",
        "answer_rationale": "Sleep disorders are common in the general adult population of Japan. Correction for reporting heterogeneity using anchoring vignettes is not a necessary tool for proper management of sleep and energy related problems among Japanese adults. Older age, gender differences in communicating sleep-related problems, the presence of multiple morbidities, and regular exercise should be the focus of policies and clinical practice to improve sleep and energy management in Japan.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Anchoring vignettes are brief texts describing a hypothetical character who illustrates a certain fixed level of a trait under evaluation. This research uses vignettes to elucidate factors associated with sleep disorders in adult Japanese before and after adjustment for reporting heterogeneity in self-reports. This study also evaluates the need for adjusting for reporting heterogeneity in the management of sleep and energy related problems in Japan.\nWe investigated a dataset of 1002 respondents aged 18 years and over from the Japanese World Health Survey, which collected information through face-to-face interview from 2002 to 2003. The ordered probit model and the Compound Hierarchical Ordered Probit (CHOPIT) model, which incorporated anchoring vignettes, were employed to estimate and compare associations of",
        "q2": " sleep and energy with socio-demographic and life-style factors before and after adjustment for differences in response category cut-points for each individual.\nThe prevalence of self-reported problems with sleep and energy was 53 %. Without correction of cut-point shifts, age, sex, and the number of comorbidities were significantly associated with a greater severity of sleep-related problems. After correction, age, the number of comorbidities, and regular exercise were significantly associated with a greater severity of sleep-related problems; sex was no longer a significant factor. Compared to the ordered probit model, the CHOPIT model provided two changes with a subtle difference in the magnitude of regression coefficients after correction for reporting heterogeneity.\nIs adjustment for reporting heterogeneity necessary in sleep disorders?",
        "generated_text": "sleep disorders with socio-demographic factors, lifestyle, and health status.\nThe ordered probit model showed that being female, having a lower income, and having a chronic disease were associated with a higher risk of sleep disorders. The CHOPIT model, which adjusted for reporting heterogeneity, showed that being female and having a chronic disease were associated with a higher risk of sleep disorders, but income was not significantly associated with sleep disorders. The CHOPIT model also showed that respondents with higher education levels were less likely to report sleep disorders, while the ordered probit model did not find a significant association between education and sleep disorders.\nAdjusting for reporting heterogeneity using anchoring vignettes can provide more accurate estimates of the associations between sleep disorders and various factors. In this",
        "levenshtein_distance": 633
    },
    {
        "realidx": "26864326",
        "question": "In this single-centre prospective study, triage nurses estimated the probability of admission using a 100\u2005mm visual analogue scale (VAS), and GAPS was generated automatically from triage data. We compared calibration using rank sum tests, discrimination using area under receiver operating characteristic curves (AUC) and accuracy with McNemar's test.\nOf 1829 attendances, 745 (40.7%) were admitted, not significantly different from GAPS' prediction of 750 (41.0%, p=0.678). In contrast, the nurses' mean VAS predicted 865 admissions (47.3%), overestimating by 6.6% (p<0.0001). GAPS discriminated between admission and discharge as well as nurses, its AUC 0.876 compared with 0.875 for VAS (p=0.93). As a binary predictor, its accuracy was 80.6%, again comparable with VAS (79.0%), p=0.18. In the minority of attendances, when nurses felt at least 95% certain of the outcome, VAS' accuracy was excellent, at 92.4%. However, in the remaining majority, GAPS significantly outperformed VAS on calibration (+1.2% vs +9.2%, p<0.0001), discrimination (AUC 0.810 vs 0.759, p=0.001) and accuracy (75.1% vs 68.9%, p=0.0009). When we used GAPS, but 'over-ruled' it when clinical certainty was \u226595%, this significantly outperformed either method, with AUC 0.891 (0.877-0.907) and accuracy 82.5% (80.7%-84.2%).\nPredicting admission at triage: are nurses better than a simple objective score?",
        "answer": "yes",
        "answer_rationale": "GAPS, a simple clinical score, is a better predictor of admission than triage nurses, unless the nurse is sure about the outcome, in which case their clinical judgement should be respected.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "In this single-centre prospective study, triage nurses estimated the probability of admission using a 100\u2005mm visual analogue scale (VAS), and GAPS was generated automatically from triage data. We compared calibration using rank sum tests, discrimination using area under receiver operating characteristic curves (AUC) and accuracy with McNemar's test.\nOf 1829 attendances, 745 (40.7%) were admitted, not significantly different from GAPS' prediction of 750 (41.0%, p=0.678). In contrast, the nurses' mean VAS predicted 865 admissions (47.3%), overestimating by 6.6% (p<0.0001). GAPS discriminated between admission and discharge as well as nurses, its AUC 0.876 compared with 0.875 for VAS (p=0.93). As a binary predictor, its accuracy was 80.6%, again comparable with V",
        "q2": "AS (79.0%), p=0.18. In the minority of attendances, when nurses felt at least 95% certain of the outcome, VAS' accuracy was excellent, at 92.4%. However, in the remaining majority, GAPS significantly outperformed VAS on calibration (+1.2% vs +9.2%, p<0.0001), discrimination (AUC 0.810 vs 0.759, p=0.001) and accuracy (75.1% vs 68.9%, p=0.0009). When we used GAPS, but 'over-ruled' it when clinical certainty was \u226595%, this significantly outperformed either method, with AUC 0.891 (0.877-0.907) and accuracy 82.5% (80.7%-84.2%).\nPredicting admission at triage: are nurses better than a simple objective score?",
        "generated_text": "AS (80.4%, p=0.92). GAPS' accuracy was similar to that of nurses' VAS, but its calibration was better, as it did not overestimate the probability of admission.",
        "levenshtein_distance": 504
    },
    {
        "realidx": "26879871",
        "question": "Studies have linked ethnic differences in depression rates with neighbourhood ethnic density although results have not been conclusive. We looked at this using a novel approach analysing whole population data covering just over one million GP patients in four London boroughs.\nUsing a dataset of GP records for all patients registered in Lambeth, Hackney, Tower Hamlets and Newham in 2013 we investigated new diagnoses of depression and antidepressant use for: Indian, Pakistani, Bangladeshi, black Caribbean and black African patients. Neighbourhood effects were assessed independently of GP practice using a cross-classified multilevel model.\nBlack and minority ethnic groups are up to four times less likely to be newly diagnosed with depression or prescribed antidepressants compared to white British patients. We found an inverse relationship between neighbourhood ethnic density and new depression diagnosis for some groups, where an increase of 10% own-ethnic density was associated with a statistically significant (p<0.05) reduced odds of depression for Pakistani [odds ratio (OR) 0.81, 95% confidence interval (CI) 0.70-0.93], Indian (OR 0.88, CI 0.81-0.95), African (OR 0.88, CI 0.78-0.99) and Bangladeshi (OR 0.94, CI 0.90-0.99) patients. Black Caribbean patients, however, showed the opposite effect (OR 1.26, CI 1.09-1.46). The results for antidepressant use were very similar although the corresponding effect for black Caribbeans was no longer statistically significant (p = 0.07).\nDoes depression diagnosis and antidepressant prescribing vary by location?",
        "answer": "yes",
        "answer_rationale": "New depression diagnosis and antidepressant use was shown to be less likely in areas of higher own-ethnic density for some, but not all, ethnic groups.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Studies have linked ethnic differences in depression rates with neighbourhood ethnic density although results have not been conclusive. We looked at this using a novel approach analysing whole population data covering just over one million GP patients in four London boroughs.\nUsing a dataset of GP records for all patients registered in Lambeth, Hackney, Tower Hamlets and Newham in 2013 we investigated new diagnoses of depression and antidepressant use for: Indian, Pakistani, Bangladeshi, black Caribbean and black African patients. Neighbourhood effects were assessed independently of GP practice using a cross-classified multilevel model.\nBlack and minority ethnic groups are up to four times less likely to be newly diagnosed with depression or prescribed antidepressants compared to white British patients. We found an inverse relationship between neighbourhood ethnic density and new depression diagnosis for some groups, where an increase of 10% own-ethnic density",
        "q2": " was associated with a statistically significant (p<0.05) reduced odds of depression for Pakistani [odds ratio (OR) 0.81, 95% confidence interval (CI) 0.70-0.93], Indian (OR 0.88, CI 0.81-0.95), African (OR 0.88, CI 0.78-0.99) and Bangladeshi (OR 0.94, CI 0.90-0.99) patients. Black Caribbean patients, however, showed the opposite effect (OR 1.26, CI 1.09-1.46). The results for antidepressant use were very similar although the corresponding effect for black Caribbeans was no longer statistically significant (p = 0.07).\nDoes depression diagnosis and antidepressant prescribing vary by location?",
        "generated_text": "was associated with a 1% decrease in the odds of new depression diagnosis. This was most pronounced for black African and black Caribbean patients, but also for Indian and Bangladeshi patients. For Pakistani patients, the relationship was positive, with higher own-ethnic density associated with higher odds of new depression diagnosis.\nOur findings suggest that the relationship between neighbourhood ethnic density and depression diagnosis is complex and varies by ethnic group. For most groups, higher own-ethnic density is associated with lower odds of new depression diagnosis, which may reflect under-diagnosis in these areas or other factors such as social support networks. For Pakistani patients, the opposite is true, suggesting different dynamics at play. These findings have implications for healthcare policy and practice, highlighting the need for culturally sensitive approaches to mental health diagnosis and treatment.",
        "levenshtein_distance": 699
    },
    {
        "realidx": "26907557",
        "question": "This clinical study investigated whether the vascular-guided multilayer preauricular approach (VMPA) to the temporomandibular joint (TMJ) could improve access and decrease complications.\nThis retrospective evaluation consisted of a consecutive series of patients who underwent TMJ surgeries through the VMPA from January through December 2013. Patients with a history of TMJ surgery were excluded. Clinical data, including operating times, subjective complaints of incision scars, functional conditions of the auriculotemporal nerve and facial nerve, and other complications, were recorded and analyzed. All patients in this study were followed for at least 6\u00a0months.\nAll patients (606 joints) had successful TMJ surgeries through the VMPA. All incisions healed favorably with an uneventful recovery. No patient developed permanent weakness of the facial nerve or other severe complications.\nCan a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications?",
        "answer": "yes",
        "answer_rationale": "The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This clinical study investigated whether the vascular-guided multilayer preauricular approach (VMPA) to the temporomandibular joint (TMJ) could improve access and decrease complications.\nThis retrospective evaluation consisted of a consecutive series of patients who underwent TMJ surgeries through the VMPA from January through December 2013. Patients with a history of TMJ surgery were excluded. Clinical data, including operating times, subjective complaints of incision scars, functional conditions of the aur",
        "q2": "iculotemporal nerve and facial nerve, and other complications, were recorded and analyzed. All patients in this study were followed for at least 6\u00a0months.\nAll patients (606 joints) had successful TMJ surgeries through the VMPA. All incisions healed favorably with an uneventful recovery. No patient developed permanent weakness of the facial nerve or other severe complications.\nCan a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications?",
        "generated_text": "iculotemporal nerve, and complications, were collected and analyzed.\nA total of 100 patients (142 joints) were included in this study. The mean operating time was 102.4 minutes per joint. The mean follow-up period was 24.5 months. The subjective complaints of incision scars were significantly less than those of the standard preauricular approach (P < .05). The functional conditions of the auric",
        "levenshtein_distance": 319
    },
    {
        "realidx": "26923375",
        "question": "Esophageal varices are present in 30% to 40% of patients in compensated cirrhosis (Child-Pugh class A) and in 60% to 85% of patients in decompensated cirrhosis (Child-Pugh classes B and C). It is important to identify patients with compensated cirrhosis at risk for esophageal varix development. We evaluated the accuracy of a duplex Doppler ultrasonographic index for predicting the presence or absence of esophageal varices in patients with compensated hepatic cirrhosis (Child-Pugh class A) by using endoscopy as the reference standard.\nFifty-six enrolled patients underwent duplex Doppler ultrasonography followed by screening endoscopy. Mean portal vein velocity (PVV), splenic index (SI), splenoportal index (SPI), hepatic and splenic arterial resistive, and pulsatility indices (hepatic artery resistive index [HARI], hepatic artery pulsatility index [HAPI], splenic artery resistive index [SARI], splenic artery pulsatility index [SAPI]) were recorded. Univariate logistic regression analysis was followed by receiver operating characteristic (ROC) curve construction for the indices that were significant.\nThe indices HARI, HAPI, SARI, SAPI were not helpful (p\u2009>\u20090.05). Mean PVV, SI, and SPI were all predictive of the presence of esophageal varices (p\u2009<\u20090.05) and SPI was found to be the most accurate parameter. Of the various cut-off levels of SPI evaluated, a cut-off value of SPI at 5.0, offered the highest diagnostic accuracy (88%). For the 28 patients with SPI<5.0, the absence of esophageal varices in 27 of them could be correctly diagnosed using only SPI without invasive screening endoscopy, with high negative predictive value (96%) and sensitivity (96%). Of the remaining 28 patients with SPI \u22655.0, presence of esophageal varices could be similarly correctly diagnosed in 22 of them by using SPI without screening endoscopy, with high positive predictive value (79%) and specificity (82%).\nIs non-invasive diagnosis of esophageal varices in patients with compensated hepatic cirrhosis possible by duplex Doppler ultrasonography?",
        "answer": "yes",
        "answer_rationale": "The SPI was accurate in predicting the presence or absence of esophageal varices in patients with compensated cirrhosis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Esophageal varices are present in 30% to 40% of patients in compensated cirrhosis (Child-Pugh class A) and in 60% to 85% of patients in decompensated cirrhosis (Child-Pugh classes B and C). It is important to identify patients with compensated cirrhosis at risk for esophageal varix development. We evaluated the accuracy of a duplex Doppler ultrasonographic index for predicting the presence or absence of esophageal varices in patients with compensated hepatic cirrhosis (Child-Pugh class A) by using endoscopy as the reference standard.\nFifty-six enrolled patients underwent duplex Doppler ultrasonography followed by screening endoscopy. Mean portal vein velocity (PVV), splenic index (SI), splenoportal index (SPI), hepatic and splenic arterial resistive, and pulsatility indices (hepatic artery resistive index [HARI], hepatic artery pulsatility index [HAPI], splenic artery resistive index [SARI], splenic artery pulsatility index [SAPI]) were recorded. Univariate logistic regression analysis was followed by receiver operating characteristic",
        "q2": " (ROC) curve construction for the indices that were significant.\nThe indices HARI, HAPI, SARI, SAPI were not helpful (p\u2009>\u20090.05). Mean PVV, SI, and SPI were all predictive of the presence of esophageal varices (p\u2009<\u20090.05) and SPI was found to be the most accurate parameter. Of the various cut-off levels of SPI evaluated, a cut-off value of SPI at 5.0, offered the highest diagnostic accuracy (88%). For the 28 patients with SPI<5.0, the absence of esophageal varices in 27 of them could be correctly diagnosed using only SPI without invasive screening endoscopy, with high negative predictive value (96%) and sensitivity (96%). Of the remaining 28 patients with SPI \u22655.0, presence of esophageal varices could be similarly correctly diagnosed in 22 of them by using SPI without screening endoscopy, with high positive predictive value (79%) and specificity (82%).\nIs non-invasive diagnosis of esophageal varices in patients with compensated hepatic cirrhosis possible by duplex Doppler ultrasonography?",
        "generated_text": "(ROC) curve analysis to determine the best predictor of esophageal varices.\nTwenty-eight patients (50%) had esophageal varices. Univariate analysis showed that PVV, SI, SPI, HARI, HAPI, SARI, and SAPI were significantly higher in patients with esophageal varices than in those without varices (P < 0.05). ROC curve analysis showed that SPI was the best predictor of esophageal varices (area under the curve [AUC], 0.84; 95% confidence interval [CI], 0.73-0.95). The optimal cutoff value for SPI was 0.72, with a sensitivity of 82.1% and a specificity of 78.6%.\nDuplex Doppler ultrasonography is a noninvasive, accurate, and reproducible method for predicting the presence or absence of esophageal varices in patients with compensated cirrhosis. The SPI is the best predictor of esophageal varices in this setting.",
        "levenshtein_distance": 718
    },
    {
        "realidx": "26965932",
        "question": "This study sought to investigate the ischemic and bleeding outcomes of patients fulfilling high bleeding risk (HBR) criteria who were randomized to zotarolimus-eluting Endeavor Sprint stent (E-ZES) or bare-metal stent (BMS) implantation followed by an abbreviated dual antiplatelet therapy (DAPT) duration for stable or unstable coronary artery disease.\nDES instead of BMS use remains controversial in HBR patients, in whom long-term DAPT poses safety concerns.\nThe ZEUS (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates) is a multinational, randomized single-blinded trial that randomized among others, in a stratified manner, 828 patients fulfilling pre-defined clinical or biochemical HBR criteria-including advanced age, indication to oral anticoagulants or other pro-hemorrhagic medications, history of bleeding and known anemia-to receive E-ZES or BMS followed by a protocol-mandated 30-day DAPT regimen. The primary endpoint of the study was the 12-month major adverse cardiovascular event rate, consisting of death, myocardial infarction, or target vessel revascularization.\nCompared with patients without, those with 1 or more HBR criteria had worse outcomes, owing to higher ischemic and bleeding risks. Among HBR patients, major adverse cardiovascular events occurred in 22.6% of the E-ZES and 29% of the BMS patients (hazard ratio: 0.75; 95% confidence interval: 0.57 to 0.98; p = 0.033), driven by lower myocardial infarction (3.5% vs. 10.4%; p<0.001) and target vessel revascularization (5.9% vs. 11.4%; p = 0.005) rates in the E-ZES arm. The composite of definite or probable stent thrombosis was significantly reduced in E-ZES recipients, whereas bleeding events did not differ between stent groups.\nIs Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?",
        "answer": "yes",
        "answer_rationale": "Among HBR patients with stable or unstable coronary artery disease, E-ZES implantation provides superior efficacy and safety as compared with conventional BMS. (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates [ZEUS]; NCT01385319).",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study sought to investigate the ischemic and bleeding outcomes of patients fulfilling high bleeding risk (HBR) criteria who were randomized to zotarolimus-eluting Endeavor Sprint stent (E-ZES) or bare-metal stent (BMS) implantation followed by an abbreviated dual antiplatelet therapy (DAPT) duration for stable or unstable coronary artery disease.\nDES instead of BMS use remains controversial in HBR patients, in whom long-term DAPT poses safety concerns.\nThe ZEUS (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates) is a multinational, randomized single-blinded trial that randomized among others, in a stratified manner, 828 patients fulfilling pre-defined clinical or biochemical HBR criteria-including advanced age, indication to oral anticoagulants or other pro-hemorrhagic medications, history of bleeding and known anemia-to receive E-ZES or BMS followed by a protocol-mandated 30-day DAPT regimen. The primary endpoint of the study was the 12-month major adverse cardiovascular event rate,",
        "q2": " consisting of death, myocardial infarction, or target vessel revascularization.\nCompared with patients without, those with 1 or more HBR criteria had worse outcomes, owing to higher ischemic and bleeding risks. Among HBR patients, major adverse cardiovascular events occurred in 22.6% of the E-ZES and 29% of the BMS patients (hazard ratio: 0.75; 95% confidence interval: 0.57 to 0.98; p = 0.033), driven by lower myocardial infarction (3.5% vs. 10.4%; p<0.001) and target vessel revascularization (5.9% vs. 11.4%; p = 0.005) rates in the E-ZES arm. The composite of definite or probable stent thrombosis was significantly reduced in E-ZES recipients, whereas bleeding events did not differ between stent groups.\nIs Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?",
        "generated_text": "defined as the composite of all-cause death, myocardial infarction, or ischemia-driven target lesion revascularization. The present analysis reports the ischemic and bleeding outcomes of the HBR population.\nAt 12 months, the primary endpoint occurred in 10.1% of the E-ZES and 12.1% of the BMS group (p=0.44). The rates of definite or probable stent thrombosis were 0.4% and 1.2% (p=0.24), respectively. The rates of major bleeding were 2.4% and 2.9% (p=0.66), and the rates of minor bleeding were 10.1% and 10.9% (p=0.74), in the E-ZES and BMS groups, respectively.\nIn HBR patients, E-ZES implantation followed by a 30-day DAPT regimen was non-inferior to BMS implantation with regards to ischemic outcomes",
        "levenshtein_distance": 587
    },
    {
        "realidx": "27040842",
        "question": "To measure the dimensions of compensatory hypertrophy of the middle turbinate in patients with nasal septal deviation, before and after septoplasty.\nThe mucosal and bony structures of the middle turbinate and the angle of the septum were measured using radiological analysis before septoplasty and at least one year after septoplasty. All pre- and post-operative measurements of the middle turbinate were compared using the paired sample t-test and Wilcoxon rank sum test.\nThe dimensions of bony and mucosal components of the middle turbinate on concave and convex sides of the septum were not significantly changed by septoplasty. There was a significant negative correlation after septoplasty between the angle of the septum and the middle turbinate total area on the deviated side (p = 0.033).\nDoes septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate?",
        "answer": "no",
        "answer_rationale": "The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To measure the dimensions of compensatory hypertrophy of the middle turbinate in patients with nasal septal deviation, before and after septoplasty.\nThe mucosal and bony structures of the middle turbinate and the angle of the septum were measured using radiological analysis before septoplasty and at least one year after septoplasty. All pre- and post-operative measurements of the middle turbinate were compared using the paired sample t-test and Wilcoxon",
        "q2": " rank sum test.\nThe dimensions of bony and mucosal components of the middle turbinate on concave and convex sides of the septum were not significantly changed by septoplasty. There was a significant negative correlation after septoplasty between the angle of the septum and the middle turbinate total area on the deviated side (p = 0.033).\nDoes septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate?",
        "generated_text": "signed rank test. The relationship between the angle of the septum and the hypertrophy of the middle turbinate was evaluated using the Pearson correlation coefficient and the Spearman correlation coefficient.\nThe mean age of the patients was 29.2 years (range: 18-45 years). The mean pre-operative angle of the septum was 22.1\u00b0, and the mean post-operative angle was 1.7\u00b0",
        "levenshtein_distance": 305
    },
    {
        "realidx": "27044366",
        "question": "The technique of induced sputum has allowed to subdivide asthma patients into inflammatory phenotypes according to their level of granulocyte airway infiltration. There are very few studies which looked at detailed sputum and blood cell counts in a large cohort of asthmatics divided into inflammatory phenotypes. The purpose of this study was to analyze sputum cell counts, blood leukocytes and systemic inflammatory markers in these phenotypes, and investigate how those groups compared with healthy subjects.\nWe conducted a retrospective cross-sectional study on 833 asthmatics recruited from the University Asthma Clinic of Liege and compared them with 194 healthy subjects. Asthmatics were classified into inflammatory phenotypes.\nThe total non-squamous cell count per gram of sputum was greater in mixed granulocytic and neutrophilic phenotypes as compared to eosinophilic, paucigranulocytic asthma and healthy subjects (p\u2009<\u20090.005). Sputum eosinophils (in absolute values and percentages) were increased in all asthma phenotypes including paucigranulocytic asthma, compared to healthy subjects (p\u2009<\u20090.005). Eosinophilic asthma showed higher absolute sputum neutrophil and lymphocyte counts than healthy subjects (p\u2009<\u20090.005), while neutrophilic asthmatics had a particularly low number of sputum macrophages and epithelial cells. All asthma phenotypes showed an increased blood leukocyte count compared to healthy subjects (p\u2009<\u20090.005), with paucigranulocytic asthmatics having also increased absolute blood eosinophils compared to healthy subjects (p\u2009<\u20090.005). Neutrophilic asthma had raised CRP and fibrinogen while eosinophilic asthma only showed raised fibrinogen compared to healthy subjects (p\u2009<\u20090.005).\nDetailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?",
        "answer": "maybe",
        "answer_rationale": "This study demonstrates that a significant eosinophilic inflammation is present across all categories of asthma, and that paucigranulocytic asthma may be seen as a low grade inflammatory disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "The technique of induced sputum has allowed to subdivide asthma patients into inflammatory phenotypes according to their level of granulocyte airway infiltration. There are very few studies which looked at detailed sputum and blood cell counts in a large cohort of asthmatics divided into inflammatory phenotypes. The purpose of this study was to analyze sputum cell counts, blood leukocytes and systemic inflammatory markers in these phenotypes, and investigate how those groups compared with healthy subjects.\nWe conducted a retrospective cross-sectional study on 833 asthmatics recruited from the University Asthma Clinic of Liege and compared them with 194 healthy subjects. Asthmatics were classified into inflammatory phenotypes.\nThe total non-squamous cell count per gram of sputum was greater in mixed granulocytic and neutrophilic phenotypes as compared to eosinophilic, paucigranulocytic asthma and healthy subjects (p\u2009<\u20090.005). Sputum eosinophils (in absolute values and percentages)",
        "q2": " were increased in all asthma phenotypes including paucigranulocytic asthma, compared to healthy subjects (p\u2009<\u20090.005). Eosinophilic asthma showed higher absolute sputum neutrophil and lymphocyte counts than healthy subjects (p\u2009<\u20090.005), while neutrophilic asthmatics had a particularly low number of sputum macrophages and epithelial cells. All asthma phenotypes showed an increased blood leukocyte count compared to healthy subjects (p\u2009<\u20090.005), with paucigranulocytic asthmatics having also increased absolute blood eosinophils compared to healthy subjects (p\u2009<\u20090.005). Neutrophilic asthma had raised CRP and fibrinogen while eosinophilic asthma only showed raised fibrinogen compared to healthy subjects (p\u2009<\u20090.005).\nDetailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?",
        "generated_text": "were higher in eosinophilic asthma compared to the other phenotypes and healthy subjects (p\u2009<\u20090.005). Sputum neutrophils (in absolute values and percentages) were higher in neutrophilic and mixed granulocytic asthma compared to the other phenotypes and healthy subjects (p\u2009<\u20090.005). Blood eosinophils were higher in eosinophilic asthma compared to the other phenotypes and healthy subjects (p\u2009<\u20090.005). Blood neutrophils were higher in neutrophilic and mixed granulocytic asthma compared to the other phenotypes and healthy subjects (p\u2009<\u20090.005). Blood lymphocytes were higher in eosinophilic asthma compared to the other phenotypes and healthy subjects (p\u2009<\u20090.005). Serum CRP was higher in neutrophilic and mixed gran",
        "levenshtein_distance": 561
    },
    {
        "realidx": "27050489",
        "question": "Misty mesentery appearance is commonly reported in daily practice, usually as a secondary finding of various pathological entities, but sometimes it is encountered as an isolated finding that cannot be attributed to any other disease entity. We aimed to assess the prevalence of cases with incidentally detected idiopathic misty mesentery on computed tomography (CT) and to summarize the pathologies leading to this appearance.\nMedical records and initial and follow-up CT features of patients with misty mesentery appearance between January 2011 and January 2013 were analysed. The study included cases with no known cause of misty mesentery according to associated CT findings, clinical history, or biochemical manifestations, and excluded patients with diseases known to cause misty mesentery, lymph nodes greater than a short-axis diameter of 5\u00a0mm, discrete mesenteric masses, or bowel wall thickening.\nThere were a total of 561 patients in whom misty mesentery appearance was depicted on abdominopelvic CT scans. A total of 80 cases were found to have isolated incidental idiopathic misty mesentery, giving a prevalence of 7%. The common indication for CT examination was abdominal pain. There was a slight female predominance (51.3%). 67.5% of all patients were classified as obese and 17.5% as overweight.\nThe Prevalence of Incidentally Detected Idiopathic Misty Mesentery on\u00a0Multidetector Computed Tomography: Can Obesity Be the Triggering Cause?",
        "answer": "yes",
        "answer_rationale": "The results of the present study show that idiopathic incidental misty mesentery appearance has a significant prevalence. Also, the high body mass index of these patients and the growing evidence of obesity-induced inflammatory changes in adipose tissue are suggestive of an association between obesity and misty mesentery appearance on CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Misty mesentery appearance is commonly reported in daily practice, usually as a secondary finding of various pathological entities, but sometimes it is encountered as an isolated finding that cannot be attributed to any other disease entity. We aimed to assess the prevalence of cases with incidentally detected idiopathic misty mesentery on computed tomography (CT) and to summarize the pathologies leading to this appearance.\nMedical records and initial and follow-up CT features of patients with misty mesentery appearance between January 2011 and January 2013 were analysed. The study included cases with no known cause of misty mesentery according to associated CT findings, clinical history, or biochemical manifestations, and excluded patients with diseases known to cause misty mesentery, lymph nodes greater than",
        "q2": " a short-axis diameter of 5\u00a0mm, discrete mesenteric masses, or bowel wall thickening.\nThere were a total of 561 patients in whom misty mesentery appearance was depicted on abdominopelvic CT scans. A total of 80 cases were found to have isolated incidental idiopathic misty mesentery, giving a prevalence of 7%. The common indication for CT examination was abdominal pain. There was a slight female predominance (51.3%). 67.5% of all patients were classified as obese and 17.5% as overweight.\nThe Prevalence of Incidentally Detected Idiopathic Misty Mesentery on\u00a0Multidetector Computed Tomography: Can Obesity Be the Triggering Cause?",
        "generated_text": "1 cm, and those with follow-up periods less than 6 months.\nA total of 10,000 abdominal CT scans were performed during the study period, and 100 cases with misty mesentery appearance were identified. Of these, 20 cases were excluded due to known causes of misty mesentery, and 10 cases were excluded due to insufficient follow-up. The remaining 70 cases were considered to have idiopathic misty mesentery.\nThe mean age of the patients was 45 years (range: 20-70 years), and there was a slight female predominance (55%). The most common symptoms reported were abdominal pain (60%), bloating (30",
        "levenshtein_distance": 467
    },
    {
        "realidx": "27096199",
        "question": "Multiple viruses are often detected in children with respiratory infection but the significance of co-infection in pathogenesis, severity and outcome is unclear.\nTo correlate the presence of viral co-infection with clinical phenotype in children admitted with acute respiratory infections (ARI).\nWe collected detailed clinical information on severity for children admitted with ARI as part of a Spanish prospective multicenter study (GENDRES network) between 2011-2013. A nested polymerase chain reaction (PCR) approach was used to detect respiratory viruses in respiratory secretions. Findings were compared to an independent cohort collected in the UK.\n204 children were recruited in the main cohort and 97 in the replication cohort. The number of detected viruses did not correlate with any markers of severity. However, bacterial superinfection was associated with increased severity (OR: 4.356; P-value = 0.005), PICU admission (OR: 3.342; P-value = 0.006), higher clinical score (1.988; P-value = 0.002) respiratory support requirement (OR: 7.484; P-value<0.001) and longer hospital length of stay (OR: 1.468; P-value<0.001). In addition, pneumococcal vaccination was found to be a protective factor in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU admission (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 0.021) respiratory support requirement (OR: 0.324; P-value = 0.016) and oxygen necessity (OR: 0.328; P-value = 0.001). All these findings were replicated in the UK cohort.\nDoes Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?",
        "answer": "no",
        "answer_rationale": "The presence of more than one virus in hospitalized children with ARI is very frequent but it does not seem to have a major clinical impact in terms of severity. However bacterial superinfection increases the severity of the disease course. On the contrary, pneumococcal vaccination plays a protective role.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Multiple viruses are often detected in children with respiratory infection but the significance of co-infection in pathogenesis, severity and outcome is unclear.\nTo correlate the presence of viral co-infection with clinical phenotype in children admitted with acute respiratory infections (ARI).\nWe collected detailed clinical information on severity for children admitted with ARI as part of a Spanish prospective multicenter study (GENDRES network) between 2011-2013. A nested polymerase chain reaction (PCR) approach was used to detect respiratory viruses in respiratory secretions. Findings were compared to an independent cohort collected in the UK.\n204 children were recruited in the main cohort and 97 in the replication cohort. The number of detected viruses did not correlate with any markers of severity. However, bacterial superinfection was associated with increased severity (OR: 4.356; P-value = 0.005), PICU admission (OR: 3.342; P-value = 0.006",
        "q2": "), higher clinical score (1.988; P-value = 0.002) respiratory support requirement (OR: 7.484; P-value<0.001) and longer hospital length of stay (OR: 1.468; P-value<0.001). In addition, pneumococcal vaccination was found to be a protective factor in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU admission (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 0.021) respiratory support requirement (OR: 0.324; P-value = 0.016) and oxygen necessity (OR: 0.328; P-value = 0.001). All these findings were replicated in the UK cohort.\nDoes Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?",
        "generated_text": "), and longer hospital stay (OR: 2.125; P-value = 0.001). In the replication cohort, the number of detected viruses did not correlate with any markers of severity, but bacterial superinfection was associated with increased severity (OR: 2.42; P-value = 0.001), PICU admission (OR: 2.12; P-value = 0.002), and longer hospital stay (OR: 1.85; P-value = 0.003). In both cohorts, the presence of RSV was associated with increased severity (OR: 2.12; P-value = 0.001 and OR: 1.98; P-value = 0.005, respectively).\nThe number of detected viruses does not correlate with severity in children with ARI. However, bacterial superinfection",
        "levenshtein_distance": 436
    },
    {
        "realidx": "27131771",
        "question": "The alterations of echocardiography and electrocardiogram (ECG) in patients received left atrial appendage LAA occlusion therapy are still unclear. The present study was to evaluate the influence of LAA occlusion device on echocardiography and ECG changes in patients with atrial fibrillation (AF).\nSeventy-three patients who had undergone Watchman, LAmbre and Lefort were enrolled in this study. Echocardiography and ECG results at pre- and post-operation were collected. Besides, echocardiography was also performed during follow-up visits at 1, 6 and 12months after discharge.\nAfter LAA occlusion, a slight and measureable movement of QRS electric axis was observed in most patients. The significant differences were also observed in heart rate (HR) and the mean-mean QT interval between pre- and post-operation for all patients. There existed no significant difference in echocardiographic parameters between before and after device implantation. However, a larger left atrial (LA) diameter was detected by echocardiography during follow-up visit at 6months when compared with pre-operation parameters. Similarly, aortic root diameter (ARD) was also larger during follow-up at 12months than the baseline dimension in pre-operation.\nDoes left atrial appendage (LAA) occlusion device alter the echocardiography and electrocardiogram parameters in patients with atrial fibrillation?",
        "answer": "yes",
        "answer_rationale": "LAA occlusion device resulted in a slightly movement in QRS axis, reduced HR and increased the mean-mean QT interval duration. In addition, LA diameter and ARD seemed to be larger after device implantation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The alterations of echocardiography and electrocardiogram (ECG) in patients received left atrial appendage LAA occlusion therapy are still unclear. The present study was to evaluate the influence of LAA occlusion device on echocardiography and ECG changes in patients with atrial fibrillation (AF).\nSeventy-three patients who had undergone Watchman, LAmbre and Lefort were enrolled in this study. Echocardiography and ECG results at pre- and post-operation were collected. Besides, echocardiography was also performed during follow-up visits at 1, 6 and 12months after discharge.\nAfter LAA occlusion, a slight and measureable movement of QRS electric axis",
        "q2": " was observed in most patients. The significant differences were also observed in heart rate (HR) and the mean-mean QT interval between pre- and post-operation for all patients. There existed no significant difference in echocardiographic parameters between before and after device implantation. However, a larger left atrial (LA) diameter was detected by echocardiography during follow-up visit at 6months when compared with pre-operation parameters. Similarly, aortic root diameter (ARD) was also larger during follow-up at 12months than the baseline dimension in pre-operation.\nDoes left atrial appendage (LAA) occlusion device alter the echocardiography and electrocardiogram parameters in patients with atrial fibrillation?",
        "generated_text": "was observed in all patients, which was more obvious in patients with left atrial enlargement. The mean QRS electric axis shifted from 42.1\u00b0\u00b132.1\u00b0 to 50.1\u00b0\u00b132.1\u00b0 (P=0.001). The mean left atrial diameter decreased from 42.1\u00b15.1mm to 40.1\u00b15.1mm (P=0.001). The mean left ventricular ejection fraction increased from 58.1%\u00b17.1% to 60.1%\u00b17.1% (P=0.001). The mean left ventricular end",
        "levenshtein_distance": 545
    },
    {
        "realidx": "27136599",
        "question": "Patient data were retrospectively collected from a database for gynaecological cancer procedures carried out between January 2013 and July 2015. All patients who underwent a colorectal resection during cytoreduction were included in the study. The primary outcome was anastomotic leakage in the presence or absence of a diverting stoma. Secondary outcome parameters were complications and reoperations.\nIn the period of study, 43 major colorectal procedures were performed on 37 women. The most common colorectal procedure was low rectal resection (n\u00a0=\u00a022; 59%) followed by anterior rectal resection (n\u00a0=\u00a07; 19%) and sigmoid resection (n\u00a0=\u00a04; 11%). Five (14%) patients underwent Hartmann's procedure. In three (8%) patients, a diverting loop ileostomy was created.\nIs it safe to perform rectal anastomosis in gynaecological debulking surgery without a diverting stoma?",
        "answer": "yes",
        "answer_rationale": "Low rectal resection during debulking procedures for gynaecological cancers with peritoneal carcinomatosis can safely be performed by an experienced surgeon without a diverting stoma.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Patient data were retrospectively collected from a database for gynaecological cancer procedures carried out between January 2013 and July 2015. All patients who underwent a colorectal resection during cytoreduction were included in the study. The primary outcome was anastomotic leakage in the presence or absence of a diverting stoma. Secondary outcome parameters were complications and reoperations.\nIn the period of study, 43 major colorectal procedures were performed on 37 women. The most common colorectal procedure was",
        "q2": " low rectal resection (n\u00a0=\u00a022; 59%) followed by anterior rectal resection (n\u00a0=\u00a07; 19%) and sigmoid resection (n\u00a0=\u00a04; 11%). Five (14%) patients underwent Hartmann's procedure. In three (8%) patients, a diverting loop ileostomy was created.\nIs it safe to perform rectal anastomosis in gynaecological debulking surgery without a diverting stoma?",
        "generated_text": "a low anterior resection (n=20). Anastomotic leakage occurred in 11 patients (25.6%). The overall complication rate was 55.8% and the reoperation rate was 25.6%. There was no significant difference in anastomotic leakage between patients with and without a diverting stoma (p=0.11). The overall complication rate was higher in patients with a diverting stoma (p=0.03).",
        "levenshtein_distance": 267
    },
    {
        "realidx": "27217036",
        "question": "Longer duration of neoadjuvant (NA) imatinib\u00a0(IM) used for locally advanced (LA) gastrointestinal stromal tumours (GIST) is not based on biology of the tumour reflected by kit mutation analysis.\nLA or locally recurrent (LR) GIST treated with NA IM from May 2008 to March 2015 from a prospective database were included in\u00a0the analysis. Archived formalin-fixed paraffin-embedded tissues (FFPE) were used for testing KIT exons 9, 11, 13 and 17 by PCR.\nOne hundred twenty-five patients with LA or LR GIST were treated with NA IM. Forty-five patients (36\u00a0%) had undergone c-kit mutation testing. Exon 11 was seen in 25 patients (55.5\u00a0%), 3 with exon 9 (6.7\u00a0%) and 2 with exon 13 (4.4\u00a0%). Twelve were wild type (26.6\u00a0%) and \u00a03 (6.7 %) were declared uninterpretable. Response rate (RR) for the exon 11 mutants was higher than the non-exon 11 mutant group (84 vs. 40\u00a0%, p\u2009=\u20090.01). Disease stabilization rate (DSR) rates were also higher in the exon 11 subgroup than non-exon 11 group (92 vs. 75\u00a0%). Eighty-four per cent exon 11 and 75\u00a0% non-exon 11 mutants were surgical candidates. Patients undergoing surgery had significantly improved event free survival (EFS) (p\u2009<\u20090.001) compared to patients not undergoing surgery, with the same trend seen in OS (p\u2009=\u20090.021). Patients with a SD on response to NA IM had a lower EFS (p\u2009=\u20090.076) and OS compared to patients achieving CR/PR. There were no differences between the various exon variants in terms of outcomes and responses\nNeoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?",
        "answer": "yes",
        "answer_rationale": "Upfront evaluation of kit mutation status may help us in delineating separate treatment strategies for potentially biologically different tumours and assessing the correct timing of surgery for this subset of GIST.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Longer duration of neoadjuvant (NA) imatinib\u00a0(IM) used for locally advanced (LA) gastrointestinal stromal tumours (GIST) is not based on biology of the tumour reflected by kit mutation analysis.\nLA or locally recurrent (LR) GIST treated with NA IM from May 2008 to March 2015 from a prospective database were included in\u00a0the analysis. Archived formalin-fixed paraffin-embedded tissues (FFPE) were used for testing KIT exons 9, 11, 13 and 17 by PCR.\nOne hundred twenty-five patients with LA or LR GIST were treated with NA IM. Forty-five patients (36\u00a0%) had undergone c-kit mutation testing. Exon 11 was seen in 25 patients (55.5\u00a0%), 3 with exon 9 (6.7\u00a0%) and 2 with exon 13 (4.4\u00a0%). Twelve were wild type (26.6\u00a0%) and \u00a03 (6.7 %) were declared uninterpretable.",
        "q2": " Response rate (RR) for the exon 11 mutants was higher than the non-exon 11 mutant group (84 vs. 40\u00a0%, p\u2009=\u20090.01). Disease stabilization rate (DSR) rates were also higher in the exon 11 subgroup than non-exon 11 group (92 vs. 75\u00a0%). Eighty-four per cent exon 11 and 75\u00a0% non-exon 11 mutants were surgical candidates. Patients undergoing surgery had significantly improved event free survival (EFS) (p\u2009<\u20090.001) compared to patients not undergoing surgery, with the same trend seen in OS (p\u2009=\u20090.021). Patients with a SD on response to NA IM had a lower EFS (p\u2009=\u20090.076) and OS compared to patients achieving CR/PR. There were no differences between the various exon variants in terms of outcomes and responses\nNeoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?",
        "generated_text": "Median duration of NA IM was 12\u00a0months (range 3\u201324). Median duration of NA IM in exon 11 was 12\u00a0months (range 3\u201324), exon 9 12\u00a0months (range 6\u201312), exon 13 12\u00a0months (range 6\u201312), wild type 12\u00a0months (range 3\u201324) and uninterpretable 12\u00a0months (range 6\u201318). There was no correlation between duration of NA IM and c-kit mutation status (p\u2009=\u20090.99). Median overall survival (OS) was 108\u00a0months (range 12\u2013120). Median OS in exon 11 was 108\u00a0months (range 12\u2013120), exon 9 108\u00a0months (range 12\u2013120), exon 13 108\u00a0months (range",
        "levenshtein_distance": 623
    },
    {
        "realidx": "27281318",
        "question": "This study aims to study femoral tunnel lengths drilled with a flexible reamer and the distance to important lateral structures obtained by flexing the knee at various angles and by drilling the guide pins arthroscopically to resemble clinical practice. The purpose of this cadaveric study was twofold: 1. to determine whether femoral tunnel lengths of greater than 20 mm can be created with a flexible reamer system at 90 \u00b0 of knee flexion and 2. to determine whether the lateral structures of the knee are safe with this technique.\nTen fresh cadaveric knees were utilized. The intra-osseous length can be measured with a specially de - signed flexible guide pin. Flexible pins were inserted with the knee at 70\u00b0, 90\u00b0, and 120\u00b0 of flexion. The intra-osseous length was measured with the measuring device. Each speci - men was dissected around the lateral aspect of the knee to identify the critical structures, the common peroneal nerve, and the LCL. The distance from the guide pins to the com - mon peroneal nerve and femoral attachment of the LCL were measured with a standard flexible paper ruler to the nearest millimeter.\nThere is a trend for progressively increasing mean intra-osseous length associated with increased flexion of the knee. The mean intra-osseous length for 70\u00b0 flexion was 25.2 mm (20 mm to 32 mm), which was statistically significant when compared to mean intra-osseous lengths of 32.1 mm (22 mm to 45 mm) and 38.0 mm (34 mm to 45 mm) in the 90\u00b0 and 120\u00b0 flexion groups, respectively (p<0.05). There were no significant differences among the groups with respect to distance to the LCL. There is a trend toward longer distances to the common peroneal nerve with increased flexion. There was a statistically significant dif - ference when comparing 120\u00b0 versus 70\u00b0 (p<0.05).\nCan Flexible Instruments Create Adequate Femoral Tunnel Lengths at 90\u00b0 of Knee Flexion in Anterior Cruciate Ligament Reconstruction?",
        "answer": "yes",
        "answer_rationale": "This study that shows that adequate femoral tunnel lengths can be safely created without knee hyperflex - ion using flexible instruments via an anteromedial portal.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study aims to study femoral tunnel lengths drilled with a flexible reamer and the distance to important lateral structures obtained by flexing the knee at various angles and by drilling the guide pins arthroscopically to resemble clinical practice. The purpose of this cadaveric study was twofold: 1. to determine whether femoral tunnel lengths of greater than 20 mm can be created with a flexible reamer system at 90 \u00b0 of knee flexion and 2. to determine whether the lateral structures of the knee are safe with this technique.\nTen fresh cadaveric knees were utilized. The intra-osseous length can be measured with a specially de - signed flexible guide pin. Flexible pins were inserted with the knee at 70\u00b0, 90\u00b0, and 120\u00b0 of flexion. The intra-osseous length was measured with the measuring device. Each speci - men was dissected around the lateral aspect of the knee to identify the critical structures, the common peroneal nerve, and the LCL. The distance from the guide pins to the com - mon peroneal nerve and",
        "q2": " femoral attachment of the LCL were measured with a standard flexible paper ruler to the nearest millimeter.\nThere is a trend for progressively increasing mean intra-osseous length associated with increased flexion of the knee. The mean intra-osseous length for 70\u00b0 flexion was 25.2 mm (20 mm to 32 mm), which was statistically significant when compared to mean intra-osseous lengths of 32.1 mm (22 mm to 45 mm) and 38.0 mm (34 mm to 45 mm) in the 90\u00b0 and 120\u00b0 flexion groups, respectively (p<0.05). There were no significant differences among the groups with respect to distance to the LCL. There is a trend toward longer distances to the common peroneal nerve with increased flexion. There was a statistically significant dif - ference when comparing 120\u00b0 versus 70\u00b0 (p<0.05).\nCan Flexible Instruments Create Adequate Femoral Tunnel Lengths at 90\u00b0 of Knee Flexion in Anterior Cruciate Ligament Reconstruction?",
        "generated_text": "the LCL was measured.\nThe mean intra-osseous length was 21.5 mm at 70\u00b0, 21.1 mm at 90\u00b0, and 20.5 mm at 120\u00b0 of flexion. The mean distance from the guide pin to the common peroneal nerve was 11.5 mm at 70\u00b0, 11.1 mm at 90\u00b0, and 10.5 mm at 120\u00b0 of flexion. The mean distance from the guide pin to the LCL was 10.5 mm at 70\u00b0, 10.1 mm at 90\u00b0, and 9.5 mm at 120\u00b0 of flexion.\nThe flexible reamer system can create femoral tunnels longer than 20 mm at 90\u00b0 of flexion. The lateral structures are safe with this technique.",
        "levenshtein_distance": 655
    },
    {
        "realidx": "27287237",
        "question": "Little is known about the validity and reliability of expert assessments of the quality of antimicrobial prescribing, despite their importance in antimicrobial stewardship. We investigated how infectious disease doctors' assessments compared with a reference standard (modal expert opinion) and with the assessments of their colleagues.\nTwenty-four doctors specialized in infectious diseases or clinical microbiology (16 specialists and 8 residents) from five hospitals were asked to assess the appropriateness of antimicrobial agents prescribed for a broad spectrum of indications in 56 paper cases. They were instructed how to handle guideline applicability and deviations. We created a reference standard of antimicrobial appropriateness using the modal assessment of 16 specialists. We calculated criterion validity and interrater and intrarater overall and specific agreement with an index expert (senior infectious disease physician) and analysed the influence of doctor characteristics on validity.\nSpecialists agreed with the reference standard in 80% of cases (range 75%-86%), with a sensitivity and specificity of 75% and 84%, respectively. This did not differ by clinical specialty, hospital or years of experience, and residents had similar results. Specialists agreed with the index expert in 76% of cases and the index expert agreed with his previous assessments in 71% of cases.\nAssessment of appropriate antimicrobial prescribing: do experts agree?",
        "answer": "yes",
        "answer_rationale": "Doctors specialized in infectious diseases and clinical microbiology assess the appropriateness of antimicrobials prescribed for a broad spectrum of indications with acceptable agreement and validity, regardless of their experience or hospital of employment. However, there is room for improvement, which merits attention in multidisciplinary discussions and education.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Little is known about the validity and reliability of expert assessments of the quality of antimicrobial prescribing, despite their importance in antimicrobial stewardship. We investigated how infectious disease doctors' assessments compared with a reference standard (modal expert opinion) and with the assessments of their colleagues.\nTwenty-four doctors specialized in infectious diseases or clinical microbiology (16 specialists and 8 residents) from five hospitals were asked to assess the appropriateness of antimicrobial agents prescribed for a broad spectrum of indications in 56 paper cases. They were instructed how to handle guideline applicability and deviations. We created a reference standard of antimicrobial appropriateness using the modal assessment of 16 specialists. We calculated",
        "q2": " criterion validity and interrater and intrarater overall and specific agreement with an index expert (senior infectious disease physician) and analysed the influence of doctor characteristics on validity.\nSpecialists agreed with the reference standard in 80% of cases (range 75%-86%), with a sensitivity and specificity of 75% and 84%, respectively. This did not differ by clinical specialty, hospital or years of experience, and residents had similar results. Specialists agreed with the index expert in 76% of cases and the index expert agreed with his previous assessments in 71% of cases.\nAssessment of appropriate antimicrobial prescribing: do experts agree?",
        "generated_text": "the proportion of assessments that agreed with the reference standard and with colleagues' assessments, and the proportion of assessments that were discordant with the reference standard and with colleagues' assessments.\nThe proportion of assessments that agreed with the reference standard was 75% (95% confidence interval [CI] 72-78%) for specialists and 67% (95% CI 62-72%) for residents. The proportion of assessments that were discordant with the reference standard was 10% (95% CI 8-12%) for specialists and 15% (95% CI",
        "levenshtein_distance": 485
    },
    {
        "realidx": "27338535",
        "question": "Current risk assessment models for surgical site occurrence (SSO) and surgical site infection (SSI) after open ventral hernia repair (VHR) have limited external validation. Our aim was to determine (1) whether existing models stratify patients into groups by risk and (2) which model best predicts the rate of SSO and SSI.\nPatients who underwent open VHR and were followed for at least 1\u00a0mo were included. Using two data sets-a retrospective multicenter database (Ventral Hernia Outcomes Collaborative) and a single-center prospective database (Prospective)-each patient was assigned a predicted risk with each of the following models: Ventral Hernia Risk Score (VHRS), Ventral Hernia Working Group (VHWG), Centers for Disease Control and Prevention Wound Class, and Hernia Wound Risk Assessment Tool (HW-RAT). Patients in the Prospective database were also assigned a predicted risk from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Areas under the receiver operating characteristic curve (area under the curve [AUC]) were compared to assess the predictive accuracy of the models for SSO and SSI. Pearson's chi-square was used to determine which models were able to risk-stratify patients into groups with significantly differing rates of actual SSO and SSI.\nThe Ventral Hernia Outcomes Collaborative database (n\u00a0=\u00a0795) had an overall SSO and SSI rate of 23% and 17%, respectively. The AUCs were low for SSO (0.56, 0.54, 0.52, and 0.60) and SSI (0.55, 0.53, 0.50, and 0.58). The VHRS (P\u00a0=\u00a00.01) and HW-RAT (P\u00a0<\u00a00.01) significantly stratified patients into tiers for SSO, whereas the VHWG (P\u00a0<\u00a00.05) and HW-RAT (P\u00a0<\u00a00.05) stratified for SSI. In the Prospective database (n\u00a0=\u00a088), 14% and 8% developed an SSO and SSI, respectively. The AUCs were low for SSO (0.63, 0.54, 0.50, 0.57, and 0.69) and modest for SSI (0.81, 0.64, 0.55, 0.62, and 0.73). The ACS-NSQIP (P\u00a0<\u00a00.01) stratified for SSO, whereas the VHRS (P\u00a0<\u00a00.01) and ACS-NSQIP (P\u00a0<\u00a00.05) stratified for SSI. In both databases, VHRS, VHWG, and Centers for Disease Control and Prevention overestimated risk of SSO and SSI, whereas HW-RAT and ACS-NSQIP underestimated risk for all groups.\nDo risk calculators accurately predict surgical site\u00a0occurrences?",
        "answer": "no",
        "answer_rationale": "All five existing predictive models have limited ability to risk-stratify patients and accurately assess risk of SSO. However, both the VHRS and ACS-NSQIP demonstrate modest success in identifying patients at risk for SSI. Continued model refinement is needed to improve the two highest performing models (VHRS and ACS-NSQIP) along with investigation to determine whether modifications to perioperative management based on risk stratification can improve outcomes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Current risk assessment models for surgical site occurrence (SSO) and surgical site infection (SSI) after open ventral hernia repair (VHR) have limited external validation. Our aim was to determine (1) whether existing models stratify patients into groups by risk and (2) which model best predicts the rate of SSO and SSI.\nPatients who underwent open VHR and were followed for at least 1\u00a0mo were included. Using two data sets-a retrospective multicenter database (Ventral Hernia Outcomes Collaborative) and a single-center prospective database (Prospective)-each patient was assigned a predicted risk with each of the following models: Ventral Hernia Risk Score (VHRS), Ventral Hernia Working Group (VHWG), Centers for Disease Control and Prevention Wound Class, and Hernia Wound Risk Assessment Tool (HW-RAT). Patients in the Prospective database were also assigned a predicted risk from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Areas under the receiver operating characteristic curve (area under the curve [AUC]) were compared to assess the predictive accuracy of the models for SSO and SSI. Pearson's chi-square was used to determine which models were able to risk-stratify patients into groups with significantly differing rates of actual SSO and SSI.\nThe Ventral Hernia Outcomes Collaborative database (n\u00a0=\u00a0795) had an overall SSO and SSI rate of 23% and 17%, respectively. The AUCs were low for SSO (",
        "q2": "0.56, 0.54, 0.52, and 0.60) and SSI (0.55, 0.53, 0.50, and 0.58). The VHRS (P\u00a0=\u00a00.01) and HW-RAT (P\u00a0<\u00a00.01) significantly stratified patients into tiers for SSO, whereas the VHWG (P\u00a0<\u00a00.05) and HW-RAT (P\u00a0<\u00a00.05) stratified for SSI. In the Prospective database (n\u00a0=\u00a088), 14% and 8% developed an SSO and SSI, respectively. The AUCs were low for SSO (0.63, 0.54, 0.50, 0.57, and 0.69) and modest for SSI (0.81, 0.64, 0.55, 0.62, and 0.73). The ACS-NSQIP (P\u00a0<\u00a00.01) stratified for SSO, whereas the VHRS (P\u00a0<\u00a00.01) and ACS-NSQIP (P\u00a0<\u00a00.05) stratified for SSI. In both databases, VHRS, VHWG, and Centers for Disease Control and Prevention overestimated risk of SSO and SSI, whereas HW-RAT and ACS-NSQIP underestimated risk for all groups.\nDo risk calculators accurately predict surgical site\u00a0occurrences?",
        "generated_text": "range, 0.52-0.57) and SSI (range, 0.52-0.56). The VHRS and VHWG models were able to stratify patients into groups with significantly different rates of SSO and SSI (P\u00a0<\u00a0.05). The Prospective database (n\u00a0=\u00a0100) had an overall SSO and SSI rate of 19% and 13%, respectively. The AUCs were low for SSO (range, 0.50-0.57) and SSI (range, 0.50-0.56). The VHRS, VHWG, and ACS-NSQIP models were able to stratify patients into groups with significantly different rates of SSO and SSI (P\u00a0<\u00a0.05).\nExisting models have limited ability to predict SSO and SSI after open VHR. The VHRS and VHWG models are able to stratify patients into groups with significantly different rates of SSO and SSI.",
        "levenshtein_distance": 526
    },
    {
        "realidx": "27394685",
        "question": "The prevalence of combined humeral and glenoid defects varies between 79 and 84\u00a0% in case of chronic posttraumatic anterior shoulder instability. The main goal of this study was to evaluate the relationship between humeral and glenoid defects based on quantitative radiological criteria.\nA retrospective study was performed between 2000 and 2011 including patients who underwent primary surgical shoulder stabilization for chronic posttraumatic anterior shoulder instability, with bone defects in both the glenoid and humerus and a healthy contralateral shoulder. The following measurements were taken: D/R ratio (Hill-Sachs lesion depth/humeral head radius) on an AP X-ray in internal rotation and the D1/D2 ratio [diameter of the involved glenoid articular surfaces (D1)/the healthy one (D2)] on a comparative Bernageau glenoid profile view. Measurements were taken by two observers. Correlations were determined by the Spearman correlation coefficients (r), Bland and Altman diagrams, and intra-class correlation coefficients (ICC). A sample size calculation was done.\nThirty patients were included, 25 men/5 women, mean age 29.8\u00a0\u00b1\u00a011.2\u00a0years. The mean D/R was 23\u00a0\u00b1\u00a012\u00a0% for observer 1 and 23\u00a0\u00b1\u00a010\u00a0% for observer 2. The mean D1/D2 was 95\u00a0\u00b1\u00a04\u00a0% for observer 1 and 94\u00a0\u00b1\u00a06\u00a0% for observer 2. No significant correlation was found between humeral and glenoid bone defects by observer 1 (r\u00a0=\u00a00.23, p\u00a0=\u00a00.22) or observer 2 (r\u00a0=\u00a00.05, p\u00a0=\u00a00.78). Agreement of the observers for the D/R ratio was excellent (ICC\u00a0=\u00a00.89\u00a0\u00b1\u00a00.04, p\u00a0<\u00a00.00001) and good for the D1/D2 ratio (ICC\u00a0=\u00a00.54\u00a0\u00b1\u00a00.14, p\u00a0=\u00a00.006).\nBony defects in chronic anterior posttraumatic dislocation of the shoulder: Is there a correlation between humeral and glenoidal lesions?",
        "answer": "no",
        "answer_rationale": "Humeral and glenoid bone defects were not correlated. Inter-observer reliability was excellent for the D/R ratio and good for the D1/D2 ratio.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The prevalence of combined humeral and glenoid defects varies between 79 and 84\u00a0% in case of chronic posttraumatic anterior shoulder instability. The main goal of this study was to evaluate the relationship between humeral and glenoid defects based on quantitative radiological criteria.\nA retrospective study was performed between 2000 and 2011 including patients who underwent primary surgical shoulder stabilization for chronic posttraumatic anterior shoulder instability, with bone defects in both the glenoid and humerus and a healthy contralateral shoulder. The following measurements were taken: D/R ratio (Hill-Sachs lesion depth/humeral head radius) on an AP X-ray in internal rotation and the D1/D2 ratio [diameter of the involved glenoid articular surfaces (D1)/the healthy one (D2)] on a comparative Bernageau glenoid profile view. Measurements were taken by two observers. Correlations were determined by the Spearman correlation coefficients (r), Bland and Altman diagrams, and intra-class correlation coefficients (ICC). A sample size calculation was done.\nThirty patients were included, 25 men/5 women, mean",
        "q2": " age 29.8\u00a0\u00b1\u00a011.2\u00a0years. The mean D/R was 23\u00a0\u00b1\u00a012\u00a0% for observer 1 and 23\u00a0\u00b1\u00a010\u00a0% for observer 2. The mean D1/D2 was 95\u00a0\u00b1\u00a04\u00a0% for observer 1 and 94\u00a0\u00b1\u00a06\u00a0% for observer 2. No significant correlation was found between humeral and glenoid bone defects by observer 1 (r\u00a0=\u00a00.23, p\u00a0=\u00a00.22) or observer 2 (r\u00a0=\u00a00.05, p\u00a0=\u00a00.78). Agreement of the observers for the D/R ratio was excellent (ICC\u00a0=\u00a00.89\u00a0\u00b1\u00a00.04, p\u00a0<\u00a00.00001) and good for the D1/D2 ratio (ICC\u00a0=\u00a00.54\u00a0\u00b1\u00a00.14, p\u00a0=\u00a00.006).\nBony defects in chronic anterior posttraumatic dislocation of the shoulder: Is there a correlation between humeral and glenoidal lesions?",
        "generated_text": "age 27.5\u00a0years (18\u201345). The mean follow-up was 4.5\u00a0years (1\u201311). The mean D/R ratio was 0.42 (0.15\u20130.75). The mean D1/D2 ratio was 0.82 (0.50\u20130.97). The correlation between the D/R ratio and the D1/D2 ratio was r\u2009=\u20090.54 (p\u2009=\u20090.002). The intra- and inter-observer reliability was excellent (ICC\u2009=\u20090.97 and 0.95, respectively). The sample size calculation showed that 28 patients were needed to obtain a power of 80\u00a0%.\nA significant correlation was found between the D/R ratio and the D1/D2 ratio, suggesting that the greater the humeral defect, the greater the glenoid defect. This study provides a better understanding of the pathophysiology of chronic posttraumatic anterior shoulder instability and may help in the",
        "levenshtein_distance": 524
    },
    {
        "realidx": "27456836",
        "question": "To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population.\nTrialNet subjects who were positive for one or more autoantibodies (microinsulin autoantibody, GAD65 autoantibody [GADA], IA-2A, and ZnT8A) with available ECL-insulin autoantibody (IAA) and ECL-GADA data at their initial visit were analyzed; after a median follow-up of 24 months, 177 of these 1,287 subjects developed diabetes.\nUnivariate analyses showed that autoantibodies by radioimmunoassays (RIAs), ECL-IAA, ECL-GADA, age, sex, number of positive autoantibodies, presence of HLA DR3/4-DQ8 genotype, HbA1c, and oral glucose tolerance test (OGTT) measurements were all significantly associated with progression to diabetes. Subjects who were ECL positive had a risk of progression to diabetes within 6 years of 58% compared with 5% for the ECL-negative subjects (P<0.0001). Multivariate Cox proportional hazards models were compared, with the base model including age, sex, OGTT measurements, and number of positive autoantibodies by RIAs. The model with positivity for ECL-GADA and/or ECL-IAA was the best, and factors that remained significantly associated with time to diabetes were area under the curve (AUC) C-peptide, fasting C-peptide, AUC glucose, number of positive autoantibodies by RIAs, and ECL positivity. Adding ECL to the Diabetes Prevention Trial risk score (DPTRS) improved the receiver operating characteristic curves with AUC of 0.83 (P<0.0001).\nDo Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?",
        "answer": "yes",
        "answer_rationale": "ECL assays improved the ability to predict time to diabetes in these autoantibody-positive relatives at risk for developing diabetes. These findings might be helpful in the design and eligibility criteria for prevention trials in the future.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population.\nTrialNet subjects who were positive for one or more autoantibodies (microinsulin autoantibody, GAD65 autoantibody [GADA], IA-2A, and ZnT8A) with available ECL-insulin autoantibody (IAA) and ECL-GADA data at their initial visit were analyzed; after a median follow-up of 24 months, 177 of these 1,287 subjects developed diabetes.\nUnivariate analyses showed that autoantibodies by radioimmunoassays (RIAs), ECL-IAA, ECL-GADA, age, sex, number of positive autoantibodies, presence of HLA DR3/4-DQ8 genotype, HbA1c, and oral glucose tolerance test (OGTT) measurements were all significantly associated with progression to diabetes. Subjects",
        "q2": " who were ECL positive had a risk of progression to diabetes within 6 years of 58% compared with 5% for the ECL-negative subjects (P<0.0001). Multivariate Cox proportional hazards models were compared, with the base model including age, sex, OGTT measurements, and number of positive autoantibodies by RIAs. The model with positivity for ECL-GADA and/or ECL-IAA was the best, and factors that remained significantly associated with time to diabetes were area under the curve (AUC) C-peptide, fasting C-peptide, AUC glucose, number of positive autoantibodies by RIAs, and ECL positivity. Adding ECL to the Diabetes Prevention Trial risk score (DPTRS) improved the receiver operating characteristic curves with AUC of 0.83 (P<0.0001).\nDo Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?",
        "generated_text": "with higher ECL-IAA and ECL-GADA levels had higher risk of progression to diabetes. In multivariate analysis, ECL-IAA and ECL-GADA were independent predictors of progression to diabetes, along with age, sex, number of positive autoantibodies, and OGTT measurements. ECL-IAA and ECL-GADA levels improved the prediction of progression to diabetes beyond that provided by the RIA autoantibodies.\nECL-IAA and ECL-GADA levels are independent predictors of progression to diabetes in the TrialNet autoantibody-positive population and improve the prediction of progression beyond that provided by the RIA autoantibodies.",
        "levenshtein_distance": 587
    },
    {
        "realidx": "27549226",
        "question": "The \"health workforce\" crisis has led to an increased interest in health professional education, including MPH programs. Recently, it was questioned whether training of mid- to higher level cadres in public health prepared graduates with competencies to strengthen health systems in low- and middle-income countries. Measuring educational impact has been notoriously difficult; therefore, innovative methods for measuring the outcome and impact of MPH programs were sought. Impact was conceptualized as \"impact on workplace\" and \"impact on society,\" which entailed studying how these competencies were enacted and to what effect within the context of the graduates' workplaces, as well as on societal health.\nThis is part of a larger six-country mixed method study; in this paper, the focus is on the qualitative findings of two English language programs, one a distance MPH program offered from South Africa, the other a residential program in the Netherlands. Both offer MPH training to students from a diversity of countries. In-depth interviews were conducted with 10 graduates (per program), working in low- and middle-income health systems, their peers, and their supervisors.\nImpact on the workplace was reported as considerable by graduates and peers as well as supervisors and included changes in management and leadership: promotion to a leadership position as well as expanded or revitalized management roles were reported by many participants. The development of leadership capacity was highly valued amongst many graduates, and this capacity was cited by a number of supervisors and peers. Wider impact in the workplace took the form of introducing workplace innovations such as setting up an AIDS and addiction research center and research involvement; teaching and training, advocacy, and community engagement were other ways in which graduates' influence reached a wider target grouping. Beyond the workplace, an intersectoral approach, national reach through policy advisory roles to Ministries of Health, policy development, and capacity building, was reported. Work conditions and context influenced conduciveness for innovation and the extent to which graduates were able to have effect. Self-selection of graduates and their role in selecting peers and supervisors may have resulted in some bias, some graduates could not be traced, and social acceptability bias may have influenced findings.\nImpact of MPH programs: contributing to health system strengthening in low- and middle-income countries?",
        "answer": "yes",
        "answer_rationale": "There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The \"health workforce\" crisis has led to an increased interest in health professional education, including MPH programs. Recently, it was questioned whether training of mid- to higher level cadres in public health prepared graduates with competencies to strengthen health systems in low- and middle-income countries. Measuring educational impact has been notoriously difficult; therefore, innovative methods for measuring the outcome and impact of MPH programs were sought. Impact was conceptualized as \"impact on workplace\" and \"impact on society,\" which entailed studying how these competencies were enacted and to what effect within the context of the graduates' workplaces, as well as on societal health.\nThis is part of a larger six-country mixed method study; in this paper, the focus is on the qualitative findings of two English language programs, one a distance MPH program offered from South Africa, the other a residential program in the Netherlands. Both offer MPH training to students from a diversity of countries. In-depth interviews were conducted with 10 graduates (per program), working in low- and middle-income health systems, their peers, and their supervisors.\nImpact on the workplace was",
        "q2": " reported as considerable by graduates and peers as well as supervisors and included changes in management and leadership: promotion to a leadership position as well as expanded or revitalized management roles were reported by many participants. The development of leadership capacity was highly valued amongst many graduates, and this capacity was cited by a number of supervisors and peers. Wider impact in the workplace took the form of introducing workplace innovations such as setting up an AIDS and addiction research center and research involvement; teaching and training, advocacy, and community engagement were other ways in which graduates' influence reached a wider target grouping. Beyond the workplace, an intersectoral approach, national reach through policy advisory roles to Ministries of Health, policy development, and capacity building, was reported. Work conditions and context influenced conduciveness for innovation and the extent to which graduates were able to have effect. Self-selection of graduates and their role in selecting peers and supervisors may have resulted in some bias, some graduates could not be traced, and social acceptability bias may have influenced findings.\nImpact of MPH programs: contributing to health system strengthening in low- and middle-income countries?",
        "generated_text": "found in the form of improved management and leadership, improved communication, and improved teamwork. Impact on society was found in the form of improved health services, improved health policies, and improved health research. The graduates' competencies were enacted in the workplace through their ability to apply their knowledge and skills in their work, their ability to influence others, and their ability to collaborate with others. The graduates' impact on society was achieved through their ability to improve health services, policies, and research, which in turn led to improved health outcomes for their communities.\nThis study provides evidence that MPH programs can have a positive impact on both the workplace and society in low- and middle-income countries. The findings suggest that MPH programs can equip graduates with the necessary competencies to strengthen health systems and improve health outcomes in their communities. The study also highlights the importance of considering the context in which graduates work and the need for ongoing support and resources to enable them to apply their skills and knowledge effectively.",
        "levenshtein_distance": 970
    },
    {
        "realidx": "27592038",
        "question": "Tinnitus can be related to many different aetiologies such as hearing loss or a noise trauma, but it can also be related to the somatosensory system of the cervical spine, called cervicogenic somatic tinnitus (CST). Case studies suggest a positive effect of cervical spine treatment on tinnitus complaints in patients with CST, but no experimental studies are available.\nTo investigate the effect of a multimodal cervical physical therapy treatment on tinnitus complaints in patients with CST.\nRandomized controlled trial.\nPatients with a combination of severe subjective tinnitus (Tinnitus Functional Index (TFI): 25-90 points) and neck complaints (Neck Bournemouth Questionnaire (NBQ)\u00a0>\u00a014 points).\nAll patients received cervical physical therapy for 6 weeks (12 sessions). Patients were randomized in an immediate-start therapy group (n\u00a0=\u00a019) and a 6-week delayed-start therapy group (n\u00a0=\u00a019).\nTFI and NBQ-scores were documented at baseline, after the wait-and-see period in the delayed-start group, after treatment and after 6 weeks follow-up. The Global Perceived Effect (GPE) was documented at all measuring moments, except at baseline.\nIn all patients (n\u00a0=\u00a038) TFI and NBQ-scores decreased significantly after treatment (p\u00a0=\u00a00.04 and p\u00a0<\u00a00.001). NBQ-scores remained significantly lower after follow-up (p\u00a0=\u00a00.001). Immediately after treatment, 53% (n\u00a0=\u00a038) experienced substantial improvement of tinnitus. This effect was maintained in 24% of patients after follow-up at six weeks.\nDoes multi-modal cervical physical therapy improve tinnitus in patients with cervicogenic somatic tinnitus?",
        "answer": "yes",
        "answer_rationale": "Cervical physical therapy can have a positive effect on subjective tinnitus complaints in patients with a combination of tinnitus and neck complaints. Larger studies, using more responsive outcome measures, are however necessary to prove this effect.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Tinnitus can be related to many different aetiologies such as hearing loss or a noise trauma, but it can also be related to the somatosensory system of the cervical spine, called cervicogenic somatic tinnitus (CST). Case studies suggest a positive effect of cervical spine treatment on tinnitus complaints in patients with CST, but no experimental studies are available.\nTo investigate the effect of a multimodal cervical physical therapy treatment on tinnitus complaints in patients with CST.\nRandomized controlled trial.\nPatients with a combination of severe subjective tinnitus (Tinnitus Functional Index (TFI): 25-90 points) and neck complaints (Neck Bournemouth Questionnaire (NBQ)\u00a0>\u00a014 points).\nAll patients received cervical physical therapy for 6 weeks (12 sessions). Patients were randomized in an immediate-start therapy group (n\u00a0=\u00a019) and a 6-week delayed",
        "q2": "-start therapy group (n\u00a0=\u00a019).\nTFI and NBQ-scores were documented at baseline, after the wait-and-see period in the delayed-start group, after treatment and after 6 weeks follow-up. The Global Perceived Effect (GPE) was documented at all measuring moments, except at baseline.\nIn all patients (n\u00a0=\u00a038) TFI and NBQ-scores decreased significantly after treatment (p\u00a0=\u00a00.04 and p\u00a0<\u00a00.001). NBQ-scores remained significantly lower after follow-up (p\u00a0=\u00a00.001). Immediately after treatment, 53% (n\u00a0=\u00a038) experienced substantial improvement of tinnitus. This effect was maintained in 24% of patients after follow-up at six weeks.\nDoes multi-modal cervical physical therapy improve tinnitus in patients with cervicogenic somatic tinnitus?",
        "generated_text": "-start therapy group (n\u00a0=\u00a019). The primary outcome measure was the TFI. Secondary outcome measures were the NBQ, the Hospital Anxiety and Depression Scale (HADS), the Numeric Rating Scale for tinnitus (NRS-T), the Tinnitus Sample Case History Questionnaire (TSCHQ), and the Tinnitus Handicap Inventory (THI). All outcome measures were assessed at baseline, after 6 weeks, and after 12 weeks.\nAt 6 weeks, the immediate-start group showed a significant improvement in TFI compared to the delayed-start group (mean difference: -10.1 points, 95% CI: -17.8 to -2.4, p\u00a0=\u00a00.011). At 12 weeks, the difference between the groups was no longer significant (mean difference: -5.",
        "levenshtein_distance": 558
    },
    {
        "realidx": "27615402",
        "question": "Parental drinking has been shown to be associated with offspring drinking. However, the relationship appears to be more complex than often assumed and few studies have tracked it over longer time periods.\nTo explore the long-term (10-year) transmission of familial drinking during adolescence to offspring drinking patterns in young adulthood.\nSwedish longitudinal study, assessing the relationship between familial drinking in 2000 and offspring drinking in 2010 using simultaneous quantile regression analysis (n=744).DATA: Data on familial drinking was gathered from the Swedish level-of-living surveys (LNU) and from partner LNU in 2000 while data on offspring drinking in young adulthood was gathered from LNU 2010. Drinking among offspring, parents and potential stepparents was measured through identical quantity-frequency indices referring to the past 12 months in 2010 and 2000 respectively.\nYoung adults whose families were abstainers in 2000 drank substantially less across quintiles in 2010 than offspring of non-abstaining families. The difference, however, was not statistically significant between quintiles of the conditional distribution. Actual drinking levels in drinking families were not at all or weakly associated with drinking in offspring. Supplementary analyses confirmed these patterns.\nDoes the familial transmission of drinking patterns persist into young adulthood?",
        "answer": "maybe",
        "answer_rationale": "The association between familial drinking and offspring drinking in young adulthood exhibits clear non-linear trends. Changes in the lower part of the familial drinking distribution are strongly related to drinking in young adults, but the actual levels of drinking in drinking families appear less important in shaping the drinking patterns of the offspring in young adulthood.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "q1": "Parental drinking has been shown to be associated with offspring drinking. However, the relationship appears to be more complex than often assumed and few studies have tracked it over longer time periods.\nTo explore the long-term (10-year) transmission of familial drinking during adolescence to offspring drinking patterns in young adulthood.\nSwedish longitudinal study, assessing the relationship between familial drinking in 2000 and offspring drinking in 2010 using simultaneous quantile regression analysis (n=744).DATA: Data on familial drinking was gathered from the Swedish level-of-living surveys (LNU) and from partner LNU in 2000 while data on offspring drinking in young adulthood",
        "q2": " was gathered from LNU 2010. Drinking among offspring, parents and potential stepparents was measured through identical quantity-frequency indices referring to the past 12 months in 2010 and 2000 respectively.\nYoung adults whose families were abstainers in 2000 drank substantially less across quintiles in 2010 than offspring of non-abstaining families. The difference, however, was not statistically significant between quintiles of the conditional distribution. Actual drinking levels in drinking families were not at all or weakly associated with drinking in offspring. Supplementary analyses confirmed these patterns.\nDoes the familial transmission of drinking patterns persist into young adulthood?",
        "generated_text": "was collected from the Swedish young adult survey (Ungdata) in 2010.\nFamilial drinking in 2000 was associated with offspring drinking in 2010, but the relationship was not uniform across the distribution of offspring drinking. The association was stronger for higher levels of offspring drinking, particularly for heavy episodic drinking and drunkenness. The relationship was also stronger for offspring of parents who were heavy drinkers compared to those whose parents were light or non-drinkers.\nThe findings suggest that the relationship between parental drinking and offspring drinking is not uniform across the distribution of offspring drinking and that heavy drinking in parents",
        "levenshtein_distance": 538
    },
    {
        "realidx": "27642458",
        "question": "Polio eradication is now feasible after removal of Nigeria from the list of endemic countries and global reduction of cases of wild polio virus in 2015 by more than 80%. However, all countries must remain focused to achieve eradication. In August 2015, the Catholic bishops in Kenya called for boycott of a polio vaccination campaign citing safety concerns with the polio vaccine. We conducted a survey to establish if the coverage was affected by the boycott.\nA cross sectional survey was conducted in all the 32 counties that participated in the campaign. A total of 90,157 children and 37,732 parents/guardians were sampled to determine the vaccination coverage and reasons for missed vaccination.\nThe national vaccination coverage was 93% compared to 94% in the November 2014 campaign. The proportion of parents/guardians that belonged to Catholic Church was 31% compared to 7% of the children who were missed. Reasons for missed vaccination included house not being visited (44%), children not being at home at time of visit (38%), refusal by parents (12%), children being as leep (1%), and various other reasons (5%). Compared to the November 2014 campaign, the proportion of children who were not vaccinated due to parent's refusal significantly increased from 6% to 12% in August 2015.\nDid the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015?",
        "answer": "no",
        "answer_rationale": "The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Polio eradication is now feasible after removal of Nigeria from the list of endemic countries and global reduction of cases of wild polio virus in 2015 by more than 80%. However, all countries must remain focused to achieve eradication. In August 2015, the Catholic bishops in Kenya called for boycott of a polio vaccination campaign citing safety concerns with the polio vaccine. We conducted a survey to establish if the coverage was affected by the boycott.\nA cross sectional survey was conducted in all the 32 counties that participated in the campaign. A total of 90,157 children and 37,732 parents/guardians were sampled to determine the vaccination coverage and reasons for missed vaccination.\nThe national vaccination coverage was ",
        "q2": "93% compared to 94% in the November 2014 campaign. The proportion of parents/guardians that belonged to Catholic Church was 31% compared to 7% of the children who were missed. Reasons for missed vaccination included house not being visited (44%), children not being at home at time of visit (38%), refusal by parents (12%), children being as leep (1%), and various other reasons (5%). Compared to the November 2014 campaign, the proportion of children who were not vaccinated due to parent's refusal significantly increased from 6% to 12% in August 2015.\nDid the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015?",
        "generated_text": "71.1% (95% CI: 70.7-71.5). The coverage was higher in the urban areas (74.1%) compared to the rural areas (68.5%). The coverage was higher in the boys (72.1%) compared to the girls (70.1%). The coverage was higher in the children aged 0-11 months (72.1%) compared to the children aged 12-59 months (70.5%). The coverage was higher in the children who had been vaccinated in the previous campaign (73.1%) compared to the children who had not been vaccinated in the previous campaign (67.",
        "levenshtein_distance": 460
    },
    {
        "realidx": "27643961",
        "question": "Comorbid major depression (MD) and alcohol use disorder (AUD), particularly in adolescents, have been shown to be associated with poorer subsequent MD outcomes.\nLongitudinal data were used to model associations between a four-level classification of MD/AUD during the period 15-18 years (neither; MD-only; AUD-only; comorbid MD/AUD) and MD over the period 18-35 years. These associations were then adjusted for confounding by a series of factors measured in childhood.\nThe three disorder groups had rates of adult MD during the period 18-35 years that were significantly (p<.05) higher than that of the group with no disorder. Furthermore, those in the comorbid MD/AUD group had significantly (p<.05) higher rates of adult MD than those in the AUD-only group, and marginally (p<.10) higher rates of adult MD than those in the MD-only group. After adjustment for confounding, the difference in rates of adult MD between the MD-only group and the MD/AUD group were no longer statistically significant. The factors that explained the associations were gender, childhood behavior problems, and exposure to physical and sexual abuse.\nThe data were obtained by self-report, and may have been subject to biases.\nMajor depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression?",
        "answer": "no",
        "answer_rationale": "The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Comorbid major depression (MD) and alcohol use disorder (AUD), particularly in adolescents, have been shown to be associated with poorer subsequent MD outcomes.\nLongitudinal data were used to model associations between a four-level classification of MD/AUD during the period 15-18 years (neither; MD-only; AUD-only; comorbid MD/AUD) and MD over the period 18-35 years. These associations were then adjusted for confounding by a series of factors measured in childhood.\nThe three disorder groups had rates of adult MD during the period 18-35 years that were significantly (p<.05) higher than that of the group with no disorder. Furthermore,",
        "q2": " those in the comorbid MD/AUD group had significantly (p<.05) higher rates of adult MD than those in the AUD-only group, and marginally (p<.10) higher rates of adult MD than those in the MD-only group. After adjustment for confounding, the difference in rates of adult MD between the MD-only group and the MD/AUD group were no longer statistically significant. The factors that explained the associations were gender, childhood behavior problems, and exposure to physical and sexual abuse.\nThe data were obtained by self-report, and may have been subject to biases.\nMajor depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression?",
        "generated_text": "the comorbid group had a significantly higher rate of adult MD than the MD-only group (p<.05). After adjustment for confounding, the association between the comorbid group and adult MD was attenuated but remained significant (p<.05). In contrast, the association between the MD-only group and adult MD was attenuated to non-significance.\nComorbid MD and AUD in adolescence is associated with increased risk of MD in adulthood, over and above that associated with MD alone. This suggests that the presence of AUD in adolescents with MD may be an important marker for poorer MD outcomes.",
        "levenshtein_distance": 449
    },
    {
        "realidx": "27757987",
        "question": "Recent studies have found a choroidal thickening in amblyopic eyes and suggested that there might be a relationship between the choroid and amblyopia. The present study aimed to evaluate the effect of a six-month treatment of amblyopia on choroidal thickness in anisometropic hyperopic amblyopic children.\nThirty-two anisometropic hyperopic children with unilateral amblyopia were included in this prospective study. Subfoveal choroidal thickness was measured as the distance between the retinal pigment epithelium and the chorioscleral edge, by using spectral domain enhanced depth imaging optical coherence tomography. The treatment of amblyopia was performed based on the full correction of the refractive error with eyeglasses, a refractive adaptation phase and occlusion by patching the fellow eye.\nThe mean visual acuity of the amblyopic eyes significantly increased from 0.35\u2009\u00b1\u20090.3 to 0.16\u2009\u00b1\u20090.2 logMAR after the treatment (p\u2009<\u20090.001). The mean initial choroidal thickness was significantly higher in the amblyopic eyes than in the fellow eyes (p\u2009=\u20090.019). There were no significant differences between the pre- and post-treatment mean choroidal thickness in the amblyopic eyes (p\u2009=\u20090.428) and in the fellow eyes (p\u2009=\u20090.343). The mean choroidal thickness was still higher in the amblyopic eyes than in the fellow eyes after the treatment (p\u2009=\u20090.006).\nDoes the treatment of amblyopia normalise subfoveal choroidal thickness in amblyopic children?",
        "answer": "no",
        "answer_rationale": "Although a six-month treatment of amblyopia increased the visual acuity of the anisometropic hyperopic amblyopic eyes, it could not significantly change choroidal thickness. Our results were in accordance with the conventional explanation, which suggests visual cortex and lateral geniculate nucleus abnormalities in the pathophysiology of amblyopia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Recent studies have found a choroidal thickening in amblyopic eyes and suggested that there might be a relationship between the choroid and amblyopia. The present study aimed to evaluate the effect of a six-month treatment of amblyopia on choroidal thickness in anisometropic hyperopic amblyopic children.\nThirty-two anisometropic hyperopic children with unilateral amblyopia were included in this prospective study. Subfoveal choroidal thickness was measured as the distance between the retinal pigment epithelium and the chorioscleral edge, by using spectral domain enhanced depth imaging optical coherence tomography. The treatment of amblyopia was performed based on the full correction of the refractive error with eyeglasses, a refractive adaptation phase and occlusion by patching the fellow eye.\nThe mean visual acuity of the amb",
        "q2": "lyopic eyes significantly increased from 0.35\u2009\u00b1\u20090.3 to 0.16\u2009\u00b1\u20090.2 logMAR after the treatment (p\u2009<\u20090.001). The mean initial choroidal thickness was significantly higher in the amblyopic eyes than in the fellow eyes (p\u2009=\u20090.019). There were no significant differences between the pre- and post-treatment mean choroidal thickness in the amblyopic eyes (p\u2009=\u20090.428) and in the fellow eyes (p\u2009=\u20090.343). The mean choroidal thickness was still higher in the amblyopic eyes than in the fellow eyes after the treatment (p\u2009=\u20090.006).\nDoes the treatment of amblyopia normalise subfoveal choroidal thickness in amblyopic children?",
        "generated_text": "lyopic eyes increased from 0.42 \u00b1 0.17 to 0.17 \u00b1 0.12 logMAR (p < 0.001). The mean subfoveal choroidal thickness increased from 215.1 \u00b1 35.1 to 240.1 \u00b1 37.1 \u03bcm (p < 0.001). There was a significant correlation between the changes in subfoveal choroidal thickness and the changes in visual acuity (r = 0.41, p = 0.01).\nThe subfoveal choroidal thickness increased after six months of treatment of amblyopia in anisometropic hyperopic children. This increase was correlated with the improvement in visual acuity.",
        "levenshtein_distance": 360
    },
    {
        "realidx": "27818079",
        "question": "This study evaluated the outcomes and complications of the surgical treatment of condylar fractures by the retromandibular transparotid approach. The authors hypothesized that such an approach would be safe and reliable for the treatment of most condylar fractures.\nA retrospective evaluation of patients who underwent surgical reduction of a condylar fracture from January 2012 to December 2014 at the Clinic of Dentistry and Maxillofacial Surgery of the University Hospital of Verona (Verona, Italy) was performed. Inclusion criteria were having undergone surgical treatment of condylar fractures with a retromandibular transparotid approach and the availability of computed tomograms of the preoperative and postoperative facial skeleton with a minimum follow-up of 1\u00a0year. Static and dynamic occlusal function, temporomandibular joint health status, presence of neurologic impairments, and esthetic outcomes were evaluated in all patients.\nThe sample was composed of 25 patients. Preinjury occlusion and temporomandibular joint health were restored in most patients. Esthetic outcomes were deemed satisfactory by clinicians and patients. Neither permanent neurologic impairments nor major postoperative complications were observed.\nIs the Retromandibular Transparotid Approach a Reliable Option for the Surgical Treatment of Condylar Fractures?",
        "answer": "yes",
        "answer_rationale": "According to the results of the present study, the retromandibular transparotid approach is a viable and safe approach for the surgical treatment of condylar fractures.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "This study evaluated the outcomes and complications of the surgical treatment of condylar fractures by the retromandibular transparotid approach. The authors hypothesized that such an approach would be safe and reliable for the treatment of most condylar fractures.\nA retrospective evaluation of patients who underwent surgical reduction of a condylar fracture from January 2012 to December 2014 at the Clinic of Dentistry and Maxillofacial Surgery of the University Hospital of Verona (Verona, Italy) was performed. Inclusion criteria were having undergone surgical treatment of condylar fractures with a retromandibular transparotid approach and the availability of computed tom",
        "q2": "ograms of the preoperative and postoperative facial skeleton with a minimum follow-up of 1\u00a0year. Static and dynamic occlusal function, temporomandibular joint health status, presence of neurologic impairments, and esthetic outcomes were evaluated in all patients.\nThe sample was composed of 25 patients. Preinjury occlusion and temporomandibular joint health were restored in most patients. Esthetic outcomes were deemed satisfactory by clinicians and patients. Neither permanent neurologic impairments nor major postoperative complications were observed.\nIs the Retromandibular Transparotid Approach a Reliable Option for the Surgical Treatment of Condylar Fractures?",
        "generated_text": "ography (CT) scans and medical records. Exclusion criteria were open fractures, multiple fractures, and patients who underwent surgical treatment with other approaches. The following data were collected: age, sex, side of the fracture, type of fracture, surgical approach, type of fixation, and complications. The patients were evaluated at 1, 3, 6, and 12 months after surgery. The primary outcome was the presence of complications, including facial nerve injury, infection, malocclusion, and ankylosis.\nA total of 25 patients met the inclusion criteria. The mean age was 34.5 years (range,",
        "levenshtein_distance": 502
    },
    {
        "realidx": "27858166",
        "question": "Traumatic aortic injury (TAI) is a rare but life-threatening type of injury. We investigate whether the anatomy of the aortic arch influences the severity of aortic injury.\nThis is a retrospective study of twenty-two cases treated with TEVAR for TAI in our department from 2009 to 2014. Aortic injury was assessed in accordance with the recommendations of the Society of Vascular Surgery. We measured the aortic arch angle and the aortic arch index, based on the initial angio-CT scan, in each of the analyzed cases.\nThe mean aortic arch index and mean aortic arch angle were 6.8\u00a0cm and 58.3\u00b0, respectively, in the type I injury group; 4.4\u00a0cm and 45.9\u00b0 in the type III group; 3.3\u00a0cm and 37\u00b0 in the type IV group. There were substantial differences in both the aortic arch index and the aortic arch angle of the type III and IV groups. A multivariate analysis confirmed that the aortic arch angle was significantly associated with the occurrence of type III damage (OR 1.5; 95% CI 1.03-2.2).\nTraumatic aortic injury: does the anatomy of the aortic arch influence aortic trauma severity?",
        "answer": "yes",
        "answer_rationale": "The severity of TAI is influenced by the sharpness of the aortic arch. There is an inverse relationship between the severity of aortic injury and the aortic arch index.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Traumatic aortic injury (TAI) is a rare but life-threatening type of injury. We investigate whether the anatomy of the aortic arch influences the severity of aortic injury.\nThis is a retrospective study of twenty-two cases treated with TEVAR for TAI in our department from 2009 to 2014. Aortic injury was assessed in accordance with the recommendations of the Society of Vascular Surgery. We measured the aortic arch angle and the aortic arch index, based on the initial angio-CT scan, in each of the analyzed cases.\nThe mean aortic arch index and mean aortic arch angle were 6.8\u00a0cm and",
        "q2": " 58.3\u00b0, respectively, in the type I injury group; 4.4\u00a0cm and 45.9\u00b0 in the type III group; 3.3\u00a0cm and 37\u00b0 in the type IV group. There were substantial differences in both the aortic arch index and the aortic arch angle of the type III and IV groups. A multivariate analysis confirmed that the aortic arch angle was significantly associated with the occurrence of type III damage (OR 1.5; 95% CI 1.03-2.2).\nTraumatic aortic injury: does the anatomy of the aortic arch influence aortic trauma severity?",
        "generated_text": "102\u00b0, respectively. The aortic arch angle was significantly higher in patients with aortic arch injury (110\u00b0 vs. 97\u00b0, p\u2009=\u20090.04). The aortic arch index was significantly lower in patients with aortic arch injury (6.2\u00a0cm vs. 7.2\u00a0cm, p\u2009=\u20090.03). The aortic arch angle and aortic arch index were significantly higher in patients with type I aortic injury (110\u00b0 vs. 97\u00b0, p\u2009=\u20090.04 and 6.",
        "levenshtein_distance": 357
    },
    {
        "realidx": "27989969",
        "question": "The relationship between the use of an endoscope during ventriculoperitoneal shunt (VPS) procedures and infection remains poorly defined. In this study, we sought to analyze whether the simultaneous use of an endoscope could in fact increase the infection rate associated with VPS procedures.\nThis study included 438 VPS procedures, 49 in which an endoscope was used (11.2%) and 389 in which an endoscope was not used (88.8%). The infection rates in these 2 main groups were calculated and compared. Subsequently, 4 new groups were created, composed of patients with a shunt inserted for the first time (groups 1A and 1B) and patients with a shunt reviewed or inserted for a second time (groups 2A and 2B). Groups 1A and 2A comprised patients in whom an endoscope was used simultaneously with VPS surgery, and groups 1B and 2B comprised patients in whom an endoscope was not used. These groups were compared to determine the infection rate.\nThe overall infection rate was 18.5%, including 22.4% in the groups in which an endoscope was used and 18% in those in which an endoscope was not used (P\u00a0=\u00a00.449). Groups 1A and 1B and groups 2A and 2B were matched for possible intervening risk factors. The infection rate was 28.6% in group 1A and 16.2% in group 1B (P\u00a0= 0.27), and 20% in group 2A and 19.8% in group 2B (P\u00a0= 0.977).\nDoes the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection?",
        "answer": "no",
        "answer_rationale": "In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The relationship between the use of an endoscope during ventriculoperitoneal shunt (VPS) procedures and infection remains poorly defined. In this study, we sought to analyze whether the simultaneous use of an endoscope could in fact increase the infection rate associated with VPS procedures.\nThis study included 438 VPS procedures, 49 in which an endoscope was used (11.2%) and 389 in which an endoscope was not used (88.8%). The infection rates in these 2 main groups were calculated and compared. Subsequently, 4 new groups were created, composed of patients with a shunt inserted for the first time (groups 1A and 1B) and patients with a shunt reviewed or inserted for a second time (groups 2A and 2B). Groups 1A and 2A comprised patients in whom an endoscope was used simultaneously with VPS surgery, and groups 1B",
        "q2": " and 2B comprised patients in whom an endoscope was not used. These groups were compared to determine the infection rate.\nThe overall infection rate was 18.5%, including 22.4% in the groups in which an endoscope was used and 18% in those in which an endoscope was not used (P\u00a0=\u00a00.449). Groups 1A and 1B and groups 2A and 2B were matched for possible intervening risk factors. The infection rate was 28.6% in group 1A and 16.2% in group 1B (P\u00a0= 0.27), and 20% in group 2A and 19.8% in group 2B (P\u00a0= 0.977).\nDoes the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection?",
        "generated_text": "and 2B comprised patients in whom an endoscope was not used. The infection rates in these 4 groups were calculated and compared. Finally, the infection rates in the 4 groups were compared with the infection rates in the 2 main groups.\nThe infection rates in the 2 main groups were 12.2% in the endoscope group and 10.8% in the non-endoscope group, with no statistically significant difference (p=0.67). In the 4 subgroups, the infection rates were 11.1% in group 1A, 13.3% in group 1B, 10.5% in group 2A, and 10.0% in group 2B, with no statistically significant difference between any of the groups (p>0.05). The infection rates in the 4 subgroups were similar to",
        "levenshtein_distance": 398
    },
    {
        "realidx": "28056802",
        "question": "It has recently been shown that non-high density lipoprotein cholesterol (non-HDL-C) may be a better predictor of cardiovascular risk than low density lipoprotein cholesterol (LDL-C). Based on known ethic differences in lipid parameters and cardiovascular risk prediction, we sought to study the predictability of attaining non-HDL-C target and long-term major adverse cardiovascular event (MACE) in Thai patients after acute myocardial infarction (AMI) compared to attaining LDL-C target.\nWe retrospectively obtained the data of all patients who were admitted at Maharaj Nakorn Chiang Mai hospital due to AMI during 2006-2013. The mean non-HDL-C and LDL-C during long-term follow-up were used to predict MACE at each time point. The patients were classified as target attainment if non-HDL-C\u2009<100\u00a0mg/dl and/or LDL-C\u2009<70\u00a0mg/dl. The MACE was defined as combination of all-cause death, nonfatal coronary event and nonfatal stroke.\nDuring mean follow-up of 2.6\u2009\u00b1\u20091.6\u00a0years among 868 patients after AMI, 34.4% achieved non-HDL-C target, 23.7% achieved LDL-C target and 21.2% experienced MACEs. LDL-C and non-HDL-C were directly compared in Cox regression model. Compared with non-HDL-C\u2009<100\u00a0mg/dl, patients with non-HDL-C of>130\u00a0mg/dl had higher incidence of MACEs (HR 3.15, 95% CI 1.46-6.80, P\u2009=\u20090.003). Surprisingly, LDL-C\u2009>100\u00a0mg/dl was associated with reduced risk of MACE as compared to LDL\u2009<70\u00a0mg/dl (HR 0.42, 95% CI 0.18-0.98, p\u2009=\u20090.046) after direct pairwise comparison with non-HDL-C level.\nIs non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol?",
        "answer": "yes",
        "answer_rationale": "Non-attaining non-HDL-C goal predicted MACE at long-term follow-up after AMI whereas non-attaining LDL-C goal was not associated with the higher risk. Therefore, non-HDL-C may be a more suitable target of dyslipidemia treatment than LDL-C in patients after AMI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "It has recently been shown that non-high density lipoprotein cholesterol (non-HDL-C) may be a better predictor of cardiovascular risk than low density lipoprotein cholesterol (LDL-C). Based on known ethic differences in lipid parameters and cardiovascular risk prediction, we sought to study the predictability of attaining non-HDL-C target and long-term major adverse cardiovascular event (MACE) in Thai patients after acute myocardial infarction (AMI) compared to attaining LDL-C target.\nWe retrospectively obtained the data of all patients who were admitted at Maharaj Nakorn Chiang Mai hospital due to AMI during 2006-2013. The mean non-HDL-C and LDL-C during long-term follow-up were used to predict MACE at each time point. The patients were classified as target attainment if non-HDL-C\u2009<100\u00a0mg/dl and/or LDL-C\u2009<70\u00a0mg/dl. The MACE was defined as combination of all-cause death, nonfatal coronary event and nonfatal stroke.\nDuring mean follow-up of 2.6\u2009\u00b1\u2009",
        "q2": "1.6\u00a0years among 868 patients after AMI, 34.4% achieved non-HDL-C target, 23.7% achieved LDL-C target and 21.2% experienced MACEs. LDL-C and non-HDL-C were directly compared in Cox regression model. Compared with non-HDL-C\u2009<100\u00a0mg/dl, patients with non-HDL-C of>130\u00a0mg/dl had higher incidence of MACEs (HR 3.15, 95% CI 1.46-6.80, P\u2009=\u20090.003). Surprisingly, LDL-C\u2009>100\u00a0mg/dl was associated with reduced risk of MACE as compared to LDL\u2009<70\u00a0mg/dl (HR 0.42, 95% CI 0.18-0.98, p\u2009=\u20090.046) after direct pairwise comparison with non-HDL-C level.\nIs non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol?",
        "generated_text": "1.8\u00a0years, 100 patients (21.7%) had MACE. The mean non-HDL-C and LDL-C during follow-up were 121.4\u2009\u00b1\u200931.7 and 80.1\u2009\u00b1\u200925.4\u00a0mg/dl, respectively. The patients who had MACE had higher mean non-HDL-C (128.4\u2009\u00b1\u200932.4 vs. 119.4\u2009\u00b1\u200931.2\u00a0mg/dl, p\u2009=\u20090.024) and LDL-C (85.1\u2009\u00b1\u200926.4 vs. 78.9\u2009\u00b1\u200925.0\u00a0mg/dl, p\u2009=\u20090.048). The patients who had MACE had lower proportion of attaining non-HDL-C target (30.0% vs. 41.1%, p\ufffd",
        "levenshtein_distance": 499
    },
    {
        "realidx": "28143468",
        "question": "Prior literature identified the use of Performance Measurement Systems (PMS) as crucial in addressing improved processes of care. Moreover, a strategic use of PMS has been found to enhance quality, compared to non-strategic use, although a clear understanding of this linkage is still to be achieved. This paper deals with the test of direct and indirect models related to the link between the strategic use of PMS and the level of improved processes in health care organizations. Indirect models were mediated by the degree of perceived managerial discretion.\nA PLS analysis on a survey of 97 Italian managers working for health care organizations in the Lombardy region was conducted. The response rate was 77.6%.\nThe strategic use of PMS in health care organizations directly and significantly (p\u2009<\u20090.001) enhances performance in terms of improved processes. Perceived managerial discretion is positively and significantly (p\u2009<\u20090.001) affected by the strategic use of PMS, whereas the mediation effect is non-significant.\nAre performance measurement systems useful?",
        "answer": "yes",
        "answer_rationale": "This study contributes to the literature investigating the design and implementation of a non-financial measurement tool, such as the non-financial information included into a balanced scorecard (BSC), in health care organizations. Managers in health care organizations can benefit from the strategic use of PMS to effectively allocate their time to strategic opportunities and threats, which might arise and affect organizational, output-related performance, such as improving processes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Prior literature identified the use of Performance Measurement Systems (PMS) as crucial in addressing improved processes of care. Moreover, a strategic use of PMS has been found to enhance quality, compared to non-strategic use, although a clear understanding of this linkage is still to be achieved. This paper deals with the test of direct and indirect models related to the link between the strategic use of PMS and the level of improved processes in health care organizations. Indirect models were mediated by the degree of perceived managerial discretion.\n",
        "q2": "A PLS analysis on a survey of 97 Italian managers working for health care organizations in the Lombardy region was conducted. The response rate was 77.6%.\nThe strategic use of PMS in health care organizations directly and significantly (p\u2009<\u20090.001) enhances performance in terms of improved processes. Perceived managerial discretion is positively and significantly (p\u2009<\u20090.001) affected by the strategic use of PMS, whereas the mediation effect is non-significant.\nAre performance measurement systems useful?",
        "generated_text": "The results of the study, based on a sample of 100 Italian hospitals, show that the strategic use of PMS is positively related to the level of improved processes, and that this relationship is mediated by the degree of perceived managerial discretion. The results also show that the strategic use of PMS is positively related to the degree of perceived managerial discretion. The paper contributes to the literature by providing empirical evidence of the relationship between the strategic use of PMS and improved processes in health care organizations, and by identifying",
        "levenshtein_distance": 411
    },
    {
        "realidx": "28196511",
        "question": "Recent studies have shown that early antiretroviral therapy (ART) initiation results in significant HIV transmission reduction. This is the rationale behind the \"test and treat\" policy of the World Health Organization (WHO). Implementation of this policy will lead to an increased incidence of ART-related adverse effects, especially in sub-Saharan Africa (SSA). Is the region yet ready to cope with such a challenging issue?\nThe introduction and widespread use of ART have drastically changed the natural history of HIV/AIDS, but exposure to ART leads to serious medication-related adverse effects mainly explained by mitochondrial toxicities, and the situation will get worse in the near future. Indeed, ART is associated with an increased risk of developing cardiovascular disease, lipodystrophy, prediabetes and overt diabetes, insulin resistance and hyperlactatemia/lactic acidosis. The prevalence of these disorders is already high in SSA, and the situation will be exacerbated by the implementation of the new WHO recommendations. Most SSA countries are characterized by (extreme) poverty, very weak health systems, inadequate and low quality of health services, inaccessibility to existing health facilities, lack of (qualified) health personnel, lack of adequate equipment, inaccessibility and unaffordability of medicines, and heavy workload in a context of a double burden of disease. Additionally, there is dearth of data on the incidence and predictive factors of ART-related adverse effects in SSA, to anticipate on strategies that should be put in place to prevent the occurrence of these conditions or properly estimate the upcoming burden and prepare an adequate response plan. These are required if we are to anticipate and effectively prevent this upcoming burden.\nAntiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new \"test and treat\" policy of the World Health Organization?",
        "answer": "no",
        "answer_rationale": "While SSA would be the first region to experience the huge benefits of implementing the \"test and treat\" policy of the WHO, the region is not yet prepared to manage the consequential increased burden of ART-related toxic and metabolic complications. Urgent measures should be taken to fill the lacunae if SSA is not to become over-burdened by the consequences of the \"test and treat\" policy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Recent studies have shown that early antiretroviral therapy (ART) initiation results in significant HIV transmission reduction. This is the rationale behind the \"test and treat\" policy of the World Health Organization (WHO). Implementation of this policy will lead to an increased incidence of ART-related adverse effects, especially in sub-Saharan Africa (SSA). Is the region yet ready to cope with such a challenging issue?\nThe introduction and widespread use of ART have drastically changed the natural history of HIV/AIDS, but exposure to ART leads to serious medication-related adverse effects mainly explained by mitochondrial toxicities, and the situation will get worse in the near future. Indeed, ART is associated with an increased risk of developing cardiovascular disease, lipodystrophy, prediabetes and overt diabetes, insulin resistance and hyperlactatemia/lactic acidosis. The prevalence of these disorders is already high in SSA, and the situation",
        "q2": " will be exacerbated by the implementation of the new WHO recommendations. Most SSA countries are characterized by (extreme) poverty, very weak health systems, inadequate and low quality of health services, inaccessibility to existing health facilities, lack of (qualified) health personnel, lack of adequate equipment, inaccessibility and unaffordability of medicines, and heavy workload in a context of a double burden of disease. Additionally, there is dearth of data on the incidence and predictive factors of ART-related adverse effects in SSA, to anticipate on strategies that should be put in place to prevent the occurrence of these conditions or properly estimate the upcoming burden and prepare an adequate response plan. These are required if we are to anticipate and effectively prevent this upcoming burden.\nAntiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new \"test and treat\" policy of the World Health Organization?",
        "generated_text": "is expected to get worse in the near future due to the increased incidence of ART-related adverse effects. The situation is even more worrisome in SSA, where the prevalence of HIV infection is the highest in the world, and where the \"test and treat\" policy is being implemented. In addition, the region is already facing a high burden of non-communicable diseases (NCDs), including cardiovascular disease, diabetes, and cancer, which are also on the rise due to lifestyle changes and aging populations.\nIn this context, it is crucial to assess the readiness of SSA to cope with the increased incidence of ART-related adverse effects, and to identify the most effective strategies to prevent and manage these disorders. This requires a comprehensive approach that takes into account the specificities of the region, including the limited resources, the high burden of HIV/AIDS and NCDs, and the cultural and social determin",
        "levenshtein_distance": 737
    },
    {
        "realidx": "28247485",
        "question": "The aim of this study was to determine the prognostic value of the first urinary albumin/creatinine ratio (ACR) for adverse maternal and neonatal outcomes and how it relates to other prognostic factors.\nWe performed a retrospective cohort study from December 2009 to February 2012 with analysis of demographic, clinical and biochemical data from two obstetric day assessment units in hospitals in Southeast Scotland. We included 717 pregnant women, with singleton pregnancies after 20 weeks' gestation, referred for evaluation of suspected preeclampsia and having their first ACR performed. The ability of ACR to predict future outcomes was assessed in both univariable and multivariable logistic regression models. The latter assessed its prognostic value independent of (adjusting for) existing prognostic factors. Primary outcome measures were maternal and neonatal composite adverse outcomes, and a secondary outcome was gestation at delivery.\nIn all, 204 women (28.5%) experienced a composite adverse maternal outcome and 146 women (20.4%) experienced a composite adverse neonatal outcome. Multivariate analysis of log-transformed ACR demonstrated that a 1-unit increase in log ACR is associated with an increased odds of adverse maternal [odds ratio 1.60, 95% confidence interval (CI) 1.45-1.80] and adverse neonatal (odds ratio 1.15, 95% CI 1.02-1.29) composite outcomes, and with reduced gestational age at delivery (coefficient: -0.46, 95% CI -0.54 to -0.38).\nIs the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome?",
        "answer": "yes",
        "answer_rationale": "ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The aim of this study was to determine the prognostic value of the first urinary albumin/creatinine ratio (ACR) for adverse maternal and neonatal outcomes and how it relates to other prognostic factors.\nWe performed a retrospective cohort study from December 2009 to February 2012 with analysis of demographic, clinical and biochemical data from two obstetric day assessment units in hospitals in Southeast Scotland. We included 717 pregnant women, with singleton pregnancies after 20 weeks' gestation, referred for evaluation of suspected preeclampsia and having their first ACR performed. The ability of ACR to predict future outcomes was assessed in both univariable and multivariable logistic regression models. The latter assessed its prognostic value independent of (adjusting for) existing prognostic factors. Primary outcome measures were maternal and neonatal composite adverse outcomes, and a secondary outcome was gestation at delivery.\n",
        "q2": "In all, 204 women (28.5%) experienced a composite adverse maternal outcome and 146 women (20.4%) experienced a composite adverse neonatal outcome. Multivariate analysis of log-transformed ACR demonstrated that a 1-unit increase in log ACR is associated with an increased odds of adverse maternal [odds ratio 1.60, 95% confidence interval (CI) 1.45-1.80] and adverse neonatal (odds ratio 1.15, 95% CI 1.02-1.29) composite outcomes, and with reduced gestational age at delivery (coefficient: -0.46, 95% CI -0.54 to -0.38).\nIs the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome?",
        "generated_text": "The prognostic value of ACR was assessed using the area under the receiver operating characteristic curve (AUC).\nThe median age of the women was 31 years (interquartile range [IQR], 27-35 years), and the median gestational age at presentation was 34 weeks (IQR, 32-36 weeks). The median ACR was 11.0 mg/mmol (IQR, 5.0-22.0 mg/mmol). The AUC for ACR in predicting adverse maternal outcome was 0.64 (95% confidence interval [CI], 0.56-0.72), and for adverse neonatal outcome was 0.62 (95% CI, 0.55-0.69). In multivariable analysis, ACR was",
        "levenshtein_distance": 520
    },
    {
        "realidx": "28359277",
        "question": "Governments are urged to determine methods to control the use of medical resources and curb the rise of healthcare costs. The question is, do health behaviors have an impact on the use of medical resources? This study aims to identify and understand the difference in the number of outpatient visits and health examinations based on various health behaviors and to determine whether patients seek medical care for illness from the same physicians.\nThis study used the dataset derived from the Department of Budget, Accounting and Statistics of Kaohsiung, Taiwan in 2005. Persons older than 15\u00a0years were surveyed using an on-site questionnaire. A total of 2911 persons were enrolled in this study. Independent t-tests, chi-square tests, one-way ANOVA, multiple linear regression and binominal logistic regression were used in the data analysis.\nThe regression model for the frequency of doctor visits, health examinations, and whether the same physician is sought for medical care has demonstrated significant correlations with gender, age and education-level variables. Four health behaviors (i.e., exercise habits, dietary habits, regular blood pressure measurement, drinking habits) exhibited a significant correlation with healthcare utilization (P<0.05).\nDo healthier lifestyles lead to less utilization of healthcare resources?",
        "answer": "no",
        "answer_rationale": "Healthy lifestyles lead to an increase in the utilization of preventive health services. However, there is not much significantly reducing the number of outpatient visits in people with health behaviors. Specifically, people with regular exercise habits and who take their blood pressure measurement regularly have an increased number of outpatient visits. It is suggested that more available and accessible health consultation services be provided to inculcate in the general public the importance of maintaining a healthy lifestyle.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Governments are urged to determine methods to control the use of medical resources and curb the rise of healthcare costs. The question is, do health behaviors have an impact on the use of medical resources? This study aims to identify and understand the difference in the number of outpatient visits and health examinations based on various health behaviors and to determine whether patients seek medical care for illness from the same physicians.\nThis study used the dataset derived from the Department of Budget, Accounting and Statistics of Kaohsiung, Taiwan in 2005. Persons older than 15\u00a0years were surveyed using an on-site questionnaire. A total",
        "q2": " of 2911 persons were enrolled in this study. Independent t-tests, chi-square tests, one-way ANOVA, multiple linear regression and binominal logistic regression were used in the data analysis.\nThe regression model for the frequency of doctor visits, health examinations, and whether the same physician is sought for medical care has demonstrated significant correlations with gender, age and education-level variables. Four health behaviors (i.e., exercise habits, dietary habits, regular blood pressure measurement, drinking habits) exhibited a significant correlation with healthcare utilization (P<0.05).\nDo healthier lifestyles lead to less utilization of healthcare resources?",
        "generated_text": "of 10,000 questionnaires were distributed, and 8,000 were returned, with 7,500 being valid. The response rate was 80%, and the valid rate was 93.75%. The data were analyzed using the SPSS 12.0 for Windows software package. The chi-square test was used to test the difference in the number of outpatient visits and health examinations based on various health behaviors. The logistic regression model was used to determine the factors affecting the number of outpatient visits and health examinations.\nThe results showed that the number",
        "levenshtein_distance": 487
    },
    {
        "realidx": "28707539",
        "question": "Measurement of visceral adipose tissue (VAT) needs to be accurate and sensitive to change for risk monitoring. The purpose of this study is to determine the CT slice location where VAT area can best reflect changes in VAT volume and body weight.\n60 plain abdominal CT images from 30 males\u00a0[mean age (range) 51 (41-68) years, mean body weight (range) 71.1 (101.9-50.9) kg] who underwent workplace screenings twice within a 1-year interval were evaluated. Automatically calculated and manually corrected areas of the VAT of various scan levels using \"freeform curve\" region of interest on CT were recorded and compared with body weight changes.\nThe strongest correlations of VAT area with VAT volume and body weight changes were shown in a slice 3 cm above the lower margin of L3 with r values of 0.853 and 0.902, respectively.\nVisceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume?",
        "answer": "yes",
        "answer_rationale": "VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Measurement of visceral adipose tissue (VAT) needs to be accurate and sensitive to change for risk monitoring. The purpose of this study is to determine the CT slice location where VAT area can best reflect changes in VAT volume and body weight.\n60 plain abdominal CT images from 30 males\u00a0[mean age (range) 51 (41-68) years, mean body weight (range) 71.1 (101.9-50.9) kg] who underwent workplace screenings twice within a 1",
        "q2": "-year interval were evaluated. Automatically calculated and manually corrected areas of the VAT of various scan levels using \"freeform curve\" region of interest on CT were recorded and compared with body weight changes.\nThe strongest correlations of VAT area with VAT volume and body weight changes were shown in a slice 3 cm above the lower margin of L3 with r values of 0.853 and 0.902, respectively.\nVisceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume?",
        "generated_text": "-year interval were included. VAT area was measured at 10 levels from the upper abdomen to the lower abdomen. VAT volume was calculated by summing up VAT areas at all levels. Correlation coefficients between VAT area and VAT volume, and between VAT area and body weight were calculated for each level. The level with the highest correlation coefficient was considered the optimal level.\nThe optimal level for VAT area reflecting VAT volume was L3 (r=0.98, p<0.001), and for",
        "levenshtein_distance": 373
    },
    {
        "realidx": "29112560",
        "question": "It is unclear whether traveling long distances to high-volume centers would compensate for travel burden among patients undergoing rectal cancer resection.\nThe purpose of this study was to determine whether operative volume outweighs the advantages of being treated locally by comparing the outcomes of patients with rectal cancer treated at local, low-volume centers versus far, high-volume centers.\nThis was a population-based study.\nThe National Cancer Database was queried for patients with rectal cancer.\nPatients with stage II or III rectal cancer who underwent surgical resection between 2006 and 2012 were included.\nThe outcomes of interest were margins, lymph node yield, receipt of neoadjuvant chemoradiation, adjuvant chemotherapy, readmission within 30 days, 30-day and 90-day mortality, and 5-year overall survival.\nA total of 18,605 patients met inclusion criteria; 2067 patients were in the long-distance/high-volume group and 1362 in the short-distance/low-volume group. The median travel distance was 62.6 miles for the long-distance/high-volume group and 2.3 miles for the short-distance/low-volume group. Patients who were younger, white, privately insured, and stage III were more likely to have traveled to a high-volume center. When controlled for patient factors, stage, and hospital factors, patients in the short-distance/low-volume group had lower odds of a lymph node yield \u226512 (OR = 0.51) and neoadjuvant chemoradiation (OR = 0.67) and higher 30-day (OR = 3.38) and 90-day mortality (OR = 2.07) compared with those in the long-distance/high-volume group. The short-distance/low-volume group had a 34% high risk of overall mortality at 5 years compared with the long-distance/high-volume group.\nWe lacked data regarding patient and physician decision making and surgeon-specific factors.\nIs the Distance Worth It?",
        "answer": "yes",
        "answer_rationale": "Our results indicate that when controlled for patient, tumor, and hospital factors, patients who traveled a long distance to a high-volume center had improved lymph node yield, neoadjuvant chemoradiation receipt, and 30- and 90-day mortality compared with those who traveled a short distance to a low-volume center. They also had improved 5-year survival. See Video Abstract at http://links.lww.com/DCR/A446.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "It is unclear whether traveling long distances to high-volume centers would compensate for travel burden among patients undergoing rectal cancer resection.\nThe purpose of this study was to determine whether operative volume outweighs the advantages of being treated locally by comparing the outcomes of patients with rectal cancer treated at local, low-volume centers versus far, high-volume centers.\nThis was a population-based study.\nThe National Cancer Database was queried for patients with rectal cancer.\nPatients with stage II or III rectal cancer who underwent surgical resection between 2006 and 2012 were included.\nThe outcomes of interest were margins, lymph node yield, receipt of neoadjuvant chemoradiation, adjuvant chemotherapy, readmission within 30 days, 30-day and 90-day mortality, and 5-year overall survival.\nA total of 18,605 patients met inclusion criteria; 2067 patients were in the long-distance/high-volume group and 1362 in the short-distance/low-volume group.",
        "q2": " The median travel distance was 62.6 miles for the long-distance/high-volume group and 2.3 miles for the short-distance/low-volume group. Patients who were younger, white, privately insured, and stage III were more likely to have traveled to a high-volume center. When controlled for patient factors, stage, and hospital factors, patients in the short-distance/low-volume group had lower odds of a lymph node yield \u226512 (OR = 0.51) and neoadjuvant chemoradiation (OR = 0.67) and higher 30-day (OR = 3.38) and 90-day mortality (OR = 2.07) compared with those in the long-distance/high-volume group. The short-distance/low-volume group had a 34% high risk of overall mortality at 5 years compared with the long-distance/high-volume group.\nWe lacked data regarding patient and physician decision making and surgeon-specific factors.\nIs the Distance Worth It?",
        "generated_text": "Patients in the long-distance/high-volume group had higher rates of neoadjuvant chemoradiation (61.1% vs 49.1%, P < .001), adjuvant chemotherapy (70.1% vs 59.1%, P < .001), and negative margins (88.1% vs 84.5%, P < .001). Patients in the short-distance/low-volume group had higher rates of readmission (11.1% vs 8.4%, P < .001), 30-day mortality (2.1% vs 1.1%, P = .001), and 90-day mortality (3.1% vs 1.7%, P < .001). There was no difference in 5-year overall survival between the 2 groups (60.1% vs 58.5%, P = .1",
        "levenshtein_distance": 595
    },
    {
        "realidx": "7482275",
        "question": "The accepted treatment protocol for necrotizing fasciitis (NF) consists of extensive surgery and wide spectrum antibiotics. Hyperbaric oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving patient mortality and outcome. However, the beneficial effect of HBO for NF remains controversial.\nA retrospective evaluation of treatment outcome in 37 patients treated for NF between 1984 and 1993 was carried out. The mortality rate, morbidity criteria, and risk factors for grave prognosis were compared between a group of 25 patients who received HBO as part of their treatment protocol and a group of the remaining 12 patients treated by surgical excision and antibiotics alone.\nThe two groups were found to be similar with regard to age, gender, the incidence of individual risk factors for ominous prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score for disease's severity on presentation. The mortality rate among the HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean number of surgical d\u00e9bridements required per patient was significantly higher in the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although the average length of hospitalization for survivors was shorter for the HBO group, the difference between the groups did not reach statistical significance.\nNecrotizing fasciitis: an indication for hyperbaric oxygenation therapy?",
        "answer": "no",
        "answer_rationale": "The results of this study cast doubt on the suggested advantage of HBO in reducing patient mortality and morbidity when used as adjuvant therapy for NF.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The accepted treatment protocol for necrotizing fasciitis (NF) consists of extensive surgery and wide spectrum antibiotics. Hyperbaric oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving patient mortality and outcome. However, the beneficial effect of HBO for NF remains controversial.\nA retrospective evaluation of treatment outcome in 37 patients treated for NF between 1984 and 1993 was carried out. The mortality rate, morbidity criteria, and risk factors for grave prognosis were compared between a group of 25 patients who received HBO as part of their treatment protocol and a group of the remaining 12 patients treated by surgical excision and antibiotics alone.\nThe two groups were found to be similar with",
        "q2": " regard to age, gender, the incidence of individual risk factors for ominous prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score for disease's severity on presentation. The mortality rate among the HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean number of surgical d\u00e9bridements required per patient was significantly higher in the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although the average length of hospitalization for survivors was shorter for the HBO group, the difference between the groups did not reach statistical significance.\nNecrotizing fasciitis: an indication for hyperbaric oxygenation therapy?",
        "generated_text": "respect to age, sex, and risk factors for NF. The mortality rate was 12% in the HBO group and 25% in the control group. The morbidity criteria were similar in both groups. The mean number of surgical procedures was 3.2 in the HBO group and 4.3 in the control group (p = 0.05). The mean hospital stay was 22 days in the HBO group and 27 days in the control group (p = 0.05). The mean number of days on ventilator support was 10 days in the HBO group and 14 days in the control group (p = 0.05).",
        "levenshtein_distance": 477
    },
    {
        "realidx": "7497757",
        "question": "To determine if temperature during cardiopulmonary bypass (CPB) has an effect on perioperative and postoperative thyroid function.\nProspective study comparing thyroid function during and after hypothermic and normothermic CPB.\nCardiac surgical unit at a university-affiliated hospital.\nTwelve patients scheduled to undergo cardiac operations with normothermic (n = 6) or hypothermic (n = 6) CPB.\nBlood was analyzed for serum concentration of total thyroxine (TT4), total triiodothyronine (TT3), free T3 (fT3), reverse T3 (rT3), and thyroid stimulating hormone (TSH) preoperatively, 60 min after CPB was initiated, 30 min after discontinuing CPB, and on postoperative days (POD) 1, 3, and 5.\nPatients who underwent either cold (26 degrees +/- 5 degrees C) or warm (35 degrees +/- 1 degree C) CPB were comparable with regard to age, body weight, duration of CPB, cross-clamp time, use of inotropes, total heparin dose, and length of hospital stay. Incidence of postoperative myocardial infarction, congestive heart failure, and death were similar. In both groups, TT4 and TT3 were reduced below baseline values beginning with CPB and persisting for up to 5 days after CPB (p<0.05), free T3 was reduced for up to 3 days after CPB (p<0.05), mean serum rT3 was elevated on POD 1 and POD 3 (p<0.05), and TSH remained unchanged.\nCardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome?",
        "answer": "no",
        "answer_rationale": "The results of this study suggest that normothermic CPB does not prevent the development of the \"euthyroid sick syndrome\" during and after CPB. Despite these changes in thyroid function, most patients in both groups had a normal postoperative recovery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine if temperature during cardiopulmonary bypass (CPB) has an effect on perioperative and postoperative thyroid function.\nProspective study comparing thyroid function during and after hypothermic and normothermic CPB.\nCardiac surgical unit at a university-affiliated hospital.\nTwelve patients scheduled to undergo cardiac operations with normothermic (n = 6) or hypothermic (n = 6) CPB.\nBlood was analyzed for serum concentration of total thyroxine (TT4), total triiodothyronine (TT3), free T3 (fT3), reverse T3 (rT3), and thyroid stimulating hormone (TSH) preoperatively, 60 min after CPB was initiated, 30 min after discontinuing CPB, and on postoperative days (POD) 1, 3, and 5.\nPatients who underwent either cold",
        "q2": " (26 degrees +/- 5 degrees C) or warm (35 degrees +/- 1 degree C) CPB were comparable with regard to age, body weight, duration of CPB, cross-clamp time, use of inotropes, total heparin dose, and length of hospital stay. Incidence of postoperative myocardial infarction, congestive heart failure, and death were similar. In both groups, TT4 and TT3 were reduced below baseline values beginning with CPB and persisting for up to 5 days after CPB (p<0.05), free T3 was reduced for up to 3 days after CPB (p<0.05), mean serum rT3 was elevated on POD 1 and POD 3 (p<0.05), and TSH remained unchanged.\nCardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome?",
        "generated_text": "or warm CPB had similar preoperative thyroid function. During CPB, TT4, TT3, fT3, and rT3 levels decreased in both groups, but the decrease was significantly greater in the hypothermic group (p < 0.05). TSH levels increased in both groups during CPB, but the increase was greater in the hypothermic group (p < 0.05). On POD 1, TT4, TT3, fT3, and rT3 levels were significantly lower in the hypothermic group compared with the normothermic group (p < 0.05). TSH levels were higher in the hypothermic group on POD 1 (p < 0.05). On POD 3 and 5, thyroid function parameters returned to preoperative levels in both groups.\nHypothermic CP",
        "levenshtein_distance": 533
    },
    {
        "realidx": "7547656",
        "question": "Bolus intravenous injection of epinephrine can decrease uterine blood flow. This study examined the effects of intravenous infusion of epinephrine on uterine blood flow in the gravid ewe.\nMaternal and fetal vascular catheters and a maternal electromagnetic uterine artery flow probe were implanted in 10 near-term gravid ewes. After recovery, saline, 0.125% bupivacaine, 0.125% bupivacaine with 1:200,000 epinephrine, 0.125% bupivacaine with 1:400,000 epinephrine, and 0.125% bupivacaine with 1:800,000 epinephrine were infused into the maternal superior vena cava. Drugs were infused at 10 mL/h for 30 minutes and then at 20 mL/h for an additional 30 minutes. Animals also received an intravenous bolus of epinephrine 15 micrograms. Throughout all infusions, maternal heart rate, systemic and pulmonary blood pressures, uterine blood flow, cardiac output, and acid-base balance were measured, as well as fetal heart rate, blood pressure, and acid-base balance.\nEpinephrine 15 micrograms decreased uterine blood flow to 68 +/- 14% of baseline (mean +/- SD). Infusion of all solutions had no effect on any measured hemodynamic variable.\nDoes continuous intravenous infusion of low-concentration epinephrine impair uterine blood flow in pregnant ewes?",
        "answer": "no",
        "answer_rationale": "In gravid ewes, intravenous infusion of<or = 1.67 micrograms/min epinephrine altered neither maternal hemodynamics nor uterine blood flow. To the extent that sheep data can be extrapolated to humans, these results suggest that continuous intravenous infusion of epinephrine in local anesthetic solutions is safe if the epidural catheter should enter a blood vessel during the infusion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Bolus intravenous injection of epinephrine can decrease uterine blood flow. This study examined the effects of intravenous infusion of epinephrine on uterine blood flow in the gravid ewe.\nMaternal and fetal vascular catheters and a maternal electromagnetic uterine artery flow probe were implanted in 10 near-term gravid ewes. After recovery, saline, 0.125% bupivacaine, 0.125% bupivacaine with 1:200,000 epinephrine, 0.125% bupivacaine with 1:400,000 epinephrine, and 0.125% bupivacaine with 1:800,000 epinephrine were infused into the maternal superior vena cava",
        "q2": ". Drugs were infused at 10 mL/h for 30 minutes and then at 20 mL/h for an additional 30 minutes. Animals also received an intravenous bolus of epinephrine 15 micrograms. Throughout all infusions, maternal heart rate, systemic and pulmonary blood pressures, uterine blood flow, cardiac output, and acid-base balance were measured, as well as fetal heart rate, blood pressure, and acid-base balance.\nEpinephrine 15 micrograms decreased uterine blood flow to 68 +/- 14% of baseline (mean +/- SD). Infusion of all solutions had no effect on any measured hemodynamic variable.\nDoes continuous intravenous infusion of low-concentration epinephrine impair uterine blood flow in pregnant ewes?",
        "generated_text": "in random order. Maternal and fetal arterial blood pressures, heart rates, and uterine blood flow were recorded.\nInfusion of bupivacaine with epinephrine caused a dose-dependent decrease in uterine blood flow (P < 0.05). The decrease in uterine blood flow was associated with a decrease in maternal arterial pressure (P < 0.05). Fetal arterial pressure and heart rate did not change.\nIntravenous infusion of epinephrine in bupivacaine causes a dose-dependent decrease in uterine blood flow in the gravid ewe. The decrease in uterine blood flow is associated with a decrease in maternal arterial pressure.",
        "levenshtein_distance": 503
    },
    {
        "realidx": "7664228",
        "question": "To determine whether decreasing lengths of stay over time for selected diagnostic categories were associated with increased hospital readmission rates and mean number of physician visits after discharge.\nRetrospective descriptive study.\nThe seven large (125 beds or more) acute care hospitals in Winnipeg.\nManitoba residents admitted to any one of the seven hospitals because acute myocardial infarction (AMI), bronchitis or asthma, transurethral prostatectomy (TURP) and uterine or adnexal procedures for nonmalignant disease during the fiscal years 1989-90 to 1992-93. Patients from out of province, those who died in hospital, those with excessively long stays (more than 60 days) and those who were transferred to or from another institution were excluded.\nLength of hospital stay, and rate of readmission within 30 days after discharge for all four categories and mean number of physician visits within 30 days after discharge for two categories (AMI and bronchitis or asthma.\nThe length of stay decreased significantly over the 4 years for all of the four categories, the smallest change being observed for patients with AMI (11.1%) and the largest for those with bronchitis or asthma (22.0%). The readmission rates for AMI, bronchitis or asthma, and TURP showed no consistent change over the 4 years. The readmission rate for uterine or adnexal procedures increased significantly between the first and second year (chi 2 = 4.28, p = 0.04) but then remained constant over the next 3 years. The mean number of physician visits increased slightly for AMI in the first year (1.92 to 2.01) and then remained virtually the same. It decreased slightly for bronchitis or asthma over the 4 years. There was no significant correlation between length of stay and readmission rates for individual hospitals in 1992-93 in any of the four categories. Also, no correlation was observed between length of stay and mean number of physician visits for individual hospitals in 1992-93 in the categories AMI and bronchitis or asthma.\nDischarging patients earlier from Winnipeg hospitals: does it adversely affect quality of care?",
        "answer": "no",
        "answer_rationale": "Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine whether decreasing lengths of stay over time for selected diagnostic categories were associated with increased hospital readmission rates and mean number of physician visits after discharge.\nRetrospective descriptive study.\nThe seven large (125 beds or more) acute care hospitals in Winnipeg.\nManitoba residents admitted to any one of the seven hospitals because acute myocardial infarction (AMI), bronchitis or asthma, transurethral prostatectomy (TURP) and uterine or adnexal procedures for nonmalignant disease during the fiscal years 1989-90 to 1992-93. Patients from out of province, those who died in hospital, those with excessively long stays (more than 60 days) and those who were transferred to or from another institution were excluded.\nLength of hospital stay, and rate of readmission within 30 days after discharge for all four categories and mean number of physician visits within 30 days after discharge for two categories (AMI and bronchitis or asthma.\nThe length of stay decreased significantly over the 4 years for all of the four categories, the smallest change being observed for patients with",
        "q2": " AMI (11.1%) and the largest for those with bronchitis or asthma (22.0%). The readmission rates for AMI, bronchitis or asthma, and TURP showed no consistent change over the 4 years. The readmission rate for uterine or adnexal procedures increased significantly between the first and second year (chi 2 = 4.28, p = 0.04) but then remained constant over the next 3 years. The mean number of physician visits increased slightly for AMI in the first year (1.92 to 2.01) and then remained virtually the same. It decreased slightly for bronchitis or asthma over the 4 years. There was no significant correlation between length of stay and readmission rates for individual hospitals in 1992-93 in any of the four categories. Also, no correlation was observed between length of stay and mean number of physician visits for individual hospitals in 1992-93 in the categories AMI and bronchitis or asthma.\nDischarging patients earlier from Winnipeg hospitals: does it adversely affect quality of care?",
        "generated_text": "AMI (from 11.5 to 10.1 days) and the largest for patients with bronchitis or asthma (from 10.1 to 7.1 days). The readmission rates increased significantly for patients with AMI (from 10.1% to 13.1%) and bronchitis or asthma (from 14.1% to 17.4%), but not for patients who had TURP or uterine or adnexal procedures. The mean number of physician visits within 30 days after discharge increased significantly for patients with AMI (from 4.4 to 5.1) and bronchitis or asthma (from 4.0 to 4.5).\nDecreasing lengths of stay for AMI and bronchitis or asthma were associated with increased readmission rates and increased mean number of physician visits after discharge. For TURP and uterine or adnexal procedures, decreasing lengths of stay were not associated with increased readmission rates.",
        "levenshtein_distance": 651
    },
    {
        "realidx": "7860319",
        "question": "We compare 30-day and 180-day postadmission hospital mortality rates for all Medicare patients and those in three categories of cardiac care: coronary artery bypass graft surgery, acute myocardial infarction, and congestive heart failure. DATA SOURCES/\nHealth Care Financing Administration (HCFA) hospital mortality data for FY 1989.\nUsing hospital level public use files of actual and predicted mortality at 30 and 180 days, we constructed residual mortality measures for each hospital. We ranked hospitals and used receiver operating characteristic (ROC) curves to compare 0-30, 31-180, and 0-180-day postadmission mortality.\nFor the admissions we studied, we found a broad range of hospital performance when we ranked hospitals using the 30-day data; some hospitals had much lower than predicted 30-day mortality rates, while others had much higher than predicted mortality rates. Data from the time period 31-180 days postadmission yield results that corroborate the 0-30 day postadmission data. Moreover, we found evidence that hospital performance on one condition is related to performance on the other conditions, but that the correlation is much weaker in the 31-180-day interval than in the 0-30-day period. Using ROC curves, we found that the 30-day data discriminated the top and bottom fifths of the 180-day data extremely well, especially for AMI outcomes.\nMeasuring hospital mortality rates: are 30-day data enough?",
        "answer": "yes",
        "answer_rationale": "Using data on cumulative hospital mortality from 180 days postadmission does not yield a different perspective from using data from 30 days postadmission for the conditions we studied.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We compare 30-day and 180-day postadmission hospital mortality rates for all Medicare patients and those in three categories of cardiac care: coronary artery bypass graft surgery, acute myocardial infarction, and congestive heart failure. DATA SOURCES/\nHealth Care Financing Administration (HCFA) hospital mortality data for FY 1989.\nUsing hospital level public use files of actual and predicted mortality at 30 and 180 days, we constructed residual mortality measures for each hospital. We ranked hospitals and used receiver operating characteristic (ROC) curves to compare 0-30, 31-180, and 0-180-day postadmission mortality.\nFor the admissions we studied, we found a broad range of hospital performance when we ranked hospitals using the",
        "q2": " 30-day data; some hospitals had much lower than predicted 30-day mortality rates, while others had much higher than predicted mortality rates. Data from the time period 31-180 days postadmission yield results that corroborate the 0-30 day postadmission data. Moreover, we found evidence that hospital performance on one condition is related to performance on the other conditions, but that the correlation is much weaker in the 31-180-day interval than in the 0-30-day period. Using ROC curves, we found that the 30-day data discriminated the top and bottom fifths of the 180-day data extremely well, especially for AMI outcomes.\nMeasuring hospital mortality rates: are 30-day data enough?",
        "generated_text": "30-day mortality measure. The ROC curves for 30-day and 180-day mortality measures were similar, with areas under the curves of 0.61 and 0.62, respectively. The 30-day measure had a higher sensitivity (0.70 vs 0.60) but lower specificity (0.52 vs 0.57) than the 180-day measure. The 30-day measure identified 70% of the hospitals in the bottom 10% of performance, but also misclassified 48% of the hospitals not in the bottom 10%. The 180-day measure identified 60% of the low",
        "levenshtein_distance": 501
    },
    {
        "realidx": "8165771",
        "question": "As part of the staging procedure in squamous cell carcinoma of the penis, we assessed the role of ultrasound examination, in particular its role in assessing the extent and the invasion into the corpora.\nFrom 1988 until 1992, all patients referred for primary treatment underwent ultrasound assessment with a 7.5 MHz linear array small parts transducer as part of the clinical workup. All ultrasound images were reviewed by one radiologist, without knowledge of the clinical outcome and were compared with the results obtained at histopathologic examination.\nIn 16 patients the primary tumor and in 1 patient a recurrent cancer after primary therapy were examined. All tumors were identified as hypoechoic lesions. Ultrasound examination in the region of the glans was not able to differentiate between invasion of the subepithelial tissue and invasion into the corpus spongiosum, but absence or presence of invasion into the tunica albuginea of the corpus cavernosum was clearly demonstrated. Accurate measurement by ultrasound of maximum tumor thickness was seen in seven of sixteen examinations.\nUltrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging?",
        "answer": "yes",
        "answer_rationale": "While ultrasound examination is inexpensive and easily done, it is not accurate enough for staging small penile cancers located at the glans penis. However, for larger tumors ultrasound can be a useful addition to physical examination by delineating reliably the anatomic relations of the tumor to structures such as the tunica albuginea, corpus cavernosum, and urethra.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "As part of the staging procedure in squamous cell carcinoma of the penis, we assessed the role of ultrasound examination, in particular its role in assessing the extent and the invasion into the corpora.\nFrom 1988 until 1992, all patients referred for primary treatment underwent ultrasound assessment with a 7.5 MHz linear array small parts transducer as part of the clinical workup. All ultrasound images were reviewed by one radiologist, without knowledge of the clinical outcome and were compared with the results obtained at histopathologic examination.\nIn 16 patients the primary tumor and",
        "q2": " in 1 patient a recurrent cancer after primary therapy were examined. All tumors were identified as hypoechoic lesions. Ultrasound examination in the region of the glans was not able to differentiate between invasion of the subepithelial tissue and invasion into the corpus spongiosum, but absence or presence of invasion into the tunica albuginea of the corpus cavernosum was clearly demonstrated. Accurate measurement by ultrasound of maximum tumor thickness was seen in seven of sixteen examinations.\nUltrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging?",
        "generated_text": "the corpora were assessed by ultrasound and by histopathologic examination. The sensitivity and specificity of ultrasound in assessing the extent of the tumor and the invasion into the corpora were 87.5% and 100%, respectively. The positive and negative predictive values were 100% and 83.3%, respectively.\nUltrasound is a useful noninvasive tool in the staging of squamous cell carcinoma of the penis. It is accurate in assessing the extent of the tumor and the invasion into the corpora.",
        "levenshtein_distance": 421
    },
    {
        "realidx": "8199520",
        "question": "To explore expressed needs, both formal and informal, of family caregivers of frail elderly. To evaluate roles of physicians.\nQuestionnaire survey of members of the Montreal Jewish community providing care for frail elderly family members.\nJewish community of Montreal.\nVolunteer caregivers who were caring for a family member or friend 60 years or older, who had greatest responsibility for providing physical or emotional support to an elderly person, who saw themselves as caregivers, and who could speak English or French were studied. Of 118 volunteers, 32 were excluded because they withdrew for personal reasons or because they did not meet study criteria.\nDemographic variables, functional status of the care receiver, use of home care services, and needs assessment to identify additional services.\nAn average of 75.4% respondents did not use formal support services. Just under half of caregivers were dissatisfied with the attention they received from the health care system, and more than one third expressed feelings of stress, depression, guilt, and isolation.\nAre physicians meeting the needs of family caregivers of the frail elderly?",
        "answer": "no",
        "answer_rationale": "Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To explore expressed needs, both formal and informal, of family caregivers of frail elderly. To evaluate roles of physicians.\nQuestionnaire survey of members of the Montreal Jewish community providing care for frail elderly family members.\nJewish community of Montreal.\nVolunteer caregivers who were caring for a family member or friend 60 years or older, who had greatest responsibility for providing physical or emotional support to an elderly person, who saw themselves as caregivers, and who could speak English or French were studied. Of 118 volunteers, 32 were",
        "q2": " excluded because they withdrew for personal reasons or because they did not meet study criteria.\nDemographic variables, functional status of the care receiver, use of home care services, and needs assessment to identify additional services.\nAn average of 75.4% respondents did not use formal support services. Just under half of caregivers were dissatisfied with the attention they received from the health care system, and more than one third expressed feelings of stress, depression, guilt, and isolation.\nAre physicians meeting the needs of family caregivers of the frail elderly?",
        "generated_text": "excluded because they did not meet the inclusion criteria, and 86 were included in the study.\nA questionnaire was developed to assess the needs of caregivers. The questionnaire was based on a review of the literature and was pretested on a small group of caregivers. The questionnaire was administered by telephone by trained interviewers. The questionnaire included questions about the caregiver's demographic characteristics, the care recipient's demographic characteristics and health status, the caregiver's relationship to the care recipient, the type and amount of care provided, the caregiver's perceived needs",
        "levenshtein_distance": 450
    },
    {
        "realidx": "8375607",
        "question": "Previous studies reported that breast-feeding protects children against a variety of diseases, but these studies were generally conducted on \"high-risk\" or hospitalized children. This paper describes the results of our study on the effects of breast-feeding on rate of illness in normal children with a family history of atopy.\nA historic cohort approach of 794 children with a family history of atopy was used to assess the effects of breast-feeding on illness rates. Family history of atopy was based on allergic diseases in family members as registered by the family physician. Illness data from birth onwards were available from the Continuous Morbidity Registration of the Department of Family Medicine. Information on breast-feeding was collected by postal questionnaire. We then compared rates of illness between children with a family history of atopy who were and who were not breast-fed.\nBreast-feeding was related to lower levels of childhood illness both in the first and the first three years of life. In the first year of life they had fewer episodes of gastroenteritis, lower respiratory tract infections, and digestive tract disorders. Over the next three years of life they had fewer respiratory tract infections and skin infections.\nIs the breast best for children with a family history of atopy?",
        "answer": "yes",
        "answer_rationale": "Our results suggest a protective effect of breast-feeding among children with a family history of atopy that is not confined to the period of breast-feeding but continues during the first three years of life. Breast-feeding should be promoted in children with a family history of atopy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Previous studies reported that breast-feeding protects children against a variety of diseases, but these studies were generally conducted on \"high-risk\" or hospitalized children. This paper describes the results of our study on the effects of breast-feeding on rate of illness in normal children with a family history of atopy.\nA historic cohort approach of 794 children with a family history of atopy was used to assess the effects of breast-feeding on illness rates. Family history of atopy was based on allergic diseases in family members as registered by the family physician. Illness data from birth onwards were available from the Continuous Morbidity",
        "q2": " Registration of the Department of Family Medicine. Information on breast-feeding was collected by postal questionnaire. We then compared rates of illness between children with a family history of atopy who were and who were not breast-fed.\nBreast-feeding was related to lower levels of childhood illness both in the first and the first three years of life. In the first year of life they had fewer episodes of gastroenteritis, lower respiratory tract infections, and digestive tract disorders. Over the next three years of life they had fewer respiratory tract infections and skin infections.\nIs the breast best for children with a family history of atopy?",
        "generated_text": "Registration (CMR) of the Health Insurance Executive. The CMR is a computerized record of all medical consultations of insured persons with their general practitioners. The study population was divided into three groups: breast-fed for more than 3 months, breast-fed for less than 3 months, and bottle-fed. The effects of breast-feeding on illness rates were assessed by means of a proportional hazards model.\nBreast-feeding for more than 3 months was associated with a significant reduction in the rates of otitis media, lower respiratory tract infections, and eczema in the first year of life. The protective",
        "levenshtein_distance": 455
    },
    {
        "realidx": "8521557",
        "question": "The insertion/deletion (ID) polymorphism of the angiotensin-converting enzyme (ACE) gene has been associated with increased coronary heart disease (CHD), although the mechanism of this association is not apparent. We tested the hypothesis that the deletion allele of the ACE gene is associated with insulin resistance.\nWe related ACE genotype to components of the insulin-resistance syndrome in 103 non-insulin-dependent diabetic (NIDDM) and 533 nondiabetic white subjects. NIDDM subjects with the DD genotype had significantly lower levels of specific insulin (DD 38.6, ID 57.1, and II 87.4 pmol.L-1 by ANOVA, P = .011). Non-insulin-treated subjects with the DD genotype had increased insulin sensitivity by HOMA % (DD 56.4%, II 29.4%, P = .027) and lower levels of des 31,32 proinsulin (DD 3.3, II 7.6 pmol.L-1, P = .012) compared with II subjects. There were no differences in prevalence of CHD or levels of blood pressure, serum lipids, or plasminogen activator inhibitor-1 (PAI-1) activity between the three ACE genotypes. In nondiabetic subjects there were no differences in insulin sensitivity, levels of insulin-like molecules, blood pressure, PAI-1, serum lipids, or CHD prevalence between the three ACE genotypes.\nThe insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?",
        "answer": "no",
        "answer_rationale": "We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The insertion/deletion (ID) polymorphism of the angiotensin-converting enzyme (ACE) gene has been associated with increased coronary heart disease (CHD), although the mechanism of this association is not apparent. We tested the hypothesis that the deletion allele of the ACE gene is associated with insulin resistance.\nWe related ACE genotype to components of the insulin-resistance syndrome in 103 non-insulin-dependent diabetic (NIDDM) and 533 nondiabetic white subjects. NIDDM subjects with the DD genotype had significantly lower levels of specific insulin (DD 38.6, ID 57.1, and II 87.4 pmol.L-1 by ANOVA, P = .011). Non-insulin-treated subjects with the DD genotype had increased insulin sensitivity by HOMA %",
        "q2": " (DD 56.4%, II 29.4%, P = .027) and lower levels of des 31,32 proinsulin (DD 3.3, II 7.6 pmol.L-1, P = .012) compared with II subjects. There were no differences in prevalence of CHD or levels of blood pressure, serum lipids, or plasminogen activator inhibitor-1 (PAI-1) activity between the three ACE genotypes. In nondiabetic subjects there were no differences in insulin sensitivity, levels of insulin-like molecules, blood pressure, PAI-1, serum lipids, or CHD prevalence between the three ACE genotypes.\nThe insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?",
        "generated_text": "S (DD 100, ID 84, and II 72, P = .0001). In nondiabetic subjects, the DD genotype was associated with higher HDL cholesterol (DD 1.53, ID 1.44, and II 1.39 mmol.L-1, P = .0001), lower triglycerides (DD 1.14, ID 1.24, and II 1.34 mmol.L-1, P = .0001), and lower systolic blood pressure (DD 125, ID 128, and II 130 mm Hg, P = .0001). The DD genotype was associated",
        "levenshtein_distance": 464
    },
    {
        "realidx": "8566975",
        "question": "To determine whether the host immune response to gonorrhoea provides limited serovar specific protection from reinfection.\n508 episodes of gonorrhoea diagnosed at a city centre genitourinary medicine clinic including 22 patients with multiple infections over a 4 year period.\nPatients with recurrent gonococcal infection were analysed with respect to the initial and subsequent serovars isolated.\nNo significant difference was seen in the prevalence of serovars isolated following a repeat infection compared with those without repeat infections. The site of the initial infection did not appear to influence the subsequent serovar isolated.\nSerovar specific immunity to Neisseria gonorrhoeae: does it exist?",
        "answer": "no",
        "answer_rationale": "We found no evidence of serovar specific immunity in our population. It remains possible that populations with a higher prevalence of gonorrhoea and more frequent infections may have a quantitatively greater immune response.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine whether the host immune response to gonorrhoea provides limited serovar specific protection from reinfection.\n508 episodes of gonorrhoea diagnosed at a city centre genitourinary medicine clinic including 22 patients with multiple infections over a 4 year period.\nPatients with recurrent gonococcal infection were analysed with respect to",
        "q2": " the initial and subsequent serovars isolated.\nNo significant difference was seen in the prevalence of serovars isolated following a repeat infection compared with those without repeat infections. The site of the initial infection did not appear to influence the subsequent serovar isolated.\nSerovar specific immunity to Neisseria gonorrhoeae: does it exist?",
        "generated_text": "the serovar of the infecting strain and the time interval between infections.\nPatients with multiple infections had a significantly higher proportion of infections with the same serovar compared with the general population (p < 0.001). The proportion of reinfections with the same serovar decreased with increasing time between infections (p",
        "levenshtein_distance": 270
    },
    {
        "realidx": "8738894",
        "question": "The purpose of this study was to search for evidence of an association between occupational arsenic exposure and diabetes mellitus, as implied by the relation of this disease to arsenic in drinking water in a recent study from Taiwan.\nA case-referent analysis on death records of 5498 individuals in the art glass producing part of southeastern Sweden was performed. Out of all the enrolled subjects, 888 were glass workers. According to occupational title, glassblowers, foundry workers, and unspecified workers were regarded as potentially exposed to arsenic. Persons with a diagnosis of diabetes mellitus either as an underlying or contributing cause of death were considered cases. Referents were decedents without any indication of cancer, cardiovascular disease, or diabetes.\nA slightly elevated risk [Mantel-Haenszel odds ratio (MH-OR) 1.2, 95% confidence interval (95% CI) 0.82-1.8] was found for diabetes mellitus among the glassworks employees, especially in combination with cardiovascular disease (MH-OR 1.4, 95% CI 0.81-2.3). For the glassblowers, other foundry workers and unspecified glassworkers probably exposed to arsenic, the M-H odds ratio was 1.4 (95% CI 0.92-2.2). Unspecified glass workers, who probably included persons with high exposure, carried the higher risk (MH-OR 1.8, 95% CI 1.1-2.8).\nDiabetes mellitus among Swedish art glass workers--an effect of arsenic exposure?",
        "answer": "no",
        "answer_rationale": "The observations from this study provide limited support for the possibility that occupational arsenic exposure could play a role in the development of diabetes mellitus. Many other metallic compounds are also used in art glass production, however, and there is a possibility of confounding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The purpose of this study was to search for evidence of an association between occupational arsenic exposure and diabetes mellitus, as implied by the relation of this disease to arsenic in drinking water in a recent study from Taiwan.\nA case-referent analysis on death records of 5498 individuals in the art glass producing part of southeastern Sweden was performed. Out of all the enrolled subjects, 888 were glass workers. According to occupational title, glassblowers, foundry workers, and unspecified workers were regarded as potentially exposed to arsenic. Persons with a diagnosis of diabetes mellitus either as an underlying or contributing cause of death were considered cases. Referents were decedents without any indication of cancer, cardiovascular disease, or diabetes.\nA slightly elevated risk [Mantel-Haenszel odds ratio (MH-OR",
        "q2": ") 1.2, 95% confidence interval (95% CI) 0.82-1.8] was found for diabetes mellitus among the glassworks employees, especially in combination with cardiovascular disease (MH-OR 1.4, 95% CI 0.81-2.3). For the glassblowers, other foundry workers and unspecified glassworkers probably exposed to arsenic, the M-H odds ratio was 1.4 (95% CI 0.92-2.2). Unspecified glass workers, who probably included persons with high exposure, carried the higher risk (MH-OR 1.8, 95% CI 1.1-2.8).\nDiabetes mellitus among Swedish art glass workers--an effect of arsenic exposure?",
        "generated_text": ") = 1.3; 95% confidence interval (CI), 0.7-2.4] was found for diabetes among glassblowers, but the difference was not statistically significant. The risk was higher among glassblowers who had worked in the industry for more than 10 years (MH-OR = 1.7; 95% CI, 0.7-4.1). The risk was also higher among foundry workers (MH-OR = 2.0; 95% CI, 0.5-7.5), but the number of cases was small (n = 2). No increased risk was found among unspecified glass workers.\nThe results of this study do not support the hypothesis that occupational exposure to arsenic is",
        "levenshtein_distance": 402
    },
    {
        "realidx": "8847047",
        "question": "The purpose of this study is to examine whether or not well differentiated (w-d) hepatocellular carcinoma (HCC) is indeed clinically early cancer.\nSeventy six patients with solitary small HCCs up to 3 cm in diameter, who underwent hepatectomy, were observed for at least 2 years for possible recurrence. These patients were divided into two groups: 10 patients with w-d HCCs (Edmondson and Steiner's grade I) and 66 patients with less differentiated (l-d) HCCs (Edmondson and Steiner's grade I-II, II-III, and III).\nThe histological analysis revealed that w-d HCCs had lower incidences of fibrous capsule formation (P<0.01), when compared to l-d HCCs. There were no significant differences in the incidence of intrahepatic metastasis, or portal vein invasion. In a resected specimen of w-d HCC, barium sulfate and gelatin were injected into portal vein and a transparent specimen was made. The transparent specimen showed that the portal vein in the tumor seemed to be intact. Microscopically, cancer cell infiltration into the fibrous frame of the portal tract was present. There were no significant differences in the disease free survival between the two groups. An analysis of tumor volume doubling time in recurrent foci suggested that minute cancerous foci had been present at the time of operation.\nPrognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?",
        "answer": "no",
        "answer_rationale": "W-d HCCs were clinically demonstrated not to be early cancer, because there was no significant difference in disease free survival between the patients with w-d and l-d HCCs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "The purpose of this study is to examine whether or not well differentiated (w-d) hepatocellular carcinoma (HCC) is indeed clinically early cancer.\nSeventy six patients with solitary small HCCs up to 3 cm in diameter, who underwent hepatectomy, were observed for at least 2 years for possible recurrence. These patients were divided into two groups: 10 patients with w-d HCCs (Edmondson and Steiner's grade I) and 66 patients with less differentiated (l-d) HCCs (Edmondson and Steiner's grade I-II, II-III, and III).\nThe histological analysis revealed that w-d HCCs had lower incidences of fibrous capsule formation (P<0.01), when compared",
        "q2": " to l-d HCCs. There were no significant differences in the incidence of intrahepatic metastasis, or portal vein invasion. In a resected specimen of w-d HCC, barium sulfate and gelatin were injected into portal vein and a transparent specimen was made. The transparent specimen showed that the portal vein in the tumor seemed to be intact. Microscopically, cancer cell infiltration into the fibrous frame of the portal tract was present. There were no significant differences in the disease free survival between the two groups. An analysis of tumor volume doubling time in recurrent foci suggested that minute cancerous foci had been present at the time of operation.\nPrognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?",
        "generated_text": "with l-d HCCs. The recurrence rate in the w-d group was 40% (4/10), which was significantly higher than that in the l-d group (12% (8/66), P<0.05). The recurrence-free survival rate in the w-d group was significantly lower than that in the l-d group (P<0.05). The recurrence pattern in the w-d group was more frequent in the liver (75% (3/4)) than in the lung (25% (1/4)), whereas in the l-d group, the recurrence pattern was more frequent in the lung (63% (5/8)) than in the liver (38% (3/8)).",
        "levenshtein_distance": 576
    },
    {
        "realidx": "8910148",
        "question": "The brain-dead donor supply has become one of the criteria limiting the performance of heart transplantation. Conventional screening criteria are too limiting and exclude suitable heart donors. Echocardiography is now widely available and is a reliable tool to assess left ventricular dysfunction in brain-dead donors. Yet few data are available on the degree of left ventricular dysfunction where a transplantation is possible.\nFifty-five potential brain-dead heart donors (age 38 +/- 11 years) were prospectively evaluated by transesophageal echocardiography (TEE) before harvesting. Fractional area change (FAC) was used to assess left ventricular function in potential brain-dead donors. Transplanted hearts were evaluated on the fifth postoperative day. The transplantation was considered a success if the recipient was alive, not retransplanted, without an assistance device or an epinephrine infusion of more than 1 mg/h and showed an ejection fraction above 40%.\nOf the 55 potential heart donors, 20 exhibited an FAC of less than 50%. Forty hearts were harvested, 36 of which were successfully transplanted. Nine patients had an FAC below 50% (group H2) and 27 had an FAC over 50% (group H1). Four patients died: 2 from hemorrhage (FAC>50% in donors); 1 from right and one from left ventricular dysfunction (FAC<50% in donors). The FAC increased significantly from 51 +/- 15% to 57 +/- 11% in 18 hearts that underwent TEE in donors and afterwards in recipients. Overall actuarial survival was 86.2% versus 64.6% at 1 and 2 years in group H1 and group H2, respectively (p = NS).\nTransesophageal echocardiographic assessment of left ventricular function in brain-dead patients: are marginally acceptable hearts suitable for transplantation?",
        "answer": "yes",
        "answer_rationale": "TEE is useful to assess left ventricular function in potential brain-dead donors. An FAC less than 50% is present in 36% of potential heart donors. Because left ventricular dysfunction is often reversible shortly after transplantation, an FAC below 50% may not necessarily preclude the use of hearts for transplantation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The brain-dead donor supply has become one of the criteria limiting the performance of heart transplantation. Conventional screening criteria are too limiting and exclude suitable heart donors. Echocardiography is now widely available and is a reliable tool to assess left ventricular dysfunction in brain-dead donors. Yet few data are available on the degree of left ventricular dysfunction where a transplantation is possible.\nFifty-five potential brain-dead heart donors (age 38 +/- 11 years) were prospectively evaluated by transesophageal echocardiography (TEE) before harvesting. Fractional area change (FAC) was used to assess left ventricular function in potential brain-dead donors. Transplanted hearts were evaluated on the fifth postoperative day. The transplantation was considered a success if the recipient was alive, not retransplanted, without an assistance device or an epinephrine infusion of more than 1 mg/h and showed an ejection fraction above 40%.\nOf the 55",
        "q2": " potential heart donors, 20 exhibited an FAC of less than 50%. Forty hearts were harvested, 36 of which were successfully transplanted. Nine patients had an FAC below 50% (group H2) and 27 had an FAC over 50% (group H1). Four patients died: 2 from hemorrhage (FAC>50% in donors); 1 from right and one from left ventricular dysfunction (FAC<50% in donors). The FAC increased significantly from 51 +/- 15% to 57 +/- 11% in 18 hearts that underwent TEE in donors and afterwards in recipients. Overall actuarial survival was 86.2% versus 64.6% at 1 and 2 years in group H1 and group H2, respectively (p = NS).\nTransesophageal echocardiographic assessment of left ventricular function in brain-dead patients: are marginally acceptable hearts suitable for transplantation?",
        "generated_text": "potential donors, 25 (45%) had a FAC of less than 25% and 30 (55%) had a FAC of 25% or more. The transplantation was successful in 14 of the 25 donors (56%) with a FAC of less than 25% and in 25 of the 30 donors (83%) with a FAC of 25% or more. The difference was significant (p < 0.05). The mean FAC in the 14 successful transplants with a FAC of less than 25% was 21.5% +/- 2.5% and in the 25 successful transplants with a FAC of 25% or more was 32.5% +/- 5.5% (p < 0.001). The mean FAC in the 11 unsuccessful",
        "levenshtein_distance": 533
    },
    {
        "realidx": "8916748",
        "question": "To assess the risk of death associated with work based and non-work based measures of socioeconomic status before and after retirement age.\nFollow up study of mortality in relation to employment grade and car ownership over 25 years.\nThe first Whitehall study.\n18,133 male civil servants aged 40-69 years who attended a screening examination between 1967 and 1970.\nDeath.\nGrade of employment was a strong predictor of mortality before retirement. For men dying at ages 40-64 the lowest employment grade had 3.12 times the mortality of the highest grade (95% confidence interval 2.4 to 4.1). After retirement the ability of grade to predict mortality declined (rate ratio 1.86; 1.6 to 2.2). A non-work based measure of socioeconomic status (car ownership) predicted mortality less well than employment grade before retirement but its ability to predict mortality declined less after retirement. Using a relative index of inequality that was sensitive to the distribution among socioeconomic groups showed employment grade and car ownership to have independent associations with mortality that were of equal magnitude after retirement. The absolute difference in death rates between the lowest and highest employment grades increased with age from 12.9 per 1000 person years at ages 40-64 to 38.3 per 1000 at ages 70-89.\nDo socioeconomic differences in mortality persist after retirement?",
        "answer": "yes",
        "answer_rationale": "Socioeconomic differences in mortality persist beyond retirement age and in magnitude increase with age. Social differentials in mortality based on an occupational status measure seem to decrease to a greater degree after retirement than those based on a non-work measure. This suggests that alongside other socioeconomic factors work itself may play an important part in generating social inequalities in health in men of working age.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To assess the risk of death associated with work based and non-work based measures of socioeconomic status before and after retirement age.\nFollow up study of mortality in relation to employment grade and car ownership over 25 years.\nThe first Whitehall study.\n18,133 male civil servants aged 40-69 years who attended a screening examination between 1967 and 1970.\nDeath.\nGrade of employment was a strong predictor of mortality before retirement. For men dying at ages 40-64 the lowest employment grade had 3.12 times the mortality of the highest grade (95% confidence interval 2.4 to 4.1). After retirement the ability of grade to predict mortality declined (rate",
        "q2": " ratio 1.86; 1.6 to 2.2). A non-work based measure of socioeconomic status (car ownership) predicted mortality less well than employment grade before retirement but its ability to predict mortality declined less after retirement. Using a relative index of inequality that was sensitive to the distribution among socioeconomic groups showed employment grade and car ownership to have independent associations with mortality that were of equal magnitude after retirement. The absolute difference in death rates between the lowest and highest employment grades increased with age from 12.9 per 1000 person years at ages 40-64 to 38.3 per 1000 at ages 70-89.\nDo socioeconomic differences in mortality persist after retirement?",
        "generated_text": "ratio 1.4, 0.9 to 2.1). Car ownership was a weaker predictor of mortality before retirement (rate ratio 1.5, 1.2 to 1.9) but was a better predictor after retirement (1.9, 1.3 to 2.7). The relative importance of employment grade and car ownership in predicting mortality changed with age. Before retirement, employment grade was a better predictor of mortality than car ownership, but after retirement car ownership was a better predictor than employment grade. The relative importance of employment grade and car ownership in predicting mortality was similar in the first 10 years of follow up and in the last 10",
        "levenshtein_distance": 483
    },
    {
        "realidx": "8921484",
        "question": "After 34 weeks gestation, summary measures of location for birthweight (e.g means and centiles) increase more slowly for Australian Aborigines than for whites. A similar pattern has been observed for blacks in the US. This study tests whether the reported pattern is due to differential misclassification of gestational age.\nSimulation was used to measure the potential effect of differential misclassification of gestational age. Reported gestational age data were obtained from Queensland Perinatal Data Collection (QPDC). Estimates of the true distributions of gestational age were obtained by assuming various (plausible) types of misclassification and applying these to the reported distributions. Previous studies and data from the QPDC were used to help specify the birthweight distributions used in the simulations.\nAt full term, the parameters of the birthweight distributions were robust to gestational age misclassification. At preterm, the 10th centiles were robust to misclassification. In contrast, the 90th centiles were sensitive to even minor misclassification. Extreme types of misclassification were required to remove the divergence in median birthweights for Aborigines and whites.\nDoes gestational age misclassification explain the difference in birthweights for Australian aborigines and whites?",
        "answer": "no",
        "answer_rationale": "Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "After 34 weeks gestation, summary measures of location for birthweight (e.g means and centiles) increase more slowly for Australian Aborigines than for whites. A similar pattern has been observed for blacks in the US. This study tests whether the reported pattern is due to differential misclassification of gestational age.\nSimulation was used to measure the potential effect of differential misclassification of gestational age. Reported gestational age data were obtained from Queensland Perinatal Data Collection (QPDC). Estimates of the true distributions of gestational age were obtained by assuming various (plausible) types of misclassification and",
        "q2": " applying these to the reported distributions. Previous studies and data from the QPDC were used to help specify the birthweight distributions used in the simulations.\nAt full term, the parameters of the birthweight distributions were robust to gestational age misclassification. At preterm, the 10th centiles were robust to misclassification. In contrast, the 90th centiles were sensitive to even minor misclassification. Extreme types of misclassification were required to remove the divergence in median birthweights for Aborigines and whites.\nDoes gestational age misclassification explain the difference in birthweights for Australian aborigines and whites?",
        "generated_text": "applying Bayes' theorem. The effect of misclassification on birthweight measures was then assessed by calculating summary measures of birthweight for the true and reported gestational age distributions.\nThe reported gestational age distributions for Aborigines and whites were similar, with a small shift towards shorter gestations for Aborigines. The true gestational age distributions were estimated to be similar for both groups. The reported birthweight measures for Aborigines were lower than for whites for all gestational ages. The difference in birthweight measures was reduced when the true gestational age distributions were used, but the difference remained substantial.\nDifferential mis",
        "levenshtein_distance": 489
    },
    {
        "realidx": "9100537",
        "question": "Cytologic criteria reported to be helpful in the distinction of proliferative breast disease without atypia (PBD) from nonproliferative breast disease (NPBD) have not been rigorously tested.\nFifty-one air-dried, Diff-Quik-stained fine-needle aspirates (FNA) of palpable breast lesions with biopsy-proven diagnoses of NPBD (34 cases) or PBD (17 cases) were reviewed. The smears were evaluated for the cellularity, size, and architectural arrangement of the epithelial groups; the presence of single epithelial cells and myoepithelial cells; and nuclear characteristics.\nThe only cytologic feature found to be significantly different between PBD and NPBD was a swirling pattern of epithelial cells. A swirling pattern was noted in 13 of 17 PBD cases (76%) and 12 of 34 NPBD cases (35%) (P = 0.008).\nCan nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology?",
        "answer": "no",
        "answer_rationale": "Because there is significant overlap in cytologic features between NPBD and PBD, the distinction between the two entities is difficult in cytologic sampling.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Cytologic criteria reported to be helpful in the distinction of proliferative breast disease without atypia (PBD) from nonproliferative breast disease (NPBD) have not been rigorously tested.\nFifty-one air-dried, Diff-Quik-stained fine-needle aspirates (FNA) of palpable breast lesions with biopsy-proven diagnoses of NPBD (34 cases) or PBD (17 cases) were reviewed. The smears were evaluated for the cellularity, size, and architectural arrangement of the",
        "q2": " epithelial groups; the presence of single epithelial cells and myoepithelial cells; and nuclear characteristics.\nThe only cytologic feature found to be significantly different between PBD and NPBD was a swirling pattern of epithelial cells. A swirling pattern was noted in 13 of 17 PBD cases (76%) and 12 of 34 NPBD cases (35%) (P = 0.008).\nCan nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology?",
        "generated_text": "epithelial clusters, the nuclear size and shape, the nuclear-to-cytoplasmic ratio, the chromatin pattern, the nucleoli, and the presence of mitoses and necrosis. The results were compared with the histologic diagnoses using the chi-square test and Fisher's exact test.\nThe cytologic features that were significantly associated with PBD were increased cellularity (P = 0.0001), increased nuclear size (P = 0.0001), increased nuclear-to-cytoplasmic ratio",
        "levenshtein_distance": 374
    },
    {
        "realidx": "9142039",
        "question": "To assess the relationship between the experience of pediatric housestaff and tests ordered on infants in the neonatal intensive care unit (ICU).\nProspective, cohort study over one full academic year.\nOne academic Level III neonatal intensive care nursery.\nData were collected prospectively on all 785 infants admitted to the neonatal ICU from July 1993 to June 1994. These infants were cared for by 14 different categorical pediatric housestaff.\nOur neonatal ICU has either a resident or an intern on-call by himself/herself at night, affording us a natural setting to compare intern vs. resident test ordering. The outcomes of interest were number of arterial blood gases, radiographs, and electrolytes ordered per infant by the on-call pediatric houseofficer, as tabulated the morning after the call night. Control variables included the severity-of-illness of the individual infant (using the Neonatal Therapeutic Intervention Scoring System), the workload of the houseofficer (number of patients, number of admissions), and supervision (rounding frequency and on-call attending). Controlling for the severity-of-illness of the infant, the workload on the call night, and supervision with multiple linear regression, we found that interns ordered significantly (p = .02) greater numbers of arterial blood gases per infant than residents, amounting to some 0.33 blood gases per infant per call night (3.22 vs. 2.89 arterial blood gases per infant per night). This increase of 0.33 blood gases per infant amounts to interns ordering $169 more arterial blood gases per call night at our institution. There was no difference between interns and residents in ordering radiographs or electrolytes.\nDoes pediatric housestaff experience influence tests ordered for infants in the neonatal intensive care unit?",
        "answer": "yes",
        "answer_rationale": "Interns order significantly more arterial blood gases per infant than junior and senior residents on-call in the neonatal ICU. Additional study is required to see if the experience of housestaff is associated with a broader array of neonatal outcomes, such as morbidity and mortality.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To assess the relationship between the experience of pediatric housestaff and tests ordered on infants in the neonatal intensive care unit (ICU).\nProspective, cohort study over one full academic year.\nOne academic Level III neonatal intensive care nursery.\nData were collected prospectively on all 785 infants admitted to the neonatal ICU from July 1993 to June 1994. These infants were cared for by 14 different categorical pediatric housestaff.\nOur neonatal ICU has either a resident or an intern on-call by himself/herself at night, affording us a natural setting to compare intern vs. resident test ordering. The outcomes of interest were number of arterial blood gases, radiographs, and electrolytes ordered per infant by the on-call pediatric houseofficer, as tabulated the morning after the call night. Control variables included the severity-of-illness of the individual infant (using the Neon",
        "q2": "atal Therapeutic Intervention Scoring System), the workload of the houseofficer (number of patients, number of admissions), and supervision (rounding frequency and on-call attending). Controlling for the severity-of-illness of the infant, the workload on the call night, and supervision with multiple linear regression, we found that interns ordered significantly (p = .02) greater numbers of arterial blood gases per infant than residents, amounting to some 0.33 blood gases per infant per call night (3.22 vs. 2.89 arterial blood gases per infant per night). This increase of 0.33 blood gases per infant amounts to interns ordering $169 more arterial blood gases per call night at our institution. There was no difference between interns and residents in ordering radiographs or electrolytes.\nDoes pediatric housestaff experience influence tests ordered for infants in the neonatal intensive care unit?",
        "generated_text": "atal Risk Adjustment for Severity of Illness [NRASI] score), the number of infants in the nursery, and the number of infants requiring intensive care.\nThe number of tests ordered per infant was higher for interns than for residents (mean 1.7 vs. 1.3, p < 0.001). This difference persisted after controlling for NRASI score, number of infants in the nursery, and number of infants requiring intensive care (p < 0.001). The difference was most pronounced for arterial blood gases (mean 0.7 vs. 0.4, p < 0.001). The number of tests ordered per infant was not related to the number of infants in the nursery or the number requiring intensive care.\nOur data suggest that pediatric housestaff with less experience order more tests per infant in the neonatal ICU. This difference",
        "levenshtein_distance": 609
    },
    {
        "realidx": "9199905",
        "question": "We observed an endoscopic abnormally in a group of children with histological esophagitis. We termed this finding \"vertical lines in esophageal mucosa\" (VLEM). We examined the relationship between the presence of VLEM and significant histologic changes in esophageal mucosal biopsies.\nBetween January 1, 1992, and August 31, 1994, the senior author (JFF) performed 255 esophageal biopsies. The procedure reports, available endoscopic photographs, and histology reports were reviewed to establish the endoscopic and histologic appearance of the esophageal mucosa. Intraepithelial cells were counted in a blind review of 42 randomly selected biopsies.\nThe esophageal mucosa had a normal appearance on 160 endoscopic studies (Group 1) and VLEM were the only mucosal abnormalities in 41 endoscopies (Group 2). Histology was normal in 92 of 160 biopsies (57.5%) from Group 1, and 1 of 41 biopsies (2.4%) from Group 2. Most patients in Group 2 had eosinophilic esophagitis (34 of 41, 83%, specificity 0.85, sensitivity 0.5, p>0.001) which was of moderate to severe intensity (31 of 34, 91.2%, specificity 0.88, sensitivity 0.73, p<0.001).\nVertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?",
        "answer": "yes",
        "answer_rationale": "Histology usually demonstrated moderate to severe inflammation when VLEM were present. VLEM may be a highly specific endoscopic feature of esophagitis in children.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We observed an endoscopic abnormally in a group of children with histological esophagitis. We termed this finding \"vertical lines in esophageal mucosa\" (VLEM). We examined the relationship between the presence of VLEM and significant histologic changes in esophageal mucosal biopsies.\nBetween January 1, 1992, and August 31, 1994, the senior author (JFF) performed 255 esophageal biopsies. The procedure reports, available endoscopic photographs, and histology reports were reviewed to establish the endoscopic and histologic appearance of the esophageal mucosa. Intraepithelial cells were counted in a blind review of 42 randomly selected biopsies.\nThe esophageal mucosa had a normal appearance on 160 endoscopic studies (Group 1",
        "q2": ") and VLEM were the only mucosal abnormalities in 41 endoscopies (Group 2). Histology was normal in 92 of 160 biopsies (57.5%) from Group 1, and 1 of 41 biopsies (2.4%) from Group 2. Most patients in Group 2 had eosinophilic esophagitis (34 of 41, 83%, specificity 0.85, sensitivity 0.5, p>0.001) which was of moderate to severe intensity (31 of 34, 91.2%, specificity 0.88, sensitivity 0.73, p<0.001).\nVertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?",
        "generated_text": "). VLEM were present in 95 endoscopic studies (Group 2). The histologic findings in Group 1 were normal in 112 biopsies (70%), and abnormal in 48 (30%). The histologic findings in Group 2 were normal in 12 biopsies (13%), and abnormal in 83 (87%). The difference between the two groups was significant (p < 0.0001). The histologic findings in Group 2 were significantly more severe than in Group 1 (p < 0.0001). The presence of VLEM was associated with a 2.9-fold increase in the risk of histologic esophagitis (p < 0.0001). The",
        "levenshtein_distance": 389
    },
    {
        "realidx": "9363244",
        "question": "To determine the effect of occupational exposure in a nuclear power plant in Griefswald, Germany on male and female fecundity.\nThe frequency of men and women exposed to ionizing radiation through work in a nuclear power plant among 270 infertile couples was retrospectively compared to a control fertile population using a pair-matched analysis. The total cumulative equivalent radiation dose was determined. In addition, the spermiograms of the male partners in both groups were compared and correlated to the degree of exposure.\nNo differences were noted in the frequency of nuclear power plant exposure between sterile and fertile groups. There was a higher rate of anomalous spermiograms in nuclear power plant workers. However, abnormalities were temporary. No correlation was found between the cumulative equivalent radiation dose and abnormal spermiograms.\nDoes occupational nuclear power plant radiation affect conception and pregnancy?",
        "answer": "yes",
        "answer_rationale": "The data suggest that occupational exposure due to ionizing radiation should be investigated as a possible cause for involuntary temporary sterility and as a risk factor for early pregnancy disorders.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To determine the effect of occupational exposure in a nuclear power plant in Griefswald, Germany on male and female fecundity.\nThe frequency of men and women exposed to ionizing radiation through work in a nuclear power plant among 270 infertile couples was retrospectively compared to a control fertile population using a pair-matched analysis. The total cumulative equivalent radiation dose was determined. In addition, the spermiograms of",
        "q2": " the male partners in both groups were compared and correlated to the degree of exposure.\nNo differences were noted in the frequency of nuclear power plant exposure between sterile and fertile groups. There was a higher rate of anomalous spermiograms in nuclear power plant workers. However, abnormalities were temporary. No correlation was found between the cumulative equivalent radiation dose and abnormal spermiograms.\nDoes occupational nuclear power plant radiation affect conception and pregnancy?",
        "generated_text": "100 men exposed to radiation and 100 unexposed men were compared.\nThe frequency of men and women exposed to radiation was significantly higher in the infertile group compared to the fertile group (p < 0.001). The mean radiation dose was 12.5 mSv in the infertile group and 5.2 mSv in the fertile group",
        "levenshtein_distance": 349
    },
    {
        "realidx": "9427037",
        "question": "The most common primary brain tumors in children and adults are of astrocytic origin. Classic histologic grading schemes for astrocytomas have included evaluating the presence or absence of nuclear abnormalities, mitoses, vascular endothelial proliferation, and tumor necrosis.\nWe evaluated the vascular pattern of 17 astrocytoma surgical specimens (seven from children and 10 from adults), and four normal brains obtained at autopsy, utilizing antibody to glial fibrillary acidic protein (GFAP) and von Willebrand factor (vWF) utilizing confocal microscopy. A modified WHO classification was used.\nAll tumor cases showed cells positive for GFAP. Control tissues showed a few, widely separated vessels. Pilocytic astrocytomas (four cases) showed lacy clusters of small-to-medium sized vessels, with intact vessel wall integrity. Diffuse, low grade astrocytoma (three cases) showed a staining pattern similar to control tissue; intermediate grade (one case), anaplastic astrocytoma (three cases) and gliobastoma multiforme (six cases) showed an increased vessel density with multiple small vessels (glomeruloid clusters), some with prominent intimal hyperplasia, loss of vessel wall integrity, and with numerous vWF-positive single cells/microvessels within the tumor substance.\nAre endothelial cell patterns of astrocytomas indicative of grade?",
        "answer": "yes",
        "answer_rationale": "Evaluation of astrocytomas utilizing antibody to vWF and confocal microscopy aids in the grading of these neoplasms.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "The most common primary brain tumors in children and adults are of astrocytic origin. Classic histologic grading schemes for astrocytomas have included evaluating the presence or absence of nuclear abnormalities, mitoses, vascular endothelial proliferation, and tumor necrosis.\nWe evaluated the vascular pattern of 17 astrocytoma surgical specimens (seven from children and 10 from adults), and four normal brains obtained at autopsy, utilizing antibody to glial fibrillary acidic protein (GFAP) and von Willebrand factor (vWF) utilizing confocal microscopy. A modified WHO classification was used.\nAll tumor cases showed cells positive for GFAP. Control tissues showed a few, widely separated vessels. Pil",
        "q2": "ocytic astrocytomas (four cases) showed lacy clusters of small-to-medium sized vessels, with intact vessel wall integrity. Diffuse, low grade astrocytoma (three cases) showed a staining pattern similar to control tissue; intermediate grade (one case), anaplastic astrocytoma (three cases) and gliobastoma multiforme (six cases) showed an increased vessel density with multiple small vessels (glomeruloid clusters), some with prominent intimal hyperplasia, loss of vessel wall integrity, and with numerous vWF-positive single cells/microvessels within the tumor substance.\nAre endothelial cell patterns of astrocytomas indicative of grade?",
        "generated_text": "omyxoid astrocytoma (PMA) and diffuse astrocytoma (DA) showed a few vessels, while pilocytic astrocytoma (PA) and anaplastic astrocytoma (AA) showed a moderate number of vessels. Glioblastoma multiforme (GBM) showed a large number of vessels. Vessels in PMA and PA were small and thin, while those in DA, AA, and GBM were large and thick. Vessels in PMA and PA were straight, while those in DA, AA, and GBM were tortuous. Vessels in PMA and PA were regular, while",
        "levenshtein_distance": 440
    },
    {
        "realidx": "9465206",
        "question": "We investigated the actual role of MRI versus arthroscopy in the detection and characterization of occult bone and/or cartilage injuries in patients with previous musculoskeletal trauma of the knee, pain and severe functional impairment. Occult post-traumatic osteochondral injuries of the knee are trauma-related bone and/or cartilage damage missed at plain radiography.\nWe retrospectively selected 70 patients (men:women = 7:3; age range: 35 +/- 7 years) with a history of acute musculoskeletal trauma, negative conventional radiographs, pain and limited joint movements. All patients were submitted to conventional radiography, arthroscopy and MRI, the latter with 0.5 T units and T1-weighted SE. T2-weighted GE and FIR sequences with fat suppression.\nWe identified three types of occult post-traumatic injuries by morpho-topographic and signal intensity patterns: bone bruises (no. 25), subchondral (no. 33) and osteochondral (no. 35) injuries. Arthroscopy depicted 45 osteochondral and 19 chondral injuries. A bone bruise was defined as a typical subcortical area of signal loss, with various shapes, on T1-weighted images and of increased signal intensity on T2-weighted and FIR images. The cortical bone and articular cartilage were normal in all cases, while osteochondral injuries exhibited associated bone and cartilage damage with the same abnormal MR signal intensity. Sprain was the mechanism of injury in 52 cases, bruise in 12 and stress in 6. In 52 sprains (30 in valgus), the injury site was the lateral compartment in 92.3% of cases (100% in valgus), associated with meniscal damage in 73% of cases (90% in valgus) and with ligament injury in 90.4% (100% in valgus). In 12 bruises, the injury site was the lateral compartment in 58.3% of cases, the knee cap in 25% and the medial compartment in 16.7%; meniscal damage was associated in 25% of cases and ligament damage in 8.3%. In 6 stress injuries, the injury site was localized in the medial tibial condyle in 80% of cases, while meniscal and ligament tears were absent.\n\"Occult\" posttraumatic lesions of the knee: can magnetic resonance substitute for diagnostic arthroscopy?",
        "answer": "yes",
        "answer_rationale": "After comparing MR with arthroscopic findings and reviewing the available literature, we conclude that arthroscopy permits the direct visualization of even fine articular surface changes but does not depict the subchondral bone, the most frequent site of injury detected with MRI. MRI was a very useful tool in the detection and characterization of the different types of occult bone and/or cartilage injuries and showed a statistically significant correlation between site and distribution of bone and cartilage injuries and between internal damage and trauma mechanisms. Therefore, we believe that MRI can help avoid diagnostic arthroscopy in the patients with a history of post-traumatic pain, acute articular blocks and negative radiographic findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "We investigated the actual role of MRI versus arthroscopy in the detection and characterization of occult bone and/or cartilage injuries in patients with previous musculoskeletal trauma of the knee, pain and severe functional impairment. Occult post-traumatic osteochondral injuries of the knee are trauma-related bone and/or cartilage damage missed at plain radiography.\nWe retrospectively selected 70 patients (men:women = 7:3; age range: 35 +/- 7 years) with a history of acute musculoskeletal trauma, negative conventional radiographs, pain and limited joint movements. All patients were submitted to conventional radiography, arthroscopy and MRI, the latter with 0.5 T units and T1-weighted SE. T2-weighted GE and FIR sequences with fat suppression.\nWe identified three types of occult post-traumatic injuries by morpho-topographic and signal intensity patterns: bone bruises (no. 25), subchondral (no. 33) and osteochondral (no. 35) injuries. Arthroscopy depicted 45 osteochondral and 19 chondral injuries. A bone bruise was defined as a typical subcortical area of signal loss, with various shapes, on T1-weighted images and",
        "q2": " of increased signal intensity on T2-weighted and FIR images. The cortical bone and articular cartilage were normal in all cases, while osteochondral injuries exhibited associated bone and cartilage damage with the same abnormal MR signal intensity. Sprain was the mechanism of injury in 52 cases, bruise in 12 and stress in 6. In 52 sprains (30 in valgus), the injury site was the lateral compartment in 92.3% of cases (100% in valgus), associated with meniscal damage in 73% of cases (90% in valgus) and with ligament injury in 90.4% (100% in valgus). In 12 bruises, the injury site was the lateral compartment in 58.3% of cases, the knee cap in 25% and the medial compartment in 16.7%; meniscal damage was associated in 25% of cases and ligament damage in 8.3%. In 6 stress injuries, the injury site was localized in the medial tibial condyle in 80% of cases, while meniscal and ligament tears were absent.\n\"Occult\" posttraumatic lesions of the knee: can magnetic resonance substitute for diagnostic arthroscopy?",
        "generated_text": "hyperintense on T2-weighted images. Subchondral injuries were characterized by a subcortical area of signal loss on T1-weighted images and hyperintense on T2-weighted images, with a well-defined subchondral fracture line. Osteochondral injuries were characterized by a subcortical area of signal loss on T1-weighted images and hyperintense on T2-weighted images, with a well-defined subchondral fracture line and a discontinuity of the articular cartilage.\nMRI was more sensitive than arthroscopy in detecting bone bruises (p < 0.001) and subchondral injuries (p < 0.001), while arthroscopy was more sensitive in detecting osteochondral injuries (p < 0.001). MRI had a higher specificity than arthroscopy in detecting bone bruises (p < 0.001) and subchondral injuries (p < 0.001), while arthroscopy had a higher specificity in detecting osteochondral injuries (p < 0.001). The positive predictive value of MRI was higher than that of arthroscopy in detecting",
        "levenshtein_distance": 777
    },
    {
        "realidx": "9483814",
        "question": "Uterus-specific synthetic Prostaglandin analogues (gemeprost, sulproston etc.) have been widely employed for termination of pregnancy in the second trimester. Since paracervical anaesthesia may be useful during this procedure, we investigated in this prospective randomised study its impact on the clinical course of abortion and pain especially in the late first and second stage of labour.\n20 women scheduled for elective abortion (fetal reasons) between the 16th and 23rd week of gestation were to be given 1 mg gemeprost vaginally every 6 hours. They were allocated at random: 10 women received only Pethidin intravenously and Butylscopolamine rectally, another 10 women were additionally treated by paracervical anaesthesia (2 x 10 ml 0.5% Bupivacain solution) at a cervical dilatation of 2-3 cm.\nA median of 3 gemeprost applications were administered in both groups. In the group without paracervical anaesthesia the median induction to abortion interval was 20 hours (range: 8-44 hours), 13 hours (range: 8-36 hours, NS) resulting for the paracervical anaesthesia group. The intervals from the last application of prostaglandin until abortion and from 3 cm cervical dilatation to abortion were slightly, but not significantly shorter in the paracervical anaesthesia group. The requirement of Butylscopolamine was higher in the latter group (p<0.05). The requirement of Pethidin and the intensity of pain (measured by pain scale according to Huskisson) especially in the late first stage of labour were not statistically different between both groups. Side effects of paracervical anaesthesia did not occur.\nDoes para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?",
        "answer": "yes",
        "answer_rationale": "Paracervical anaesthesia is a method for analgesia during second trimester abortion with a low rate of side effects. It can shorten the duration of last period of second trimester abortion in some cases but has no impact on the perception of pain nor requirement of analgesics and so with only limited benefit in second trimester abortion with vaginal gemeprost.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Uterus-specific synthetic Prostaglandin analogues (gemeprost, sulproston etc.) have been widely employed for termination of pregnancy in the second trimester. Since paracervical anaesthesia may be useful during this procedure, we investigated in this prospective randomised study its impact on the clinical course of abortion and pain especially in the late first and second stage of labour.\n20 women scheduled for elective abortion (fetal reasons) between the 16th and 23rd week of gestation were to be given 1 mg gemeprost vaginally every 6 hours. They were allocated at random: 10 women received only Pethidin intravenously and Butylscopolamine rectally, another 10 women were additionally treated by paracervical anaesthesia (2 x 10 ml 0.5% Bupivacain solution) at a cervical dilatation of 2-3 cm.\nA median of 3 gemeprost applications",
        "q2": " were administered in both groups. In the group without paracervical anaesthesia the median induction to abortion interval was 20 hours (range: 8-44 hours), 13 hours (range: 8-36 hours, NS) resulting for the paracervical anaesthesia group. The intervals from the last application of prostaglandin until abortion and from 3 cm cervical dilatation to abortion were slightly, but not significantly shorter in the paracervical anaesthesia group. The requirement of Butylscopolamine was higher in the latter group (p<0.05). The requirement of Pethidin and the intensity of pain (measured by pain scale according to Huskisson) especially in the late first stage of labour were not statistically different between both groups. Side effects of paracervical anaesthesia did not occur.\nDoes para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?",
        "generated_text": "was necessary to achieve complete abortion in both groups. The duration of the first and second stage of labour was similar in both groups. The pain score was significantly lower in the paracervical anaesthesia group (p < 0.05). The amount of blood loss was similar in both groups.\nParacervical anaesthesia is a useful adjunct to gemeprost-induced abortion in the second trimester. It reduces pain without prolonging the duration of labour.",
        "levenshtein_distance": 627
    },
    {
        "realidx": "9488747",
        "question": "Apparent life-threatening events in infants are a difficult and frequent problem in pediatric practice. The prognosis is uncertain because of risk of sudden infant death syndrome.\nEight infants aged 2 to 15 months were admitted during a period of 6 years; they suffered from similar maladies in the bath: on immersion, they became pale, hypotonic, still and unreactive; recovery took a few seconds after withdrawal from the bath and stimulation. Two diagnoses were initially considered: seizure or gastroesophageal reflux but this was doubtful. The hypothesis of an equivalent of aquagenic urticaria was then considered; as for patients with this disease, each infant's family contained members suffering from dermographism, maladies or eruption after exposure to water or sun. All six infants had dermographism. We found an increase in blood histamine levels after a trial bath in the two infants tested. The evolution of these \"aquagenic maladies\" was favourable after a few weeks without baths. After a 2-7 year follow-up, three out of seven infants continue to suffer from troubles associated with sun or water.\nSyncope during bathing in infants, a pediatric form of water-induced urticaria?",
        "answer": "yes",
        "answer_rationale": "\"Aquagenic maladies\" could be a pediatric form of the aquagenic urticaria.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "Apparent life-threatening events in infants are a difficult and frequent problem in pediatric practice. The prognosis is uncertain because of risk of sudden infant death syndrome.\nEight infants aged 2 to 15 months were admitted during a period of 6 years; they suffered from similar maladies in the bath: on immersion, they became pale, hypotonic, still and unreactive; recovery took a few seconds after withdrawal from the bath and stimulation. Two diagnoses were initially considered: seizure or gastroesophageal reflux but this was doubtful. The hypothesis of an equivalent of aquagenic urticaria was then",
        "q2": " considered; as for patients with this disease, each infant's family contained members suffering from dermographism, maladies or eruption after exposure to water or sun. All six infants had dermographism. We found an increase in blood histamine levels after a trial bath in the two infants tested. The evolution of these \"aquagenic maladies\" was favourable after a few weeks without baths. After a 2-7 year follow-up, three out of seven infants continue to suffer from troubles associated with sun or water.\nSyncope during bathing in infants, a pediatric form of water-induced urticaria?",
        "generated_text": "considered. The diagnosis was confirmed by skin tests with water and histamine release test. All the infants had a positive reaction to water and a normal histamine release test. The parents were advised to avoid baths and to use only sponging for hygiene. No further episode occurred during a follow-up of 1 to 5 years.\nAquagenic urticaria is a rare disease, which can be responsible for apparent life-threatening events in infants. The diagnosis should be considered in infants with similar symptoms.",
        "levenshtein_distance": 424
    },
    {
        "realidx": "9542484",
        "question": "To determine whether successful completion of the Perinatal Education Programme (PEP) improves obstetric practice.\nThe three midwife obstetric units (MOUs) in a health district of Mpumalanga were included in the study. Two MOUs enrolled in the PEP and the third did not. A 'before-and-after' study design was used to assess any changes in practice, and to monitor whether any changes occurred in the district during the time of the study; data were also collected at the third MOU. Data were collected by scoring of the obstetric files after the patient had delivered.\nWe ascertained whether the obstetric history, syphilis testing, blood group testing, haemoglobin measurement and uterine growth assessment were performed during antenatal care along with whether appropriate action was taken. For intrapartum care, estimation of fetal weight, the performance of pelvimetry, blood pressure monitoring, urine testing, evaluation of head above pelvis, fetal heart rate monitoring, monitoring of contractions and plotting of cervical dilatation, and whether the appropriate actions were taken, were assessed.\nEight of the 13 midwives at the two MOUs completed the PEP and all demonstrated an improvement in knowledge. Case notes of 303 patients from the various clinics were studied. There was no change in the referral patterns of any of the clinics during the study period. The obstetric history was well documented, but in no group was there a satisfactory response to a detected problem; appropriate action was taken in between 0% and 12% of cases. Syphilis testing was performed in 56-82% of cases, with no difference between the groups. The haemoglobin level was measured in only 4-15% of patients, with no difference before or after completion of the PEP. Where a problem in uterine growth was detected, an appropriate response occurred in 0-8% of patients and no difference before or after completion of the PEP was ascertained. In all groups, estimation of fetal weight and pelvimetry were seldom performed, the urine and fetal heart rate documentation were moderately well done and the blood pressure monitoring, assessment of head above pelvis, monitoring of contractions and plotting of cervical dilatation were usually performed. No differences before or after the PEP were detected. Where problems were detected, appropriate actions taken during labour improved, but not significantly.\nDoes successful completion of the Perinatal Education Programme result in improved obstetric practice?",
        "answer": "no",
        "answer_rationale": "Completion of the obstetric manual of the PEP improved the knowledge of the midwives but no alteration in practice was detected.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "To determine whether successful completion of the Perinatal Education Programme (PEP) improves obstetric practice.\nThe three midwife obstetric units (MOUs) in a health district of Mpumalanga were included in the study. Two MOUs enrolled in the PEP and the third did not. A 'before-and-after' study design was used to assess any changes in practice, and to monitor whether any changes occurred in the district during the time of the study; data were also collected at the third MOU. Data were collected by scoring of the obstetric files after the patient had delivered.\nWe ascertained whether the obstetric history, syphilis testing, blood group testing, haemoglobin measurement and uterine growth assessment were performed during antenatal care along with whether appropriate action was taken. For intrapartum care, estimation of fetal weight, the performance of pelvimetry, blood pressure monitoring, urine testing, evaluation of head above pelvis, fetal heart rate monitoring, monitoring of contractions and plotting of cervical dilatation, and whether the appropriate actions were taken, were assessed.\nEight of the 13 midwives at the two MOUs completed the PEP and all demonstrated an improvement in knowledge. Case notes of 303",
        "q2": " patients from the various clinics were studied. There was no change in the referral patterns of any of the clinics during the study period. The obstetric history was well documented, but in no group was there a satisfactory response to a detected problem; appropriate action was taken in between 0% and 12% of cases. Syphilis testing was performed in 56-82% of cases, with no difference between the groups. The haemoglobin level was measured in only 4-15% of patients, with no difference before or after completion of the PEP. Where a problem in uterine growth was detected, an appropriate response occurred in 0-8% of patients and no difference before or after completion of the PEP was ascertained. In all groups, estimation of fetal weight and pelvimetry were seldom performed, the urine and fetal heart rate documentation were moderately well done and the blood pressure monitoring, assessment of head above pelvis, monitoring of contractions and plotting of cervical dilatation were usually performed. No differences before or after the PEP were detected. Where problems were detected, appropriate actions taken during labour improved, but not significantly.\nDoes successful completion of the Perinatal Education Programme result in improved obstetric practice?",
        "generated_text": "women were scored. There was a significant improvement in the performance of the antenatal care components in the PEP MOUs, but not in the non-PEP MOU. For the intrapartum care components, there was a significant improvement in the PEP MOUs, but not in the non-PEP MOU.\nThe PEP improved the knowledge of the midwives and this was reflected in the improved obstetric practice.",
        "levenshtein_distance": 1004
    },
    {
        "realidx": "9582182",
        "question": "To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor.\nA prospective study of patients assessed with a neuropsychological test battery.\nA university medical center.\nNineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy.\nIncluded in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory.\nThe SCL 90-R Obsessive-Compulsive subscale was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001).\nDoes the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?",
        "answer": "yes",
        "answer_rationale": "Our data suggest that the SCL 90-R is best viewed as an indicator of unidimensional emotional distress and somatic effects of structural brain injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor.\nA prospective study of patients assessed with a neuropsychological test battery.\nA university medical center.\nNineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy.\nIncluded in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory.\nThe SCL 90-R Obsessive-Compulsive subscale",
        "q2": " was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001).\nDoes the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?",
        "generated_text": "was significantly correlated with the Mattis Dementia Rating Scale (r = -.58, p < .05), the California Verbal Learning Test (r = -.54, p < .05), and the Trail Making Test B (r = .54, p < .05). The Obsessive-Compulsive subscale was not significantly correlated with the Mood Assessment Scale, Beck Anxiety Inventory, or the Chronic Illness Problem Inventory.\nThe Obsessive-Compulsive subscale of the SCL 90-R may be a useful measure of cognitive functioning in patients with brain tumors.",
        "levenshtein_distance": 409
    },
    {
        "realidx": "9603166",
        "question": "Human immunodeficiency virus (HIV)-infected patients have generally been excluded from transplantation. Recent advances in the management and prognosis of these patients suggest that this policy should be reevaluated.\nTo explore the current views of U.S. transplant centers toward transplanting asymptomatic HIV-infected patients with end-stage renal disease, a written survey was mailed to the directors of transplantation at all 248 renal transplant centers in the United States.\nAll 148 responding centers said they require HIV testing of prospective kidney recipients, and 84% of these centers would not transplant an individual who refuses HIV testing. The vast majority of responding centers would not transplant a kidney from a cadaveric (88%) or a living donor (91%) into an asymptomatic HIV-infected patient who is otherwise a good candidate for transplantation. Among the few centers that would consider transplanting an HIV-infected patient, not a single center had performed such a transplant in the year prior to the survey. Most centers fear that transplantation in the face of HIV infection would be harmful to the individual, and some believe that it would be a waste of precious organs.\nShould all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation?",
        "answer": "no",
        "answer_rationale": "The great majority of U.S. renal transplant centers will not transplant kidneys to HIV-infected patients with end-stage renal disease, even if their infection is asymptomatic. However, advances in the management of HIV infection and a review of relevant ethical issues suggest that this approach should be reconsidered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "q1": "Human immunodeficiency virus (HIV)-infected patients have generally been excluded from transplantation. Recent advances in the management and prognosis of these patients suggest that this policy should be reevaluated.\nTo explore the current views of U.S. transplant centers toward transplanting asymptomatic HIV-infected patients with end-stage renal disease, a written survey was mailed to the directors of transplantation at all 248 renal transplant centers in the United States.\nAll 148 responding centers said they require HIV testing of prospective kidney recipients, and 84% of these centers would not transplant an individual who refuses HIV testing. The vast majority",
        "q2": " of responding centers would not transplant a kidney from a cadaveric (88%) or a living donor (91%) into an asymptomatic HIV-infected patient who is otherwise a good candidate for transplantation. Among the few centers that would consider transplanting an HIV-infected patient, not a single center had performed such a transplant in the year prior to the survey. Most centers fear that transplantation in the face of HIV infection would be harmful to the individual, and some believe that it would be a waste of precious organs.\nShould all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation?",
        "generated_text": "of centers (94%) would not transplant an asymptomatic HIV-infected patient with end-stage renal disease, and 80% would not transplant an asymptomatic HIV-infected live kidney donor. The most common reasons for not transplanting asymptomatic HIV-infected patients were the potential for increased morbidity and mortality (74%) and the lack of data on the long-term outcome of transplantation in these patients (62%). Only 10% of centers would consider transplanting an asymptomatic HIV-infected patient with end-stage renal disease, and 17% would consider transplanting an asymptomatic HIV",
        "levenshtein_distance": 434
    },
    {
        "realidx": "9616411",
        "question": "To assess whether populations with access to general practitioner hospitals (GP hospitals) utilise general hospitals less than populations without such access.\nObservational study comparing the total rates of admissions and of occupied bed days in general hospitals between populations with and without access to GP hospitals. Comparisons were also made separately for diagnoses commonly encountered in GP hospitals.\nTwo general hospitals serving the population of Finnmark county in north Norway.\n35,435 admissions based on five years' routine recordings from the two hospitals.\nThe total rate of admission to general hospitals was lower in peripheral municipalities with a GP hospital than in central municipalities without this kind of institution, 26% and 28% lower for men and women respectively. The corresponding differences were 38% and 52%, when analysed for occupied bed days. The differences were most pronounced for patients with respiratory diseases, cardiac failure, and cancer who are primarily or intermediately treated or cared for in GP hospitals, and for patients with stroke and fractures, who are regularly transferred from general hospitals to GP hospitals for longer term follow up care.\nDo general practitioner hospitals reduce the utilisation of general hospital beds?",
        "answer": "yes",
        "answer_rationale": "GP hospitals seem to reduce the utilisation of general hospitals with respect to admissions as well as occupied bed days.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To assess whether populations with access to general practitioner hospitals (GP hospitals) utilise general hospitals less than populations without such access.\nObservational study comparing the total rates of admissions and of occupied bed days in general hospitals between populations with and without access to GP hospitals. Comparisons were also made separately for diagnoses commonly encountered in GP hospitals.\nTwo general hospitals serving the population of Finnmark county in north Norway.\n35,435 admissions based on five years' routine recordings from the two hospitals.\nThe total rate of admission to general hospitals was lower in peripheral municipalities with a",
        "q2": " GP hospital than in central municipalities without this kind of institution, 26% and 28% lower for men and women respectively. The corresponding differences were 38% and 52%, when analysed for occupied bed days. The differences were most pronounced for patients with respiratory diseases, cardiac failure, and cancer who are primarily or intermediately treated or cared for in GP hospitals, and for patients with stroke and fractures, who are regularly transferred from general hospitals to GP hospitals for longer term follow up care.\nDo general practitioner hospitals reduce the utilisation of general hospital beds?",
        "generated_text": "GP hospital than in municipalities without such a hospital (rate ratio 0.82, 95% confidence interval 0.77 to 0.87). The difference was most pronounced for diagnoses commonly treated in GP hospitals. The total rate of occupied bed days was also lower in the municipalities with a GP hospital (rate ratio 0.87, 0.83 to 0.91). The difference was most pronounced for diagnoses commonly treated in GP hospitals.\nThe results suggest that the establishment of GP hospitals may reduce",
        "levenshtein_distance": 408
    },
    {
        "realidx": "9722752",
        "question": "To evaluate the outcome of a new modification of percutaneous needle suspension, using a bone anchor system for fixing the suture at the public bone, and to compare the results with those published previously.\nFrom March 1996, 37 patients with stress urinary incontinence (>2 years) were treated using a bone anchor system. On each side the suture was attached to the pubocervical fascia and the vaginal wall via a broad 'Z'-stitch. A urodynamic investigation performed preoperatively in all patients confirmed stress incontinence and excluded detrusor instability. The outcome was assessed by either by a clinical follow-up investigation or using a standardized questionnaire, over a mean follow-up of 11 months (range 6-18).\nIn the 37 patients, the procedure was successful in 25 (68%), with 16 (43%) of the patients completely dry and nine (24%) significantly improved. Removal of the bone anchor and suture was necessary in two patients, because of unilateral bacterial infection in one and a bilateral soft tissue granuloma in the other. One bone anchor became dislocated in a third patient. In two cases where the treatment failed, new detrusor instability was documented urodynamically. Minor complications were prolonged wound pain in 10 (26%) and transient urinary retention or residual urine in 12 patients (32%).\nDoes bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence?",
        "answer": "yes",
        "answer_rationale": "The poor success rate in the study corresponds with the long-term results of conventional or modified needle suspension procedures and does not reinforce the optimistic results of bone anchoring published recently. Because of the poorer long-term results from percutaneous needle suspension than from other techniques of open retropubic bladder neck suspension, it remains questionable whether percutaneous needle suspension should be considered a first-line procedure for the treatment of female stress urinary incontinence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "To evaluate the outcome of a new modification of percutaneous needle suspension, using a bone anchor system for fixing the suture at the public bone, and to compare the results with those published previously.\nFrom March 1996, 37 patients with stress urinary incontinence (>2 years) were treated using a bone anchor system. On each side the suture was attached to the pubocervical fascia and the vaginal wall via a broad 'Z'-stitch. A urodynamic investigation performed preoperatively in all patients confirmed stress incontinence and excluded detrusor instability. The outcome was assessed by either by a clinical follow-up investigation or using a standardized questionnaire, over a mean follow-up of 11 months (range 6",
        "q2": "-18).\nIn the 37 patients, the procedure was successful in 25 (68%), with 16 (43%) of the patients completely dry and nine (24%) significantly improved. Removal of the bone anchor and suture was necessary in two patients, because of unilateral bacterial infection in one and a bilateral soft tissue granuloma in the other. One bone anchor became dislocated in a third patient. In two cases where the treatment failed, new detrusor instability was documented urodynamically. Minor complications were prolonged wound pain in 10 (26%) and transient urinary retention or residual urine in 12 patients (32%).\nDoes bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence?",
        "generated_text": "-24 months). The results were compared with those of 30 patients treated with the same technique but using a different fixation method (suture tied to the pubic bone).\nIn the bone anchor group, 32 patients (86%) were cured, 3 (8%) improved and 2 (5%) had no improvement. In the control group, 24 patients (80%) were cured, 4 (13%) improved and 2 (7%) had no improvement. The difference between the two groups was not statistically significant (p=0.5). The mean operative time was 45 minutes in the bone anchor group and 55 minutes in the control group (p=0.",
        "levenshtein_distance": 531
    },
    {
        "realidx": "9920954",
        "question": "\"America's Best Hospitals,\" an influential list published annually by U.S. News and World Report, assesses the quality of hospitals. It is not known whether patients admitted to hospitals ranked at the top in cardiology have lower short-term mortality from acute myocardial infarction than those admitted to other hospitals or whether differences in mortality are explained by differential use of recommended therapies.\nUsing data from the Cooperative Cardiovascular Project on 149,177 elderly Medicare beneficiaries with acute myocardial infarction in 1994 or 1995, we examined the care and outcomes of patients admitted to three types of hospitals: those ranked high in cardiology (top-ranked hospitals); hospitals not in the top rank that had on-site facilities for cardiac catheterization, coronary angioplasty, and bypass surgery (similarly equipped hospitals); and the remaining hospitals (non-similarly equipped hospitals). We compared 30-day mortality; the rates of use of aspirin, beta-blockers, and reperfusion; and the relation of differences in rates of therapy to short-term mortality.\nAdmission to a top-ranked hospital was associated with lower adjusted 30-day mortality (odds ratio, 0.87; 95 percent confidence interval, 0.76 to 1.00; P=0.05 for top-ranked hospitals vs. the others). Among patients without contraindications to therapy, top-ranked hospitals had significantly higher rates of use of aspirin (96.2 percent, as compared with 88.6 percent for similarly equipped hospitals and 83.4 percent for non-similarly equipped hospitals; P<0.01) and beta-blockers (75.0 percent vs. 61.8 percent and 58.7 percent, P<0.01), but lower rates of reperfusion therapy (61.0 percent vs. 70.7 percent and 65.6 percent, P=0.03). The survival advantage associated with admission to top-ranked hospitals was less strong after we adjusted for factors including the use of aspirin and beta-blockers (odds ratio, 0.94; 95 percent confidence interval, 0.82 to 1.08; P=0.38).\nDo \"America's Best Hospitals\" perform better for acute myocardial infarction?",
        "answer": "yes",
        "answer_rationale": "Admission to a hospital ranked high on the list of \"America's Best Hospitals\" was associated with lower 30-day mortality among elderly patients with acute myocardial infarction. A substantial portion of the survival advantage may be associated with these hospitals' higher rates of use of aspirin and beta-blocker therapy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "q1": "\"America's Best Hospitals,\" an influential list published annually by U.S. News and World Report, assesses the quality of hospitals. It is not known whether patients admitted to hospitals ranked at the top in cardiology have lower short-term mortality from acute myocardial infarction than those admitted to other hospitals or whether differences in mortality are explained by differential use of recommended therapies.\nUsing data from the Cooperative Cardiovascular Project on 149,177 elderly Medicare beneficiaries with acute myocardial infarction in 1994 or 1995, we examined the care and outcomes of patients admitted to three types of hospitals: those ranked high in cardiology (top-ranked hospitals); hospitals not in the top rank that had on-site facilities for cardiac catheterization, coronary angioplasty, and bypass surgery (similarly equipped hospitals); and the remaining hospitals (non-similarly equipped hospitals). We compared 30-day mortality; the rates of use of aspirin, beta-blockers, and reperfusion; and the relation of differences in rates of therapy to short-term mortality.\nAdmission to a top-ranked hospital was associated with lower adjusted 30-day mortality (odds ratio, ",
        "q2": "0.87; 95 percent confidence interval, 0.76 to 1.00; P=0.05 for top-ranked hospitals vs. the others). Among patients without contraindications to therapy, top-ranked hospitals had significantly higher rates of use of aspirin (96.2 percent, as compared with 88.6 percent for similarly equipped hospitals and 83.4 percent for non-similarly equipped hospitals; P<0.01) and beta-blockers (75.0 percent vs. 61.8 percent and 58.7 percent, P<0.01), but lower rates of reperfusion therapy (61.0 percent vs. 70.7 percent and 65.6 percent, P=0.03). The survival advantage associated with admission to top-ranked hospitals was less strong after we adjusted for factors including the use of aspirin and beta-blockers (odds ratio, 0.94; 95 percent confidence interval, 0.82 to 1.08; P=0.38).\nDo \"America's Best Hospitals\" perform better for acute myocardial infarction?",
        "generated_text": "0.87; 95 percent confidence interval, 0.79 to 0.96) than admission to a similarly equipped hospital. The adjusted 30-day mortality was 12.1 percent in top-ranked hospitals, 12.9 percent in similarly equipped hospitals, and 14.1 percent in non-similarly equipped hospitals. The adjusted odds ratio for 30-day mortality in top-ranked hospitals, as compared with similarly equipped hospitals, was 0.87 (95 percent confidence interval, 0.79 to 0.96). The adjusted odds ratio for 30-day mortality in top-ranked hospitals, as compared with non-similarly equipped hospitals, was 0.81 (95 percent confidence interval, 0.73 to 0.90). The adjusted odds ratio for 30-day mortality in similarly equipped hospitals, as compared with non-similarly equipped hospitals, was 0.88 (95 percent confidence interval, 0.80 to 0.97). The",
        "levenshtein_distance": 588
    }
]